Citrus Sinensis ID: 015965

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------
Protein Sequence
MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH
Secondary Structure (PSIPRED)
cEEEEEEcccccccHHHHHHHHHHHcccccccccccccccccEEEEEEcccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEcccccccccEEEccccccEEEEEEcccccEEEEEccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEccccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccccEEEccccccccccccccccHHHHHccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHcccHHHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEccccHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEcccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEcHHHEEEEEEEEcccccEEEEEEEcccEEEEEEEEcccccccccccHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHHccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccHcccccHHHHHHHHHHHHHcccccccccccccccccccHHcccccc
Coil and Loop (DISEMBL)
mheitfstddkpKLLSQLTALLADIGLNIqeahafstvdgysldvfvvdgwpyeETEQLRAALEKEVLKLErqgwpshrsssptsepedtgmkshpyhlkipndgtdvweidpkhlkfgskvasgsygdlyrgtycsqdvaikvlkperinsdMQKEFAQEVFIMRKVRHKNVVQFIgactkppslcivtefmsggsvYDYLHKLKGVFKLPSLLKVAIDVSkgmnylhqnnIIHRDLKAANLLMDENEVVKVADFGVARVKAqsgvmtaetgtyrwmapeviehkpydhkadvFSFGIVLWELLtgklpyeyltPLQAAVGVVqkglrptipknsqPKLAELLERCwqqdpalrpdFSEIIEILQQIAKEVGEENEerrkekssggflSVLRRGHH
Flexible Loop (DISEMBL)
mheitfstddkpklLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLerqgwpshrsssptsepedtgmkSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLkperinsdMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVArvkaqsgvmtaetgtyrWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEvgeeneerrkekssggflsvlrrghh
Low Complexity Region (SEG)
MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKevgeeneerrkekssgGFLSVLRRGHH
Disordered region (IsUnstruct)
*************LLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALE**V*******************************LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI*******LAELLERCWQQDPALRPDFSEIIEILQQIA****************************
Disordered Region (DISOPRED)
MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW*******************************************************DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG**TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL*************************VL*****
Disordered Region (DISEMBL)
**********KPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLE**********************SHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE***************GFLSVLRRGHH
Disordered Region (DISPRO)
MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTS******MKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV*************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPxxxxxxxxxxxxxxxxxxxxxGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIxxxxxxxxxxxxxxxxxxxxxKSSGGFLSVLRRGHH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	397	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.670	0.682	0.450	2e-70
Q55GU0	916	Probable serine/threonine	yes	no	0.652	0.282	0.442	2e-64
Q54H46	642	Probable serine/threonine	no	no	0.692	0.428	0.423	1e-60
Q05609	821	Serine/threonine-protein	no	no	0.725	0.350	0.403	2e-59
Q54H45	690	Probable serine/threonine	no	no	0.657	0.378	0.426	4e-59
Q9FPR3	933	Serine/threonine-protein	no	no	0.677	0.288	0.419	2e-57
Q54TM7	1288	Probable serine/threonine	no	no	0.675	0.208	0.411	1e-55
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.695	0.166	0.399	6e-55
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.667	0.163	0.407	6e-55
Q54TA1	749	Probable serine/threonine	no	no	0.654	0.347	0.407	9e-52

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  266 bits (680), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 122/271 (45%), Positives = 183/271 (67%), Gaps = 5/271 (1%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK----PERINSDMQKEFAQEVFI 164
           W  D   L  G+K ASG++  +YRG Y  + VA+K+++     E   + ++++F  EV +
Sbjct: 79  WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSK 223
           + ++ H N+VQFI AC KPP  CI+TE+MS G++  YL+K +     + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 283
           GM YLH   +IHRDLK+ NLL+++   VKVADFG + ++ Q        GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
           + KPY  K DV+SFGIVLWEL T  LP++ +TP+QAA  V +K  RP +P + QP LA L
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHL 318

Query: 344 LERCWQQDPALRPDFSEIIEILQQIAKEVGE 374
           ++RCW ++P+ RPDFS I+ +L++  + V E
Sbjct: 319 IKRCWSENPSKRPDFSNIVAVLEKYDECVKE 349

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  246 bits (629), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 115/260 (44%), Positives = 175/260 (67%), Gaps = 1/260 (0%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKV 168
           EI    LK  SK+  G++G +Y+G +    VAIK +K  E +N+ + +EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           RH N+V  + ACT PP+LC +TE++ GGS+YD LH  K    +    K+AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           H + +IHRD+K+ NLL+DE+  VK+ DFG++++K++S  MT   G+  WM+PE++  + Y
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDY 835

Query: 289 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
             K DV++FGI+LWEL TG+LPY  L  +Q A+ V  K LRP IP     +L+ L++ CW
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACW 895

Query: 349 QQDPALRPDFSEIIEILQQI 368
            QDP  RP F+EI+ +L +I
Sbjct: 896 HQDPLKRPSFTEILNLLNEI 915

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  233 bits (595), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 119/281 (42%), Positives = 175/281 (62%), Gaps = 6/281 (2%)

Query: 93  KSHPYHLKIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER 149
           +S  Y+    ND T   D  +ID   +K G ++  G+YG++Y GT+    VA+K L    
Sbjct: 348 RSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN 407

Query: 150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 209
           IN ++ KEF +E+ +M+ +RH NV+QF+G+C  PP +CI TE+M  GS+Y  LH      
Sbjct: 408 INENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQL 467

Query: 210 KLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
           +   L+K+ ID +KG+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   
Sbjct: 468 QWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGAT 527

Query: 268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 327
           MTA  GT  W +PEV+  + Y  KADV+SFGI+LWE  T + PY  + P Q    V ++G
Sbjct: 528 MTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREG 586

Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           +RP +P+N  PK  +LL  C  ++P+ RP   + +E L+ I
Sbjct: 587 MRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  230 bits (586), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 187/302 (61%), Gaps = 14/302 (4%)

Query: 84  TSEPEDTGMKSHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           +++ E   M + P    +PN        DG D+ +I    L    K+ +GS+G ++R  +
Sbjct: 512 SNQIEAAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEW 570

Query: 136 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 195
              DVA+K+L  +  +++   EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S 
Sbjct: 571 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 630

Query: 196 GSVYDYLHKLKGVFKLPSL--LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV 251
           GS+Y  LHK     +L     L +A DV+KGMNYLH  N  I+HRDLK+ NLL+D+   V
Sbjct: 631 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTV 690

Query: 252 KVADFGVARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
           KV DFG++R+KA + + + +  GT  WMAPEV+  +P + K+DV+SFG++LWEL T + P
Sbjct: 691 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 750

Query: 311 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           +  L P Q    V  K  R  IP+N  P++A ++E CW  +P  RP F+ I+++L+ + K
Sbjct: 751 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810

Query: 371 EV 372
             
Sbjct: 811 SA 812

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  228 bits (582), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 114/267 (42%), Positives = 168/267 (62%), Gaps = 6/267 (2%)

Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           DG D   ID + +K G ++  G++G++Y GT+    VA+K L    IN ++ KEF +E+ 
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +M+ +RH NV+QF+G+C   P +CI TE+M  GS+Y  LH  K       + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498

Query: 224 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           V+  + Y  KADV+SFGI+LWE  T + PY  + P Q    V ++G+RP  PK   PK  
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617

Query: 342 ELLERCWQQDPALRPDFSEIIEILQQI 368
           +LL+ C  ++P+ RP   + +EIL+ I
Sbjct: 618 QLLKDCLNENPSQRPTMEQCLEILESI 644

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  223 bits (568), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 115/274 (41%), Positives = 167/274 (60%), Gaps = 5/274 (1%)

Query: 104 DGTDV--WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 161
           D  DV   EI    L    ++  GSYG++Y   +   +VA+K    +  +     EF  E
Sbjct: 655 DDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSE 714

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V IMR++RH NVV F+GA T+PP+L IVTEF+  GS+Y  LH+ K        +K+A+DV
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774

Query: 222 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-GTYRWM 278
           + GMN LH +   I+HRDLK  NLL+D N  VKV DFG++R+K  + + +  T GT  WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           APEV+ ++P + K DV+SFG++LWEL T +LP+  + P+Q    V  +  R  IPK   P
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 372
            +  ++  CWQ DP LRP F+++ E+L+ + + V
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLV 928

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  217 bits (552), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 112/272 (41%), Positives = 167/272 (61%), Gaps = 4/272 (1%)

Query: 109  WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
            WE+    +  G+++  G YG ++RG++   +VA+K+L  + +N  +  +  +EV ++ K+
Sbjct: 844  WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903

Query: 169  RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            RH N+V F+GACT+P S CIVTE++S GS+ + L            L++  D ++GM YL
Sbjct: 904  RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963

Query: 229  HQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
            H  N  IIHRDLK  NLL+D++  VKVADFG+A VK+ +   T   GT  W+APEV+  +
Sbjct: 964  HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022

Query: 287  PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
             Y  KADV+S+ IVLWELLT  +PY     +Q  V  + +G R  +P    PK A L+ R
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ-VVRSIDRGERLPMPAWCPPKYAALMNR 1081

Query: 347  CWQQDPALRPDFSEIIEILQQIAKEVGEENEE 378
            CW+ DP  RP F EI+ I++ +  E  +E +E
Sbjct: 1082 CWETDPTHRPSFPEILPIMEGMISEFQKEKKE 1113

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  215 bits (547), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 115/288 (39%), Positives = 178/288 (61%), Gaps = 12/288 (4%)

Query: 97   YHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER-INSDMQ 155
            + L+     +D WEID   L+ G ++ +G++G++++GT+   +VA+K++ P++ I  D++
Sbjct: 767  FSLRFRKGISDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIE 826

Query: 156  KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
            + F  EV +M  +RH NVV F+ A TKPP +CIV EFM+ GS++D L K + +  +P  L
Sbjct: 827  RNFKDEVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFAL 885

Query: 216  KVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-- 271
            KV I    SKGM++LH + I HRDLK+ NLL+D    VKV+DFG+ + K+    +  E  
Sbjct: 886  KVKIAYQASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKF 945

Query: 272  TGTYRWMAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
             GT +W APE++ E +  D+  +DV+SFGI++WEL+T   PY  ++P   AV V++   R
Sbjct: 946  AGTIQWTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYR 1005

Query: 330  PTIPKNSQ----PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 373
            P I    +    P+  ELL  CW  DP +RP F EI+  L  +  + G
Sbjct: 1006 PVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMGDSG 1053

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  215 bits (547), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 113/277 (40%), Positives = 173/277 (62%), Gaps = 12/277 (4%)

Query: 103  NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 162
            N   + WEID   L+ G  + +G YG++Y+  +   +VA+K++  + ++ DM++ F +EV
Sbjct: 773  NTTNNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEV 832

Query: 163  FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AID 220
             IM  +RH NVV F+ A TK P++CIV EFMS GS+YD L   + + ++P  LK+  A  
Sbjct: 833  KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGN-ELIPEIPYALKIKMAYQ 891

Query: 221  VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE---TGTYRW 277
             SKGM++LH + I+HRDLK+ NLL+D    VKV+DFG+ +VK++           GT  W
Sbjct: 892  ASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHW 951

Query: 278  MAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
            +APE++ +    D+  ADV+SFGI+LWELLT + PY+ +TP   AV V++ G+RP I   
Sbjct: 952  IAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPPISDE 1011

Query: 336  S----QPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +      +  +L+++CW  D  +RP F EI+  L  I
Sbjct: 1012 AVTAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRLSNI 1048

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  204 bits (519), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 110/270 (40%), Positives = 158/270 (58%), Gaps = 10/270 (3%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD---MQKEFAQEVF 163
           ++  ID   +   +++  GS  +++ GT+    VAIK  K + +N D      E AQE  
Sbjct: 482 EIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIK--KAKLLNEDDEDFLNELAQEAT 539

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           IM ++RH N+ QF+G C  PP + IV E+M  GS+Y  LH        P +  +A+D++K
Sbjct: 540 IMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAK 599

Query: 224 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAET--GTYRWM 278
           GMNYLH  +  +IHRDLK+ NLL+DE+  VK++DFG++ R K      TA T  GT  W 
Sbjct: 600 GMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWT 659

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           APEV+ + PY  KADVFSF IVLWE++T + PY+ +   Q  + V Q  LRP +P     
Sbjct: 660 APEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSA 719

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQI 368
               L+  CW +DP  RP F EI++ L+ +
Sbjct: 720 PFTRLITECWSEDPQQRPSFQEIVKRLEAM 749

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	397
297744550	580	unnamed protein product [Vitis vinifera]	0.997	0.682	0.884	0.0
359474826	1515	PREDICTED: uncharacterized mscS family p	0.994	0.260	0.881	0.0
449454245	573	PREDICTED: protein-tyrosine kinase 2-bet	0.994	0.689	0.851	0.0
255560441	558	protein kinase, putative [Ricinus commun	0.952	0.677	0.853	0.0
224080668	494	predicted protein [Populus trichocarpa]	0.977	0.785	0.854	0.0
283132359	578	ACT-domain-containing protein kinase [Lo	0.997	0.685	0.816	0.0
224286063	594	unknown [Picea sitchensis]	0.992	0.663	0.815	0.0
356574129	581	PREDICTED: uncharacterized protein LOC10	0.989	0.676	0.809	0.0
224103451	370	predicted protein [Populus trichocarpa]	0.929	0.997	0.827	0.0
378750734	547	serine threonine protein kinase [Piper c	0.997	0.723	0.788	0.0

>gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera]

 Score =  732 bits (1889), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/397 (88%), Positives = 373/397 (93%), Gaps = 1/397 (0%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFS+DDKPKLLSQLT LL+++ LNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR
Sbjct: 185 MHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 244

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            ALEKEV K+E+Q WP+H S SPT E E+TG+K     + IPNDGTDVWEID + LKF +
Sbjct: 245 TALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQLKFEN 304

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC
Sbjct: 305 KVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 364

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           T+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+LLKV+IDVSKGMNYLHQNNIIHRDLKA
Sbjct: 365 TRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIHRDLKA 424

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV
Sbjct: 425 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 484

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGKLPYEYLTPLQAAVGVVQKGLRPT+PKN+ PKLAELLERCWQQDP LRPDFSE
Sbjct: 485 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTMPKNTHPKLAELLERCWQQDPTLRPDFSE 544

Query: 361 IIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 397
           IIEILQQIAKEVG+E E+RRKEKSS GFLSVLRRGHH
Sbjct: 545 IIEILQQIAKEVGDE-EDRRKEKSSSGFLSVLRRGHH 580

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera]

 Score =  727 bits (1876), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/396 (88%), Positives = 372/396 (93%), Gaps = 1/396 (0%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFS+DDKPKLLSQLT LL+++ LNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR
Sbjct: 211 MHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 270

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            ALEKEV K+E+Q WP+H S SPT E E+TG+K     + IPNDGTDVWEID + LKF +
Sbjct: 271 TALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQLKFEN 330

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC
Sbjct: 331 KVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 390

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           T+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+LLKV+IDVSKGMNYLHQNNIIHRDLKA
Sbjct: 391 TRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIHRDLKA 450

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV
Sbjct: 451 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 510

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGKLPYEYLTPLQAAVGVVQKGLRPT+PKN+ PKLAELLERCWQQDP LRPDFSE
Sbjct: 511 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTMPKNTHPKLAELLERCWQQDPTLRPDFSE 570

Query: 361 IIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGH 396
           IIEILQQIAKEVG+E E+RRKEKSS GFLSVLRRG+
Sbjct: 571 IIEILQQIAKEVGDE-EDRRKEKSSSGFLSVLRRGY 605

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus]

 Score =  707 bits (1824), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/397 (85%), Positives = 366/397 (92%), Gaps = 2/397 (0%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE+L+
Sbjct: 179 MHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETERLK 238

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            ALE EVL +ER+GWP+ +SSSP  E + T  K     ++IP DGTDVWEI+P+HLKF  
Sbjct: 239 TALESEVLLVERRGWPNQKSSSPVGELDITA-KCESDRVEIPTDGTDVWEINPRHLKFEH 297

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLY+GTYCSQ+VAIKVLK ER+N+DMQ EFAQEV+IMRKVRHKNVVQFIGAC
Sbjct: 298 KVASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVYIMRKVRHKNVVQFIGAC 357

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           TKPPSLCIVTEFMSGGSVYDYLHK KG F+LPSLLKVAIDVSKGMNYLHQNNIIHRDLKA
Sbjct: 358 TKPPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 417

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV
Sbjct: 418 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 477

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGKLPYE+LTPLQAAVGVVQKGLRPT+PK++ PKLA+LLE+CWQQDP+ RPDF E
Sbjct: 478 LWELLTGKLPYEFLTPLQAAVGVVQKGLRPTMPKHTNPKLADLLEKCWQQDPSCRPDFCE 537

Query: 361 IIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 397
           II+IL QI KEV EE E+RRKEK SGGFLSVLRR HH
Sbjct: 538 IIDILLQITKEVAEEGEDRRKEK-SGGFLSVLRRNHH 573

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis]

 Score =  694 bits (1790), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/397 (85%), Positives = 360/397 (90%), Gaps = 19/397 (4%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGWPYE      
Sbjct: 180 MHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE------ 233

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
                      +  WP+  S SP+SE + T +K  P H+ IPNDGTDVWEIDPK+LKF +
Sbjct: 234 -----------KHTWPT-LSLSPSSEHKQTKIKCDPDHVTIPNDGTDVWEIDPKNLKFEN 281

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLY+GTYCSQ+VAIK+LKPERINSD++KEFAQEVFIMRKVRHKNVVQFIGAC
Sbjct: 282 KVASGSYGDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMRKVRHKNVVQFIGAC 341

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           TKPPSLCIVTEFMSGGSVYDYLHK KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA
Sbjct: 342 TKPPSLCIVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 401

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKAD+FSF IV
Sbjct: 402 ANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADIFSFAIV 461

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK++ PKLAELLE+CWQQDPALRPDFSE
Sbjct: 462 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKHTHPKLAELLEKCWQQDPALRPDFSE 521

Query: 361 IIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 397
           IIE+LQQI KEVGEE  E RKEKSSGGFLSVLRRGHH
Sbjct: 522 IIEMLQQIVKEVGEEG-EGRKEKSSGGFLSVLRRGHH 557

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224080668|ref|XP_002306203.1| predicted protein [Populus trichocarpa] gi|222849167|gb|EEE86714.1| predicted protein [Populus trichocarpa]

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/398 (85%), Positives = 362/398 (90%), Gaps = 10/398 (2%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFSTDDKPKLLSQLT+L+ADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR
Sbjct: 102 MHEITFSTDDKPKLLSQLTSLVADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 161

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTG----MKSHPYHLKIPNDGTDVWEIDPKHL 116
            AL KEV K+E        S  P S    TG    +K    H+ IPNDGTDVWEIDPK+L
Sbjct: 162 DALAKEVSKIE-----EFNSGIPISNSYSTGNGQEIKCDTNHVAIPNDGTDVWEIDPKYL 216

Query: 117 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           KF +KVASGSYGDLY+GTYCSQ+VAIK+LKPER+NSD+QKEFAQEV+IMRKVRHKNVVQF
Sbjct: 217 KFENKVASGSYGDLYKGTYCSQEVAIKILKPERVNSDLQKEFAQEVYIMRKVRHKNVVQF 276

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IGACTKPPSLCIVTEFM GGSVYDYLHK +GVFKLP+LLKVAIDVSKGM+YLHQNNIIHR
Sbjct: 277 IGACTKPPSLCIVTEFMHGGSVYDYLHKQRGVFKLPNLLKVAIDVSKGMDYLHQNNIIHR 336

Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           DLK ANLLMDENEVVKVADFGVARVKAQ+G+MTAETGTYRWMAPEVIEHKPYDHKADVFS
Sbjct: 337 DLKGANLLMDENEVVKVADFGVARVKAQTGIMTAETGTYRWMAPEVIEHKPYDHKADVFS 396

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 356
           FGIVLWELLTGK+PYEYLTPLQAAVGVVQKGLRPTIPKN+QPKLAELLE+CWQQDPALRP
Sbjct: 397 FGIVLWELLTGKIPYEYLTPLQAAVGVVQKGLRPTIPKNTQPKLAELLEKCWQQDPALRP 456

Query: 357 DFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRR 394
           DFSEIIEILQQIAKEVG+   E RKEKSSG FLSVLRR
Sbjct: 457 DFSEIIEILQQIAKEVGDCG-EWRKEKSSGRFLSVLRR 493

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus]

 Score =  687 bits (1773), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/397 (81%), Positives = 359/397 (90%), Gaps = 1/397 (0%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFST+DKPKLLSQLTALLA+IGLNIQEAHAFST DGYSLDVFVVDGWPYEETE+L+
Sbjct: 183 MHEITFSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYSLDVFVVDGWPYEETEKLK 242

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            ALEKE+LK+ERQ   + +S S   EP+   MK    HL IPNDGTDVWEID KHL +G+
Sbjct: 243 VALEKEILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIPNDGTDVWEIDAKHLTYGN 302

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           ++ASGSYG+L++GTYCSQ+VAIKVLK E +N++MQ+EF QEV+IMRKVRHKNVVQFIGAC
Sbjct: 303 QIASGSYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEVYIMRKVRHKNVVQFIGAC 362

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           TKPP LCI+TEFMSGGSVYDYLHK KG FK PSLLKVAIDVSKGMNYLHQ+NIIHRDLK 
Sbjct: 363 TKPPRLCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVSKGMNYLHQHNIIHRDLKG 422

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLLMDEN VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG+V
Sbjct: 423 ANLLMDENGVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGVV 482

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGKLPYEYLTPLQAA+GVVQKGLRPTIPKN+ PK  ELLER WQQD  LRPDFSE
Sbjct: 483 LWELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPKFVELLERSWQQDSTLRPDFSE 542

Query: 361 IIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 397
           II+ILQ++AKEVG++ E+RR++K SGGFLS LRRGHH
Sbjct: 543 IIDILQKLAKEVGDDGEDRRRDK-SGGFLSALRRGHH 578

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224286063|gb|ACN40743.1| unknown [Picea sitchensis]

 Score =  665 bits (1716), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/395 (81%), Positives = 348/395 (88%), Gaps = 1/395 (0%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFS+DDKPKLLSQLT+LLAD+GLNIQEAHAFST DGYSLDVFVVDGWP EE EQLR
Sbjct: 195 MHEITFSSDDKPKLLSQLTSLLADLGLNIQEAHAFSTTDGYSLDVFVVDGWPLEEMEQLR 254

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            ALE E+   E+  W     SS   E    G  S+   ++IPNDGTD WEID K LKF  
Sbjct: 255 QALESEIANTEKTTWSKPSPSSSPIEQMAVGSGSNVECVRIPNDGTDDWEIDSKFLKFDY 314

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLYRGTYC QDVAIKVLK ER+++D+Q+EFAQEVFIMRKVRHKNVVQFIGAC
Sbjct: 315 KVASGSYGDLYRGTYCGQDVAIKVLKSERLDADLQREFAQEVFIMRKVRHKNVVQFIGAC 374

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           T+PP+LCIVTEFMSGGSVYDYLHK KGVFKLP+LLKVAIDVS+GM+YLHQNNIIHRDLKA
Sbjct: 375 TRPPNLCIVTEFMSGGSVYDYLHKQKGVFKLPALLKVAIDVSRGMDYLHQNNIIHRDLKA 434

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLLMDENEVVKVADFGVARV+AQSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIV
Sbjct: 435 ANLLMDENEVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIV 494

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGKLPY+YLTPLQAAVGVVQKGLRPTIPKN+ P+LA+LLERCWQQDP LRPDFSE
Sbjct: 495 LWELLTGKLPYDYLTPLQAAVGVVQKGLRPTIPKNTHPRLADLLERCWQQDPTLRPDFSE 554

Query: 361 IIEILQQIAKEVGEENE-ERRKEKSSGGFLSVLRR 394
           + EILQQ  KE G+E E ERRK+KSSGGF S  RR
Sbjct: 555 MTEILQQTLKEAGDEGENERRKDKSSGGFFSAFRR 589

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574129|ref|XP_003555204.1| PREDICTED: uncharacterized protein LOC100804170 [Glycine max]

 Score =  662 bits (1708), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/398 (80%), Positives = 357/398 (89%), Gaps = 5/398 (1%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEIT STDDKPKLLSQLTALL++IGLNIQEAHAFST DG+SLDVFVV+GWP+EETE+L+
Sbjct: 188 MHEITISTDDKPKLLSQLTALLSEIGLNIQEAHAFSTTDGFSLDVFVVEGWPHEETEKLK 247

Query: 61  AALEKEVLK-LERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFG 119
           AALE+ VLK +E +  P  +S S   +P+   MKS   +L IP DGTDVWEIDPKHLK+G
Sbjct: 248 AALERGVLKKIEVKSSP--QSVSSVDKPDQAKMKSELDYLTIPTDGTDVWEIDPKHLKYG 305

Query: 120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +++ASGSYG+L++G YCSQ+VAIKVLK + +NS++Q+EFAQEV+IMRKVRHKNVVQFIGA
Sbjct: 306 TQIASGSYGELFKGVYCSQEVAIKVLKADHVNSELQREFAQEVYIMRKVRHKNVVQFIGA 365

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
           CTKPP LCIVTEFMSGGSVYDYLHK KG FK P+LLKVAIDVSKGMNYLHQ+NIIHRDLK
Sbjct: 366 CTKPPGLCIVTEFMSGGSVYDYLHKQKGFFKFPTLLKVAIDVSKGMNYLHQHNIIHRDLK 425

Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 299
           AANLLMDEN  VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI
Sbjct: 426 AANLLMDENCTVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 485

Query: 300 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
           VLWELLTGKLPYEYLTPLQAA+GVVQKGLRPTIPKN+ PK  ELLER WQQDP LRPDFS
Sbjct: 486 VLWELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPKYVELLERSWQQDPTLRPDFS 545

Query: 360 EIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 397
           EIIEILQQ+AKEVG + EER K+K  GG LSVLRRGHH
Sbjct: 546 EIIEILQQLAKEVG-DGEERHKDK-YGGLLSVLRRGHH 581

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103451|ref|XP_002334052.1| predicted protein [Populus trichocarpa] gi|222839744|gb|EEE78067.1| predicted protein [Populus trichocarpa]

 Score =  657 bits (1696), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/394 (82%), Positives = 349/394 (88%), Gaps = 25/394 (6%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEITFSTDDKPKLLSQLT+L+ADIGLNIQEAHAFSTVDG          WPYEETEQLR
Sbjct: 1   MHEITFSTDDKPKLLSQLTSLVADIGLNIQEAHAFSTVDG----------WPYEETEQLR 50

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            AL KEV K+E +              E   +K    H+ IPNDGTDVWEIDPK+LKF +
Sbjct: 51  DALAKEVSKIEDR--------------EQFRIKYDTNHVAIPNDGTDVWEIDPKYLKFEN 96

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLY+GTYCSQ+VAIK+LKPER+NSD+QKEFAQEV+IMRKVRHKNVVQFIGAC
Sbjct: 97  KVASGSYGDLYKGTYCSQEVAIKILKPERVNSDLQKEFAQEVYIMRKVRHKNVVQFIGAC 156

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           TKPPSLCIVTEFM GGSVYDYLHK  GVFKLP+LLKVAIDVSKGM+YLHQNNIIHRDLKA
Sbjct: 157 TKPPSLCIVTEFMYGGSVYDYLHKQGGVFKLPNLLKVAIDVSKGMDYLHQNNIIHRDLKA 216

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           ANLL+DENEVVKVADFGVARVKAQ+G+MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV
Sbjct: 217 ANLLLDENEVVKVADFGVARVKAQTGIMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 276

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWELLTGK+PYEYLTPLQAAVGVVQKGLRPTIPKN+QPKLAELLE+CWQQDPALRPDFSE
Sbjct: 277 LWELLTGKIPYEYLTPLQAAVGVVQKGLRPTIPKNTQPKLAELLEKCWQQDPALRPDFSE 336

Query: 361 IIEILQQIAKEVGEENEERRKEKSSGGFLSVLRR 394
           IIEILQQIAKEVG+   E RKEKSSG FLSVLRR
Sbjct: 337 IIEILQQIAKEVGDCG-EWRKEKSSGRFLSVLRR 369

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|378750734|gb|AFC37605.1| serine threonine protein kinase [Piper colubrinum]

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/397 (78%), Positives = 348/397 (87%), Gaps = 1/397 (0%)

Query: 1   MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
           MHEIT ST DKPK+L+ LT +LA+IGLNI+EAH FST DG+SLDVFVVDGWPYEETE L+
Sbjct: 151 MHEITLSTYDKPKILNLLTLMLAEIGLNIKEAHVFSTSDGFSLDVFVVDGWPYEETELLK 210

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
            A+E E++K+E+Q W   RS    +    T + +   H++IP+DGTDVWEID + LKF +
Sbjct: 211 EAIEMEIIKIEKQMWLKPRSGLSIANIGKTCLSTASDHVEIPSDGTDVWEIDVRKLKFEN 270

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           KVASGSYGDLY GTYCSQDVAIKVLKPERIN DMQ+EFAQEV+IMRKVRHKNVVQFIGAC
Sbjct: 271 KVASGSYGDLYHGTYCSQDVAIKVLKPERINLDMQREFAQEVYIMRKVRHKNVVQFIGAC 330

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           TKPPSLCIVTEFMSGGS+YD LHK KGVFKLP+LLKVA+DVSKGMNYLHQNNI+HRDLK 
Sbjct: 331 TKPPSLCIVTEFMSGGSLYDVLHKKKGVFKLPTLLKVALDVSKGMNYLHQNNIVHRDLKT 390

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE-VIEHKPYDHKADVFSFGI 299
           ANLLMDE+EVVKVADFGVARVKAQSGVMTAETGTYRWMAPE VI HK YDHKADVFSFGI
Sbjct: 391 ANLLMDEHEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEMVIAHKAYDHKADVFSFGI 450

Query: 300 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
           VLWELLT K+PYEYLTP+QAAVGVVQKGLRPTIPK++ PKLAELLERCWQQDP  RPDF+
Sbjct: 451 VLWELLTAKIPYEYLTPVQAAVGVVQKGLRPTIPKHTHPKLAELLERCWQQDPNGRPDFA 510

Query: 360 EIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGH 396
           EI EILQ IAKEV  + +ER KE+SSGGF SVLRR H
Sbjct: 511 EITEILQHIAKEVAADGDERHKERSSGGFFSVLRRNH 547

Source: Piper colubrinum

Species: Piper colubrinum

Genus: Piper

Family: Piperaceae

Order: Piperales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	397
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.992	0.685	0.779	7.6e-167
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.984	0.685	0.705	4.8e-149
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.929	0.675	0.729	2e-143
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.667	0.643	0.494	1.6e-70
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.672	0.649	0.476	1.8e-69
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.657	0.284	0.445	4e-61
TAIR|locus:2180992	333	AT5G01850 [Arabidopsis thalian	0.642	0.765	0.468	1e-59
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.670	0.506	0.406	7.3e-59
DICTYBASE|DDB_G0289791	642	drkA "DRK subfamily protein ki	0.692	0.428	0.419	8.4e-58
TAIR|locus:2084314	773	AT3G06620 [Arabidopsis thalian	0.738	0.379	0.399	3.6e-57

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 1623 (576.4 bits), Expect = 7.6e-167, P = 7.6e-167
 Identities = 314/403 (77%), Positives = 343/403 (85%)

Query:     1 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
             +HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEETE+LR
Sbjct:   176 LHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLR 235

Query:    61 AALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 118
              +LEKE  K+E   Q WP  +S SP  E   TG ++H   + IPNDGTDVWEI+ KHLKF
Sbjct:   236 ISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINLKHLKF 292

Query:   119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
             G K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNVVQFIG
Sbjct:   293 GHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIG 352

Query:   179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
             ACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNIIHRDL
Sbjct:   353 ACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDL 412

Query:   239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 298
             KAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKADVFS+G
Sbjct:   413 KAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYG 472

Query:   299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
             IVLWELLTGKLPYEY+TPLQAAVGVVQKGLRPTIPKN+ PKLAELLER W+ D   RPDF
Sbjct:   473 IVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDF 532

Query:   359 SEIIEILQQIAKXXXXXXXXXXXXXXXXG--FLSVLRRG--HH 397
             SEIIE LQ+IAK                G    + LRR   HH
Sbjct:   533 SEIIEQLQEIAKEVGEEGEEKKKSSTGLGGGIFAALRRSTTHH 575

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1455 (517.2 bits), Expect = 4.8e-149, P = 4.8e-149
 Identities = 280/397 (70%), Positives = 326/397 (82%)

Query:     1 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
             MHEITFST D+PKLLSQLT++L ++GLNIQEAHAFST DG+SLDVFVVDGW  EETE L+
Sbjct:   178 MHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLK 237

Query:    61 AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSH-PYHLKIPNDGTDVWEIDPKHLKFG 119
              AL+KE+ K + Q  P  +  S T    D       P  ++IP DGTD WEID K LK  
Sbjct:   238 DALKKEIRKFKDQ--PCSKQKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIE 295

Query:   120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
              KVA GSYG+L+RGTYCSQ+VAIK+LKPER+N++M +EF+QEV+IMRKVRHKNVVQFIGA
Sbjct:   296 KKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGA 355

Query:   180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             CT+ P+LCIVTEFM+ GS+YD+LHK KGVFK+ SLLKVA+DVSKGMNYLHQNNIIHRDLK
Sbjct:   356 CTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLK 415

Query:   240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 299
              ANLLMDE+EVVKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPYDH+ADVFS+ I
Sbjct:   416 TANLLMDEHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAI 475

Query:   300 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
             VLWELLTG+LPY YLTPLQAAVGVVQKGLRP IPK + PKL ELLE+CWQQDPALRP+F+
Sbjct:   476 VLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFA 535

Query:   360 EIIEILQQIAKXXXXXXXXXXXXXXXXGFLSVLRRGH 396
             EIIE+L Q+ +                G+ S L++GH
Sbjct:   536 EIIEMLNQLIREVGDDERHKDKHG---GYFSGLKKGH 569

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1402 (498.6 bits), Expect = 2.0e-143, P = 2.0e-143
 Identities = 270/370 (72%), Positives = 312/370 (84%)

Query:     1 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
             MHEITFST DKPKLLSQLT+LL ++GLNIQEAHAFSTVDG+SLDVFVVDGW  EET+ LR
Sbjct:   172 MHEITFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLR 231

Query:    61 AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
              AL KE+LKL+ Q     +S S   E + +  +  P  ++IP DGTD WEID   LK   
Sbjct:   232 DALSKEILKLKDQPGSKQKSIS-FFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEK 290

Query:   121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
             KVASGSYGDL+RGTYCSQ+VAIK LKP+R+N++M +EF+QEVFIMRKVRHKNVVQF+GAC
Sbjct:   291 KVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGAC 350

Query:   181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
             T+ P+LCIVTEFM+ GS+YD+LHK K  FKL +LLKVA+DV+KGM+YLHQNNIIHRDLK 
Sbjct:   351 TRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKT 410

Query:   241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
             ANLLMDE+ +VKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPY+HKADVFS+ IV
Sbjct:   411 ANLLMDEHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIV 470

Query:   301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
             LWELLTG +PY +LTPLQAAVGVVQKGLRP IPK + PK+  LLERCW QDP  RP F E
Sbjct:   471 LWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEE 530

Query:   361 IIEILQQIAK 370
             IIE+LQQI K
Sbjct:   531 IIEMLQQIMK 540

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 714 (256.4 bits), Expect = 1.6e-70, P = 1.6e-70
 Identities = 137/277 (49%), Positives = 194/277 (70%)

Query:   100 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-----PERIN 151
             K P +G    + W ID + L  G   A G++G LYRGTY  +DVAIK+L+     PE+  
Sbjct:   112 KYPTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQ 171

Query:   152 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
             + ++++F QEV ++  ++H N+V+FIGAC KP   CIVTE+  GGSV  +L K +    +
Sbjct:   172 A-LEQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNR-AV 229

Query:   212 PSLLKV--AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 269
             P  L V  A+DV++GM Y+H+ N IHRDLK+ NLL+  +  +K+ADFGVAR++ Q+  MT
Sbjct:   230 PLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMT 289

Query:   270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
              ETGTYRWMAPE+I+H+PY  K DV+SFGIVLWEL+TG LP++ +T +QAA  VV +G+R
Sbjct:   290 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVR 349

Query:   330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
             PT+P +  P L E++ RCW  DP +RP F+EI+ +L+
Sbjct:   350 PTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLE 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 704 (252.9 bits), Expect = 1.8e-69, P = 1.8e-69
 Identities = 131/275 (47%), Positives = 192/275 (69%)

Query:   100 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSD-- 153
             + P +G    D W ID + L  G   A G++G LY+GTY  +DVAIK+L +PE       
Sbjct:   111 RYPTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQ 170

Query:   154 -MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKL 211
              M+++F QEV ++  ++H N+V+FIGAC KP   CIVTE+  GGSV  +L + +     L
Sbjct:   171 FMEQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 230

Query:   212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 271
                +K A+DV++GM Y+H  N IHRDLK+ NLL+  ++ +K+ADFGVAR++ Q+  MT E
Sbjct:   231 KLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 290

Query:   272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
             TGTYRWMAPE+I+H+ Y+ K DV+SFGIVLWEL+TG LP++ +T +QAA  VV +G+RPT
Sbjct:   291 TGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPT 350

Query:   332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
             +P +  P L++++ RCW  +P +RP F E++++L+
Sbjct:   351 VPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLE 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 628 (226.1 bits), Expect = 4.0e-61, P = 4.0e-61
 Identities = 118/265 (44%), Positives = 181/265 (68%)

Query:   106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI 164
             +D+ EI    LK  SK+  G++G +Y+G +    VAIK +K  E +N+ + +EF +E+ I
Sbjct:   653 SDI-EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711

Query:   165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
             + ++RH N+V  + ACT PP+LC +TE++ GGS+YD LH  K    +    K+AI +++G
Sbjct:   712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771

Query:   225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
             MNYLH + +IHRD+K+ NLL+DE+  VK+ DFG++++K++S  MT   G+  WM+PE++ 
Sbjct:   772 MNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLM 831

Query:   285 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP-KLAEL 343
              + Y  K DV++FGI+LWEL TG+LPY  L  +Q A+ V  K LRP IP N+ P +L+ L
Sbjct:   832 GEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP-NAWPYQLSHL 890

Query:   344 LERCWQQDPALRPDFSEIIEILQQI 368
             ++ CW QDP  RP F+EI+ +L +I
Sbjct:   891 IQACWHQDPLKRPSFTEILNLLNEI 915

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)]

 Score = 612 (220.5 bits), Expect = 1.0e-59, P = 1.0e-59
 Identities = 127/271 (46%), Positives = 183/271 (67%)

Query:   111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL----KPERINSDMQKEFAQEVFIMR 166
             +DPK L  GSK+  G++G +Y+G Y  Q VAIKV+    KP++  S ++  F +EV +M 
Sbjct:    13 VDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQ-QSSLESRFVREVNMMS 71

Query:   167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 225
             +V+H N+V+FIGAC K P + IVTE + G S+  YL  ++  +  LP  L  A+D+++ +
Sbjct:    72 RVQHHNLVKFIGAC-KDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARAL 130

Query:   226 NYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI- 283
             + LH N IIHRDLK  NLL+ EN + VK+ADFG+AR ++ + +MTAETGTYRWMAPE+  
Sbjct:   131 HCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYS 190

Query:   284 -------EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
                    E K Y++K DV+SFGIVLWELLT ++P+E ++ LQAA     K  RP +P+  
Sbjct:   191 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGI 250

Query:   337 QPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
              P LA +++ CW +DP +RP FS+II +L +
Sbjct:   251 SPSLAFIVQSCWVEDPNMRPSFSQIIRLLNE 281

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
 Identities = 111/273 (40%), Positives = 178/273 (65%)

Query:   104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PER-----INSDMQKE 157
             + ++ + +D   L FG K A G Y  LY G Y  + VA+K++  P+      + + ++K+
Sbjct:   195 EASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQ 254

Query:   158 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLK 216
             F +EV ++ ++ H NV++F+GA   PP  C++T+++  GS+  +LHK +     L  L++
Sbjct:   255 FTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIE 314

Query:   217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
              AID+++GM Y+H   IIHRDLK  N+L+DE   +K+ADFG+A  +    ++  + GTYR
Sbjct:   315 FAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYR 374

Query:   277 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
             WMAPE+I+ KP+  KADV+SFG+VLWE++ G +PYE + P+QAA  VV K +RP IP + 
Sbjct:   375 WMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDC 434

Query:   337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIA 369
                +  L+E+CW   P  RP+F +I+++L+Q A
Sbjct:   435 PVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFA 467

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
 Identities = 118/281 (41%), Positives = 175/281 (62%)

Query:    93 KSHPYHLKIPNDGTDVWE---IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER 149
             +S  Y+    ND T + +   ID   +K G ++  G+YG++Y GT+    VA+K L    
Sbjct:   348 RSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN 407

Query:   150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 209
             IN ++ KEF +E+ +M+ +RH NV+QF+G+C  PP +CI TE+M  GS+Y  LH      
Sbjct:   408 INENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQL 467

Query:   210 KLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
             +   L+K+ ID +KG+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   
Sbjct:   468 QWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGAT 527

Query:   268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 327
             MTA  GT  W +PEV+  + Y  KADV+SFGI+LWE  T + PY  + P Q    V ++G
Sbjct:   528 MTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREG 586

Query:   328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             +RP +P+N  PK  +LL  C  ++P+ RP   + +E L+ I
Sbjct:   587 MRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)]

 Score = 588 (212.0 bits), Expect = 3.6e-57, P = 3.6e-57
 Identities = 121/303 (39%), Positives = 189/303 (62%)

Query:    75 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDV-WEIDPKHLKFGSKVASGSYGDLYRG 133
             W S  +++ TS     G  S     K+  D   + +EI    L  G +V  GS G +Y G
Sbjct:   452 WSSPINANSTSSASSCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHG 511

Query:   134 TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 193
              +   DVA+KV   +  ++++ + F QEV +M+++RH NV+ F+GA T P  LCIV+EF+
Sbjct:   512 LWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFL 571

Query:   194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV 251
               GS++  L K          + +A+D+++GMNYLH  +  IIHRDLK++NLL+D+N  V
Sbjct:   572 PRGSLFRLLQKSTSKLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTV 631

Query:   252 KVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL 309
             KVADFG++R+K ++  +T+++G  T +WMAPEV+ ++  D K+D++SFG+VLWEL T K+
Sbjct:   632 KVADFGLSRIKHET-YLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKI 690

Query:   310 PYEYLTPLQA--AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             P+E L  +Q   AVG + + L   IPK+  P+   L+E CW  D  LRP F E+++ L+ 
Sbjct:   691 PWETLNSMQVIGAVGFMDQRLE--IPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRD 748

Query:   368 IAK 370
             + +
Sbjct:   749 LQR 751

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0000956 "nuclear-transcribed mRNA catabolic process" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	397
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-95
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-94
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-93
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-84
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-75
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-75
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-68
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-67
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-67
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-65
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-65
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-63
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-60
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-60
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-57
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-57
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-56
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-56
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-56
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-56
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-54
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-54
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-53
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-53
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-53
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-53
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-52
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-51
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-51
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-51
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-51
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-51
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-50
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-50
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-50
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-50
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-49
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-49
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-49
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-48
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-47
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-47
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-46
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-46
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-46
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-46
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-45
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-45
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-44
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-44
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-43
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-42
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-42
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-42
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-42
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-41
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-41
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-41
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-41
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-41
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-41
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-41
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-40
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-40
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-40
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-40
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-40
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-39
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-39
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-39
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-39
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-38
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-38
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-38
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-38
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-38
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-38
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-38
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-37
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-37
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-37
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-36
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-36
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-36
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-36
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-36
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-36
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-35
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-35
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-35
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-35
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-35
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-34
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-34
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-34
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-34
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-34
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-34
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-34
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-33
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-33
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-33
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-32
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-32
cd04928	68	cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC	1e-32
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-32
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-32
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-32
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-32
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-31
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-31
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-31
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-31
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-31
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-31
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-30
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-29
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-29
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-29
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-29
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-29
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-28
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-28
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-28
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-28
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-28
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-28
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-28
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-28
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-28
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-28
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-27
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-27
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-26
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-26
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-26
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-25
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-25
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-25
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-24
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-24
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-24
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-22
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-22
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-21
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-21
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-21
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-21
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-21
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-19
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-18
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-18
cd04900	73	cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU	2e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-18
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-17
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-17
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-16
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-16
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-12
cd04873	70	cd04873, ACT_UUR-ACR-like, ACT domains of the bact	5e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-12
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-08
PRK05092	931	PRK05092, PRK05092, PII uridylyl-transferase; Prov	4e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-07
cd02116	60	cd02116, ACT, ACT domains are commonly involved in	6e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
pfam01842	66	pfam01842, ACT, ACT domain	3e-06
cd04899	70	cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain	4e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-06
COG2844	867	COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran	1e-05
TIGR01693	850	TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-05
PRK05007	884	PRK05007, PRK05007, PII uridylyl-transferase; Prov	2e-04
PRK00275	895	PRK00275, glnD, PII uridylyl-transferase; Provisio	4e-04
PRK03381	774	PRK03381, PRK03381, PII uridylyl-transferase; Prov	6e-04
PRK05092	931	PRK05092, PRK05092, PII uridylyl-transferase; Prov	0.002
COG2844	867	COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.004
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  284 bits (729), Expect = 5e-95
 Identities = 101/259 (38%), Positives = 151/259 (58%), Gaps = 11/259 (4%)

Query: 116 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           L  G K+  G++G++Y+G           +VA+K LK +  +    +EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H NVV+ +G CT+   L IV E+M GG +  YL K +    L  LL  A+ +++GM YL 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKP 287
             N IHRDL A N L+ EN VVK++DFG++R            G    RWMAPE ++   
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           +  K+DV+SFG++LWE+ T G+ PY  ++  +  +  ++ G R   P N  P+L +L+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 347 CWQQDPALRPDFSEIIEIL 365
           CW +DP  RP FSE++EIL
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  281 bits (722), Expect = 6e-94
 Identities = 99/260 (38%), Positives = 156/260 (60%), Gaps = 12/260 (4%)

Query: 116 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           L+ G K+  G++G++Y+GT           VA+K LK    + + ++EF +E  IM+K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS 59

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H N+V+ +G CT+   L IVTE+M GG + D+L K      L  LL++A+ ++KGM YL 
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHK 286
             N +HRDL A N L+ EN VVK++DFG++R   +        G     +WMAPE ++  
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            +  K+DV+SFG++LWE+ T G+ PY  ++  +  + +++ G R   P+N   +L EL+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELML 238

Query: 346 RCWQQDPALRPDFSEIIEIL 365
           +CW  DP  RP FSE++E L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  280 bits (719), Expect = 2e-93
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 12/260 (4%)

Query: 116 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           L  G K+  G++G++Y+GT          +VA+K LK +  +    +EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLD 59

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYL 228
           H N+V+ +G CT+   L IV E+M GG + DYL K +     L  LL  A+ +++GM YL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHK 286
              N IHRDL A N L+ EN VVK++DFG++R          + G    RWMAPE ++  
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            +  K+DV+SFG++LWE+ T G+ PY  ++  +  +  ++KG R   P N  P+L +L+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 346 RCWQQDPALRPDFSEIIEIL 365
           +CW +DP  RP FSE++EIL
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  257 bits (659), Expect = 2e-84
 Identities = 100/260 (38%), Positives = 152/260 (58%), Gaps = 19/260 (7%)

Query: 124 SGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            G++G++Y+G        + +VA+K LK E  + + +K+F +E  +M+K+ H NVV+ +G
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--------LLKVAIDVSKGMNYLHQ 230
            CT+   L +V E+M GG + DYL K + VF  P         LL  AI ++KGM YL  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKP 287
              +HRDL A N L+ E+ VVK++DFG++R          +TG     RWMAPE ++   
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           +  K+DV+SFG++LWE+ T G  PY  L+  +  +  ++KG R   P+    +L EL+  
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLS 242

Query: 347 CWQQDPALRPDFSEIIEILQ 366
           CWQ DP  RP FSE++E L+
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  235 bits (601), Expect = 1e-75
 Identities = 93/257 (36%), Positives = 146/257 (56%), Gaps = 10/257 (3%)

Query: 116 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
            +   K+ SGS+G +Y+  +    + VA+K+LK     S   +   +E+ I+R++ H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V+ I A      L +V E+  GG ++DYL +  G        K+A+ + +G+ YLH N I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKPYDHK 291
           IHRDLK  N+L+DEN VVK+ADFG+A+   +S   +T   GT  +MAPEV+     Y  K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 292 ADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLER 346
            DV+S G++L+ELLTGK P+     L  LQ    ++   L    PK  +   +  +L+++
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 347 CWQQDPALRPDFSEIIE 363
           C  +DP+ RP   EI++
Sbjct: 240 CLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  232 bits (595), Expect = 9e-75
 Identities = 80/251 (31%), Positives = 128/251 (50%), Gaps = 6/251 (2%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +   K+  GS+G +Y        + VAIKV+K ++I  D ++   +E+ I++K++H N+V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNIV 60

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +          L +V E+  GG ++D L K +G             +   + YLH   I+
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 294
           HRDLK  N+L+DE+  VK+ADFG+AR       +T   GT  +MAPEV+  K Y    D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDP 352
           +S G++L+ELLTGK P+     L      + K   P  P      P+  +L+ +   +DP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239

Query: 353 ALRPDFSEIIE 363
             R    E ++
Sbjct: 240 EKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  213 bits (545), Expect = 7e-68
 Identities = 77/247 (31%), Positives = 129/247 (52%), Gaps = 39/247 (15%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
            G +G +Y        + VAIK++K E  +S ++ E  +E+ I++K+ H N+V+  G   
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGVFE 61

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               L +V E+  GGS+ D L + +G      +L++ + + +G+ YLH N IIHRDLK  
Sbjct: 62  DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121

Query: 242 NLLMDENE-VVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFG 298
           N+L+D +   VK+ADFG+++ + +   ++    GT  +MAPEV+  K  Y  K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181

Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+EL                                 P+L +L+ +  Q+DP  RP  
Sbjct: 182 VILYEL---------------------------------PELKDLIRKMLQKDPEKRPSA 208

Query: 359 SEIIEIL 365
            EI+E L
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  214 bits (547), Expect = 1e-67
 Identities = 105/264 (39%), Positives = 159/264 (60%), Gaps = 12/264 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W I+ K LK G+ +  G +GD+  G Y  Q VA+K LK    +S   + F  E  +M  +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 227
           RH N+VQ +G   +   L IVTE+M+ GS+ DYL  + + V  L   L  A+DV +GM Y
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 285
           L + N +HRDL A N+L+ E+ V KV+DFG+A+ +A  G    ++G    +W APE +  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173

Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG R   P+   P++ +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232

Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
           + CW+ DPA RP F ++ E L  I
Sbjct: 233 KDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  212 bits (542), Expect = 5e-67
 Identities = 97/262 (37%), Positives = 151/262 (57%), Gaps = 14/262 (5%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDP  L F  ++ SG +G ++ G +  + DVAIK+++   ++ D   +F +E  +M K+ 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H N+VQ  G CTK   + IVTE+M+ G + +YL + KG      LL +  DV + M YL 
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIE 284
            N  IHRDL A N L+ E+ VVKV+DFG+AR  +  Q    T+  GT    +W  PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
           +  +  K+DV+SFG+++WE+ + GK+PYE  +  +  V  V  G R   PK +  ++  +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTI 233

Query: 344 LERCWQQDPALRPDFSEIIEIL 365
           +  CW + P  RP F +++  L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  209 bits (534), Expect = 1e-65
 Identities = 88/246 (35%), Positives = 139/246 (56%), Gaps = 7/246 (2%)

Query: 115 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 172
             +   K+  G +G++Y+  +    ++VAIKV+K E  + + +++   E+ I++K +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPN 58

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +V++ G+  K   L IV EF SGGS+ D L           +  V  ++ KG+ YLH N 
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           IIHRD+KAAN+L+  +  VK+ DFG++   + +       GT  WMAPEVI  KPYD+KA
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 350
           D++S GI   EL  GK PY  L P++A   +   G  P +    +   +  + L++C Q+
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQK 237

Query: 351 DPALRP 356
           +P  RP
Sbjct: 238 NPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  207 bits (528), Expect = 8e-65
 Identities = 100/264 (37%), Positives = 150/264 (56%), Gaps = 15/264 (5%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEID   ++   K+ +G +G+++ G +  +  VA+K LKP  ++    K+F  E  IM+K
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKK 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 226
           +RH  ++Q    CT    + IVTE M  GS+ +YL    G   KLP L+ +A  V+ GM 
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 283
           YL   N IHRDL A N+L+ EN + KVADFG+ARV  +  +  A  G     +W APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176

Query: 284 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
            +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  V +G R   P     +L +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYD 235

Query: 343 LLERCWQQDPALRPDFSEIIEILQ 366
           ++  CW++DP  RP F    E LQ
Sbjct: 236 IMLDCWKEDPDDRPTF----ETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  204 bits (522), Expect = 8e-64
 Identities = 103/267 (38%), Positives = 156/267 (58%), Gaps = 13/267 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE-FAQEVFIMR 166
           WEI  + LK   K+ +G +G+++ GT+  +  VA+K LKP      M  E F QE  IM+
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP----GTMSPEAFLQEAQIMK 56

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGM 225
           K+RH  +VQ    C++   + IVTE+MS GS+ D+L   +G   +LP L+ +A  +++GM
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 282
            YL   N IHRDL A N+L+ EN V K+ADFG+AR+       TA  G     +W APE 
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEA 175

Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
             +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  V++G R   P N   +L 
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELY 234

Query: 342 ELLERCWQQDPALRPDFSEIIEILQQI 368
           +L+ +CW +DP  RP F  +   L+  
Sbjct: 235 DLMLQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  202 bits (517), Expect = 5e-63
 Identities = 79/246 (32%), Positives = 128/246 (52%), Gaps = 9/246 (3%)

Query: 119 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           G  +  GS+G +Y          +A+K ++    + +  +   +E+ I+  ++H N+V++
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 177 IGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
            G+       +L I  E++SGGS+   L K  G    P + K    + +G+ YLH N I+
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHK 291
           HRD+K AN+L+D + VVK+ADFG A+               GT  WMAPEVI  + Y   
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQKGLRPTIPKNSQPKLAELLERCWQQ 350
           AD++S G  + E+ TGK P+  L    AA+  +   G  P IP++   +  + L +C ++
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243

Query: 351 DPALRP 356
           DP  RP
Sbjct: 244 DPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  195 bits (497), Expect = 3e-60
 Identities = 97/268 (36%), Positives = 156/268 (58%), Gaps = 14/268 (5%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMR 166
           WE++   +    K+  G YG++Y G +      VA+K LK + +  +   EF +E  +M+
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMK 57

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKG 224
           +++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +     ++ +  LL +A  +S  
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSA 116

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPE 175

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++KG R   P+   PK+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKV 234

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQI 368
            EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  194 bits (495), Expect = 6e-60
 Identities = 91/249 (36%), Positives = 141/249 (56%), Gaps = 11/249 (4%)

Query: 115 HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 172
           + + G  +  G++G +Y+G        VAIK +  E+I  +  K   QE+ +++ ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---KGMNYLH 229
           +V++IG+     SL I+ E+   GS+   + K       P  L VA+ V    +G+ YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLH 116

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           +  +IHRD+KAAN+L  ++ VVK+ADFGVA ++   S    +  GT  WMAPEVIE    
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 289 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
              +D++S G  + ELLTG  PY  L P+ A   +VQ    P +P+   P+L + L +C+
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCF 235

Query: 349 QQDPALRPD 357
           Q+DP LRP 
Sbjct: 236 QKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  188 bits (478), Expect = 2e-57
 Identities = 89/252 (35%), Positives = 141/252 (55%), Gaps = 9/252 (3%)

Query: 121 KVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           K+  G++GD+Y+G      +VA+K  +        +K F QE  I+++  H N+V+ IG 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
           C +   + IV E + GGS+  +L K K    +  LL++++D + GM YL   N IHRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVF 295
           A N L+ EN V+K++DFG++R + + G+ T   G      +W APE + +  Y  ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179

Query: 296 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           S+GI+LWE  + G  PY  ++  Q     ++ G R   P+    ++  L+ +CW  DP  
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238

Query: 355 RPDFSEIIEILQ 366
           RP FSEI   LQ
Sbjct: 239 RPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  187 bits (477), Expect = 4e-57
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 13/267 (4%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQK-EFAQEVFI 164
           IDP ++     +  G +G++ RG          DVAIK LK    +SD Q+ +F  E  I
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASI 58

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + I+TE+M  GS+  +L +  G F +  L+ +   ++ G
Sbjct: 59  MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG--TYRWMAPE 281
           M YL + N +HRDL A N+L++ N V KV+DFG++R    S    T + G    RW APE
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I ++ +   +DV+SFGIV+WE+++ G+ PY  ++  Q  +  V+ G R   P +    L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSAL 237

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQ 367
            +L+  CWQ+D   RP FS+I+  L +
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  186 bits (473), Expect = 1e-56
 Identities = 95/260 (36%), Positives = 150/260 (57%), Gaps = 10/260 (3%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           I P  L    ++ SG +G ++ G +  +  VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS 57

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G CT+   +C+V EFM  G + DYL   +G F   +LL + +DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 286
            +N+IHRDL A N L+ EN+VVKV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176

Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y  K+DV+SFG+++WE+ + GK PYE  +  +  V  +  G R   P+ +   + EL++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQ 235

Query: 346 RCWQQDPALRPDFSEIIEIL 365
            CW++ P  RP FS ++  L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  185 bits (472), Expect = 2e-56
 Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 7/264 (2%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WE   +      K+ SG +G+++ G +     VAIK+LK +  +   Q++F +EV  +++
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 226
           +RHK+++     C+    + I+TE M  GS+  +L   +G V  + SL+ +A  V++GM 
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-YRWMAPEVIEH 285
           YL + N IHRDL A N+L+ E+ V KVADFG+AR+  +   ++++    Y+W APE   H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
             +  K+DV+SFGI+L+E+ T G++PY  +         +  G R   P     ++ +++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237

Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
             CW  +P  RP F  + E L  I
Sbjct: 238 LECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  184 bits (469), Expect = 3e-56
 Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 10/263 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56

Query: 169 RHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 226
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           YL  NN +HRDL A N+L+ E+ V KV+DFG+   K  S          +W APE +  K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALREK 174

Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + ++++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233

Query: 346 RCWQQDPALRPDFSEIIEILQQI 368
           +CW  D A RP F ++ E L+ I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  185 bits (471), Expect = 6e-56
 Identities = 88/264 (33%), Positives = 143/264 (54%), Gaps = 22/264 (8%)

Query: 112 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           DP +  K   K+  G+ G++Y+ T  +  ++VAIK +   R+    ++    E+ IM+  
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDC 72

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           +H N+V +  +      L +V E+M GGS+ D + +       P +  V  +V +G+ YL
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPE 281
           H  N+IHRD+K+ N+L+ ++  VK+ADFG A   AQ   +T E        GT  WMAPE
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAPE 186

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPK 339
           VI+ K Y  K D++S GI+  E+  G+ PY    PL+A   +  KG+ P +  P+   P+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPE 245

Query: 340 LAELLERCWQQDPALRPDFSEIIE 363
             + L +C  +DP  RP   E+++
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  181 bits (460), Expect = 1e-54
 Identities = 90/259 (34%), Positives = 145/259 (55%), Gaps = 8/259 (3%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           I+P  L F  ++ SG +G ++ G + +Q  VAIK +    ++ +   +F +E  +M K+ 
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G CT+   L IVTEFM  G + +YL + +G      LL +  DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKP 287
           +N+ IHRDL A N L+    VVKV+DFG+ R        ++    +  +W  PEV     
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y  K+DV+SFG+++WE+ T GK+P+E  +  +  V ++ +G R   PK +   + E++  
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPKLASMTVYEVMYS 236

Query: 347 CWQQDPALRPDFSEIIEIL 365
           CW + P  RP F+E++  +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  180 bits (457), Expect = 2e-54
 Identities = 94/261 (36%), Positives = 148/261 (56%), Gaps = 10/261 (3%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M K+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H+ +VQ  G CTK   + IVTE+MS G + +YL +    F+   LL++  DV +GM YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 286
               IHRDL A N L+D+   VKV+DFG++R        T+  G+    RW  PEV+ + 
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYS 176

Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            +  K+DV++FG+++WE+ + GK+PYE     +    V Q GLR   P  +  K+  ++ 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMY 235

Query: 346 RCWQQDPALRPDFSEIIEILQ 366
            CW +    RP F +++  ++
Sbjct: 236 SCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  178 bits (454), Expect = 1e-53
 Identities = 83/258 (32%), Positives = 143/258 (55%), Gaps = 18/258 (6%)

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDM---QKEFA-QEVFIMRKVRHKNVVQ 175
           ++  GS+G +Y       D  + VLK   I+ S+M   ++E A  EV I++K+ H N+++
Sbjct: 7   QIGKGSFGKVYLVR-RKSDGKLYVLK--EIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---LLKVAIDVSKGMNYLHQNN 232
           +  +  +   LCIV E+  GG +   + K K   K      +L   + +   + YLH   
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDH 290
           I+HRD+K  N+ +  N +VK+ DFG+++V + +  + A+T  GT  +++PE+ ++KPY++
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNY 182

Query: 291 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 350
           K+D++S G VL+EL T K P+E    L+ A+ +++    P IP     +L  L+    Q+
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQK 241

Query: 351 DPALRPDFSEIIEILQQI 368
           DP  RP    I +ILQ  
Sbjct: 242 DPEERPS---IAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  178 bits (454), Expect = 1e-53
 Identities = 89/271 (32%), Positives = 139/271 (51%), Gaps = 11/271 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 163
           +EI  + +  G  +  G +GD+Y+G Y S +     VA+K  K     S  +K F QE +
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           IMR+  H ++V+ IG  T+ P   IV E    G +  YL   K    L SL+  +  +S 
Sbjct: 60  IMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 281
            + YL     +HRD+ A N+L+   + VK+ DFG++R         A  G    +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N  P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 237

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKE 371
             L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  177 bits (452), Expect = 3e-53
 Identities = 88/266 (33%), Positives = 143/266 (53%), Gaps = 13/266 (4%)

Query: 116 LKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           L+    + SG++G +Y+G +  +       VAIKVL+ E  +    KE   E ++M  V 
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H +VV+ +G C     + ++T+ M  G + DY+   K       LL   + ++KGM+YL 
Sbjct: 68  HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 286
           +  ++HRDL A N+L+   + VK+ DFG+A+ +        AE G    +WMA E I H+
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186

Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y HK+DV+S+G+ +WEL+T G  PYE + P      +++KG R   P      +  +L 
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLV 245

Query: 346 RCWQQDPALRPDFSEIIEILQQIAKE 371
           +CW  D   RP F E+I    ++A++
Sbjct: 246 KCWMIDAESRPTFKELINEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  176 bits (448), Expect = 5e-53
 Identities = 88/263 (33%), Positives = 151/263 (57%), Gaps = 14/263 (5%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ + L  G  +  G +G + +G Y  Q VA+K +K +       + F +E  +M K+
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKL 56

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 227
            HKN+V+ +G       L IV E MS G++ ++L  + + +  +  LL+ ++DV++GM Y
Sbjct: 57  HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 285
           L    ++HRDL A N+L+ E+ V KV+DFG+ARV    G M  +      +W APE ++H
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKH 171

Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           K +  K+DV+S+G++LWE+ + G+ PY  ++ L+     V+KG R   P+     +  L+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLM 230

Query: 345 ERCWQQDPALRPDFSEIIEILQQ 367
             CW+ +P  RP F ++ E L++
Sbjct: 231 TSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  175 bits (447), Expect = 2e-52
 Identities = 86/283 (30%), Positives = 139/283 (49%), Gaps = 32/283 (11%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQD-----VAIKVLKPERINSDMQKEFAQE 161
           WE+  + +    ++  GS+G +Y G      +      VAIK +  E  +   + EF  E
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNE 59

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLL 215
             +M++    +VV+ +G  +      +V E M+ G +  YL   +           P+L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 216 KV---AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--------KAQ 264
           K    A +++ GM YL     +HRDL A N ++ E+  VK+ DFG+ R         K  
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179

Query: 265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
            G++       RWMAPE ++   +  K+DV+SFG+VLWE+ T  + PY+ L+  +    V
Sbjct: 180 KGLLPV-----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234

Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           +  G    +P+N   KL EL+  CWQ +P +RP F EI+  L+
Sbjct: 235 IDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  171 bits (436), Expect = 3e-51
 Identities = 84/256 (32%), Positives = 137/256 (53%), Gaps = 13/256 (5%)

Query: 121 KVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           K+  GS+G + RG + +       VA+K LK +++ SD+  +F +E  IM  + H+N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
             G     P L +VTE    GS+ D L K   G F + +L   A+ ++ GM YL     I
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAPEVIEHKPYDH 290
           HRDL A N+L+  ++ VK+ DFG+ R   Q+    VM       + W APE +  + + H
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179

Query: 291 KADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
            +DV+ FG+ LWE+ T G+ P+  L+  Q    + ++G R   P+     +  ++ +CW 
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239

Query: 350 QDPALRPDFSEIIEIL 365
            +PA RP F+ + E L
Sbjct: 240 HNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  172 bits (438), Expect = 4e-51
 Identities = 86/260 (33%), Positives = 129/260 (49%), Gaps = 36/260 (13%)

Query: 121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            +  GS+G++Y+      +Q VAIKV+  E    +++ +  QE+  + + R   + ++ G
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYG 66

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L I+ E+  GGS  D L    G      +  +  +V  G+ YLH+   IHRD+
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPEVIEHKPYDHK 291
           KAAN+L+ E   VK+ADFGV      SG +T+         GT  WMAPEVI+   YD K
Sbjct: 125 KAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---------E 342
           AD++S GI   EL  G+ P   L P++         L   IPKN+ P L          +
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRV--------LF-LIPKNNPPSLEGNKFSKPFKD 229

Query: 343 LLERCWQQDPALRPDFSEII 362
            +  C  +DP  RP   E++
Sbjct: 230 FVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  172 bits (438), Expect = 5e-51
 Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 39/288 (13%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +HLKF  ++  G +G +    Y          VA+K L           +F +E+ I+R 
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62

Query: 168 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           + H+N+V++ G C KP   SL ++ E++  GS+ DYL + +    L  LL  +  + KGM
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMTAETGTYRWMAPE 281
           +YL     IHRDL A N+L++  ++VK++DFG+A+V  +      V         W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
            +    +   +DV+SFG+ L+EL T      Y  P Q+      + +     +    +L 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT------YGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 342 ELLE--------------------RCWQQDPALRPDFSEIIEILQQIA 369
           ELL+                     CW+ +P  RP F+++I I+ ++ 
Sbjct: 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  171 bits (436), Expect = 5e-51
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 19/266 (7%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
              +    +  G+   +Y    C   ++ VAIK +  E+  + +  E  +EV  M +  H
Sbjct: 1   DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL-HKLK-GVFKLPSLLKVAIDVSKGMNYL 228
            NVV++  +      L +V  ++SGGS+ D +      G      +  V  +V KG+ YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVI 283
           H N  IHRD+KA N+L+ E+  VK+ADFGV+   A  G  T +      GT  WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 284 E-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK--- 339
           E    YD KAD++SFGI   EL TG  PY    P++  +  +Q    P++   +  K   
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYS 237

Query: 340 --LAELLERCWQQDPALRPDFSEIIE 363
               +++  C Q+DP+ RP   E+++
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  171 bits (434), Expect = 7e-51
 Identities = 98/264 (37%), Positives = 160/264 (60%), Gaps = 12/264 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + L+   K+ +G +G+++ GT+  +  VA+K LKP  ++ +    F +E  IM+K
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 226
           +RH  +VQ     ++ P + IVTE+MS GS+ D+L   +G   KLP+L+ +A  V+ GM 
Sbjct: 58  LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 283
           Y+ + N IHRDL++AN+L+ +  V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 284 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
            +  +  K+DV+SFGI+L EL+T G++PY  +   +  +  V++G R   P++    L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHE 234

Query: 343 LLERCWQQDPALRPDFSEIIEILQ 366
           L+ +CW++DP  RP F  +   L+
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  170 bits (433), Expect = 1e-50
 Identities = 84/251 (33%), Positives = 134/251 (53%), Gaps = 7/251 (2%)

Query: 119 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHKNV 173
           G  + SGS+G +Y G         A+K +         Q   K+  QE+ ++ K++H N+
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           VQ++G   +  +L I  E + GGS+   L K  G F  P +      +  G+ YLH  N 
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKA 292
           +HRD+K AN+L+D N VVK+ADFG+A+   +     +  G+  WMAPEVI  +  Y   A
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G  + E+ TGK P+  L  + A   + +    P IP +   +  + + +C Q+DP
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243

Query: 353 ALRPDFSEIIE 363
           +LRP  +E++E
Sbjct: 244 SLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  169 bits (429), Expect = 4e-50
 Identities = 87/263 (33%), Positives = 153/263 (58%), Gaps = 10/263 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WE+  + LK   K+ +G +G+++ G Y     VAIK LK   ++ +    F  E  +M++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 226
           ++H  +V+     T+ P + I+TE+M  GS+ D+L   +G+   +  L+ +A  +++GM 
Sbjct: 58  LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           ++ + N IHRDL+AAN+L+ E    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
           +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L EL
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYEL 235

Query: 344 LERCWQQDPALRPDFSEIIEILQ 366
           +  CW++ P  RP F  +  +L+
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  169 bits (428), Expect = 6e-50
 Identities = 102/264 (38%), Positives = 157/264 (59%), Gaps = 12/264 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP    + M + F QE  IM+K
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 226
           +RH  +V      ++ P + IVTEFM  GS+ D+L +  G + KLP L+ +A  ++ GM 
Sbjct: 58  LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 283
           Y+ + N IHRDL+AAN+L+ +N V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 284 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
            +  +  K+DV+SFGI+L EL+T G++PY  +   +  +  V++G R   P+     L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHE 234

Query: 343 LLERCWQQDPALRPDFSEIIEILQ 366
           L++ CW++DP  RP F  I   L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  168 bits (427), Expect = 6e-50
 Identities = 88/247 (35%), Positives = 142/247 (57%), Gaps = 12/247 (4%)

Query: 122 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           +  G++G++++GT   +  VA+K  K E +  +++ +F  E  I+++  H N+V+ IG C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           T+   + IV E + GG    +L K K   K   L+K A+D + GM YL   N IHRDL A
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 241 ANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
            N L+ EN V+K++DFG++R     + + SG+        +W APE + +  Y  ++DV+
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVW 178

Query: 296 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           S+GI+LWE  + G  PY  +T  Q A   V+KG R + P+     + ++++RCW   P  
Sbjct: 179 SYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237

Query: 355 RPDFSEI 361
           RP FSE+
Sbjct: 238 RPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  167 bits (424), Expect = 2e-49
 Identities = 81/243 (33%), Positives = 126/243 (51%), Gaps = 14/243 (5%)

Query: 121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GSYG +Y+  +    Q VAIKV+  E    ++ KE    + I+++     +V++ G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L IV E+   GSV D +           +  +     KG+ YLH N  IHRD+
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 296
           KA N+L++E    K+ADFGV+  +    +    T  GT  WMAPEVI+   Y++KAD++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK---GLRPTIPKNSQPKLAELLERCWQQDPA 353
            GI   E+  GK PY  + P++A   +  K    L    P+   P+  + +++C  +DP 
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPEKWSPEFNDFVKKCLVKDPE 242

Query: 354 LRP 356
            RP
Sbjct: 243 ERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  167 bits (424), Expect = 2e-49
 Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 14/255 (5%)

Query: 124 SGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            G++G + +G Y  +      VA+K LK E I +  +KEF +E  +M ++ H  +V+ IG
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIG 63

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
            C K   L +V E    G +  YL K +    +  L ++A  V+ GM YL   + +HRDL
Sbjct: 64  VC-KGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121

Query: 239 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKADV 294
            A N+L+      K++DFG++R + A S    A T      +W APE I +  +  K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181

Query: 295 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           +S+G+ LWE  + G  PY  +      + +++ G R   P+    ++  ++  CW+  P 
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE 240

Query: 354 LRPDFSEIIEILQQI 368
            RP FSE+    ++ 
Sbjct: 241 DRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  166 bits (422), Expect = 3e-49
 Identities = 98/264 (37%), Positives = 157/264 (59%), Gaps = 12/264 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M+K
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 226
           +RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ GM 
Sbjct: 58  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 283
           Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 284 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
            +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 234

Query: 343 LLERCWQQDPALRPDFSEIIEILQ 366
           L+ +CW+++P  RP F  +   L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  165 bits (418), Expect = 2e-48
 Identities = 88/262 (33%), Positives = 153/262 (58%), Gaps = 9/262 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + +K   K+ +G +G+++ G Y  S  VA+K LKP  ++    + F +E  +M+ 
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 226
           ++H  +V+     TK   + I+TE+M+ GS+ D+L   +G    LP L+  +  +++GM 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              +  K+DV+SFGI+L+E++T GK+PY  ++        +Q+G R    +N   +L ++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236

Query: 344 LERCWQQDPALRPDFSEIIEIL 365
           ++ CW++    RP F  +  +L
Sbjct: 237 MKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  163 bits (414), Expect = 2e-47
 Identities = 88/300 (29%), Positives = 154/300 (51%), Gaps = 41/300 (13%)

Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 153
           +P D    WE+    L  G  +  G++G + +      D       VA+K+LK +    D
Sbjct: 1   LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58

Query: 154 MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 202
           +  +   E+ +M+ + +HKN++  +G CT+   L +V E+ + G++ D+L          
Sbjct: 59  L-SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 203 -----HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
                   +       L+  A  V++GM +L     IHRDL A N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 258 VAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GK 308
           +AR         K  +G +       +WMAPE +  + Y H++DV+SFG++LWE+ T G 
Sbjct: 178 LARDIHHIDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232

Query: 309 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            PY  + P++    ++++G R   P+N   +L  L+  CW + P+ RP F +++E L ++
Sbjct: 233 SPYPGI-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  161 bits (408), Expect = 4e-47
 Identities = 84/253 (33%), Positives = 144/253 (56%), Gaps = 10/253 (3%)

Query: 121 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           ++  G++G+++ G   + +  VA+K  + E +  D++ +F QE  I+++  H N+V+ IG
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
            CT+   + IV E + GG    +L       K+  L+++  + + GM YL   + IHRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADV 294
            A N L+ E  V+K++DFG++R + + GV  +  G      +W APE + +  Y  ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 295 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           +SFGI+LWE  + G +PY  L+  Q     +++G+R   P+     +  L+ERCW+ DP 
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238

Query: 354 LRPDFSEIIEILQ 366
            RP FS + + LQ
Sbjct: 239 QRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  160 bits (406), Expect = 1e-46
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 12/269 (4%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           EI P H+     + +G +G+++RG           VAIK LKP       Q +F  E  I
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASI 59

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK     I+TE+M  G++  YL    G F    L+ +   ++ G
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 280
           M YL   N +HRDL A N+L++ N   KV+DFG++RV      G  T   G    RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+SFGIV+WE+++ G+ PY  ++     +  +  G R   P +    
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSA 238

Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + +L+ +CWQQD A RP F +I+ +L ++
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  160 bits (405), Expect = 2e-46
 Identities = 95/268 (35%), Positives = 139/268 (51%), Gaps = 25/268 (9%)

Query: 122 VASGSYGDLYRGTYCSQD--------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           + SG++G++Y GT             VA+K L+    + + +KEF +E  +M    H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNY 227
           V+ +G C       I+ E M GG +  YL   +       +  L  LL + +DV+KG  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 228 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGVMTAETG---TYRWMA 279
           L Q + IHRDL A N L+ E       VVK+ DFG+AR   +S     E       RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           PE +    +  ++DV+SFG+++WE+LT G+ PY  L   +  +  V  G R   P+N   
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPD 240

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQ 366
           K+ +L+  CW QDP+ RP F  I EILQ
Sbjct: 241 KIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  159 bits (403), Expect = 4e-46
 Identities = 78/262 (29%), Positives = 132/262 (50%), Gaps = 16/262 (6%)

Query: 113 PKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKE---FAQEVFI 164
           P + + G  +  G++G +Y    C      +++A+K +  +  + + +KE      E+ +
Sbjct: 1   PTNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           ++ ++H+ +VQ+ G      +L I  E+M GGSV D L K  G        K    + +G
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEG 116

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAP 280
           + YLH N I+HRD+K AN+L D    VK+ DFG ++    + +    M + TGT  WM+P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
           EVI  + Y  KADV+S G  + E+LT K P+     + A   +  +   P +P +  P  
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236

Query: 341 AELLERCWQQDPALRPDFSEII 362
              L R + ++   RP   E++
Sbjct: 237 RNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  159 bits (405), Expect = 4e-46
 Identities = 90/289 (31%), Positives = 154/289 (53%), Gaps = 26/289 (8%)

Query: 96  PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPE 148
           PY LK        WE    +L FG  + +G++G +   T            VA+K+LKP 
Sbjct: 25  PYDLK--------WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP- 75

Query: 149 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 207
             +S  ++    E+ IM  +  H+N+V  +GACT    + ++TE+   G + ++L + + 
Sbjct: 76  TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135

Query: 208 VF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS 265
            F  L  LL  +  V+KGM +L   N IHRDL A N+L+   ++VK+ DFG+AR +   S
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195

Query: 266 GVMTAETGTYR----WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
             +    G  R    WMAPE I +  Y  ++DV+S+GI+LWE+ + G  PY  +      
Sbjct: 196 NYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253

Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 369
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++ +  
Sbjct: 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 2e-45
 Identities = 83/251 (33%), Positives = 133/251 (52%), Gaps = 11/251 (4%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
            ++ SG+YGD+Y  R     + VAIKV+K E    D  +   QE+ ++++ RH N+V + 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
           G+  +   L IV E+  GGS+ D     +G      +  V  +  KG+ YLH+   IHRD
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126

Query: 238 LKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVIEHK---PYDHKAD 293
           +K AN+L+ E+  VK+ADFGV A++ A      +  GT  WMAPEV   +    YD K D
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ---PKLAELLERCWQQ 350
           +++ GI   EL   + P   L P++A   + +    P   K+ +   P   + +++C  +
Sbjct: 187 IWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTK 246

Query: 351 DPALRPDFSEI 361
           DP  RP  +++
Sbjct: 247 DPKKRPTATKL 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  156 bits (396), Expect = 4e-45
 Identities = 79/260 (30%), Positives = 134/260 (51%), Gaps = 17/260 (6%)

Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 172
            L+    +  GS G +Y+  +    +  A+K +     + + +K+  +E+  +R      
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPY 60

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN- 231
           VV+  GA  K   + IV E+M GGS+ D L K  G    P L  +A  + KG++YLH   
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDH 290
           +IIHRD+K +NLL++    VK+ADFG+++V   +        GT  +M+PE I+ + Y +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 291 KADVFSFGIVLWELLTGKLPYE------YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAEL 343
            AD++S G+ L E   GK P+       +   +QA    +  G  P++P     P+  + 
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPPPSLPAEEFSPEFRDF 235

Query: 344 LERCWQQDPALRPDFSEIIE 363
           +  C Q+DP  RP  +E+++
Sbjct: 236 ISACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  155 bits (394), Expect = 6e-45
 Identities = 69/246 (28%), Positives = 132/246 (53%), Gaps = 15/246 (6%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G +++    +  +  A+K +   ++N   ++E   E  ++ K+    ++++  
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHR 236
           +      L IV E+   G ++  L   +G   LP   + +  I +  G+ +LH   I+HR
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 294
           D+K+ NL +D  + VK+ D GVA++ + +    A T  GT  +++PE+ E KPY+ K+DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDV 184

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNSQPKLAELLERCWQQD 351
           ++ G+VL+E  TGK P++          ++ K +R   P + +    +LA+L+++C  +D
Sbjct: 185 WALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240

Query: 352 PALRPD 357
              RPD
Sbjct: 241 YRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  154 bits (391), Expect = 1e-44
 Identities = 91/263 (34%), Positives = 152/263 (57%), Gaps = 10/263 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M+ 
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 226
           ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G    LP L+  +  +++GM 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L  +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 235

Query: 344 LERCWQQDPALRPDFSEIIEILQ 366
           + RCW+  P  RP F  I  +L 
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  153 bits (387), Expect = 8e-44
 Identities = 84/270 (31%), Positives = 141/270 (52%), Gaps = 14/270 (5%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           ID   +K    + +G +G++ RG           VAIK LK        +++F  E  IM
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
            +  H N++   G  TK   + I+TEFM  G++  +L +  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------RWMA 279
            YL + N +HRDL A N+L++ N V KV+DFG++R           T +       RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           PE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++  R   P +   
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPT 238

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQI 368
            L +L+  CWQ+D   RP F +I+  L ++
Sbjct: 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  150 bits (381), Expect = 7e-43
 Identities = 91/284 (32%), Positives = 138/284 (48%), Gaps = 36/284 (12%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEFAQEV 162
           E+    +     +  G++G++Y G Y  +D       VA+K L PE  +   + +F  E 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEA 60

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------LLK 216
            IM K  H+N+V+ IG   +     I+ E M+GG +  +L + +   + PS      LL 
Sbjct: 61  LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETG 273
            A DV+KG  YL +N+ IHRD+ A N L+       V K+ADFG+AR   ++        
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY------ 174

Query: 274 TYR----------WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 322
            YR          WM PE      +  K DV+SFG++LWE+ + G +PY   T  Q  + 
Sbjct: 175 -YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVME 232

Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V  G R   PK     +  ++  CWQ  P  RP+F+ I+E +Q
Sbjct: 233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  151 bits (382), Expect = 1e-42
 Identities = 89/301 (29%), Positives = 149/301 (49%), Gaps = 41/301 (13%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G +G + R      D         VA+K+LK    + D+  +  
Sbjct: 7   WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLI 65

Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------ 206
            E+ +M+ + +HKN++  +G CT+   L ++ E+ + G++ ++L   +            
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 207 ---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 260
                     L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 261 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
                 K  +G +       +WMAPE +  + Y H++DV+SFGI++WE+ T G  PY  +
Sbjct: 186 DIDYYKKTSNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 374
            P++    ++++G R   P N   +L  L+  CW   P  RP F +++E L ++   V E
Sbjct: 241 -PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299

Query: 375 E 375
           E
Sbjct: 300 E 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  149 bits (378), Expect = 2e-42
 Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 12/268 (4%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 165
           ID   +K    + +G +G++  G           VAIK LK        +++F  E  IM
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
            +  H N++   G  TK   + IVTE+M  GS+  +L K  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAPE 281
            YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P +    L
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAAL 238

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQI 368
            +L+  CWQ+D   RP F +I+ IL ++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  149 bits (379), Expect = 2e-42
 Identities = 83/278 (29%), Positives = 142/278 (51%), Gaps = 28/278 (10%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQEV 162
           EI    ++F  ++  G++G +Y+G          +  VAIK LK E     +Q+EF QE 
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 207
            +M  ++H N+V  +G CTK    C++ E+++ G ++++L                 +K 
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 266
                  L +AI ++ GM YL  ++ +HRDL A N L+ E   VK++DFG++R    +  
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179

Query: 267 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
             V +      RWM PE I +  +  ++D++SFG+VLWE+ + G  PY Y    Q  + +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY-YGFSNQEVIEM 238

Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           ++       P++   ++  L+  CW + PA RP F +I
Sbjct: 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  149 bits (377), Expect = 2e-42
 Identities = 82/259 (31%), Positives = 135/259 (52%), Gaps = 16/259 (6%)

Query: 116 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           L++  ++ +G+ G     L+R T   + +A+K ++ E IN  +QK+  +E+ I+ K    
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPT--GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-Q 230
            +V F GA      + I  E+M GGS+   L +++G      L K+A+ V KG+ YLH +
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
           + IIHRD+K +N+L++    +K+ DFGV+     S   T   GT  +MAPE I+   Y  
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSV 178

Query: 291 KADVFSFGIVLWELLTGKLPY-----EYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELL 344
           K+D++S G+ L EL TG+ PY           +    +V     P +P     P   + +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFV 237

Query: 345 ERCWQQDPALRPDFSEIIE 363
             C  +DP  RP + E++E
Sbjct: 238 NLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 1e-41
 Identities = 84/262 (32%), Positives = 139/262 (53%), Gaps = 20/262 (7%)

Query: 122 VASGSYGDLYRGTY--CSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRH---KNV 173
           +  G+YG +YRG +    + VA+K++    P+   SD+Q+E A    ++ ++R     N+
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNI 64

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
            ++ G+  K P L I+ E+  GGSV   +    G      +  +  +V   + Y+H+  +
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGV 122

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHK 291
           IHRD+KAAN+L+     VK+ DFGVA +  Q S   +   GT  WMAPEVI E K YD K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQ 350
           AD++S GI ++E+ TG  PY  +   + A+ ++ K   P +  N     L E +  C  +
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFR-AMMLIPKSKPPRLEDNGYSKLLREFVAACLDE 241

Query: 351 DPALRPDFSEIIEI--LQQIAK 370
           +P  R    E+++   ++  +K
Sbjct: 242 EPKERLSAEELLKSKWIKAHSK 263

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  146 bits (370), Expect = 3e-41
 Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 41/283 (14%)

Query: 116 LKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           LK G  +  G +G +  G     D     VA+K +K +       +EF  E   M+   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 171 KNVVQFIGAC------TKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SLLKVAI 219
            NV++ IG C       K P   ++  FM  G ++ +L   +      KLP  +LLK  +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----Y 275
           D++ GM YL   N IHRDL A N ++ E+  V VADFG+++ K  SG    +        
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYSGDYYRQGRIAKMPV 179

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP---------YEYLTPLQAAVGVVQ 325
           +W+A E +  + Y  K+DV++FG+ +WE+ T G+ P         Y+YL          +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL----------R 229

Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            G R   P++   +L +L+  CW+ DP  RP F+++ E+L+ I
Sbjct: 230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 4e-41
 Identities = 83/271 (30%), Positives = 141/271 (52%), Gaps = 22/271 (8%)

Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE-FAQ 160
           +  D+WEI         ++  G++G +Y+  +    +  A K+++   I S+ + E F  
Sbjct: 2   NPNDIWEII-------GELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMV 51

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           E+ I+ + +H N+V    A      L I+ EF  GG++   + +L+     P +  V   
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 279
           + + +N+LH + +IHRDLKA N+L+  +  VK+ADFGV A+ K+         GT  WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 280 PEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI-- 332
           PEV+     +  PYD+KAD++S GI L EL   + P+  L P++  +  + K   PT+  
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQ 230

Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           P        + L+ C  +DP  RP  +E+++
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  145 bits (368), Expect = 4e-41
 Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 26/265 (9%)

Query: 122 VASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQK--EFAQEVFIMRKVRHKNVV 174
           +  G +G +Y GT    D      A+K L   RI +D+++  +F +E  IM+   H NV+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 175 QFIGACTKPPSL-CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
             +G C        +V  +M  G + +++        +  L+   + V+KGM YL     
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119

Query: 234 IHRDLKAANLLMDENEVVKVADFGVAR---------VKAQSGVMTAETGTYRWMAPEVIE 284
           +HRDL A N ++DE+  VKVADFG+AR         V   +G         +WMA E ++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQ 175

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
            + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEV 234

Query: 344 LERCWQQDPALRPDFSEIIEILQQI 368
           +  CW   P +RP FSE++  ++QI
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  145 bits (368), Expect = 5e-41
 Identities = 83/261 (31%), Positives = 146/261 (55%), Gaps = 20/261 (7%)

Query: 119 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSD-------MQKEFAQEVFIMRKVR 169
           G+ + SGS+G +Y G   S    +A+K ++   +++        M    A+E+ ++++++
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H+N+VQ++G+      L I  E++ GGSV   L+   G F+   +      + KG+NYLH
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH 123

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--------WMAPE 281
              IIHRD+K AN+L+D    +K++DFG+++ K ++  ++ +T   R        WMAPE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           V++   Y  KAD++S G ++ E+LTGK P+   T LQA   + +    P IP N   +  
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAI 241

Query: 342 ELLERCWQQDPALRPDFSEII 362
           + LE+ ++ D   RP  +E++
Sbjct: 242 DFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  145 bits (367), Expect = 5e-41
 Identities = 74/248 (29%), Positives = 132/248 (53%), Gaps = 7/248 (2%)

Query: 120 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
            K+  GSYG +Y+    S  Q  A+K +    ++   +++   E+ I+  V H N++ + 
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
            A      LCIV E+   G +   + K    + +     + ++ I + +G+  LH+  I+
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 294
           HRDLK+AN+L+  N++VK+ D G+++V  +  +   + GT  +MAPEV + +PY +K+D+
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           +S G +L+E+ T   P+E  + +Q     VQ+G  P IP      L   +    Q  P L
Sbjct: 185 WSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKL 243

Query: 355 RPDFSEII 362
           RP+  +I+
Sbjct: 244 RPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  145 bits (369), Expect = 9e-41
 Identities = 89/305 (29%), Positives = 144/305 (47%), Gaps = 56/305 (18%)

Query: 110 EIDPKHLKFGSKVASGSYGDLY-RGTYCSQD-----------------VAIKVLKPERIN 151
           E   + L F  K+  G +G+++       QD                 VA+KVL+P+  +
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-AS 59

Query: 152 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK------- 204
            + +++F +EV I+ ++   N+ + +G CT  P LC++ E+M  G +  +L K       
Sbjct: 60  DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119

Query: 205 -LKGVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 261
                  L   +LL +A  ++ GM YL   N +HRDL   N L+ +N  +K+ADFG++R 
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178

Query: 262 KAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GK 308
                     +  Y           RWMA E +    +  K+DV++FG+ LWE+LT   +
Sbjct: 179 -------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Query: 309 LPYEYLTP---LQAAVGVVQKGLRPTI---PKNSQPKLAELLERCWQQDPALRPDFSEII 362
            PYE+LT    ++ A    +   R      P N    + EL+  CW++D   RP F EI 
Sbjct: 232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291

Query: 363 EILQQ 367
             LQ+
Sbjct: 292 LFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  145 bits (367), Expect = 1e-40
 Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 27/253 (10%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K+LK E  ++DMQ +F +E  +M +  H N+V+ +G C     +C++ E+M+ G + 
Sbjct: 38  VAVKMLK-EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 200 DYLH-----------------KLKGVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDL 238
           ++L                  +  G+  LP      L +A  V+ GM YL +   +HRDL
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVF 295
              N L+ EN VVK+ADFG++R    +    A        RWM PE I +  Y  ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216

Query: 296 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           ++G+VLWE+ + G  PY Y    +  +  V+ G   + P N   +L  L+  CW + P+ 
Sbjct: 217 AYGVVLWEIFSYGMQPY-YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275

Query: 355 RPDFSEIIEILQQ 367
           RP F+ I  ILQ+
Sbjct: 276 RPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  145 bits (366), Expect = 2e-40
 Identities = 83/260 (31%), Positives = 142/260 (54%), Gaps = 13/260 (5%)

Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL +  ++H
Sbjct: 74  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH 132

Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A      AE G    +WMA E I H+ Y H++
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192

Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 251

Query: 352 PALRPDFSEIIEILQQIAKE 371
              RP F E+I    ++A++
Sbjct: 252 ADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  143 bits (363), Expect = 2e-40
 Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 17/259 (6%)

Query: 119 GSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           G+K+  G++G +Y     + D    +A+K ++ +  +    KE A E+ ++  ++H N+V
Sbjct: 5   GNKIGGGTFGKVYTAV--NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           ++ G       + I  E+ SGG++ + L     +     +    + + +G+ YLH + I+
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYD 289
           HRD+K AN+ +D N V+K+ DFG A     +     E      GT  +MAPEVI      
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 290 HK---ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELL 344
                AD++S G V+ E+ TGK P+  L      +  V  G +P IP + Q  P+  + L
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL 241

Query: 345 ERCWQQDPALRPDFSEIIE 363
           +RC + DP  RP  SE+++
Sbjct: 242 DRCLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  144 bits (365), Expect = 3e-40
 Identities = 88/294 (29%), Positives = 148/294 (50%), Gaps = 41/294 (13%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G +G +        D         VA+K+LK +    D+  +  
Sbjct: 13  WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLI 71

Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL                
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 260
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 261 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
                 K  +G +       +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  +
Sbjct: 192 HIDYYKKTTNGRLPV-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 247 -PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  144 bits (365), Expect = 5e-40
 Identities = 90/294 (30%), Positives = 152/294 (51%), Gaps = 41/294 (13%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G +G +        D         VA+K+LK +  + D+  +  
Sbjct: 7   WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLV 65

Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +           K
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 211 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 260
           LP        L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Query: 261 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
                 K  +G +       +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  +
Sbjct: 186 NIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L ++
Sbjct: 241 -PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  144 bits (363), Expect = 6e-40
 Identities = 90/303 (29%), Positives = 154/303 (50%), Gaps = 43/303 (14%)

Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERI 150
           ++P D    WE     L  G  +  G +G +        D         VA+K+LK +  
Sbjct: 3   ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 151 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--- 206
             D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +   
Sbjct: 61  EKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 207 -----GVFKLPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 254
                 + ++P        L+     V++GM YL     IHRDL A N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179

Query: 255 DFGVAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 306
           DFG+AR         K  +G +       +WMAPE +  + Y H++DV+SFG+++WE+ T
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Query: 307 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
            G  PY  + P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L
Sbjct: 235 LGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Query: 366 QQI 368
            +I
Sbjct: 294 DRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  141 bits (358), Expect = 1e-39
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 16/259 (6%)

Query: 119 GSKVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDM-QKEFA---QEVFIMRKVRHKNV 173
           G  +  G+YG +Y G T   Q +A+K ++ +  N    +KE+    +EV +++ ++H N+
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           VQ++G C    ++ I  EF+ GGS+   L++  G    P   K    +  G+ YLH N +
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKA-------QSGVMTAETGTYRWMAPEVIEHK 286
           +HRD+K  N+++  N ++K+ DFG AR  A        S ++ +  GT  WMAPEVI   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA--AVGVVQKGLRPTIPKNSQPKLAELL 344
            Y  K+D++S G  ++E+ TGK P   +  L A   +G   +GL P +P +      + +
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFV 242

Query: 345 ERCWQQDPALRPDFSEIIE 363
             C  +D   RP   +++ 
Sbjct: 243 TSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 3e-39
 Identities = 91/291 (31%), Positives = 137/291 (47%), Gaps = 53/291 (18%)

Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQE 161
           D T ++E+          +  G+YG +Y+  +    Q VAIK++    I  D ++E  +E
Sbjct: 3   DPTGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEE 52

Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 214
             I+RK   H N+  F GA  K           +V E   GGSV D +   KG+ K    
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109

Query: 215 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGV 267
           LK         +  +G+ YLH+N +IHRD+K  N+L+ +N  VK+ DFGV+  + +  G 
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 268 MTAETGTYRWMAPEVI--EHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                GT  WMAPEVI  + +P   YD ++DV+S GI   EL  GK P   + P++A   
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF- 228

Query: 323 VVQKGLRPTIPKNSQPKLA----------ELLERCWQQDPALRPDFSEIIE 363
                    IP+N  P L           + +  C  ++   RP   E++E
Sbjct: 229 --------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  141 bits (357), Expect = 3e-39
 Identities = 92/293 (31%), Positives = 149/293 (50%), Gaps = 34/293 (11%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           WE     +KF   +  G++G + R          + AIK+LK E  + +  ++FA E+ +
Sbjct: 1   WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55

Query: 165 MRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------- 213
           + K+  H N++  +GAC     L I  E+   G++ D+L K + +   P+          
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 214 -----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 268
                LL+ A DV+ GM YL +   IHRDL A N+L+ EN   K+ADFG++R +      
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 327
           T      RWMA E + +  Y  K+DV+SFG++LWE+++ G  PY  +T  +    + Q G
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G 234

Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERR 380
            R   P+N   ++ EL+ +CW+  P  RP F+       QI+ ++    E R+
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFA-------QISVQLSRMLEARK 280

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  141 bits (356), Expect = 5e-39
 Identities = 87/282 (30%), Positives = 149/282 (52%), Gaps = 23/282 (8%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           ++   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62

Query: 167 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 213
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 214 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
              LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T 
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241

Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
              P N   ++ +L+ +CW++ P  RP F++I+  L ++ +E
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  139 bits (353), Expect = 1e-38
 Identities = 83/277 (29%), Positives = 141/277 (50%), Gaps = 40/277 (14%)

Query: 122 VASGSYGDLYRGTYCS----QD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +  G++G ++ G         D   VA+K LK E  ++D +K+F +E  ++   +H+N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHK-------------LKGVFKLPSLLKVAIDV 221
           +F G CT+     +V E+M  G +  +L                 G   L  LL++A+ +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------ 275
           + GM YL   + +HRDL   N L+  + VVK+ DFG++R      V T  T  Y      
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184

Query: 276 ----RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 330
               RWM PE I ++ +  ++DV+SFG+VLWE+ T GK P+ Y    +  +  + +G   
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEVIECITQGRLL 243

Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             P+    ++ +++  CW++DP  R +  +I E LQ+
Sbjct: 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  139 bits (351), Expect = 1e-38
 Identities = 80/269 (29%), Positives = 141/269 (52%), Gaps = 14/269 (5%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQEV 162
           E+D K +K    + +G +G+L RG  C +        VAI  L+    +   ++ F  E 
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRG--CLKLPSKRELPVAIHTLR-AGCSDKQRRGFLAEA 57

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
             + +  H N+V+  G  T+  ++ IVTE+MS G++  +L K +G      L+ +   ++
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAP 280
            GM YL +   +H+ L A  +L++ + V K++ F   +      + T  +G     W AP
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I++  +   +DV+SFGIV+WE+++ G+ PY  ++  Q  +  V+ G R   P+N    
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNL 236

Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           L +L+  CWQ++   RP FS+I  IL ++
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  138 bits (350), Expect = 2e-38
 Identities = 81/260 (31%), Positives = 140/260 (53%), Gaps = 13/260 (5%)

Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +          VAIKVL+ E  +    KE   E ++M  V    V +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ +VT+ M  G + DY+ + K       LL   + ++KGM+YL +  ++H
Sbjct: 74  LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132

Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+     VK+ DFG+AR +        A+ G    +WMA E I H+ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192

Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ +CW  D
Sbjct: 193 DVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMID 251

Query: 352 PALRPDFSEIIEILQQIAKE 371
              RP F E+++   ++A++
Sbjct: 252 SECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  138 bits (348), Expect = 4e-38
 Identities = 82/246 (33%), Positives = 135/246 (54%), Gaps = 7/246 (2%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G++++G      + VAIK++  E    +++ +  QE+ ++ +     V ++ G
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 127

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 297
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 188 GITAIELAKGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246

Query: 358 FSEIIE 363
             E+++
Sbjct: 247 AKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  138 bits (348), Expect = 4e-38
 Identities = 84/254 (33%), Positives = 132/254 (51%), Gaps = 23/254 (9%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           ++  GS+G++Y+G      + VAIK++  E    +++ +  QE+ ++ +     + ++ G
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L I+ E++ GGS  D L    G  +   +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           KAAN+L+ E   VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL--------AELLERCWQ 349
           GI   EL  G+ P   L P++             IPKNS P L         E +E C  
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQYSKPFKEFVEACLN 238

Query: 350 QDPALRPDFSEIIE 363
           +DP  RP   E+++
Sbjct: 239 KDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  138 bits (348), Expect = 4e-38
 Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 22/265 (8%)

Query: 119 GSKVASGSYGDLYRGTYCS--QDVAIK-VLKPERINS-------DMQKEFAQEVFIMRKV 168
           G  +  G+YG +Y     +  + +A+K V  P  I         DM K    E+  ++ +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H N+VQ++G  T    L I  E++ GGS+   L    G F+   +      V +G+ YL
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYL 124

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAPEVIE 284
           H   I+HRDLKA NLL+D + + K++DFG+++    +      M+ + G+  WMAPEVI 
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIH 183

Query: 285 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL-- 340
              + Y  K D++S G V+ E+  G+ P+     + A   +  K   P IP +    L  
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243

Query: 341 --AELLERCWQQDPALRPDFSEIIE 363
              + L  C+  +P  RP   E+++
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  137 bits (347), Expect = 6e-38
 Identities = 77/257 (29%), Positives = 131/257 (50%), Gaps = 21/257 (8%)

Query: 132 RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIV 189
            G    + VA+K LKPE   + +  +  +E+ I+R + H+N+V++ G CT+     + ++
Sbjct: 28  EGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            EF+  GS+ +YL + K    L   LK A+ + KGM+YL     +HRDL A N+L++   
Sbjct: 87  MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146

Query: 250 VVKVADFGVAR-VKAQSGVMTAE---TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
            VK+ DFG+ + ++      T +        W APE +    +   +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 306 T--------GKLPYEYLTPLQAA------VGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           T          L  + + P          V V+++G R   P N   ++ +L+ +CW+  
Sbjct: 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266

Query: 352 PALRPDFSEIIEILQQI 368
           P+ R  F  +IE  + I
Sbjct: 267 PSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  137 bits (345), Expect = 2e-37
 Identities = 82/260 (31%), Positives = 141/260 (54%), Gaps = 13/260 (5%)

Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK+L  E        EF  E  IM  + H ++V+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C  P ++ +VT+ M  G + DY+H+ K       LL   + ++KGM YL +  ++H
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132

Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+     VK+ DFG+AR ++       A+ G    +WMA E I ++ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192

Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ +CW  D
Sbjct: 193 DVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMID 251

Query: 352 PALRPDFSEIIEILQQIAKE 371
              RP F E+     ++A++
Sbjct: 252 ADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  135 bits (342), Expect = 2e-37
 Identities = 70/247 (28%), Positives = 133/247 (53%), Gaps = 7/247 (2%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++G+  LYR T     V  K +   R++   +++   E+ I+  ++H N++ +   
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 180 CTKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                +L I  E+ +GG++YD +  +   +F+   +L     +   ++Y+H+  I+HRD+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 296
           K  N+ + +  ++K+ DFG++++      M AET  GT  +M+PE+ +   Y+ K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 356
            G VL+ELLT K  ++   PL   V +VQ    P +   S  +L  L+    QQDP  RP
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHSLLQQDPEKRP 245

Query: 357 DFSEIIE 363
              E+++
Sbjct: 246 TADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  135 bits (341), Expect = 4e-37
 Identities = 83/252 (32%), Positives = 139/252 (55%), Gaps = 19/252 (7%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           ++  GS+G++++G      Q VAIK++  E    +++ +  QE+ ++ +     V ++ G
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
           +  K   L I+ E++ GGS  D L       F++ ++LK   ++ KG++YLH    IHRD
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126

Query: 238 LKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           +KAAN+L+ E   VK+ADFGVA      ++K  + V     GT  WMAPEVI+   YD K
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIQQSAYDSK 181

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           AD++S GI   EL  G+ P   + P++  + ++ K   PT+         E ++ C  +D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240

Query: 352 PALRPDFSEIIE 363
           P+ RP   E+++
Sbjct: 241 PSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  135 bits (341), Expect = 4e-37
 Identities = 78/251 (31%), Positives = 129/251 (51%), Gaps = 20/251 (7%)

Query: 131 YRGTYCSQDV------AIKVLKPERINSDMQKEFAQ----EVFIMRKVRHKNVVQFIGAC 180
           +   Y ++DV      A+K +   R  S  Q+E  +    E+ +M ++ H ++++ +GA 
Sbjct: 13  FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
            +     +  E+M+GGSV   L K  G FK   ++     + +G++YLH+N IIHRD+K 
Sbjct: 73  CEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG 131

Query: 241 ANLLMDEN-EVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYDHKADV 294
           ANLL+D   + +++ADFG A   A  G    E      GT  +MAPEV+  + Y    DV
Sbjct: 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191

Query: 295 FSFGIVLWELLTGKLPY---EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           +S G V+ E+ T K P+   ++   L     +      P+IP++  P L ++  RC +  
Sbjct: 192 WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ 251

Query: 352 PALRPDFSEII 362
           P  RP   E++
Sbjct: 252 PEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  136 bits (343), Expect = 2e-36
 Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 27/273 (9%)

Query: 117 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRH-KNVV 174
           +   K+  GS+G++Y      + VA+KVL  +  + S   + F +E+ I+  + H  N+V
Sbjct: 3   RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +         SL +V E++ GGS+ D L K+  KG       L +   +   + YLH   
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121

Query: 233 IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-------MTAETGTYRWMAPEVIE 284
           IIHRD+K  N+L+D +  VVK+ DFG+A++    G         +   GT  +MAPEV+ 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 285 HK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-----------GLRP 330
                     +D++S GI L+ELLTG  P+E      A    ++             L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           + P+      ++LL++   +DP  R   S  + 
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  134 bits (338), Expect = 2e-36
 Identities = 83/282 (29%), Positives = 138/282 (48%), Gaps = 29/282 (10%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS-QD-----VAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +HLKF  ++  G++G +    Y   QD     VA+K L+     ++  ++F +E+ I++ 
Sbjct: 4   RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKS 61

Query: 168 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           ++H N+V++ G C      +L +V E++  GS+ DYL K +       LL  A  + KGM
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYR--WMAPE 281
            YL     +HRDL   N+L++    VK+ DFG+ +V  Q        E G     W APE
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYL------TPLQAAV----GVVQK 326
            +    +   +DV+SFG+VL+EL T        P E++         Q  V     +++ 
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241

Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             R   P     ++  +++ CW  DP+ RP FSE+   ++ I
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  133 bits (337), Expect = 2e-36
 Identities = 86/282 (30%), Positives = 143/282 (50%), Gaps = 31/282 (10%)

Query: 114 KHLKFGSKVASGSYGD--LYRGTYCSQD----VAIKVLKPERINSDMQKE-FAQEVFIMR 166
           ++LK    +  G +G   LY     +      VA+K LK E          + +E+ I++
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61

Query: 167 KVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            + H+N+V++ G C++     L ++ E++  GS+ DYL K K    L  LL  A  + +G
Sbjct: 62  TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEG 119

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYR--WMAP 280
           M YLH  + IHRDL A N+L+D + +VK+ DFG+A+   +        E G     W A 
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLTGKLPY--------EYLTPLQAAVGVV------QK 326
           E ++   + + +DV+SFG+ L+ELLT             E + P Q  + VV      ++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239

Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           G+R   PKN   ++  L++ CW+ +   RP F  +I IL+++
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  133 bits (335), Expect = 3e-36
 Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 23/261 (8%)

Query: 122 VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 176
           +  G++G + +          D AIK +K E  + D  ++FA E+ ++ K+  H N++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------------LLKVAIDV 221
           +GAC     L +  E+   G++ D+L K + +   P+               LL  A DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           ++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T      RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R   P N   ++
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEV 240

Query: 341 AELLERCWQQDPALRPDFSEI 361
            +L+ +CW++ P  RP F++I
Sbjct: 241 YDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  133 bits (335), Expect = 3e-36
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 28/272 (10%)

Query: 116 LKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV 168
           ++F  ++   ++G +Y+G         +Q VAIK LK   IN+  Q  EF QE  +M ++
Sbjct: 7   VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAEL 64

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL----------------HKLKGVFKLP 212
            H N+V  +G  T+   +C++ E+++ G ++++L                  +K      
Sbjct: 65  HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 272
             L +AI ++ GM YL  +  +H+DL A N+L+ E   VK++D G++R    +     + 
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 273 GTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
            +    RWM PE I +  +   +D++SFG+VLWE+ +  L   Y    Q  + +V+K   
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
               ++  P++  L+  CWQ+ P+ RP F +I
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  132 bits (333), Expect = 6e-36
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 32/284 (11%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF  E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNE 59

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPSL- 214
             +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PSL 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 215 --LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQ 264
             +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K  
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
            G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ ++  Q    V
Sbjct: 180 KGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
           ++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 235 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  131 bits (331), Expect = 2e-35
 Identities = 79/287 (27%), Positives = 146/287 (50%), Gaps = 36/287 (12%)

Query: 116 LKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           L  G  +  G +G + + T            VA+K+LK E  +S   ++   E  ++++V
Sbjct: 2   LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQV 60

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------- 208
            H +V++  GAC++   L ++ E+   GS+  +L + + V                    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 209 ---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQ 264
                +  L+  A  +S+GM YL +  ++HRDL A N+L+ E   +K++DFG++R V  +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 265 SGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  + P +   
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLF 239

Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +++ G R   P+N   ++  L+  CW+Q+P  RP F++I + L+++
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  130 bits (329), Expect = 4e-35
 Identities = 76/244 (31%), Positives = 120/244 (49%), Gaps = 27/244 (11%)

Query: 151 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGS---VYDYLHKL 205
           N D+QK+  +E+ I +  +   +V++ GA     S  + I  E+  GGS   +Y  + K 
Sbjct: 39  NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 265
            G      L K+A  V KG++YLH   IIHRD+K +N+L+     VK+ DFGV+     S
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158

Query: 266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 325
              T  TGT  +MAPE I+ KPY   +DV+S G+ L E+   + P+    P +    +  
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF----PPEGEPPLGP 213

Query: 326 KGLRPTIPKNSQPKLAE--------------LLERCWQQDPALRPDFSEIIE---ILQQI 368
             L   I     P+L +               +++C ++DP  RP   +++E   I  Q+
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273

Query: 369 AKEV 372
            K+V
Sbjct: 274 KKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  129 bits (327), Expect = 6e-35
 Identities = 73/263 (27%), Positives = 132/263 (50%), Gaps = 26/263 (9%)

Query: 125 GSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFI 177
           G++G ++ G          ++V +K +K     S++Q     QE  ++  + H+N++  +
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPIL 74

Query: 178 GACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS-------LLKVAIDVSKGMNY 227
             C +   PP +     +M+ G++  +L + +              L+ +AI ++ GM+Y
Sbjct: 75  HVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR---WMAPEVIE 284
           LH+  +IH+D+ A N ++DE   VK+ D  ++R               R   WMA E + 
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
           +K Y   +DV+SFG++LWEL+T G+ PY  + P + A   ++ G R   P N   +L  +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAV 251

Query: 344 LERCWQQDPALRPDFSEIIEILQ 366
           +  CW  DP  RP FS++++ L 
Sbjct: 252 MACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  129 bits (326), Expect = 6e-35
 Identities = 79/249 (31%), Positives = 135/249 (54%), Gaps = 13/249 (5%)

Query: 125 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 183
           G+YG +Y     S  V I + + PER +  +Q    +E+ +   ++H+N+VQ++G+ ++ 
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSDSEN 77

Query: 184 PSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               I  E + GGS+   L    G  K    +++     + +G+ YLH N I+HRD+K  
Sbjct: 78  GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137

Query: 242 NLLMDE-NEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP--YDHKADVFSF 297
           N+L++  + VVK++DFG ++  A     T   TGT ++MAPEVI+  P  Y   AD++S 
Sbjct: 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197

Query: 298 GIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           G  + E+ TGK P+  L   QAA   VG+ +    P IP++   +    + RC++ DP  
Sbjct: 198 GCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDK 255

Query: 355 RPDFSEIIE 363
           R    ++++
Sbjct: 256 RASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  129 bits (326), Expect = 7e-35
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 29/264 (10%)

Query: 125 GSYGDLY----RGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           G +G+++    +G         V +K L+ +  + ++Q EF +E+ + RK+ HKNVV+ +
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRKLSHKNVVRLL 74

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSL-----LKVAIDVSKGMNYLH 229
           G C +     ++ E+   G +  +L   K      K P L     + +   ++ GM++L 
Sbjct: 75  GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-------RWMAPEV 282
               +HRDL A N L+     VKV+   +++    S     E           RW+APE 
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-----EYYKLRNALIPLRWLAPEA 189

Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           ++   +  K+DV+SFG+++WE+ T G+LP+  L+  +    +    L   +P+    +L 
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249

Query: 342 ELLERCWQQDPALRPDFSEIIEIL 365
           +L+ RCW  +P  RP FSE++  L
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  128 bits (322), Expect = 1e-34
 Identities = 76/250 (30%), Positives = 136/250 (54%), Gaps = 12/250 (4%)

Query: 121 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           ++ SG++G + +G Y  +    DVAIKVLK E   S  + E  +E  IM ++ +  +V+ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRM 60

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IG C +  +L +V E  SGG +  +L   K    + +++++   VS GM YL   N +HR
Sbjct: 61  IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 237 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKA 292
           DL A N+L+      K++DFG+++ + A      A +      +W APE I  + +  ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+GI +WE  + G+ PY+ +   +  +  +++G R   P    P++  L++ CW   
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238

Query: 352 PALRPDFSEI 361
              RP+F+++
Sbjct: 239 WEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 2e-34
 Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 7/218 (3%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+KVLK ++I    + E    E  I+ ++ H  +V+   A      L +V E+  GG ++
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
            +L K +G F        A ++   + YLH   II+RDLK  N+L+D +  +K+ DFG+A
Sbjct: 82  SHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140

Query: 260 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 317
           +  + S      T  GT  ++APEV+  K Y    D +S G++L+E+LTGK P+ Y    
Sbjct: 141 KELS-SEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDR 198

Query: 318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           +     + K      P+   P+  +L+    Q+DP  R
Sbjct: 199 KEIYEKILKD-PLRFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  128 bits (323), Expect = 2e-34
 Identities = 82/291 (28%), Positives = 142/291 (48%), Gaps = 46/291 (15%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKP-----ERINSDM 154
           WE+  + +    ++  GS+G +Y G   ++D         VA+K +       ERI    
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGN--ARDIIKGEAETRVAVKTVNESASLRERI---- 54

Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---- 210
             EF  E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +    
Sbjct: 55  --EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 211 -----LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----- 260
                L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R     
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 261 ---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 316
               K   G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+ 
Sbjct: 173 DYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227

Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            Q    V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+ 
Sbjct: 228 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  128 bits (322), Expect = 2e-34
 Identities = 82/256 (32%), Positives = 129/256 (50%), Gaps = 36/256 (14%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG------ACTKPPSLCIVTE 191
           Q VA+K+LK +  +S   +EF +E   M++  H NV++ IG      A  + P   ++  
Sbjct: 28  QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87

Query: 192 FMSGGSVYDYLHKLK---GVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 246
           FM  G ++ +L   +     F LP  +L++  ID++ GM YL   N IHRDL A N +++
Sbjct: 88  FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147

Query: 247 ENEVVKVADFGVARVKAQSGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 302
           EN  V VADFG+++ K  SG       A     +W+A E +    Y   +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 303 ELLT-GKLP---------YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           E++T G+ P         Y YL           KG R   P +    + EL+ +CW  +P
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYLI----------KGNRLKQPPDCLEDVYELMCQCWSPEP 256

Query: 353 ALRPDFSEIIEILQQI 368
             RP F  + + L+ I
Sbjct: 257 KCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  126 bits (319), Expect = 4e-34
 Identities = 68/245 (27%), Positives = 131/245 (53%), Gaps = 5/245 (2%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           V  G++G ++  R     + V IK +  E++  D +     E  +++ + H N++++   
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
             +  +L IV E+  GG++ +Y+ K    +    ++L   + +   ++++H   I+HRDL
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 239 KAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  N+L+D+++ VVK+ DFG++++ +         GT  +++PE+ E KPY+ K+D+++ 
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           G VL+EL + K  +E    L A V  +  G    I     P L +L+      DP+ RP 
Sbjct: 188 GCVLYELASLKRAFEAAN-LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQ 246

Query: 358 FSEII 362
            S+I+
Sbjct: 247 LSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  127 bits (319), Expect = 4e-34
 Identities = 72/250 (28%), Positives = 138/250 (55%), Gaps = 12/250 (4%)

Query: 121 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           ++ SG++G + +G Y      + VA+K+LK +  +  ++ E  +E  +M+++ +  +V+ 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IG C +  S  +V E    G +  +L K K V    ++ ++   VS GM YL + N +HR
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 237 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKA 292
           DL A N+L+      K++DFG+++ + A      A+T G +  +W APE + +  +  K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179

Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+SFG+++WE  + G+ PY+ +   +    +++ G R   P+   P++ +L++ CW   
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG 238

Query: 352 PALRPDFSEI 361
              RP F+ +
Sbjct: 239 VDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  126 bits (318), Expect = 8e-34
 Identities = 72/269 (26%), Positives = 138/269 (51%), Gaps = 13/269 (4%)

Query: 113 PKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMR 166
              L+    + SG +G +++G +  +       VAIK ++ +R      +E    +  M 
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMG 64

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
            + H  +V+ +G C    SL +VT+    GS+ D++ + +       LL   + ++KGM 
Sbjct: 65  SLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVI 283
           YL ++ ++HR+L A N+L+  + +V++ADFGVA +     +    +      +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 284 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
               Y H++DV+S+G+ +WE+++ G  PY  + P      +++KG R   P+     +  
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLAQPQICTIDVYM 242

Query: 343 LLERCWQQDPALRPDFSEIIEILQQIAKE 371
           ++ +CW  D  +RP F E+     ++A++
Sbjct: 243 VMVKCWMIDENVRPTFKELANEFTRMARD 271

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  126 bits (317), Expect = 8e-34
 Identities = 74/253 (29%), Positives = 137/253 (54%), Gaps = 11/253 (4%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKP---ERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           ++  GS+G +Y  +      +  +KVLK      +N +   +  QE  ++ K+ H  +V+
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN 232
           F  +  +  + CI+TE+  G  +   L +LK          + +  I +  G++Y+HQ  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAPEVIEHKPYDHK 291
           I+HRDLKA N+ +  N ++K+ DFGV+R+   S  + T  TGT  +M+PE ++H+ YD K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           +D++S G +L+E+      +E    L   + +V+ G  P++P+    +L  +++    +D
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIMQSMLNKD 244

Query: 352 PALRPDFSEIIEI 364
           P+LRP  +EI+  
Sbjct: 245 PSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  126 bits (319), Expect = 1e-33
 Identities = 90/312 (28%), Positives = 138/312 (44%), Gaps = 84/312 (26%)

Query: 115 HLKFGSKVASGSYGDLYRGTYCSQD---------------------VAIKVLKPERINSD 153
           HL F  K+  G +G+++    C                        VA+K+L+P+  N +
Sbjct: 6   HLLFKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKN 61

Query: 154 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG---- 207
            + +F +EV I+ +++  N+++ +G C     LC++TE+M  G +  +L  H L      
Sbjct: 62  ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 208 ------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 255
                            SLL VA+ ++ GM YL   N +HRDL   N L+ EN  +K+AD
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 256 FGVARVKAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWEL 304
           FG++R            G Y           RWMA E I    +   +DV++FG+ LWE+
Sbjct: 182 FGMSR--------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233

Query: 305 LT--GKLPYEYLTPLQAAVGVVQKG-------------LRPTIPKNSQPKLAELLERCWQ 349
           L    + PY  LT  Q    V++                RP  P   Q  L EL+ +CW 
Sbjct: 234 LMLCKEQPYGELTDEQ----VIENAGEFFRDQGRQVYLFRP--PPCPQG-LYELMLQCWS 286

Query: 350 QDPALRPDFSEI 361
           +D   RP FS+I
Sbjct: 287 RDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  125 bits (315), Expect = 2e-33
 Identities = 73/245 (29%), Positives = 128/245 (52%), Gaps = 21/245 (8%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V E+M  G + 
Sbjct: 38  VAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 200 DYL-------HKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
            +L         L        G   L  +L +A  ++ GM YL   + +HRDL   N L+
Sbjct: 96  RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155

Query: 246 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 302
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++D++SFG+VLW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215

Query: 303 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           E+ T GK P+  L+  + A+  + +G     P+   P++  +++ CWQ++P  R    +I
Sbjct: 216 EIFTYGKQPWYQLSNTE-AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Query: 362 IEILQ 366
              LQ
Sbjct: 275 HSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  124 bits (313), Expect = 4e-33
 Identities = 66/257 (25%), Positives = 123/257 (47%), Gaps = 16/257 (6%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            +  GS+G + +    S  + +  K +    +    +++   EV I+R+++H N+V++  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 179 ACTKPPS--LCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---- 229
                 +  L IV E+  GG    +     K +   +   + ++   +   +   H    
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 230 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHK 286
             N ++HRDLK AN+ +D N  VK+ DFG+A++        A+T  GT  +M+PE + H 
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQLNHM 185

Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
            YD K+D++S G +++EL     P+     LQ A   +++G    IP     +L E+++ 
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELNEVIKS 244

Query: 347 CWQQDPALRPDFSEIIE 363
               DP  RP   E+++
Sbjct: 245 MLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  123 bits (311), Expect = 8e-33
 Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 22/273 (8%)

Query: 116 LKFGSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           L  G  +  G +G +  G     D    VA+K +K         ++F  E   M++  H 
Sbjct: 1   LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 172 NVVQFIGACTKP------PSLCIVTEFMSGGSVYDYL--HKLKGV-FKLPS--LLKVAID 220
           NV++ IG C +       PS  ++  FM  G ++ +L   +L      LP+  L+K   D
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE----TGTYR 276
           ++ GM YL   + IHRDL A N +++EN  V VADFG+++ K  +G    +        +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVK 179

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           W+A E +  + Y  K+DV+SFG+ +WE+ T G+ PY  +   +     +++G R   P +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPD 238

Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
               L  L+  CW  +P  RP F  +   L++ 
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  123 bits (309), Expect = 1e-32
 Identities = 68/249 (27%), Positives = 139/249 (55%), Gaps = 7/249 (2%)

Query: 120 SKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
            K+  GS+G   L +     +   IK +   +++   ++E  +EV ++  ++H N+VQ+ 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
            +  +  +L IV ++  GG +Y  ++  +GV F    +L   + +   + ++H   I+HR
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125

Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 294
           D+K+ N+ + ++  +K+ DFG+ARV   S V  A T  GT  +++PE+ E++PY++K+D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           ++ G VL+E+ T K  +E    ++  V  + +G  P +  +    L  L+ + ++++P  
Sbjct: 185 WALGCVLYEMCTLKHAFE-AGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243

Query: 355 RPDFSEIIE 363
           RP  + I+E
Sbjct: 244 RPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-32
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 53/303 (17%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------------------VAIKVLKPERI 150
           E   + L+   K+  G +G+++    C  +                   VA+K+L+ + +
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56

Query: 151 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------K 204
               + +F +E+ IM ++++ N+++ +G C     LC++TE+M  G +  +L        
Sbjct: 57  TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 205 LKGVFKLPS-----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
                 +PS     LL +A+ ++ GM YL   N +HRDL   N L+  +  +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 260 RVKAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWEL--LTGKLPYEY 313
           R    SG      G      RWMA E I    +   +DV++FG+ LWE+  L  + PY  
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235

Query: 314 LTPLQAAVGVVQ----KGLRPTIPKNSQPKLA-----ELLERCWQQDPALRPDFSEIIEI 364
           L+  Q      +    +G +  +   SQ  L      +L+ RCW +D   RP F++I   
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292

Query: 365 LQQ 367
           L++
Sbjct: 293 LRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

 Score =  116 bits (293), Expect = 1e-32
 Identities = 45/68 (66%), Positives = 53/68 (77%)

Query: 1  MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 60
          MHEITF+  DKPKLLSQL++LL D+GLNI EAHAFST DG +LD+FVV GW   ET  L 
Sbjct: 1  MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60

Query: 61 AALEKEVL 68
           AL+KE+ 
Sbjct: 61 HALQKEID 68

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  122 bits (308), Expect = 3e-32
 Identities = 76/253 (30%), Positives = 132/253 (52%), Gaps = 28/253 (11%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K LK   + +  +K+F +E  ++  ++H+++V+F G C     L +V E+M  G + 
Sbjct: 38  VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 200 DYLH---------------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
            +L                + KG   L  +L +A  ++ GM YL   + +HRDL   N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 245 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVL 301
           +  N +VK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG++L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215

Query: 302 WELLT-GKLPYEYLTPLQAAVGVVQKGL--RPTI-PKNSQPKLAELLERCWQQDPALRPD 357
           WE+ T GK P+  L+  +    + Q  +  RP + PK    ++ +++  CWQ++P  R +
Sbjct: 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK----EVYDIMLGCWQREPQQRLN 271

Query: 358 FSEIIEILQQIAK 370
             EI +IL  + K
Sbjct: 272 IKEIYKILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  122 bits (306), Expect = 4e-32
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 37/267 (13%)

Query: 122 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 178
           V +G+YG +Y+G +    Q  AIKV+    +  D ++E  QE+ +++K   H+N+  + G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 179 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 231
           A  K  PP     L +V EF   GSV D +   KG   K   +  +  ++ +G+++LHQ+
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 232 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 287
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190

Query: 288 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---- 341
             YD K+D++S GI   E+  G  P   + P++A            IP+N  P+L     
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 241

Query: 342 -----ELLERCWQQDPALRPDFSEIIE 363
                  +E C  ++ + RP   ++++
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  122 bits (307), Expect = 4e-32
 Identities = 76/247 (30%), Positives = 130/247 (52%), Gaps = 19/247 (7%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K LK    N+  +K+F +E  ++  ++H+++V+F G C +   L +V E+M  G + 
Sbjct: 38  VAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 200 DYL--HKLKGVF----------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 247
            +L  H    V               +L +A  ++ GM YL   + +HRDL   N L+ E
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155

Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWEL 304
           N +VK+ DFG++R    +        T    RWM PE I ++ +  ++DV+S G+VLWE+
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215

Query: 305 LT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
            T GK P+  L+     +  + +G     P+    ++ +L+  CWQ++P +R +  EI  
Sbjct: 216 FTYGKQPWYQLSN-NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274

Query: 364 ILQQIAK 370
           +LQ +AK
Sbjct: 275 LLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  120 bits (303), Expect = 8e-32
 Identities = 74/249 (29%), Positives = 136/249 (54%), Gaps = 8/249 (3%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G +Y  +    S+   IK +   ++    ++   +EV ++ K++H N+V F  
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
           +  +   L IV E+  GG +   +++ +GV F    +L   + +S G+ ++H   I+HRD
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126

Query: 238 LKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 294
           +K+ N+ + +N  V K+ DFG+AR    S +  A T  GT  +++PE+ +++PY++K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           +S G VL+EL T K P+E     Q  + + Q    P  P  S+  L  L+ + ++  P  
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR-DLRSLISQLFKVSPRD 244

Query: 355 RPDFSEIIE 363
           RP  + I++
Sbjct: 245 RPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  120 bits (304), Expect = 1e-31
 Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 14/251 (5%)

Query: 125 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTK 182
           G+YG + +  +      + V +    +NS  QK    ++ I MR V     V F GA  +
Sbjct: 12  GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71

Query: 183 PPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NIIHRDL 238
              + I  E M   S+   Y         +P   L K+A+ + K + YLH   ++IHRD+
Sbjct: 72  EGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADV 294
           K +N+L++ N  VK+ DFG++     S   T + G   +MAPE I      K YD K+DV
Sbjct: 131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190

Query: 295 FSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDP 352
           +S GI + EL TG+ PY+ + TP Q    VV +   P +P     P+  + + +C +++ 
Sbjct: 191 WSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNY 249

Query: 353 ALRPDFSEIIE 363
             RP++ E+++
Sbjct: 250 KERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  120 bits (301), Expect = 2e-31
 Identities = 80/235 (34%), Positives = 124/235 (52%), Gaps = 28/235 (11%)

Query: 122 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 178
           V +G+YG +Y+G +    Q  AIKV+    +  D ++E   E+ +++K   H+N+  + G
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 179 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 231
           A  K  PP     L +V EF   GSV D +   KG   K   +  +  ++ +G+ +LH +
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 232 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 287
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200

Query: 288 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
             YD+++D++S GI   E+  G  P   + P++A            IP+N  PKL
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKL 246

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  119 bits (300), Expect = 4e-31
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 14/210 (6%)

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           EV IMR  +H N+V+   +      L +V EF+ GG++ D +   +       +  V + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMA 279
           V K +++LH   +IHRD+K+ ++L+  +  VK++DFG  A+V  +     +  GT  WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-- 337
           PEVI   PY  + D++S GI++ E++ G+ PY    PLQA      K +R  +P   +  
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKNL 238

Query: 338 ----PKLAELLERCWQQDPALRPDFSEIIE 363
               P+L   L+R   +DPA R   +E++ 
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  118 bits (299), Expect = 5e-31
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 15/237 (6%)

Query: 140 VAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
            AIKV+ K + I  +   +   E  I+ + +   VV+   +     +L +V E++ GG +
Sbjct: 21  YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
              L  + G            ++   + YLH N IIHRDLK  N+L+D N  +K+ DFG+
Sbjct: 81  ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGL 139

Query: 259 ARVKAQS-----GVMTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL 309
           ++V              E     GT  ++APEVI  + +    D +S G +L+E L G  
Sbjct: 140 SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199

Query: 310 PYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 364
           P+   TP +     +  G    P   + S  +  +L+ +    DP  R     I EI
Sbjct: 200 PFHGETP-EEIFQNILNGKIEWPEDVEVS-DEAIDLISKLLVPDPEKRLGAKSIEEI 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 6e-31
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 121 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y+       + VA+K ++ +     +     +E+ ++++++H N+V+ + 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 179 ACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                  L +V E+       D   YL K  G      +  +   + +G+ Y H + I+H
Sbjct: 66  VIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121

Query: 236 RDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--YRWMAPEVI-EHKP 287
           RDLK  N+L++ + V+K+ADFG+AR     ++      T E  T  YR  APE++   K 
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYR--APEILLGSKH 175

Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    D++S G +  E++TGK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  118 bits (299), Expect = 7e-31
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 42/272 (15%)

Query: 117 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----R 169
           KFG  +  GS+  +        +++ AIK+L   ++    +K   + V I ++V      
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV--KYVKIEKEVLTRLNG 60

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +++         +L  V E+   G +  Y+ K  G          A ++   + YLH
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARV-----------------KAQSGVMTAET 272
              IIHRDLK  N+L+D++  +K+ DFG A+V                  +Q        
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 273 ----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP----YEYLTPLQAAVGVV 324
               GT  +++PE++  KP    +D+++ G +++++LTGK P     EYLT  Q     +
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK----I 234

Query: 325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRP 356
            K L  + P N  P   +L+E+    DP  R 
Sbjct: 235 LK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  118 bits (296), Expect = 9e-31
 Identities = 72/246 (29%), Positives = 128/246 (52%), Gaps = 6/246 (2%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           V  GSYG+  L R     +   IK L     +   +K   QE  ++ +++H N+V +  +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 180 CTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAIDVSKGMNYLHQNNIIHRD 237
                  L IV  F  GG +Y  L + KG     + +++  + ++  + YLH+ +I+HRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+ +    ++KV D G+ARV + Q  + +   GT  +M+PE+  +KPY++K+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 356
            G  ++E+ T K  +     + + V  + +G  P +PK+  P+L EL+     + P  RP
Sbjct: 188 LGCCVYEMATLKHAFN-AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRP 246

Query: 357 DFSEII 362
               I+
Sbjct: 247 SVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  115 bits (290), Expect = 6e-30
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 13/261 (4%)

Query: 113 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 167
           P + + G  +  G++G +Y        +++A+K ++ +  + +  KE      E+ +++ 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60

Query: 168 VRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           + H+ +VQ+ G    P   +L I  E M GGS+ D L K  G        K    + +G+
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGV 119

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAPE 281
           +YLH N I+HRD+K AN+L D    VK+ DFG ++       SG  M + TGT  WM+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           VI  + Y  KAD++S G  + E+LT K P+     + A   +  +   P +P +      
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239

Query: 342 ELLERCWQQDPALRPDFSEII 362
           + L+R + +   LRP   E++
Sbjct: 240 DFLKRIFVE-AKLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  115 bits (289), Expect = 2e-29
 Identities = 84/298 (28%), Positives = 143/298 (47%), Gaps = 42/298 (14%)

Query: 110 EIDPKHLKFGSKVASGSYGDL----------YRGTYCSQD--------VAIKVLKPERIN 151
           E   K L F  K+  G +G++          +     S D        VA+K+L+ E  N
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59

Query: 152 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG-- 207
            + + +F +E+ IM +++  N+++ +  C     LC++TE+M  G +  +L  H+ +   
Sbjct: 60  KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119

Query: 208 ------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 261
                      +L+ +A  ++ GM YL   N +HRDL   N L+ +N  +K+ADFG++R 
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178

Query: 262 KAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLT 315
              SG      G      RWM+ E I    +   +DV++FG+ LWE+LT   + PY  L+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238

Query: 316 PLQAAVGVVQ----KGLRPTIPKNSQ-PK-LAELLERCWQQDPALRPDFSEIIEILQQ 367
             Q      +    +G +  +PK +  P  L +L+  CW+++   RP F EI   L +
Sbjct: 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  115 bits (289), Expect = 2e-29
 Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 20/276 (7%)

Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ 155
           H++   D  +VWEI         ++  G++G +Y+          A KV+  E  + +  
Sbjct: 3   HVRRDLDPNEVWEII-------GELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEEL 53

Query: 156 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           +++  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      P + 
Sbjct: 54  EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113

Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 274
            +   + + + YLH   IIHRDLKA N+L+  +  +K+ADFGV+    ++     +  GT
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 275 YRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
             WMAPEV+     +  PYD+KAD++S GI L E+   + P+  L P++  + +  K   
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEP 232

Query: 330 PTI--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           PT+  P     +  + L+    + P  RP  ++++E
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  114 bits (287), Expect = 3e-29
 Identities = 77/270 (28%), Positives = 142/270 (52%), Gaps = 26/270 (9%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 162
           + WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 5   EFWEII-------GELGDGAFGKVYK----AQNKETGVLAAAKVIDTKSEEELEDYMVEI 53

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+     P +  V     
Sbjct: 54  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 280
           + +NYLH+N IIHRDLKA N+L   +  +K+ADFGV+  K    +   ++  GT  WMAP
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 172

Query: 281 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 333
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQP 231

Query: 334 KNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                +  + L++C +++   R   +++++
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  115 bits (290), Expect = 3e-29
 Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 14/167 (8%)

Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQS 265
           L+  +  V++GM +L     IHRDL A N+L+ EN VVK+ DFG+AR        V+  S
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235

Query: 266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 324
             +       +WMAPE I  K Y  ++DV+SFG++LWE+ + G  PY  +   +     +
Sbjct: 236 ARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290

Query: 325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           + G R   P+N+ P++  ++  CWQ DP  RP FS ++EIL  + +E
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  114 bits (286), Expect = 5e-29
 Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 15/260 (5%)

Query: 112 DP--KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DP  K+ +F  K+  G+ G +Y     +  Q+VAIK +    +    +KE    E+ +MR
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMR 71

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + +H N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 129

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 248

Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC + D   R    E+++
Sbjct: 249 LNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  115 bits (290), Expect = 6e-29
 Identities = 53/158 (33%), Positives = 93/158 (58%), Gaps = 4/158 (2%)

Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET 272
           LL  +  V+KGM++L   N IHRDL A N+L+    + K+ DFG+AR ++  S  +    
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 273 GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
                +WMAPE I +  Y  ++DV+S+GI+LWE+ + G  PY  +        ++++G R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
              P+ +  ++ ++++ CW  DP  RP F +I+++++Q
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (283), Expect = 6e-29
 Identities = 72/236 (30%), Positives = 122/236 (51%), Gaps = 16/236 (6%)

Query: 113 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 167
           P + + G  +  G++G++Y        +++A+K +  +  + +  KE      E+ +++ 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60

Query: 168 VRHKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           +RH  +VQ+ G C + P    L I  E+M GGS+ D L K  G        +    + +G
Sbjct: 61  LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMA 279
           ++YLH N I+HRD+K AN+L D    VK+ DFG ++ + Q+  M+       TGT  WM+
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMS 177

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           PEVI  + Y  KADV+S    + E+LT K P+     + A   +  +  +P +P  
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  113 bits (283), Expect = 6e-29
 Identities = 79/262 (30%), Positives = 132/262 (50%), Gaps = 15/262 (5%)

Query: 113 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 167
           P + + G  +  G++G +Y        +++A K ++ +  + +  KE +    E+ +++ 
Sbjct: 1   PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60

Query: 168 VRHKNVVQFIGACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           ++H+ +VQ+ G C +     +L I  E+M GGSV D L K  G        K    + +G
Sbjct: 61  LQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG 118

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAP 280
           M+YLH N I+HRD+K AN+L D    VK+ DFG ++       SG  + + TGT  WM+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
           EVI  + Y  KADV+S G  + E+LT K P+     + A   +  +   P +P +     
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238

Query: 341 AELLERCWQQDPALRPDFSEII 362
            + L  C   +   RP   E++
Sbjct: 239 RDFL-GCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  114 bits (288), Expect = 7e-29
 Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 34/260 (13%)

Query: 116 LKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           L+  +++ SG+ G +Y    R T   +  A+KV+        ++++  +E+ I+R V H 
Sbjct: 76  LERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH-EDTVRRQICREIEILRDVNHP 132

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLH 229
           NVV+          + ++ EFM GGS       L+G  +     L  VA  +  G+ YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGS-------LEGTHIADEQFLADVARQILSGIAYLH 185

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVI--- 283
           + +I+HRD+K +NLL++  + VK+ADFGV+R+ AQ+  M    +  GT  +M+PE I   
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTD 243

Query: 284 -EHKPYDHKA-DVFSFGIVLWELLTGKLPYEY-----LTPLQAAVGVVQKGLRPTIPKNS 336
             H  YD  A D++S G+ + E   G+ P+          L  A+ + Q    P  P  +
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---PEAPATA 300

Query: 337 QPKLAELLERCWQQDPALRP 356
             +    +  C Q++PA R 
Sbjct: 301 SREFRHFISCCLQREPAKRW 320

Length = 353

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  114 bits (287), Expect = 1e-28
 Identities = 61/165 (36%), Positives = 95/165 (57%), Gaps = 4/165 (2%)

Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 268
           L  L+  +  V++GM +L     IHRDL A N+L+ EN VVK+ DFG+AR   K    V 
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231

Query: 269 TAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 326
             +     +WMAPE I  K Y  ++DV+SFG++LWE+ + G  PY  +   +     +++
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291

Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           G R   P+ + P++  ++  CW  +P  RP FSE++EIL  + +E
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  112 bits (282), Expect = 1e-28
 Identities = 71/249 (28%), Positives = 129/249 (51%), Gaps = 12/249 (4%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 177
           K+  G+ G ++     +  Q+VAIK +    +    +KE    E+ +M+++++ N+V F+
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +      L +V E+++GGS+ D +   +       +  V  +  + + +LH N +IHRD
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 238 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           +K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPAL 354
            GI+  E++ G+ PY    PL+A   +   G  P +  P+   P   + L RC + D   
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEK 259

Query: 355 RPDFSEIIE 363
           R    E+++
Sbjct: 260 RGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  112 bits (281), Expect = 1e-28
 Identities = 76/243 (31%), Positives = 126/243 (51%), Gaps = 17/243 (6%)

Query: 107 DVWEIDPKH-LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D+   +P+H  +   +V SG+YGD+Y  R  +  +  A+K++K E    D      QE+F
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIF 58

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++++ +H N+V + G+      L I  E+  GGS+ D  H + G      +  V  +  +
Sbjct: 59  MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQ 117

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV 282
           G+ YLH    +HRD+K AN+L+ +N  VK+ADFGV A++ A      +  GT  WMAPEV
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Query: 283 I---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
               ++  Y+   D+++ GI   EL   + P   L P++A   + +   +P       PK
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP-------PK 230

Query: 340 LAE 342
           L +
Sbjct: 231 LKD 233

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  112 bits (282), Expect = 2e-28
 Identities = 79/257 (30%), Positives = 134/257 (52%), Gaps = 9/257 (3%)

Query: 112 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 17  DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V K ++ LH 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA 134

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +     +  GT  WMAPE+I   PY 
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194

Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ---PKLAELLER 346
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P + KN     P L   L+R
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKL-KNLHKVSPSLKGFLDR 252

Query: 347 CWQQDPALRPDFSEIIE 363
              +DPA R   +E+++
Sbjct: 253 LLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  112 bits (283), Expect = 2e-28
 Identities = 90/298 (30%), Positives = 140/298 (46%), Gaps = 33/298 (11%)

Query: 112 DPKHLKFG-SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRK 167
           DP+ L     ++  GS+G +Y  R    ++ VAIK +      S+ + ++  +EV  +++
Sbjct: 12  DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           +RH N +++ G   +  +  +V E+  G S  D L   K   +   +  +     +G+ Y
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVI-- 283
           LH +  IHRD+KA N+L+ E   VK+ADFG A +   A S V     GT  WMAPEVI  
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185

Query: 284 -EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLA 341
            +   YD K DV+S GI   EL   K P   +  + A   + Q    PT+  N       
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSNDWSDYFR 244

Query: 342 ELLERCWQQDPALRPDFSE---------------IIEILQQIAKEVGE-ENEERRKEK 383
             ++ C Q+ P  RP   E               II+++Q+    V E +N + RK K
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNLQYRKMK 302

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  112 bits (281), Expect = 2e-28
 Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 20/220 (9%)

Query: 152 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
           S ++K+  +E+ IM + R   +V F GA     ++C+  EFM  GS+ D ++K  G   +
Sbjct: 44  SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102

Query: 212 PSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
             L K+A+ V +G+ YL+  + I+HRD+K +N+L++    +K+ DFGV+     S    A
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA 159

Query: 271 ET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL 328
           +T  GT  +M+PE I+   Y  K+DV+S GI + EL  GK P+ + + +         G+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGI 218

Query: 329 -----------RPTIPKNSQPKLAELL-ERCWQQDPALRP 356
                       P +P +  P+      + C  +DP  RP
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  111 bits (278), Expect = 3e-28
 Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 18/255 (7%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA---QEVFIMRKVRHKNVVQ 175
           ++ SG+YGD+Y  R     +  AIKV+K E       ++FA   QE+ +M+  +H N+V 
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
           + G+  +   L I  EF  GGS+ D  H + G      +  V+ +  +G+ YLH    +H
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129

Query: 236 RDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV--IEHK-PYDHK 291
           RD+K AN+L+ +N  VK+ADFGV A++ A      +  GT  WMAPEV  +E K  Y+  
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP---KLAELLERCW 348
            D+++ GI   EL   + P   L P++A   + +   +P   K+           ++   
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249

Query: 349 QQDPALRPDFSEIIE 363
            ++P  RP   ++++
Sbjct: 250 TKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  111 bits (279), Expect = 5e-28
 Identities = 77/253 (30%), Positives = 121/253 (47%), Gaps = 15/253 (5%)

Query: 125 GSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEV-FIMRKVRHKNVVQFIGACT 181
           G++G + +  +      + V K  R   D   QK    ++  +MR      +V+F GA  
Sbjct: 15  GAFGTVNKMLHKPSGTIMAV-KRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73

Query: 182 KPPSLCIVTEFM--SGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRD 237
           +     I  E M  S    Y Y++  LK V     L K+A+   K +NYL +   IIHRD
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADV 294
           +K +N+L+D N  +K+ DFG++     S   T + G   +MAPE I+      YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----LRPTIPKNSQPKLAELLERCWQQ 350
           +S GI L+E+ TGK PY     +   +  V KG    L  +  +   P     +  C  +
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK 253

Query: 351 DPALRPDFSEIIE 363
           D + RP + E++E
Sbjct: 254 DESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  110 bits (277), Expect = 5e-28
 Identities = 77/257 (29%), Positives = 129/257 (50%), Gaps = 22/257 (8%)

Query: 128 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 187
           G+ +RG   ++ V +K L+      D Q  F QEV   R++ H NV+Q +G C +     
Sbjct: 14  GEAHRGMSKAR-VVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71

Query: 188 IVTEFMSGGSVYDYLHKLKGVFKLPS----LLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
           +V EF   G + +YL   +G+    +    L ++A +V+ G+ +LHQ + IH DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 244 LMDENEVVKVADFGVARVK-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDH--KAD 293
            +  +  VK+ D+G+A  +  +   +T +      RW+APE++E       P D   K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191

Query: 294 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ----KGLRPTIPKNSQPKLAELLERCW 348
           ++S G+ +WEL T    PY  L+  Q    VV+    K  +P +      +  E+++ CW
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW 251

Query: 349 QQDPALRPDFSEIIEIL 365
             DP  RP   E+ E+L
Sbjct: 252 -LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score =  112 bits (281), Expect = 5e-28
 Identities = 61/164 (37%), Positives = 93/164 (56%), Gaps = 4/164 (2%)

Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 263
           K V  L  L+  +  V+KGM +L     IHRDL A N+L+ EN VVK+ DFG+AR   K 
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 264 QSGVMTAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  113 bits (284), Expect = 5e-28
 Identities = 54/159 (33%), Positives = 96/159 (60%), Gaps = 4/159 (2%)

Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 273
           L+  +  V+ GM +L   N +HRDL A N+L+ E ++VK+ DFG+AR   +     ++  
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300

Query: 274 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
           T+   +WMAPE I +  Y   +DV+SFGI+LWE+ T G  PY  L   +     +++G R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360

Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              P ++  ++ E++++CW++   +RPDFS+++ ++  +
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  111 bits (278), Expect = 6e-28
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 28/257 (10%)

Query: 121 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 173
           K+  GS G   + R  +  + VA+K++       D++K+        EV IMR  +H+NV
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V+   +      L ++ EF+ GG++ D + + +       +  V   V + + YLH   +
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGV 138

Query: 234 IHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           IHRD+K+ ++L+  +  VK++DFG  A++        +  GT  WMAPEVI   PY  + 
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQ---PKLAELLER 346
           D++S GI++ E++ G+ PY   +P+QA      K LR + P   KN+    P L + LER
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNAHKISPVLRDFLER 253

Query: 347 CWQQDPALRPDFSEIIE 363
              ++P  R    E+++
Sbjct: 254 MLTREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 7e-28
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
            K+  G+YG +Y  R     + VAIK +K    +  + K   +E+ +++++ H N+++ +
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                   L +V EFM    +Y  +   +       +      + +G+ + H + I+HRD
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123

Query: 238 LKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWM-APEVI-EHKPYDHKADV 294
           LK  NLL++   V+K+ADFG+AR         T    T RW  APE++   K Y    D+
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDI 182

Query: 295 FSFGIVLWELLTGK 308
           +S G +  ELL+ +
Sbjct: 183 WSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  110 bits (276), Expect = 9e-28
 Identities = 65/260 (25%), Positives = 135/260 (51%), Gaps = 13/260 (5%)

Query: 120 SKVASGSYGDLYRG--TYCSQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
            K+  G +  +Y+       + VA+K ++  E +++  +++  +E+ +++++ H NV+++
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67

Query: 177 IGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           + +  +   L IV E    G +     +  K K +    ++ K  + +   + ++H   I
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHK 291
           +HRD+K AN+ +    VVK+ D G+ R  + S    A +  GT  +M+PE I    Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 292 ADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCW 348
           +D++S G +L+E+   + P Y     L +    ++K   P +P +  S+  L +L+ RC 
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE-LRDLVSRCI 245

Query: 349 QQDPALRPDFSEIIEILQQI 368
             DP  RPD S ++++ +++
Sbjct: 246 NPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  110 bits (277), Expect = 9e-28
 Identities = 75/260 (28%), Positives = 133/260 (51%), Gaps = 15/260 (5%)

Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAIK +    +    +KE    E+ +MR
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMR 71

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D +   +       +  V  +  + ++
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALD 129

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDF 248

Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC + D   R    E+++
Sbjct: 249 LNRCLEMDVDRRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  110 bits (276), Expect = 9e-28
 Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 4/203 (1%)

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAI 219
            I  ++RH N+V++     +   L IV + + G  + ++ + LK     F    +  + +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 220 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 278
            +   + YLH +  I+HRDL   N+++ E++ V + DFG+A+ K     +T+  GT  + 
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
            PE+++++PY  KADV++FG +L+++ T + P+     L  A  +V+    P        
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240

Query: 339 KLAELLERCWQQDPALRPDFSEI 361
            + +++  C   D   RPD  ++
Sbjct: 241 DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  109 bits (275), Expect = 1e-27
 Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 122 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           +  G +G +      S++   A+K +K   I    Q+E    E  I+ +  H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  + ++ E+  GG ++  L   +G+F +  +   +A  V     YLH   II+RD
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  NLL+D N  VK+ DFG A+ K +SG  T    GT  ++APE+I +K YD   D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Query: 297 FGIVLWELLTGKLPY 311
            GI+L+ELLTG+ P+
Sbjct: 178 LGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  110 bits (276), Expect = 1e-27
 Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 14/266 (5%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK 167
           +  D   L+   ++ SG+ G +Y+  +      + V +  R  N +  K    ++ ++ K
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69

Query: 168 VRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGM 225
                 +V+  G       + I  E MS  +  D L K ++G      L K+ + + K +
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 226 NYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
           +YL +   +IHRD+K +N+L+D +  VK+ DFG++     S   T   G   +MAPE I+
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID 187

Query: 285 HKP----YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIP--KNSQ 337
                  YD +ADV+S GI L EL TG+ PY+   T  +    ++Q+   P++P  +   
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSLPPNEGFS 246

Query: 338 PKLAELLERCWQQDPALRPDFSEIIE 363
           P     ++ C  +D   RP + E+++
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  109 bits (274), Expect = 2e-27
 Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 16/225 (7%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           +A+KV+ P  I  ++QK+   E+ I+ K     ++ F GA      + I TEFM GGS+ 
Sbjct: 29  LAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
            Y            L ++A+ V KG+ YL    I+HRD+K +N+L++    VK+ DFGV+
Sbjct: 88  VY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142

Query: 260 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE------- 312
                S +     GT  +MAPE I  + Y   +DV+S GI   EL  G+ PY        
Sbjct: 143 TQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201

Query: 313 YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDPALRP 356
            L PLQ    +V +   P +P      K    + +C ++ P  RP
Sbjct: 202 SLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 173
           ++  G+YG +Y+       + VA+K     +I  + +KE       +E+ +++K+RH N+
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 174 VQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK-------- 223
           V+     T     S+ +V E+M         H L G+   P + K      K        
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEV-KFTESQIKCYMKQLLE 111

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 279
           G+ YLH N I+HRD+K +N+L++ + V+K+ADFG+AR   K  S   T    T  YR   
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--P 169

Query: 280 PEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           PE++     Y  + D++S G +L EL  GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  108 bits (272), Expect = 6e-27
 Identities = 72/247 (29%), Positives = 122/247 (49%), Gaps = 16/247 (6%)

Query: 116 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 170
            +F   + +GS+G      ++G+   +  A+K+L   +I    Q E    E  I++ +RH
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
             +V   G+     +L +V E++ GG ++ +L K  G F  P     A  V   + YLH 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS 119

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
            +I++RDLK  NLL+D +  +K+ DFG A+ + +    T   GT  ++APE+I  K Y  
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYTL-CGTPEYLAPEIILSKGYGK 177

Query: 291 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCW 348
             D ++ GI+++E+L G  P+    P+Q    + +K L  +   P    P   +L+    
Sbjct: 178 AVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSFFSPDAKDLIRNLL 233

Query: 349 QQDPALR 355
           Q D   R
Sbjct: 234 QVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  108 bits (270), Expect = 7e-27
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)

Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D +   +       +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249

Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC   D   R    E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  108 bits (271), Expect = 8e-27
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)

Query: 117 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHK 171
           + G K+  G+Y  +Y+       + VAIK +K                +E+ ++++++H 
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------KG 224
           N++  +       ++ +V EFM           L+ V K  S++    D+        +G
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFMET--------DLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWM-APEV 282
           + YLH N I+HRDLK  NLL+  + V+K+ADFG+AR        MT +  T RW  APE+
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPEL 173

Query: 283 I---EHKPYDHKADVFSFGIVLWELLTGKLPY 311
           +    H  Y    D++S G +  ELL    P+
Sbjct: 174 LFGARH--YGVGVDMWSVGCIFAELLLRV-PF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  107 bits (267), Expect = 2e-26
 Identities = 68/278 (24%), Positives = 135/278 (48%), Gaps = 28/278 (10%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 162
           EI+   ++F  ++    +G +Y+G          +Q VAIK LK ++    +++EF  E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 207
            +  +++H N+V  +G  TK   L ++  + S   ++++L                 +K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS- 265
             +    + +   ++ GM +L  ++++H+DL   N+L+ +   VK++D G+ R V A   
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179

Query: 266 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
             +M       RWM+PE I +  +   +D++S+G+VLWE+ + G  PY   +  Q  + +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238

Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           ++       P +    +  L+  CW + P+ RP F +I
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  106 bits (266), Expect = 2e-26
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 7/214 (3%)

Query: 143 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 202
           K ++   + + +      E  I++++ H  +V    +     ++ +V + + GG +  +L
Sbjct: 37  KCVEKGSVRNVLN-----ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL 91

Query: 203 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 262
            + K  F    +     ++   + YLH   IIHRD+K  N+L+DE   V + DF +A   
Sbjct: 92  SQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAV 321
               + T+ +GT  +MAPEV+  + Y    D +S G+  +E L GK PY      ++  +
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
              Q+      P     +  + + +  ++DP  R
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  107 bits (267), Expect = 2e-26
 Identities = 86/290 (29%), Positives = 128/290 (44%), Gaps = 52/290 (17%)

Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQE 161
           D +D WEI          +  G+YG +++          A+K+L P     D+ +E   E
Sbjct: 15  DPSDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAE 64

Query: 162 VFIMRKVR-HKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKL---- 211
             I++ +  H NVV+F G   K        L +V E  +GGSV D +   KG  K     
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121

Query: 212 --PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVM 268
             P +  +  +   G+ +LH N  IHRD+K  N+L+     VK+ DFGV A++ +     
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 269 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 323
               GT  WMAPEVI         YD + DV+S GI   EL  G  P   L P++A    
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239

Query: 324 VQKGLRPTIPKNSQPKLAE----------LLERCWQQDPALRPDFSEIIE 363
                   IP+N  P L +           + +C  +D   RP  S++++
Sbjct: 240 -------KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  105 bits (264), Expect = 2e-26
 Identities = 67/245 (27%), Positives = 134/245 (54%), Gaps = 6/245 (2%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           V  GS+G   L +     Q  A+K ++  + +S ++    +E  ++ K++H N+V F  +
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKES 66

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                 L IV E+  GG +   +   +G +F   ++L+  + +  G+ ++H+  ++HRD+
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 297
           K+ N+ + +N  VK+ DFG AR+    G       GT  ++ PE+ E+ PY++K+D++S 
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           G +L+EL T K P++  +     + V Q   +P +P +   +L  L+++ ++++P  RP 
Sbjct: 187 GCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPS 245

Query: 358 FSEII 362
            + I+
Sbjct: 246 ATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  106 bits (266), Expect = 3e-26
 Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 4/171 (2%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K +   R+   +  +  +E+  ++  +H  VV+ +          +V E+M    + 
Sbjct: 28  VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
           + L   +       +      + KG+ Y+H N I+HRDLK ANLL+  + V+K+ADFG+A
Sbjct: 87  EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146

Query: 260 RV--KAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTG 307
           R+  + +  + + +  T  + APE++     YD   D+++ G +  ELL G
Sbjct: 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 7e-26
 Identities = 72/249 (28%), Positives = 110/249 (44%), Gaps = 28/249 (11%)

Query: 122 VASGSYGDLY------RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK-NV 173
           ++ G++G +Y       G Y     AIKVLK   + +  Q      E  IM        V
Sbjct: 4   ISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
            +   +      L +V E+++GG     +  L G        +   +V  G+  LHQ  I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 292
           IHRD+K  NLL+D+   +K+ DFG++R     G+   +  GT  ++APE I     D  +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMS 174

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQ----PKLAELLER 346
           D +S G V++E L G  P+   TP      V    L   I  P+  +    P+  +L+ R
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINR 230

Query: 347 CWQQDPALR 355
               DPA R
Sbjct: 231 LLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  104 bits (260), Expect = 2e-25
 Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 38/278 (13%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 177
            V  GSYG +   +     Q VAIK    E  +  M K+ A +E+ +++++RH+N+V  I
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
               +   L +V EF+   +V D L K         + K    + +G+ + H +NIIHRD
Sbjct: 67  EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVIEHKP-YDHKADVF 295
           +K  N+L+ ++ VVK+ DFG AR  A  G +  +    RW  APE++     Y    D++
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185

Query: 296 SFGIVLWELLTGK--LPYE------------------------YLTPLQAAVGVVQ---- 325
           + G ++ E+LTG+   P +                           PL A + + +    
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245

Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           + L    PK S   + +L ++C + DP  RP  S+++ 
Sbjct: 246 EPLEKRFPKLS-GLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  104 bits (262), Expect = 2e-25
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 125 GSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIG 178
           GS+G +     +GT   +  A+KVLK + I  D   E    E  ++    +H  + Q   
Sbjct: 6   GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  L  V E+++GG +  ++ +  G F  P     A ++  G+ +LH+  II+RDL
Sbjct: 64  CFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  N+L+D    +K+ADFG+ +     GV T+   GT  ++APE++ ++PY    D ++ 
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182

Query: 298 GIVLWELLTGKLPYE 312
           G++L+E+L G+ P+E
Sbjct: 183 GVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  103 bits (259), Expect = 3e-25
 Identities = 89/291 (30%), Positives = 130/291 (44%), Gaps = 54/291 (18%)

Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQ 160
           D TD WEI          +  G+YG +Y+ T   +D    A+K+L P    SD+ +E   
Sbjct: 19  DPTDTWEII-------ETIGKGTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEA 67

Query: 161 EVFIMRKV-RHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 214
           E  I++ +  H NVV+F G   K        L +V E  +GGSV + +   KG+      
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQR 124

Query: 215 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGV 267
           L  A+          G+ +LH N IIHRD+K  N+L+     VK+ DFGV A++ +    
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 268 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                GT  WMAPEVI  +      YD + DV+S GI   EL  G  P   + P++    
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF- 243

Query: 323 VVQKGLRPTIPKNSQPKL----------AELLERCWQQDPALRPDFSEIIE 363
                    IP+N  P L             + +C  +D   RP  + ++E
Sbjct: 244 --------KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  104 bits (260), Expect = 3e-25
 Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 15/273 (5%)

Query: 99  LKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRGT--YCSQDVAIKVLK--PERINSD 153
           +K P      ++ DP+ +  G  ++  GS+G +Y  T  + ++ VA+K +    ++ N  
Sbjct: 5   VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK 64

Query: 154 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 213
            Q +  +EV  +++++H N +++ G   K  +  +V E+  G S  D L   K   +   
Sbjct: 65  WQ-DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 122

Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 273
           +  +     +G+ YLH +N+IHRD+KA N+L+ E   VK+ADFG A   + +       G
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VG 179

Query: 274 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 330
           T  WMAPEVI   +   YD K DV+S GI   EL   K P   +  + A   + Q    P
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP 238

Query: 331 TIPKNS-QPKLAELLERCWQQDPALRPDFSEII 362
           T+  N         ++ C Q+ P  RP  +E++
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  103 bits (258), Expect = 3e-25
 Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 18/227 (7%)

Query: 121 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 177
           K+  GS G +   T  +  + VA+K +    +    ++E    EV IMR   H+NVV   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMY 85

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +      L +V EF+ GG++ D +   +       +  V + V + ++YLH   +IHRD
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 238 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           +K+ ++L+  +  +K++DFG  A+V  +     +  GT  WMAPEVI   PY  + D++S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
            GI++ E++ G+ PY    PLQA      + +R  +P    P++ + 
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLP----PRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  103 bits (258), Expect = 1e-24
 Identities = 53/159 (33%), Positives = 88/159 (55%), Gaps = 7/159 (4%)

Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 273
           LL     V++GM +L   N +HRDL A N+L+ + ++VK+ DFG+AR         ++  
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298

Query: 274 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
           T+   +WMAPE I    Y   +DV+S+GI+LWE+ + G  PY  +         ++ G R
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDF---SEIIEIL 365
              P ++  ++ +++ +CW  +P  RP F   S+I+E L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  103 bits (257), Expect = 2e-24
 Identities = 56/169 (33%), Positives = 96/169 (56%), Gaps = 16/169 (9%)

Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------V 261
           L  LL+ +  V++GM++L   N IHRD+ A N+L+ +  V K+ DFG+AR         V
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
           K  + +        +WMAPE I    Y  ++DV+S+GI+LWE+ + GK PY  +      
Sbjct: 271 KGNARL------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324

Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 369
             +V++G + + P  + P++  +++ CW  +P  RP FS+I +++Q+  
Sbjct: 325 YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 8/194 (4%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
             V  G+YG +   R     + VAIK  K    + D++K   +EV ++R++RH+N+V   
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            A  +   L +V E++   ++ + L    G     ++      + + + Y H +NIIHRD
Sbjct: 67  EAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWM-APEV-IEHKPYDHKAD 293
           +K  N+L+ E+ V+K+ DFG AR         +T    T RW  APE+ +    Y    D
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT-RWYRAPELLVGDTNYGKPVD 184

Query: 294 VFSFGIVLWELLTG 307
           V++ G ++ ELL G
Sbjct: 185 VWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 73/263 (27%), Positives = 129/263 (49%), Gaps = 19/263 (7%)

Query: 116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN 172
           ++   ++  G+YG +Y+  +    V    +K  R+  D  K F Q   E+ I+ K     
Sbjct: 3   IEVLDELGKGNYGSVYKVLHRPTGV-TMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYL- 228
           +V F GA     ++ +  E+M  GS+   Y      +G+ +   L ++   V KG+ +L 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLK 119

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----- 283
            ++NIIHRD+K  N+L++ N  VK+ DFGV+     S   T   G   +MAPE I     
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGP 178

Query: 284 -EHKPYDHKADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            ++  Y  ++DV+S G+ + E+  G+ PY  E    + A +  +  G  PT+P       
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238

Query: 341 AELLERCWQQDPALRPDFSEIIE 363
            + + +C  + P  RP +++++E
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  100 bits (251), Expect = 5e-24
 Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 15/274 (5%)

Query: 99  LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLK-PERINSD 153
           LK P      ++ DP+ L F    ++  GS+G +Y  R    ++ VAIK +    + +++
Sbjct: 9   LKDPEIAELFFKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67

Query: 154 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 213
             ++  +EV  +++++H N +++ G   +  +  +V E+  G S  D L   K   +   
Sbjct: 68  KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 126

Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 273
           +  +     +G+ YLH +N+IHRD+KA N+L+ E   VK+ADFG A + + +       G
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VG 183

Query: 274 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 330
           T  WMAPEVI   +   YD K DV+S GI   EL   K P   +  + A   + Q    P
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP 242

Query: 331 TIPKNS-QPKLAELLERCWQQDPALRPDFSEIIE 363
           T+  N         ++ C Q+ P  RP   E+++
Sbjct: 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 99.7 bits (248), Expect = 5e-24
 Identities = 66/258 (25%), Positives = 134/258 (51%), Gaps = 11/258 (4%)

Query: 121 KVASGSYGDLYRGTYC---SQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           K+  G + ++YR T C    + VA+K ++  E +++  +++  +E+ +++++ H NV+++
Sbjct: 9   KIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67

Query: 177 IGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           + +  +   L IV E    G +     Y  K K +    ++ K  + +   + ++H   +
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 234 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +HRD+K AN+ +    VVK+ D G+ R   +++    +  GT  +M+PE I    Y+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 293 DVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELLERCWQQ 350
           D++S G +L+E+   + P Y     L +    +++   P +P  +   KL EL+  C   
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247

Query: 351 DPALRPDFSEIIEILQQI 368
           DP  RPD   + +I +Q+
Sbjct: 248 DPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 99.7 bits (248), Expect = 8e-24
 Identities = 71/242 (29%), Positives = 122/242 (50%), Gaps = 10/242 (4%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 180 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            T     P  LC + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADV 294
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 295 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D +
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239

Query: 354 LR 355
            R
Sbjct: 240 KR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 77/243 (31%), Positives = 119/243 (48%), Gaps = 12/243 (4%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 177
           ++  GS+G +Y  R    S+ VAIK +      S+ + ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
           G   +  +  +V E+  G S  D L   K   +   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADV 294
           +KA N+L+ E  +VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDPA 353
           +S GI   EL   K P   +  + A   + Q    P +            ++ C Q+ P 
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSEYFRNFVDSCLQKIPQ 256

Query: 354 LRP 356
            RP
Sbjct: 257 DRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 73/228 (32%), Positives = 118/228 (51%), Gaps = 6/228 (2%)

Query: 141 AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           A+KVL+ + + N   QK   A+   +++ V+H  +V    +      L  V +F++GG +
Sbjct: 24  AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
           + +L + +  F  P     A +++  + YLH  NI++RDLK  N+L+D    V + DFG+
Sbjct: 84  FFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142

Query: 259 ARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 317
            +   AQS   T   GT  ++APEVI  +PYD+  D +  G VL+E+L G  P+      
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202

Query: 318 QAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           +    ++ K L  RP     +   L ELLE+  Q+    + DF EI E
Sbjct: 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 9/186 (4%)

Query: 131 YRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVF-IMRKVRHKNVVQFIGACTKPPSL 186
           Y+ T   +  AIK LK   I +  + E     + +F      RH  +V           +
Sbjct: 20  YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77

Query: 187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 246
           C V E+ +GG +  ++H    VF  P  +  A  V  G+ YLH+N I++RDLK  NLL+D
Sbjct: 78  CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135

Query: 247 ENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
               VK+ADFG+ +     G  T+   GT  ++APEV+    Y    D +  G++++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195

Query: 306 TGKLPY 311
            G+ P+
Sbjct: 196 VGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 6/220 (2%)

Query: 141 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L  +R+     ++ A  E  I+ KV  + +V    A      LC+V   M+GG + 
Sbjct: 22  ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81

Query: 200 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +++ + +  F     +  A  +  G+ +LHQ  I++RDLK  N+L+D++  V+++D G+
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141

Query: 259 A-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 317
           A  +K    +     GT  +MAPEV++ + YD   D F+ G  L+E++ G+ P+      
Sbjct: 142 AVELKGGKKI-KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200

Query: 318 QAAVGVVQKGLRP--TIPKNSQPKLAELLERCWQQDPALR 355
                + ++ L      P    P+  +L E   Q+DP  R
Sbjct: 201 VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 97.3 bits (242), Expect = 4e-23
 Identities = 70/246 (28%), Positives = 123/246 (50%), Gaps = 18/246 (7%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 180 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 236 RDLKAANLLMDENEVVKVADFGVA----RVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH 290
           RDLK AN+L+DE+  V+++D G+A    + K  + V     GT+ +MAPEV++    YD 
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDS 175

Query: 291 KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
            AD FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 350 QDPALR 355
           +D   R
Sbjct: 236 RDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.1 bits (236), Expect = 3e-22
 Identities = 58/257 (22%), Positives = 129/257 (50%), Gaps = 9/257 (3%)

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           K+  G + ++YR T     V + + K +    +++  + +  +E+ +++++ H NV+++ 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL---PSLLKVAIDVSKGMNYLHQNNII 234
            +  +   L IV E    G +   +   K   +L    ++ K  + +   + ++H   ++
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128

Query: 235 HRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 293
           HRD+K AN+ +    VVK+ D G+ R   +++    +  GT  +M+PE I    Y+ K+D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188

Query: 294 VFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQD 351
           ++S G +L+E+   + P Y     L +    +++   P +P +    +L +L+  C   D
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248

Query: 352 PALRPDFSEIIEILQQI 368
           P  RPD + + ++ +++
Sbjct: 249 PEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 95.3 bits (237), Expect = 6e-22
 Identities = 66/243 (27%), Positives = 126/243 (51%), Gaps = 21/243 (8%)

Query: 125 GSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQEVFIMRKVRHKNV 173
           GS+G ++      G    Q  A+KVLK       +R+ + M+++      I+ +V H  +
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD------ILAEVNHPFI 60

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V+   A      L ++ +F+ GG ++  L K + +F    +     +++  +++LH   I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 292
           I+RDLK  N+L+DE   +K+ DFG+++             GT  +MAPEV+  + +   A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D +SFG++++E+LTG LP++     +    +++  L   +P+   P+   LL   ++++P
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNP 237

Query: 353 ALR 355
           A R
Sbjct: 238 ANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 59/247 (23%), Positives = 120/247 (48%), Gaps = 13/247 (5%)

Query: 130 LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ----FIGACTKPP 184
           +Y+G + +++V I+  K       +  +    E+  +R++   N+++     I      P
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAAN 242
            L ++ E+ + G + + L K K + FK  + L +AID  KG+  L++  N  +++L + +
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKDLSFK--TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153

Query: 243 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV 300
            L+ EN  +K+   G+ ++ +           Y   + +++      Y  K D++S G+V
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVV 211

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           LWE+ TGK+P+E LT  +    ++ K     +P +   ++  ++E C   D   RP+  E
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271

Query: 361 IIEILQQ 367
           I+  L  
Sbjct: 272 ILYNLSL 278

Length = 283

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 63/247 (25%), Positives = 127/247 (51%), Gaps = 8/247 (3%)

Query: 122 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 177
           +  GS+G +    + +++   A+KVL+ + I    +++   ++   +++ V+H  +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +      L  V ++++GG ++ +L + +  F  P     A +++  + YLH  NI++RD
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRD 121

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+L+D    + + DFG+ +   + +G  +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPAL 354
            G VL+E+L G  P+      +    ++ K   L+P I  +++  L  LL++   +    
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA 241

Query: 355 RPDFSEI 361
           + DF EI
Sbjct: 242 KDDFMEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 24/235 (10%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           V +KVL  +  +S     F +   +M ++ HK++V+  G C +  ++ +V E++  G + 
Sbjct: 33  VVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENE----VVK 252
            +LH+ K    L   L VA  ++  ++YL    ++H ++   N+L+     NE     +K
Sbjct: 89  VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148

Query: 253 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE--HKPYDHKADVFSFGIVLWELLT-G 307
           ++D G+        V++ E    R  W+APE I          AD +SFG  L E+ + G
Sbjct: 149 LSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203

Query: 308 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
           + P   L+  +       +     +P     +LA L+ +CW  DP  RP F  I+
Sbjct: 204 EEPLSTLSSSEKERFYQDQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 71/249 (28%), Positives = 120/249 (48%), Gaps = 12/249 (4%)

Query: 122 VASGSYGDLYRGTYCSQDV--AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFI 177
           +  GS+G +    + +     A+KVL+ + I     QK   A+   +++ V+H  +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +      L  V ++++GG ++ +L + +  F  P     A +++  + YLH  NII+RD
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+L+D    V + DFG+ +   + S   +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR- 355
            G VL+E+L G  P+      +    ++ K LR  +  N       LLE   Q+D   R 
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKRL 239

Query: 356 ---PDFSEI 361
               DF EI
Sbjct: 240 GAKDDFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 91.5 bits (227), Expect = 4e-21
 Identities = 69/264 (26%), Positives = 127/264 (48%), Gaps = 25/264 (9%)

Query: 121 KVASGSYGDLYRGT----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           ++ +G +G +  G     Y    V +K L+      + Q +F +E    R ++H N++Q 
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQC 60

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP----SLLKVAIDVSKGMNYLHQNN 232
           +G CT+     +V EF   G +  YL   +    +     +L ++A +++ G+ +LH+NN
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEH---- 285
            IH DL   N L+  +  VK+ D+G++  K +          +   RW+APE+++     
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180

Query: 286 ---KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV-QKGLRPTIPKNSQP-- 338
                   +++V+S G+ +WEL   G  PY +L+  Q     V ++ L+   P+   P  
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240

Query: 339 -KLAELLERCWQQDPALRPDFSEI 361
            +  E+++ CW Q P  RP   E+
Sbjct: 241 DRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 92.6 bits (231), Expect = 5e-21
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRKV 168
             +    + SG+YG +         + VAIK  K   +  D     A+    E+ ++R +
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDD--LIDAKRILREIKLLRHL 56

Query: 169 RHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--- 219
           RH+N++  +    +PPS      + IVTE M      D LHK   V K P  L       
Sbjct: 57  RHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHK---VIKSPQPLTDDHIQY 107

Query: 220 ---DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 272
               + +G+ YLH  N+IHRDLK +N+L++ N  +K+ DFG+AR     + + G +T   
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 273 GT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
            T  YR  APE++     Y    D++S G +  ELLT K
Sbjct: 168 VTRWYR--APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 93.0 bits (231), Expect = 5e-21
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 1/145 (0%)

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           E  +++ V H +V++           C+V    S   +Y YL K      +   L +   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 280
           + +G+ YLH   IIHRD+K  N+ +++ + V + D G A+    +       GT    AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Query: 281 EVIEHKPYDHKADVFSFGIVLWELL 305
           EV+    Y+ KAD++S GIVL+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 54/232 (23%)

Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRK 167
             +   K+  G++G++Y+       + VA+K     +I    +K+       +E+ I++K
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63

Query: 168 VRHKNVVQFI--------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           ++H NVV  I         +  K  S+ +VT +M         H L G+ + PS   V +
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDLSGLLENPS---VKL 112

Query: 220 DVSK----------GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 261
             S+          G+NYLH+N+I+HRD+KAAN+L+D   ++K+ADFG+AR         
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 262 KAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           K   G  T + T     RW   PE++   + Y    D++  G V  E+ T +
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 57/200 (28%), Positives = 109/200 (54%), Gaps = 6/200 (3%)

Query: 118 FGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNV 173
           F   +  GS+G +        D   AIK+LK + +  + D++    ++  +  + +   +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
            Q          L  V E+++GG +  ++ ++ G FK P  +  A ++S G+ +LH+  I
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGI 122

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 292
           I+RDLK  N+++D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 293 DVFSFGIVLWELLTGKLPYE 312
           D +++G++L+E+L G+ P++
Sbjct: 183 DWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 53/178 (29%), Positives = 99/178 (55%), Gaps = 10/178 (5%)

Query: 141 AIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPPSLCIVTEFMSG 195
           AIK+LK + I   +Q +  +   + ++V     +   + Q          L  V E+++G
Sbjct: 29  AIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85

Query: 196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 255
           G +  ++ ++ G FK P  +  A +++ G+ +LH   II+RDLK  N+++D    +K+AD
Sbjct: 86  GDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIAD 144

Query: 256 FGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           FG+ +     G  T    GT  ++APE+I ++PY    D ++FG++L+E+L G+ P++
Sbjct: 145 FGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 92.0 bits (228), Expect = 7e-21
 Identities = 46/128 (35%), Positives = 80/128 (62%), Gaps = 2/128 (1%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           L  V E+++GG +   + ++ G FK P  +  A +++ G+ +LH   II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 246 DENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 304
           D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG++L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 305 LTGKLPYE 312
           L G+ P+E
Sbjct: 195 LAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 5/194 (2%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+LK E I   D       E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +      LC V E+++GG ++ +L + + VF          ++   ++YLH   I++RDL
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 239 KAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     +  M    GT  ++APEV+E   Y    D +  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 298 GIVLWELLTGKLPY 311
           G+V++E++ G+LP+
Sbjct: 182 GVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 28/217 (12%)

Query: 116 LKFGSKVASGSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 170
            + G  + +GS+G +    ++GT   +  AIK LK   I    Q +  AQE  I+ ++ H
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK------- 223
             +V  + +      +  + EF+ GG ++ +L K     + P+      DV+K       
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPN------DVAKFYHAELV 128

Query: 224 -GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPE 281
               YLH  +II+RDLK  NLL+D    VKV DFG A +V  ++  +    GT  ++APE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPE 185

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 318
           VI+ K +    D ++ G++L+E + G  P+   TP +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 57/291 (19%)

Query: 117 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA--------QEVFIMR 166
           K   ++  G++G +Y        + VAIK +K         K+F         +EV  +R
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLR 52

Query: 167 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKG 224
           K+  H N+V+      +   L  V E+M G ++Y  +   KG     S+++  I  + +G
Sbjct: 53  KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI 283
           + ++H++   HRDLK  NLL+   EVVK+ADFG+AR        T    T RW  APE++
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RWYRAPEIL 170

Query: 284 EHKP-YDHKADVFSFGIVLWELLTGKLP--------------YEYL-TP----------L 317
                Y    D+++ G ++ EL T + P                 L TP          L
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 318 QAAVG-----VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
            + +G          L   IP N+ P+  +L++   + DP  RP  S+ ++
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 71/253 (28%), Positives = 119/253 (47%), Gaps = 20/253 (7%)

Query: 122 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 177
           +  GS+G +      S     A+KVL+ + I    ++    A+   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +      L  V ++++GG ++ +L + +  F  P     A +V+  + YLH  NII+RD
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRD 121

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVIEHKPYDHKA 292
           LK  N+L+D    V + DFG+ +     GV   ET     GT  ++APEV+  +PYD   
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D +  G VL+E+L G  P+      Q    ++ K L+  +P        +LL     +D 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKDQ 235

Query: 353 ALR----PDFSEI 361
             R     DF EI
Sbjct: 236 RRRLGAKADFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 51/175 (29%), Positives = 93/175 (53%), Gaps = 7/175 (4%)

Query: 141 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           A+K+LK E I +  + E A    E  +++  RH  +     +      LC V E+ +GG 
Sbjct: 24  AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           ++ +L + + VF          ++   + YLH  ++++RDLK  NL++D++  +K+ DFG
Sbjct: 82  LFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140

Query: 258 VARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           + +     G  M    GT  ++APEV+E   Y    D +  G+V++E++ G+LP+
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF-- 176
           ++  G+YG +YR   T   + VA+K ++ +     +     +E+ ++  +RH N+V+   
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 177 IGACTKPPSLCIVTEFMSG--GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +       S+ +V E+      S+ D    +   F    +  + + + +G+ YLH+N II
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHKA 292
           HRDLK +NLL+ +   +K+ADFG+AR     +  MT +  T  + APE++     Y    
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190

Query: 293 DVFSFGIVLWELLTGK 308
           D+++ G +L ELL  K
Sbjct: 191 DMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 41/215 (19%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 172
           +K+  G++G+++  R     Q VA+K     ++  + +KE F     +E+ I++ ++H+N
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQLLKHEN 72

Query: 173 VVQFIGACTKPP--------SLCIVTEFMSGGSVYDYLHKLKGV-------FKLPSLLKV 217
           VV  I  C            S  +V EF          H L G+       F L  + KV
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV 124

Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAET 272
              +  G+ Y+H+N I+HRD+KAAN+L+ ++ ++K+ADFG+AR       ++    T   
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLT 306
            T  +  PE+ +  + Y    D++  G ++ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 51/174 (29%), Positives = 94/174 (54%), Gaps = 2/174 (1%)

Query: 141 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV- 198
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
           +   H  +  F+    +  A ++  G+  LHQ  I++RDLK  N+L+D++  ++++D G+
Sbjct: 89  FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL 148

Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           A    +   +    GT  +MAPEV++++ Y    D ++ G +L+E++ G+ P++
Sbjct: 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 235
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 119

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 295 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 345
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 237

Query: 346 RCWQQDPALR 355
               +DP  R
Sbjct: 238 SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 65/260 (25%), Positives = 123/260 (47%), Gaps = 29/260 (11%)

Query: 128 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 187
            ++Y  T  ++ V +K LK    +S  Q EF Q+    R ++H N++Q +G C +     
Sbjct: 14  SEIYTDTGVAR-VVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71

Query: 188 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           +V E+   G +  YL +    +   +L  L ++A +++ G+ ++H++N +H DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 245 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDH 290
           +  +  VKV D+G+   + +   +  E       RW+APE++           + KP   
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188

Query: 291 KADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQ----KGLRPTIPKNSQPKLAELLE 345
            ++V++ G+ LWEL      PY +L+  +    V++    K  +P +      +  E+L+
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ 247

Query: 346 RCWQQDPALRPDFSEIIEIL 365
            CW   P  R    E+  +L
Sbjct: 248 FCWLS-PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 4e-19
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 18/193 (9%)

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVMTAETGTY 275
           I V   ++++H  ++IHRD+K+AN+L+  N +VK+ DFG +++ A +    V     GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
            ++APE+   KPY  KAD+FS G++L+ELLT K P++    ++  +     G    +P +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPS 268

Query: 336 SQPKLAELLERCWQQDPALRPD-------------FSEIIEILQ-QIAKEVGEENEERRK 381
             P++ E++      DP  RP               S ++EI+Q Q        +   R+
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQ 328

Query: 382 EKSSGGFLSVLRR 394
            + +   L V RR
Sbjct: 329 IQQTKQLLQVERR 341

Length = 496

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 4/152 (2%)

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV---FKLPSLLKVAID 220
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F  P        
Sbjct: 46  ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ 105

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 279
           +  G+ +LHQ  II+RDLK  N+L+D +  V+++D G+A  +K          GT  +MA
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           PE+++ + YD   D F+ G+ L+E++  + P+
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y+G      Q VA+K ++ E     +     +E+ ++++++H N+V    
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHR 236
              +   L ++ EF+S   +  YL  L KG +    L+K  +  + +G+ + H   ++HR
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125

Query: 237 DLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKP-YDH 290
           DLK  NLL+D   V+K+ADFG+AR     V+    V T E  T  + APEV+   P Y  
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 291 KADVFSFGIVLWELLTGK 308
             D++S G +  E+ T K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 6/218 (2%)

Query: 141 AIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+K+LK E I   D       E  +++  RH  +     +      LC V E+ +GG ++
Sbjct: 24  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +L + + VF          ++   ++YLH + N+++RDLK  NL++D++  +K+ DFG+
Sbjct: 84  FHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 142

Query: 259 ARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 317
            +   + G  M    GT  ++APEV+E   Y    D +  G+V++E++ G+LP+      
Sbjct: 143 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202

Query: 318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 203 KLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 85.8 bits (212), Expect = 7e-19
 Identities = 49/173 (28%), Positives = 91/173 (52%), Gaps = 2/173 (1%)

Query: 141 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88

Query: 200 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +++ +    F+    L  A ++  G+  LH+ N ++RDLK  N+L+D+   ++++D G+
Sbjct: 89  FHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL 148

Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           A    +   +    GT  +MAPEV+ ++ Y    D +  G +++E++ G+ P+
Sbjct: 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 44/235 (18%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-------- 159
            I  ++++ G+ +  G+YG + +   T   + VAIK +K   I++D+ K+          
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 160 ----QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
               +E+ IM +++H+N++  +    +   + +V + M+          LK V      L
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DLKKVVDRKIRL 116

Query: 216 KVA------IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 267
             +      + +  G+N LH+   +HRDL  AN+ ++   + K+ADFG+AR         
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 268 -------------MTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
                        MT++  T  + APE++   + Y    D++S G +  ELLTGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 38/208 (18%)

Query: 125 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           GS+G +     +GT  ++  AIK LK + +  D   E      + R+V        +   
Sbjct: 6   GSFGKVMLAELKGT--NEFFAIKALKKDVVLEDDDVECT---MVERRV--------LALA 52

Query: 181 TKPPSLC-------------IVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGM 225
            + P L               V E+++GG   D +  +   G F        A ++  G+
Sbjct: 53  WEHPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGL 109

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI 283
            +LH+  II+RDLK  N+L+D++  +K+ADFG+ +    +G   A T  GT  ++APE++
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEIL 168

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPY 311
           + + Y+   D +SFG++L+E+L G+ P+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 37/210 (17%)

Query: 120 SKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 172
           +++  G+YG +YR         VA+K LK E+     +KE F     +E+ I+ K++H N
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-----EKEGFPITSLREINILLKLQHPN 65

Query: 173 VVQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK------LPSLLK-VAIDVSK 223
           +V    +   +    + +V E++         H LK + +      L S +K + + +  
Sbjct: 66  IVTVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMA 279
           G+ +LH N I+HRDLK +NLL++   ++K+ DFG+AR +  S     T    T  YR  A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYR--A 174

Query: 280 PEVIEHKP-YDHKADVFSFGIVLWELLTGK 308
           PE++     Y    D++S G +  ELLT K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 11/196 (5%)

Query: 125 GSYGDLYR-----GTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQF 176
           G YG +++     G    +  A+KVLK   I  + QK+ A    E  I+  V+H  +V  
Sbjct: 7   GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDL 65

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           I A      L ++ E++SGG ++ +L + +G+F   +      ++S  + +LHQ  II+R
Sbjct: 66  IYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYR 124

Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVF 295
           DLK  N+L+D    VK+ DFG+ +     G +T    GT  +MAPE++    +    D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184

Query: 296 SFGIVLWELLTGKLPY 311
           S G +++++LTG  P+
Sbjct: 185 SLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 65/292 (22%), Positives = 120/292 (41%), Gaps = 49/292 (16%)

Query: 117 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
             G          L +    +  VA+K +  +  + +  K   QE+   R+++H N++ +
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAI--DVSKGMNYLHQNN 232
           + +      L +V+  M+ GS  D    LK  F   LP L    I  DV   ++Y+H   
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIE 284
            IHR +KA+++L+  +  V ++    +        R +       +      W++PEV++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 285 H--KPYDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGL-RPTIP---- 333
              + Y+ K+D++S GI   EL  G +P++ +      L+   G V   L + T P    
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241

Query: 334 --KNSQPKLA---------------------ELLERCWQQDPALRPDFSEII 362
               S+                         + +E C Q+DP  RP  S+++
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

 Score = 78.3 bits (194), Expect = 2e-18
 Identities = 29/72 (40%), Positives = 40/72 (55%), Gaps = 6/72 (8%)

Query: 1  MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---E 54
            E+   T D+P L +++   L  +GLNI +A  F+T DGY+LD FVV   DG P    E
Sbjct: 1  GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60

Query: 55 ETEQLRAALEKE 66
             ++R ALE  
Sbjct: 61 RLARIREALEDA 72

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 125 GSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           GS+G   L R     +  A+KVLK + I  + D++    ++  +     H  + Q     
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
             P  L  V EF++GG +  ++ K +  F        A +++  + +LH   II+RDLK 
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKL 124

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 299
            N+L+D     K+ADFG+ +    +G  T+   GT  ++APE+++   Y    D ++ G+
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184

Query: 300 VLWELLTGKLPYE 312
           +L+E+L G  P+E
Sbjct: 185 LLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 62/239 (25%), Positives = 120/239 (50%), Gaps = 12/239 (5%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           V +G++G ++  R        A+KV+    +    Q++    E  ++++V H  +++   
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  L ++ E++ GG ++ YL +  G F   + L  A ++   + YLH   I++RDL
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 298
           K  N+L+D+   +K+ DFG A+ K +    T   GT  ++APEVI+ K ++   D ++ G
Sbjct: 128 KPENILLDKEGHIKLTDFGFAK-KLRDRTWTL-CGTPEYLAPEVIQSKGHNKAVDWWALG 185

Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALR 355
           I+++E+L G  P+    P     G+ +K L   +  P++      +L+++    D   R
Sbjct: 186 ILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 57/203 (28%), Positives = 109/203 (53%), Gaps = 22/203 (10%)

Query: 122 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 175
           +  GS+G ++    +GT  +Q  AIK LK + +  + D++    ++  +     H  +  
Sbjct: 3   LGKGSFGKVFLAELKGT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
                    +L  V E+++GG +  ++   HK    F LP     A ++  G+ +LH   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKG 116

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKPY 288
           I++RDLK  N+L+D +  +K+ADFG+ +   ++ +  A+T    GT  ++APE++  + Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 289 DHKADVFSFGIVLWELLTGKLPY 311
           +   D +SFG++L+E+L G+ P+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 82.6 bits (204), Expect = 8e-18
 Identities = 49/174 (28%), Positives = 92/174 (52%), Gaps = 2/174 (1%)

Query: 141 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88

Query: 200 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +++ +    F     +  A +++ G+  LH+  I++RDLK  N+L+D+   ++++D G+
Sbjct: 89  FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148

Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           A    +   +    GT  +MAPEV++++ Y    D +  G +++E++ GK P+ 
Sbjct: 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.3 bits (203), Expect = 8e-18
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 21/234 (8%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           V +KVL P   + D+   F +   +MR+V HK++V   G C +     +V EF+  G + 
Sbjct: 35  VILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 252
            ++H+   V   P   KVA  ++  ++YL   +++H ++   N+L+       +    +K
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152

Query: 253 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE-HKPYDHKADVFSFGIVLWEL-LTGK 308
           ++D G+        V++ +    R  W+APE +E  K     AD +SFG  LWE+   G+
Sbjct: 153 LSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207

Query: 309 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
           +P +  T L       +       P  S  +LA+L+  C   DP  RP F  I+
Sbjct: 208 IPLKDKT-LAEKERFYEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 27/216 (12%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           VWE+ P   +  S V SG+YG +     T   + VAIK L     ++   K   +E+ ++
Sbjct: 10  VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68

Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYL--HKLKG---VFKLPSL 214
           + + H+NV+  +   T   SL       +VT  M G  + + +   KL      F +  +
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI 127

Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
           L+       G+ Y+H   IIHRDLK +N+ ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVAT 178

Query: 275 YRW-MAPEVIEHK-PYDHKADVFSFGIVLWELLTGK 308
            RW  APE++ +   Y+   D++S G ++ ELLTGK
Sbjct: 179 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 125 GSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           GS+G +        D   AIKVLK + I  + D+     ++  +    +H  +       
Sbjct: 6   GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
                L  V E+++GG +   + + +  F  P     A +V+  + +LH++ +I+RDLK 
Sbjct: 66  QTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124

Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 299
            N+L+D     K+ADFG+ +    +GV T    GT  ++APE+++   Y    D ++ G+
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184

Query: 300 VLWELLTGKLPYE 312
           +++E++ G+ P+E
Sbjct: 185 LMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 117 KFGSKVASGSYGDLYR------GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR- 169
           K   K+  G++ ++ +      G Y     AIK +K +   S  Q    +E+  +R++  
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMK-KHFKSLEQVNNLREIQALRRLSP 56

Query: 170 HKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           H N+++ I      K   L +V E M   ++Y+ +   K       +      + K +++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APE-VIEH 285
           +H+N I HRD+K  N+L+  ++++K+ADFG  R        T    T RW  APE ++  
Sbjct: 116 MHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTD 173

Query: 286 KPYDHKADVFSFGIVLWELLT 306
             Y  K D+++ G V +E+L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 40/213 (18%)

Query: 120 SKVASGSYGDLYRGTYC--SQDVAIKVLKP-ERINSDMQKEFAQ----EVFIMRKVRHKN 172
           S +  G+YG +   T+      VAIK + P E       + F Q    E+ I+R+ +H+N
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------QTFCQRTLREIKILRRFKHEN 64

Query: 173 VVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-----DV 221
           ++  I    +PPS        IV E M        L+K   + K   L    I      +
Sbjct: 65  IIG-ILDIIRPPSFESFNDVYIVQELMETD-----LYK---LIKTQHLSNDHIQYFLYQI 115

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMTAETGTYRW 277
            +G+ Y+H  N++HRDLK +NLL++ N  +K+ DFG+AR+       +G +T    T RW
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RW 174

Query: 278 M-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 308
             APE+ +  K Y    D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 64/251 (25%), Positives = 127/251 (50%), Gaps = 25/251 (9%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L R     Q  A+KV+K E ++ D   ++ Q E  +  +      +  + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 235
           +C +  S L +V E+++GG +  ++ + +   KLP       A ++   +N+LH+  II+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D +  +K+ D+G+ +     G  T+   GT  ++APE++  + Y    D 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 295 FSFGIVLWELLTGKLPYEYLTP----------LQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           ++ G++++E++ G+ P++ +T            Q    +++K +R  IP+    K + +L
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---ILEKPIR--IPRFLSVKASHVL 234

Query: 345 ERCWQQDPALR 355
           +    +DP  R
Sbjct: 235 KGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 13/177 (7%)

Query: 137 SQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMS 194
            Q+VAIK ++KP       ++ + +E+ +++ +RH+N++        P   +  VTE + 
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93

Query: 195 GGSVYDYLHKLKGVFKL-PSLLK-VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 252
                  LH+L     L    ++     + +G+ Y+H   ++HRDLK +N+L++EN  +K
Sbjct: 94  TD-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148

Query: 253 VADFGVARVKAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 308
           + DFG+AR+  Q   MT    T  + APE+ +  + YD + D++S G +  E+L GK
Sbjct: 149 ICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 23/200 (11%)

Query: 121 KVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF---IMRKVRHKNV 173
           K+  G +G +     + T   +    K++K +  N+        E     +M+   + N 
Sbjct: 23  KLIDGKFGKVSVLKHKPT--QKLFVQKIIKAKNFNAI-------EPMVHQLMKD--NPNF 71

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           ++   + T      ++ +++  G ++D L K +G      + K+   + + +N LH++NI
Sbjct: 72  IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNI 130

Query: 234 IHRDLKAANLLMDENEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           IH D+K  N+L D  +  + + D+G+ ++           GT  + +PE I+   YD   
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSF 187

Query: 293 DVFSFGIVLWELLTGKLPYE 312
           D ++ G++ +ELLTGK P++
Sbjct: 188 DWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 45/174 (25%), Positives = 93/174 (53%), Gaps = 2/174 (1%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L  +R+     ++ A  E  I+ KV    +V    A      LC+V   M+GG + 
Sbjct: 22  ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK 81

Query: 200 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +++ +     ++  ++  +  ++ G+ +LH  +I++RD+K  N+L+D+    +++D G+
Sbjct: 82  YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL 141

Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           A        +T   GT  +MAPE+++ +PY +  D F+ G  ++E++ G+ P++
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)

Query: 114 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV 168
           K  +  ++V  G YG ++    + T   + VA+K +K   +   +  +    E  I+   
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           + + +V+ + A      L +  E++ GG     L+ L GV           ++ + ++ L
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDAL 117

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEH 285
           H+   IHRDLK  N L+D +  +K+ DFG+++     A S V     G+  +MAPEV+  
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRG 172

Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
           K YD   D +S G +L+E L G  P+   TP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 22/164 (13%)

Query: 169 RHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL----LKVA 218
           +H NV+  +    +PP +       +VTE M        LHK+  +     L    +KV 
Sbjct: 57  KHDNVLSALDI-LQPPHIDPFEEIYVVTELMQSD-----LHKI--IVSPQPLSSDHVKVF 108

Query: 219 I-DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--QSGVMTAETGTY 275
           +  + +G+ YLH   I+HRD+K  NLL++ N V+K+ DFG+ARV+   +S  MT E  T 
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 276 RWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 318
            + APE++     Y    D++S G +  ELL  ++ ++  +P+Q
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 10/177 (5%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           Q+VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       +V E
Sbjct: 42  QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101

Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 251
            M   ++   +       ++  LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 102 LMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157

Query: 252 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 308
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G 
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)

Query: 116 LKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-QEVFIMRKVRHK 171
             F   + +GS+G +   TY ++D   VAIK  +  +I    Q +    E  I+  + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMNYLH 229
             V   G+      L +V EF+ GG  + +L + K   + P+ +    A  +     YL 
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ 148

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
             NI++RDLK  NLL+D++  +K+ DFG A+V   +   T   GT  ++APE++ +  + 
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHG 206

Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPL 317
             AD ++ GI ++E+L G  P+    PL
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 52/172 (30%), Positives = 92/172 (53%), Gaps = 6/172 (3%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           L  V EF++GG +  ++   KG F L      A ++  G+ +LH   II+RDLK  N+++
Sbjct: 71  LFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129

Query: 246 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 303
           D +  +K+ADFG+ +     G   A T  GT  ++APE+++   Y    D +SFG++L+E
Sbjct: 130 DRDGHIKIADFGMCKENV-FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188

Query: 304 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           +L G+ P+      +    +      P  P+    +  ++LE+ +++DP  R
Sbjct: 189 MLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 66/250 (26%), Positives = 126/250 (50%), Gaps = 21/250 (8%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L       +  A+KV+K E +N D   ++ Q E  +     +   +  + 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 235
           +C +  S L  V EF+SGG   D +  ++   KLP       + ++S  +N+LH+  II+
Sbjct: 63  SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 295 FSFGIVLWELLTGKLPYEYLT----PLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 345
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K + +L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKASSVLK 237

Query: 346 RCWQQDPALR 355
               +DP  R
Sbjct: 238 GFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 23/252 (9%)

Query: 132 RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVT 190
           RG+   + V  K +    +N + Q  +A+ E+  +    H  +V+          L ++ 
Sbjct: 88  RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144

Query: 191 EFMSGGSVYDYLHKLKGVFK--LP------SLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
           E+ SGG   D   ++K   K  LP       LL   I ++  ++ +H   ++HRDLK+AN
Sbjct: 145 EYGSGG---DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRDLKSAN 199

Query: 243 LLMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 299
           + +    ++K+ DFG ++  + S    V ++  GT  ++APE+ E K Y  KAD++S G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259

Query: 300 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
           +L+ELLT   P++  +  +    V+     P  P      +  LL+    ++PALRP   
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 360 EII--EILQQIA 369
           +++  E L+ +A
Sbjct: 319 QLLHTEFLKYVA 330

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 46/176 (26%), Positives = 92/176 (52%), Gaps = 7/176 (3%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           L ++ ++++GG ++ +L++ +  F    +     ++   +++LHQ  II+RD+K  N+L+
Sbjct: 80  LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138

Query: 246 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP--YDHKADVFSFGIVL 301
           D    V + DFG+++         A +  GT  +MAPEVI      +D   D +S G++ 
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 355
           +ELLTG  P+       +   + ++ L+  P  PK    +  + +++  ++DP  R
Sbjct: 199 FELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           SK+  GSYG ++  R     Q VAIK       +  ++K   +E+ ++++++H N+V  I
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLL--KVAIDVSKGMNYLHQNNII 234
               +   L +V E+      +  L++L K    +P  L  K+     + +N+ H++N I
Sbjct: 67  EVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI-EHKPYDHKA 292
           HRD+K  N+L+ +   +K+ DFG AR+    G    +    RW  APE++     Y    
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182

Query: 293 DVFSFGIVLWELLTG 307
           DV++ G V  ELLTG
Sbjct: 183 DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 51/168 (30%), Positives = 90/168 (53%), Gaps = 15/168 (8%)

Query: 150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 209
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+ D +  LK   
Sbjct: 38  IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQV--LKKAG 94

Query: 210 KLPS--LLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVA----RVK 262
           ++P   L K++I V +G+ YL +   I+HRD+K +N+L++    +K+ DFGV+       
Sbjct: 95  RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154

Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
           A S V     GT  +M+PE ++   Y  ++D++S G+ L E+  G+ P
Sbjct: 155 ANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 37/261 (14%)

Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           G +   G YG+L++      +V +KVL  ++ + +  + F +   +M ++ HK++V   G
Sbjct: 14  GIRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYG 66

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
            C       +V E++  GS+  YL K K +  +   L+VA  ++  +++L    + H ++
Sbjct: 67  VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNV 126

Query: 239 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEH-KP 287
            A N+L+   E         +K++D G++       V+  E    R  W+ PE IE+ + 
Sbjct: 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQN 181

Query: 288 YDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGL-----RPTIPKNSQPKLA 341
               AD +SFG  LWE+ +G   P   L          QK L     R  +P     +LA
Sbjct: 182 LSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRHQLPAPKWTELA 233

Query: 342 ELLERCWQQDPALRPDFSEII 362
            L+ +C   +P  RP F  II
Sbjct: 234 NLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 12  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 71  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRW 182

Query: 277 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 308
           + APE+ +    Y+   D++S G ++ ELLTG+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 16/220 (7%)

Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           A E  I+R + H +++Q  G  T     C++        +Y YL   + +  +  +L + 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI-AICDILAIE 188

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA--RVKAQSGVMTAETGTYR 276
             V + + YLH+N IIHRD+KA N+ ++    V + DFG A   V   +       GT  
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK--------LPYEYLTPLQAAVGVVQKGL 328
             APE++   PY    D++S GIVL+E+ T          L  +  +  Q  + + + G 
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308

Query: 329 RPT-IPKNSQPKLAELLERCWQQD---PALRPDFSEIIEI 364
            P   P ++Q  L E+     ++    P  RP ++ + E+
Sbjct: 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348

Length = 391

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 160
           VWE+ P+      +V SG+YG +     CS       + VAIK L     +    K   +
Sbjct: 10  VWEL-PERYTSLKQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY----LHKLKGV-FKLPSLL 215
           E+ +++ ++H+NV+  +   T   S     EF     V  Y    L K+ G       + 
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSG---DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120

Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 275
            +   +  G+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    T 
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTR 178

Query: 276 RWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
            + APEVI +   Y+   D++S G ++ E+LTGK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 58/193 (30%), Positives = 105/193 (54%), Gaps = 9/193 (4%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           V  G+YG +   R     + VAIK  K    N ++++   +E+ ++R ++ +N+V+   A
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 237
             +   L +V E++   ++ + L ++  GV   P  ++  I  + K +++ H+N+I+HRD
Sbjct: 69  FRRRGKLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRD 125

Query: 238 LKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWM-APEVIEHKPYDHKADVF 295
           +K  NLL+  N+V+K+ DFG AR +   S     E    RW  +PE++   PY    D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185

Query: 296 SFGIVLWELLTGK 308
           S G +L EL  G+
Sbjct: 186 SVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 45/266 (16%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKV----RHKNV 173
           +++G+YG +Y  R     Q  A+K     +IN    + +   Q+VF+ R +     +  V
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMK-----KINKQNLILRNQIQQVFVERDILTFAENPFV 63

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP---SLLKVAIDVSKGMNYLHQ 230
           V    +      LC+V E++ GG   D    LK +  LP   + +  A  V   + YLH 
Sbjct: 64  VSMFCSFETKRHLCMVMEYVEGG---DCATLLKNIGALPVDMARMYFAETVL-ALEYLHN 119

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------------------ 272
             I+HRDLK  NLL+     +K+ DFG++++    G+M+  T                  
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 273 --GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR- 329
             GT  ++APEVI  + Y    D ++ GI+L+E L G +P+   TP +    V+   +  
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 330 PTIPKNSQPKLAELLERCWQQDPALR 355
           P   +       +L+ R  +Q+P  R
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 2/173 (1%)

Query: 141 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK 88

Query: 200 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +++ +    F     +  A ++  G+  L +  I++RDLK  N+L+D+   ++++D G+
Sbjct: 89  FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL 148

Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           A    +   +    GT  +MAPEVI ++ Y    D +  G +++E++ G+ P+
Sbjct: 149 AVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161

Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Query: 308 KL 309
            +
Sbjct: 222 GV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 78/325 (24%)

Query: 130 LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 189
           L R T     V +++   E    +  K    EV +    RH N++      T    L ++
Sbjct: 18  LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77

Query: 190 TEFMSGGSVYDYLHKLKGVFK-------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
           + FM+ GS       LK  F        + ++L  A+   +G+NYLHQN  IHR++KA++
Sbjct: 78  SPFMAYGSAN---SLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASH 131

Query: 243 LLMDENEVVKVADFGV--------ARVKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKA 292
           +L+  + +V ++             + K         T    W++PE++      Y+ K+
Sbjct: 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191

Query: 293 DVFSFGIVLWELLTGKLPYEYL---------------TPLQAAV---------------- 321
           D++S GI   EL TG++P++ +               +PL                    
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251

Query: 322 -----GVVQKGLRPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
                 VV  G+  T+          K   P    L+E C QQDP  RP  S ++     
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HA 309

Query: 368 IAKEVGEENEERRKEKSSGGFLSVL 392
             K+V        KE++ G  LS+L
Sbjct: 310 FFKQV--------KEQTQGSILSLL 326

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFA-QEVFIMRKVRHKNVVQFI 177
           K+  G+YG +++     +   I  LK  R++ D +     A +E+ ++++++HKN+V+  
Sbjct: 7   KIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                   L +V E+     +  Y     G      +      + KG+ + H +N++HRD
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124

Query: 238 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHK 291
           LK  NLL+++N  +K+ADFG+AR     V+  S    AE  T  +  P+V+   K Y   
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRPPDVLFGAKLYSTS 180

Query: 292 ADVFSFGIVLWELLTGKLP 310
            D++S G +  EL     P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 64/237 (27%), Positives = 111/237 (46%), Gaps = 21/237 (8%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           V +KVL P   + D+   F +   +M +V H ++    G C +     +V EF+  G + 
Sbjct: 47  VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 252
             L K KG   +   + VA  ++  ++YL   N++H ++ A N+L+         +  +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 253 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKA-DVFSFGIVLWEL-LTGK 308
           ++D GV+        ++ E    R  W+APE +        A D +SFG  L E+   G+
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 309 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
           +P +  TP +      +K  R  +P+ S  +LA L+ +C   +P  RP F  I+  L
Sbjct: 220 VPLKERTPSEKE-RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 33/201 (16%)

Query: 132 RGTY---CS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           RG Y   CS       + VAIK +     N    K   +E+ ++R + H+NV+  I    
Sbjct: 15  RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIM 73

Query: 182 KPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLH 229
            PP       + IV E M        LH+   + +    L           + +G+ Y+H
Sbjct: 74  PPPHREAFNDVYIVYELMDTD-----LHQ---IIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKP 287
             N++HRDLK +NLL++ N  +K+ DFG+AR  ++ G  MT    T  + APE++     
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    DV+S G +  ELL  K
Sbjct: 186 YTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 50/162 (30%), Positives = 88/162 (54%), Gaps = 3/162 (1%)

Query: 150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 209
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+ D + K  G  
Sbjct: 42  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 100

Query: 210 KLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 268
               L KV+I V KG+ YL + + I+HRD+K +N+L++    +K+ DFGV+     S + 
Sbjct: 101 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159

Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
            +  GT  +M+PE ++   Y  ++D++S G+ L E+  G+ P
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 7/164 (4%)

Query: 150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 209
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+   L + K   
Sbjct: 42  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 98

Query: 210 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 266
           ++P   L KV+I V +G+ YL + + I+HRD+K +N+L++    +K+ DFGV+     S 
Sbjct: 99  RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157

Query: 267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
           +  +  GT  +M+PE ++   Y  ++D++S G+ L EL  G+ P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 47/223 (21%)

Query: 117 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK 171
           +    +  G+YG +Y+         ++ AIK  K ++     + +   +E+ ++R+++H+
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDY----------LHKLKGVFKLP-----SLLK 216
           NVV  +    +     +   ++    ++DY           H+      +P     SLL 
Sbjct: 63  NVVSLVEVFLEHADKSV---YL----LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAE- 271
             ++   G++YLH N ++HRDLK AN+L+     E  VVK+ D G+AR+        A+ 
Sbjct: 116 QILN---GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 272 -----TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLT 306
                T  YR  APE++    H  Y    D+++ G +  ELLT
Sbjct: 173 DPVVVTIWYR--APELLLGARH--YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 14/197 (7%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ E  +  +     +E+ +++++ H N+V+ + 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 237
                  L +V EF+    +  Y+         P L+K  +  + +G+ Y H + ++HRD
Sbjct: 66  VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124

Query: 238 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDHK 291
           LK  NLL+D    +K+ADFG+AR     V+      T E  T  + APE+ +  + Y   
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTP 180

Query: 292 ADVFSFGIVLWELLTGK 308
            D++S G +  E++  +
Sbjct: 181 VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQD--- 96

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 97  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

Query: 308 KLPY 311
           K+ +
Sbjct: 215 KILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 28/234 (11%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           VWE+ P+  +  + V SG+YG +     T   Q VA+K L     +    +   +E+ ++
Sbjct: 10  VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           + ++H+NV+  +   T   S+       +VT  M           L  + K   L    +
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA--------DLNNIVKCQKLSDEHV 120

Query: 220 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
                 + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR       MT    T
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVAT 178

Query: 275 YRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
             + APE+ +    Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 120 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 173
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 174 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-VAIDVSKGMNY 227
           V+    CT     +   L +V E +    +  YL K+         +K +   + +G+++
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+    
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185

Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    D++S G +  E+   K
Sbjct: 186 YATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)

Query: 156 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           K   +E+ I++ + H+ ++  I A     ++C+V          D    +     LP  L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK----CDLFTYVDRSGPLP--L 184

Query: 216 KVAIDVSKGM----NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 271
           + AI + + +     YLH   IIHRD+K  N+ +DE E   + DFG A    +       
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241

Query: 272 TGTYRWM------APEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
              Y W       +PE++   PY  K D++S G+VL+E+    + 
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)

Query: 139 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEF 192
           +VA+K L     N    K   +E+ +++ V HKN++  +   T   SL       +V E 
Sbjct: 48  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 252
           M   ++   +H      ++  LL     +  G+ +LH   IIHRDLK +N+++  +  +K
Sbjct: 108 MDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163

Query: 253 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           + DFG+AR    + +MT    T  + APEVI    Y    D++S G ++ EL+ G + ++
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 39/200 (19%)

Query: 136 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 179
           C + VA+K +    + +D Q  K   +E+ I+R++ H N+V+               +G+
Sbjct: 29  CDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 234
            T+  S+ IV E+M           L  V +   L +         + +G+ Y+H  N++
Sbjct: 85  LTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136

Query: 235 HRDLKAANLLMD-ENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPEVIEH-KPY 288
           HRDLK AN+ ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P ++     Y
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196

Query: 289 DHKADVFSFGIVLWELLTGK 308
               D+++ G +  E+LTGK
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 51/195 (26%), Positives = 102/195 (52%), Gaps = 10/195 (5%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQF 176
           K+  G+Y  +Y+G      + VA+K +    ++++        +E+ +M++++H+N+V+ 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 177 IGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                    L +V E+M      Y   H ++G     ++      + KG+ + H+N ++H
Sbjct: 64  HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123

Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKAD 293
           RDLK  NLL+++   +K+ADFG+AR         + E  T  + AP+V+   + Y    D
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183

Query: 294 VFSFGIVLWELLTGK 308
           ++S G ++ E++TG+
Sbjct: 184 IWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 12/196 (6%)

Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+    +  ++         LP +      + +G+ + H + ++HRD
Sbjct: 67  VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEV-IEHKPYDHKA 292
           LK  NLL++    +K+ADFG+AR     GV     T E  T  + APE+ +  K Y    
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182

Query: 293 DVFSFGIVLWELLTGK 308
           D++S G +  E++T +
Sbjct: 183 DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 3/131 (2%)

Query: 183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
              L +VT++MSGG ++ +L K +G F          ++   + +LH+ +I++RDLK  N
Sbjct: 68  DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126

Query: 243 LLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEV-IEHKPYDHKADVFSFGIV 300
           +L+D    + + DFG+++        T    GT  ++APEV ++ K Y    D +S G++
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186

Query: 301 LWELLTGKLPY 311
           ++E+  G  P+
Sbjct: 187 VFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 16/197 (8%)

Query: 121 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 173
           K+  G+Y  +Y+G     D  VA+K ++ E       +E A     +EV +++ ++H N+
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLE------HEEGAPCTAIREVSLLKDLKHANI 66

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V          SL +V E++    +  YL        + ++      + +G+NY H+  +
Sbjct: 67  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHK 291
           +HRDLK  NLL++E   +K+ADFG+AR K+  +   + E  T  +  P++ +    Y  +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185

Query: 292 ADVFSFGIVLWELLTGK 308
            D++  G + +E+ TG+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 29/217 (13%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           +WE+ P   +   +V SG+YG     T CS         VAIK L     +    K   +
Sbjct: 10  IWEV-PDRYRDLKQVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ +++ ++H+NV+  +   T   SL       +V  FM        L KL    KL   
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD-----LGKLMKHEKLSED 118

Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 272
            +  +   + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT   
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYV 176

Query: 273 GTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
            T  + APEVI     Y    D++S G ++ E+LTGK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 51/278 (18%)

Query: 122 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQF 176
           +  G+YG +Y+       + VA+K ++       +     +E+ +++++    H N+V+ 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 177 IGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSK----GMN 226
           +  C  P       L +V E +    +  YL K       P L    I D+ +    G++
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVD 121

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVIE 284
           +LH + I+HRDLK  N+L+  +  VK+ADFG+AR+ +    +T+   T  YR  APEV+ 
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR--APEVLL 179

Query: 285 HKPYDHKADVFSFGIVLWEL---------------------LTGKLPYEYLTPLQAAVGV 323
              Y    D++S G +  EL                     + G LP E   P   ++  
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LPSEEEWPRNVSLPR 238

Query: 324 VQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRP 356
                       S       +  +LL++    +P  R 
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      L +V E+M GG + + +       K         +V   ++ +H   +IHRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 168

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 292
           K  N+L+D++  +K+ADFG      ++G++  +T  GT  +++PEV++ +     Y  + 
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 293 DVFSFGIVLWELLTGKLPY 311
           D +S G+ L+E+L G  P+
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 31/248 (12%)

Query: 137 SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI-VTEFMS 194
             +VAIK+L+ +    + Q   F +E  +  ++ H N+V  + +   PP L   V E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---V 251
           G ++ + L    G        ++ + V   +   H   I+HRDLK  N+++ +  V    
Sbjct: 63  GRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 252 KVADFGVARV-----KAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 303
           KV DFG+  +      A    +T  T   GT  + APE +  +P    +D++++G++  E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 304 LLTGK----------LPYEYLTPLQAAVGVVQKG------LRPTIPKNSQPKLAELLERC 347
            LTG+          + Y+ L+P+  ++     G      LR  + K+ + + A      
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR-AASAPAL 240

Query: 348 WQQDPALR 355
            ++  AL 
Sbjct: 241 AERFRALE 248

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 49/175 (28%), Positives = 94/175 (53%), Gaps = 6/175 (3%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           L ++ +++SGG ++ +L++ +  F    +   + ++   + +LH+  I++RD+K  N+L+
Sbjct: 80  LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138

Query: 246 DENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA-DVFSFGIVLW 302
           D    V + DFG+++  +  +     +  GT  +MAPE+I  K    KA D +S GI+++
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198

Query: 303 ELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 355
           ELLTG  P+           V ++ L+  P  P    P+  +LL +  ++DP  R
Sbjct: 199 ELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 30/216 (13%)

Query: 115 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRK 167
                 ++  G+YG +Y  R     + VA+K     ++  D +KE       +E+ I+R+
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62

Query: 168 VRHKNVVQFIGACT-KPPSLCIVTEFMSGGSVYDYL-HKLKGVFK----------LPSLL 215
           + H+N+V      T K  +L    +  +   V++Y+ H L G+ +          + S +
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETG 273
           K  ++   G+NY H+ N +HRD+K +N+L++    +K+ADFG+AR+    +S   T +  
Sbjct: 123 KQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 274 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 308
           T  +  PE ++  + Y    DV+S G +L EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 173
           K+  G+Y  +++G        VA+K ++ E       +E A     +EV +++ ++H N+
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLE------HEEGAPCTAIREVSLLKNLKHANI 65

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI---DVSKGMNYLHQ 230
           V           L +V E++      D    L     L S+  V I    + +G++Y H+
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPY 288
             I+HRDLK  NLL++E   +K+ADFG+AR K+  +   + E  T  +  P+V +    Y
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 289 DHKADVFSFGIVLWELLTGK 308
               D++  G +L+E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      L +V E+M GG + + +       K         +V   ++ +H    IHRD+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHRDV 168

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 292
           K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  + 
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 293 DVFSFGIVLWELLTGKLPY 311
           D +S G+ L+E+L G  P+
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 174
           +++  G+YG +Y  R  +    VA+K ++ +     +     +EV +++++    H N+V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 175 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKG----VFKLPSLLKVAIDVSKGM 225
           + +  C      +   + +V E +    +  YL K+         +  L++  +   +G+
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 285
           ++LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +T    T  + APEV+  
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 286 KPYDHKADVFSFGIVLWELLTGK 308
             Y    D++S G +  E+   K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 9/94 (9%)

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------VMTAETGTYR 276
           K + Y+H  N+IHRDLK +N+L++ +  VK+ADFG+AR  ++        V+T    T R
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-R 176

Query: 277 WM-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 308
           W  APE+ +    Y    D++S G +L E+L GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 51/198 (25%), Positives = 102/198 (51%), Gaps = 15/198 (7%)

Query: 121 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y+      ++ +A+K ++ E+ +  +     +E+ ++++++H N+V+   
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 237
                  L +V E++    +  ++       K P L+K  +  + +G+ Y H + ++HRD
Sbjct: 69  VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127

Query: 238 LKAANLLMDE-NEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDH 290
           LK  NLL+D     +K+ADFG+AR     V+      T E  T  + APE+ +  + Y  
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRT----FTHEVVTLWYRAPEILLGSRHYST 183

Query: 291 KADVFSFGIVLWELLTGK 308
             D++S G +  E++  K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     Q  A+K+L K E I       F +E  IM     + +VQ   
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110

Query: 179 ACTKPPSLCIVTEFMSGG------SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           A      L +V E+M GG      S YD   K    +    +L  A+D       +H   
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL--ALDA------IHSMG 162

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE----HK 286
            IHRD+K  N+L+D++  +K+ADFG       +G++  +T  GT  +++PEV++      
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
            Y  + D +S G+ L+E+L G  P+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 47/276 (17%)

Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           ++ G  G  Y+G      +   V +   +NS    E A     M K++H N+V+ IG C 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDL 238
                 ++ E++ G ++ + L  L    +     K+AI ++K + +LH      ++    
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRR----KIAIGIAKALRFLHCRCSPAVV---- 805

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKADVFS 296
                L  E  ++   D    R+     + T         ++APE  E K    K+D++ 
Sbjct: 806 --VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGV----------------VQKGLRPTIPKNSQPKL 340
           FG++L ELLTGK      +P  A  GV                +   + P+I  +     
Sbjct: 864 FGLILIELLTGK------SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917

Query: 341 AELLE------RCWQQDPALRPDFSEIIEILQQIAK 370
            E++E       C   DP  RP  +++++ L+  ++
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 8/92 (8%)

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWM 278
           G+ Y+H  N++HRDLK  NLL++ +  +K+ DFG+AR         +G MT    T RW 
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175

Query: 279 -APEV-IEHKPYDHKADVFSFGIVLWELLTGK 308
            APE+ +  + Y    DV+S G +L ELL  K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 59/248 (23%), Positives = 122/248 (49%), Gaps = 15/248 (6%)

Query: 122 VASGSYGDLY-----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN-V 173
           + +G+YG ++      G    +  A+KVLK   I   +   +    E  ++  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V    A      L ++ ++++GG ++ +L + +  FK   +   + ++   + +LH+  I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE--HKPYD 289
           I+RD+K  N+L+D N  V + DFG+++   +  V  A +  GT  +MAP+++      +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 347
              D +S G++++ELLTG  P+       +   + ++ L+  P  P+       ++++R 
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246

Query: 348 WQQDPALR 355
             +DP  R
Sbjct: 247 LMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 47/192 (24%), Positives = 97/192 (50%), Gaps = 6/192 (3%)

Query: 121 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+Y  +++G     +  VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                 SL +V E++    +  Y+     +  + ++      + +G+ Y H+  ++HRDL
Sbjct: 72  IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130

Query: 239 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFS 296
           K  NLL++E   +K+ADFG+AR K+  +   + E  T  +  P+V +    Y  + D++ 
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190

Query: 297 FGIVLWELLTGK 308
            G + +E+ +G+
Sbjct: 191 VGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 8/90 (8%)

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----GVMTAETGTYRW 277
           +G+ Y+H  N+IHRDLK +NLL++E+  +++ DFG+AR  + S       MT    T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176

Query: 278 M-APEVIEHKP-YDHKADVFSFGIVLWELL 305
             APE++   P Y    D++S G +  E+L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 58/239 (24%), Positives = 111/239 (46%), Gaps = 9/239 (3%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +  GS+G +   R     +  A+K ++   I   S++    A+   ++ +V    +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLK 59

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +   P  L +V  F++GG ++ +L + +G F L        ++   +  LH+ N+I+RD
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 238 LKAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+L+D    + + DFG+ ++            GT  ++APE++    Y    D ++
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
            G++L+E+LTG  P+      +    ++Q+ LR   P        +LL     +DP  R
Sbjct: 179 LGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)

Query: 121 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 176
           K+  GSY  +Y+G      + VA+KV+   R+  +    F   +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
                   +L +V E++    +  Y+ K  G     ++      + +G++Y+HQ  I+HR
Sbjct: 69  HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127

Query: 237 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 294
           DLK  NLL+ +   +K+ADFG+AR K+  S   + E  T  +  P+V +    Y    D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187

Query: 295 FSFGIVLWELLTGKLPYEYLTPLQ 318
           +  G +  E++ G   +  +  +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 67/292 (22%), Positives = 135/292 (46%), Gaps = 48/292 (16%)

Query: 121 KVASGSYGDLY-------RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           K+ +G +G+++       +  +C + ++ + LK ER  S    +   EV +MR+++HKN+
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKS----QLVIEVNVMRELKHKNI 74

Query: 174 VQFIGACTKPPS--LCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 228
           V++I       +  L I+ EF   G +   +   +K+ G  +  +++ +   +   + Y 
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 229 HQ-------NNIIHRDLKAANLLM-----------------DENEVVKVADFGVARVKAQ 264
           H          ++HRDLK  N+ +                 +   + K+ DFG+++    
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 265 SGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
             +  +  GT  + +PE++ H  K YD K+D+++ G +++EL +GK P+         + 
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254

Query: 323 VVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 373
            +++G  P +P K    +L  L++         RP  S +  +  QI K VG
Sbjct: 255 ELKRG--PDLPIKGKSKELNILIKNLLNLSAKERP--SALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 80/293 (27%), Positives = 119/293 (40%), Gaps = 68/293 (23%)

Query: 122 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNV 173
           +  GSYG +     T+  + VAIK     +IN      SD  +   +E+ ++R +RH ++
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATR-ILREIKLLRLLRHPDI 61

Query: 174 VQFIGACTKPPS------LCIVTEFMSGG-----SVYDYLHKLKGVFKLPSLLKVAIDVS 222
           V+ I     PPS      + +V E M           D L      F L  LL+      
Sbjct: 62  VE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWM- 278
             + Y+H  N+ HRDLK  N+L + +  +K+ DFG+ARV      + +   +    RW  
Sbjct: 115 -ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 279 APEVIE--HKPYDHKADVFSFGIVLWELLTGK-------------LPYEYL-TPLQAAVG 322
           APE+       Y    D++S G +  E+LTGK             L  + L TP    + 
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 323 VVQ--------KGLRPTIP-------KNSQPKLAELLERCWQQDPALRPDFSE 360
            V+          +R   P        N+ P    LLER    DP  RP   E
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 10/194 (5%)

Query: 121 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 176
           K+  GSY  +Y+G      Q VA+KV+    + ++    F   +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
                   +L  V E+M    +  Y+ +  G     ++      + +G+ Y+H  +I+HR
Sbjct: 69  HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 237 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 294
           DLK  NLL+     +K+ADFG+AR K+  S   ++E  T  +  P+V+     Y    D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 295 FSFGIVLWELLTGK 308
           +  G +  E+L G+
Sbjct: 188 WGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 20/195 (10%)

Query: 128 GDLYRGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 186
           GD+Y         A+KV+K   + +      F +E  I+       + Q   A     +L
Sbjct: 26  GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76

Query: 187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANLLM 245
            +V E+  GG +   L++ +  F    + +  + ++   ++ +HQ   +HRD+K  N+L+
Sbjct: 77  YLVMEYQPGGDLLSLLNRYEDQFD-EDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 246 DENEVVKVADFG-VARVKAQSGVM-TAETGTYRWMAPEVIE------HKPYDHKADVFSF 297
           D    +K+ADFG  AR+ A   V      GT  ++APEV+          Y  + D +S 
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195

Query: 298 GIVLWELLTGKLPYE 312
           G++ +E++ G+ P+ 
Sbjct: 196 GVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD

 Score = 60.6 bits (148), Expect = 5e-12
 Identities = 24/69 (34%), Positives = 35/69 (50%), Gaps = 2/69 (2%)

Query: 3  EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-DGWPYEETEQLRA 61
           +     D+P LL+ +T +LAD+GLNI +A   ST    +LDVF V D        +  A
Sbjct: 2  VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60

Query: 62 ALEKEVLKL 70
           LE+ +   
Sbjct: 61 RLEEALEDA 69

This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.4 bits (162), Expect = 8e-12
 Identities = 42/144 (29%), Positives = 77/144 (53%), Gaps = 4/144 (2%)

Query: 122 VASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           ++ G++G +Y  R    S+  A+KV+ K + IN +M  +   E   +   +   +V    
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     ++ +V E++ GG V   LH + G F     +K   +V+  ++YLH++ IIHRDL
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130

Query: 239 KAANLLMDENEVVKVADFGVARVK 262
           K  N+L+     +K+ DFG+++V 
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           V ++ +  E   ++M      E+ + +   H N+V +         L +VT FM+ GS  
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87

Query: 200 DYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV---- 253
           D +  H + G+ +L ++  +   V K ++Y+H    +HR +KA+++L+  +  V +    
Sbjct: 88  DLICTHFMDGMSEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146

Query: 254 ADFGVARVKAQSGVMTAETGTYR-----WMAPEVIEH--KPYDHKADVFSFGIVLWELLT 306
           ++  +     Q   +  +   Y      W++PEV++   + YD K+D++S GI   EL  
Sbjct: 147 SNLSMIN-HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205

Query: 307 GKLPYEYLTPLQAAVGVVQKGLRPTIP 333
           G +P++ +   Q    ++ + L  T+P
Sbjct: 206 GHVPFKDMPATQ----MLLEKLNGTVP 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 10/193 (5%)

Query: 121 KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 176
           K+  GSY  +Y+G      Q VA+K +   R+  +    F   +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
                   +L +V E++    +  Y+    G   + ++      + +G+ Y HQ  ++HR
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127

Query: 237 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 294
           DLK  NLL+ E   +K+ADFG+AR K+  S   + E  T  +  P+V+     Y    D+
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187

Query: 295 FSFGIVLWELLTG 307
           +  G + +E+ TG
Sbjct: 188 WGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 45/163 (27%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-------VAIDVSKGMNYLHQNNIIHRDL 238
           L +V E+M GG + + L + K VF      +       +A+D       +H+   IHRD+
Sbjct: 76  LYLVMEYMPGGDLMNLLIR-KDVFP-EETARFYIAELVLALD------SVHKLGFIHRDI 127

Query: 239 KAANLLMDENEVVKVADFGVA-----------------------------RVKAQSGVMT 269
           K  N+L+D +  +K+ADFG+                              R   Q  V  
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 270 -AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
            +  GT  ++APEV+   PY  + D +S G++L+E+L G  P+
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 61.3 bits (149), Expect = 4e-11
 Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 20/170 (11%)

Query: 196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 255
            S+ D L           +  V +     +  LH+        K+ N+L+  + ++K+  
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52

Query: 256 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 315
            G     A      +    Y +MAPEVI+ + Y  KAD++S GI L+E L  +LPY    
Sbjct: 53  DGSV---AFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108

Query: 316 PLQAAVGVVQKGLRPTIPKNSQPK--------LAELLERCWQQDPALRPD 357
            L A + ++  G+    P++              + +  C  + P  R  
Sbjct: 109 ELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 38/226 (16%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFI 177
            +  G  G++Y      CS+ VA+K ++ +   N  ++K F +E  I   + H  +V   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-------------LPSLLKVAIDVSKG 224
             C+    +     ++ G   Y     LK V++             + + L +   +   
Sbjct: 69  SICSDGDPVYYTMPYIEG---YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK------------AQSGVMTAE- 271
           + Y+H   ++HRDLK  N+L+     V + D+G A  K             +  +  +  
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 272 ------TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                  GT  +MAPE +   P     D+++ G++L+++LT   PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 121 KVASGSYGDLYRGTYCSQDVA---IKVLKPERINSD-------------MQKEFAQEVFI 164
           K+  G+YG +Y+    ++D     +  LK  R+  D             + +  ++ ++I
Sbjct: 8   KIGEGTYGKVYK----ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLP--SLLKVAIDV 221
           +R +  ++V +  G     PSL +V E++      +   +       LP  ++      +
Sbjct: 64  VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARV-KAQSGVMTAETGTYRWMA 279
            KG+ + H++ ++HRDLK  NLL+D +  ++K+AD G+ R         T E  T  + A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 280 PEV-IEHKPYDHKADVFSFGIVLWELLTG 307
           PEV +    Y    D++S G +  E+   
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 28/236 (11%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           K  K G+ + +GS+G +Y    C   S+ VAIK     ++  D Q +  +E+ IM+ + H
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIK-----KVLQDPQYK-NRELLIMKNLNH 118

Query: 171 KNVV----QFIGACTKPPS----LCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLK--VAI 219
            N++     +   C K       L +V EF+   +V+ Y+ H  +    LP  L    + 
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR--VKAQSGVMTAETGTYR 276
            + + + Y+H   I HRDLK  NLL+D N   +K+ DFG A+  +  Q  V    +  YR
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237

Query: 277 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
             APE+ +    Y    D++S G ++ E++ G   +   + +   V ++Q    PT
Sbjct: 238 --APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Length = 440

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)

Query: 96  PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPE 148
           P  L  P D    WE+   +L  G  + SG++G +   T         +  VA+K+LK  
Sbjct: 23  PMQL--PYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST 78

Query: 149 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 207
             +S+ Q     E+ IM  +  H N+V  +GACTK   + I+TE+   G + DYLH+ K 
Sbjct: 79  ARSSEKQA-LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Query: 208 VF 209
            F
Sbjct: 138 TF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)

Query: 141 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+KVL K E I  +  K    E  I+  + H  +     +      LC+V ++  GG ++
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 200 DYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF-- 256
             L +  G           A +V   + YLH   I++RDLK  N+L+ E+  + ++DF  
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149

Query: 257 -------GVARVKAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 288
                       KA                  + E         GT  ++APEVI    +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209

Query: 289 DHKADVFSFGIVLWELLTGKLPY 311
               D ++ GI+L+E+L G  P+
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 3/109 (2%)

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           +Y YL        L  +  VA  +   ++Y+H   IIHRD+K  N+L++  E + + DFG
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305

Query: 258 VA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 303
            A   R    +       GT    APEV+   PY    D++S G+V++E
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 36/136 (26%), Positives = 73/136 (53%), Gaps = 11/136 (8%)

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAAN 242
           +L +V ++  GG +   L K +   +LP  +      ++   ++ +HQ + +HRD+K  N
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132

Query: 243 LLMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHKP-----YDHKADVF 295
           +LMD N  +++ADFG      + G +  +   GT  +++PE+++        Y  + D +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192

Query: 296 SFGIVLWELLTGKLPY 311
           S G+ ++E+L G+ P+
Sbjct: 193 SLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 57/183 (31%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANLL 244
           L  V +++ GG +   L +L G+F+   L +  I +++  +  +H+   IHRD+K  N+L
Sbjct: 76  LYFVMDYIPGGDMMSLLIRL-GIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133

Query: 245 MDENEVVKVADFGVA--------------------------------------------- 259
           +D +  +K+ DFG+                                              
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193

Query: 260 ----RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 315
               R  A S V     GT  ++APEV+    Y    D +S G++L+E+L G+ P+   T
Sbjct: 194 RQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248

Query: 316 PLQ 318
           P +
Sbjct: 249 PAE 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 37/135 (27%), Positives = 74/135 (54%), Gaps = 11/135 (8%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 243
           L +V ++  GG +   L K +   +LP  + +  I ++   ++ +HQ + +HRD+K  N+
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133

Query: 244 LMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHK-----PYDHKADVFS 296
           L+D N  +++ADFG      Q G +  +   GT  +++PE+++        Y  + D +S
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193

Query: 297 FGIVLWELLTGKLPY 311
            G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 41/122 (33%), Positives = 62/122 (50%), Gaps = 11/122 (9%)

Query: 99  LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQ---DVAIKVLKPERIN 151
           +++P D    WE     L  G  + SG++G +  GT      SQ    VA+K+LKP   +
Sbjct: 24  MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81

Query: 152 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 210
           S+ Q     E+ IM  +  H N+V  +GACTK   + I+TE+   G + +YLHK +  F 
Sbjct: 82  SEKQA-LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140

Query: 211 LP 212
             
Sbjct: 141 SR 142

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 56/227 (24%)

Query: 119 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           G KV  G+YG +Y+         +D A+K ++   I+    +E A    ++R+++H NV+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----LLRELKHPNVI 61

Query: 175 QFIGACTKPPSLCIVTEFMSGGS-----VYDY----------LHKLKGVFKLP------- 212
                        +   F+S        ++DY           H+     K P       
Sbjct: 62  S------------LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109

Query: 213 --SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSG 266
             SLL   +D   G++YLH N ++HRDLK AN+L+     E   VK+AD G AR+     
Sbjct: 110 VKSLLYQILD---GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 267 VMTAETG----TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 308
              A+      T+ + APE ++  + Y    D+++ G +  ELLT +
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           +L ++ EF+ GG +   L K   + +  +   +A +    ++ +HQ   IHRD+K  NLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGFIHRDIKPDNLL 133

Query: 245 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 268
           +D    VK++DFG+                              ++ KA++       + 
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193

Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
            +  GT  ++APEV     Y+   D +S G++++E+L G  P+   TP
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           +L ++ EF+ GG +   L K   + +  +   +A  V   ++ +HQ   IHRD+K  NLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLGFIHRDIKPDNLL 133

Query: 245 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 268
           +D    VK++DFG+                              ++ KA++       + 
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193

Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
            +  GT  ++APEV     Y+   D +S G++++E+L G  P+   TP
Sbjct: 194 YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 54/235 (22%)

Query: 141 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+K L K + +N +       E  I+ +  ++ VV+   +     +L  V +++ GG + 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 200 DYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
             L ++  VF  P +L      +++  +  +H+   IHRD+K  N+L+D +  +K+ DFG
Sbjct: 90  SLLIRM-EVF--PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 258 V------------------------------------------------ARVKAQSGVMT 269
           +                                                A  + Q  +  
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 324
           +  GT  ++APEV+  K Y    D +S G++L+E+L G+ P+   TP +  + V+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 34/216 (15%)

Query: 119 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           G KV  G+YG +Y+         ++ A+K ++   I+    +E A    ++R+++H NV+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA----LLRELKHPNVI 61

Query: 175 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLP-SLLKVAI-DV 221
             Q +        + ++ ++      +D  H +K            +LP S++K  +  +
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 222 SKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETG---- 273
             G++YLH N ++HRDLK AN+L+     E   VK+AD G AR+        A+      
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 274 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 308
           T+ + APE ++  + Y    D+++ G +  ELLT +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 7/73 (9%)

Query: 3   EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 59
           E+T    D P L S++    A  G NI +A  F+T DG +LD F +    G   +E  +L
Sbjct: 734 EVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRL 793

Query: 60  ---RAALEKEVLK 69
                A+E   L 
Sbjct: 794 ARLAKAIED-ALS 805

Length = 931

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 37/135 (27%), Positives = 75/135 (55%), Gaps = 11/135 (8%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 243
           L +V ++  GG +   L K +   +LP  + +  + ++   ++ +HQ   +HRD+K  N+
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133

Query: 244 LMDENEVVKVADFGVA-RVKAQSGVMTA-ETGTYRWMAPEVIE-----HKPYDHKADVFS 296
           L+D+N  +++ADFG   R+ A   V +    GT  +++PE+++        Y  + D +S
Sbjct: 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193

Query: 297 FGIVLWELLTGKLPY 311
            G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 30/106 (28%), Positives = 58/106 (54%), Gaps = 9/106 (8%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGT---YCSQD----VAIKVLKPERINSDMQKEFA 159
           + WE    +L+FG  + +G++G +   T      +D    VA+K+LK    ++D ++   
Sbjct: 31  EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKA-SAHTDEREALM 89

Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK 204
            E+ I+  + +HKN+V  +GACT    + ++TE+   G + ++L K
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 49/128 (38%)

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVA---------------------------- 259
           +H+   IHRD+K  NLL+D    +K++DFG+                             
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 260 ----------------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 303
                           R  A S V     GT  ++APEV     Y+ + D +S G++++E
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 304 LLTGKLPY 311
           +L G  P+
Sbjct: 232 MLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 53/211 (25%)

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 243
           +L  V +++ GG +   L ++ G+F    L +  I +++  +  +H+   IHRD+K  N+
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132

Query: 244 LMDENEVVKVADFGV--------------------------------------------- 258
           L+D +  +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 259 ---ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 315
              A  + Q  +  +  GT  ++APEV+    Y    D +S G++L+E+L G+ P+   T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252

Query: 316 PLQAAVGVVQKGLRPTIPKNSQ--PKLAELL 344
           PL+  + V+       IP  ++  P+ ++L+
Sbjct: 253 PLETQMKVINWQTSLHIPPQAKLSPEASDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme

 Score = 45.7 bits (109), Expect = 6e-07
 Identities = 24/62 (38%), Positives = 38/62 (61%), Gaps = 3/62 (4%)

Query: 4  ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAA 62
          +T S  D+P LL+++ ++LA+ G+NI      ++ DG   D+F VVDG    + E+L  A
Sbjct: 1  LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD--GDLEKLLEA 58

Query: 63 LE 64
          LE
Sbjct: 59 LE 60

Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 8/109 (7%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     LK G  +  G++G +          T   + VA+K+LK    +S+ +   ++ 
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 61

Query: 162 VFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 209
             ++    H NVV  +GACTKP   L ++ EF   G++ +YL   +G F
Sbjct: 62  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 14/112 (12%)

Query: 109 WEIDPKHLKFGSKVASGSYG--------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 160
           WE     LK G  +  G++G         + +   C + VA+K+LK E   +   K    
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLK-EGATASEYKALMT 59

Query: 161 EVFIMRKV-RHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVF 209
           E+ I+  +  H NVV  +GACTKP  P + IV E+   G++ +YL   +  F
Sbjct: 60  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|190133 pfam01842, ACT, ACT domain

 Score = 44.3 bits (105), Expect = 3e-06
 Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 2  HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRA 61
            +     D+P LL+++   LAD G+NI+     ++ D   +   VV     E+ E    
Sbjct: 1  TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59

Query: 62 ALEK 65
          AL+K
Sbjct: 60 ALKK 63

This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66

>gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

 Score = 44.0 bits (105), Expect = 4e-06
 Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 6/63 (9%)

Query: 10 DKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY--EETEQLRAALE 64
          D+P LL+ +T +LA++GLNI  A   +T+   + DVF V   DG P   E  E LRAAL 
Sbjct: 9  DRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEALRAALG 67

Query: 65 KEV 67
          + +
Sbjct: 68 EAL 70

This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 9/171 (5%)

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           S+ +V +   GG ++ ++ K   +     + + A ++   ++ LH+  I+ RDL   N+L
Sbjct: 59  SVFLVLQHAEGGKLWSHISKFLNI-PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL 117

Query: 245 MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 304
           +D+   +++  F        S    A    Y   APEV          D +S G +L+EL
Sbjct: 118 LDDRGHIQLTYFSRWSEVEDSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFEL 175

Query: 305 LTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           LTGK      T ++     +       IP+    +   LL++  Q +P  R
Sbjct: 176 LTGK------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 12/111 (10%)

Query: 109 WEIDPKHLKFGSKVASGSYGDL--------YRGTYCSQDVAIKVLKPERINSDMQKEFAQ 160
           WE     L+ G  +  G++G +         + + C   VA+K+LK E   +   K    
Sbjct: 2   WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLK-EGATASEHKALMS 59

Query: 161 EVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 209
           E+ I+  +  H NVV  +GACTKP   L ++ EF   G++ ++L   +  F
Sbjct: 60  ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 21/144 (14%)

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLL 244
           +CIV     G  + D++ K  G F    L ++       ++Y H   +++H DLK  N+L
Sbjct: 207 MCIVMP-KYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264

Query: 245 MDENEV----------------VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           M+ ++                 V++ D G    +  S      T  YR  +PEV+    +
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGW 322

Query: 289 DHKADVFSFGIVLWELLTGKLPYE 312
            +  D++S G +++EL TGKL Y+
Sbjct: 323 MYSTDMWSMGCIIYELYTGKLLYD 346

Length = 467

>gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones]

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 3   EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 59
           E+     D+P+L + + A L+  GL+I +A  F+T DGY+LD F+V   DG+P EE  + 
Sbjct: 686 EVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTTRDGYALDTFIVLEPDGFPVEEDRRA 745

Query: 60  R------AALEKEVLKLERQGWPSHRSSSPTSEPE 88
                   AL     +  R+     +       P 
Sbjct: 746 ALRGELIEALLSGKAQPPRRRRIPRKLRHFPIPPR 780

Length = 867

>gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 3/64 (4%)

Query: 3   EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 59
           E+     D+P L +++   LA + L++ +A   +T DG +LD FVV    G P       
Sbjct: 670 EVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVF 729

Query: 60  RAAL 63
           +  L
Sbjct: 730 QELL 733

This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 8/129 (6%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 30  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             +     H N+V  +GACT      ++TE+   G + ++L + +  F  P     A   
Sbjct: 90  KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAA 149

Query: 222 SKGMNYLHQ 230
               N LHQ
Sbjct: 150 LY-KNLLHQ 157

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 43/207 (20%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 136 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 195
           C + +A +V    R    ++     E+  + ++ H+N+++         +  ++T+    
Sbjct: 192 CERLIAKRVKAGSRAAIQLE----NEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247

Query: 196 GSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDENEVV 251
             +Y +++     +K   LLK    + K     + Y+H   +IHRD+K  N+ ++ +  +
Sbjct: 248 -DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306

Query: 252 KVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
            + DFG A      R     G +    GT    +PE++    Y    D++S G++L ++L
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Query: 306 TGKLPYEYLTPLQAAVGVVQKGLRPTI 332
           +         P+    G   K L   I
Sbjct: 363 SHD-----FCPIGDGGGKPGKQLLKII 384

Length = 501

>gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 22/68 (32%), Positives = 38/68 (55%), Gaps = 5/68 (7%)

Query: 3   EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEET--E 57
           EI   + D+P L + + A L    L++ +A  F++ DG ++D F+V   DG P  +   +
Sbjct: 703 EIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQ 762

Query: 58  QLRAALEK 65
            +R ALE+
Sbjct: 763 VIRKALEQ 770

Length = 884

>gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 7/72 (9%)

Query: 8   TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY----EETEQLR 60
             D+    +   A +  + LNI +A   ++   ++LD ++V   DG P        EQ+R
Sbjct: 711 APDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIR 770

Query: 61  AALEKEVLKLER 72
             L + +   + 
Sbjct: 771 EGLTEALRNPDD 782

Length = 895

>gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 8   TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAALEKE 66
             D+P LL++L   L   G++++ A   +T+    +DVF V         +  RAA+E+ 
Sbjct: 714 AADRPGLLARLARALERAGVDVRWARV-ATLGADVVDVFYVTGAAGGPLADA-RAAVEQA 771

Query: 67  VL 68
           VL
Sbjct: 772 VL 773

Length = 774

>gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 9/85 (10%)

Query: 4   ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY---SLDVF-VVDGWPYEETEQL 59
           I  +  D+P LL  LT  L+D+ LNI  AH    +  Y   ++DVF V D +  + T + 
Sbjct: 846 IEVNGRDRPGLLYDLTRALSDLNLNIASAH----IATYGERAVDVFYVTDLFGLKITNEA 901

Query: 60  R-AALEKEVLKLERQGWPSHRSSSP 83
           R AA+ + +L    +G    R++ P
Sbjct: 902 RQAAIRRALLAALAEGEAEARAARP 926

Length = 931

>gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones]

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 19/67 (28%), Positives = 33/67 (49%), Gaps = 4/67 (5%)

Query: 3   EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAA 62
            +     D+P LL+ L  + AD+GL++  A   +T      DVF+V      + + L A 
Sbjct: 793 VLEVRALDRPGLLAALAGVFADLGLSLHSAKI-TTFGERVEDVFIVTD---ADGQALNAE 848

Query: 63  LEKEVLK 69
           L + +L+
Sbjct: 849 LRQSLLQ 855

Length = 867

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.0 bits (89), Expect = 0.004
 Identities = 18/73 (24%), Positives = 38/73 (52%), Gaps = 6/73 (8%)

Query: 188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 247
           IV E++ G  + D ++           L+++ ++ + +  LH   IIH DL  +N+++  
Sbjct: 76  IVMEYIEGEPLKDLINSNG-----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130

Query: 248 NEVVKVADFGVAR 260
            ++  + DFG+A 
Sbjct: 131 GKIY-LIDFGLAE 142

Length = 211

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 18/39 (46%), Positives = 25/39 (64%)

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
           V  G+  LH+  I+HRD+K  NLL+  +  VK+ DFG A
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	397
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
PRK14879	211	serine/threonine protein kinase; Provisional	99.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
smart00090	237	RIO RIO-like kinase.	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.63
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
KOG1243	690	consensus Protein kinase [General function predict	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.52
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.48
cd04928	68	ACT_TyrKc Uncharacterized, N-terminal ACT domain o	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
COG4248	637	Uncharacterized protein with protein kinase and he	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.31
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.16
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.1
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.02
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.01
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.95
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.9
PRK09902	216	hypothetical protein; Provisional	98.86
cd04900	73	ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1,	98.84
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
PF01636	239	APH: Phosphotransferase enzyme family This family	98.58
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.52
cd04927	76	ACT_ACR-like_2 Second ACT domain, of a novel type	98.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.49
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.46
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.46
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.42
cd04925	74	ACT_ACR_2 ACT domain-containing protein which is c	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.39
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.33
PLN02876	822	acyl-CoA dehydrogenase	98.32
cd04897	75	ACT_ACR_3 ACT domain-containing protein which is c	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.17
cd04895	72	ACT_ACR_1 ACT domain-containing protein which is c	98.14
cd04896	75	ACT_ACR-like_3 ACT domain-containing protein which	98.08
PRK10593	297	hypothetical protein; Provisional	98.02
cd04926	72	ACT_ACR_4 C-terminal ACT domain, of a novel type o	97.95
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.86
PF01842	66	ACT: ACT domain; InterPro: IPR002912 The ACT domai	97.86
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.84
PRK05231	319	homoserine kinase; Provisional	97.76
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.75
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.73
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.68
cd04873	70	ACT_UUR-ACR-like ACT domains of the bacterial sign	97.6
PRK05092	931	PII uridylyl-transferase; Provisional	97.58
PRK04374	869	PII uridylyl-transferase; Provisional	97.54
PRK03059	856	PII uridylyl-transferase; Provisional	97.53
PRK00275	895	glnD PII uridylyl-transferase; Provisional	97.53
cd04893	77	ACT_GcvR_1 ACT domains that comprise the Glycine C	97.52
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.47
TIGR01693	850	UTase_glnD [Protein-PII] uridylyltransferase. This	97.47
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.42
cd04899	70	ACT_ACR-UUR-like_2 C-terminal ACT domains of the b	97.42
cd04875	74	ACT_F4HF-DF N-terminal ACT domain of formyltetrahy	97.42
cd04872	88	ACT_1ZPV ACT domain proteins similar to the yet un	97.35
PRK01759	854	glnD PII uridylyl-transferase; Provisional	97.3

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-58  Score=441.65  Aligned_cols=271  Identities=49%  Similarity=0.894  Sum_probs=253.1

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEECCcc-eEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ....|.++.+++.+.+.||+|+||+||+|.|.++. ||||++..........+.|.+|+.+|.+++|||||+++|+|.++
T Consensus        32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34668999999999999999999999999999999 99999998766555578999999999999999999999999998


Q ss_pred             C-ceEEEEEeccCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEeCCCC-ceEEcccccc
Q 015965          184 P-SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENE-VVKVADFGVA  259 (397)
Q Consensus       184 ~-~~~lv~E~~~g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~Nili~~~~-~vkl~DfG~a  259 (397)
                      . .++|||||+++|+|.++++. .+..+++..++.++.||++||+|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            8 79999999999999999988 4788999999999999999999999999 99999999999999997 9999999999


Q ss_pred             cccccC-CcccCCCCCcccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          260 RVKAQS-GVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       260 ~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      +..... ..++...||+.|||||++.  ...|+.|+||||||++||||+||..||....+.+.+..++..+.+|.+|..+
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            987765 4556689999999999999  6699999999999999999999999999999999999999999999999999


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchh
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  375 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~  375 (397)
                      ++.+..++.+||+.||..||++.+++..|+.+.......
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence            999999999999999999999999999999998877654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-56  Score=424.88  Aligned_cols=262  Identities=37%  Similarity=0.737  Sum_probs=238.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECCc-ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+.|+++.+.+++++.||+|.||+||.|.|.+. +||+|.++.....   ...|.+|+.+|++|+|+|||+++++|..+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            678999999999999999999999999999887 8999999976544   356889999999999999999999999988


Q ss_pred             ceEEEEEeccCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      .+|||||||+.|+|.++|+. ....+....++.++.||+.||+||+++++|||||.++|||++++..+||+|||+|+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999987 45679999999999999999999999999999999999999999999999999999555


Q ss_pred             cCCcccCCC--CCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ++......-  -+..|+|||.+....|+.+|||||||++||||+| |+.||.+++..+.+.. +.++.|.+.|..||+++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~v  433 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEV  433 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHH
Confidence            443322222  2678999999999999999999999999999999 9999999998877755 77888999999999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .++|..||+.+|++||||..+...|+++...
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            9999999999999999999999999988653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-55  Score=399.28  Aligned_cols=251  Identities=31%  Similarity=0.551  Sum_probs=225.2

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc-
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  185 (397)
                      ..+..++++.++.||+|+.|+||++.+.  ++-+|+|++... .+....+++.+|+++++.++||+||.+||+|..+.. 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            3466678999999999999999999875  677999999543 456678899999999999999999999999999985 


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ++|+||||.||||.+++... +.+++..+.+++.++++||.|||. .+||||||||+|||++..|.|||||||.++....
T Consensus       153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            99999999999999999874 889999999999999999999995 9999999999999999999999999999988776


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhhcCCCCCCCCC-CcH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIPKN-SQP  338 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~  338 (397)
                      + .-.+++||..|||||.+.+..|+.++||||||++++||++|+.||...     ...+....++. ...|..|.. +++
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSP  309 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCH
Confidence            6 557889999999999999999999999999999999999999999764     45555555554 346677776 999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++++|+..||++||.+||++.|+++
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999999974

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-53  Score=408.56  Aligned_cols=248  Identities=27%  Similarity=0.478  Sum_probs=228.2

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ..+|+.++.||+|+|+.+|+++.  +++.||+|++.+... .....+.+.+||+|.+.|+|||||+++++|++.+++|||
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            36799999999999999999986  678899999987554 344567799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Ccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~  268 (397)
                      .|+|..++|..++++ +..++++.++.++.||+.||.|||+++|||||||..|+|++++-+|||+|||+|.....+ ...
T Consensus        97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            999999999999984 789999999999999999999999999999999999999999999999999999876644 677


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      .+.+|||-|+|||++....++..+||||+||+||.||+|++||+..+-.+.+..+.....  .+|..++.+.++||.++|
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL  253 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLL  253 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHHh
Confidence            888999999999999999999999999999999999999999999988888888776643  477799999999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      +.||.+|||+++++.
T Consensus       254 ~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  254 RPNPSERPSLDEVLD  268 (592)
T ss_pred             cCCcccCCCHHHHhc
Confidence            999999999999974

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-53  Score=391.21  Aligned_cols=247  Identities=30%  Similarity=0.578  Sum_probs=223.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .+|.+.++||+|+||+||+|++  .+..||||.+.....+....+.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            5688889999999999999987  45779999999887778778889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC------CceEEcccccccccccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------EVVKVADFGVARVKAQS  265 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~------~~vkl~DfG~a~~~~~~  265 (397)
                      ||.||+|.+|++. .+.+++..+..++.||+.||++||+++||||||||+||||+..      -.+||+|||+||.....
T Consensus        90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            9999999999998 5789999999999999999999999999999999999999864      46999999999999888


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-CCCCCCCCCcHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELL  344 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll  344 (397)
                      ....+.+|++.|||||++....|+.|+|+||+|+++|+|++|+.||+..++.+....+.+.. ..+.++..+++.+.+++
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll  248 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELL  248 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence            77888899999999999999999999999999999999999999999999888776544332 35666777788888999


Q ss_pred             HHhchhCCCCCCCHHHH
Q 015965          345 ERCWQQDPALRPDFSEI  361 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~el  361 (397)
                      ...+..+|..|-++.+-
T Consensus       249 ~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  249 ISLLQRNPKDRISFEDF  265 (429)
T ss_pred             hHHHhcCccccCchHHh
Confidence            99999999999877664

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-53  Score=389.08  Aligned_cols=245  Identities=27%  Similarity=0.468  Sum_probs=222.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+.+++|+++++||+|+||+||.++.  +++-+|+|++++..... ...+....|..+|.+++||+||+++..|+++..+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45678999999999999999999865  56779999998765433 3567789999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      |+|+||+.||.|..+|++ ++.+++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++..... 
T Consensus       101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999999987 689999999999999999999999999999999999999999999999999999865554 


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                      ....+.+||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+..+....+.+.. .+..|...+.+.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence            44556799999999999999999999999999999999999999999999988888887765 34566678999999999


Q ss_pred             HhchhCCCCCC
Q 015965          346 RCWQQDPALRP  356 (397)
Q Consensus       346 ~cl~~dp~~Rp  356 (397)
                      ++|..||++|.
T Consensus       259 ~LL~rdp~~RL  269 (357)
T KOG0598|consen  259 KLLKRDPRQRL  269 (357)
T ss_pred             HHhccCHHHhc
Confidence            99999999996

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-53  Score=391.91  Aligned_cols=251  Identities=24%  Similarity=0.399  Sum_probs=217.1

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ..+.|.+.+.||+|+||.|-+|..  +++.||||++++.....     .....+.+|+++|++|+|||||++++++..+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            346788999999999999999965  67889999998754322     12334679999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC---CceEEcccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARV  261 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~---~~vkl~DfG~a~~  261 (397)
                      ..||||||++||.|.+.+-. .+.+.+..-..++.||+.|+.|||+.||+||||||+|||+..+   -.+||+|||+|++
T Consensus       250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999999999976 5678888889999999999999999999999999999999866   6899999999999


Q ss_pred             cccCCcccCCCCCcccccccccCCCCC--C-CchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCC--CCCCCCC
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPY--D-HKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGL--RPTIPKN  335 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~-~~~~~~~~~~--~~~~~~~  335 (397)
                      ......|.+.||||.|.|||++.++.+  + .++|+|||||+||-+++|.+||....... ....+.+..+  -|.....
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            998889999999999999999976643  3 37899999999999999999998765544 5555554433  3445577


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++++..+||.+||..||++|||+.|+|+
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            8999999999999999999999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-53  Score=374.87  Aligned_cols=252  Identities=24%  Similarity=0.447  Sum_probs=222.6

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeee-EEecCCc-eE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG-ACTKPPS-LC  187 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~  187 (397)
                      ...+|++.++||+|+||+||++..  ++..+|.|.++-+..+.........|+.+|++|+|||||++++ .+.++.. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            346799999999999999999965  6788999999988888888889999999999999999999998 5555554 89


Q ss_pred             EEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCcEEeCCCCceEEccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~--~~--iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      ||||||.+|+|...++..   +..++++.+|+++.|++.||.++|+  ..  |+||||||.||+++.+|.|||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            999999999999998643   4679999999999999999999999  44  9999999999999999999999999999


Q ss_pred             ccccCCc-ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          261 VKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       261 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....... ..+.+|||.||+||++...+|+.+|||||+||++|||+.-+.||.+.+-.+...++.+....|......+.+
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD  256 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence            8776543 456799999999999999999999999999999999999999999998888888877765544444788999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +..++..|+..||+.||+...++.
T Consensus       257 l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             HHHHHHHHccCCcccCCCcchHHH
Confidence            999999999999999998544433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=401.54  Aligned_cols=268  Identities=37%  Similarity=0.739  Sum_probs=238.7

Q ss_pred             CCCCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      +....|+|..+++.++..||+|+||+||+|.|.| +||||+++.+..+.+..+.|++|+.++++-+|.||+-|.|+|..+
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            3446899999999999999999999999999977 699999999888888899999999999999999999999999998


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +. .||+.+|+|-+|+.+++..+.+|....++.|+.||++||.|||.++|||||||..||++.+++.|||+|||++....
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            76 99999999999999999888899999999999999999999999999999999999999999999999999997654


Q ss_pred             cC---CcccCCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC---CC
Q 015965          264 QS---GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PK  334 (397)
Q Consensus       264 ~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~  334 (397)
                      ..   .......|...|||||++.   ..+|+..+||||||+++|||++|.+||......+.++.+-+..++++.   ..
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence            42   3344557889999999984   457999999999999999999999999976666666655454444443   35


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .++.++++|+..||..++++||.|.+|+..|++++..+.
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence            688899999999999999999999999999999987643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=384.63  Aligned_cols=252  Identities=25%  Similarity=0.443  Sum_probs=224.6

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChH-HHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  185 (397)
                      .-.+.+|.+++.||.|+|++|++|+.  .++.||||++.+.....+ ..+-+..|-..|.+| .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34568999999999999999999976  567899999986654332 335577899999999 79999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+|+||+++|.|.++|.+. +.|++..++.++.||+.||+|||++|||||||||+|||+|.++++||+|||.|+.....
T Consensus       149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999984 89999999999999999999999999999999999999999999999999999865542


Q ss_pred             Cc--------------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC
Q 015965          266 GV--------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT  331 (397)
Q Consensus       266 ~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~  331 (397)
                      ..              ..+++||..|.+||++.....+..+|+|+|||+||.|+.|.+||.+.+......+++.-  .-.
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--~y~  305 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--DYE  305 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--ccc
Confidence            11              14578999999999999999999999999999999999999999999988877777664  446


Q ss_pred             CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       332 ~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                      +|..+++...+|++++|..||.+|+|+.+|.+.
T Consensus       306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            888999999999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-52  Score=393.86  Aligned_cols=257  Identities=33%  Similarity=0.662  Sum_probs=237.2

Q ss_pred             CCCCCCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          102 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       102 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      .....+.|+|.-+.+.-++.||+|+.|.||+|+..++.||||.++.-         -..+|+-|++|+||||+.|.|+|.
T Consensus       112 k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  112 KQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             hhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeec
Confidence            34455689998888888899999999999999999999999986521         124788999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ..+.+|||||||..|-|+.+|+. ..+++...+..|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++.
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e  261 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKE  261 (904)
T ss_pred             CCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHh
Confidence            99999999999999999999987 67889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ...-..+..++||..|||||++...+.+.|+|||||||+|||||||..||.+.+....++++-...+....|..||..|+
T Consensus       262 ~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  262 LSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             hhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence            87777788899999999999999999999999999999999999999999999888888888888888899999999999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      -||++||+-.|.+||+|++++..|+=.
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            999999999999999999999888744

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.3e-51  Score=362.95  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=220.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|+.+.++|+|+||+||++++  +|+.||||.+.....++...+-.++|+++|++++|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688889999999999999975  67889999998776677777889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc-cCCcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-~~~~~~~  270 (397)
                      ||+ -++.+-|+.....++...+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+||... ++...+.
T Consensus        82 ~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            995 46667777778889999999999999999999999999999999999999999999999999999887 5667788


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-------------------CCC-
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------GLR-  329 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~-------------------~~~-  329 (397)
                      ++.|.+|+|||.+.+ ..|...+||||+||++.||++|.+-|.+.+..+....+...                   +.+ 
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            899999999999987 67999999999999999999999999998887766654421                   111 


Q ss_pred             CCCC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHH
Q 015965          330 PTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIA  369 (397)
Q Consensus       330 ~~~~---------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l~  369 (397)
                      |..+         ...+.-+.+|+.+||..||++|++.++++.  .+++++
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            1111         234567889999999999999999999983  344443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-50  Score=374.97  Aligned_cols=252  Identities=29%  Similarity=0.519  Sum_probs=219.2

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC--ceEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCI  188 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l  188 (397)
                      ..++..++.||+|+||.||++...  +...|||.+.....  ...+.+.+|+.+|++++|||||+++|......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            356788899999999999999886  58899999876522  22567889999999999999999999744433  6899


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEccccccccccc---
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ---  264 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~~---  264 (397)
                      .|||+++|||.+++....+.++++.+..++.||+.||.|||++|||||||||+|||++. ++.+||+|||.++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999987668999999999999999999999999999999999999999 79999999999976553   


Q ss_pred             -CCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          265 -SGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       265 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                       ........||+.|||||++... ....++|||||||++.||+||..||.. ....+....+......|.+|..++++.+
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence             2334467899999999999853 333599999999999999999999998 6667777777777777899999999999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      +|+.+|+..||++||||.++|+.--
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChh
Confidence            9999999999999999999986543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=357.46  Aligned_cols=238  Identities=27%  Similarity=0.480  Sum_probs=219.1

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|++.+.||.|+||.|.+++.  .+..+|+|++++...-. ...+...+|..+|+.+.||+++++++.+.+.+.+|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            36799999999999999999876  56779999998765432 3456688899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      |||++||.|..++++ .++++++.++.++.||+.|++|||+++|++|||||+|||+|.+|.+||+|||+|+.....  ..
T Consensus       123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~  199 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TW  199 (355)
T ss_pred             EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EE
Confidence            999999999999998 588999999999999999999999999999999999999999999999999999866543  66


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      +.||||.|+|||++..++|..++|+||||+++|||+.|.+||...++.+...+++...++  +|..+++++++|+.++|+
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~~LL~  277 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSSDAKDLLKKLLQ  277 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCHHHHHHHHHHHh
Confidence            789999999999999999999999999999999999999999999999999999887654  888999999999999999


Q ss_pred             hCCCCC
Q 015965          350 QDPALR  355 (397)
Q Consensus       350 ~dp~~R  355 (397)
                      .|-.+|
T Consensus       278 vD~t~R  283 (355)
T KOG0616|consen  278 VDLTKR  283 (355)
T ss_pred             hhhHhh
Confidence            999988

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-50  Score=390.41  Aligned_cols=337  Identities=27%  Similarity=0.486  Sum_probs=279.9

Q ss_pred             HHHHHHhh--cCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCC
Q 015965           17 QLTALLAD--IGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKS   94 (397)
Q Consensus        17 ~~~~~~~~--~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~ss~~~~~~~~~~~~   94 (397)
                      ||..-.++  -.||++++.+|+++...+|+-+   |+.+.++++|++++.+.....+..+|.++.-....+......   
T Consensus        20 qL~qf~s~lr~~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~p~h~~~t---   93 (1039)
T KOG0199|consen   20 QLDQFISQLRFLLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGADPSHPAQT---   93 (1039)
T ss_pred             HHHHHHHHHHHHhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCCccccccc---
Confidence            44444444  3689999999999999999876   999999999999999877766666665433221111100000   


Q ss_pred             CCCcccCCCCCCCccccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCC
Q 015965           95 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR  169 (397)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~  169 (397)
                        ..... .......-|...++++.++||+|+||.|++|.|+.     -.||||+++...... ....|++|+.+|.+|+
T Consensus        94 --~~~~~-p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~  169 (1039)
T KOG0199|consen   94 --NSVAN-PSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQ  169 (1039)
T ss_pred             --cCCCC-cCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhcc
Confidence              00001 12233346777889999999999999999999954     249999999877665 5688999999999999


Q ss_pred             CCCeeeeeeEEecCCceEEEEEeccCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 015965          170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  248 (397)
Q Consensus       170 h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~  248 (397)
                      |||++++||++.+ ..+.||||++++|||.+.|++ .+..|....+..|+.||+.||.||.++++|||||..+|||+-..
T Consensus       170 H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp  248 (1039)
T KOG0199|consen  170 HPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP  248 (1039)
T ss_pred             CcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc
Confidence            9999999999988 568899999999999999988 56789999999999999999999999999999999999999999


Q ss_pred             CceEEcccccccccccCCcccCC----CCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 015965          249 EVVKVADFGVARVKAQSGVMTAE----TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV  323 (397)
Q Consensus       249 ~~vkl~DfG~a~~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~  323 (397)
                      ..|||+|||++|....+..+...    .-.+.|||||.++...|+.++|||++|++||||++ |..||.+....+.+..+
T Consensus       249 rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i  328 (1039)
T KOG0199|consen  249 RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI  328 (1039)
T ss_pred             ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence            99999999999987766544332    23678999999999999999999999999999999 99999999999888876


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       324 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                      - .+.+...|+.|++++++++..||..+|.+||+|..|.+.+
T Consensus       329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            5 7778889999999999999999999999999999997543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=380.15  Aligned_cols=249  Identities=29%  Similarity=0.570  Sum_probs=223.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC---hHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  184 (397)
                      .....|.+++.||+|+||.|++|..  .+..||+|++......   ....+.+.+|+.+++.++ ||||++++.++..+.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999976  5688999988765222   134556778999999999 999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEccccccccc-
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVK-  262 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~~~-  262 (397)
                      .+|+||||+.||.|.+++.. .+++++..+.+++.||+.|++|||++||+||||||+|||++.+ +++||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999998 8999999999999999999999999999999999999999999 99999999999988 


Q ss_pred             ccCCcccCCCCCcccccccccCCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCC-cHH
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKP-YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPK  339 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  339 (397)
                      .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..+.......+...  ...+|..+ +++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLSPE  250 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCCHH
Confidence            5667788999999999999999988 87 6799999999999999999999998877777765444  44577778 999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                      ++.|+.+||..||.+|+++.+++
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHh
Confidence            99999999999999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-49  Score=378.91  Aligned_cols=262  Identities=34%  Similarity=0.661  Sum_probs=221.8

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC  180 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  180 (397)
                      |++..++|++.++||+|+||.||+|.+.       ++.||||+++... .......+.+|+.+++++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            7888899999999999999999999742       3569999987543 333456789999999999 899999999988


Q ss_pred             ecCC-ceEEEEEeccCCCHHHHHHhcc-----------------------------------------------------
Q 015965          181 TKPP-SLCIVTEFMSGGSVYDYLHKLK-----------------------------------------------------  206 (397)
Q Consensus       181 ~~~~-~~~lv~E~~~g~sL~~~l~~~~-----------------------------------------------------  206 (397)
                      ...+ .++++|||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            7644 5899999999999999997532                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---ccCCCCCc
Q 015965          207 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTY  275 (397)
Q Consensus       207 --------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~  275 (397)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   .....+++
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2377788899999999999999999999999999999999999999999999975432211   12234578


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      .|+|||++.+..++.++||||||+++|||++ |..||......+.....+..+..+..+..+++++.+++.+||+.||.+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999997 999998866555455555555566677888999999999999999999


Q ss_pred             CCCHHHHHHHHHHHHHH
Q 015965          355 RPDFSEIIEILQQIAKE  371 (397)
Q Consensus       355 Rps~~ell~~L~~l~~~  371 (397)
                      |||+.++++.|++++++
T Consensus       321 RPs~~el~~~l~~~~~~  337 (338)
T cd05102         321 RPTFSALVEILGDLLQE  337 (338)
T ss_pred             CcCHHHHHHHHHHHHhc
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6e-49  Score=373.96  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=219.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|+++++||+|+||.||+++-  +|+.+|+|++++... .....+.++.|..+|...++|+||++|.+|++..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            34557899999999999999999964  678899999987654 445677899999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc--
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--  264 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~--  264 (397)
                      ||||||++||++..+|.+ .+.+++..+..++.+++.|++.||+.|||||||||+|+|||..|++||+|||++.....  
T Consensus       217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999999987 68999999999999999999999999999999999999999999999999999842110  


Q ss_pred             --------------------CCcc--------------------------cCCCCCcccccccccCCCCCCCchhHHHHH
Q 015965          265 --------------------SGVM--------------------------TAETGTYRWMAPEVIEHKPYDHKADVFSFG  298 (397)
Q Consensus       265 --------------------~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG  298 (397)
                                          ....                          ...+|||-|||||++.++.|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                0000                          013699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHhhhcC--CCCCCCCCCcHHHHHHHHHhchhCCCCCCC---HHHHH
Q 015965          299 IVLWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPKNSQPKLAELLERCWQQDPALRPD---FSEII  362 (397)
Q Consensus       299 ~~l~ell~g~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps---~~ell  362 (397)
                      |||||||.|.+||...++.++..+++...  +.-+....++++..+||.+|+. ||++|..   +.||.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            99999999999999999999999988765  3333345677999999999999 9999975   55554

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-49  Score=381.29  Aligned_cols=269  Identities=33%  Similarity=0.654  Sum_probs=243.4

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-----cc-eEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QD-VAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIG  178 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~-vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~  178 (397)
                      ...|++..++..+.++||+|+||+||+|++.-     .. ||||..+... .......+|.+|+++|++++|||||++||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            45699999999999999999999999997632     23 8999998633 56777899999999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      ++.....+++|||+|+||+|.++|++..+.++......++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999999999777899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccc-CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          259 ARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       259 a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      ++....-.... ...-+..|+|||.+....|+.++||||||+++||+++ |..||.+....+....++..+.+...|...
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            98665222222 1134689999999999999999999999999999999 899999999999999988999999999999


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      |.++..++.+||..+|+.||++.++.+.|+.+......
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999999877653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=373.55  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=220.7

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCC-ceE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP-SLC  187 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~  187 (397)
                      ..++|.++++||.|+||.||+|+.  .++.||||.++......+ .-.-++|+..|++++ |||||++.+++.+.+ .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            457899999999999999999975  567899999997655533 233568999999999 999999999998887 899


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +||||| ..+|++++..++..|++..+..|+.||++||+|+|++|+.|||+||+||||.....|||+|||+||.......
T Consensus        87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence            999999 6799999999888999999999999999999999999999999999999999999999999999999888888


Q ss_pred             ccCCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC----------------
Q 015965          268 MTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------------  330 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~----------------  330 (397)
                      .+.++.|.+|+|||++ ...-|+.+.||||+||+++|+++-++.|.+.+..+.+.++..--..|                
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            9999999999999997 45669999999999999999999999999988887777665311110                


Q ss_pred             ----C--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          331 ----T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       331 ----~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                          .        .-..+++++.++|.+|+.+||++||||.|+++.
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                0        113478899999999999999999999999764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-47  Score=359.48  Aligned_cols=257  Identities=22%  Similarity=0.402  Sum_probs=223.8

Q ss_pred             ccCccccccc--ceeeeeCCceEEEEEECCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEec----
Q 015965          110 EIDPKHLKFG--SKVASGSYGDLYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTK----  182 (397)
Q Consensus       110 ~~~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----  182 (397)
                      .++.++++..  ..||+|++|.||+|.+.++.||||.++...... ...+.+.+|+.+|++++||||+++++++.+    
T Consensus        14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            4455555555  679999999999999999999999998654332 335678899999999999999999999876    


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ...+++||||++||+|.+++.+ ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            4568999999999999999987 46789999999999999999999985 999999999999999999999999999976


Q ss_pred             cccCCcccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....  .....|+..|+|||++.+  ..++.++||||||+++|||++|..||...+..+....+.....++..+..++++
T Consensus       173 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  250 (283)
T PHA02988        173 LSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLE  250 (283)
T ss_pred             hccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHH
Confidence            5432  234578999999999976  679999999999999999999999999988877777776666677777789999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      +.+++.+||+.||++|||+.++++.|+.+.
T Consensus       251 l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        251 IKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=359.50  Aligned_cols=257  Identities=32%  Similarity=0.525  Sum_probs=225.2

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ...|-++.++|++..+||.|..++||+|..  .++.||||++..+..+.+ ...+.+|+..|+.++||||++++..|..+
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            345788889999999999999999999976  567899999998876665 68899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ..+++||.||.+||+.+.+... ...+.+..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||++-..
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999999754 567999999999999999999999999999999999999999999999999988654


Q ss_pred             ccCCc----c-cCCCCCcccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC------
Q 015965          263 AQSGV----M-TAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------  329 (397)
Q Consensus       263 ~~~~~----~-~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~------  329 (397)
                      ..++.    . .+.+||++|||||++.  ...|+.|+||||||++..||.+|..||..+.+.+....-++....      
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            44331    1 4568999999999963  457999999999999999999999999999999988776655331      


Q ss_pred             --CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                        .+..+..+..+++++..||..||.+|||++++++
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              1122446678999999999999999999999984

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-48  Score=378.29  Aligned_cols=245  Identities=27%  Similarity=0.442  Sum_probs=221.1

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  185 (397)
                      .+..++|++.++||+|+||+|+++..+  ++.+|||++++... ..+..+....|.+|+...+ ||.+++++..|++..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            567789999999999999999999875  46699999998754 4556777888999988776 9999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc-c
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-Q  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-~  264 (397)
                      +|+||||+.||++..+.+  .+.+++..+..|+..++.||.|||++||||||||.+|||+|.+|++||+|||+++... .
T Consensus       444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999544433  4789999999999999999999999999999999999999999999999999998655 5


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      +...++.+|||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+....++..  .+..|..++.+..++|
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence            55677889999999999999999999999999999999999999999999988888887765  5568899999999999


Q ss_pred             HHhchhCCCCCCCH
Q 015965          345 ERCWQQDPALRPDF  358 (397)
Q Consensus       345 ~~cl~~dp~~Rps~  358 (397)
                      +++|..||++|...
T Consensus       600 ~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhccCcccccCC
Confidence            99999999999854

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.4e-49  Score=373.80  Aligned_cols=246  Identities=30%  Similarity=0.571  Sum_probs=224.5

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|.+.+.||+|+||+||+|+.  +.+.||||.+.+........+.+.+|++|++.++|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5788889999999999999975  45779999999888777778889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-ccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-~~~  270 (397)
                      |+.| +|..++.. ++.++++.+..++.|++.||.|||+++|+|||+||.|||++.++.+|+||||+|+....+.. .+.
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9966 99999987 78999999999999999999999999999999999999999999999999999998877654 345


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|||.|||||+..+.+|+..+|+|||||++|||+.|++||...+-.+....++....+  .|...+..+..|+...|.+
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--CcccccHHHHHHHHHHhhc
Confidence            57999999999999999999999999999999999999999887777777777666443  4568899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      ||..|.+..+++.
T Consensus       238 dP~~RltW~~Ll~  250 (808)
T KOG0597|consen  238 DPAQRLTWTDLLG  250 (808)
T ss_pred             ChhhcccHHHHhc
Confidence            9999999999873

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=373.90  Aligned_cols=246  Identities=30%  Similarity=0.553  Sum_probs=221.5

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ..|.-..+||+|+.|.||.+..  .++.||||.+.......  .+-+.+|+.+|+..+|+|||.+++.+...+.+++|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            4567778999999999999976  45679999988654433  3558899999999999999999999988899999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      ||+||+|.|.+..  ..+++.++..++.++++||+|||.+||+|||||.+|||++.+|.|||+|||++....... ...+
T Consensus       351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            9999999999976  458999999999999999999999999999999999999999999999999998766554 5667


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+|||.|||||++..+.|+.+.||||||++.+||+-|.+||-..++..+.+.+...+. ....+..+++.|++|+.+||.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            7999999999999999999999999999999999999999999999999988877654 334567899999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .|+++|+++.+||+
T Consensus       509 ~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  509 VDVEQRASAKELLE  522 (550)
T ss_pred             cchhcCCCHHHHhc
Confidence            99999999999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-48  Score=374.50  Aligned_cols=247  Identities=31%  Similarity=0.530  Sum_probs=225.9

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCC-CCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      -|++++.||.|+.|.|.+|++  +|+.+|||++.+. .........+.+|+-||+.+.|||++++|++|++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            467789999999999999987  6899999998765 3344445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      |++||.|.+++-. ++++++..+.+++.||+.|+.|+|..+|+||||||+|+|++..++|||+|||+|.....+....+.
T Consensus        93 yv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS  171 (786)
T KOG0588|consen   93 YVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS  171 (786)
T ss_pred             ecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence            9999999999987 689999999999999999999999999999999999999999999999999999999888889999


Q ss_pred             CCCcccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          272 TGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ||+|.|.|||++.|.+|+ .++||||.|+|||.||+|.+||++.+-...+.++.+..  ..+|..++++.++||++|+..
T Consensus       172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f~MPs~Is~eaQdLLr~ml~V  249 (786)
T KOG0588|consen  172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--FEMPSNISSEAQDLLRRMLDV  249 (786)
T ss_pred             CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--ccCCCcCCHHHHHHHHHHhcc
Confidence            999999999999999987 57999999999999999999999887777777765543  357899999999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 015965          351 DPALRPDFSEIIEI  364 (397)
Q Consensus       351 dp~~Rps~~ell~~  364 (397)
                      ||..|.|..+|++.
T Consensus       250 Dp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  250 DPSTRITTEEILKH  263 (786)
T ss_pred             CccccccHHHHhhC
Confidence            99999999999753

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.6e-48  Score=386.30  Aligned_cols=265  Identities=31%  Similarity=0.601  Sum_probs=233.2

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeee
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI  177 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~  177 (397)
                      .....++...+.++.+.||+|+||+||+|+..+       .-||||.++... +.+...+|.+|+.++..++|||||+++
T Consensus       477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl  555 (774)
T KOG1026|consen  477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL  555 (774)
T ss_pred             ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            445668888999999999999999999998643       449999999653 445688999999999999999999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  244 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  244 (397)
                      |+|...+.+|||+|||..|+|.++|....             ..++..+.+.|+.||+.||.||-++.+|||||..+|+|
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence            99999999999999999999999996542             23788899999999999999999999999999999999


Q ss_pred             eCCCCceEEcccccccccccCCcc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015965          245 MDENEVVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA  320 (397)
Q Consensus       245 i~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~  320 (397)
                      |+++-.|||+|||++|..-.....   ....-..+|||||.+..+.|+.+|||||+||+|||+++ |..||.+.++.+.+
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            999999999999999843222111   12344789999999999999999999999999999999 99999999999988


Q ss_pred             HHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      ..+....+ ...|..||.++++||..||+.+|.+||+|+||-..|++..+.
T Consensus       716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            87666655 778999999999999999999999999999999999887553

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=368.32  Aligned_cols=267  Identities=31%  Similarity=0.642  Sum_probs=239.9

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEECCc------ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeee
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG  178 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  178 (397)
                      +...+++......+.+.||.|.||.||+|.+..-      .||||..|.+... +..+.|++|..+|++++|||||+++|
T Consensus       380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIG  458 (974)
T KOG4257|consen  380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIG  458 (974)
T ss_pred             CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheee
Confidence            3446788888888999999999999999988542      3999999976543 44788999999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      +|.+.+ .+||||.++-|.|..||+..+..++...+..++.||+.||.|||++.+|||||..+|||+....-|||+|||+
T Consensus       459 v~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  459 VCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             eeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence            998854 8999999999999999999889999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcccCCCC--CcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCC
Q 015965          259 ARVKAQSGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN  335 (397)
Q Consensus       259 a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  335 (397)
                      +|...+........|  +..|||||.++-..++.++|||.||++|||++. |..||.+..+.+.+ ..+.++.|++.|+.
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLPCPPN  616 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCCCCCC
Confidence            998887766555555  567999999999999999999999999999988 99999998876655 34677889999999


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ||+.|+.|+.+||..+|.+||.|.++...|.+++++-+.
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~  655 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI  655 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence            999999999999999999999999999999999986554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.8e-47  Score=333.78  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=216.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|...++||+|.||.||+|++  +++.||||.++.............+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688889999999999999987  57889999999876655556778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-ccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-~~~  270 (397)
                      || ..+|+..++.....++...+..|+.++++|++|||++.|+||||||.|+||+.+|.+||+|||+++....... .+.
T Consensus        82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            99 5699999998888899999999999999999999999999999999999999999999999999998776543 334


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC---------------------
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------------  328 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~---------------------  328 (397)
                      .+-|.+|+|||.+.| +.|+...|+||.||++.||+-|.+-|.+.+..+....+.+.-.                     
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~  240 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ  240 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence            478999999998865 5699999999999999999999999988887666555442210                     


Q ss_pred             CCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          329 RPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       329 ~~~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                      .|.     +...++++..+|+.+||..||.+|++++|.++.
T Consensus       241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            011     223456788999999999999999999998753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-47  Score=361.95  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=217.9

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  187 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  187 (397)
                      ..+.|+.+++||+|.||.||+|++  +++.||+|.+..+...........+||.||++|+||||+++.+.....  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            346799999999999999999987  567799999998776666677889999999999999999999998776  6899


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||+||| .-+|.-++....-+|++.++.-|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+++.... 
T Consensus       195 lVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            999999 458888887755689999999999999999999999999999999999999999999999999999766543 


Q ss_pred             -cccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------
Q 015965          267 -VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  328 (397)
Q Consensus       267 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------  328 (397)
                       .++..+-|.+|+|||++.|. .|+.++|+||.||||.||+.|++.|.+.+..+....+.+--.                
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             57778889999999998765 699999999999999999999999999988777666553211                


Q ss_pred             --CCCC---------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 --RPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 --~~~~---------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                        ++..         ...+++...+|+..+|..||.+|.||.+.++
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              1111         1456788899999999999999999998863

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-46  Score=348.95  Aligned_cols=256  Identities=30%  Similarity=0.579  Sum_probs=220.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      ++.++|++.+.||+|+||.||+|.+.     +..||+|.++... .......+.+|+.++++++||||+++++++...+.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            56678999999999999999999753     3569999988653 33445679999999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      .++||||+++++|.+++....+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cccc--CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                      ....  ...++..|+|||++.+..++.++|||||||++||+++ |..||...+..+....+ ..+..+..+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHH
Confidence            2111  2345678999999999999999999999999999875 99999988776655543 444555677889999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ++.+||+.+|.+||++.++++.|.++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-46  Score=367.16  Aligned_cols=263  Identities=32%  Similarity=0.629  Sum_probs=225.1

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      .+.|.+..++|++++.||+|+||.||++.+.       ...||||+++.... .+....+.+|+.+++.+ +|+||++++
T Consensus        30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            4568888899999999999999999998752       24699999986532 34456788999999999 899999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc---------------------------------------------------
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  206 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------------------------------------------  206 (397)
                      +++...+..|+||||+++|+|.+++....                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            99999999999999999999999986421                                                   


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          207 ------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       207 ------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                                        ..+++..+++++.||+.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                              24678889999999999999999999999999999999999999999999999754433211


Q ss_pred             ---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          269 ---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       269 ---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                         ....+++.|+|||++.+..++.++||||||+++|+|++ |..||..................+..+...++++.+++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM  348 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence               12235678999999998899999999999999999997 99999887665556666666666667777899999999


Q ss_pred             HHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+||+.||.+|||+.++++.|++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.4e-47  Score=367.93  Aligned_cols=262  Identities=30%  Similarity=0.613  Sum_probs=224.0

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEE-------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      ...|.+..++|++.++||+|+||.||+|++       .+..||||+++.... ......+.+|+.+++.+ +||||++++
T Consensus        27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            345788888999999999999999999974       234699999975432 33456788999999999 899999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc---------------------------------------------------
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  206 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------------------------------------------  206 (397)
                      +++...+..++||||++||+|.+++....                                                   
T Consensus       106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            99999999999999999999999986532                                                   


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          207 -----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       207 -----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                                             ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                   146788899999999999999999999999999999999999999999999997654


Q ss_pred             cCCcc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          264 QSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       264 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      .....   ....++..|+|||++.+..++.++||||||+++|+|++ |..||............+..+.++..+...+.+
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE  345 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence            33211   12335678999999999999999999999999999998 999998877666666667766666677778899


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +.+++.+||+.||++||++.++++.|++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-47  Score=390.55  Aligned_cols=263  Identities=35%  Similarity=0.657  Sum_probs=233.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC---c----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS---Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      ++..+..++.+.||+|.||.||.|.+.+   .    .||||.++... +.....+|.+|..+|++++|||||+++|++.+
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            4667889999999999999999998743   2    28899888653 45567889999999999999999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                      ....+|++|||+||+|..+|++.      ...++...++.++.||++|+.||+++++|||||..+|+|++....|||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999987      567999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc-CCc-ccCC-CCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCC
Q 015965          257 GVARVKAQ-SGV-MTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI  332 (397)
Q Consensus       257 G~a~~~~~-~~~-~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~  332 (397)
                      |+|+..-. ... .... .-...|||||.+....|+.|+||||||++|||+++ |..||...++.+....++..+ |.+.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~  925 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDP  925 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCC
Confidence            99993322 211 1112 33578999999999999999999999999999999 999999999988887777666 9999


Q ss_pred             CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          333 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       333 ~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      |..||..+.++|.+||+.+|++||+|..|++++.++.+....
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            999999999999999999999999999999999999887654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=353.98  Aligned_cols=246  Identities=23%  Similarity=0.397  Sum_probs=214.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++...  ++.||+|++..... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999875  67899999875432 2234566889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+++++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence            99999999999976 467899999999999999999999999999999999999999999999999999765432  234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..+++.+.+++.+||+.
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcCC
Confidence            57999999999999999999999999999999999999999988877666665544  3456777899999999999999


Q ss_pred             CCCCCCC-----HHHHHHH
Q 015965          351 DPALRPD-----FSEIIEI  364 (397)
Q Consensus       351 dp~~Rps-----~~ell~~  364 (397)
                      ||.+||+     +.++++.
T Consensus       236 dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         236 DRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CHHHccCCccCCHHHHhcC
Confidence            9999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=360.39  Aligned_cols=247  Identities=33%  Similarity=0.561  Sum_probs=219.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ..|+..+.||+|+||.||+|.+  .++.||||++..+.. .+...++.+|+.+|..++++||.++|+.+.....++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4567778999999999999987  567899999997753 4456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      ||.||++.+.++. ...+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.|||+|||++....... ...+
T Consensus        92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            9999999999976 4455888899999999999999999999999999999999999999999999997655443 3477


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ++|||.|||||++.+..|+.++||||||++.+||++|.+||....+......+ .+...|.....+++.+++|+..||+.
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccCHHHHHHHHHHhhc
Confidence            89999999999999999999999999999999999999999999986554443 34446666778999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      ||+.||+|.++++
T Consensus       250 ~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  250 NPEFRPSAKELLK  262 (467)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999985

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-47  Score=359.14  Aligned_cols=251  Identities=25%  Similarity=0.459  Sum_probs=231.4

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc-eEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv  189 (397)
                      .++|..++++|+|+||.+++.+.  .++.+++|.+..........+...+|+.++++++|||||.+.+.|..++. +|||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36789999999999999887755  45679999999888777777789999999999999999999999999888 9999


Q ss_pred             EEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-c
Q 015965          190 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V  267 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~  267 (397)
                      |+|++||+|.+.+.+.+ ..++++.+..|+.||+.|+.|||++.|+|||||+.||+++.++.|||+|||+|+...... .
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999999999998766 569999999999999999999999999999999999999999999999999999888776 6


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ..+..||+.||+||++.+.+|+.|+|||||||++|||++-+++|...+....+.++.+.. -.++|...+.+++.++..|
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHH
Confidence            667799999999999999999999999999999999999999999999988888887765 4567889999999999999


Q ss_pred             chhCCCCCCCHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEI  364 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~  364 (397)
                      +..+|..||++.+++..
T Consensus       242 l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  242 LRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhcCCccCCCHHHHhhC
Confidence            99999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-45  Score=361.65  Aligned_cols=264  Identities=32%  Similarity=0.622  Sum_probs=225.6

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~  177 (397)
                      ...|+++.++|+++++||+|+||.||+|++.+       ..||||+++... .......+.+|+.+++++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            35688999999999999999999999998632       249999997543 3334567999999999996 99999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc---------------------------------------------------
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  206 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------------------------------------------  206 (397)
                      +++......||||||+++|+|.+++.+..                                                   
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            99999999999999999999999986531                                                   


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          207 --------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       207 --------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                                                                  ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        236778889999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~  318 (397)
                      ||++.++.+||+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999976443221   223356788999999998899999999999999999997 999998876655


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      .....+....++..+..+++++.+++.+||+.||++||++.++.+.|+++..
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            5555566666666777889999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3e-46  Score=358.16  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=215.7

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|+.++++++||||+++++++..++.+|+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            3468999999999999999999874  57799999875422 22335678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      ||||++|++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            9999999999999986 467899999999999999999999999999999999999999999999999999765432  2


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...++.+....+...  ...+|..+++.+.+|+.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHHHHHh
Confidence            3457999999999999999999999999999999999999999988877666665543  34567778999999999999


Q ss_pred             hhCCCCCCC-----HHHHHH
Q 015965          349 QQDPALRPD-----FSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps-----~~ell~  363 (397)
                      +.||.+||+     +.+++.
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhc
Confidence            999999996     677763

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-47  Score=347.36  Aligned_cols=247  Identities=23%  Similarity=0.489  Sum_probs=224.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .+|++.+.||+|.||.|-++..  .++.||||.++++.. +....-.+.+|++||..|+||||+++|.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            5799999999999999999965  678899999987765 3445677899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||..+|.|+||+.. ++.+++..+..|+.||+.|+.|+|+++++|||||.+|||+|.++++||+|||++..+.+.....+
T Consensus       133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT  211 (668)
T KOG0611|consen  133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT  211 (668)
T ss_pred             EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence            99999999999998 68899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ++|+|.|.+||++++.+|. +.+|-||||++||.|+.|.+||++.+.......+.....+.   +.-|.....||+.||.
T Consensus       212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRWMLM  288 (668)
T ss_pred             hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHHHHh
Confidence            9999999999999999986 57999999999999999999999998877777766655442   2345578899999999


Q ss_pred             hCCCCCCCHHHHHHH
Q 015965          350 QDPALRPDFSEIIEI  364 (397)
Q Consensus       350 ~dp~~Rps~~ell~~  364 (397)
                      .||++|.|+.++...
T Consensus       289 VNP~RRATieDiAsH  303 (668)
T KOG0611|consen  289 VNPERRATIEDIASH  303 (668)
T ss_pred             cCcccchhHHHHhhh
Confidence            999999999998654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.9e-46  Score=357.35  Aligned_cols=241  Identities=26%  Similarity=0.461  Sum_probs=209.4

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +.||+|+||.||++..  .++.||||+++.... .......+.+|+.++++++||||+++++.+...+.+|+||||++|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  467899999885432 2334566888999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCCc
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY  275 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~  275 (397)
                      +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999976 56789999999999999999999999999999999999999999999999999875332 22344567999


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      .|+|||++.+..++.++|||||||++|||++|..||...+.......+...  ...++..+++++.+++.+||+.||++|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            999999999999999999999999999999999999887766555554433  345677899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 015965          356 P-----DFSEIIE  363 (397)
Q Consensus       356 p-----s~~ell~  363 (397)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~ll~  250 (323)
T cd05571         238 LGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            9     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=360.90  Aligned_cols=262  Identities=37%  Similarity=0.726  Sum_probs=236.5

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECCc--ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+.|+++..++.+..+||-|.||.||.|.|+.-  .||||.++.+..   ..++|+.|+.+|+.++|||+|+++|+|..+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            478999999999999999999999999999764  499999986543   368899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ..+|||+|||..|+|.+||++++. .++.-.++.++.||..||+||..+++|||||..+|+|+.++..|||+|||+++.+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999999998754 4667778889999999999999999999999999999999999999999999987


Q ss_pred             ccCCcccCCCC---CcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          263 AQSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       263 ~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ..+. .+...|   ...|.|||-+..+.++.|+|||+||++|||+.| |--||.+.+..+ .++.+.+++|.+.|..||+
T Consensus       416 tgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  416 TGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             cCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccccCCCCCCH
Confidence            6542 333344   578999999999999999999999999999999 999999988655 4577899999999999999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+++||++||+++|.+||+|.|+-+.|+.++.+-
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            9999999999999999999999999999887543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=352.77  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=211.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh------------HHHHHHHHHHHHHhcCCCCCeeee
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------------DMQKEFAQEVFIMRKVRHKNVVQF  176 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~  176 (397)
                      ...++|++++.||+|+||.|-+|..  .++.||||++.+.....            ...+...+||.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3447899999999999999999987  56779999997543221            113578999999999999999999


Q ss_pred             eeEEecC--CceEEEEEeccCCCHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEE
Q 015965          177 IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV  253 (397)
Q Consensus       177 ~~~~~~~--~~~~lv~E~~~g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl  253 (397)
                      +++..++  ..+|||+|||..|.+...=.  ... +++.++++|+.+++.||+|||.+|||||||||+|+|++++|+|||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            9998775  46999999999887754321  234 899999999999999999999999999999999999999999999


Q ss_pred             cccccccccccC------CcccCCCCCcccccccccCCC---C-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 015965          254 ADFGVARVKAQS------GVMTAETGTYRWMAPEVIEHK---P-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV  323 (397)
Q Consensus       254 ~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~---~-~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~  323 (397)
                      +|||.+......      ......+|||.|+|||...+.   . -+.+.||||+|++||.|+.|++||-+....+...++
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999999765322      233446899999999998652   2 345789999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       324 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +...+..+....+.+.+++||.+||.+||+.|.+..++..
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            8887765555567899999999999999999999988753

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.4e-45  Score=347.78  Aligned_cols=254  Identities=32%  Similarity=0.593  Sum_probs=210.6

Q ss_pred             CcccccccceeeeeCCceEEEEEEC------------------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV  173 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  173 (397)
                      ...+|++.++||+|+||.||++.+.                  +..||+|+++... .......+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4568999999999999999999752                  2359999988653 34456779999999999999999


Q ss_pred             eeeeeEEecCCceEEEEEeccCCCHHHHHHhcc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 015965          174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIH  235 (397)
Q Consensus       174 v~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH  235 (397)
                      +++++++...+..++||||+++++|.+++....                  ..+++..++.++.||+.||.|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999986531                  23677889999999999999999999999


Q ss_pred             CCCCCCcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCC
Q 015965          236 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLP  310 (397)
Q Consensus       236 rDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~P  310 (397)
                      |||||+|||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999975433221   223345789999999988889999999999999999987  6788


Q ss_pred             CCCCChHHHHHHhhh---c---CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          311 YEYLTPLQAAVGVVQ---K---GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       311 ~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      |...+..+.......   .   ...+..+..+++.+.+++.+||+.||.+|||+.++.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            887766554433221   1   1123345678899999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-45  Score=347.28  Aligned_cols=248  Identities=21%  Similarity=0.351  Sum_probs=208.7

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      |++.+.||+|+||.||++..  +++.||+|.+...... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999976  5788999998754332 22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          193 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      +++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++............
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR  161 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence            9999999888653 346899999999999999999999999999999999999999999999999999875544444556


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh--cCCCCCCCCCCcHHHHHHHHHhch
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..  .......+..+++++.+|+.+||+
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  241 (285)
T cd05631         162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT  241 (285)
T ss_pred             CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhh
Confidence            799999999999999999999999999999999999999987554222111111  122334567789999999999999


Q ss_pred             hCCCCCCC-----HHHHHH
Q 015965          350 QDPALRPD-----FSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps-----~~ell~  363 (397)
                      .||.+||+     +.++++
T Consensus       242 ~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         242 KNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCHHHhcCCCCCCHHHHhc
Confidence            99999997     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-47  Score=326.25  Aligned_cols=249  Identities=23%  Similarity=0.430  Sum_probs=223.9

Q ss_pred             cccccccceeeeeCCceEEEEEECC--cceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|++++.||+|-||.||+|..+.  -.||+|++.+... .......+.+|++|...|+||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            3689999999999999999998754  4599999865433 334457789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          190 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      +||.++|+|+..|+..+ ..+++...+.++.|++.|+.|+|.+++|||||||+|+|++..|.+||+|||-+...+ ....
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR  179 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR  179 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence            99999999999998543 459999999999999999999999999999999999999999999999999997665 6667


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      .+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||+..+..+.+.++.+-  +..+|..++.+.+++|.+|+
T Consensus       180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~is~~a~dlI~~ll  257 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTISGGAADLISRLL  257 (281)
T ss_pred             eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCcccChhHHHHHHHHh
Confidence            7889999999999999999999999999999999999999999999877777777654  44577999999999999999


Q ss_pred             hhCCCCCCCHHHHHHH
Q 015965          349 QQDPALRPDFSEIIEI  364 (397)
Q Consensus       349 ~~dp~~Rps~~ell~~  364 (397)
                      ..+|.+|.+..|+++.
T Consensus       258 ~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  258 VKNPIERLALTEVMDH  273 (281)
T ss_pred             ccCccccccHHHHhhh
Confidence            9999999999998753

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-45  Score=353.75  Aligned_cols=261  Identities=33%  Similarity=0.644  Sum_probs=221.5

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC  180 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  180 (397)
                      |.+..++|++.+.||.|+||.||+|...       ++.||+|+++... .......+.+|+.+++++ +|+||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            7888899999999999999999999643       2569999987543 233456688899999999 799999999988


Q ss_pred             ec-CCceEEEEEeccCCCHHHHHHhcc-----------------------------------------------------
Q 015965          181 TK-PPSLCIVTEFMSGGSVYDYLHKLK-----------------------------------------------------  206 (397)
Q Consensus       181 ~~-~~~~~lv~E~~~g~sL~~~l~~~~-----------------------------------------------------  206 (397)
                      .. ...++++|||+++++|.+++....                                                     
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            65 456889999999999999986422                                                     


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---ccCCCCCcc
Q 015965          207 -------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYR  276 (397)
Q Consensus       207 -------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~  276 (397)
                             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......   .....++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2578899999999999999999999999999999999999999999999999976533221   222345778


Q ss_pred             cccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       277 y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      |+|||++.+..++.++|||||||++|+|++ |..||......+..........++..+...++++.+++.+||+.+|++|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999998 9999987665555555556666666777888999999999999999999


Q ss_pred             CCHHHHHHHHHHHHH
Q 015965          356 PDFSEIIEILQQIAK  370 (397)
Q Consensus       356 ps~~ell~~L~~l~~  370 (397)
                      |++.++++.|+++++
T Consensus       321 Ps~~ell~~l~~~~~  335 (337)
T cd05054         321 PTFSELVEILGDLLQ  335 (337)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=336.29  Aligned_cols=302  Identities=23%  Similarity=0.394  Sum_probs=244.4

Q ss_pred             CCchhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCC------CCCCCCCCCCcccCCCCCCCccccCcccccccceeee
Q 015965           51 WPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEP------EDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS  124 (397)
Q Consensus        51 ~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~ss~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~  124 (397)
                      .+.+++++|.+|++....+++++..-.... +|....      .+....+...+...+......-.+..++|.++++||+
T Consensus       100 es~~eRq~W~~AIq~vsn~l~q~e~~~tn~-~p~~~~d~~~~s~s~d~~~e~m~i~~t~~~~~~~kvTm~dFdfLKvLGk  178 (516)
T KOG0690|consen  100 ESAEERQEWIEAIQAVSNRLKQEELMDTNG-NPEGEMDVNMGSPSDDFGSEEMSIAETEEAKRKNKVTMEDFDFLKVLGK  178 (516)
T ss_pred             CCHHHHHHHHHHHHHHhhhhhhhhhcccCC-CccccccccCCCCCccccceeeeecccccccccceeccchhhHHHHhcC
Confidence            357889999999998776666544211111 110000      0001111111111122222333567789999999999


Q ss_pred             eCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHHHH
Q 015965          125 GSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY  201 (397)
Q Consensus       125 G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~  201 (397)
                      |.||.|-+++.  .++.+|||+++++.. ..+....-+.|-++|+..+||.+..+...|+..+++|+||||+.||.|.-+
T Consensus       179 GTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~H  258 (516)
T KOG0690|consen  179 GTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFH  258 (516)
T ss_pred             CccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeee
Confidence            99999998865  678899999998754 445566778899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCCcccccc
Q 015965          202 LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAP  280 (397)
Q Consensus       202 l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~~y~aP  280 (397)
                      |.. ...++++....+...|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.... ...+.+.+|||.|.||
T Consensus       259 Lsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  259 LSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAP  337 (516)
T ss_pred             hhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCc
Confidence            877 57899999999999999999999999999999999999999999999999999986444 4567788999999999


Q ss_pred             cccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 015965          281 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP  356 (397)
Q Consensus       281 E~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rp  356 (397)
                      |++....|+...|+|.+|++||||+||++||...+......-++...+  .+|..++++.+.|+..+|.+||.+|.
T Consensus       338 EVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  338 EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence            999999999999999999999999999999998877666666655543  47899999999999999999999996

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.6e-46  Score=344.33  Aligned_cols=247  Identities=37%  Similarity=0.723  Sum_probs=210.4

Q ss_pred             cccceeeeeCCceEEEEEEC------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          117 KFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       117 ~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++.+.||.|+||.||+|++.      +..|+||.++.. ......+.|.+|+..+++++||||++++|++...+..++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence            45678999999999999987      466999999753 34445788999999999999999999999999888899999


Q ss_pred             EeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC---
Q 015965          191 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~---  266 (397)
                      ||+++|+|.+++... ...+++..++.++.||+.||.|||+++++|+||+++||+++.++.+||+|||+++......   
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999886 5789999999999999999999999999999999999999999999999999998663221   


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                      ......+...|+|||.+....++.++||||||+++|||++ |..||...+..+....+ ....++..+..++..+.+++.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHH
Confidence            1233456789999999988889999999999999999999 78999998877766665 666677788889999999999


Q ss_pred             HhchhCCCCCCCHHHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~~L  365 (397)
                      +||+.||++||++.++++.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-46  Score=355.24  Aligned_cols=248  Identities=24%  Similarity=0.362  Sum_probs=213.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999874  67899999875432 2234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ....
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999976 46789999999999999999999999999999999999999999999999999975543  3345


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC---CCCCC---CCCcHHHHHHH
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---RPTIP---KNSQPKLAELL  344 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~l~~ll  344 (397)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....   .+...   ..+++++.+++
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            6799999999999999999999999999999999999999998877666555443221   11111   25689999999


Q ss_pred             HHhchhCCCCCCCHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~  364 (397)
                      .+||..+|.+||++.++++.
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhC
Confidence            99999999999999999854

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.4e-46  Score=356.14  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=217.2

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC---cceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      .+..++|++.+.||+|+||.||+|.+.+   ..||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            5666789999999999999999998643   4699999864322 23345678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999999976 467899999999999999999999999999999999999999999999999999765432


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++......+....  ..+|..+++.+.++++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLMK  260 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence              345679999999999999889999999999999999999999999888776666655443  3457778999999999


Q ss_pred             HhchhCCCCCC-----CHHHHHHH
Q 015965          346 RCWQQDPALRP-----DFSEIIEI  364 (397)
Q Consensus       346 ~cl~~dp~~Rp-----s~~ell~~  364 (397)
                      +||+.||.+|+     ++.++++.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcC
Confidence            99999999995     78887653

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-45  Score=336.31  Aligned_cols=251  Identities=35%  Similarity=0.675  Sum_probs=216.4

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +++++|++.+.||+|+||.||++.+.. ..+|+|.++.....   ...+.+|+.++++++||||+++++++......++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            356789999999999999999998754 47999987754332   35688899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc-
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~-  268 (397)
                      |||+++++|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999999876667899999999999999999999999999999999999999999999999998754332211 


Q ss_pred             -cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          269 -TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       269 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                       ....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+.. +.++..+...+.++.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHH
Confidence             22245678999999998889999999999999999999 9999988887766665543 33455566778999999999


Q ss_pred             hchhCCCCCCCHHHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~~L  365 (397)
                      ||+.+|++||++.++++.|
T Consensus       237 c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         237 CWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HccCCcccCcCHHHHHHhh
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=370.56  Aligned_cols=261  Identities=33%  Similarity=0.641  Sum_probs=236.8

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--C---cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+|+.+..+|.++||.|.||+||+|..+  +   ..||||.+|... ....+.+|+.|+.||-+.+||||+++.|+....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            4899999999999999999999999763  2   459999999664 455578899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..+.||+|||++|+|+.+|++.++.++.-++..+++.|+.||.||.+.|+|||||..+|||++.+-.+||+|||++|...
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999765


Q ss_pred             cCC--cccCCCC--CcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          264 QSG--VMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       264 ~~~--~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ++.  ..++.-|  +.+|.|||.+....++.+|||||+|++|||.++ |..||-.+++.+.+.. +.+++|.+.|.+||.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpPmDCP~  861 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPPMDCPA  861 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCCCCCcH
Confidence            443  1222222  578999999999999999999999999999988 9999999998776655 677889999999999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .|.+||..||++|-.+||.|.||+..|.+++..
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            999999999999999999999999999999764

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=340.61  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=224.4

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      -.+..+.|++++.||+|.-|+||+++..+  ..+|+|++.+.... .....+...|..||+.++||.++.+|..++.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            46777899999999999999999999876  67999999876553 3445667789999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .|++||||+||+|...++++. ..+++..++.++.+++.||+|||..|||+|||||+||||.++|+|.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999999999998764 4699999999999999999999999999999999999999999999999998731100


Q ss_pred             ---------------------------------C-C-----------------------cccCCCCCcccccccccCCCC
Q 015965          265 ---------------------------------S-G-----------------------VMTAETGTYRWMAPEVIEHKP  287 (397)
Q Consensus       265 ---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~  287 (397)
                                                       . .                       .....+||-.|.|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                       011236999999999999999


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCC----HHHHH
Q 015965          288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD----FSEII  362 (397)
Q Consensus       288 ~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps----~~ell  362 (397)
                      .+.++|+|+||+++|||+.|..||.+.+..++..+++.+.+..+-...++..+++||+++|.+||.+|..    |.||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999887765555578899999999999999999997    77775

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-45  Score=341.37  Aligned_cols=255  Identities=31%  Similarity=0.622  Sum_probs=218.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      +...+|++.+.||+|+||.||+|...+       ..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            344689999999999999999998643       359999987543 344456799999999999999999999999998


Q ss_pred             CceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  248 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~  248 (397)
                      ...|++|||+++++|.+++....               ..+++..++.++.|++.||.|||++|++||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            89999999999999999997531               457888999999999999999999999999999999999999


Q ss_pred             CceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 015965          249 EVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV  324 (397)
Q Consensus       249 ~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~  324 (397)
                      +.++|+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.... +
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-I  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence            999999999997543321   2233456889999999988889999999999999999998 9999988877665544 4


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       325 ~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      .....+..+..+++++.+|+.+||+.||.+||++.++++.|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            4444556778899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.9e-45  Score=337.77  Aligned_cols=256  Identities=37%  Similarity=0.717  Sum_probs=221.7

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      |++...+|.+.+.||+|+||.||+|.+.  ++.||+|+++...   .....+.+|+.+++.++||||+++++++...+.+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            6778888999999999999999999874  6779999987542   2346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          187 CIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||+++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999999999754 346899999999999999999999999999999999999999999999999999765433


Q ss_pred             Ccc--cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 GVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.. ........+..+..+++++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCCCCCCCCCCHHHHH
Confidence            211  12234668999999999999999999999999999998 99999887665443 334555667778889999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ++.+||+.||++||++.++++.|+++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-44  Score=336.36  Aligned_cols=255  Identities=35%  Similarity=0.639  Sum_probs=220.3

Q ss_pred             CcccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      ++++|++.+.||+|+||.||+|.+.     ...||||.++... .......|.+|+.++++++||||+++++.+......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            4578999999999999999999874     2369999987553 334456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      +++|||+++++|.+++....+.+++..++.++.|++.|+.|||++||+||||||+||+++.++.++|+|||+++..... 
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999999876778999999999999999999999999999999999999999999999999999876421 


Q ss_pred             Cccc--CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                      ....  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ........+..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHH
Confidence            1111  2234678999999999899999999999999999998 99999887766555443 344455566788999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ++.+||+.+|++||++.++++.|+++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.5e-45  Score=356.40  Aligned_cols=263  Identities=33%  Similarity=0.641  Sum_probs=226.9

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~  177 (397)
                      ...|++..++|.++++||+|+||.||+|++.+       +.||+|+++.... ......+.+|+.+|.++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            34589999999999999999999999998643       4699999986532 333457889999999997 99999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc---------------------------------------------------
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  206 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------------------------------------------  206 (397)
                      +++...+..++||||+++|+|.++++...                                                   
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            99999999999999999999999997532                                                   


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 015965          207 ----------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  240 (397)
Q Consensus       207 ----------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp  240 (397)
                                                                    ..+++..++.++.||+.||.|||+.+|+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                          1356677889999999999999999999999999


Q ss_pred             CcEEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015965          241 ANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  316 (397)
Q Consensus       241 ~Nili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~  316 (397)
                      +|||++.++.+||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999999999999997543221   1223356789999999998889999999999999999998 8999988776


Q ss_pred             HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+.....+..+.++..+..++.++.+++.+||..+|.+||++.+|++.|++++
T Consensus       348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            66666666677777778889999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-45  Score=350.94  Aligned_cols=241  Identities=25%  Similarity=0.464  Sum_probs=208.5

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +.||+|+||.||++..  .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999986  467899999876432 2334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCCc
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY  275 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~  275 (397)
                      +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99998876 46789999999999999999999999999999999999999999999999999875322 22334567999


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+.......+....  ..+|..+++++.+++.+||+.||++|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            9999999999999999999999999999999999998877766655554432  34677889999999999999999999


Q ss_pred             C-----CHHHHHH
Q 015965          356 P-----DFSEIIE  363 (397)
Q Consensus       356 p-----s~~ell~  363 (397)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~~l~  250 (323)
T cd05595         238 LGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            8     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.5e-45  Score=336.82  Aligned_cols=256  Identities=34%  Similarity=0.675  Sum_probs=220.4

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |.+..++|++.++||+|+||.||+|... +..||+|.+.....   ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            6788899999999999999999999864 45699998875432   2467899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||+++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999999754 3568899999999999999999999999999999999999999999999999998654332


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ....+...+..++.++.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            1  122345678999999988889999999999999999998 99999887766555443 3344555556788999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +.+||+.+|++||++.++++.|+++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-46  Score=358.46  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=215.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||||+++..... ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999885  788999998754322 234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999874 789999999999999999999999999999999999999999999999999997654332    


Q ss_pred             --------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015965          267 --------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA  320 (397)
Q Consensus       267 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~  320 (397)
                                                ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                      223457999999999999999999999999999999999999999988877776


Q ss_pred             HHhhh--cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-HHHHHHH
Q 015965          321 VGVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALRPD-FSEIIEI  364 (397)
Q Consensus       321 ~~~~~--~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps-~~ell~~  364 (397)
                      ..+..  .....+....+++++.++|.+||. ||.+||+ +.++++.
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            66665  222222233469999999999998 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=351.00  Aligned_cols=238  Identities=24%  Similarity=0.396  Sum_probs=206.3

Q ss_pred             eeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||+|+||.||++.+.  ++.||+|+++.... .......+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999874  56799999875422 333456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCCCCCccc
Q 015965          199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW  277 (397)
Q Consensus       199 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~~gt~~y  277 (397)
                      .+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            999976 567999999999999999999999999999999999999999999999999999754332 233445799999


Q ss_pred             ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCC
Q 015965          278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD  357 (397)
Q Consensus       278 ~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps  357 (397)
                      +|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..+++++.+++.+||+.||.+||+
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            9999999999999999999999999999999999988777666665543  34567788999999999999999999985


Q ss_pred             ---HHHHH
Q 015965          358 ---FSEII  362 (397)
Q Consensus       358 ---~~ell  362 (397)
                         +.+++
T Consensus       238 ~~~~~e~l  245 (312)
T cd05585         238 YNGAQEIK  245 (312)
T ss_pred             CCCHHHHH
Confidence               45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-44  Score=345.20  Aligned_cols=258  Identities=30%  Similarity=0.610  Sum_probs=220.0

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--Cc----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +...+|++.+.||+|+||.||+|.+.  ++    .||+|+++... ......++.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            45678999999999999999999862  33    38999987542 334456789999999999999999999998764 


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++++||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            57899999999999999988667789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ....   ....++..|+|||++.+..++.++||||||+++|||++ |..||......+. ..+.........+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHH
Confidence            3221   12234678999999999999999999999999999998 9999988765543 44555555666677888999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+++.+||..||.+||++.+++..|..+.+.
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            9999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-44  Score=346.86  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=210.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +..++|++.+.||+|+||.||++.+.  +..+|+|+++... .......+.+|+.++++++||||+++++++...+..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999875  5679999987643 34456779999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            9999999999999976 45689999999999999999999986 6999999999999999999999999998755432 2


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh------------------------
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV------------------------  323 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~------------------------  323 (397)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+                        
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            34557999999999999999999999999999999999999999765543322111                        


Q ss_pred             ---------------------hhcCCCCCC-CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          324 ---------------------VQKGLRPTI-PKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       324 ---------------------~~~~~~~~~-~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                                           +....++.. ...+++++.+|+.+||..||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 001111111 12467899999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-45  Score=351.07  Aligned_cols=242  Identities=25%  Similarity=0.448  Sum_probs=209.3

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +.||+|+||.||++..  .++.||+|+++.... .......+.+|+.+++.++||||+++++.+...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  467899999976432 2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCCc
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY  275 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~  275 (397)
                      +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99998876 46789999999999999999999999999999999999999999999999999875332 22334567999


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...+|..+++++.+++.+||..||++|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            999999999999999999999999999999999999887766555444332  345677889999999999999999999


Q ss_pred             C-----CHHHHHHH
Q 015965          356 P-----DFSEIIEI  364 (397)
Q Consensus       356 p-----s~~ell~~  364 (397)
                      |     ++.++++.
T Consensus       238 ~~~~~~~~~~il~h  251 (328)
T cd05593         238 LGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCCHHHHhcC
Confidence            7     88988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-45  Score=343.63  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=206.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++...........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999884  5679999998665444456678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--ccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--~~~  269 (397)
                      |++++.+..+ ......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            9988766544 4445679999999999999999999999999999999999999999999999999998654322  223


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-------------------C-C
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------L-R  329 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-------------------~-~  329 (397)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....                   . .
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4578999999999999899999999999999999999999998776544333221100                   0 0


Q ss_pred             C----------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 P----------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ~----------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +          .....+++++.+|+.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0          011236788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-44  Score=332.54  Aligned_cols=254  Identities=39%  Similarity=0.738  Sum_probs=222.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      |.++.++|++.+.||.|+||.||++...++.||+|.++....   ..+.+.+|+.++++++|+||+++++.+......++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            456778999999999999999999999999999999986533   45778999999999999999999999998899999


Q ss_pred             EEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          189 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||.++...... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999997643 368999999999999999999999999999999999999999999999999998663322 


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                       ....++..|+|||.+....++.++|+||||+++|+|++ |..||...+..+... .+....++..+..+++++.+++.+
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHHHHHHHH
Confidence             23345678999999988889999999999999999997 999998776655443 344455566677889999999999


Q ss_pred             hchhCCCCCCCHHHHHHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ||..+|++||++.+++++|+++
T Consensus       235 ~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         235 CWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HhccChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-44  Score=334.10  Aligned_cols=251  Identities=35%  Similarity=0.680  Sum_probs=216.0

Q ss_pred             CcccccccceeeeeCCceEEEEEECCc-ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      +.++|++.+.||+|+||.||++.+.+. .+|+|.++.....   ...+.+|+.++++++||||+++++++......+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            457899999999999999999987654 5999998754332   356889999999999999999999999888899999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc--
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~--  268 (397)
                      ||+++++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.++........  
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999999999999876567899999999999999999999999999999999999999999999999998755433211  


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. ...++..+...++.+.+++.+|
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC  237 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHH
Confidence            12245678999999988889999999999999999998 999998877665555443 4445556677889999999999


Q ss_pred             chhCCCCCCCHHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~  366 (397)
                      |+.||.+||++.++++.|+
T Consensus       238 l~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         238 WHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             cCCCcccCCCHHHHHHhhC
Confidence            9999999999999988763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-44  Score=340.76  Aligned_cols=249  Identities=22%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.++||.|+||.||+|..  +++.||+|+++..... .....+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            36799999999999999999986  4577999998754322 22356778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||++ ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        83 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          83 EYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             eCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            9996 5999999876667899999999999999999999999999999999999999999999999999754332 2234


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-------------------
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------------  329 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-------------------  329 (397)
                      ...|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......                   
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            4578999999999865 56899999999999999999999999887765544433221000                   


Q ss_pred             -CC--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 -PT--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 -~~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                       +.        ....+++++.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             00        11246788999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-44  Score=333.12  Aligned_cols=253  Identities=36%  Similarity=0.702  Sum_probs=218.2

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe-cCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~  187 (397)
                      |.++.++|++.+.||+|+||.||++...+..+|+|.++...    ..+.+.+|+.++++++|+|++++++++. .....+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            56778899999999999999999999999999999987432    2456889999999999999999999764 456789


Q ss_pred             EEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++.+... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..... 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            99999999999999976433 4889999999999999999999999999999999999999999999999998754332 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                       .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+.... +.....+..+..+++.+.+++.
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHHHHHHHH
Confidence             123345678999999999899999999999999999998 9999987766554444 3445556677788999999999


Q ss_pred             HhchhCCCCCCCHHHHHHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +||+.+|++|||+.++++.|+++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.1e-45  Score=348.79  Aligned_cols=241  Identities=27%  Similarity=0.461  Sum_probs=208.3

Q ss_pred             ceeeeeCCceEEEEEE-----CCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          120 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +.||+|+||.||+++.     .++.||||+++....  .......+.+|+.+|+.++||||+++++.+..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999875     456799999875422  122345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~  271 (397)
                      ++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999976 567889999999999999999999999999999999999999999999999998754332 223345


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      .||+.|+|||++.+..++.++||||||+++|||++|..||...+.......+...  ...++..+++++.+++.+||+.|
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccC
Confidence            7999999999999988999999999999999999999999988877666665543  34567788999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 015965          352 PALRP-----DFSEIIE  363 (397)
Q Consensus       352 p~~Rp-----s~~ell~  363 (397)
                      |++||     ++.++++
T Consensus       239 p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         239 PSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HhHcCCCCCCCHHHHhc
Confidence            99999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.3e-45  Score=341.46  Aligned_cols=249  Identities=23%  Similarity=0.411  Sum_probs=204.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcC---CCCCeeeeeeEEe-----c
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K  182 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~  182 (397)
                      .+|++.+.||+|+||.||+|.+.   ++.||+|.++...........+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863   46699999876544333344566777777665   6999999999885     3


Q ss_pred             CCceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ...+++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            456899999995 69999987643 4589999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-----------
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------  330 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-----------  330 (397)
                      ...........||+.|+|||++.+..++.++||||||+++|+|++|.+||...+..+....+......+           
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            655544556678999999999988899999999999999999999999999887766555543221100           


Q ss_pred             --------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 --------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 --------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                    .....+++.+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                          011346788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=355.54  Aligned_cols=248  Identities=22%  Similarity=0.361  Sum_probs=211.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++..  .++.||||+++.... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            3688999999999999999987  467899999975422 2334566888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||++|++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++......    
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999976 4679999999999999999999999999999999999999999999999999986432111    


Q ss_pred             -----------------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015965          267 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY  311 (397)
Q Consensus       267 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~  311 (397)
                                                         .....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011246999999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHhchhCCCCCCC---HHHHHH
Q 015965          312 EYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPD---FSEIIE  363 (397)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~dp~~Rps---~~ell~  363 (397)
                      ...++.+....+.........+.  .+++++.++|.+|+. +|.+|++   +.++++
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            98888777666654333323333  468999999999997 9999997   888865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.9e-44  Score=338.51  Aligned_cols=257  Identities=33%  Similarity=0.598  Sum_probs=216.9

Q ss_pred             ccccccceeeeeCCceEEEEEECC--c--ceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  188 (397)
                      ++|++.+.||+|+||.||+|....  .  .+++|.++... .....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            578999999999999999997643  2  36888877432 333456789999999999 69999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEE
Q 015965          189 VTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV  253 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl  253 (397)
                      +|||+++++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999999999999997532               35888999999999999999999999999999999999999999999


Q ss_pred             cccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCC
Q 015965          254 ADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI  332 (397)
Q Consensus       254 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~  332 (397)
                      +|||++..............+..|+|||++.+..++.++||||||+++|+|++ |..||......+....+ .....+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~~~~~~~  239 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRMEK  239 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCC
Confidence            99999864332211222233567999999998889999999999999999997 99999888776655543 34455666


Q ss_pred             CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          333 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       333 ~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +..+++++.+++.+||+.+|.+||++.++++.|.++++..
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            7789999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-44  Score=331.84  Aligned_cols=245  Identities=28%  Similarity=0.579  Sum_probs=211.5

Q ss_pred             eeeeeCCceEEEEEE----CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          121 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +||+|+||.||+|.+    .+..+|+|+++.........+++.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999975    35679999998665555667789999999999999999999998864 5678999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc----ccCCC
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET  272 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~----~~~~~  272 (397)
                      +|.+++.. ...+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||+++.......    .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999976 45789999999999999999999999999999999999999999999999999976543321    12223


Q ss_pred             CCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       273 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      ++..|+|||.+....++.++|+||||+++|||++ |..||......+... .+..+..+..|..+++++.++|.+||+.|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4678999999988889999999999999999998 999998877655444 34555567788889999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 015965          352 PALRPDFSEIIEILQQI  368 (397)
Q Consensus       352 p~~Rps~~ell~~L~~l  368 (397)
                      |++||++.+|.+.|++.
T Consensus       239 p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         239 VDERPGFAVVELRLRNY  255 (257)
T ss_pred             chhCcCHHHHHHHHhcc
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.5e-45  Score=355.40  Aligned_cols=248  Identities=22%  Similarity=0.358  Sum_probs=208.4

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .|++++.||+|+||+||+|.+  .++.||||+++.... .......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999987  456799999975432 33445678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC------
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------  265 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~------  265 (397)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999976 467899999999999999999999999999999999999999999999999997532100      


Q ss_pred             ------------------------------------------CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHH
Q 015965          266 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE  303 (397)
Q Consensus       266 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  303 (397)
                                                                ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123479999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHHhc--hhCCCCCCCHHHHHH
Q 015965          304 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCW--QQDPALRPDFSEIIE  363 (397)
Q Consensus       304 ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl--~~dp~~Rps~~ell~  363 (397)
                      |++|..||...++.+....+.........+  ..+++++.+++.+|+  ..++..||++.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999998887766655555433222333  357899999999954  556666999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-47  Score=326.85  Aligned_cols=250  Identities=21%  Similarity=0.393  Sum_probs=223.1

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|.+.++||+|.|+.||+...  +|+.+|+|++..........+++.+|+.|.+.|+|||||++.+........|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46789999999999999998754  6788999998877666666788999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccccccCCc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~~~~~~  267 (397)
                      |+|.|+.|..-+-+ +..+++..+-.++.||+.+|.|+|.+||||||+||+|+++-.   ...+||+|||++........
T Consensus        90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            99999999876655 356888899999999999999999999999999999999953   44699999999988775555


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLE  345 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ll~  345 (397)
                      .....|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.+......++++.....  .....++++.++|++
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            667899999999999999999999999999999999999999999988888888888776543  344678999999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||..||.+|.|+.|.|+
T Consensus       249 rML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  249 RMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccChhhhccHHHHhC
Confidence            999999999999999873

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-44  Score=332.50  Aligned_cols=256  Identities=37%  Similarity=0.676  Sum_probs=220.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |++..++|++.+.||+|+||.||+|.+. ++.||+|.++.....   .+.+.+|+.++++++||||+++++++...+..|
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            5778889999999999999999999864 456999998765332   456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++.... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997643 468999999999999999999999999999999999999999999999999998655332


Q ss_pred             cc--cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      ..  .....+..|+|||++.+..++.++|+||||+++|+|++ |+.||...+.......+ ........+..++..+.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            11  11123457999999998899999999999999999999 99999988776655544 3344455667788999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +.+||+.+|++||++.++++.|+++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-44  Score=352.24  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=209.3

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||+||++..  .++.||||+++.... .......+.+|+.++++++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            3688999999999999999987  467899999875432 2334466888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999986 5679999999999999999999999999999999999999999999999999987432110    


Q ss_pred             --------------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015965          267 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL  314 (397)
Q Consensus       267 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~  314 (397)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012347999999999999999999999999999999999999999988


Q ss_pred             ChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHHhch--hCCCCCCCHHHHHHH
Q 015965          315 TPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQ--QDPALRPDFSEIIEI  364 (397)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~--~dp~~Rps~~ell~~  364 (397)
                      ++.+....+........+|  ..+++++.+++.+|+.  .++..||++.++++.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            8877776666533233333  3467899999999764  233356899999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-44  Score=331.55  Aligned_cols=250  Identities=36%  Similarity=0.684  Sum_probs=215.3

Q ss_pred             CcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      +..+|++.+.||+|+||.||++.+.+ ..+|+|++......   ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            45678999999999999999998754 46999998754332   246788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc--
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~--  268 (397)
                      ||++|++|.+++......+++..++.++.||+.|+.|||++||+||||||+||+++.++.+||+|||+++........  
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999999876668899999999999999999999999999999999999999999999999998755432211  


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+.... .....++..+..+++++.+++.+|
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHH
Confidence            11223457999999998899999999999999999999 8999988776655544 444556667778999999999999


Q ss_pred             chhCCCCCCCHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L  365 (397)
                      |..+|++|||+.++++.|
T Consensus       238 l~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         238 WHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             hcCChhhCcCHHHHHHHh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=335.26  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=213.5

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec---
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---  182 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  182 (397)
                      .|++. ..|...+.||+|+||.|..+.+  +++.||||.+.....+.-..++..+|+.+|+.++|+||+.+++++..   
T Consensus        17 ~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   17 LFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             EEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            34444 4555589999999999999876  56889999998766677778899999999999999999999998865   


Q ss_pred             --CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          183 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       183 --~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                        -..+|+|+|+| +.+|.+.++. +..++...+..++.||++||.|+|+.||+||||||.|++++.+..+||+|||+||
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence              24589999999 7799999976 4559999999999999999999999999999999999999999999999999999


Q ss_pred             cccc---CCcccCCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-----------
Q 015965          261 VKAQ---SGVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-----------  325 (397)
Q Consensus       261 ~~~~---~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~-----------  325 (397)
                      ....   .+.++.++.|.+|.|||++ ....|+.+.||||+||++.||++|++-|.+.+.......++.           
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8764   5667888999999999997 556799999999999999999999999987665443332221           


Q ss_pred             -------------cCCCCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          326 -------------KGLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       326 -------------~~~~~~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                   ....+.     +.+..++...+|+++||..||.+|+|+.|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                         111111     12467899999999999999999999999874

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=350.05  Aligned_cols=256  Identities=33%  Similarity=0.595  Sum_probs=210.8

Q ss_pred             cccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-ceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-SLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~  190 (397)
                      .++|.-...||+|+||.||+|...+ ..||||.+.......  .++|.+|+.++.+++|||+|+++|+|.+.+ ..+||+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            4677777899999999999999866 789999887654432  456999999999999999999999999988 499999


Q ss_pred             EeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEeCCCCceEEccccccccccc-C
Q 015965          191 EFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDENEVVKVADFGVARVKAQ-S  265 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~  265 (397)
                      |||++|+|.++|+.... .++|..+.+|+.++++||+|||...   ||||||||+|||+|++.+.||+|||+|+.... .
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            99999999999987666 8999999999999999999999864   99999999999999999999999999976654 3


Q ss_pred             CcccCC-CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHhhhc-----CCCCCCC
Q 015965          266 GVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT------PLQAAVGVVQK-----GLRPTIP  333 (397)
Q Consensus       266 ~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~------~~~~~~~~~~~-----~~~~~~~  333 (397)
                      ...... .||..|+|||.+.....+.|+||||||++|+||++|+.|.+...      ..+.....+..     ...+.+.
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            333333 89999999999998889999999999999999999998887532      11111122222     2233332


Q ss_pred             -CCCc-----HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          334 -KNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       334 -~~~~-----~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                       ...+     ..+..+..+|++.+|.+||++.++++.|+.+..
T Consensus       312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence             2222     337788899999999999999999888865543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-44  Score=335.69  Aligned_cols=256  Identities=31%  Similarity=0.582  Sum_probs=216.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      |++..++|++.+.||+|+||.||+|.+.+       ..||||.++... ......++.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            67778899999999999999999997643       459999986543 2334567899999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceE
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      .....++||||+++++|.+++....         ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999999997532         2356778899999999999999999999999999999999999999


Q ss_pred             EcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCC
Q 015965          253 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       253 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~  328 (397)
                      |+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875432211   112345788999999998899999999999999999999 799998877665554433 333


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      .+..+..+++.+.+++.+||+.||++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            45567788999999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-44  Score=341.95  Aligned_cols=248  Identities=23%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|+.  .++.||||+++...... ....+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            6799999999999999999987  46789999987543222 23457789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |+ +++|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          84 YV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             CC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            99 56898888876678999999999999999999999999999999999999999999999999998754322 23345


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhhc---C-------------CCCC-
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQK---G-------------LRPT-  331 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~-~~~~~~---~-------------~~~~-  331 (397)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+...   .             ..+. 
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            678999999999865 45888999999999999999999999876543222 111110   0             0000 


Q ss_pred             ----CC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 ----IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ----~~---------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                          .+         ...++.+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                00         123467899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-44  Score=340.07  Aligned_cols=260  Identities=32%  Similarity=0.652  Sum_probs=223.4

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeE
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA  179 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~  179 (397)
                      .|.+..++|.+.+.||+|+||.||++++.       +..||+|.++... .......+.+|+.+++++ +||||+++++.
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            47788889999999999999999999752       2369999987543 233456789999999999 79999999999


Q ss_pred             EecCCceEEEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          180 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       180 ~~~~~~~~lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      +...+..+++|||+++++|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999999999976433 489999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCC
Q 015965          259 ARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK  334 (397)
Q Consensus       259 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  334 (397)
                      ++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+........+.++..+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            975443221   122345788999999998889999999999999999998 9999988776665556566665666667


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ..++++.+++.+||+.+|++||++.++++.|+++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            7889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-45  Score=352.08  Aligned_cols=238  Identities=26%  Similarity=0.438  Sum_probs=207.3

Q ss_pred             ceeeeeCCceEEEEEE-----CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          120 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      +.||+|+||.||++..     .++.||+|+++...........+.+|+.++++++||||+++++++..++.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999865     46789999998654333344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCCCC
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG  273 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~~g  273 (397)
                      +++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......|
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            9999999976 467899999999999999999999999999999999999999999999999999765443 23345679


Q ss_pred             CcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCC
Q 015965          274 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA  353 (397)
Q Consensus       274 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~  353 (397)
                      |+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...  ...+|..+++.+.+++.+||+.||+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            99999999999988999999999999999999999999988877666655443  3346777899999999999999999


Q ss_pred             CCCCHHH
Q 015965          354 LRPDFSE  360 (397)
Q Consensus       354 ~Rps~~e  360 (397)
                      +||++.+
T Consensus       239 ~R~~a~~  245 (318)
T cd05582         239 NRLGAGP  245 (318)
T ss_pred             HcCCCCC
Confidence            9999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.8e-44  Score=339.47  Aligned_cols=265  Identities=32%  Similarity=0.634  Sum_probs=224.2

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  176 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~  176 (397)
                      ..|++..++|.+.+.||+|+||.||++.+.+         ..+|+|.++... .......+.+|+.+++++ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3578888999999999999999999997532         359999998653 233456788899999999 79999999


Q ss_pred             eeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 015965          177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  241 (397)
Q Consensus       177 ~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~  241 (397)
                      ++++...+..|+||||+++++|.+++....               ..+++..++.++.|++.||+|||++|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999997642               24788899999999999999999999999999999


Q ss_pred             cEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015965          242 NLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  317 (397)
Q Consensus       242 Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~  317 (397)
                      ||+++.++.+||+|||.++.......   .....+++.|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999999875433211   112234578999999998889999999999999999998 89999876654


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      + ....+....+...+..++.++.+++.+||..+|++||++.++++.|++++....
T Consensus       250 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 E-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             H-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            4 334445555666777889999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-44  Score=335.03  Aligned_cols=256  Identities=32%  Similarity=0.600  Sum_probs=220.3

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      |++..++|++.+.||+|+||.||+|.+.+       ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            67888999999999999999999998643       569999987543 3334567889999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceE
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      .....++||||+++++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999996532         2467889999999999999999999999999999999999999999


Q ss_pred             EcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCC
Q 015965          253 VADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       253 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~  328 (397)
                      |+|||+++......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence            99999987544332   1223456789999999988889999999999999999998 999998887766555444 445


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      .+..+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            56677888999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=331.21  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=212.0

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  189 (397)
                      ++|+.+++|++|+||.||+|+++  ++.||+|.++.+.......-.-++||.+|.+++|||||.+-.+...  -+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            67999999999999999999874  5669999998765443334557899999999999999999987654  4569999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Ccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~  268 (397)
                      |||| .-+|..++.....++....+.-++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+||.+..+ ..+
T Consensus       156 Me~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  156 MEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             HHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            9999 45999999998889999999999999999999999999999999999999999999999999999987765 456


Q ss_pred             cCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------------------
Q 015965          269 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------  327 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~--------------------  327 (397)
                      +..+-|.+|+|||++.+ ..|+.+.|+||+|||+.||+++.+-|.+.+....+..+.+.-                    
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            77788999999999866 469999999999999999999999999887766665554320                    


Q ss_pred             ---------CCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 ---------LRPTIPKN-SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ---------~~~~~~~~-~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                               ++..++.. .++.-.+|+..+|..||.+|.||.+.|+
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                     11111122 5578899999999999999999999864

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-44  Score=346.05  Aligned_cols=244  Identities=27%  Similarity=0.461  Sum_probs=206.9

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHH---hcCCCCCeeeeeeEEecCCceEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIM---RKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      |++.+.||+|+||.||++.+  .++.||||+++.... .......+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            57789999999999999987  467899999975432 223345566676654   567899999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~  268 (397)
                      |||++|++|..++..  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ....
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988864  5799999999999999999999999999999999999999999999999999875332 2234


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  .+..+..+++.+.+++.+||
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence            4567999999999999999999999999999999999999999988877666655543  33466788999999999999


Q ss_pred             hhCCCCCC-----CHHHHHH
Q 015965          349 QQDPALRP-----DFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rp-----s~~ell~  363 (397)
                      +.||.+||     ++.++++
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhh
Confidence            99999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-44  Score=346.42  Aligned_cols=262  Identities=34%  Similarity=0.646  Sum_probs=220.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE-------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC  180 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  180 (397)
                      |++..++|++.+.||+|+||.||+|.+       .++.||||+++.... ......+.+|+.+++++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            778888999999999999999999974       346799999976432 33456788999999999 689999999988


Q ss_pred             ecC-CceEEEEEeccCCCHHHHHHhcc-----------------------------------------------------
Q 015965          181 TKP-PSLCIVTEFMSGGSVYDYLHKLK-----------------------------------------------------  206 (397)
Q Consensus       181 ~~~-~~~~lv~E~~~g~sL~~~l~~~~-----------------------------------------------------  206 (397)
                      ... ..++++|||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 46789999999999999986532                                                     


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---ccC
Q 015965          207 -------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTA  270 (397)
Q Consensus       207 -------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~  270 (397)
                                   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         2367788899999999999999999999999999999999999999999999975432211   112


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.....+..+.++..+...++++.+++.+||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            345678999999988899999999999999999997 9999987665555555566666666777788999999999999


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHH
Q 015965          350 QDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       350 ~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .||++||++.++++.|+.+++.
T Consensus       321 ~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.6e-44  Score=339.20  Aligned_cols=265  Identities=31%  Similarity=0.628  Sum_probs=223.7

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ  175 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  175 (397)
                      ...|.+..++|.+.++||+|+||.||+++..         ...+|+|+++... .......+.+|+.+++++ +||||++
T Consensus         4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099           4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeee
Confidence            4457888899999999999999999999752         2459999987543 234456788999999999 5999999


Q ss_pred             eeeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 015965          176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  240 (397)
Q Consensus       176 ~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp  240 (397)
                      +++++.....+|++|||+++++|.+++....               ..+++..+..++.||+.||.|||++||+||||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  162 (314)
T cd05099          83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA  162 (314)
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            9999999899999999999999999997632               3478889999999999999999999999999999


Q ss_pred             CcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015965          241 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  316 (397)
Q Consensus       241 ~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~  316 (397)
                      +||+++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999975543211   122234568999999988889999999999999999999 8999988776


Q ss_pred             HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+.... .........+..++.++.+++.+||+.||++||++.++++.|+++...+
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         243 EELFKL-LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            554443 3444455667788899999999999999999999999999999987655

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=355.08  Aligned_cols=249  Identities=20%  Similarity=0.301  Sum_probs=208.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.++||+|+||.||++..  .++.||||++..... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688899999999999999976  567899999865322 2344567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||++|++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986321100    


Q ss_pred             --------------------------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHH
Q 015965          267 --------------------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW  302 (397)
Q Consensus       267 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~  302 (397)
                                                                  .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHhchhCCCCC---CCHHHHHHH
Q 015965          303 ELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALR---PDFSEIIEI  364 (397)
Q Consensus       303 ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~dp~~R---ps~~ell~~  364 (397)
                      ||++|..||...+..+....+.........|.  .+++++.+++.+|+. +|.+|   +++.+++..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999988877666555554332333333  478999999999997 77765   599988764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-44  Score=345.43  Aligned_cols=241  Identities=25%  Similarity=0.417  Sum_probs=207.9

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCC-CeeeeeeEEecCCceEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  190 (397)
                      +|++.+.||+|+||.||+|.+.  ++.||||+++.... .......+..|+.+++.++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999875  45799999876432 233456688899999999764 6888999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc-cCCccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-~~~~~~  269 (397)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99999999999876 4678999999999999999999999999999999999999999999999999986432 222334


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  .+..+..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence            557999999999999999999999999999999999999999988877666665543  445677889999999999999


Q ss_pred             hCCCCCCCH
Q 015965          350 QDPALRPDF  358 (397)
Q Consensus       350 ~dp~~Rps~  358 (397)
                      .||.+|++.
T Consensus       238 ~~P~~R~~~  246 (324)
T cd05587         238 KHPAKRLGC  246 (324)
T ss_pred             cCHHHcCCC
Confidence            999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-44  Score=339.23  Aligned_cols=261  Identities=32%  Similarity=0.606  Sum_probs=217.6

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--Cc--ceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCc
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  185 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  185 (397)
                      +..++|++.+.||+|+||.||+|.+.  +.  .+|+|.++.. ........+.+|+.++.++ +||||+++++++...+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            45578999999999999999999864  33  3577776643 2344456788999999999 89999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  250 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~  250 (397)
                      .|+||||+++++|.+++....               ..+++..++.++.||+.|++|||++||+||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999997532               25789999999999999999999999999999999999999999


Q ss_pred             eEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCC
Q 015965          251 VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR  329 (397)
Q Consensus       251 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~  329 (397)
                      +||+|||+++............++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... .....+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~  241 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR  241 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCc
Confidence            99999999864322211222334678999999988889999999999999999998 9999987776554443 334445


Q ss_pred             CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       330 ~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      +..+..+++++.+++.+||+.+|++||++.+++..|.+++....
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            55666788999999999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-45  Score=350.34  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=213.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++..  .++.||||+++.... .......+.+|+.+++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3688999999999999999986  467899999986433 2334566889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--c
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--~  268 (397)
                      ||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99999999999988767899999999999999999999999999999999999999999999999999976544322  2


Q ss_pred             cCCCCCcccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHH
Q 015965          269 TAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKL  340 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l  340 (397)
                      ....||+.|+|||++.      ...++.++|||||||++|+|++|..||...+.......+.........+  ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            2347899999999986      4567899999999999999999999998887776666655433222222  3578999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+|+.+||. +|.+||++.+++.
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhC
Confidence            999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-44  Score=352.50  Aligned_cols=253  Identities=22%  Similarity=0.329  Sum_probs=214.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||+++.  .++.||+|+++.... .......+.+|+.+++.++||||+++++++.++..+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45667899999999999999999987  467799999875322 223345578899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||++||+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999999865  468899999999999999999999999999999999999999999999999997654332


Q ss_pred             c--ccCCCCCcccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCC--CCcH
Q 015965          267 V--MTAETGTYRWMAPEVIEHK----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP  338 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  338 (397)
                      .  .....||+.|+|||++.+.    .++.++|||||||++|||++|..||...+.......+.........|.  .++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence            2  2345799999999998653    478899999999999999999999998887766666655433333343  5789


Q ss_pred             HHHHHHHHhchhCCCC--CCCHHHHHHH
Q 015965          339 KLAELLERCWQQDPAL--RPDFSEIIEI  364 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~--Rps~~ell~~  364 (397)
                      ++.+++.+||+.+|.+  |+++.++++.
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            9999999999999987  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-44  Score=345.34  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-----ceE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC  187 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  187 (397)
                      +|++.++||+|+||.||+|..  .++.||||.++...........+.+|+.++++++||||+++++++....     .+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478899999999999999986  4678999998754333344567889999999999999999999875432     479


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      +||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            999999 5799998876 4578999999999999999999999999999999999999999999999999997543221 


Q ss_pred             ---cccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh-----------------
Q 015965          267 ---VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV-----------------  324 (397)
Q Consensus       267 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~-----------------  324 (397)
                         ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...+.......+.                 
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234579999999999865  678999999999999999999999997765432211100                 


Q ss_pred             ---------hcCCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          325 ---------QKGLRPT---IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       325 ---------~~~~~~~---~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                               .......   ....+++.+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                     0000000   11246788999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.6e-44  Score=336.91  Aligned_cols=261  Identities=31%  Similarity=0.642  Sum_probs=223.5

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  178 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  178 (397)
                      ..|+++.++|++.+.||+|+||.||++.+.+       ..+|+|.++.... ......+.+|+.+++++ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4578889999999999999999999998642       4599999886533 33456788999999999 7999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  243 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni  243 (397)
                      ++...+.++++|||+++++|.++++..               ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999999642               34688999999999999999999999999999999999


Q ss_pred             EeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015965          244 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA  319 (397)
Q Consensus       244 li~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~  319 (397)
                      +++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999986543221   122235678999999988899999999999999999998 9999988776555


Q ss_pred             HHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      ... ......+..+..++..+.+|+.+||..||++|||+.++++.|++++
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKL-LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH-HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            443 4444556677788999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-43  Score=330.53  Aligned_cols=252  Identities=31%  Similarity=0.582  Sum_probs=215.2

Q ss_pred             ccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc-----
Q 015965          116 LKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-----  185 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  185 (397)
                      |++++.||+|+||.||+|....     ..||+|.++...........+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998642     569999998765555566789999999999999999999998866544     


Q ss_pred             -eEEEEEeccCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          186 -LCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       186 -~~lv~E~~~g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                       .+++|||+++++|..++...     ...+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999999998543     236899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCC
Q 015965          260 RVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN  335 (397)
Q Consensus       260 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  335 (397)
                      +.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||....+.+....+ ..+..+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  239 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQPED  239 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcC
Confidence            76543321   112235678999999998899999999999999999999 99999887776655443 44455667788


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +++++.+++.+||+.||++||++.++++.|+++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            999999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-43  Score=332.25  Aligned_cols=257  Identities=28%  Similarity=0.576  Sum_probs=216.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCc----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +...+|++.+.||.|+||+||+|.+  .++    .+++|.+.... ......++..|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            3456889999999999999999987  344    37777765332 23344678889999999999999999998764 5


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++++||+++|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57899999999999999987677899999999999999999999999999999999999999999999999999976543


Q ss_pred             CC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ..   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+... ..++..+..+..+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHH
Confidence            22   1223356778999999998889999999999999999998 9999988766543 34455666666677788899


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      .+++.+||..||.+|||+.++++.|..+.+
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.6e-44  Score=333.51  Aligned_cols=255  Identities=30%  Similarity=0.587  Sum_probs=215.2

Q ss_pred             cCcccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +..++|++.+.||+|+||.||+|.+      .+..+|+|.++... .......+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            3446789999999999999999975      33569999987543 3344567889999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhc----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL----------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  248 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~----------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~  248 (397)
                      ..|++|||+++++|.+++...                ...+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998532                1247888999999999999999999999999999999999999


Q ss_pred             CceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 015965          249 EVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV  324 (397)
Q Consensus       249 ~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~  324 (397)
                      +.+||+|||+++......   ......++..|+|||++.+..++.++||||||+++|||++ |..||....+...... +
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-V  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence            999999999997643321   1233456778999999988889999999999999999998 9999988766544333 4


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       325 ~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      .....+..+..+++++.+++.+||+.||.+||++.++++.|..
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            4444555677889999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.6e-44  Score=360.10  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=216.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC----
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  184 (397)
                      ....+|++.+.||+|+||+||++.+  .++.||||++............+.+|+.++..++|+||++++..+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3447899999999999999999976  5788999999877666666778899999999999999999988765432    


Q ss_pred             ----ceEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccc
Q 015965          185 ----SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       185 ----~~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                          .+++||||+++|+|.+++...   ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                368999999999999998653   3468999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCC
Q 015965          258 VARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK  334 (397)
Q Consensus       258 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~  334 (397)
                      +++.....   .......||+.|+|||++.+..++.++||||||+++|||++|..||...+..+....+.. +.....+.
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~  267 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLPP  267 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCC
Confidence            99765432   223455799999999999999999999999999999999999999998777665555443 33445677


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++++.+++.+||+.||.+||++.++++
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            88999999999999999999999999875

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.3e-45  Score=348.42  Aligned_cols=242  Identities=26%  Similarity=0.462  Sum_probs=208.1

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +.||+|+||.||++..  .++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  567899999986432 2334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      +|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            99998876 4678999999999999999999997 7999999999999999999999999999875332 2233455799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..+++++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999999999999999999999887766555544433  34467788999999999999999999


Q ss_pred             CC-----CHHHHHHH
Q 015965          355 RP-----DFSEIIEI  364 (397)
Q Consensus       355 Rp-----s~~ell~~  364 (397)
                      |+     ++.++++.
T Consensus       238 R~~~~~~~~~~il~h  252 (325)
T cd05594         238 RLGGGPDDAKEIMQH  252 (325)
T ss_pred             hCCCCCCCHHHHhcC
Confidence            97     89888743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-44  Score=328.97  Aligned_cols=250  Identities=29%  Similarity=0.515  Sum_probs=218.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh---HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +.|.+.+.||+|++|.||++..  .++.+|+|.+.......   .....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999975  56889999987543322   234568889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-  267 (397)
                      ||||++|++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++....... 
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999999876 46689999999999999999999999999999999999999999999999999875433211 


Q ss_pred             ---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          268 ---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       268 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                         .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..............+..+..+++.+.+++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence               13356888999999999988999999999999999999999999888777766666666666778888999999999


Q ss_pred             HHhchhCCCCCCCHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~  364 (397)
                      .+||..+|++||++.++++.
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhC
Confidence            99999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.9e-44  Score=334.16  Aligned_cols=258  Identities=30%  Similarity=0.586  Sum_probs=219.6

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      |...+|.+.+.||.|+||.||++...       +..+|+|.+...  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            45678999999999999999999742       234889988643  334456799999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCce
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  251 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~v  251 (397)
                      +..++||||+++++|.+++....            ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997532            248999999999999999999999999999999999999999999


Q ss_pred             EEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 015965          252 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  327 (397)
Q Consensus       252 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~  327 (397)
                      +|+|||+++......   ......++..|+|||++.+..++.++|+||||+++|+|++ |..||...........+.. +
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~-~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-G  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence            999999997543221   1223345788999999998899999999999999999998 9999988877665555443 3


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      ..+..+..+++++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            34455667889999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.2e-44  Score=330.14  Aligned_cols=256  Identities=36%  Similarity=0.668  Sum_probs=217.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |.+...+|++.++||+|+||.||+|++.+ ..||+|.++.....   ...+.+|+.++++++||||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            56777889999999999999999998744 46999998864332   3568899999999999999999998754 5689


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999999999997643 458899999999999999999999999999999999999999999999999997654432


Q ss_pred             cc--cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      ..  ....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ........+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hcCCCCCCccccCHHHHHH
Confidence            21  12346678999999988889999999999999999999 89999887766555443 3333444566788999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      +.+||+.||++||++.++++.|++.+
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.9e-44  Score=331.45  Aligned_cols=256  Identities=34%  Similarity=0.646  Sum_probs=220.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +....+|++.++||.|+||.||+|.+. +..+|+|+++...  ......+.+|+.+++.++||||+++++++......++
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            444567999999999999999999875 4679999987543  2234668899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          189 VTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||||+++++|.+++... ...+++..+..++.||+.|+.|||++||+|+||+|+||+++.++.+||+|||.+....... 
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999764 3468999999999999999999999999999999999999999999999999997654322 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. ...++..+..+++++.+++.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHH
Confidence            1223346778999999988899999999999999999998 899998877666555544 45566677889999999999


Q ss_pred             HhchhCCCCCCCHHHHHHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +||+.||.+|||+.++++.|+++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         239 ECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHcCCCchhCcCHHHHHHHHhcC
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.7e-44  Score=330.23  Aligned_cols=255  Identities=24%  Similarity=0.453  Sum_probs=214.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|+.  .++.||||.++... ........+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4788999999999999999986  56889999887533 23445567899999999999999999999999989999999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||+++++|.+++...   ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            999999999988642   3458899999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....  ......+......+..+...+..+.+++
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            12345688999999999888899999999999999999999999965432  2333332222333333456788999999


Q ss_pred             HHhchhCCCCCCCHHHHHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .+||..+|++||++.++++.|+++
T Consensus       242 ~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         242 SMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHCCCCcccCcCHHHHHHHHHHh
Confidence            999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-44  Score=334.11  Aligned_cols=253  Identities=31%  Similarity=0.599  Sum_probs=216.2

Q ss_pred             CcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ...+|.+.+.||+|+||.||+|...       +..||||.++.... ......+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4567899999999999999999753       35699999875432 334578999999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCce
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  251 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~v  251 (397)
                      ..++||||+++++|.+++....             ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999997532             347888999999999999999999999999999999999999999


Q ss_pred             EEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 015965          252 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  327 (397)
Q Consensus       252 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~  327 (397)
                      +|+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .+
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~  240 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QG  240 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cC
Confidence            999999987543221   1223346788999999999999999999999999999998 999998877666555444 44


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ..+..+..++..+.+++.+||..||++||++.|+++.|+
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            444556778999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-43  Score=330.30  Aligned_cols=252  Identities=29%  Similarity=0.545  Sum_probs=211.1

Q ss_pred             ccccceeeeeCCceEEEEEECCc----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------Cc
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS  185 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  185 (397)
                      +.++++||+|+||.||+|.+...    .+|+|.++...........+.+|+.+++.++||||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678999999999999987442    489999887655556677899999999999999999999987432      24


Q ss_pred             eEEEEEeccCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      .+++|||+++++|.+++...     ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            68999999999999987432     2357899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          261 VKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       261 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      .......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ...+..+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQPPDC  239 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            6543321   122246778999999999999999999999999999999 8999988776554443 4444444566778


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +..+.+++.+||+.||++|||+.++++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            89999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-43  Score=328.64  Aligned_cols=245  Identities=31%  Similarity=0.624  Sum_probs=210.0

Q ss_pred             eeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          121 KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      .||+|+||.||+|.+.    +..||+|+++... .......+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999999764    2359999987553 34445679999999999999999999998864 5789999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc----ccCCC
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET  272 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~----~~~~~  272 (397)
                      +|.+++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.......    .....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            99999987667899999999999999999999999999999999999999999999999999975433221    11223


Q ss_pred             CCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       273 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      +++.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..+.++..+..+++++.+++.+||..|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            3678999999988889999999999999999996 99999888766544 445556667788889999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 015965          352 PALRPDFSEIIEILQQI  368 (397)
Q Consensus       352 p~~Rps~~ell~~L~~l  368 (397)
                      |++||++.++.+.|+.+
T Consensus       239 ~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         239 WEDRPNFAKVEERMRTY  255 (257)
T ss_pred             hhhCcCHHHHHHHHhhh
Confidence            99999999999998875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-44  Score=344.89  Aligned_cols=236  Identities=25%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++...  ++.||||+++.... .......+..|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  56799999875432 223445677888888776 699999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            999999876 46799999999999999999999999999999999999999999999999999875332 2334456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ....+..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999999999999999999999999999999988877766665543  34456778999999999999999999


Q ss_pred             CCCH
Q 015965          355 RPDF  358 (397)
Q Consensus       355 Rps~  358 (397)
                      ||++
T Consensus       238 R~~~  241 (320)
T cd05590         238 RLGS  241 (320)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.7e-44  Score=342.47  Aligned_cols=250  Identities=25%  Similarity=0.443  Sum_probs=207.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +..++|++.++||.|+||.||++.+.  +..+|+|+++... .......+.+|+.++++++||||+++++++...+.+++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            45688999999999999999999874  5679999887653 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            9999999999999976 46689999999999999999999985 7999999999999999999999999998754322 2


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------------------
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-------------------------  322 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~-------------------------  322 (397)
                      .....||..|+|||++.+..++.++|+|||||++|+|++|+.||......+....                         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            2345789999999999998999999999999999999999999976543222110                         


Q ss_pred             ------------------hhhcCCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          323 ------------------VVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       323 ------------------~~~~~~~~~~~-~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                        .......+..+ ...++++.+|+.+||+.||++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                              00011111121 235788999999999999999999999963

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-43  Score=331.88  Aligned_cols=257  Identities=31%  Similarity=0.617  Sum_probs=217.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--Cc----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +..++|++.++||+|+||+||+|++.  ++    .||+|+++... .......+.+|+.+++.++||||+++++++.. .
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            45578999999999999999999863  33    38999987543 34445778999999999999999999999875 4


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..+++|||+++|+|.+++....+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999999999999987667899999999999999999999999999999999999999999999999999976543


Q ss_pred             CCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......... ..+.....+..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHH
Confidence            322   112235678999999998899999999999999999998 99999877665443 3445555556677889999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      .+++.+||+.||++||++.++++.|.++..
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999998877743

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.2e-44  Score=331.24  Aligned_cols=255  Identities=33%  Similarity=0.626  Sum_probs=218.1

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--C---cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      +..+|++.+.||+|+||.||+|.+.  +   ..+|+|.++.... ......+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4578899999999999999999763  2   2599999876432 34456889999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+++++|.+++....+.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999999998766778999999999999999999999999999999999999999999999999997654322


Q ss_pred             c--c--cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          267 V--M--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       267 ~--~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      .  .  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+ ....++..+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCcCCCCCCCCHHHH
Confidence            1  1  11233568999999998889999999999999999887 99999887765554443 34445556667889999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +++.+||+.+|.+||++.++++.|+++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.5e-44  Score=334.69  Aligned_cols=255  Identities=25%  Similarity=0.525  Sum_probs=216.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ++..+|++.++||+|+||.||+|.+.       ++.||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            45577999999999999999999864       3569999988543 333456788999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  248 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~  248 (397)
                      ...++++||+++++|.+++...               +..+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998531               2347888899999999999999999999999999999999999


Q ss_pred             CceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 015965          249 EVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV  324 (397)
Q Consensus       249 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~  324 (397)
                      +.+||+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875433221   223356789999999988889999999999999999998 899998877766555544


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       325 ~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      . ......+..+++.+.+++.+||+.+|.+||++.+++..|+.
T Consensus       241 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 N-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             c-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            3 33445677899999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-43  Score=327.80  Aligned_cols=254  Identities=37%  Similarity=0.685  Sum_probs=217.6

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |++..++|++.++||+|+||.||++... +..+|+|.++.....   ...+.+|+.++++++|+|++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence            6778889999999999999999999864 467999998865443   3468899999999999999999998754 5689


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999999999997643 458999999999999999999999999999999999999999999999999997654332


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+ .....+..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            1  122345678999999988889999999999999999999 99999887766655544 3445556677889999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      +.+||..+|.+|||+.++.+.|++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-43  Score=333.35  Aligned_cols=259  Identities=29%  Similarity=0.568  Sum_probs=217.2

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      |+++.++|++.++||+|+||.||+|...       +..||+|.++.... ......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            7888999999999999999999998653       23699998875432 233456889999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceE
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      .....|+||||+++|+|.+++....         ..++...+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532         2346678899999999999999999999999999999999999999


Q ss_pred             EcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCC
Q 015965          253 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       253 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~  328 (397)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+....+. .+.
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGG  238 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875433211   122345778999999998889999999999999999998 899998877665444433 333


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+..+..+++.+.+++.+||+.||++|||+.++++.|++.+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            44556778899999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-44  Score=342.81  Aligned_cols=240  Identities=25%  Similarity=0.441  Sum_probs=203.5

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||+|++.  ++.||||+++.... .......+..|..++.. .+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  46699999986432 22233445566666664 5799999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            999999876 46799999999999999999999999999999999999999999999999999975432 2333455799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..  ..+..+..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999999999999999999998887666655443  355677889999999999999999999


Q ss_pred             CCCHH-HHH
Q 015965          355 RPDFS-EII  362 (397)
Q Consensus       355 Rps~~-ell  362 (397)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05592         238 RLGVDGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-43  Score=326.04  Aligned_cols=245  Identities=33%  Similarity=0.665  Sum_probs=209.0

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS  197 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~s  197 (397)
                      +.||+|+||.||+|++  .++.+|+|.+.... ..+....+.+|+.++++++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4699999999999987  56789999877442 34455779999999999999999999999999999999999999999


Q ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCccc---CCCCC
Q 015965          198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT---AETGT  274 (397)
Q Consensus       198 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~---~~~gt  274 (397)
                      |.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........   ...++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            999997655678999999999999999999999999999999999999999999999999987543221111   11234


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA  353 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~  353 (397)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..||...+....... .....+...+..++..+.+++.+||+.+|+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            57999999998889999999999999999998 9999987776544333 334455567778899999999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 015965          354 LRPDFSEIIEILQ  366 (397)
Q Consensus       354 ~Rps~~ell~~L~  366 (397)
                      +|||+.++++.|+
T Consensus       239 ~Rps~~~~~~~l~  251 (252)
T cd05084         239 QRPSFSTVHQELQ  251 (252)
T ss_pred             hCcCHHHHHHHHh
Confidence            9999999998876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-44  Score=352.66  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .|+++++||+|+||.||+|..  .++.||+|++..... .......+.+|+.++++++||||+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999987  457799999875422 23345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC------
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------  265 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~------  265 (397)
                      |++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999976 467899999999999999999999999999999999999999999999999997522100      


Q ss_pred             ------------------------------------------CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHH
Q 015965          266 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE  303 (397)
Q Consensus       266 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  303 (397)
                                                                ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00123468999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHHhchhCCCCCCC---HHHHHH
Q 015965          304 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPD---FSEIIE  363 (397)
Q Consensus       304 ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~~dp~~Rps---~~ell~  363 (397)
                      |++|..||...++.+....+.........|  ..+++++.+++.+|+ .+|.+|++   +.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999888877766665433333333  457899999999986 59999987   877764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-44  Score=344.37  Aligned_cols=241  Identities=23%  Similarity=0.366  Sum_probs=206.9

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      ++||+|+||.||+|++.  ++.||||+++.... ..+....+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875  46799999876432 233445677888888865 799999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            999999876 46789999999999999999999999999999999999999999999999999875332 2234455799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+....  ...|..+++++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHH
Confidence            99999999999999999999999999999999999999888777766655443  3456678899999999999999999


Q ss_pred             CC-------CHHHHHH
Q 015965          355 RP-------DFSEIIE  363 (397)
Q Consensus       355 Rp-------s~~ell~  363 (397)
                      ||       ++.++++
T Consensus       238 R~~~~~~~~~~~~~~~  253 (321)
T cd05591         238 RLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCCCCCCCCCHHHHhc
Confidence            99       6777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-44  Score=336.28  Aligned_cols=249  Identities=22%  Similarity=0.378  Sum_probs=209.3

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .|++.++||+|+||.||++..  +++.||+|++....... .....+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377889999999999999986  46789999987543322 223457789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          192 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||+++..........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999988653 34689999999999999999999999999999999999999999999999999986554444445


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh--cCCCCCCCCCCcHHHHHHHHHhc
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ..|++.|+|||++.+..++.++||||+|+++|+|++|..||...........+..  ....+..+..+++.+.+|+.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            6789999999999988999999999999999999999999987654332222111  12234456678999999999999


Q ss_pred             hhCCCCCC-----CHHHHHH
Q 015965          349 QQDPALRP-----DFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rp-----s~~ell~  363 (397)
                      ..||.+||     ++.+++.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhc
Confidence            99999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.7e-44  Score=342.79  Aligned_cols=241  Identities=24%  Similarity=0.415  Sum_probs=207.5

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      +|++.+.||+|+||.||+|.+.  ++.||||+++.... .......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999874  46799999886432 223345567788888777 4899999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~  269 (397)
                      ||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999876 46789999999999999999999999999999999999999999999999999975432 22334


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ....|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHHcc
Confidence            567999999999999999999999999999999999999999988877766665554  344677889999999999999


Q ss_pred             hCCCCCCCH
Q 015965          350 QDPALRPDF  358 (397)
Q Consensus       350 ~dp~~Rps~  358 (397)
                      .||.+|+++
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05616         238 KHPGKRLGC  246 (323)
T ss_pred             cCHHhcCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-44  Score=329.61  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=213.7

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC-eeeeeeEEecCC-----
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPP-----  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-----  184 (397)
                      ...|..+++||+|+||+||+|..  .|+.||+|.+..+...+.......+|+.+|+.++|+| ||.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45688889999999999999976  6778999999876544334456789999999999999 999999998776     


Q ss_pred             -ceEEEEEeccCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          185 -SLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       185 -~~~lv~E~~~g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                       .+++|+||+ ..+|.+++....   ..++...+..++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             799999999 679999998865   467888999999999999999999999999999999999999999999999999


Q ss_pred             cccc-CCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--------
Q 015965          261 VKAQ-SGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------  330 (397)
Q Consensus       261 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--------  330 (397)
                      .... ....+..++|.+|+|||++.+. .|+...||||+||+++||++++..|.+.+..+....+.+.-..|        
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            7774 3457788999999999999776 79999999999999999999999999988877766655321111        


Q ss_pred             --------CC-----C-------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          331 --------TI-----P-------KNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       331 --------~~-----~-------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                              .+     +       +...+...+++.+|++.+|.+|.|+...++.
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                    01     1       1223578899999999999999999998865

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-43  Score=335.57  Aligned_cols=264  Identities=31%  Similarity=0.620  Sum_probs=223.9

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      .|++...+|.+.+.||+|+||.||++.+.         +..||+|.++... .......+.+|+.+++.+ +||||++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            47888899999999999999999999752         2359999987543 233456788999999999 799999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      +++......|++|||+++++|.+++....               ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997632               247788899999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~  318 (397)
                      |+++.++.+||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999997654321   1222345678999999988889999999999999999998 889998877655


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .... +....+...+..++.++.+++.+||..+|.+||++.++++.|+++..-..
T Consensus       248 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         248 LFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            5444 44445556677889999999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-44  Score=347.54  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=212.5

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||++.+.  ++.+|+|++..... .......+.+|+.+++.++||||+++++++.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344578999999999999999999874  56799999865322 223345688899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||++||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            999999999999999965  468999999999999999999999999999999999999999999999999998654332


Q ss_pred             c--ccCCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCC--CCcH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP  338 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  338 (397)
                      .  .....||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+.........|.  .+++
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence            2  23557999999999997543    78899999999999999999999998887777766665443344443  4689


Q ss_pred             HHHHHHHHhchhCCCC--CCCHHHHHHH
Q 015965          339 KLAELLERCWQQDPAL--RPDFSEIIEI  364 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~--Rps~~ell~~  364 (397)
                      .+.+++.+|+..++.+  |+++.++++.
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            9999999999855543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.7e-44  Score=357.38  Aligned_cols=247  Identities=22%  Similarity=0.359  Sum_probs=212.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ..|.+.+.||+|+||.||++...   ++.||+|.+...  .......+.+|+.+++.++|||||++++++...+.+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            45899999999999999999763   456888876543  2334456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||++||+|.+++...   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999999988642   3468899999999999999999999999999999999999999999999999998654432 


Q ss_pred             --cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          267 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       267 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .+..+..+++++.++|
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGMKALL  303 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCccCCHHHHHHH
Confidence              2334579999999999999999999999999999999999999998887766665554433 3345667889999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||..||++||++.+++.
T Consensus       304 ~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        304 DPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhccChhhCcCHHHHHh
Confidence            9999999999999999864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-43  Score=343.83  Aligned_cols=247  Identities=27%  Similarity=0.456  Sum_probs=204.0

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ...++|++.++||+|+||.||++++.  ++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            34467889999999999999999874  6789999987543 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-c
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~  267 (397)
                      ||||+++++|.+.     ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus       150 v~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        150 LLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            9999999998653     235677888999999999999999999999999999999999999999999997654332 2


Q ss_pred             ccCCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHhhhcCCCCCCCCCCcHHH
Q 015965          268 MTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      .....||..|+|||++..     ...+.++|||||||++|||++|+.||......  ............+..+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            345679999999999743     23456899999999999999999999743221  22222222334555677889999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||.+||+.||++||++.|+++
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999975

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.2e-44  Score=344.97  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=204.1

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      .++|++.+.||+|+||.||++.+  .++.||+|+++...........+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            37899999999999999999976  4678999999866555555677889999999999999999999886543      


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+|+||||+. ++|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            4799999995 56776664   3488899999999999999999999999999999999999999999999999986655


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  328 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------  328 (397)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.....                
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            5555566899999999999999999999999999999999999999987654332221111000                


Q ss_pred             ----CC--------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 ----RP--------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ----~~--------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                          ++                    ......++++.+|+.+||..||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                00                    011234678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-44  Score=353.32  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=208.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++..  .++.||||++..... .......+.+|+.+|++++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3689999999999999999986  457799999875322 2223456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----  265 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-----  265 (397)
                      ||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......     
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999999999976 467899999999999999999999999999999999999999999999999997422100     


Q ss_pred             ---------------------------------------CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 015965          266 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT  306 (397)
Q Consensus       266 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  306 (397)
                                                             ......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                   00113469999999999999999999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhhhcCCCCCC--CCCCcHHHHHHHHHhchhCCCCCC---CHHHHHHH
Q 015965          307 GKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALRP---DFSEIIEI  364 (397)
Q Consensus       307 g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~cl~~dp~~Rp---s~~ell~~  364 (397)
                      |..||...++.+....+.........  ...+++++.+++.+|+ .+|.+|+   ++.++++.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999988876665554433222222  3467899999999987 5999999   88988754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-43  Score=332.68  Aligned_cols=254  Identities=30%  Similarity=0.608  Sum_probs=216.4

Q ss_pred             cccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +|++.+.||+|+||.||+|....       ..+++|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47788999999999999998632       3588888875533 333567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 015965          188 IVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  244 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  244 (397)
                      ++|||+.+++|.+++....                       ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999986531                       24788899999999999999999999999999999999


Q ss_pred             eCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015965          245 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA  320 (397)
Q Consensus       245 i~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~  320 (397)
                      +++++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.+..
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999975433221   122345778999999988889999999999999999998 99999887765543


Q ss_pred             HHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                       ...........+..++.++.+++.+||+.+|++||++.++++.|++++.
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 -NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             4455556666778889999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-43  Score=332.81  Aligned_cols=257  Identities=29%  Similarity=0.580  Sum_probs=218.6

Q ss_pred             CcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ...+|.+.+.||+|+||.||++++.       +..+++|.++...  ....+.+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            3467888999999999999999753       2348888876432  333467889999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      ..++||||+++++|.+++....               +.+++..++.++.||+.|+.|||++||+||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999997532               3478999999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 015965          250 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~  325 (397)
                      .++|+|||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... ..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~~  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-IT  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-Hh
Confidence            99999999997543322   1233456889999999999999999999999999999998 9999988777665444 34


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+..+..+..++..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            4445556677889999999999999999999999999999999664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-43  Score=327.71  Aligned_cols=254  Identities=33%  Similarity=0.650  Sum_probs=217.9

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |++..++|++.++||+|+||.||+|.. .++.||+|.+......   ...+.+|+.++++++||||+++++++. ....+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            678889999999999999999999986 4577999998765433   356889999999999999999999875 45689


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999999999987543 468999999999999999999999999999999999999999999999999997654322


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... .....+...+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence            1  123345778999999998889999999999999999999 9999988776555444 34445556677888999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      +.+||+.+|++||++++++..|++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.3e-44  Score=341.61  Aligned_cols=241  Identities=24%  Similarity=0.419  Sum_probs=206.6

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++.+.  ++.||||+++.... .......+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  56799999885432 223345677888999877 699999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~~gt  274 (397)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            999998876 467999999999999999999999999999999999999999999999999998753322 223345789


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+...  .+..+..+++++.+++.+||..||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999999999999999999999888776665555443  34466788999999999999999999


Q ss_pred             CCCH-----HHHHH
Q 015965          355 RPDF-----SEIIE  363 (397)
Q Consensus       355 Rps~-----~ell~  363 (397)
                      ||++     .++++
T Consensus       238 R~s~~~~~~~~ll~  251 (318)
T cd05570         238 RLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCCCCCCHHHHhc
Confidence            9999     76654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-43  Score=325.02  Aligned_cols=248  Identities=25%  Similarity=0.484  Sum_probs=217.1

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|.+.+.||+|+||.||++..  .++.|++|.+............+.+|+.++++++||||+++++.+...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477889999999999999987  467899999886655566677899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          193 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      ++|++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++...... ....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            9999999999875 4578999999999999999999999999999999999999999999999999987654432 2234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+.. ...+.++..+++.+.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHccC
Confidence            5688999999999999999999999999999999999999988876555554433 445556668889999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      +|++||++.++++
T Consensus       240 ~p~~Rp~~~~ll~  252 (256)
T cd08529         240 DYRQRPDTFQLLR  252 (256)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-44  Score=342.71  Aligned_cols=241  Identities=23%  Similarity=0.417  Sum_probs=201.7

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++++  .++.||||+++..... ......+.+|+.+++++ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999987  4577999999865332 23345688899999988 699999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc-cCCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-~~~~~~~~~gt  274 (397)
                      ++|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........||
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            999998876 4679999999999999999999999999999999999999999999999999987422 23334456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------PLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||....        ........... ....+|..+++++.+++.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~  238 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASSVLKG  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999996321        11122222222 2345677889999999999


Q ss_pred             hchhCCCCCCC------HHHHH
Q 015965          347 CWQQDPALRPD------FSEII  362 (397)
Q Consensus       347 cl~~dp~~Rps------~~ell  362 (397)
                      ||+.||.+||+      +.+++
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHh
Confidence            99999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-43  Score=328.72  Aligned_cols=255  Identities=32%  Similarity=0.606  Sum_probs=217.2

Q ss_pred             CcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      +..+|++.+.||+|+||.||+|....     ..||||+++... .......|..|+.++++++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            34578899999999999999998642     249999987543 344567899999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++||||+++++|.+++....+.+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999999999998766779999999999999999999999999999999999999999999999999987544322


Q ss_pred             cc---cCCC---CCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          267 VM---TAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       267 ~~---~~~~---gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ..   ....   .+..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ....+...+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHH
Confidence            11   1111   2457999999998899999999999999999887 99999887766555544 334444556678899


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +.+++.+||..+|.+||++.+++..|+++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.5e-44  Score=344.14  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             cccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCce
Q 015965          115 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL  186 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  186 (397)
                      +|++.+.||+|+||.||+++.     .++.||+|+++....  .....+.+.+|+.+++.++ ||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999875     457799999875322  2233456888999999995 89999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            999999999999999976 4678999999999999999999999999999999999999999999999999997543322


Q ss_pred             --cccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          267 --VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       267 --~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....   ........ ....+.++..+++.+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHH
Confidence              22345799999999999765 478899999999999999999999964322   12221111 123456777889999


Q ss_pred             HHHHHHhchhCCCCCC-----CHHHHHH
Q 015965          341 AELLERCWQQDPALRP-----DFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rp-----s~~ell~  363 (397)
                      .+++.+||+.||++||     ++.++++
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            9999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-44  Score=340.86  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++++  .++.||+|+++.... .......+..|..++.. .+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999987  456799999986432 12234556677777765 4899999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            999999876 46789999999999999999999999999999999999999999999999999874322 2234456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..  ..+..+..++.++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999999999999999999988776655544432  245567788999999999999999999


Q ss_pred             CCCHH-HHH
Q 015965          355 RPDFS-EII  362 (397)
Q Consensus       355 Rps~~-ell  362 (397)
                      ||++. +++
T Consensus       238 R~~~~~~~~  246 (316)
T cd05620         238 RLGVVGNIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-43  Score=329.67  Aligned_cols=260  Identities=27%  Similarity=0.552  Sum_probs=220.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-  182 (397)
                      .++.++|++.+.||+|+||.||+|.+..      ..|++|.++.. ........+.+|+.++++++||||+++++++.. 
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3566889999999999999999998754      66999988743 344456778999999999999999999998766 


Q ss_pred             CCceEEEEEeccCCCHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD  255 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~D  255 (397)
                      +...++++||+++++|.+++....       ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            467899999999999999997642       4588999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCC
Q 015965          256 FGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT  331 (397)
Q Consensus       256 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~  331 (397)
                      ||+++.......   .....++..|+|||++.+..++.++||||||+++|++++ |..||...++.+... ......++.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHcCCCCC
Confidence            999975433221   122346778999999998889999999999999999999 999998877665443 344455555


Q ss_pred             CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       332 ~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+..+++++.+++.+||..||++|||+.++++.|+++.++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            6667899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-43  Score=325.59  Aligned_cols=255  Identities=38%  Similarity=0.702  Sum_probs=219.8

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |++..++|++.++||+|+||.||++...+ +.+|||.+......   ...+.+|+.++++++||||+++++++......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            67888999999999999999999998643 56999998865433   356889999999999999999999999888999


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997643 468999999999999999999999999999999999999999999999999987654321


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.......+. ...+...+...+.++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHH
Confidence            1  112234678999999998889999999999999999998 999998877665555543 344555667778999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      +.+||+.+|.+||++.++++.|++
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-43  Score=325.41  Aligned_cols=254  Identities=38%  Similarity=0.690  Sum_probs=215.6

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |++..++|.+.++||+|+||.||++.+.+ ..+|+|.+......   ...+.+|+.++++++|||++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY   76 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence            56677789999999999999999998754 46999987754322   3568889999999999999999998754 5689


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||+++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999999997643 347899999999999999999999999999999999999999999999999997654332


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+.+....+ .....+..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHHHHH
Confidence            1  122346778999999998889999999999999999999 99999987776655443 3444555667788999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      +.+||..||++||++.++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-43  Score=327.06  Aligned_cols=259  Identities=32%  Similarity=0.632  Sum_probs=220.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ++...+|.+.+.||.|+||.||+|.+..     ..||||...... .....+.+.+|+.++++++||||+++++++.. .
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            4566789999999999999999998643     358999887543 24456689999999999999999999998876 4


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            57899999999999999987656789999999999999999999999999999999999999999999999999976544


Q ss_pred             CCcc--cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          265 SGVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       265 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ....  ....++..|+|||.+....++.++||||||+++|+|++ |..||...+..+.... .....+...+..+++.+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLY  238 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHH
Confidence            3221  12234568999999988889999999999999999986 9999988877655544 344445566778899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +++.+||..+|.+|||+.++++.|+++.++
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.2e-44  Score=354.68  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=202.9

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------  183 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  183 (397)
                      ...+|+++++||+|+||.||+|..  .++.||||.+....      ....+|+.+|+.++||||+++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            346799999999999999999987  46789999886432      2234799999999999999998876432      


Q ss_pred             --CceEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccc
Q 015965          184 --PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFG  257 (397)
Q Consensus       184 --~~~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG  257 (397)
                        ..+++||||++ ++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              24679999996 578777653   246789999999999999999999999999999999999999664 79999999


Q ss_pred             cccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---------
Q 015965          258 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------  327 (397)
Q Consensus       258 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~---------  327 (397)
                      +++............||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.+..         
T Consensus       217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            9987655555556788999999999865 468999999999999999999999998877665554443211         


Q ss_pred             ------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH--HHHHHH
Q 015965          328 ------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQI  368 (397)
Q Consensus       328 ------------------~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell--~~L~~l  368 (397)
                                        ++..+|...++++.+||.+||..||.+|||+.|++  ..++++
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                              01123445778999999999999999999999998  345554

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=340.38  Aligned_cols=247  Identities=23%  Similarity=0.426  Sum_probs=229.3

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .-|.+.+.||+|-|++|-++++  +|..||||++.+...+.-....+.+|++.|+.++|||||++|++...+..+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3577788999999999999864  89999999999988877777889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEcccccccccccCCcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      +=.+|+|++|+-++...+.+..+.+|+.||+.|+.|+|+..+|||||||+||.+- .-|.|||.|||++..+.++....+
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            9999999999999989999999999999999999999999999999999998775 678999999999998888888999


Q ss_pred             CCCCcccccccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+|+..|-|||++.+..|+. ++||||||++||.|+||++||+..+..+.+..++.-.  ...|..++.++++||..||.
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--YtvPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--YTVPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--ccCchhhhHHHHHHHHHHHh
Confidence            99999999999999999985 6899999999999999999999998888888777664  35788999999999999999


Q ss_pred             hCCCCCCCHHHHH
Q 015965          350 QDPALRPDFSEII  362 (397)
Q Consensus       350 ~dp~~Rps~~ell  362 (397)
                      .||.+|.+.++|.
T Consensus       256 RdPkkRAslEeI~  268 (864)
T KOG4717|consen  256 RDPKKRASLEEIV  268 (864)
T ss_pred             cCchhhccHHHHh
Confidence            9999999999986

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.6e-44  Score=342.86  Aligned_cols=237  Identities=27%  Similarity=0.431  Sum_probs=201.6

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHH-HHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||+||++.+  .++.||||++..... .......+.+|.. +++.++||||+++++.+...+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999987  467899999875432 2222344555554 56889999999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            999999976 56789999999999999999999999999999999999999999999999999875332 2334455799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+...++.+.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            99999999999999999999999999999999999999887776666655443  3355667999999999999999999


Q ss_pred             CCCHH
Q 015965          355 RPDFS  359 (397)
Q Consensus       355 Rps~~  359 (397)
                      ||++.
T Consensus       238 R~~~~  242 (323)
T cd05575         238 RLGAK  242 (323)
T ss_pred             CCCCC
Confidence            99875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=341.23  Aligned_cols=249  Identities=24%  Similarity=0.477  Sum_probs=223.8

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  188 (397)
                      ...|.+.+.||+|.||.||++..  +++.+|+|++++..... .....+.+|+.+|+++. |||||++++++++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            36789999999999999999976  46789999998765432 34567899999999999 9999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC----CceEEccccccccccc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQ  264 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~----~~vkl~DfG~a~~~~~  264 (397)
                      |||++.||.|.+.+...  .+++..+..++.|++.++.|||+.||+||||||+|+|+...    +.+|++|||++.....
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999875  39999999999999999999999999999999999999633    4799999999998887


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCCcHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAE  342 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  342 (397)
                      .......+||+.|+|||++...+|+..+||||+|+++|.|++|..||...+.......+....+  .......++..+.+
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd  271 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD  271 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence            6678888999999999999999999999999999999999999999999998888877776654  33344667899999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++++|+..||..|+|+.++++
T Consensus       272 ~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  272 FIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHhcccCcccCCCHHHHhc
Confidence            999999999999999999987

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-43  Score=324.26  Aligned_cols=245  Identities=40%  Similarity=0.730  Sum_probs=215.8

Q ss_pred             ceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          120 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      +.||+|+||.||++...     +..|++|.++...... ....+.+|+.+++.++|+||+++++++......+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            46999999999999875     6679999998664433 46789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          195 GGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       195 g~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +++|.+++...        ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999876        4779999999999999999999999999999999999999999999999999998665432


Q ss_pred             ---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          267 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       267 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                         ......+++.|+|||.+....++.++||||||+++|+|++ |..||......+....+. .+.+...+..+++++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELYE  238 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHHHH
Confidence               2334467889999999988889999999999999999999 699999887766655544 35566677888999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ++.+||..+|.+|||+.++++.|+
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHhhC
Confidence            999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.9e-44  Score=342.90  Aligned_cols=239  Identities=26%  Similarity=0.438  Sum_probs=201.2

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHH-HHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEV-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++.+.  ++.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999874  466999998754221 12223444444 457889999999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            999999976 46788999999999999999999999999999999999999999999999999875332 2334456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+..+++.+.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCHHH
Confidence            99999999999999999999999999999999999999888777666655443  2345678899999999999999999


Q ss_pred             CCCHHHH
Q 015965          355 RPDFSEI  361 (397)
Q Consensus       355 Rps~~el  361 (397)
                      ||++.+.
T Consensus       238 R~~~~~~  244 (325)
T cd05602         238 RLGAKDD  244 (325)
T ss_pred             CCCCCCC
Confidence            9987743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-43  Score=338.68  Aligned_cols=240  Identities=24%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||+|.+.  ++.||||+++.... .......+..|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  46799999886432 12234456677777775 5899999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            999999976 46789999999999999999999999999999999999999999999999999874322 2233455799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  .+..+..++.++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCHhh
Confidence            9999999999999999999999999999999999999888776655544332  34566778899999999999999999


Q ss_pred             CCCHH-HHH
Q 015965          355 RPDFS-EII  362 (397)
Q Consensus       355 Rps~~-ell  362 (397)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05619         238 RLGVKGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9e-44  Score=346.38  Aligned_cols=253  Identities=21%  Similarity=0.310  Sum_probs=211.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||++.+.  ++.+|+|++..... .......+.+|+.+++.++||||+++++.+.....+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            556688999999999999999999874  57799999864322 223345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||++|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            999999999999999875  458999999999999999999999999999999999999999999999999998654432


Q ss_pred             c--ccCCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC--CCCCcH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQP  338 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  338 (397)
                      .  .....||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+........+  +..+++
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence            2  23557999999999986543    788999999999999999999999988877666666554322223  346889


Q ss_pred             HHHHHHHHhchhCCCC--CCCHHHHHHH
Q 015965          339 KLAELLERCWQQDPAL--RPDFSEIIEI  364 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~--Rps~~ell~~  364 (397)
                      .+.+++.+|+..++.+  |+++.++++.
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            9999999999843332  6788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.8e-43  Score=325.03  Aligned_cols=256  Identities=34%  Similarity=0.641  Sum_probs=217.6

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--Cc---ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      +..++|+..+.||+|+||.||+|...  ++   .+|+|.++... .......+.+|+.++++++||||+++++++.....
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45567888999999999999999863  22   58999887543 23345678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      .++||||+++++|.+++....+.+++..+..++.|++.|+.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999998755432


Q ss_pred             Ccc----cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          266 GVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       266 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...    .....++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .......+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHH
Confidence            111    11123567999999988889999999999999999998 999998777655544443 344545566788999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .+++.+||+.+|++||++.++++.|+++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-43  Score=336.08  Aligned_cols=264  Identities=31%  Similarity=0.626  Sum_probs=223.4

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  176 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~  176 (397)
                      ..|++...+|++++.||+|+||.||++.+.+         ..||+|+++... .......+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            4688998999999999999999999997522         258999887542 333457789999999999 79999999


Q ss_pred             eeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 015965          177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  241 (397)
Q Consensus       177 ~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~  241 (397)
                      ++++...+..+++|||+++++|.+++....               ..++...+..++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999997532               24778888999999999999999999999999999


Q ss_pred             cEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015965          242 NLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  317 (397)
Q Consensus       242 Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~  317 (397)
                      ||+++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976543221   122334578999999999999999999999999999998 89999887765


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +.... +.....+..+..++.++.+++.+||+.+|++||++.++++.|+++....
T Consensus       244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 ELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            54443 4444556667788999999999999999999999999999999997544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-43  Score=328.56  Aligned_cols=251  Identities=31%  Similarity=0.573  Sum_probs=206.7

Q ss_pred             ccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceE
Q 015965          116 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  187 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  187 (397)
                      |++.+.||+|+||+||++.+      .++.||+|+++... .......+.+|+.++++++||||+++++++...  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            48889999999999988754      34569999987653 223456788999999999999999999987653  3588


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ++|||+++++|.+++..  ..+++..++.++.|++.|+.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus        85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999999976  4699999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHhhhcCCC
Q 015965          268 ----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--------------QAAVGVVQKGLR  329 (397)
Q Consensus       268 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~--------------~~~~~~~~~~~~  329 (397)
                          .....++..|+|||++.+..++.++||||||+++|+|++|..||......              ............
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence                12234567799999998888999999999999999999999998643221              111112223334


Q ss_pred             CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       330 ~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      +..+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            4456778899999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-43  Score=331.00  Aligned_cols=242  Identities=22%  Similarity=0.373  Sum_probs=199.7

Q ss_pred             eeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||+|+||.||++..  .++.||+|.+....... .....+..|+.++++++||||+++++.+......|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999976  47889999987543322 2234456799999999999999999999999999999999999999


Q ss_pred             HHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCccc
Q 015965          199 YDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW  277 (397)
Q Consensus       199 ~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y  277 (397)
                      .+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.............|+..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            9888653 235889999999999999999999999999999999999999999999999999766554444456799999


Q ss_pred             ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---CCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       278 ~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +|||++.+..++.++|||||||++|+|++|..||...........+......   +.....+++++.+++.+||+.||++
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            9999999888999999999999999999999999765432222222222111   1223467899999999999999999


Q ss_pred             CCCHHHHHH
Q 015965          355 RPDFSEIIE  363 (397)
Q Consensus       355 Rps~~ell~  363 (397)
                      ||++.|+++
T Consensus       241 R~~~~~~~~  249 (277)
T cd05607         241 RLGSREKND  249 (277)
T ss_pred             CCCCccchh
Confidence            999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.2e-44  Score=346.85  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=208.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++..  .++.||||+++.... .......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688899999999999999987  467899999875322 2334567888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||++|++|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986432110    


Q ss_pred             --------------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015965          267 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL  314 (397)
Q Consensus       267 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~  314 (397)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                            012347999999999999999999999999999999999999999988


Q ss_pred             ChHHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHhchhCCCCCCC---HHHHHH
Q 015965          315 TPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPD---FSEIIE  363 (397)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~dp~~Rps---~~ell~  363 (397)
                      ++......+........+|.  .+++++.+++.+|+. ||.+|++   +.++++
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            88777666654332223333  368899999999874 9999985   566554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-43  Score=326.12  Aligned_cols=258  Identities=33%  Similarity=0.624  Sum_probs=220.0

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--Cc----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +...+|++.+.||+|+||.||+|.+.  +.    .+|+|.++.... ......+.+|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45578999999999999999999863  22    489998875533 3445678999999999999999999999987 7


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            89999999999999999988777799999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ....   ....++..|+|||.+....++.++|+||||+++||+++ |..||......+....+ ........+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-EKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHH
Confidence            2211   11223578999999988889999999999999999998 99999988766654443 3444555667788999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+++.+||..||.+||++.++++.|.++.+.
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.3e-43  Score=327.86  Aligned_cols=253  Identities=29%  Similarity=0.576  Sum_probs=214.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEE-------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ++..+|.+.++||+|+||.||++..       .+..+|+|.++..  .......+.+|+.+++.++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4557889999999999999999964       2346888887643  344567899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      ...+++|||+++++|.+++....              ..+++..++.++.||+.|++|||++|++||||||+||++++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997643              2478899999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 015965          250 VVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~  325 (397)
                      .+||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+ .
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-T  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-H
Confidence            999999999875432211   122345788999999998899999999999999999998 99999887766655444 3


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      .+..+..+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            33445566788999999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-43  Score=325.45  Aligned_cols=248  Identities=33%  Similarity=0.617  Sum_probs=207.2

Q ss_pred             ceeeeeCCceEEEEEECC--c--ceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEecc
Q 015965          120 SKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      +.||+|+||.||+|...+  .  .+++|.++... .......+.+|+.+++++ +||||+++++++...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999998743  2  46888877432 334456788999999999 79999999999999999999999999


Q ss_pred             CCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          195 GGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       195 g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                      +++|.+++....               ..+++..+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999997532               24788999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ..............+..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... .....+...+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDD  238 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-HhCCCCCCCCCcCCH
Confidence            63322211122234667999999998899999999999999999997 9999987766554443 334445556677889


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      ++.+++.+||..||.+|||+.+++..|++++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         239 EVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=339.23  Aligned_cols=260  Identities=28%  Similarity=0.559  Sum_probs=222.9

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .-++..+.+.+.++||+|.||.|.++...+ ..||||.++.+. +....++|..|+++|.+|+|||||.++|+|..++.+
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            346777889999999999999999998877 889999999764 455678999999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      |+|||||++|+|.+++.++..+ +......+|+.||+.||+||.+.++|||||.++|+|++.++++||+|||++|..-..
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999999999886433 355567789999999999999999999999999999999999999999999854322


Q ss_pred             Ccc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHhh---hc---CCCCCCCC
Q 015965          266 GVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQAAVGVV---QK---GLRPTIPK  334 (397)
Q Consensus       266 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~P~~~~~~~~~~~~~~---~~---~~~~~~~~  334 (397)
                      ...   ...+-+.+|||||.+..+.++.++|+|+||+++||+++  ...||..++..+.....-   ..   ..-+..|.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            211   12245789999999999999999999999999999865  788999998877655422   11   12345678


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .|+.++.++|.+||..+-.+||+|+++...|++.
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            8999999999999999999999999999888765

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.9e-43  Score=342.16  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------C
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  184 (397)
                      .++|++.+.||+|+||.||++.+  .++.||||++............+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46899999999999999999986  467799999986655555567788999999999999999999987543      3


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+|+||||++ ++|.+++..   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            5799999995 578777743   478899999999999999999999999999999999999999999999999987665


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------  329 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---------------  329 (397)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....++.....               
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            55555678999999999999999999999999999999999999999877765544433321100               


Q ss_pred             -----C--------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 -----P--------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 -----~--------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                           +                    ......+.++.+||.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 0                    011123467899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=339.22  Aligned_cols=251  Identities=18%  Similarity=0.303  Sum_probs=208.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+++..  ++.||+|++.... ........+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999874  6779999987532 22233456888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--c
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--~  268 (397)
                      ||++|++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999987667899999999999999999999999999999999999999999999999999875543322  1


Q ss_pred             cCCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC---CCCCCcHHH
Q 015965          269 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPKNSQPKL  340 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  340 (397)
                      ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+..+....+........   ....+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            23469999999999863     4578899999999999999999999988877666665554332222   223478999


Q ss_pred             HHHHHHhchhCCC--CCCCHHHHHHH
Q 015965          341 AELLERCWQQDPA--LRPDFSEIIEI  364 (397)
Q Consensus       341 ~~ll~~cl~~dp~--~Rps~~ell~~  364 (397)
                      ++++++|+..+++  .|+++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999998865443  37889888755

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-43  Score=341.30  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=205.6

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------C
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  184 (397)
                      .++|++.+.||+|+||.||++.+  .++.||||.+............+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            36899999999999999999976  467899999987655555567788999999999999999999988643      3


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..|+||||++ ++|.+.+..   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        96 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          96 DVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             eeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            4799999995 577776643   488899999999999999999999999999999999999999999999999987665


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  328 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------  328 (397)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..........                
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence            5555667899999999999999999999999999999999999999987664433222211100                


Q ss_pred             ------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          329 ------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       329 ------------------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                                              ....+...+.++.+||.+||..||.+|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                    000112235678999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.4e-43  Score=329.47  Aligned_cols=254  Identities=33%  Similarity=0.595  Sum_probs=212.5

Q ss_pred             CcccccccceeeeeCCceEEEEEECC------------------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV  173 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  173 (397)
                      ...+|++.+.||+|+||.||+++...                  ..||+|.+..... ......+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence            34679999999999999999987632                  3489999886533 3456789999999999999999


Q ss_pred             eeeeeEEecCCceEEEEEeccCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 015965          174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  243 (397)
Q Consensus       174 v~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni  243 (397)
                      +++++++...+..+++|||+++++|.+++....          ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997643          2689999999999999999999999999999999999


Q ss_pred             EeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHH
Q 015965          244 LMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ  318 (397)
Q Consensus       244 li~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~P~~~~~~~~  318 (397)
                      +++.++.++|+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999987543322   1223456788999999988889999999999999999998  788998776655


Q ss_pred             HHHHhhhc------CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          319 AAVGVVQK------GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       319 ~~~~~~~~------~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ........      ......+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            44433221      1112234567789999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-43  Score=339.13  Aligned_cols=237  Identities=22%  Similarity=0.404  Sum_probs=198.1

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++...  ++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  56799999986533 233445677898888776 799999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            999998876 46799999999999999999999999999999999999999999999999999875322 2233456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------PLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      +.|+|||++.+..++.++||||||+++|+|++|..||....        .......... .....+|..++.++.+++.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~  238 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKS  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999995321        1112222222 22345778889999999999


Q ss_pred             hchhCCCCCCCH
Q 015965          347 CWQQDPALRPDF  358 (397)
Q Consensus       347 cl~~dp~~Rps~  358 (397)
                      ||+.||.+||++
T Consensus       239 ~L~~dP~~R~~~  250 (329)
T cd05618         239 FLNKDPKERLGC  250 (329)
T ss_pred             HhcCCHHHcCCC
Confidence            999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-43  Score=330.03  Aligned_cols=255  Identities=27%  Similarity=0.552  Sum_probs=211.0

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC----------------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCee
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS----------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV  174 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  174 (397)
                      +...+|++.++||+|+||.||++...+                ..||+|.++... .......+.+|+.++++++||||+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            345689999999999999999987532                248999988653 344566799999999999999999


Q ss_pred             eeeeEEecCCceEEEEEeccCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 015965          175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  243 (397)
Q Consensus       175 ~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni  243 (397)
                      ++++++...+..++||||+++++|.+++....           ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532           1367888999999999999999999999999999999


Q ss_pred             EeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHH
Q 015965          244 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ  318 (397)
Q Consensus       244 li~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~P~~~~~~~~  318 (397)
                      +++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|+||||+++|+|++  |..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999875433221   122345778999999988889999999999999999988  678988777655


Q ss_pred             HHHHhhh------cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          319 AAVGVVQ------KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       319 ~~~~~~~------~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      .......      .......+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            4443321      11223345567899999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.9e-43  Score=323.10  Aligned_cols=250  Identities=34%  Similarity=0.685  Sum_probs=214.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      -+..++|++.+.||+|+||.||++...++.||+|..+...    ....+.+|+.++++++||||+++++++... ..+++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             cccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            3455789999999999999999999999999999987532    235788999999999999999999998764 47999


Q ss_pred             EEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          190 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |||+++++|.+++.... ..+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++......  .
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~  154 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V  154 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence            99999999999997643 35899999999999999999999999999999999999999999999999998754322  2


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... ...+.++..+..+++.+.+++.+|
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHHHHHHHHH
Confidence            23344678999999998889999999999999999998 9999988876655443 344556666778899999999999


Q ss_pred             chhCCCCCCCHHHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~~  367 (397)
                      |+.+|++||++.++++.|++
T Consensus       234 l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         234 WETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCChhhCcCHHHHHHHHcc
Confidence            99999999999999988763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.4e-43  Score=321.29  Aligned_cols=251  Identities=36%  Similarity=0.712  Sum_probs=214.9

Q ss_pred             CcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++.+|++.+.||.|+||.||++.+. ++.+|+|.++.....   ...+.+|+.++++++||||+++++++......+++|
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            4568899999999999999999875 678999998755433   246889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--c
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--~  268 (397)
                      ||+++++|.+++....+.+++..++.++.|++.|+.|||+.|++||||||+||+++.++.++|+|||.++.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999999987667789999999999999999999999999999999999999999999999999875433211  1


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||........... ...+.++..+...+..+.+++.+|
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHH
Confidence            12235678999999998889999999999999999998 9999987766554444 334445555667889999999999


Q ss_pred             chhCCCCCCCHHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~  366 (397)
                      |+.+|++||++.++++.|+
T Consensus       238 l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         238 WKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             cccChhhCCCHHHHHHhhC
Confidence            9999999999999998773

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6e-43  Score=322.79  Aligned_cols=245  Identities=33%  Similarity=0.641  Sum_probs=212.4

Q ss_pred             ceeeeeCCceEEEEEECC---c--ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          120 SKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~---~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      ++||+|+||.||+|.+..   +  .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...+++|||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998633   2  5899999876544 556789999999999999999999999988 88999999999


Q ss_pred             CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc----cc
Q 015965          195 GGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MT  269 (397)
Q Consensus       195 g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~----~~  269 (397)
                      +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+++.......    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999998754 5789999999999999999999999999999999999999999999999999976544211    12


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........+...+..+.+++.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW  238 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence            3457789999999999899999999999999999998 999998887777665555444455566678899999999999


Q ss_pred             hhCCCCCCCHHHHHHHHH
Q 015965          349 QQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       349 ~~dp~~Rps~~ell~~L~  366 (397)
                      +.+|++||++.++++.|.
T Consensus       239 ~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         239 AHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCcccCCCHHHHHHHhc
Confidence            999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=321.41  Aligned_cols=245  Identities=31%  Similarity=0.596  Sum_probs=208.6

Q ss_pred             ceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          120 SKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      ++||+|+||.||+|.+..     ..+|+|.++..... .....+.+|+.+++.+.||||+++++++.. +..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            479999999999997633     46999998866543 445778999999999999999999998764 56899999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc----cC
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----TA  270 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~----~~  270 (397)
                      +++|.+++... ..+++..++.++.|++.||.|||..|++||||||+||+++.++.+||+|||+++........    ..
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999874 47899999999999999999999999999999999999999999999999999765433211    11


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... .........+..+++.+.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            123568999999998899999999999999999998 9999988876554443 34444556777889999999999999


Q ss_pred             hCCCCCCCHHHHHHHHHHH
Q 015965          350 QDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       350 ~dp~~Rps~~ell~~L~~l  368 (397)
                      .+|++||++.++++.|+++
T Consensus       237 ~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         237 YRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CChhhCcCHHHHHHHHHhc
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-43  Score=342.28  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-----ceE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC  187 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  187 (397)
                      +|++.+.||+|+||.||++..  .++.||||.+..........+.+.+|+.+++.++||||+++++++..+.     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999986  5688999998765444445567889999999999999999999998776     789


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC--
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--  265 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~--  265 (397)
                      +||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            9999995 688888765 467999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-------------------
Q 015965          266 GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------------------  325 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~-------------------  325 (397)
                      .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...++.+....+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            233445789999999998764 478999999999999999999999987766544333221                   


Q ss_pred             ----cCCCC-------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          326 ----KGLRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       326 ----~~~~~-------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                          ....+       ......++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                11111       123446789999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.1e-44  Score=327.55  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=206.2

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--C---ceE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P---SLC  187 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~---~~~  187 (397)
                      .|.-.+++|+|+||.||+|...  ++.||||..-.+..      .-.+|+.+|++++|||||++..+|...  .   .+.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4667789999999999999864  57799998765432      223699999999999999999887532  2   356


Q ss_pred             EEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEcccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKA  263 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~~~~  263 (397)
                      +|||||+ .+|+++++..   +..++.-.+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            8999995 6999999753   5678888899999999999999999999999999999999965 999999999999998


Q ss_pred             cCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-------------
Q 015965          264 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------  329 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-------------  329 (397)
                      .+....++..|..|+|||.+.+ ..|+.+.||||.||++.||+.|++-|.+.+....+..+++--..             
T Consensus       178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            8888888999999999999865 56999999999999999999999999988776665554421100             


Q ss_pred             -----C---------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH--HHHHHHH
Q 015965          330 -----P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQIA  369 (397)
Q Consensus       330 -----~---------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell--~~L~~l~  369 (397)
                           |         -.....++++.+|+.++|..+|.+|.++.|++  ..++++.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                 0         13356789999999999999999999999987  3455543

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7e-43  Score=326.45  Aligned_cols=254  Identities=32%  Similarity=0.594  Sum_probs=213.1

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      +..++|.+.+.||+|+||.||+|.+.+       ..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            344679999999999999999998744       558888876443 233356789999999999999999999999988


Q ss_pred             CceEEEEEeccCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ceEEc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVA  254 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~vkl~  254 (397)
                      ...++||||++|++|.+++....      ..+++..++.++.||+.|+.|||+++++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999997643      2588999999999999999999999999999999999998654   69999


Q ss_pred             ccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCC
Q 015965          255 DFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP  330 (397)
Q Consensus       255 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~  330 (397)
                      |||+++.......   ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+..... ..+....++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCcC
Confidence            9999976532211   112234568999999998889999999999999999997 99999887765544 334444556


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ..+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            677888999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.5e-43  Score=322.31  Aligned_cols=248  Identities=26%  Similarity=0.470  Sum_probs=214.2

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.++||.|+||.||++.+  .++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+...+.+|++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            478889999999999999987  467799999875432 33456788899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-ccC
Q 015965          193 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-~~~  270 (397)
                      +++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.++....... ...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            9999999998754 34589999999999999999999999999999999999999999999999999976544322 234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .+.....+..++..+.+++.+||+.
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhC
Confidence            578999999999999889999999999999999999999998877666555543 3444456777889999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 015965          351 DPALRPDFSEIIEI  364 (397)
Q Consensus       351 dp~~Rps~~ell~~  364 (397)
                      ||++||++.+++..
T Consensus       239 ~P~~Rp~~~~il~~  252 (255)
T cd08219         239 NPRSRPSATTILSR  252 (255)
T ss_pred             CcccCCCHHHHhhc
Confidence            99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3e-43  Score=336.55  Aligned_cols=241  Identities=24%  Similarity=0.414  Sum_probs=206.9

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  190 (397)
                      +|++.+.||+|+||.||++..  .++.||||+++.... .....+.+..|+.+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367789999999999999987  467899999875432 2233456778889988886 577888999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999999876 467999999999999999999999999999999999999999999999999998754322 2233


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....  ...|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcc
Confidence            4569999999999999999999999999999999999999999888777666665543  34667889999999999999


Q ss_pred             hCCCCCCCH
Q 015965          350 QDPALRPDF  358 (397)
Q Consensus       350 ~dp~~Rps~  358 (397)
                      .+|.+|++.
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05615         238 KHPSKRLGC  246 (323)
T ss_pred             cCHhhCCCC
Confidence            999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.5e-43  Score=326.36  Aligned_cols=249  Identities=29%  Similarity=0.487  Sum_probs=208.1

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.+.||+|+||.||+|+.  .++.||+|+++....  .....+.+|+.++++++||||+++++.+......++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            36799999999999999999986  457799999875422  22356788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++..... ....
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999876 467899999999999999999999999999999999999999999999999999765432 2233


Q ss_pred             CCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC---CCCCcHHHHHH
Q 015965          270 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAEL  343 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  343 (397)
                      ...|++.|+|||.+.   ...++.++|+||||+++|+|++|..||....+......+......+..   ...++..+.++
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            457899999999984   445788999999999999999999999766655444333333222221   23467899999


Q ss_pred             HHHhchhCCCCCCCHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~  364 (397)
                      +.+||+.+|++||++.++++.
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcC
Confidence            999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.8e-43  Score=324.73  Aligned_cols=256  Identities=22%  Similarity=0.442  Sum_probs=214.3

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++..  .++.+|||.+.... ........+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999985  56789999876533 23344567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||+++++|.+++...   ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            999999999998642   3568999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....  .+....+......+..+..+++.+.+++
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence            22345789999999999988899999999999999999999999975433  2222222222223333456888999999


Q ss_pred             HHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+||..||++|||+.++++.++++.
T Consensus       242 ~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         242 NMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHhcCCCcccCCCHHHHHHHHhhhc
Confidence            9999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.8e-44  Score=340.49  Aligned_cols=238  Identities=27%  Similarity=0.433  Sum_probs=201.6

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHH-HHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++..  .++.||+|++..... .......+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987  467899999875422 2233345555554 57789999999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            999998876 56799999999999999999999999999999999999999999999999999875322 2334456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+...+..+.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHh
Confidence            99999999999999999999999999999999999999887776666655433  2344568899999999999999999


Q ss_pred             CCCHHH
Q 015965          355 RPDFSE  360 (397)
Q Consensus       355 Rps~~e  360 (397)
                      ||++.+
T Consensus       238 R~~~~~  243 (325)
T cd05604         238 RLGAKE  243 (325)
T ss_pred             cCCCCC
Confidence            998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4e-43  Score=328.86  Aligned_cols=242  Identities=24%  Similarity=0.376  Sum_probs=199.6

Q ss_pred             eeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||+|+||+||++.+  +++.||+|.+...... ......+..|+.+++.++||||+++++++......|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999976  4678999998754332 22345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCCCCC
Q 015965          199 YDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGT  274 (397)
Q Consensus       199 ~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~~gt  274 (397)
                      .+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            9887542   3568999999999999999999999999999999999999999999999999997554332 23345789


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--CCCCCCCCCcHHHHHHHHHhchhCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPKNSQPKLAELLERCWQQDP  352 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ll~~cl~~dp  352 (397)
                      +.|+|||++.+..++.++||||||+++|+|++|+.||................  .....+..+++.+.+++.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            99999999999999999999999999999999999997654322111111111  1234556789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 015965          353 ALRP-----DFSEIIE  363 (397)
Q Consensus       353 ~~Rp-----s~~ell~  363 (397)
                      ++||     ++.++++
T Consensus       241 ~~R~~~~~~~~~~~l~  256 (280)
T cd05608         241 EKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHhcCCCCCCHHHHhc
Confidence            9999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-43  Score=339.28  Aligned_cols=251  Identities=18%  Similarity=0.323  Sum_probs=210.0

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+++..  ++.||+|++.... ........+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46899999999999999999874  5679999987532 22333456888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc--
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~--  268 (397)
                      ||++||+|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            999999999999876678999999999999999999999999999999999999999999999999999765443222  


Q ss_pred             cCCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC---CCCcHHH
Q 015965          269 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKL  340 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  340 (397)
                      ....||+.|+|||++.+     ..++.++||||||+++|+|++|+.||...+..+....+.....+...+   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            23569999999999875     468889999999999999999999999888777666665544333333   3468999


Q ss_pred             HHHHHHhchhCCCC--CCCHHHHHHH
Q 015965          341 AELLERCWQQDPAL--RPDFSEIIEI  364 (397)
Q Consensus       341 ~~ll~~cl~~dp~~--Rps~~ell~~  364 (397)
                      .+++.+|+..++++  |+++.++++.
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcC
Confidence            99999999866544  4578877643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.3e-43  Score=327.90  Aligned_cols=248  Identities=22%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      |+..+.||+|+||+||++.+  +++.+|+|.+....... .....+.+|+.+++.++|+||+.+++.+...+..|++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999987  46789999987653322 2345578899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          193 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            99999999886543 46999999999999999999999999999999999999999999999999999765443334456


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--CCCCCCCCCCcHHHHHHHHHhch
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+...  ......+..+++++.+|+.+||+
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT  241 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence            7999999999999889999999999999999999999999877654433332221  11234556788999999999999


Q ss_pred             hCCCCCCC-----HHHHHH
Q 015965          350 QDPALRPD-----FSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps-----~~ell~  363 (397)
                      .||.+||+     +.+++.
T Consensus       242 ~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         242 KDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHhHcCCCcccChHHHHc
Confidence            99999999     555543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-42  Score=319.97  Aligned_cols=249  Identities=24%  Similarity=0.456  Sum_probs=217.3

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||.|+||.||.++.  .++.+++|.+.....+......+.+|+.++++++|+||+++++++.....++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999998887765  567799999876655566667889999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          193 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      +++++|.+++... ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.+||+|||+++...... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            9999999999764 3568999999999999999999999999999999999999999999999999997654433 2344


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..... +..+..++.++.+++.+||..
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCccccCHHHHHHHHHHccc
Confidence            5789999999999888899999999999999999999999988777666666554433 344567889999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 015965          351 DPALRPDFSEIIEI  364 (397)
Q Consensus       351 dp~~Rps~~ell~~  364 (397)
                      +|.+||++.++++.
T Consensus       240 ~p~~R~s~~~ll~~  253 (256)
T cd08221         240 DPEKRPTADEVLDQ  253 (256)
T ss_pred             CcccCCCHHHHhhC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-42  Score=325.14  Aligned_cols=254  Identities=30%  Similarity=0.562  Sum_probs=208.8

Q ss_pred             cccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~  184 (397)
                      ..+|++.+.||+|+||.||++.+      .+..||+|.++..  .....+.+.+|+.++++++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            35788999999999999999875      3567999998754  34445778999999999999999999998754  34


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            68999999999999999987667799999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc----cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHHHhhh
Q 015965          265 SGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------------QAAVGVVQ  325 (397)
Q Consensus       265 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---------------~~~~~~~~  325 (397)
                      ....    ....++..|+|||++.+..++.++||||||+++|||++|..|+......               ......+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3211    1122345699999999888999999999999999999987776432211               01112233


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .......+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            3444455677889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-42  Score=320.92  Aligned_cols=254  Identities=35%  Similarity=0.667  Sum_probs=216.4

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      |++..++|++.++||+|+||.||++.+. +..+|+|.++...   .....+.+|+.++++++|+||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            6788899999999999999999999864 4569999887532   234678899999999999999999999887 7789


Q ss_pred             EEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++|||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764 3457888999999999999999999999999999999999999999999999997654322


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....++..|+|||++....++.++|+||||+++|+|++ |..||...+.......+ ........+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCCHHHHHH
Confidence            1  122345678999999998889999999999999999998 99999887765554433 3444445567788999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      +.+||+.+|++||++.++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-42  Score=321.72  Aligned_cols=248  Identities=30%  Similarity=0.579  Sum_probs=212.1

Q ss_pred             cccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCC----hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +|++.+.||.|+||.||+|.. .++.+|+|.++.....    ......+.+|+.++++++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999976 5677999998754322    22345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC----
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----  265 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~----  265 (397)
                      |||++|++|.+++.+ .+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......    
T Consensus        81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999976 467899999999999999999999999999999999999999999999999998754221    


Q ss_pred             ---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CCCCCCCCCCcHHHH
Q 015965          266 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIPKNSQPKLA  341 (397)
Q Consensus       266 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  341 (397)
                         .......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... ...+..+..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence               1223446899999999999988999999999999999999999999877765554443332 345567778899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++.+||+.+|.+||++.+++.
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-42  Score=326.45  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=211.0

Q ss_pred             cccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--C
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~  184 (397)
                      ...|++.+.||+|+||.||++++      .+..||+|.++... .......+.+|+.++++++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            34578999999999999999874      35679999987553 233456799999999999999999999998775  5


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||++|++|.+++.+....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            68999999999999999977555789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHHHhhhc
Q 015965          265 SGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--------------TPLQAAVGVVQK  326 (397)
Q Consensus       265 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~--------------~~~~~~~~~~~~  326 (397)
                      ...    .....++..|+|||++.+..++.++||||||+++|+|++++.|+...              ............
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            321    12345677899999998888999999999999999999987664221              111122222333


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       327 ~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ..+...+..+++.+.+|+.+||+.||++||++.++++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            444555677899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-42  Score=321.67  Aligned_cols=247  Identities=32%  Similarity=0.610  Sum_probs=212.4

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-------HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      +|.+.+.||.|+||.||+|..  .++.+|+|.+.......       ...+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999986  45789999887543321       233568889999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      .+++|||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            9999999999999999976 467899999999999999999999999999999999999999999999999998765422


Q ss_pred             C-------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          266 G-------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       266 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      .       ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+. ....+..+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS  238 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCH
Confidence            1       1123458899999999998889999999999999999999999999877666554433 3456677788899


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+.+++.+||+.||++||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhh
Confidence            9999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.7e-43  Score=338.11  Aligned_cols=251  Identities=18%  Similarity=0.315  Sum_probs=210.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.++||+|+||.||++...  ++.+|+|++..... .......+.+|+.++..++|+||+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36889999999999999999874  46699999864321 2233455888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--c
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  268 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--~  268 (397)
                      ||+++|+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999987667899999999999999999999999999999999999999999999999999875433322  2


Q ss_pred             cCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC---CCCCcHHH
Q 015965          269 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKL  340 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  340 (397)
                      ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.....+...   ...+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2357999999999985     346889999999999999999999999988887777776654433333   34678999


Q ss_pred             HHHHHHhchhCCCC--CCCHHHHHHH
Q 015965          341 AELLERCWQQDPAL--RPDFSEIIEI  364 (397)
Q Consensus       341 ~~ll~~cl~~dp~~--Rps~~ell~~  364 (397)
                      .+++.+|+..++++  |+++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCC
Confidence            99999999655444  6889988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.6e-43  Score=328.74  Aligned_cols=247  Identities=24%  Similarity=0.407  Sum_probs=207.7

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      |++.+.||+|+||.||++.+  .++.||+|.+...... ......+.+|+.++++++|+||+.+++.+...+..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999987  4678999998754332 22345577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          193 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      ++|++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR  161 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence            9999999998653 246899999999999999999999999999999999999999999999999999765544444455


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      .|+..|+|||++.+..++.++||||||+++|+|++|..||......   ....... .......+..+++++.+|+.+||
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHHHHh
Confidence            7999999999999999999999999999999999999999865432   2222222 22233456678899999999999


Q ss_pred             hhCCCCCCC-----HHHHHH
Q 015965          349 QQDPALRPD-----FSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps-----~~ell~  363 (397)
                      +.||++|||     +.++++
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCHHHccCCCCCchHHHHc
Confidence            999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-43  Score=328.55  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=200.7

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC---CCCCeeeeeeEEec-----CC
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK-----PP  184 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~  184 (397)
                      +|++.+.||+|+||.||+|.+  +++.||+|.++...........+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            478889999999999999987  467799999876533332233455677766655   69999999998764     24


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..+++|||++ ++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            5799999996 58999887643 458999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----------------
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------  327 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~----------------  327 (397)
                      .........||..|+|||++.+..++.++|||||||++|+|++|.+||...........+....                
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            5444455678999999999998899999999999999999999999998776654443332210                


Q ss_pred             --CCC-------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 --LRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 --~~~-------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                        ..+       .....++.++.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              000       011346788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-42  Score=321.28  Aligned_cols=256  Identities=23%  Similarity=0.472  Sum_probs=215.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||.|+||.||+|..  .++.||+|.++.... .......+.+|+.++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4688999999999999999987  478899999875333 3344677899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++...... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999998643   3458999999999999999999999999999999999999999999999999987554322 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCCCCCCCC-CCcHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPK-NSQPKLAELL  344 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~l~~ll  344 (397)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..........+..+..+. .++..+.+++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            22345688999999999988899999999999999999999999965432 112222223333344444 7888999999


Q ss_pred             HHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+||..+|++||++.++++.|+++.
T Consensus       242 ~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHcCCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-43  Score=338.03  Aligned_cols=237  Identities=26%  Similarity=0.429  Sum_probs=200.8

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHH-HHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEV-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      ++||+|+||.||++++  .++.||+|++..... .......+.+|+ .+++.++||||+++++.+.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  457799999875432 222334455555 468889999999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            999998876 46789999999999999999999999999999999999999999999999999875322 2334455799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++...+.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            9999999999999999999999999999999999999888776666555543  34566778899999999999999999


Q ss_pred             CCCHH
Q 015965          355 RPDFS  359 (397)
Q Consensus       355 Rps~~  359 (397)
                      ||++.
T Consensus       238 R~~~~  242 (321)
T cd05603         238 RLGAK  242 (321)
T ss_pred             cCCCC
Confidence            99764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-42  Score=326.78  Aligned_cols=255  Identities=31%  Similarity=0.593  Sum_probs=214.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ++.++|++.+.||.|+||.||++...       +..||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            45578999999999999999999863       4679999987543 344457799999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhcc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLK---------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      ...+++|||+++++|.+++....                     ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                     246788899999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~  318 (397)
                      |+++.++.++|+|||+++......   .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999987543221   1122345678999999998899999999999999999998 889998877766


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      ....+. .+.....+..++.++.+++.+||+.||.+|||+.|+++.|++
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            555433 333344566788999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-43  Score=336.18  Aligned_cols=237  Identities=22%  Similarity=0.390  Sum_probs=199.7

Q ss_pred             ceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||++...  ++.||+|+++..... ......+.+|+.++.++ +||||+++++.+...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  567999999865432 23456688899999888 599999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc-cCCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-~~~~~~~~~gt  274 (397)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            999998876 4679999999999999999999999999999999999999999999999999987532 22334456799


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL------TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      +.|+|||++.+..++.++||||||+++|+|++|..||...      ...+........ ....+|..++..+.+++.+||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L  238 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHVLKGFL  238 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999632      222233332222 234467788999999999999


Q ss_pred             hhCCCCCCCH
Q 015965          349 QQDPALRPDF  358 (397)
Q Consensus       349 ~~dp~~Rps~  358 (397)
                      +.||.+|+++
T Consensus       239 ~~dP~~R~~~  248 (327)
T cd05617         239 NKDPKERLGC  248 (327)
T ss_pred             ccCHHHcCCC
Confidence            9999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-42  Score=319.58  Aligned_cols=249  Identities=32%  Similarity=0.591  Sum_probs=206.9

Q ss_pred             ceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe-cCCceEEEEEec
Q 015965          120 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLCIVTEFM  193 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~E~~  193 (397)
                      +.||+|+||.||+|.+.     ...+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999863     2359999876432 3344567889999999999999999999775 455689999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-----cc
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VM  268 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-----~~  268 (397)
                      .+++|.+++......+++..+..++.|++.|+.|||+.+++||||||+|||++.++.+||+|||+++......     ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            9999999998766667888889999999999999999999999999999999999999999999987543221     11


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+.... +..+..+..+..+++.+.+++.+|
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-LLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHHH
Confidence            23345778999999988889999999999999999999 5778877766554443 334445555667889999999999


Q ss_pred             chhCCCCCCCHHHHHHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      |..+|++||++.++++.|++++.
T Consensus       239 l~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         239 WHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             cCCChhhCCCHHHHHHHHHHHhc
Confidence            99999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-43  Score=342.07  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=197.4

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +....|++.+.||+|+||.||++.+  .++.||+|...        ...+.+|+.++++++||||+++++++......++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            4557899999999999999999987  46779999744        2346789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC--C
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--G  266 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~--~  266 (397)
                      |||++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       161 v~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        161 ILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            99999 5789998876 457899999999999999999999999999999999999999999999999999753322  2


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHhh---------------
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVV---------------  324 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-------~~~~~~~~---------------  324 (397)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||-....       ......+.               
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            23345799999999999999999999999999999999999987643210       00000000               


Q ss_pred             -----------hcCC-CCC-CC-----CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          325 -----------QKGL-RPT-IP-----KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       325 -----------~~~~-~~~-~~-----~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                 .... .+. .+     ...+.++.+||.+||+.||.+|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                       0000 000 00     124668999999999999999999999974

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-42  Score=316.83  Aligned_cols=245  Identities=35%  Similarity=0.666  Sum_probs=210.0

Q ss_pred             ceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          120 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ++||+|+||.||+|... ++.+|+|+++... .......+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999763 5669999987553 334445788999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc--cCCCCCcc
Q 015965          199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--TAETGTYR  276 (397)
Q Consensus       199 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~--~~~~gt~~  276 (397)
                      .+++......+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.........  ....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            9999876667899999999999999999999999999999999999999999999999998754332211  12234677


Q ss_pred             cccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       277 y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      |+|||++.+..++.++||||||+++|+|++ |..||........... .....+...+..++..+.+++.+||+.+|++|
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            999999998889999999999999999998 9999988876655544 34455666677889999999999999999999


Q ss_pred             CCHHHHHHHHH
Q 015965          356 PDFSEIIEILQ  366 (397)
Q Consensus       356 ps~~ell~~L~  366 (397)
                      |++.++++.|.
T Consensus       239 p~~~~l~~~l~  249 (250)
T cd05085         239 PKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHhc
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=353.13  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=217.5

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEE-ec
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC-TK  182 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~  182 (397)
                      ..+++..-++++.+.|.+|+|+.||++...+  ..||+|.+-..  +....+.+.+||.+|++|. |+|||.+++.. ..
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            4578888999999999999999999998743  68999988755  6667888999999999998 99999999932 21


Q ss_pred             C------CceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCceEE
Q 015965          183 P------PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKV  253 (397)
Q Consensus       183 ~------~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~vkl  253 (397)
                      .      ..++|.||||.||+|-|++.++ ...|++..+++|+.|+++|+.+||...  |||||||-+||||+.+|++||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence            1      2367999999999999999854 456999999999999999999999998  999999999999999999999


Q ss_pred             cccccccccccCCcc----------cCCCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015965          254 ADFGVARVKAQSGVM----------TAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA  320 (397)
Q Consensus       254 ~DfG~a~~~~~~~~~----------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~  320 (397)
                      ||||.+......-..          ....-|+.|+|||++   .+.+.+.|+|||+|||+||.|+....||+.....   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            999999754432211          112469999999997   5778999999999999999999999999876443   


Q ss_pred             HHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                       .|+...+..+.....+..|.+||+.||+.||++||++.+++..+..+.+
T Consensus       265 -aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 -AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence             3344444434446788999999999999999999999999999988854

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.4e-43  Score=330.88  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=205.3

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|.+.++||+|+||.||+|..  .++.||+|.++..... .....+.+|+.++++++||||+++++++..++..|+||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            36799999999999999999986  4567999998755322 22345778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ....
T Consensus        84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            9996 5899988876667899999999999999999999999999999999999999999999999999754332 2233


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---------------------
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------------------  327 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~---------------------  327 (397)
                      ...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+...-                     
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            4568999999999865 568899999999999999999999998776544333222110                     


Q ss_pred             CCC-------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 LRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ~~~-------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ...       .....+++++.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000       011346789999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-42  Score=327.01  Aligned_cols=254  Identities=29%  Similarity=0.557  Sum_probs=209.1

Q ss_pred             cccccccceeeeeCCceEEEEEECC------------------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCee
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV  174 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  174 (397)
                      .++|++.++||+|+||.||++.+.+                  ..+|+|+++... .......+.+|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4679999999999999999985432                  248999987543 334457799999999999999999


Q ss_pred             eeeeEEecCCceEEEEEeccCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 015965          175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  244 (397)
Q Consensus       175 ~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  244 (397)
                      ++++++...+..+++|||+++++|.+++....          ..+++..+..++.||+.|++|||++||+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999997642          23677889999999999999999999999999999999


Q ss_pred             eCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 015965          245 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQA  319 (397)
Q Consensus       245 i~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~P~~~~~~~~~  319 (397)
                      ++.++.++|+|||+++.......   .....+++.|+|||+..+..++.++|+||||+++|||++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999875433221   122334678999999888889999999999999999998  7899987766554


Q ss_pred             HHHhhh------cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          320 AVGVVQ------KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       320 ~~~~~~------~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      ......      .......+..+++.+.+++.+||+.||++||++.++++.|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            433211      111223456678999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=320.56  Aligned_cols=248  Identities=32%  Similarity=0.541  Sum_probs=213.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|+||.||++..  .++.+++|++.....  ...+.+.+|+.++++++||||+++++.+.....+|++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            5788999999999999999987  456799999875532  245778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            999999999998765789999999999999999999999999999999999999999999999999987654332 2344


Q ss_pred             CCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC---CCCCCcHHHHHHH
Q 015965          271 ETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPKNSQPKLAELL  344 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ll  344 (397)
                      ..++..|+|||++.+.   .++.++|+||||+++|+|++|..||...++.+...........+.   .+...+.++.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI  240 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence            5788999999999776   889999999999999999999999988776666555444433222   2334578899999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||..+|.+|||+.+++.
T Consensus       241 ~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         241 KKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHcCCChhhCCCHHHHhc
Confidence            9999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-43  Score=363.11  Aligned_cols=253  Identities=22%  Similarity=0.426  Sum_probs=211.5

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~  185 (397)
                      +....+|+++++||+|+||+||++.+.  ++.||+|++............+.+|+.++++++|||||+++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445578999999999999999999874  4669999998766666667789999999999999999999998854  356


Q ss_pred             eEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCcEEeCC--------
Q 015965          186 LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-------NIIHRDLKAANLLMDE--------  247 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~-------~iiHrDlkp~Nili~~--------  247 (397)
                      +||||||+++++|.+++...   .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999753   35799999999999999999999985       4999999999999964        


Q ss_pred             ---------CCceEEcccccccccccCCcccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015965          248 ---------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTP  316 (397)
Q Consensus       248 ---------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~  316 (397)
                               .+.+||+|||+++............||+.|+|||++.+  ..++.++|||||||+||+|++|..||.....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                     23599999999987655444455679999999999854  4588999999999999999999999987766


Q ss_pred             HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .......+..... ......++++.+||.+||..+|.+||++.+++.
T Consensus       249 ~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        249 FSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            5555554444322 122456889999999999999999999999984

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-43  Score=325.86  Aligned_cols=247  Identities=33%  Similarity=0.612  Sum_probs=207.5

Q ss_pred             ccccceeeeeCCceEEEEEECCc--ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |++++.||+|+||+||++...+.  .||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            67889999999999999998654  5999999977544444445567999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc-ccCCcccCCC
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK-AQSGVMTAET  272 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~-~~~~~~~~~~  272 (397)
                      ++++|.+++.. ...+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999984 578899999999999999999999999999999999999999999999999999753 3334455678


Q ss_pred             CCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhhcCCCC--CCCCCCcHHHHHHHHH
Q 015965          273 GTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRP--TIPKNSQPKLAELLER  346 (397)
Q Consensus       273 gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~l~~ll~~  346 (397)
                      +++.|+|||++. +..++.++|+||||+++|+|++|..||......   .............  ......++++.+++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 888999999999999999999999999987322   2222222211111  1112234899999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||++||++.++++
T Consensus       240 ~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HSSSSGGGSTTHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-42  Score=317.57  Aligned_cols=248  Identities=33%  Similarity=0.589  Sum_probs=215.9

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC---ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +|+..+.||+|+||.||+|..  .++.|++|.+.....   .....+.+.+|+.+++.++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            366778999999999999987  467899998865432   234557789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      |||+++++|.+++.. .+.+++..+..++.||+.|+.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            999999999999976 3568999999999999999999999999999999999999999999999999997665444445


Q ss_pred             CCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          270 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ...|+..|+|||.+.... ++.++|+||||+++|+|++|..||......+...........+.++..+++.+.+++.+||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            567899999999987776 8999999999999999999999998877666665555444566677788999999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      +.+|++||++.+++.
T Consensus       240 ~~~p~~Rp~~~~~l~  254 (258)
T cd06632         240 QRDPSLRPTAAELLE  254 (258)
T ss_pred             hcCcccCcCHHHHhc
Confidence            999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-42  Score=316.76  Aligned_cols=248  Identities=27%  Similarity=0.489  Sum_probs=212.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-CCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~E  191 (397)
                      .|++.+.||+|++|.||++..  .++.||+|.+............+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            478899999999999999976  45679999987665555556778999999999999999999998764 446799999


Q ss_pred             eccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          192 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      |+++++|.+++... ...+++..++.++.|++.|+.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            99999999999764 345899999999999999999999999999999999999999999999999999765432 2233


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .+..+..+...++++.+++.+||+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhc
Confidence            4568999999999999999999999999999999999999998777655544433 334455667889999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++||++.+++.
T Consensus       240 ~~p~~Rp~~~~~l~  253 (257)
T cd08223         240 KRPEKRPSVKSILR  253 (257)
T ss_pred             cCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.5e-42  Score=317.12  Aligned_cols=248  Identities=25%  Similarity=0.453  Sum_probs=216.0

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||.|+||.||++..  .++.+|+|.+............+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999876  567799999987655556677899999999999999999999999988999999999


Q ss_pred             ccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEcccccccccccCCcccC
Q 015965          193 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      +++++|.+++.... ..+++..+..++.|++.++.|||++|++|+||+|+||+++.+ +.++|+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            99999999998753 458999999999999999999999999999999999999865 4689999999987655444445


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ....++..+++++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-TFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCCCCcCHHHHHHHHHHccC
Confidence            67899999999999888999999999999999999999999887766655554443 34456677899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      +|.+|||+.+++.
T Consensus       240 ~p~~Rpt~~~ll~  252 (256)
T cd08220         240 DPSKRPQLSQIMA  252 (256)
T ss_pred             ChhhCCCHHHHhh
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.7e-42  Score=323.31  Aligned_cols=249  Identities=27%  Similarity=0.485  Sum_probs=210.9

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .+.|++.++||.|+||.||+|+..  ++.+++|++...  .......+.+|+.+++.++||||+++++.+..+...|+||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            367999999999999999999874  577999998754  3445677889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||+++++|..++.+....+++..+..++.|++.++.|||+.|++||||||+||+++.++.++|+|||++...... ....
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            999999999988776678999999999999999999999999999999999999999999999999998653322 2233


Q ss_pred             CCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHH
Q 015965          270 AETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAEL  343 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  343 (397)
                      ...+++.|+|||++.     ...++.++|+||||+++|+|++|..||...++.+.......... ....+..++.++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            456889999999984     34578899999999999999999999988776655544432221 122345678899999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+||+.||++||++.++++
T Consensus       249 i~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         249 LKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHhcCCcccCcCHHHHhc
Confidence            99999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=326.22  Aligned_cols=245  Identities=25%  Similarity=0.424  Sum_probs=217.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECCc--ceEEEEecCCCCC-hHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERIN-SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  185 (397)
                      .+...+|.++.+||+|+||.|.++...+.  .+|||+++++... .+..+--..|-++|.... -|.+++++..++..++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            56778999999999999999999988764  5999999987542 233344455777777664 6899999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+||||+.||+|.-.+++ -+++.++.+..++.+|+.||-+||++|||+||||.+|||++.+|+|||+|||+++...-.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999999987 588999999999999999999999999999999999999999999999999999865444


Q ss_pred             C-cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          266 G-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       266 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      + ...+.+|||.|+|||++..++|+.++|+||+|++||||+.|++||++.+..+....++....  ..|+.++.+..++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ic  581 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAIC  581 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHH
Confidence            3 45578999999999999999999999999999999999999999999999888888887754  47899999999999


Q ss_pred             HHhchhCCCCCCC
Q 015965          345 ERCWQQDPALRPD  357 (397)
Q Consensus       345 ~~cl~~dp~~Rps  357 (397)
                      ...|.++|.+|..
T Consensus       582 kg~ltK~P~kRLG  594 (683)
T KOG0696|consen  582 KGLLTKHPGKRLG  594 (683)
T ss_pred             HHHhhcCCccccC
Confidence            9999999999963

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-42  Score=315.73  Aligned_cols=245  Identities=35%  Similarity=0.683  Sum_probs=210.2

Q ss_pred             ceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          120 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ++||.|+||.||++.+. ++.||+|.++..... .....+.+|+.++++++||||+++++++......++||||++|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            46999999999999875 788999998765433 4457799999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc---cCCCCCc
Q 015965          199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTY  275 (397)
Q Consensus       199 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~  275 (397)
                      .+++......++...+..++.+++.++.|||++|++||||+|+||+++.++.++|+|||+++........   ....++.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            9999776667899999999999999999999999999999999999999999999999999755422111   1123356


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      .|+|||.+.+..++.++|+||||+++|+|++ |..||........... .........+..++.++.+++.+||..+|.+
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence            7999999988889999999999999999999 8999988776554443 3333455567788999999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 015965          355 RPDFSEIIEILQ  366 (397)
Q Consensus       355 Rps~~ell~~L~  366 (397)
                      ||++.++++.|+
T Consensus       239 Rp~~~ell~~l~  250 (251)
T cd05041         239 RPSFSEIYNELQ  250 (251)
T ss_pred             CcCHHHHHHHhh
Confidence            999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-42  Score=325.75  Aligned_cols=258  Identities=31%  Similarity=0.625  Sum_probs=216.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCc----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +...+|+..+.||+|+||.||+|.+  .+.    .+|+|.+.... ......++.+|+.+++.++||||+++++.+... 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4457788999999999999999986  333    47888887543 233345688999999999999999999998754 


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++++||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            57799999999999999987666789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...   .....++..|+|||++.+..++.++||||||+++|||++ |..||......+ ..........+..+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHH
Confidence            221   122345778999999999999999999999999999997 999998765443 344455555556667788999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+++.+||..+|++||++.++++.|.++.+.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=322.55  Aligned_cols=247  Identities=30%  Similarity=0.521  Sum_probs=211.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|+||.||++.+.  +..+|+|+++..  .......+.+|+.++++++||||+++++.+..+...|+|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            56899999999999999999874  677999998744  34445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |+++++|.+++.+....+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++...... .....
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            99999999999876678999999999999999999999999999999999999999999999999988654332 22334


Q ss_pred             CCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHHHHH
Q 015965          271 ETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAEL  343 (397)
Q Consensus       271 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l  343 (397)
                      ..+++.|+|||++.     ...++.++|+||||+++|+|++|..||...+..+....+.. ...+  ..+..++.++.++
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-CCCCCcCCcccCCHHHHHH
Confidence            56899999999974     44578899999999999999999999988877665555433 2222  2355678999999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+||+.+|.+||++.++++
T Consensus       242 i~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHhccChhhCcCHHHHhc
Confidence            99999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=347.22  Aligned_cols=241  Identities=30%  Similarity=0.554  Sum_probs=211.0

Q ss_pred             eeeeeCCceEEEEEECCc--ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          121 KVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      +||+|.||+||-|++...  ..|||.+...  +.....-+.+||.+.++|+|.|||+++|.+.+++.+-|.||.++||||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            699999999999987554  4788877633  333456688999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEcccccccccccC-CcccCCCCC
Q 015965          199 YDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQS-GVMTAETGT  274 (397)
Q Consensus       199 ~~~l~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~~-~~~~~~~gt  274 (397)
                      .+.|+..-|++  .+..+..+.+||+.||.|||.+.|||||||-+||||+ ..|.+||+|||.++....- ....+++||
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            99999888888  7889999999999999999999999999999999997 5799999999999765543 345577999


Q ss_pred             cccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          275 YRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       275 ~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      ..|||||++..+  .|..++|||||||++.||.||++||-.+...++++ ++-.-...|++|..++.+.+.+|.+|+.+|
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd  819 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD  819 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence            999999999654  58999999999999999999999998877666654 333334578999999999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 015965          352 PALRPDFSEIIE  363 (397)
Q Consensus       352 p~~Rps~~ell~  363 (397)
                      |..||+|.+++.
T Consensus       820 ~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  820 PCDRPSAKDLLQ  831 (1226)
T ss_pred             cccCccHHHhcc
Confidence            999999999863

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.2e-42  Score=317.01  Aligned_cols=248  Identities=25%  Similarity=0.468  Sum_probs=214.8

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVT  190 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  190 (397)
                      +|++.+.||.|+||.||++..  .++.+|+|+++...........+.+|+.++++++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999976  45779999998765556666778999999999999999999997754  45679999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH-----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH-----~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ||+++++|.+++...   ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999764   467899999999999999999999     899999999999999999999999999999876


Q ss_pred             ccCCc-ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          263 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       263 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..... ........+..+...+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH-HHHhcCCCCCCccccCHHHH
Confidence            55433 34457899999999999888999999999999999999999999887754443 33444555567778899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++.+||+.+|++||++.++++
T Consensus       240 ~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHccCCcccCCCHHHHhh
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.3e-42  Score=322.66  Aligned_cols=248  Identities=26%  Similarity=0.389  Sum_probs=204.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||+|+.  .++.||||.++...........+.+|+.++++++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            478889999999999999987  467899999876544444456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          193 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       193 ~~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ++ ++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            96 68988886543  56899999999999999999999999999999999999999999999999998754432 2233


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--------------------
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------------  328 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--------------------  328 (397)
                      ...+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.............                    
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            4567899999998865 4578899999999999999999999987665443332221100                    


Q ss_pred             -------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 -------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 -------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                             .......+++++.++|.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   00112347889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-42  Score=322.37  Aligned_cols=255  Identities=31%  Similarity=0.619  Sum_probs=214.5

Q ss_pred             cccccccceeeeeCCceEEEEEEC------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~  184 (397)
                      ..+|++.+.||+|+||.||++.+.      +..+|||+++..... .....+.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            357888899999999999999864      467999999865443 346779999999999999999999999877  55


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..+++|||+++++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            78999999999999999987666799999999999999999999999999999999999999999999999999986653


Q ss_pred             CCcc----cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHhhhc
Q 015965          265 SGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGVVQK  326 (397)
Q Consensus       265 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--------------~~~~~~~~~~  326 (397)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++|..|+.....              .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2211    122456679999999888899999999999999999999999865322              1122233344


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       327 ~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ..+...+..++.++.+++.+||+.+|++||++.+++++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            444455667889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.1e-42  Score=317.35  Aligned_cols=248  Identities=29%  Similarity=0.528  Sum_probs=210.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC---ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  186 (397)
                      .+|++.+.||+|+||.||++..  .++.||||.+.....   .....+.+.+|+.++++++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788999999999999999986  457799998864322   123456788999999999999999999988763  457


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      +++|||++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999998763 56889999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                         .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||..................+..|...+..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               12334568999999999988889999999999999999999999998877666665555444456677778889999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+||. +|++||++.+++.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhc
Confidence            9999995 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.7e-42  Score=320.39  Aligned_cols=248  Identities=29%  Similarity=0.508  Sum_probs=208.0

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.+.||+|+||.||+|.+  .++.||+|+++...  ......+.+|+.+++.++||||+++++.+...+..|++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            35789999999999999999987  46789999987653  223456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||+++++|.+++.. .+.+++..++.++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++...... ....
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99999999999876 567999999999999999999999999999999999999999999999999998654332 2234


Q ss_pred             CCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC---CCCCcHHHHHH
Q 015965          270 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAEL  343 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  343 (397)
                      ...|++.|+|||++.   ...++.++|+|||||++|+|++|..||....+.............+..   ...++..+.++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            457899999999974   456889999999999999999999999766655444433333322221   12467889999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+||..+|++||++.++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHccCCchhCcCHHHHhc
Confidence            99999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.7e-42  Score=319.45  Aligned_cols=247  Identities=31%  Similarity=0.522  Sum_probs=207.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecC------C
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP------P  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~  184 (397)
                      +.|++.+.||.|+||.||+|..  .++.||+|++.....   ....+.+|+.+++++ +||||+++++.+...      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4688889999999999999987  456799999875432   235678899999998 699999999998653      4


Q ss_pred             ceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      .+|++|||+++++|.+++... ...+++..+..++.|++.|+.|||+++|+||||||+||++++++.++|+|||+++...
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            589999999999999999864 3468999999999999999999999999999999999999999999999999997644


Q ss_pred             cC-CcccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          264 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       264 ~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      .. .......|++.|+|||++.     +..++.++||||||+++|+|++|..||....+............+...+..++
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence            32 2334557899999999985     34688899999999999999999999987776665555444444444456678


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .++.+|+.+||..||.+|||+.++++
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            99999999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=310.74  Aligned_cols=254  Identities=28%  Similarity=0.493  Sum_probs=221.8

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecC
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP  183 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  183 (397)
                      ..+..+.++++++..||+|+.|.|++..+..  ...|||.+.... +....++++..+.++.+.. +|+||+.+|+|..+
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            3455667888999999999999999998865  779999998765 4555677888888877665 89999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ..+++.||.| +.-+..++....+++++..+-++...++.||.||..+ ||||||+||+|||+|+.|+||+||||.+...
T Consensus       164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence            9999999999 6788888888889999999999999999999999865 9999999999999999999999999999998


Q ss_pred             ccCCcccCCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhhcCCCCCCCC--CC
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPK--NS  336 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~-~~~~~~~~~~~~~~~~~~~~--~~  336 (397)
                      .++...+...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.+- +..+....++. ...|.++.  .+
T Consensus       243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gF  321 (391)
T KOG0983|consen  243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGF  321 (391)
T ss_pred             ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCc
Confidence            88888889999999999999954   36889999999999999999999999874 55666666665 34455543  37


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+.+|+..||++|+.+||.+.++++
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            999999999999999999999999975

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-42  Score=334.82  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--  183 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  183 (397)
                      .|++ +++|++.+.||+|+||.||++.+  .++.||||+++...........+.+|+.++++++||||+++++++...  
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            3444 36899999999999999999976  456799999876544434456688999999999999999999887543  


Q ss_pred             ----CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          184 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       184 ----~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                          ...|++|+++ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                3478999998 8899988754  56999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------  328 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------  328 (397)
                      +....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....          
T Consensus       166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            76543  2345678999999999876 5689999999999999999999999987665444333221100          


Q ss_pred             -----------CCCC--------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 -----------RPTI--------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 -----------~~~~--------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                 .+..        ....++.+.+|+.+||..||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       0001        1235677899999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.2e-42  Score=319.84  Aligned_cols=254  Identities=27%  Similarity=0.544  Sum_probs=214.5

Q ss_pred             CcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ..++|++.+.||+|+||.||+|+..       .+.+++|.+.... .......+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            3467889999999999999999863       3569999876532 2334677999999999999999999999999988


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                      ..|+||||+++++|.+++....        ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999997643        15899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCC
Q 015965          257 GVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIP  333 (397)
Q Consensus       257 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~  333 (397)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....................+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9986433221  2223356778999999988889999999999999999999 899998777666555544444444456


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ..++..+.+++.+||+.+|.+||++.+++..|.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            678899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.2e-42  Score=320.98  Aligned_cols=242  Identities=29%  Similarity=0.493  Sum_probs=202.3

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||+|.+  .++.||+|++.... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            578889999999999999986  56779999987543 344456799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  272 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  272 (397)
                      +++++|..+     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence            999999754     34688899999999999999999999999999999999999999999999999755432 234567


Q ss_pred             CCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHhhhcCCCCC-CCCCCcHHHHHHH
Q 015965          273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-------QAAVGVVQKGLRPT-IPKNSQPKLAELL  344 (397)
Q Consensus       273 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~l~~ll  344 (397)
                      ||..|+|||++.+..++.++|+||||+++|+|++|..||......       +....+... ..+. .....++++.+++
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-DPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-CCCCCCCCcCCHHHHHHH
Confidence            999999999999989999999999999999999999999653221       111111111 1222 2345778999999


Q ss_pred             HHhchhCCCCCCCHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~  364 (397)
                      .+||+.+|++||++.++++.
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcC
Confidence            99999999999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-42  Score=318.53  Aligned_cols=238  Identities=27%  Similarity=0.505  Sum_probs=195.8

Q ss_pred             ceeeeeCCceEEEEEECC--------------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          120 SKVASGSYGDLYRGTYCS--------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      +.||+|+||.||+|++..              ..|++|++...  ..+....+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999998532              24888887654  23445678899999999999999999999999899


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc-------eEEccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-------VKVADFGV  258 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~-------vkl~DfG~  258 (397)
                      .+++|||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.       ++++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999998876677999999999999999999999999999999999999987664       89999999


Q ss_pred             ccccccCCcccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          259 ARVKAQSGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       259 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell-~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      +.....   .....++..|+|||++. +..++.++||||||+++|+|+ .|..||......+.. .......  ......
T Consensus       159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~--~~~~~~  232 (262)
T cd05077         159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC--MLVTPS  232 (262)
T ss_pred             CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc--cCCCCC
Confidence            864432   23446788999999986 567899999999999999998 589998766543332 2122211  223334


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                      ++++.+++.+||+.||++||++.++++.|
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            67899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=339.82  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=226.2

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .|.-++.||.|+||.||-+.+  +.+.||||.+....- +.....+++.|+..|++++|||++.+-|.|..+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466778999999999999976  457799999987654 34567889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      || -||-.|.+.-.+.++.+-.+..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|....+.   .++
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsF  182 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSF  182 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcc
Confidence            99 67999999888889999999999999999999999999999999999999999999999999999876654   578


Q ss_pred             CCCccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          272 TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       272 ~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      +|||.|||||++   ..+.|+-++||||||++..||.-.++|+-.++...+.+.+.+...+.-.....+..++.|+..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            999999999997   45679999999999999999999999999999999999988876544445678899999999999


Q ss_pred             hhCCCCCCCHHHHHH-----------HHHHHHHHhc
Q 015965          349 QQDPALRPDFSEIIE-----------ILQQIAKEVG  373 (397)
Q Consensus       349 ~~dp~~Rps~~ell~-----------~L~~l~~~~~  373 (397)
                      ++=|.+|||..+++.           .|.+++++.+
T Consensus       263 qKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTK  298 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTK  298 (948)
T ss_pred             hhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHH
Confidence            999999999999873           4556655544

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9e-42  Score=317.49  Aligned_cols=245  Identities=28%  Similarity=0.511  Sum_probs=198.0

Q ss_pred             ceeeeeCCceEEEEEECC----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||+|.+.+    ..+|+|.++.... ......+.+|+.++++++||||+++++.+.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            468999999999998643    4589998876543 23345788999999999999999999999998899999999999


Q ss_pred             CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---c
Q 015965          196 GSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M  268 (397)
Q Consensus       196 ~sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~  268 (397)
                      ++|.+++....    ...++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            99999997532    2456677889999999999999999999999999999999999999999999975433221   1


Q ss_pred             cCCCCCcccccccccCCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC-C---CCCCCCCC
Q 015965          269 TAETGTYRWMAPEVIEHK-------PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG-L---RPTIPKNS  336 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~-~---~~~~~~~~  336 (397)
                      ....++..|+|||++.+.       .++.++|+||||+++|||++ |..||....+.+......... .   .+......
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            234578889999998642       35789999999999999996 999998877665443322221 1   23333456


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ++.+.+++.+|| .+|++|||+.+|+..|+
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            788999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.6e-42  Score=329.60  Aligned_cols=251  Identities=22%  Similarity=0.410  Sum_probs=202.4

Q ss_pred             ccceeeee--CCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          118 FGSKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       118 ~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      ++++||+|  +||+||++..  +++.||+|.++...........+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  6789999976  4678999999876555555667888999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC------
Q 015965          194 SGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------  266 (397)
Q Consensus       194 ~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~------  266 (397)
                      ++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+........+      
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            999999999754 3458999999999999999999999999999999999999999999999998654322111      


Q ss_pred             --cccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-------------
Q 015965          267 --VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------  329 (397)
Q Consensus       267 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-------------  329 (397)
                        ......++..|+|||++.+  ..++.++|||||||++|+|++|..||......+...........             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              1122356788999999976  46899999999999999999999999876554433322211100             


Q ss_pred             -------------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 015965          330 -------------------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       330 -------------------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l  368 (397)
                                                     ......+++.+.+|+.+||+.||++|||+.++++  .++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                           0011235678999999999999999999999986  35544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.1e-42  Score=318.05  Aligned_cols=245  Identities=30%  Similarity=0.547  Sum_probs=199.2

Q ss_pred             ceeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      ++||+|+||.||+|...    ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            36999999999999752    2357888766432 334456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---c
Q 015965          196 GSVYDYLHKLKG----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M  268 (397)
Q Consensus       196 ~sL~~~l~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~  268 (397)
                      ++|.+++.....    ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999999976432    346778899999999999999999999999999999999999999999999865433221   1


Q ss_pred             cCCCCCcccccccccC-------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCC----CCCCCCCC
Q 015965          269 TAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL----RPTIPKNS  336 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~----~~~~~~~~  336 (397)
                      ....++..|+|||++.       ...++.++||||||+++|+|++ |..||....+.+..........    .+..+..+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY  239 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence            2234577899999974       3457889999999999999999 8999988877665555444322    23345567


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ++.+.+++..|| .||++||++.++++.|.
T Consensus       240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         240 SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            889999999999 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.8e-42  Score=317.79  Aligned_cols=248  Identities=29%  Similarity=0.505  Sum_probs=210.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC---hHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  186 (397)
                      .+|++.+.||+|+||.||++..  .+..||+|.+......   ......+.+|+.+++.++||||+++++.+..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688889999999999999986  4678999988754322   2344668899999999999999999998865  3567


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      +++|||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||+++..... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            899999999999999976 456899999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+...........+.++..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence               11223468899999999999889999999999999999999999998877766666555555567777788899999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++ +||..+|++||++.++++
T Consensus       241 li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhc
Confidence            99 688889999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-42  Score=319.37  Aligned_cols=246  Identities=33%  Similarity=0.554  Sum_probs=212.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|+||.||+|..  .++.||+|++.... .......+.+|+.+++.++|+||+++++.+..+..+|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            3688889999999999999987  45779999987653 23345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |+++++|.+++..  ..+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||+++..... .....
T Consensus        80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            9999999999976  37899999999999999999999999999999999999999999999999999766543 23345


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCC-CcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN-SQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~cl~  349 (397)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|..||...++......+ .....+..+.. +++++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-PKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-hhcCCCCCcccccCHHHHHHHHHHhh
Confidence            57889999999999888999999999999999999999999877765554433 33344445545 88999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .+|++||++.+++.
T Consensus       237 ~~p~~Rpt~~~il~  250 (274)
T cd06609         237 KDPKERPSAKELLK  250 (274)
T ss_pred             CChhhCcCHHHHhh
Confidence            99999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.3e-42  Score=314.60  Aligned_cols=248  Identities=41%  Similarity=0.761  Sum_probs=213.2

Q ss_pred             ccccceeeeeCCceEEEEEECC------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +++.+.||.|+||.||++.+..      ..||+|.++.... ......+.+|+.+++.++|+||+++++.+...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3567899999999999998864      6799999976533 22467899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          190 TEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |||+++++|.+++...... +++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||+++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999999865444 899999999999999999999999999999999999999999999999999765543222


Q ss_pred             c--CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          269 T--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       269 ~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                      .  ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+. ....+..+..++.++.+++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence            1  2236789999999988889999999999999999998 899998877666555543 34455666778999999999


Q ss_pred             HhchhCCCCCCCHHHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~~L  365 (397)
                      +||..||++|||+.++++.|
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      239 QCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHCcCChhhCcCHHHHHhhC
Confidence            99999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.9e-42  Score=356.48  Aligned_cols=258  Identities=21%  Similarity=0.375  Sum_probs=210.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .+|++.++||+|+||.||+|.+  .++.||||+++.... .....+.+.+|+.++++++||||+++++++.+.+..|++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5789999999999999999987  467899999976543 2344567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          191 EFMSGGSVYDYLHKL----------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       191 E~~~g~sL~~~l~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      ||++|++|.+++...          ....+...++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999998642          1235567788999999999999999999999999999999999999999999997


Q ss_pred             ccccCC-------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015965          261 VKAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV  321 (397)
Q Consensus       261 ~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~  321 (397)
                      ......                   .....+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            552110                   1112469999999999999999999999999999999999999998755433222


Q ss_pred             Hh-hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCC-CHHHHHHHHHHHHHH
Q 015965          322 GV-VQKGLRPTIPKNSQPKLAELLERCWQQDPALRP-DFSEIIEILQQIAKE  371 (397)
Q Consensus       322 ~~-~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rp-s~~ell~~L~~l~~~  371 (397)
                      .. ............+++.+.+++.+||+.||++|| ++.++++.|+..++.
T Consensus       242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            21 111111112246788999999999999999996 677788888887664

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-42  Score=322.61  Aligned_cols=244  Identities=27%  Similarity=0.464  Sum_probs=212.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++.+  .++.+|+|+++.... .......+.+|+.++++++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            3688899999999999999987  467899999875432 2234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence            99999999999987 467999999999999999999999999999999999999999999999999999765443  344


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..  ..+.++...++.+++++.+||..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCccCCccCCHHHHHHHHHHccC
Confidence            5789999999999888899999999999999999999999988776555554442  24456777899999999999999


Q ss_pred             CCCCCC-----CHHHHH
Q 015965          351 DPALRP-----DFSEII  362 (397)
Q Consensus       351 dp~~Rp-----s~~ell  362 (397)
                      ||.+|+     ++.+++
T Consensus       236 ~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         236 DLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CHHHccCcccCCHHHHH
Confidence            999999     677775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-42  Score=315.81  Aligned_cols=246  Identities=32%  Similarity=0.548  Sum_probs=211.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|...  ++.+++|.++...    ....+.+|+.++++++||||+++++.+......|+++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            67899999999999999999875  5779999987442    15779999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+++++|.+++......+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            999999999998767789999999999999999999999999999999999999999999999999987654432 2334


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..++..|+|||++.+..++.++||||||+++|+|++|..||....+.+....+..... ....+..++.++.+++.+||+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV  238 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence            4688999999999998999999999999999999999999987766554433322111 112344567899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.++++
T Consensus       239 ~~P~~Rps~~~il~  252 (256)
T cd06612         239 KDPEERPSAIQLLQ  252 (256)
T ss_pred             cChhhCcCHHHHhc
Confidence            99999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.5e-42  Score=319.50  Aligned_cols=247  Identities=28%  Similarity=0.501  Sum_probs=209.0

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      .|++.+.||.|+||.||+|.+.  +..+++|.+...  .......+.+|+.+++.++||||+++++.+......++||||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            3678899999999999999874  456888887643  334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~  271 (397)
                      +++++|..++......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            9999999988766678999999999999999999999999999999999999999999999999998654332 223345


Q ss_pred             CCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHH
Q 015965          272 TGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLE  345 (397)
Q Consensus       272 ~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~  345 (397)
                      .++..|+|||++.     +..++.++|+||||+++|+|++|..||...++.+.......... ....+..++.++.+++.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            6899999999983     45678899999999999999999999988877666555443221 22345668899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+||++.++++
T Consensus       244 ~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-42  Score=319.85  Aligned_cols=237  Identities=27%  Similarity=0.482  Sum_probs=195.5

Q ss_pred             eeeeeCCceEEEEEECC--------------------------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCee
Q 015965          121 KVASGSYGDLYRGTYCS--------------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV  174 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~~~--------------------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  174 (397)
                      .||+|+||.||+|....                          ..|++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            69999999999986411                          23888888643  233456788999999999999999


Q ss_pred             eeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-----
Q 015965          175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----  249 (397)
Q Consensus       175 ~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-----  249 (397)
                      ++++++...+..++||||+++++|..++....+.+++..+..++.||+.||+|||++||+||||||+||+++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999987677899999999999999999999999999999999999997644     


Q ss_pred             --ceEEcccccccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHhhh
Q 015965          250 --VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       250 --~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell-~g~~P~~~~~~~~~~~~~~~  325 (397)
                        .+|++|||++.....   .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+... ...
T Consensus       160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE  235 (274)
T ss_pred             cceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence              489999998854322   123457888999998865 56899999999999999995 6999998776654322 222


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                      ..  ...+...++.+.+++.+||+.+|++||++.++++.|
T Consensus       236 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         236 KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            22  223444567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9e-42  Score=322.32  Aligned_cols=246  Identities=27%  Similarity=0.503  Sum_probs=209.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .+|++.+.||+|+||.||+|..  .++.||+|.+......  ....+.+|+.+++.++||||+++++.+......|+|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            5788999999999999999986  4678999998765432  24668899999999999999999999999899999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |++|++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            9999999999865  468899999999999999999999999999999999999999999999999987544322 2234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..|++.|+|||.+.+..++.++||||||+++|+|++|..||....+............ ....+..+++.+.+++.+||.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence            5789999999999988899999999999999999999999987776544433332221 122355678899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++||++.+++.
T Consensus       256 ~~p~~Rpt~~eil~  269 (296)
T cd06654         256 MDVEKRGSAKELLQ  269 (296)
T ss_pred             CCcccCcCHHHHhh
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.3e-42  Score=314.65  Aligned_cols=248  Identities=24%  Similarity=0.481  Sum_probs=215.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||++..  .++.||+|.+............+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999876  567899999876544455567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-ccC
Q 015965          193 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-~~~  270 (397)
                      +++++|.+++.... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            99999999997643 3688999999999999999999999999999999999999999999999999976543322 223


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. .+..+..+..++.++.+++.+||+.
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence            468899999999998889999999999999999999999998777666555544 3445556778899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      +|.+||++.++++
T Consensus       240 ~p~~Rp~~~~vl~  252 (256)
T cd08218         240 NPRDRPSVNSILE  252 (256)
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-43  Score=309.26  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=219.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC------ChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCC
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  184 (397)
                      ..|...+.||.|..+.|.++..  .++.+|+|++.....      .....+.-.+|+.||+++. ||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4567778999999999988754  678899998864321      1234556778999999985 999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+++|+|.|+.|.|.|+|.. .-.+++....+++.|++.|++|||.++||||||||+|||++++-++||+|||++.....
T Consensus        97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999987 56799999999999999999999999999999999999999999999999999999888


Q ss_pred             CCcccCCCCCcccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCC
Q 015965          265 SGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNS  336 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~  336 (397)
                      +......+|||+|.|||.+.      ...|+...|+|++|++||.|+.|.+||-.....-+...+++...  +.+-..+.
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            88888999999999999985      34688899999999999999999999976655555555555543  33445678


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK  370 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l~~  370 (397)
                      +...++||.+||+.||.+|.|++|.|.  .+..+..
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            899999999999999999999999984  3544443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=338.99  Aligned_cols=243  Identities=28%  Similarity=0.432  Sum_probs=203.6

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-C-----CCeeeeeeEEecCCce
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-H-----KNVVQFIGACTKPPSL  186 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~  186 (397)
                      +|.+.+.||+|+||.|.++.+  +++.||||+++..   .....+-..|+.+|..++ |     -|+|+++++|...+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            789999999999999999987  4678999999964   444566777999999997 4     4899999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC--CceEEcccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKA  263 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~--~~vkl~DfG~a~~~~  263 (397)
                      |||+|.+ +.+|++++...+ ..++...++.|+.||+.||.+||+.||||+||||+|||+..-  ..|||+|||.|....
T Consensus       264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            9999999 789999998653 469999999999999999999999999999999999999753  479999999998766


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-----------------
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-----------------  326 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~-----------------  326 (397)
                      +.-.  .++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+....+++-                 
T Consensus       343 q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  343 QRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             Ccce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            5432  788999999999999999999999999999999999999999877655444332210                 


Q ss_pred             ---------------------------------CCCCCCC-----------CCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          327 ---------------------------------GLRPTIP-----------KNSQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       327 ---------------------------------~~~~~~~-----------~~~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                                                       ......|           ......+.+++.+||..||.+|+|+.+.+
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence                                             0000011           12345689999999999999999999987


Q ss_pred             H
Q 015965          363 E  363 (397)
Q Consensus       363 ~  363 (397)
                      +
T Consensus       501 ~  501 (586)
T KOG0667|consen  501 N  501 (586)
T ss_pred             c
Confidence            4

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.2e-42  Score=322.80  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|.+.++||.|+||.||+|.+.  ++.||+|.++..... .....+.+|+.++++++||||+++++++..+...|+||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            367999999999999999999874  577999998754322 22345778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-ccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~  269 (397)
                      ||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            9995 69999998766778999999999999999999999999999999999999999999999999997544322 233


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--------------------
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------------  328 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--------------------  328 (397)
                      ...+++.|+|||++.+ ..++.++||||||+++|+|++|++||...+..+....+...-.                    
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            4567899999999865 4578899999999999999999999987765443322211000                    


Q ss_pred             CC--------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 RP--------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ~~--------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+        .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00        011356789999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-41  Score=313.94  Aligned_cols=248  Identities=30%  Similarity=0.544  Sum_probs=210.3

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||+|..  .++.|++|.++.........+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            478889999999999999986  567899999987655545678899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc----
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----  268 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~----  268 (397)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........    
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999976 356889999999999999999999999999999999999999999999999999765443221    


Q ss_pred             -cCCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCC--cHHHHH
Q 015965          269 -TAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--QPKLAE  342 (397)
Q Consensus       269 -~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~  342 (397)
                       ....+++.|+|||++.+..   ++.++||||||+++|+|++|..||..................+..|...  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             2346789999999998766   8899999999999999999999997664333222222224444555544  899999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+||+.+|.+||++.+++.
T Consensus       240 li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhc
Confidence            999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-41  Score=316.18  Aligned_cols=252  Identities=24%  Similarity=0.476  Sum_probs=214.1

Q ss_pred             cccccceeeeeCCceEEEEEECC---cceEEEEecCCC--------CChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEec
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPER--------INSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTK  182 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  182 (397)
                      .|++.+.||+|+||.||+|.+.+   +.+|+|.+....        .......++.+|+.++.+ ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999998754   679999876432        122344567789988875 799999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      .+..+++|||++|++|.+++..   ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998854   24568999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       259 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      +.............|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+......+.....+++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            98765554445667899999999999888999999999999999999999999877766666555554444444446789


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      ++.+++.+||+.||++||++.++.+++.
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            9999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.9e-42  Score=319.14  Aligned_cols=247  Identities=30%  Similarity=0.532  Sum_probs=202.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHH-HhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++.+  +++.||||.++....... ...+..|+.+ ++.++||||+++++++...+..|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            3688899999999999999987  467899999886543333 3445556554 67778999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ||++ ++|.+++...   ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9995 6888887642   34689999999999999999999997 99999999999999999999999999998655443


Q ss_pred             cccCCCCCcccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCCCCCCC-CCCcHHH
Q 015965          267 VMTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRPTIP-KNSQPKL  340 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~l  340 (397)
                      ......|+..|+|||++.+    ..++.++|+||||+++|+|++|..||.... ..+....... ...+..+ ..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  237 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEF  237 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHH
Confidence            3344578999999999864    457889999999999999999999997543 3344434333 2233333 4578999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++.+||..+|++||++.++++
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.3e-42  Score=319.63  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=205.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888999999999999999874  6789999987554333334568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+++++|..++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            9998888777654 4578999999999999999999999999999999999999999999999999997655433 2334


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-------------------C-C
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------L-R  329 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-------------------~-~  329 (397)
                      ..++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+....                   . .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            568899999999865 557889999999999999999999998877655443322100                   0 0


Q ss_pred             CC---------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ~~---------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +.         .....+..+.+|+.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00         01245788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.4e-42  Score=318.27  Aligned_cols=247  Identities=31%  Similarity=0.528  Sum_probs=210.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|+||.||++...  ++.+|+|.+..... ......+.+|+.++++++||||+++++.+......++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            35788899999999999999885  67899999876543 3456778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      |+++++|.+++......+++..+..++.|++.|+.|||+ .|++|+||||+||+++.++.++|+|||.+......... .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~  158 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-T  158 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-c
Confidence            999999999998766789999999999999999999999 99999999999999999999999999998755433222 2


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHhhhcCCCCCCCCC-CcHHHHHHH
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT-----PLQAAVGVVQKGLRPTIPKN-SQPKLAELL  344 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll  344 (397)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||....     ..+...... ....+..+.. +++++.++|
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li  237 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQDFV  237 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHHHHH
Confidence            678999999999999999999999999999999999999997542     222222222 2234444444 888999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||..||++|||+.+++.
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         238 NLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHcCCCchhCcCHHHHhh
Confidence            9999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-41  Score=316.92  Aligned_cols=247  Identities=33%  Similarity=0.581  Sum_probs=213.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ..|+..++||.|+||.||+|.+  .++.||+|+++.... ......+.+|+.++++++||||+++++.+.+....|+|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            3577889999999999999986  467899999875432 3445778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |++|++|.+++..  +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            9999999999865  568999999999999999999999999999999999999999999999999997654332 2233


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|..||...++...... ......+..+..++..+.+++.+||+.
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHHHccc
Confidence            4678899999999988899999999999999999999999988776655443 333445566677889999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 015965          351 DPALRPDFSEIIEI  364 (397)
Q Consensus       351 dp~~Rps~~ell~~  364 (397)
                      +|++||++.+++..
T Consensus       240 ~p~~Rp~~~~il~~  253 (277)
T cd06640         240 DPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCcCHHHHHhC
Confidence            99999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-42  Score=320.97  Aligned_cols=250  Identities=29%  Similarity=0.500  Sum_probs=209.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +..++|++.+.||+|+||.||++.+.  ++.||+|++.... .....+.+.+|+.+++.++||||+++++.+...+.+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            45578999999999999999999875  6789999887543 23446778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||||+++++|.+++.+ .+.+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++...... .
T Consensus        81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-I  158 (284)
T ss_pred             EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-c
Confidence            9999999999999876 4678999999999999999999997 59999999999999999999999999998654322 2


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHhhhcCCCCCCCC-C
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-----------QAAVGVVQKGLRPTIPK-N  335 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-----------~~~~~~~~~~~~~~~~~-~  335 (397)
                      .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......           +....+.. ...+.++. .
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSD  237 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchh
Confidence            23457899999999998888999999999999999999999999865442           11222222 11223333 3


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                      ++.++.+|+.+||+.||++||++.++++.
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            77899999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=334.26  Aligned_cols=240  Identities=23%  Similarity=0.365  Sum_probs=197.2

Q ss_pred             eeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC---CCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          122 VASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       122 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      ||+|+||+||+|..  .++.||||++..... .......+..|..++...   +||||+++++.+.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999987  467899999864322 222334455677777655   699999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt  274 (397)
                      ++|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            999999876 56799999999999999999999999999999999999999999999999999875332 2333456799


Q ss_pred             cccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCC
Q 015965          275 YRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA  353 (397)
Q Consensus       275 ~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~  353 (397)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....+ .....+++++.+++.+||+.||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCCHH
Confidence            999999998654 5899999999999999999999999887776665554433322 12235789999999999999999


Q ss_pred             CCC----CHHHHHH
Q 015965          354 LRP----DFSEIIE  363 (397)
Q Consensus       354 ~Rp----s~~ell~  363 (397)
                      +||    ++.++++
T Consensus       239 ~R~~~~~~~~~ll~  252 (330)
T cd05586         239 HRLGAHRDAVELKE  252 (330)
T ss_pred             HCCCCCCCHHHHhc
Confidence            998    4555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-41  Score=323.07  Aligned_cols=248  Identities=24%  Similarity=0.422  Sum_probs=205.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++.+.  +..+|+|.++... .......+.+|+.++++++||||+++++.+..++.+|+|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            36889999999999999999874  5668999887542 34445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      |++|++|.+++.+ .+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ....
T Consensus        80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~  157 (308)
T cd06615          80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  157 (308)
T ss_pred             ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence            9999999999987 3678999999999999999999997 59999999999999999999999999998754332 2344


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--------------------------
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--------------------------  324 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~--------------------------  324 (397)
                      ..|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.........                          
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            578999999999988889999999999999999999999996544322211110                          


Q ss_pred             ---------hcCCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          325 ---------QKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       325 ---------~~~~~~~~~-~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                               .....+..+ ..++.++++++.+||..||++||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     001112222 2367889999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.3e-42  Score=320.11  Aligned_cols=248  Identities=26%  Similarity=0.465  Sum_probs=208.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||+|.++... .......+.+|+.++++++||||+++++.+..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            36889999999999999999874  6789999887542 33445678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |+++++|..++...  ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++...... ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence            99999999988763  2378999999999999999999997 59999999999999999999999999998755332 23


Q ss_pred             cCCCCCcccccccccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--hhhcCCCCCCCCCCcHHH
Q 015965          269 TAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG--VVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l  340 (397)
                      ....+++.|+|||++.+.      .++.++|+||||+++|+|++|..||...........  .......+..+..+++++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            345688899999998544      357899999999999999999999976544332221  122334456677789999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++.+||+.+|++||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhc
Confidence            99999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-41  Score=316.73  Aligned_cols=246  Identities=38%  Similarity=0.681  Sum_probs=206.7

Q ss_pred             ceeeeeCCceEEEEEECC--------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          120 SKVASGSYGDLYRGTYCS--------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.||+|+||.||+|+...        +.+|||.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998643        468999876542 22335678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-----ceEEccccccc
Q 015965          192 FMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKVADFGVAR  260 (397)
Q Consensus       192 ~~~g~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-----~vkl~DfG~a~  260 (397)
                      |+++++|.+++...      ...+++..+..++.|++.|+.|||+++++|+||||+||+++.++     .++|+|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999999753      23478899999999999999999999999999999999999877     89999999987


Q ss_pred             ccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          261 VKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       261 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      ......   ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ........+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENC  238 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccCCcccc
Confidence            543221   1122345788999999998899999999999999999998 99999887766554443 334455666778


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      ++.+.+++.+||..+|.+||++.++++.|++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            9999999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=323.56  Aligned_cols=250  Identities=22%  Similarity=0.349  Sum_probs=212.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh-HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++...  ++.||+|.+....... .....+.+|+.+++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999874  5789999988654432 34567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC---
Q 015965          191 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~---  266 (397)
                      ||+.|++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......   
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764 3568999999999999999999999999999999999999999999999999986433211   


Q ss_pred             ---------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015965          267 ---------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA  319 (397)
Q Consensus       267 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~  319 (397)
                                                 ......||..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       01123688999999999988899999999999999999999999988887766


Q ss_pred             HHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCC----HHHHHH
Q 015965          320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD----FSEIIE  363 (397)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps----~~ell~  363 (397)
                      ...+.............++.+.+++.+||..||++||+    +.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            66665544333333347899999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.1e-41  Score=313.74  Aligned_cols=248  Identities=34%  Similarity=0.569  Sum_probs=211.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|+||+||+|..  .+..+|+|++....... ....+.+|+.+++.++|+||+++++.+......+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4688999999999999999986  45679999987654433 46779999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--
Q 015965          192 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  267 (397)
Q Consensus       192 ~~~g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--  267 (397)
                      ++++++|.+++...  ...+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++........  
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999999764  25689999999999999999999999999999999999999999999999999876554322  


Q ss_pred             ---ccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC-----CCCcH
Q 015965          268 ---MTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-----KNSQP  338 (397)
Q Consensus       268 ---~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  338 (397)
                         .....|+..|+|||++... .++.++|+||||+++|+|++|..||...++.+.......... +..+     ..+++
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGADYKKYSK  238 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcCCccccccccH
Confidence               2334689999999998766 789999999999999999999999988777665555544321 1111     25678


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+.+++.+||..||++||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhh
Confidence            9999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-41  Score=339.08  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=195.2

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC------CCeeeeeeEEe
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACT  181 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~  181 (397)
                      ++...+|++.++||+|+||.||+|.+  .++.||||+++...   .....+..|+.+++.++|      ++++++++++.
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34457899999999999999999987  45679999987432   223445567777766654      56889998887


Q ss_pred             cC-CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCC----------
Q 015965          182 KP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE----------  249 (397)
Q Consensus       182 ~~-~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~----------  249 (397)
                      .+ .++|+|||++ |++|.+++.+ .+.+++..+..++.||+.||+|||+ .|||||||||+|||++.++          
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            64 5789999998 8899999876 4679999999999999999999998 5999999999999998765          


Q ss_pred             ------ceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 015965          250 ------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV  323 (397)
Q Consensus       250 ------~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~  323 (397)
                            .+||+|||.+....  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+....+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                  49999999885432  2344568999999999999999999999999999999999999999877654433222


Q ss_pred             hhcC-------------------------CCCCC---------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          324 VQKG-------------------------LRPTI---------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       324 ~~~~-------------------------~~~~~---------------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ....                         +++..               .....+.+.+||.+||..||++|||+.|+++
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            1100                         00000               0012456789999999999999999999986

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-41  Score=314.22  Aligned_cols=236  Identities=26%  Similarity=0.499  Sum_probs=195.7

Q ss_pred             ceeeeeCCceEEEEEECCcc------------eEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          120 SKVASGSYGDLYRGTYCSQD------------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~------------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +.||+|+||.||+|.+.+..            +++|+++.....   ...+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999885433            777876644221   5778899999999999999999999988 7789


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-------ceEEccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-------VVKVADFGVAR  260 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-------~vkl~DfG~a~  260 (397)
                      +||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++       .+||+|||+++
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999999987655789999999999999999999999999999999999999887       79999999997


Q ss_pred             ccccCCcccCCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      ....   .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...+..+...... ..  ...+....
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~--~~~~~~~~  230 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQ--HRLPMPDC  230 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cC--CCCCCCCc
Confidence            6443   2334567889999999776  78999999999999999999 688887775433322222 21  12222334


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                      ..+.+++.+||..+|.+||++.++++.|
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            7899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-41  Score=317.73  Aligned_cols=252  Identities=32%  Similarity=0.578  Sum_probs=213.7

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|+..+.||+|+||.||+|.+  .++.||+|+++.... ......+.+|+.++++++||||+++++.+...+..|+|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            3577788999999999999976  456799999875432 3345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+++++|.+++..  +.+++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++....... ....
T Consensus        83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            9999999998864  578999999999999999999999999999999999999999999999999997654332 2223


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..|+..|+|||++.+..++.++|+||||+++|+|++|..||....+...... ......+..+..++.++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            4688999999999998999999999999999999999999987665554433 333344556667889999999999999


Q ss_pred             CCCCCCCHHHHHH--HHHHHH
Q 015965          351 DPALRPDFSEIIE--ILQQIA  369 (397)
Q Consensus       351 dp~~Rps~~ell~--~L~~l~  369 (397)
                      +|++||++.+++.  .+....
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         240 DPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             CcccCcCHHHHHHhHHHHHHh
Confidence            9999999999987  444443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.9e-42  Score=321.54  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||+|.+  .++.||+|.++...........+.+|+.++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            478889999999999999987  467899999876544333345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~  271 (397)
                      ++ ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++..... ......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence            95 6898888776678999999999999999999999999999999999999999999999999999754432 223345


Q ss_pred             CCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHhhhc------------------CCCC-
Q 015965          272 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQK------------------GLRP-  330 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~-~~~~~~~~~~~~~~------------------~~~~-  330 (397)
                      .+++.|+|||++.+. .++.++||||||+++|+|++|..||. ..+..+....+...                  ...+ 
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07839         160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM  239 (284)
T ss_pred             ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence            678999999998664 47899999999999999999888853 33332222211110                  0000 


Q ss_pred             --------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 --------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                              .....+++++.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                    112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-41  Score=314.00  Aligned_cols=252  Identities=30%  Similarity=0.560  Sum_probs=209.4

Q ss_pred             ccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          116 LKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      |++.+.||+|+||.||+|.+.     ++.||||+++.........+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753     467999999876656666778999999999999999999999886532      


Q ss_pred             ceEEEEEeccCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                      ..++++||+.+++|.+++...     ...++...+..++.|++.|++|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            247889999999999887532     124788899999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCC
Q 015965          260 RVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN  335 (397)
Q Consensus       260 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  335 (397)
                      +......   ......+++.|++||.+....++.++||||||+++|+|++ |..||...+..+....+. .......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  239 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD  239 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence            7553322   1123345678999999998889999999999999999999 899998777655444333 3333344566


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .++.+.+++.+||+.+|++||++.++++.|+++
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            789999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-42  Score=317.56  Aligned_cols=238  Identities=26%  Similarity=0.494  Sum_probs=198.2

Q ss_pred             ceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          120 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      +.||+|+||.||+|....         ..+|+|.+...  .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999997632         34888887543  2334567889999999999999999999999989999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc--------eEEccccccccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VKVADFGVARVK  262 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~--------vkl~DfG~a~~~  262 (397)
                      ||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.        ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999999876667899999999999999999999999999999999999987664        699999998654


Q ss_pred             ccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ..   .....++..|+|||++.+ ..++.++||||||+++|+|++| .+||...++..... ....  +...|...+.++
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~  232 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQLPAPKWTEL  232 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccCCCCCcHHH
Confidence            32   234568889999999976 4588999999999999999998 57776665544322 2222  345666677899


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                      .+++.+||+.||++|||+.++++.|
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHhc
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=338.89  Aligned_cols=247  Identities=29%  Similarity=0.519  Sum_probs=215.2

Q ss_pred             cccccceeeeeCCceEEEEEECCc--ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      -|.|+..||.|+||.||++.....  -.|-|++...  +......++-||.||..++||+||+++++|..++.++|+.||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            466778899999999999976533  2566776543  455678899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc-cccCCcccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~-~~~~~~~~~~  271 (397)
                      |.||-++..+-.....++++++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||++-. ...-....++
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence            999999999988889999999999999999999999999999999999999999999999999998742 3333445678


Q ss_pred             CCCccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHH
Q 015965          272 TGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLE  345 (397)
Q Consensus       272 ~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~  345 (397)
                      .|||+|||||+.     ...+|+.++||||||++|.||..+.+|-...++...+..+.+... ....|...+..+.+|+.
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk  270 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK  270 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence            999999999996     456899999999999999999999999999999988887655432 12246678899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||..||+.||++.++++
T Consensus       271 ~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  271 RCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHhcCCccCCCHHHHhh
Confidence            999999999999999873

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-41  Score=320.95  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=212.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++...  ++.|++|.+..... .......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999874  46799999876532 2234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||++|++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......    
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986421110    


Q ss_pred             ------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCC
Q 015965          267 ------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIP  333 (397)
Q Consensus       267 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~  333 (397)
                                  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.++.+.......... .+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                        11123578899999999888899999999999999999999999988777665555444332 23333


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                      ..+++++.+++.+||+.||++||++.++.+.|+.
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            4678999999999999999999997777666665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=304.64  Aligned_cols=260  Identities=20%  Similarity=0.332  Sum_probs=211.8

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--  183 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  183 (397)
                      ..-|+.++|+|.+.||.|+|+-||+++.  +++.+|+|.+....  .+..+..++|+...++++|||+++++++...+  
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            3468899999999999999999999975  56779999988654  45578899999999999999999999876433  


Q ss_pred             ---CceEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCceEEcc
Q 015965          184 ---PSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVAD  255 (397)
Q Consensus       184 ---~~~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~vkl~D  255 (397)
                         ...||+++|...|||.+.++..   ...+++..+++|+.+|++||.+||...  +.||||||.|||+++.+.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence               3489999999999999999765   236999999999999999999999998  99999999999999999999999


Q ss_pred             cccccccccCC----------cccCCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHH
Q 015965          256 FGVARVKAQSG----------VMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QAA  320 (397)
Q Consensus       256 fG~a~~~~~~~----------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~--~~~  320 (397)
                      ||.++......          .......|..|+|||.+.   +...+.++|||||||+||.|+.|.-||+..-..  ..+
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            99987543221          123346799999999985   456788999999999999999999999642211  111


Q ss_pred             HHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      ..+......-+.....++.+.+++..||+.||.+||++.+++..++++.
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1111111121222348899999999999999999999999999998874

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-41  Score=317.21  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=209.4

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||.|+||.||+|.+  .++.||+|++............+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478899999999999999987  467899999987654455567799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--cccC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--~~~~  270 (397)
                      + +++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            9 999999998766789999999999999999999999999999999999999999999999999998665433  2344


Q ss_pred             CCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-------------------
Q 015965          271 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------------------  330 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-------------------  330 (397)
                      ..|+..|+|||++.+. .++.++||||||+++|+|++|.+||...........+......+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            5789999999998654 46889999999999999999999997766554443332211100                   


Q ss_pred             ---------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ---------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                               ......+.++.+++.+||+.||++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     011345689999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-42  Score=317.67  Aligned_cols=246  Identities=22%  Similarity=0.360  Sum_probs=212.7

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +|++.+.||.|+||.||++.+.  ++.||+|++..... .....+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999874  68899999876443 22456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      |+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++............
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999773 68999999999999999999999999999999999999999999999999999876555444556


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.  .......... ..+..+...+..+.++|.+||+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHcc
Confidence            789999999999888899999999999999999999999987663  2222222221 4556777889999999999999


Q ss_pred             hCCCCCCCH--HHHH
Q 015965          350 QDPALRPDF--SEII  362 (397)
Q Consensus       350 ~dp~~Rps~--~ell  362 (397)
                      .||.+||++  ++++
T Consensus       239 ~~p~~R~~~~~~~l~  253 (258)
T cd05578         239 RDPQKRLGDNLKDLK  253 (258)
T ss_pred             CChhHcCCccHHHHh
Confidence            999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-42  Score=349.86  Aligned_cols=263  Identities=32%  Similarity=0.682  Sum_probs=234.5

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeee
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI  177 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~  177 (397)
                      .|+++.+++.+.+.||+|.||.|++|...         ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            79999999999999999999999999742         345999999977655 66788999999999986 99999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      |+|...+.+++|+||+..|+|.++++..+               ..++...++.++.||+.||+||++..+|||||..+|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            99999999999999999999999998876               348999999999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCCcc--cCCCC--CcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSGVM--TAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  317 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~~~--~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~  317 (397)
                      ||++++..+||+|||+++........  ....|  ...|||||.+....|+.++||||||++||||++ |..||.+....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999854443322  22232  456999999999999999999999999999999 99999997745


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +.....++.+.+...|..|++++.++|+.||+.+|++||+|.++.+.|...+.+
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            555678899999999999999999999999999999999999999999997654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-41  Score=318.19  Aligned_cols=246  Identities=28%  Similarity=0.520  Sum_probs=211.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .+|++.+.||.|+||.||+|..  .++.|++|.+.....  .....+.+|+.+++.++||||+++++.+......|+|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            5689999999999999999975  568899999875432  234678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-ccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-~~~  270 (397)
                      |+++++|.+++..  ..+++..+..++.|++.|+.|||+.|++||||||+||+++.++.++|+|||++........ ...
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            9999999999865  4689999999999999999999999999999999999999999999999999875443322 234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+..... ....+..+++.+.+++.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            4689999999999988899999999999999999999999988877655544433221 223456788999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||.+||++.+++.
T Consensus       255 ~dp~~Rpt~~~il~  268 (296)
T cd06655         255 MDVEKRGSAKELLQ  268 (296)
T ss_pred             cChhhCCCHHHHhh
Confidence            99999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=335.77  Aligned_cols=248  Identities=28%  Similarity=0.491  Sum_probs=225.7

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ...|.+.+.||+|.|+.|.+++.  ++..||||++++...+......+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            35688899999999999999976  6788999999998888777777999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+.+|.+++++.+ .+...+..+..++.|++.|++|||+++|+|||||++|||++.+-++||+|||++..+.......+
T Consensus       135 eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  135 EYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             EeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence            99999999999988 46677799999999999999999999999999999999999999999999999999998888889


Q ss_pred             CCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ++|++.|.|||++.+..|+ +.+|+||+|+++|.|++|.+||++.+-.+.-..++...++  +|..++.++.++|++++-
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~lv  291 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLRKFLV  291 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHHHhhc
Confidence            9999999999999998875 5799999999999999999999988776666665555444  667778899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      ++|.+|++.+++.+
T Consensus       292 l~Pskr~~~dqim~  305 (596)
T KOG0586|consen  292 LNPSKRGPCDQIMK  305 (596)
T ss_pred             cCccccCCHHHhhh
Confidence            99999999999863

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-41  Score=313.31  Aligned_cols=241  Identities=27%  Similarity=0.439  Sum_probs=209.3

Q ss_pred             eeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||.|+||.||++...  ++.+|+|++..... .....+.+.+|+.+++.++||||+++++.+.++...|++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999986  78899999876543 234457799999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCcccc
Q 015965          199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM  278 (397)
Q Consensus       199 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~  278 (397)
                      .+++.+ ...++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+++............|++.|+
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            999976 3568999999999999999999999999999999999999999999999999998665443334457899999


Q ss_pred             cccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 015965          279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP  356 (397)
Q Consensus       279 aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rp  356 (397)
                      +||.+.+..++.++|+||||+++|+|++|..||....  +.+....+......+..|...++++.+++.+||+.||++||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            9999988889999999999999999999999998776  55555555543445666777789999999999999999999


Q ss_pred             C-----HHHHHH
Q 015965          357 D-----FSEIIE  363 (397)
Q Consensus       357 s-----~~ell~  363 (397)
                      +     +.|+++
T Consensus       240 ~~~~~~~~~l~~  251 (262)
T cd05572         240 GNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHhc
Confidence            9     777664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-41  Score=331.27  Aligned_cols=245  Identities=23%  Similarity=0.406  Sum_probs=199.4

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      +...+|.+++.||+|+||.||++...+    ..||+|.+...       ..+.+|+.++++++||||+++++++......
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            344679999999999999999997543    56899987643       2345799999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |++||++ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus       162 ~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        162 CMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9999999 5789998854 5789999999999999999999999999999999999999999999999999997544322


Q ss_pred             ---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhh---------------
Q 015965          267 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQ---------------  325 (397)
Q Consensus       267 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---~~~~~~~~---------------  325 (397)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....   .....+..               
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence               122457999999999999999999999999999999999999999654321   11111110               


Q ss_pred             ----------cCCCCCC--C-----CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          326 ----------KGLRPTI--P-----KNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       326 ----------~~~~~~~--~-----~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                                ...++..  +     ...+.++.++|.+||..||++||++.+++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      0011111  1     2346789999999999999999999998754

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-41  Score=316.94  Aligned_cols=247  Identities=30%  Similarity=0.522  Sum_probs=205.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEec------CC
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK------PP  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~  184 (397)
                      +.|++.+.||.|+||.||+|.+  .++.+|+|++...   ......+..|+.+++++ +||||+++++++..      ..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            5788889999999999999987  4577999998643   22345688899999988 69999999998853      45


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            6899999999999999997643 458888999999999999999999999999999999999999999999999987544


Q ss_pred             cC-CcccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          264 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       264 ~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      .. .......|++.|+|||++.     ...++.++|+||||+++|+|++|..||....+......+............++
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS  252 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence            22 2234457899999999985     35688899999999999999999999987776555544333333333345688


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .++.++|.+||+.||.+||++.++++
T Consensus       253 ~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         253 KKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            99999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.1e-41  Score=312.10  Aligned_cols=252  Identities=29%  Similarity=0.489  Sum_probs=206.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +++.+.+.....||+|+||.||+|.+.  +..||+|.+...  .....+.+.+|+.++++++|+||+++++++..++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            334444555568999999999999864  456999987754  2334567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEccccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ  264 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~~  264 (397)
                      +++||+++++|.+++......+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999999998654555  88889999999999999999999999999999999976 67999999999875433


Q ss_pred             C-CcccCCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhhcCCCCCCCCCCcHHH
Q 015965          265 S-GVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      . .......|++.|+|||++.+.  .++.++|+||||+++|+|++|..||........ ..........+.++..+++++
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA  241 (268)
T ss_pred             CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence            2 223344689999999998654  378899999999999999999999976543222 222222233456777889999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++.+||+.+|.+|||+.+++.
T Consensus       242 ~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         242 KNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHh
Confidence            99999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-41  Score=320.36  Aligned_cols=246  Identities=28%  Similarity=0.504  Sum_probs=209.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .+|++.+.||+|+||.||++..  .++.||+|.+......  ..+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            6789999999999999999986  5788999998754332  24668899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+++++|.+++.+  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            9999999999865  568899999999999999999999999999999999999999999999999987544332 2234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++..........+. ....+...++.+.+++.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence            5789999999999998899999999999999999999999987665444333222221 122455678899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++||++.++++
T Consensus       255 ~~p~~Rps~~~il~  268 (297)
T cd06656         255 MDVDRRGSAKELLQ  268 (297)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-41  Score=329.60  Aligned_cols=243  Identities=24%  Similarity=0.390  Sum_probs=196.1

Q ss_pred             CcccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ....|++.+.||+|+||.||+|.+.+  +.||+|+....        ....|+.++++++||||+++++++......|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34579999999999999999998854  57999985432        234689999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      ||++ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus       136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  214 (357)
T PHA03209        136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL  214 (357)
T ss_pred             EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence            9999 569999988767789999999999999999999999999999999999999999999999999997654444444


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChH---------HHHHHhhhc-CCC-CCC-----
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEYLTPL---------QAAVGVVQK-GLR-PTI-----  332 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~-~P~~~~~~~---------~~~~~~~~~-~~~-~~~-----  332 (397)
                      ...||+.|+|||++.+..++.++|||||||++|||+++. .+|......         .....+... +.. ..+     
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            567999999999999999999999999999999999854 444332110         011111110 000 000     


Q ss_pred             -------------------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          333 -------------------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       333 -------------------------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                               ...++.++.+||.+||+.||.+|||+.|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                     0134667788999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=310.86  Aligned_cols=248  Identities=28%  Similarity=0.504  Sum_probs=212.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCC---CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  186 (397)
                      .+|++.+.||+|+||.||++.+  .++.||+|.+....   ........+.+|+.++++++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5688999999999999999986  46789999875432   1233456788999999999999999999988664  458


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      +++|||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            899999999999999876 356899999999999999999999999999999999999999999999999999754321 


Q ss_pred             ---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                         .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.................++.+|..+++++.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence               12234568999999999998889999999999999999999999998887777666666666667788899999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+||. +|..||++.+++.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhc
Confidence            9999999 5799999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-41  Score=313.25  Aligned_cols=248  Identities=30%  Similarity=0.543  Sum_probs=209.1

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC----hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      +|+..+.||+|+||.||++..  +++.+|+|+++.....    ......+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            377789999999999999976  5678999998754322    2245678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccCC-
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG-  266 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~~-  266 (397)
                      ||||++|++|.+++.+ .+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+....... 
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999976 46789999999999999999999999999999999999998776 69999999987654321 


Q ss_pred             ----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCCCCCCCCcHH
Q 015965          267 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                          ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.....   .............+..+...+++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                11234678999999999888899999999999999999999999975432   22233333334456677788899


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+++.+||..+|.+||++.++++
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhc
Confidence            999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-41  Score=318.94  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  189 (397)
                      ++|++.+.||.|+||.||+|++.  ++.+|+|.++...........+.+|+.++++++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57899999999999999999884  67799999986544433445677899999999999999999998777  889999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Ccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~  268 (397)
                      |||++ ++|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||+++..... ...
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            99996 5999999876667999999999999999999999999999999999999999999999999999865543 233


Q ss_pred             cCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------------------
Q 015965          269 TAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------  327 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~--------------------  327 (397)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...-                    
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            445678999999998654 46889999999999999999999998776655443332110                    


Q ss_pred             ---------CCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 ---------LRPTIPKN-SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ---------~~~~~~~~-~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                               ....++.. +++.+.+++.+||+.||++|||+.|++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                     01112223 5888999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.5e-41  Score=311.32  Aligned_cols=245  Identities=25%  Similarity=0.490  Sum_probs=197.9

Q ss_pred             ceeeeeCCceEEEEEEC-Cc---ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC-SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||+|+||.||+|... +.   .+++|.++... .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            36999999999999753 22   35566655432 233467899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC---Cccc
Q 015965          196 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVMT  269 (397)
Q Consensus       196 ~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~---~~~~  269 (397)
                      ++|.+++.+..   ...+...+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++......   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            99999997642   34667778899999999999999999999999999999999999999999998643221   1123


Q ss_pred             CCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC----CCCCCCCCCc
Q 015965          270 AETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG----LRPTIPKNSQ  337 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~----~~~~~~~~~~  337 (397)
                      ...++..|+|||++..       ..++.++||||||+++|||++ |..||...+..+....+....    .++..+...+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            4567899999999743       345789999999999999997 678998777766555544332    2345556678


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      +.+.+++..|| .+|++||++.++++.|.
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            99999999999 68999999999988774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=319.32  Aligned_cols=245  Identities=32%  Similarity=0.529  Sum_probs=215.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      .-|.++.+||+|+||.||++.+  .|+.+|||.+..+.    ...++..|+.+|++++.|++|++||.+.....++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3477889999999999999965  67889999987442    35788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      ||..||+.+.++.++.++++..+..++.+-+.||+|||...-||||||..|||++.+|..||+|||++....+. ....+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            99999999999988899999999999999999999999999999999999999999999999999999654432 23456


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHhc
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCW  348 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl  348 (397)
                      ..|||.|||||++..-.|+.++||||||++..||..|++||....+..++.-+-.+. .|.  .|...+.++.+++++||
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P-PPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP-PPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC-CCCCCChHhhhhHHHHHHHHHh
Confidence            689999999999999999999999999999999999999999988877665443221 222  24557889999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      -++|++|.|+.++++
T Consensus       268 iK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  268 IKKPEERKTALRLCE  282 (502)
T ss_pred             cCCHHHHHHHHHHhh
Confidence            999999999999975

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-41  Score=309.55  Aligned_cols=248  Identities=31%  Similarity=0.537  Sum_probs=213.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|++|.||++...  ++.|++|++...... .....+.+|+..+++++|+||+++++.+......++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            36788899999999999999874  678999998865432 446779999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc-c
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-T  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~-~  269 (397)
                      |+++++|.+++... ..+++..++.++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++......... .
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            99999999999764 778999999999999999999999 99999999999999999999999999999765543322 2


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhhcCCCCCCCCC-CcHHHHHHHHH
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKN-SQPKLAELLER  346 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~  346 (397)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||....  ..............+..+.. ++..+.+++.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA  238 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence            4568899999999999899999999999999999999999998774  22222233333344455556 88999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||..+|++||++.++++
T Consensus       239 ~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         239 CLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HccCChhhCCCHHHHHh
Confidence            99999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.7e-41  Score=308.58  Aligned_cols=248  Identities=28%  Similarity=0.541  Sum_probs=219.0

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||++.+.  ++.+++|++............+.+|+.+++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999886  77899999987666556677899999999999999999999999998999999999


Q ss_pred             ccCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cc
Q 015965          193 MSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  268 (397)
Q Consensus       193 ~~g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~  268 (397)
                      +++++|.+++....   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            99999999998753   779999999999999999999999999999999999999999999999999997655443 23


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+........ ..+..+..++..+.+++.+||
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHc
Confidence            3457899999999998888999999999999999999999999888766665554443 345567788999999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      ..+|++||++.++++
T Consensus       240 ~~~p~~Rp~~~~ll~  254 (258)
T cd08215         240 QKDPEERPSIAQILQ  254 (258)
T ss_pred             CCChhhCcCHHHHhc
Confidence            999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=357.02  Aligned_cols=252  Identities=21%  Similarity=0.355  Sum_probs=221.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|.++++||+|+||.|.+++.  +++.||+|++.+-.. .......|..|..+|..-+.+.|++++.+|+++.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            45678999999999999999999977  457799999876332 234456799999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+|||||+||+|..++.+.. ++++.++..|+..|+.||+.||+.|+|||||||+|||||..|+|||+|||.+-....++
T Consensus       151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            99999999999999999976 89999999999999999999999999999999999999999999999999997766555


Q ss_pred             cc--cCCCCCcccccccccC----C-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCc
Q 015965          267 VM--TAETGTYRWMAPEVIE----H-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQ  337 (397)
Q Consensus       267 ~~--~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~  337 (397)
                      ..  ...+|||-|++||++.    + +.|+..+|+||+|+++|||++|..||...+-.+++-+|+...-...+|  ..+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            43  3458999999999983    3 569999999999999999999999999999899998888775555555  5689


Q ss_pred             HHHHHHHHHhchhCCCCCCC---HHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPD---FSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps---~~ell~  363 (397)
                      ++.++||++.+. +|+.|..   +.++..
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            999999999987 7788887   777653

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-41  Score=315.14  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=204.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEe-----
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT-----  181 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----  181 (397)
                      ....++|++.+.||+|+||.||++..  .++.+|+|+++...   .....+.+|+.+++.+ +||||+++++++.     
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            33457899999999999999999977  45779999876432   1235677899999999 6999999999874     


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      ..+..++||||++|++|.+++...   ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence            345689999999999999987632   35688999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-cccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-CCCC
Q 015965          259 ARVKAQSG-VMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPT  331 (397)
Q Consensus       259 a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-~~~~  331 (397)
                      ++...... ......|++.|+|||++.     +..++.++||||||+++|+|++|..||....+........... ....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH  250 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence            87654322 223446899999999985     3457889999999999999999999998776655443322221 1112


Q ss_pred             CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       332 ~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                      .+..++..+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            344567899999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-40  Score=306.38  Aligned_cols=248  Identities=32%  Similarity=0.581  Sum_probs=217.4

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceEEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVT  190 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  190 (397)
                      +|++.+.||+|++|.||+|...  ++.|++|++............+.+|+.++++++||||+++++.+...  ...+++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3677899999999999999885  67899999887655455667899999999999999999999999888  7899999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---  267 (397)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999874 4899999999999999999999999999999999999999999999999999987665543   


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+......+.++...+..+.+++.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            445678999999999988889999999999999999999999998765 3333444333345566778889999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||++||++.+++.
T Consensus       240 ~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         240 CLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCcCChhhCCCHHHHhh
Confidence            99999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.2e-41  Score=317.26  Aligned_cols=246  Identities=29%  Similarity=0.455  Sum_probs=209.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ..|.+.+.||+|+||.||+|..  .++.||+|++..... .......+.+|+.+++.++||||+++++++......|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4588899999999999999986  467899999865432 3344567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+. ++|.+++......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......   ..
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            9995 6888888766678999999999999999999999999999999999999999999999999998754332   34


Q ss_pred             CCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          271 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       271 ~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ..+++.|+|||++.   ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.+++.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            56889999999874   456888999999999999999999999888776665554433222222345788999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||++||++.+++.
T Consensus       251 l~~~p~~Rp~~~~il~  266 (307)
T cd06607         251 LQKIPQDRPSSEELLK  266 (307)
T ss_pred             hcCChhhCcCHHHHhc
Confidence            9999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-41  Score=312.43  Aligned_cols=248  Identities=31%  Similarity=0.542  Sum_probs=206.7

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC--------hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +|.+.+.||.|+||.||+|..  .++.+|+|.++.....        ....+.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999975  5678999988643211        112356788999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999874 6789999999999999999999999999999999999999999999999999975432


Q ss_pred             CC---cccCCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC----CC
Q 015965          265 SG---VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP----KN  335 (397)
Q Consensus       265 ~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~----~~  335 (397)
                      ..   ......|+..|+|||++....  ++.++|+||||+++|+|++|..||......+...........+..+    ..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN  240 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence            21   123346889999999987654  8899999999999999999999998766655554443333333333    34


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.++.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         241 LSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            6889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-42  Score=324.78  Aligned_cols=255  Identities=21%  Similarity=0.354  Sum_probs=211.9

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCC
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP  184 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  184 (397)
                      ..+.+....|+++++||+|+.+.||++...+ +.+|+|.+.....+.....-|.+|+.+|.+|+ |.+||++|++-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            4567888999999999999999999998754 56888887766667777888999999999997 899999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+||||||= ..+|..+|++.....+...+..+..||+.++.++|+.||||.||||.|+|+- .|.+||+|||.|.....
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            999999976 6799999998766667668999999999999999999999999999999997 57899999999986654


Q ss_pred             C---CcccCCCCCcccccccccCCCC-----------CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh-hcCCC
Q 015965          265 S---GVMTAETGTYRWMAPEVIEHKP-----------YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV-QKGLR  329 (397)
Q Consensus       265 ~---~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~-~~~~~  329 (397)
                      +   ......+||+-||+||.+....           .++++|||||||+||+|+.|+.||....+.......+ ..+..
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            3   2345668999999999985433           4578999999999999999999998766444333322 22222


Q ss_pred             CCCCCCCc-HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 PTIPKNSQ-PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ~~~~~~~~-~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .++|..-+ .++.++++.||..||++||+..+||+
T Consensus       592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            23443333 33999999999999999999999984

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.5e-41  Score=315.76  Aligned_cols=247  Identities=30%  Similarity=0.501  Sum_probs=201.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|...+.||+|+||.||++.+  .++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            5677889999999999999987  4577999998755433 44567889999999996 999999999999989999999


Q ss_pred             EeccCCCHHHHHH---h-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          191 EFMSGGSVYDYLH---K-LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       191 E~~~g~sL~~~l~---~-~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      ||+. ++|.++..   . ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||+++.....
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            9984 56655432   2 236789999999999999999999975 9999999999999999999999999999765544


Q ss_pred             CcccCCCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCCCCC----CCCCCc
Q 015965          266 GVMTAETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPT----IPKNSQ  337 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~----~~~~~~  337 (397)
                      .......|+..|+|||++.+.   .++.++||||||+++|+|++|..||...... +....... ...+.    .+..++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  240 (288)
T cd06616         162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEEREFS  240 (288)
T ss_pred             CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCCccC
Confidence            444555789999999999766   6899999999999999999999999765432 22222221 11222    223578


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++.+|+.+||+.||.+|||+.+++.
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=315.22  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=206.5

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||+|.+.  ++.||+|.++...........+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6889999999999999999874  67899999886554555567789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--cccC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--~~~~  270 (397)
                      ++++.+..+..+ ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.......  ....
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            987666655543 5668999999999999999999999999999999999999999999999999987655433  3345


Q ss_pred             CCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---------------------C
Q 015965          271 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------------------L  328 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~---------------------~  328 (397)
                      ..++..|+|||++.+. .++.++|+||||+++|+|++|..||......+.........                     .
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF  240 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence            5788999999999887 88999999999999999999999998765544333221100                     0


Q ss_pred             ---------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 ---------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ---------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                               ....+..+++++.+++.+||..+|++||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                     00123345889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.9e-41  Score=318.43  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=205.9

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCI  188 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  188 (397)
                      .++|++.+.||.|+||.||+|.+  .++.||+|+++...........+.+|+.++++++|+||+++++++...  +.+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46799999999999999999987  467899999875543333334567899999999999999999998754  46899


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~  267 (397)
                      ||||+. ++|.+++......+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...... ..
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            999995 5899998876678999999999999999999999999999999999999999999999999999765443 22


Q ss_pred             ccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC----------------
Q 015965          268 MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------------  330 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~----------------  330 (397)
                      .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...++.+....+......+                
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK  244 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence            333456888999999865 568899999999999999999999999887766655443311000                


Q ss_pred             -CC-----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 -TI-----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 -~~-----------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                       ..           ....++++.++|.+||+.||++|||+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             00           0125788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-40  Score=304.34  Aligned_cols=246  Identities=35%  Similarity=0.633  Sum_probs=213.1

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|.+.+.||+|++|.||++...  ++.+++|++.....  .....+.+|+.++++++|+||+++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4677899999999999999885  67799999876543  3457789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  272 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  272 (397)
                      +++++|.+++......+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||.+.............
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            99999999998755689999999999999999999999999999999999999999999999999997665543344567


Q ss_pred             CCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCC--CcHHHHHHHHHhchh
Q 015965          273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCWQQ  350 (397)
Q Consensus       273 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~cl~~  350 (397)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+..  ++..+.+++.+||+.
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccC
Confidence            89999999999888899999999999999999999999988766555544433 223333333  378999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      ||++|||+.++++
T Consensus       238 ~p~~R~t~~~~l~  250 (253)
T cd05122         238 NPEKRPTAEQLLK  250 (253)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.5e-41  Score=323.85  Aligned_cols=247  Identities=25%  Similarity=0.363  Sum_probs=203.9

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------C
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  184 (397)
                      .++|++.+.||+|+||.||++..  .++.||||++............+.+|+.++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            36799999999999999999986  567899999876544445556788899999999999999999988643      3


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..|+||||+ .++|.+.+..   .++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        95 ~~~lv~e~~-~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELM-DANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEecc-CCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            579999999 4688888764   289999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  328 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------  328 (397)
                      ........++..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...-.                
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            5444556789999999999999999999999999999999999999987654333222211000                


Q ss_pred             ----CC---------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 ----RP---------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ----~~---------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                          ++                     ..+...++.+.+++.+||+.||++|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                00                     001234667899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-41  Score=333.84  Aligned_cols=243  Identities=23%  Similarity=0.332  Sum_probs=196.4

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ...|.+.+.||+|+||.||++.+.  ++.||||....        ..+.+|+.+|++++|+|||++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            347999999999999999999874  46799996431        23568999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc---
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---  267 (397)
                      |++ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus       240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            999 5799999877666799999999999999999999999999999999999999999999999999976543221   


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHhhhcCC------------
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT-------PLQAAVGVVQKGL------------  328 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-------~~~~~~~~~~~~~------------  328 (397)
                      .....||+.|+|||++.+..++.++|||||||+||||++|..|+-...       ....+..+++...            
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            223469999999999999999999999999999999999876542211       0112222222110            


Q ss_pred             --------------CCCCC-------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          329 --------------RPTIP-------KNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       329 --------------~~~~~-------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                                    ++...       ...++++.+||.+||+.||.+|||+.|+|+.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                          00000       1245689999999999999999999999863

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.8e-41  Score=308.33  Aligned_cols=248  Identities=28%  Similarity=0.506  Sum_probs=211.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|+||.||++..  .+..+|+|.+..........+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477889999999999999987  457799999876544444456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccCCc-cc
Q 015965          193 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-MT  269 (397)
Q Consensus       193 ~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~~~-~~  269 (397)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||++++++ .++|+|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            99999999997643 3579999999999999999999999999999999999999876 469999999976544322 22


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+........ ..+..+...+.++.+++.+||.
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-YFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-cCCCCCCCCCHHHHHHHHHHhc
Confidence            346899999999998888999999999999999999999999877766655554433 3344556778899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .+|++|||+.+++.
T Consensus       240 ~~p~~Rpt~~~ll~  253 (257)
T cd08225         240 VSPRDRPSITSILK  253 (257)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-40  Score=311.23  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=200.5

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecC--CceEEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP--PSLCIVT  190 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  190 (397)
                      |++.++||+|+||.||+|..  .++.||+|.++....... .....+|+.+++++. |+||+++++++.+.  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            56788999999999999987  567799999876533332 234457888888885 99999999999887  8899999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||++ ++|.+++......+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||+++..........
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence            9995 5888888775667999999999999999999999999999999999999999 9999999999986654444445


Q ss_pred             CCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----------------CCCCC-
Q 015965          271 ETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------LRPTI-  332 (397)
Q Consensus       271 ~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~----------------~~~~~-  332 (397)
                      ..++..|+|||++. +..++.++|||||||++|+|++|..||...+..+.........                ..... 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            67899999999764 4557889999999999999999999998876654433322100                00001 


Q ss_pred             ----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          333 ----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       333 ----------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                ...++.++.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                      1246789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.8e-41  Score=315.65  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=205.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.++||+|+||.||+|.+.  ++.||+|++..........+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999874  6789999987654444445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |+++++|..+... ...+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++...... .....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            9999888887654 456899999999999999999999999999999999999999999999999998764332 22334


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------------------CC
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------LR  329 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~--------------------~~  329 (397)
                      ..++..|+|||++.+ ..++.++||||||+++|+|++|.+||......+....+....                    ..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            568899999999865 447889999999999999999999997665443332222100                    00


Q ss_pred             C---------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ~---------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +         .....++..+.+++.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0         012356788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=310.29  Aligned_cols=248  Identities=33%  Similarity=0.531  Sum_probs=205.1

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCC-----
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP-----  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----  184 (397)
                      .++|++.+.||.|+||.||+|...  ++.+++|++.....   ....+.+|+.+++++ .|+||+++++.+....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            367999999999999999999874  46799999875432   346788999999998 6999999999997644     


Q ss_pred             -ceEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          185 -SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       185 -~~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                       .+++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence             489999999999999998754   3678999999999999999999999999999999999999999999999999987


Q ss_pred             ccccC-CcccCCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-CCC
Q 015965          261 VKAQS-GVMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIP  333 (397)
Q Consensus       261 ~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-~~~  333 (397)
                      ..... .......|+..|+|||++..     ..++.++||||||+++|+|++|..||...........+....... ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP  241 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence            54432 22334568999999998753     347788999999999999999999998776655555544332111 122


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ...++++.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         242 ENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            346789999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-40  Score=309.46  Aligned_cols=246  Identities=34%  Similarity=0.588  Sum_probs=211.7

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      -|++.++||+|+||.||+|..  .+..||||+...... ......+.+|+.++++++||||+++++.+......++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            477889999999999999976  457799999865432 23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~  271 (397)
                      +++++|.+++..  +.+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            999999999864  568999999999999999999999999999999999999999999999999987544322 22334


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ......+..+..++.++.+++.+||..+
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            688999999999888899999999999999999999999987776554444 3334455566778899999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 015965          352 PALRPDFSEIIEI  364 (397)
Q Consensus       352 p~~Rps~~ell~~  364 (397)
                      |.+||++.+++..
T Consensus       241 p~~Rp~~~~~l~~  253 (277)
T cd06641         241 PSFRPTAKELLKH  253 (277)
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-40  Score=317.60  Aligned_cols=240  Identities=23%  Similarity=0.388  Sum_probs=186.4

Q ss_pred             cceeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEEEEEe
Q 015965          119 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF  192 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~E~  192 (397)
                      +++||+|+||.||+|...    ++.||+|.++.....    ..+.+|+.++++++||||+++++++..  ...+|++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999863    366999998754332    346789999999999999999998854  4568899999


Q ss_pred             ccCCCHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe----CCCCceEEccccccc
Q 015965          193 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  260 (397)
Q Consensus       193 ~~g~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili----~~~~~vkl~DfG~a~  260 (397)
                      + +++|.+++...        ...+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            9 56898887532        1258899999999999999999999999999999999999    456789999999998


Q ss_pred             ccccCC----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHhhhc
Q 015965          261 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAVGVVQK  326 (397)
Q Consensus       261 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---------~~~~~~~~~  326 (397)
                      ......    ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||......         .....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654321    2334578999999999876 45899999999999999999999999643210         111111000


Q ss_pred             -----------------------CCC-C------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          327 -----------------------GLR-P------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       327 -----------------------~~~-~------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                             ... .            ......++++.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence                                   000 0            001123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=310.12  Aligned_cols=245  Identities=31%  Similarity=0.557  Sum_probs=206.7

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC---CCCeeeeeeEEecCCceEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  189 (397)
                      .|++.+.||+|+||.||+|.+  .++.||+|.++... .......+.+|+.++++++   |||++++++++...+..|+|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            477889999999999999987  46779999987543 2333567889999999987   99999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~  268 (397)
                      |||++|++|.+++..  +.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            999999999999865  478999999999999999999999999999999999999999999999999987654432 23


Q ss_pred             cCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCC-CCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~ll~~  346 (397)
                      ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+. ....+.++. ..+.++.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcccCCHHHHHHHHH
Confidence            34578999999998864 457899999999999999999999998876655443322 222333333 378899999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||++||++.+++.
T Consensus       238 ~l~~~p~~R~~~~~il~  254 (277)
T cd06917         238 CLDEEPKERLSAEELLK  254 (277)
T ss_pred             HcCCCcccCcCHHHHhh
Confidence            99999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.7e-40  Score=313.41  Aligned_cols=255  Identities=26%  Similarity=0.496  Sum_probs=209.1

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecC
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP  183 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  183 (397)
                      ..|.++.++|++.+.||+|+||.||+|.+.  ++.||||.++..... .....+.+|+.++.+.. ||||+++++++...
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            345677789999999999999999999986  788999998755332 33455667777666665 99999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ...|++|||+ +++|.+++......+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus        87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            9999999999 568888887766789999999999999999999997 59999999999999999999999999999765


Q ss_pred             ccCCcccCCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCCCCCCC--CC
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIP--KN  335 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~~~~~~~~~~~--~~  335 (397)
                      ..........++..|+|||.+.+..    ++.++|+||||+++|+|++|..||..... .+....+.... .+..+  ..
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCC
Confidence            5444444556888999999987553    78899999999999999999999976433 33333333332 22222  24


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                      ++.++.+++.+||+.||++||++.+++..
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            68899999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-40  Score=311.20  Aligned_cols=247  Identities=33%  Similarity=0.591  Sum_probs=211.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|++.+.||.|+||.||++.+.  ++.+++|+++....   ....+.+|+.+++.++|+||+++++.+......|+++|
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            45788899999999999999885  67899999876533   35678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |++|++|.+++......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence            999999999998854489999999999999999999999999999999999999999999999999986544321 2234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC-CCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-IPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ll~~cl~  349 (397)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|..||....+......+......+. .+..++..+.+++.+||+
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV  255 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhc
Confidence            4578899999999988899999999999999999999999988777655554443332221 223378899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .+|.+||++.++++
T Consensus       256 ~~p~~Rpt~~~il~  269 (286)
T cd06614         256 KDPEKRPSAEELLQ  269 (286)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-40  Score=314.47  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=204.9

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC---hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +|++.+.||.|+||.||+|.+  .++.||||.++.....   ......+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477889999999999999987  4678999999865443   33445677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Ccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~  268 (397)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+++..... ...
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 89999999764447999999999999999999999999999999999999999999999999999765443 223


Q ss_pred             cCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC------------------
Q 015965          269 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------------  329 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~------------------  329 (397)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...++......+......                  
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            34467889999999854 46788999999999999999998888776654433332211000                  


Q ss_pred             ---CC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ---PT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ---~~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                         +.     .....+..+.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               00     11345788999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=302.91  Aligned_cols=247  Identities=35%  Similarity=0.644  Sum_probs=216.4

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||+|++|.||++..  .++.|++|.+............+.+|+.++++++|||++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            477889999999999999976  457799999987765545667899999999999999999999999998999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-ccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-~~~~  271 (397)
                      +++++|.+++... +.+++..++.++.|++.|+.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999999764 7799999999999999999999999999999999999999999999999999976554322 2345


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      .++..|+|||...+..++.++|+||||+++|+|++|..||............. ....+..+..+++.+.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            68999999999988889999999999999999999999998877655555543 33455677788999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 015965          352 PALRPDFSEIIE  363 (397)
Q Consensus       352 p~~Rps~~ell~  363 (397)
                      |++||++.+++.
T Consensus       239 p~~R~~~~~~l~  250 (254)
T cd06627         239 PNLRPTAKQLLK  250 (254)
T ss_pred             hhhCcCHHHHhc
Confidence            999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-40  Score=313.59  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=212.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ..|...+.||+|+||.||++..  .+..+|+|.+..... .......+.+|+.++++++|||++++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3478889999999999999986  467799999875432 3344567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+. |+|.+.+......+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....   ...
T Consensus       105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS  180 (317)
T ss_pred             eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence            9996 588888876667899999999999999999999999999999999999999999999999999865432   234


Q ss_pred             CCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          271 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       271 ~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ..|++.|+|||++.   ...++.++||||||+++|+|++|..||...........+......+..+..+++.+.+++.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            57899999999973   456889999999999999999999999887776666665555444444556788999999999


Q ss_pred             chhCCCCCCCHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L  365 (397)
                      |+.+|.+||++.++++.+
T Consensus       261 l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         261 LQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ccCCcccCcCHHHHHhCh
Confidence            999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-40  Score=306.03  Aligned_cols=247  Identities=29%  Similarity=0.519  Sum_probs=215.3

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.++||.|+||.||++..  .++.+|+|.+............+.+|+.++++++|+||+++++.+......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999976  457799999887655555567788999999999999999999999988999999999


Q ss_pred             ccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCccc
Q 015965          193 MSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       193 ~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~  159 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK  159 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence            9999999998653   356899999999999999999999999999999999999999999999999999766544 333


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. ....+..+..++.++.+++.+||+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHHHcC
Confidence            4568999999999999999999999999999999999999998887665544433 344455666788999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .+|++||++.++++
T Consensus       239 ~~p~~Rp~~~~~l~  252 (256)
T cd08530         239 VKPKLRPNCDKILA  252 (256)
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-40  Score=311.63  Aligned_cols=248  Identities=21%  Similarity=0.387  Sum_probs=204.3

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.+.||.|+||.||+|..  .++.||||.++...........+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            378889999999999999987  467899999876544444446788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          193 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       193 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      +. ++|.+++... ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||+++...... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            95 6899988654 3568999999999999999999999999999999999999999999999999987544322 2233


Q ss_pred             CCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-------------------
Q 015965          271 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------------------  330 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-------------------  330 (397)
                      ..+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..............+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            45788999999886644 6889999999999999999999998766554443333211110                   


Q ss_pred             --------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 --------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                              .....+++++.++|.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                    012346788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4e-40  Score=309.90  Aligned_cols=248  Identities=29%  Similarity=0.475  Sum_probs=204.7

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecC-----C
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-----P  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~  184 (397)
                      .++|.+.+.||+|+||.||++..  .++.+|+|++....   .....+.+|+.+++++ +|||++++++++...     .
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            46799999999999999999987  46779999987532   2235677899999998 799999999998653     3


Q ss_pred             ceEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ..++||||++|++|.++++.   ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            58999999999999998864   245789999999999999999999999999999999999999999999999999876


Q ss_pred             cccCC-cccCCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCC
Q 015965          262 KAQSG-VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPK  334 (397)
Q Consensus       262 ~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~  334 (397)
                      ..... ......|+..|+|||++...     .++.++||||||+++|+|++|+.||....+.+....+..... ....+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence            44322 22345689999999998543     368899999999999999999999988877666655433321 112244


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..+..+.+++.+||+.+|++||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            56788999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-40  Score=309.42  Aligned_cols=241  Identities=25%  Similarity=0.407  Sum_probs=200.4

Q ss_pred             eeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||+|+||+||++..  .++.||+|++...... ......+.+|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999976  4678999998754322 22345577899999999999999999999999999999999999999


Q ss_pred             HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCccc
Q 015965          199 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW  277 (397)
Q Consensus       199 ~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y  277 (397)
                      .+++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99997643 36899999999999999999999999999999999999999999999999999765544444456788999


Q ss_pred             ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh--cCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       278 ~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      +|||++.+..++.++|+||||+++|+|++|..||...........+..  .......+..+++.+.+++.+||+.||.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            999999888899999999999999999999999976543211111111  122345566789999999999999999999


Q ss_pred             C-----CHHHHH
Q 015965          356 P-----DFSEII  362 (397)
Q Consensus       356 p-----s~~ell  362 (397)
                      |     ++.+++
T Consensus       241 ~~~~~~~~~~ll  252 (277)
T cd05577         241 LGCRGGSADEVR  252 (277)
T ss_pred             cCCCcccHHHHH
Confidence            9     555565

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-42  Score=330.90  Aligned_cols=243  Identities=27%  Similarity=0.528  Sum_probs=203.0

Q ss_pred             ccccceeeeeCCceEEEEEECC--cceEEEEecCC--CCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc--eEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPE--RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIV  189 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv  189 (397)
                      .++..+||+|+|-+||+|.+..  -.||--.++..  ..++.....|..|+.+|+.|+||||+++|++|.+...  +-+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            4666789999999999997743  33443333222  2244556889999999999999999999999987665  7789


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEeC-CCCceEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +|.+.+|+|..|+.+. +......+..|++||++||.|||++  -|||||||.+||+|+ ..|.|||+|+|+|.....+.
T Consensus       122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999999885 6678889999999999999999998  499999999999997 56999999999999887765


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhhcCCCC-CCCCCCcHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRP-TIPKNSQPKLAELL  344 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ll  344 (397)
                      ... ..|||.|||||+.. ..|+..+||||||++|+||+|+..||..- ++.+.+.+ +..+..| .+.+--.+++++||
T Consensus       201 aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK-V~SGiKP~sl~kV~dPevr~fI  277 (632)
T KOG0584|consen  201 AKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK-VTSGIKPAALSKVKDPEVREFI  277 (632)
T ss_pred             cce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH-HHcCCCHHHhhccCCHHHHHHH
Confidence            544 78999999999998 56999999999999999999999999764 45555555 4444444 34445579999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+|+.. ..+|||+.|||.
T Consensus       278 ekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  278 EKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHhcC-chhccCHHHHhh
Confidence            999999 899999999973

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=311.30  Aligned_cols=248  Identities=24%  Similarity=0.399  Sum_probs=199.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|..  .++.||||.+....... ....+.+|+.++++++||||+++++++......|+|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999987  46789999987543221 23456789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |+. ++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus        84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            996 5999999876678899999999999999999999999999999999999999999999999998754322 11223


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhh---cC------------------
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQ---KG------------------  327 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~~~---~~------------------  327 (397)
                      ..++..|+|||++.+ ..++.++||||+|+++|+|++|..||..... .+....+..   ..                  
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            457889999999865 4588999999999999999999999976552 221111110   00                  


Q ss_pred             CCC-------CCCCCCc--HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 LRP-------TIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ~~~-------~~~~~~~--~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ...       ......+  .++.+++.+||+.+|++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000       0001233  78899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.5e-41  Score=314.74  Aligned_cols=244  Identities=29%  Similarity=0.484  Sum_probs=205.7

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      .|.....||.|+||.||++..  .+..||||.+...  .....+.+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            344457799999999999976  4678999998643  233456688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~  271 (397)
                      +++++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++....... .....
T Consensus       101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999998854  568999999999999999999999999999999999999999999999999987543322 22345


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHhch
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl~  349 (397)
                      .|+..|+|||.+.+..++.++|+||||+++|||++|..||...++.+....+. ....+.  .....+..+.+++.+||.
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCccccccccCHHHHHHHHHHcc
Confidence            68999999999998889999999999999999999999998877665544332 222222  223567899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||.+|||+.++++
T Consensus       258 ~~P~~Rpt~~~il~  271 (292)
T cd06658         258 REPSQRATAQELLQ  271 (292)
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=313.63  Aligned_cols=254  Identities=17%  Similarity=0.246  Sum_probs=192.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECCc-----ceEEEEecCCCCChHH---------HHHHHHHHHHHhcCCCCCeee
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNVVQ  175 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~  175 (397)
                      ++...+|++.++||+|+||.||+|.+.+.     .+|+|+..........         ......+...+..+.|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            56668899999999999999999987543     5677764432211100         011223445566778999999


Q ss_pred             eeeEEecCC----ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCce
Q 015965          176 FIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  251 (397)
Q Consensus       176 ~~~~~~~~~----~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~v  251 (397)
                      +++.+....    ..++++|++ ..++.+.+.. ....++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            998765443    246788887 5577777765 3446788899999999999999999999999999999999999999


Q ss_pred             EEcccccccccccCC--------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-
Q 015965          252 KVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-  322 (397)
Q Consensus       252 kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~-  322 (397)
                      +|+|||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|..||........... 
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999997653221        12234699999999999999999999999999999999999999987743222111 


Q ss_pred             ----hhhcCCCC-CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          323 ----VVQKGLRP-TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       323 ----~~~~~~~~-~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                          .......+ .....+++++.+++..||..+|++||++.++++.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                11111111 12345688999999999999999999999998876

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.6e-40  Score=307.60  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=204.7

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  189 (397)
                      ++|.+.++||.|++|.||++.+  .++.+|+|.+..... ......+.+|+.++++++||||+++++++..  .+.+|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            3578889999999999999987  457799999875433 3445778999999999999999999998854  3468999


Q ss_pred             EEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |||++|++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999988754   24568899999999999999999999999999999999999999999999999986544322


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhhcCCCCCCC------CC
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIP------KN  335 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~-----~~~~~~~~~~~~~~~~~~~------~~  335 (397)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...     .+.+....+.. ...+..+      ..
T Consensus       160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (287)
T cd06621         160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGIK  237 (287)
T ss_pred             -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCCc
Confidence             22446788999999999989999999999999999999999999765     22232222222 1112211      23


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l  368 (397)
                      .++.+.+++.+||..+|.+|||+.|++.  .+.+.
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            4678999999999999999999999986  45443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=304.84  Aligned_cols=242  Identities=27%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHH-HhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.||.|+||.||+|..  .++.||+|+++..... ......+..|..+ ....+|+||+++++.+...+..|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999987  5678999998754322 2222334455544 4456899999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCc
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY  275 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~  275 (397)
                      ++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++....   .....|++
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            999999976 46789999999999999999999999999999999999999999999999999875433   23446889


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCCcHHHHHHHHHhchhCCC
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPA  353 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ll~~cl~~dp~  353 (397)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....  .......+++.+.+++.+||+.||+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            99999999888899999999999999999999999988777665554443322  2234446789999999999999999


Q ss_pred             CCCCHHHHHHHH
Q 015965          354 LRPDFSEIIEIL  365 (397)
Q Consensus       354 ~Rps~~ell~~L  365 (397)
                      +||++.++.+.|
T Consensus       238 ~R~~~~~~~~~l  249 (260)
T cd05611         238 KRLGANGYQEIK  249 (260)
T ss_pred             HccCCCcHHHHH
Confidence            999776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=309.03  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=204.7

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |++.+.||.|++|.||+|.+  .+..||+|++............+.+|+.++++++|||++++++++...+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56778999999999999986  5788999998765444444466888999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCC
Q 015965          194 SGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  271 (397)
Q Consensus       194 ~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~  271 (397)
                       +++|.+++.... ..+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||.++..... ......
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence             569999987643 36899999999999999999999999999999999999999999999999999754332 222344


Q ss_pred             CCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---------------------
Q 015965          272 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------------  329 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---------------------  329 (397)
                      .+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.+....                     
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            678999999988654 5788999999999999999999999877765544443321100                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                            ......+++.+.+++.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  0112456789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.3e-40  Score=309.05  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=198.7

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|..  .++.||+|+++..... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            5788999999999999999976  4678999998754322 223456789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+ +++|.+++......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++...... ....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          84 YM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             cc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            99 478888776655678888999999999999999999999999999999999999999999999987543322 2334


Q ss_pred             CCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhhc---------------------C
Q 015965          271 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQK---------------------G  327 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~-~~~~~~~---------------------~  327 (397)
                      ..+++.|+|||++.+. .++.++||||||+++|+|++|..||........ .......                     .
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            4678999999998654 578899999999999999999999986554221 1111100                     0


Q ss_pred             CCCCCC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 LRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ~~~~~~---------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .....+         ...++++.+++.+|+..||.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000         113578999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-40  Score=310.93  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=202.3

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCc-----
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS-----  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----  185 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||+|+++...........+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3688899999999999999987  4678999998765443334467888999999996 6999999999877665     


Q ss_pred             eEEEEEeccCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVAR  260 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~  260 (397)
                      .|+||||+++ +|.+++....    ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||+++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999975 8988886532    35899999999999999999999999999999999999998 8899999999987


Q ss_pred             ccccC-CcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--------
Q 015965          261 VKAQS-GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------  330 (397)
Q Consensus       261 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--------  330 (397)
                      ..... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......+        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            54332 22233467889999998854 457899999999999999999999998877666554433211000        


Q ss_pred             ------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                        .....+++++.++|.+||..||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                              001347788999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.6e-40  Score=307.43  Aligned_cols=244  Identities=30%  Similarity=0.516  Sum_probs=206.1

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      .|.-.+.||.|++|.||++..  .++.+++|.++..  .....+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            344457999999999999976  4577999988643  223345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~  271 (397)
                      ++|++|.+++..  +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+....... .....
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            999999999876  578999999999999999999999999999999999999999999999999886543322 22335


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC--CCCCcHHHHHHHHHhch
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQ  349 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~cl~  349 (397)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+... ..+..  +..+++.+.+++.+||+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  254 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLV  254 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHcc
Confidence            6899999999999888999999999999999999999999887766555444332 22222  23478899999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .+|++||++.++++
T Consensus       255 ~~p~~Rpt~~~il~  268 (285)
T cd06648         255 RDPAQRATAAELLN  268 (285)
T ss_pred             cChhhCcCHHHHcc
Confidence            99999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6e-40  Score=309.16  Aligned_cols=249  Identities=22%  Similarity=0.387  Sum_probs=202.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||.|++|.||+|.+  .++.||+|.+............+.+|+.++++++||||+++++++......|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4688999999999999999986  45779999987654444445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEcccccccccccC-Ccc
Q 015965          192 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS-GVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~~~-~~~  268 (397)
                      |++ ++|.+++..... .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... ...
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            995 588888765332 3678889999999999999999999999999999999985 567999999999754332 222


Q ss_pred             cCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-----------------
Q 015965          269 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------------  330 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-----------------  330 (397)
                      ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+                 
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            34467899999998865 457899999999999999999999998877655554432210000                 


Q ss_pred             --C--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 --T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 --~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                        .        .....++++.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0        12346788999999999999999999999875

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-40  Score=312.59  Aligned_cols=245  Identities=28%  Similarity=0.473  Sum_probs=206.1

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |.....||.|+||.||++..  .++.||+|++.....  ...+.+.+|+.+++.++||||+++++.+......|++|||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            44456899999999999976  568899999865432  23456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCCC
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  272 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~~  272 (397)
                      ++++|.+++..  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ......
T Consensus       101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            99999998754  568999999999999999999999999999999999999999999999999987543322 223457


Q ss_pred             CCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhchhC
Q 015965          273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       273 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      |+..|+|||++.+..++.++||||||+++|+|++|..||....+.+....+..... ....+...++.+.+++.+||+.+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  258 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE  258 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCC
Confidence            89999999999988899999999999999999999999987776655544322211 12233457889999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 015965          352 PALRPDFSEIIEI  364 (397)
Q Consensus       352 p~~Rps~~ell~~  364 (397)
                      |++||++.++++.
T Consensus       259 P~~Rps~~~ll~~  271 (297)
T cd06659         259 PQERATAQELLDH  271 (297)
T ss_pred             cccCcCHHHHhhC
Confidence            9999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-40  Score=311.19  Aligned_cols=247  Identities=28%  Similarity=0.508  Sum_probs=207.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++..  .++.||+|.+....  ......+.+|+.++++++||||+++++.+......|+|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            6789999999999999999975  56779999986432  2234668899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |+++++|.+++.+  ..+++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            9999999999875  467899999999999999999999999999999999999999999999999886544332 2234


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..... ....+..++..+.+++++||.
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE  254 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHcc
Confidence            4688999999999888899999999999999999999999987665443332222111 112234567889999999999


Q ss_pred             hCCCCCCCHHHHHHH
Q 015965          350 QDPALRPDFSEIIEI  364 (397)
Q Consensus       350 ~dp~~Rps~~ell~~  364 (397)
                      .+|++||++.+++..
T Consensus       255 ~~p~~Rp~~~~il~h  269 (293)
T cd06647         255 MDVEKRGSAKELLQH  269 (293)
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-40  Score=314.95  Aligned_cols=240  Identities=23%  Similarity=0.387  Sum_probs=185.5

Q ss_pred             cceeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEEEEEe
Q 015965          119 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF  192 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~E~  192 (397)
                      +++||+|+||.||+|+..    +..||+|.++....    ...+.+|+.++++++||||+++++++..  ...+++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            368999999999999863    35699999875432    2357789999999999999999998853  4568999999


Q ss_pred             ccCCCHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe----CCCCceEEccccccc
Q 015965          193 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  260 (397)
Q Consensus       193 ~~g~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili----~~~~~vkl~DfG~a~  260 (397)
                      +. ++|.+++...        ...+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            94 6888887532        1358889999999999999999999999999999999999    456799999999998


Q ss_pred             ccccCC----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHhhh-
Q 015965          261 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAVGVVQ-  325 (397)
Q Consensus       261 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---------~~~~~~~~-  325 (397)
                      ......    ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||......         .....+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            654332    2234568999999999876 45889999999999999999999999643211         00000000 


Q ss_pred             ----------------------cCC-------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          326 ----------------------KGL-------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       326 ----------------------~~~-------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                            ...             ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                                  000             00011223567889999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-42  Score=318.63  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=214.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEE--ECCcceEEEEecCCCCChH-HHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..+.|+.-++||+|+||.||-+.  .+|+-+|+|.+.+.+.... ...-.++|..+|.+++.+.||.+-.++++.+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            4667888889999999999999664  5788899998865544322 234467899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          187 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      |+||..|+||+|.-+|.... ..+++..+..++.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|.|+|......
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999998887653 47999999999999999999999999999999999999999999999999999988888


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh--cCCCCCCCCCCcHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l  343 (397)
                      ......+||.+|||||++.+..|+...|+|||||+||||+.|+-||........-..+-+  .......+..++++.+++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            888888999999999999999999999999999999999999999975433221111111  122345678999999999


Q ss_pred             HHHhchhCCCCCCCHH
Q 015965          344 LERCWQQDPALRPDFS  359 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~  359 (397)
                      .+..|+.||.+|...+
T Consensus       421 c~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHccCHHHhccCC
Confidence            9999999999998654

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.8e-40  Score=306.86  Aligned_cols=241  Identities=28%  Similarity=0.452  Sum_probs=194.1

Q ss_pred             eeeeeCCceEEEEEE--CCcceEEEEecCCCCChH-HHHHHHHHHHHH---hcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIM---RKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      .||+|+||.||++..  .++.+|+|.+........ ....+.+|..++   ...+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987  467899999876543222 223344454433   34579999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCC
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  274 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  274 (397)
                      |++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++...... ......|+
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT  158 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence            9999999876 467999999999999999999999999999999999999999999999999998754332 22345789


Q ss_pred             cccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCC
Q 015965          275 YRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP  352 (397)
Q Consensus       275 ~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp  352 (397)
                      ..|+|||.+. +..++.++|+||||+++|+|++|..||....... ..............+..+++++.+++.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986 4668999999999999999999999997543211 1111122233455677889999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 015965          353 ALRP-----DFSEIIE  363 (397)
Q Consensus       353 ~~Rp-----s~~ell~  363 (397)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~~~~  254 (279)
T cd05633         239 SKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHhcCCCCCCHHHHHh
Confidence            9999     5888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-40  Score=314.09  Aligned_cols=253  Identities=25%  Similarity=0.447  Sum_probs=202.9

Q ss_pred             ceeeee--CCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      ..||.|  +||+||++++  .++.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999987  678899999987655555567889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-------
Q 015965          196 GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-------  267 (397)
Q Consensus       196 ~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-------  267 (397)
                      ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++++||+.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            9999998764 24589999999999999999999999999999999999999999999999986543222111       


Q ss_pred             -ccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------------
Q 015965          268 -MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-----------------  327 (397)
Q Consensus       268 -~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-----------------  327 (397)
                       .....++..|+|||++.+  ..++.++|||||||++|+|++|..||......+.........                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             111235677999999976  347899999999999999999999998776544443322110                 


Q ss_pred             ----------------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH--HHHHHHHHHh
Q 015965          328 ----------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQIAKEV  372 (397)
Q Consensus       328 ----------------------------~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell--~~L~~l~~~~  372 (397)
                                                  .+...+..+++.+.+|+++||..||++|||+.+++  ..+..+.++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~  318 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT  318 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence                                        01112234567899999999999999999999997  4566665544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.3e-40  Score=310.46  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=204.5

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-----
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----  184 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  184 (397)
                      ..++|++.+.||+|+||.||+|..  .++.||+|+++...........+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            346789999999999999999987  4678999998765433333456778999999999999999999987654     


Q ss_pred             -----ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          185 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       185 -----~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                           .+++|+||+++ +|.+.+......+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence                 78999999965 788888765567999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc--ccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC------
Q 015965          260 RVKAQSGV--MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  330 (397)
Q Consensus       260 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~------  330 (397)
                      ........  .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+......+      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            76544321  223356888999998864 457889999999999999999999998776655443333211000      


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ----------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                            .....+++.+.+++.+||+.||.+||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                  011246889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.4e-40  Score=310.30  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=199.4

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      .++|++.++||+|+||.||++..  +++.||||.+............+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            36799999999999999999987  4678999988754433333445678999999999999999999987654      


Q ss_pred             --ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          185 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       185 --~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                        ..++||||+ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCC-CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence              349999999 46899888775567999999999999999999999999999999999999999999999999999755


Q ss_pred             ccCCc-----ccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--CCCCC---
Q 015965          263 AQSGV-----MTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPT---  331 (397)
Q Consensus       263 ~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~--~~~~~---  331 (397)
                      .....     .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...++......+..-  ...+.   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            43221     2234578899999988654 4788999999999999999999999876654332211110  00000   


Q ss_pred             ------------C-------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 ------------I-------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ------------~-------------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                  .             +...++.+.++|.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                        0             1123567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.7e-40  Score=304.63  Aligned_cols=242  Identities=26%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             eeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||.|+||.||++.+.  ++.+++|++..... .......+.+|+.++++++||||+++++.+......|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999885  78899999876533 234456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC---------ccc
Q 015965          199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---------VMT  269 (397)
Q Consensus       199 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~---------~~~  269 (397)
                      .+++... +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......         ...
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999874 478999999999999999999999999999999999999999999999999987544331         223


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCC--CcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~c  347 (397)
                      ...++..|+|||.+....++.++|+||||+++|+|++|..||....+.+....+.....  ..+..  .++.+.+++.+|
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~  237 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVSDEAIDLISKL  237 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCCHHHHHHHHHH
Confidence            34678899999999888899999999999999999999999988877766655544332  23333  389999999999


Q ss_pred             chhCCCCCCCHHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~  366 (397)
                      |+.+|.+|||+..+.+.|+
T Consensus       238 l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         238 LVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             hcCCHhhcCCCccHHHHhc
Confidence            9999999999955554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=305.54  Aligned_cols=247  Identities=25%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             ccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceEEEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTE  191 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~E  191 (397)
                      |++.+.||.|+||.||+|...  ++.+|+|.++...........+.+|+.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999875  47899999987643344456788999999999999999999999887  78999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--ccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--~~~  269 (397)
                      |++ ++|.+++......+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++.......  ...
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            996 58999887655689999999999999999999999999999999999999999999999999997655443  233


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-------------------
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------------  329 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-------------------  329 (397)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+......                   
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            4467889999998764 45789999999999999999999999877655443333221000                   


Q ss_pred             ----------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ----------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ----------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                ......+++.+.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                      0011223789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-40  Score=332.07  Aligned_cols=250  Identities=17%  Similarity=0.297  Sum_probs=189.2

Q ss_pred             cccccccceeeeeCCceEEEEEECC---cceEEEEe---------------cCCCCChHHHHHHHHHHHHHhcCCCCCee
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVL---------------KPERINSDMQKEFAQEVFIMRKVRHKNVV  174 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~---------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv  174 (397)
                      .++|+++++||+|+||+||++....   ..+++|.+               +...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3679999999999999999986532   11222211               11111223445688999999999999999


Q ss_pred             eeeeEEecCCceEEEEEeccCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc
Q 015965          175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  250 (397)
Q Consensus       175 ~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~  250 (397)
                      ++++++...+..|+|+|++ +++|.+++...    ........+..++.||+.||.|||++|||||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999999 56888877542    123345677889999999999999999999999999999999999


Q ss_pred             eEEcccccccccccCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCC--hHHHHHHhhh
Q 015965          251 VKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYLT--PLQAAVGVVQ  325 (397)
Q Consensus       251 vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~-P~~~~~--~~~~~~~~~~  325 (397)
                      +||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|.. ||....  +......++.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999998654432  2234579999999999999999999999999999999999875 453322  2222222111


Q ss_pred             cC------C---------------CCCC---------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          326 KG------L---------------RPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       326 ~~------~---------------~~~~---------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..      +               ....         ...++..+.+++.+||+.||.+|||+.|++.
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00      0               0000         1134567888999999999999999999975

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=322.16  Aligned_cols=244  Identities=25%  Similarity=0.420  Sum_probs=211.4

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCC
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS  197 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~s  197 (397)
                      ++||+|.||+||-|++  +|++||||++.+.+........+.+|+.||++++||.||.+...|++++.+++|||.+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            6899999999998875  68999999999887776666788999999999999999999999999999999999996655


Q ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC---CceEEcccccccccccCCcccCCCCC
Q 015965          198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVMTAETGT  274 (397)
Q Consensus       198 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~---~~vkl~DfG~a~~~~~~~~~~~~~gt  274 (397)
                      |.-.|...++.+++.....++.||+.||.|||-+||+|+||||+|||+...   -++||||||+||+........+.+||
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT  729 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT  729 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence            666667778999999999999999999999999999999999999999643   47999999999999988888889999


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      |.|.|||++..+.|...-|+||+|+++|--+.|..||...........-..--..+.....++++..+||..+|+..-.+
T Consensus       730 PAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~k  809 (888)
T KOG4236|consen  730 PAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRK  809 (888)
T ss_pred             ccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999996543322111111111244555678999999999999999999


Q ss_pred             CCCHHHHHH
Q 015965          355 RPDFSEIIE  363 (397)
Q Consensus       355 Rps~~ell~  363 (397)
                      |-|....+.
T Consensus       810 Rysvdk~ls  818 (888)
T KOG4236|consen  810 RYSVDKSLS  818 (888)
T ss_pred             hcchHhhcc
Confidence            999887653

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-39  Score=308.87  Aligned_cols=247  Identities=30%  Similarity=0.451  Sum_probs=208.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ..|...+.||.|+||.||+|..  .++.+|+|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4577788999999999999987  457799999875422 3344567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+. ++|.+++......+++..+..++.|++.|+.|||+++++||||+|+||+++.++.++|+|||++.....   ...
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~  170 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANX  170 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---ccc
Confidence            9995 688888866566789999999999999999999999999999999999999999999999999875543   234


Q ss_pred             CCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          271 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       271 ~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ..+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+..+....+.........+..++..+.++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            56889999999974   356788999999999999999999999877766555554444333333456888999999999


Q ss_pred             chhCCCCCCCHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEI  364 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~  364 (397)
                      |..+|++||++.+++..
T Consensus       251 l~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         251 LQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             hhCCcccCCCHHHHhhC
Confidence            99999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-40  Score=316.39  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=204.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-----Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  186 (397)
                      .+|.+.+.||+|+||.||++..  +++.||||.++...........+.+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4699999999999999999986  467899999876543333455677899999999999999999987654     347


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      |++|||+ +++|.+++.. .+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            9999999 5789998876 467999999999999999999999999999999999999999999999999999765443 


Q ss_pred             CcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-------------------
Q 015965          266 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------------------  325 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~-------------------  325 (397)
                      .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+.......+..                   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            23345578999999998864 4688999999999999999999999976543222111110                   


Q ss_pred             ----c-C--CC---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 015965          326 ----K-G--LR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI  368 (397)
Q Consensus       326 ----~-~--~~---~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~--L~~l  368 (397)
                          . .  .+   ......+++++.+++.+||+.+|.+|||+.++++.  |..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                0 0  00   01124578899999999999999999999999865  6554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=306.39  Aligned_cols=247  Identities=24%  Similarity=0.392  Sum_probs=208.0

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |++.+.||.|++|.||++..  .++.+++|.++...........+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56678999999999999986  4677999998876555445677889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCCC
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  272 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~~  272 (397)
                      + ++|.+++......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            6 58999888766789999999999999999999999999999999999999999999999999997665443 333456


Q ss_pred             CCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC---------------------
Q 015965          273 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------------  330 (397)
Q Consensus       273 gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~---------------------  330 (397)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+                     
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            88899999998776 78999999999999999999999998877655443332211100                     


Q ss_pred             -------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 -------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 -------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                             .....++.++.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   112346789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-39  Score=307.83  Aligned_cols=244  Identities=29%  Similarity=0.455  Sum_probs=207.3

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      |...++||+|+||.||+|+.  .++.|++|++..... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999986  567899999875433 334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  272 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  272 (397)
                      +. ++|.+++......+++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++....   ......
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~  178 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV  178 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence            95 68888887666779999999999999999999999999999999999999999999999999986432   233557


Q ss_pred             CCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          273 GTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       273 gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      |+..|+|||++.   ...++.++||||||+++|+|++|..||...+....................++..+.+++.+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            899999999984   45688899999999999999999999988877666665554433333344577889999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .+|.+||++.+++.
T Consensus       259 ~~P~~Rp~~~~~l~  272 (313)
T cd06633         259 KIPQERPASAELLR  272 (313)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=304.74  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=204.0

Q ss_pred             ccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcC---CCCCeeeeeeEEecCCc-----
Q 015965          116 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPS-----  185 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  185 (397)
                      |++.+.||.|+||.||+|++.  ++.||+|.++...........+.+|+.+++++   +||||+++++.+.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999984  67899999986544443445567788777665   59999999999988776     


Q ss_pred             eEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+++|||++ ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            899999996 58999887643 3689999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------  330 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--------------  330 (397)
                      ........++..|+|||++.+..++.++|+||||+++|+|++|.+||...+..+....+......+              
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence            544445568899999999999899999999999999999999999998877666555443321100              


Q ss_pred             ---C--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ---T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ---~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                         .        .....++.+.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               0        01134577899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.1e-40  Score=311.56  Aligned_cols=248  Identities=22%  Similarity=0.396  Sum_probs=202.4

Q ss_pred             ccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccC
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.+++.+|.|+++.||++..+++.||||+++...........+.+|+.+++.++||||+++++++......+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            45566677777778888888889999999987644555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--------
Q 015965          196 GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--------  266 (397)
Q Consensus       196 ~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--------  266 (397)
                      ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.......        
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999999764 3568999999999999999999999999999999999999999999999999886443221        


Q ss_pred             cccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------
Q 015965          267 VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  328 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------  328 (397)
                      ......++..|+|||++.+  ..++.++|+||||+++|+|++|..||.................                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1233457888999999866  3588999999999999999999999987665444332221110                


Q ss_pred             ----------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 ----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ----------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                      .......++.++.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                            00111233567899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=322.95  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=229.1

Q ss_pred             cCcccccccceeeeeCCceEEEEEECCcc--eEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +...+++++..||-|+||.|-++...++.  +|+|++++... .....+.+..|.++|..++.|.||++|..|.+...+|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            44567888889999999999999887766  89999887543 4455677889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +.||-|-||.|...|++ ++.+.......++..++.|++|||++|||+|||||+|++++.+|.+||.|||+|+....+..
T Consensus       497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999999988 78899999999999999999999999999999999999999999999999999999998888


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      .-+++|||.|.|||++.++..+.++|+||||+++|||++|.+||.+.++..++..+++..-...+|..++....+|++++
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L  655 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL  655 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence            89999999999999999999999999999999999999999999999999999988887777788999999999999999


Q ss_pred             chhCCCCCCC
Q 015965          348 WQQDPALRPD  357 (397)
Q Consensus       348 l~~dp~~Rps  357 (397)
                      ...+|.+|..
T Consensus       656 Cr~~P~ERLG  665 (732)
T KOG0614|consen  656 CRDNPTERLG  665 (732)
T ss_pred             HhcCcHhhhc
Confidence            9999999985

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-39  Score=304.50  Aligned_cols=247  Identities=25%  Similarity=0.443  Sum_probs=202.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|++.++||.|++|.||+|+.  .++.||||+++..... .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            478889999999999999987  4677999998865432 2235577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-ccc
Q 015965          193 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  269 (397)
Q Consensus       193 ~~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~  269 (397)
                      ++ ++|.+++....  ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||+++...... ...
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            96 48999887543  468999999999999999999999999999999999999999999999999997554322 223


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------CCC-
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------RPT-  331 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------~~~-  331 (397)
                      ...++..|++||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.....                ... 
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            4567899999999865 4578899999999999999999999987765544333322110                000 


Q ss_pred             ----------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ----------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                ....+++.+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      11245788999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-40  Score=310.54  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=196.1

Q ss_pred             cccccceeeeeCCceEEEEEE----CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--CceE
Q 015965          115 HLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  187 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  187 (397)
                      +|++.+.||+|+||.||+|..    .++.||+|.+..... .......+.+|+.++++++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            477889999999999999987    457899999886431 122335678899999999999999999999887  7899


Q ss_pred             EEEEeccCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC----CCceEEcccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----NEVVKVADFGVA  259 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~----~~~vkl~DfG~a  259 (397)
                      +||||++ ++|.+++....    ..+++..++.++.||+.||.|||++||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999995 57777765332    36899999999999999999999999999999999999999    899999999999


Q ss_pred             cccccCCc----ccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHhhh
Q 015965          260 RVKAQSGV----MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ---------AAVGVVQ  325 (397)
Q Consensus       260 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~---------~~~~~~~  325 (397)
                      +.......    .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......         ....++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            76543322    223467899999998865 458899999999999999999999997554321         0000000


Q ss_pred             ------------------------cCCCCCCC-----------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          326 ------------------------KGLRPTIP-----------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       326 ------------------------~~~~~~~~-----------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                              .......+           ...+.++.+++.+||+.||++|||+.++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                                    00011111           156678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.7e-40  Score=304.98  Aligned_cols=247  Identities=25%  Similarity=0.481  Sum_probs=211.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  189 (397)
                      ++|.+.+.||+|+||.||++..  .++.||+|++..... .......+.+|+.++++++ ||||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            3688899999999999999987  568899999876433 2334567889999999999 99999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC---
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~---  266 (397)
                      |||+++++|.+++.+ .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999999987 4579999999999999999999999999999999999999999999999999987544322   


Q ss_pred             ------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC
Q 015965          267 ------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       267 ------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~  328 (397)
                                        ......++..|+|||++....++.++|+||||++++++++|..||...+.......+..  .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~  237 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK--L  237 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--c
Confidence                              11233578999999999888899999999999999999999999998776555554442  2


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCH----HHHHH
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDF----SEIIE  363 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~----~ell~  363 (397)
                      ....+..+++.+.+++.+||+.+|.+||++    .+++.
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            345667789999999999999999999999    76653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=352.85  Aligned_cols=248  Identities=30%  Similarity=0.489  Sum_probs=215.6

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      ++.-+..||.|.||.||-+..  +|...|+|.++...........+.+|..++..++|||+|++||+-.+...++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            455667899999999999875  677799998886655444456688999999999999999999999988899999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-----Cc
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----GV  267 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-----~~  267 (397)
                      |.||+|.+.++. .+..++.....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|.....+     +.
T Consensus      1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999999999876 456777788889999999999999999999999999999999999999999999755443     23


Q ss_pred             ccCCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      .....||+.|||||++.+   ++...++|||||||++.||+||+-||..++..-.++=-+..+-.|.+|..++++-.+||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            445689999999999965   44667899999999999999999999988877666666777788999999999999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||..||+.|-++.||++
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHH
Confidence            9999999999988887654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.5e-39  Score=301.86  Aligned_cols=241  Identities=28%  Similarity=0.428  Sum_probs=194.7

Q ss_pred             eeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-HHHHHHHHHH---HHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEV---FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      .||+|+||.||++..  .++.||+|++....... .....+..|.   .+++...||+|+.+++.+...+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999876  46789999987654322 1122233443   34555679999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCC
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  274 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  274 (397)
                      |++|.+++.. .+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...... ......|+
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence            9999998875 567999999999999999999999999999999999999999999999999998754332 22345789


Q ss_pred             cccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCC
Q 015965          275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP  352 (397)
Q Consensus       275 ~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp  352 (397)
                      ..|+|||++.+ ..++.++||||+|+++|+|++|..||....... ...........+..+..+++++.+++.+||..+|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            99999999874 468999999999999999999999997663211 1111122233456677789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 015965          353 ALRP-----DFSEIIE  363 (397)
Q Consensus       353 ~~Rp-----s~~ell~  363 (397)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~ll~  254 (278)
T cd05606         239 NRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HhccCCCCCCHHHHHh
Confidence            9999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=312.47  Aligned_cols=251  Identities=26%  Similarity=0.449  Sum_probs=199.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-----Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  186 (397)
                      ++|++.+.||+|+||.||+|.+  +++.||||+++... .......+.+|+.++++++||||+++++++...     ...
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            5799999999999999999976  56789999987532 223456688899999999999999999887544     347


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+++||+. ++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            99999995 588887754  578999999999999999999999999999999999999999999999999987544322


Q ss_pred             ----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh---------------c
Q 015965          267 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ---------------K  326 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~---------------~  326 (397)
                          ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..               .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence                1233468999999998654 5689999999999999999999999976543322111110               0


Q ss_pred             C---------CCCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 015965          327 G---------LRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI  368 (397)
Q Consensus       327 ~---------~~~~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~--L~~l  368 (397)
                      .         ..+.     .....++++.+++.+||+.||++|||+.++++.  |+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            0         0000     112457789999999999999999999999865  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=312.44  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-----ceE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC  187 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  187 (397)
                      +|++.+.||.|+||.||+|...  ++.||||.+..........+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999874  578999998865444455677999999999999999999999987765     789


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ++|||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+....... 
T Consensus        81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            9999996 589998876 4589999999999999999999999999999999999999999999999999998665442 


Q ss_pred             ---cccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC------------
Q 015965          267 ---VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------  330 (397)
Q Consensus       267 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~------------  330 (397)
                         ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+......+            
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               24455789999999999887 89999999999999999999999998777655444333211100            


Q ss_pred             -----------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHHH
Q 015965          331 -----------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQIA  369 (397)
Q Consensus       331 -----------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~--L~~l~  369 (397)
                                       .....+++.+.+++.+||+.+|.+||++.+++..  |+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                             0123467889999999999999999999999863  55543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-39  Score=304.92  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=202.1

Q ss_pred             cccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCce
Q 015965          115 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  186 (397)
                      .|++.+.||.|+||.||++..     +++.||+|+++....  .....+.+.+|+.+++++ +|+||+++++.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            377889999999999999976     567899999875432  122346688899999999 589999999999998899


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999999999999976 4678999999999999999999999999999999999999999999999999997654322


Q ss_pred             --cccCCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhhcCCCCCCCCCCcHH
Q 015965          267 --VMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       267 --~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                        ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......   ......... ..+..+..+++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL  238 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHH
Confidence              22345689999999998653  4678999999999999999999999643322   112221211 234456778999


Q ss_pred             HHHHHHHhchhCCCCCC-----CHHHHHH
Q 015965          340 LAELLERCWQQDPALRP-----DFSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rp-----s~~ell~  363 (397)
                      +.+++.+||+.||.+||     ++.+++.
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            99999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=328.08  Aligned_cols=256  Identities=32%  Similarity=0.610  Sum_probs=226.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ..++..++||+|+||+||+|.|-      +-+||||++.... ......++++|+.+|.+++|||+++++++|.... +-
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            45666789999999999999873      3469999987543 3344678999999999999999999999998755 88


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||++||++|+|.++++.+++.+-.+.++.|..||++||.|||.++++||||..+|||+.+-.+|||.|||+++.......
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999997665432


Q ss_pred             -ccCCCC--CcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          268 -MTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       268 -~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                       .....|  .+.|||-|.+....|++++|||||||++||++| |..||.+.... .+.+.++.+.|...|..++.++..+
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRLsqPpiCtiDVy~~  932 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERLSQPPICTIDVYMV  932 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccCCCCCCccHHHHHH
Confidence             222223  678999999999999999999999999999999 99999988764 4567788888999999999999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +.+||..|+..||+|+++.+.+.++.++.
T Consensus       933 mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            99999999999999999999999886653

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-39  Score=313.46  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----CCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~  187 (397)
                      ++|++.+.||.|+||.||+|..  .++.||+|++............+.+|+.+|++++||||+++++++..    ...+|
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6788899999999999999976  46789999988654433445677889999999999999999988753    34689


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      +||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        85 lv~e~~-~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLM-ESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehh-hhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            999999 4689998865 4569999999999999999999999999999999999999999999999999987543322 


Q ss_pred             ----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc---------------
Q 015965          267 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK---------------  326 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~---------------  326 (397)
                          ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                1234578999999999865 45889999999999999999999999776543322111110               


Q ss_pred             ---------CCCCCC-----CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          327 ---------GLRPTI-----PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       327 ---------~~~~~~-----~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                               ......     ....++++.+++.+||+.+|++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                     001111     1346889999999999999999999998875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=298.39  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=213.8

Q ss_pred             CCCCccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHH-HhcCCCCCeeeeeeEE
Q 015965          104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGAC  180 (397)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~  180 (397)
                      +....|++..++++-+..||.|+||+|++-.+  .++..|||.++.... ...+++++.|... ++.-++||||++||++
T Consensus        54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            34456788889999999999999999998765  567899999987654 3345678888766 4555799999999999


Q ss_pred             ecCCceEEEEEeccCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcc
Q 015965          181 TKPPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVAD  255 (397)
Q Consensus       181 ~~~~~~~lv~E~~~g~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~D  255 (397)
                      ..++..+|.||.| ..||..+...    .+..+++..+-.|....+.||+||-.. .|||||+||+|||++..|.|||||
T Consensus       133 F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  133 FSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             hcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence            9999999999999 6787765432    256799999999999999999999865 899999999999999999999999


Q ss_pred             cccccccccCCcccCCCCCcccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCCCCCC
Q 015965          256 FGVARVKAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTI  332 (397)
Q Consensus       256 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~~  332 (397)
                      ||.+.....+...+...|...|||||.+.  ...|+.+||+||||++|||+.||..||...+.. +.+..++ .+-.|.+
T Consensus       212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-~gdpp~l  290 (361)
T KOG1006|consen  212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-IGDPPIL  290 (361)
T ss_pred             ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-cCCCCee
Confidence            99998887777788889999999999994  346999999999999999999999999987653 3333333 3322221


Q ss_pred             --C---CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          333 --P---KNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       333 --~---~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                        +   ...+..+..++.-|+.+|-..||.+.++++.
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              2   2367899999999999999999999998653

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=301.28  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=202.0

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      |++.+.||+|+||.||+|..  .++.|+||.+.......+ .....+|+..+++++ ||||+++++.+..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            56788999999999999987  457799999875543222 234557899999999 99999999999999999999999


Q ss_pred             ccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCC
Q 015965          193 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  271 (397)
                      + +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence            9 889999987654 47899999999999999999999999999999999999999999999999999866554444556


Q ss_pred             CCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---------------------
Q 015965          272 TGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------------  329 (397)
Q Consensus       272 ~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---------------------  329 (397)
                      .++..|+|||++. ...++.++|+||||+++|+|++|..||...+.......+......                     
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            7899999999874 455889999999999999999999999877654443322210000                     


Q ss_pred             -------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 -------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 -------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                             .......+..+.+++++||+.||++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                   0011123678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.8e-39  Score=303.16  Aligned_cols=242  Identities=30%  Similarity=0.492  Sum_probs=203.6

Q ss_pred             cccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          117 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       117 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      ....+||+|+||.||++..  .++.||||.+...  .......+.+|+.+++.++|+||+++++.+...+..+++|||++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3346899999999999977  5678999987643  23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCCCC
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG  273 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~~g  273 (397)
                      +++|.+++..  +.+++..+..++.|++.|+.|||+.|++||||+|+||++++++.++|+|||++...... .......|
T Consensus       101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            9999998754  56899999999999999999999999999999999999999999999999998654332 12334568


Q ss_pred             CcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHhchhC
Q 015965          274 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       274 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl~~d  351 (397)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+ .....+.  ....+++.+.+++.+||+.|
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            99999999998888999999999999999999999999877665544332 2222222  23457889999999999999


Q ss_pred             CCCCCCHHHHHH
Q 015965          352 PALRPDFSEIIE  363 (397)
Q Consensus       352 p~~Rps~~ell~  363 (397)
                      |.+||++.+++.
T Consensus       258 P~~R~~~~~ll~  269 (292)
T cd06657         258 PAQRATAAELLK  269 (292)
T ss_pred             cccCcCHHHHhc
Confidence            999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.1e-39  Score=298.67  Aligned_cols=247  Identities=29%  Similarity=0.533  Sum_probs=207.1

Q ss_pred             cccccceeeeeCCceEEEEEECC--cceEEEEecCCC---CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +|.+.++||+|+||.||++.+..  ..+++|+++...   ........+.+|+.++++++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998753  456777766432   2223345577899999999999999999999998999999


Q ss_pred             EEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          190 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      |||+++++|.+++...   ...+++..++.++.|++.|+.|||++|++|+||+|+||+++. +.++|+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            9999999999988642   356899999999999999999999999999999999999975 57999999998765433 


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                      .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............. .+..+..+..++.++.+++.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHH
Confidence            22334568899999999988889999999999999999999999998776655554443 34455667788899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||++||++.++++
T Consensus       239 ~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         239 SMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHhcCChhhCcCHHHHhh
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=296.16  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=200.2

Q ss_pred             ccccc-ceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEec----CCce
Q 015965          115 HLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPSL  186 (397)
Q Consensus       115 ~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~  186 (397)
                      +|.+. ++||-|-.|.|..+..  +++.+|+|++...       ....+|+++.-.. .|||||.+++++..    ...+
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            44443 4799999999998854  6788999997632       3356788885554 59999999998754    4567


Q ss_pred             EEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVK  262 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~  262 (397)
                      .+|||.|+||.|.+.+++.. ..+++..+..|+.||..|+.|||+.+|.||||||+|+|...   +..+||+|||+|+..
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            89999999999999998753 46999999999999999999999999999999999999974   557999999999988


Q ss_pred             ccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHhhhcCC--CCCCCCCC
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL----QAAVGVVQKGL--RPTIPKNS  336 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~----~~~~~~~~~~~--~~~~~~~~  336 (397)
                      ..+..+.+.+-||.|.|||++....|+..+|+||+|++||-|+||.+||......    .+..++.....  ..+-...+
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence            8788888999999999999999999999999999999999999999999765432    22222222222  22223467


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++..+++|+++|..+|.+|.|+.++++
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            899999999999999999999999874

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.6e-39  Score=306.71  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=199.3

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      .++|++.++||+|+||.||+|.+.  ++.+|||++............+.+|+.+++.++||||+++++.+....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            368999999999999999999874  677999988654333323345678999999999999999998875433      


Q ss_pred             --ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          185 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       185 --~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                        .+++||||+. ++|...+......+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||+++..
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence              4699999995 5788887765668999999999999999999999999999999999999999999999999999754


Q ss_pred             ccCCc------------ccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC
Q 015965          263 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR  329 (397)
Q Consensus       263 ~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~  329 (397)
                      .....            .+...+++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+.......+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            43221            122356888999998765 45889999999999999999999999877765544333221100


Q ss_pred             C---------------------CC-------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 P---------------------TI-------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ~---------------------~~-------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +                     ..       ....++.+.+++.+||+.||.+|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0                     00       0234468899999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-39  Score=309.19  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=207.3

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-  184 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  184 (397)
                      .|.+ .++|++.+.||+|+||.||++..  .++.||||.++...........+.+|+.+|++++||||+++++++.... 
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4555 36799999999999999999976  4677999998765444445567889999999999999999999887654 


Q ss_pred             -----ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          185 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       185 -----~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                           ..++||||+ |++|.+++..  ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                 358999999 8899988864  57899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---------
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------  329 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---------  329 (397)
                      ......  .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......         
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            754332  234567899999999865 45888999999999999999999999876654443332221100         


Q ss_pred             --------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH--HHHHHH
Q 015965          330 --------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQI  368 (397)
Q Consensus       330 --------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell--~~L~~l  368 (397)
                                          ......+++.+.+++.+|++.||.+|||+.+++  ..++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                                012245778899999999999999999999988  344443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.3e-39  Score=310.29  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecC--CceEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP--PSLCI  188 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~l  188 (397)
                      ++|++.+.||+|+||.||+|.+  .++.+|+|.+............+.+|+.+++++ +||||+++++++...  ...|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            5789999999999999999987  467899998865443444456677899999999 999999999988643  35899


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--  266 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--  266 (397)
                      ||||++ ++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.++......  
T Consensus        87 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          87 VFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             Eecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            999996 599998875  378889999999999999999999999999999999999999999999999997544322  


Q ss_pred             ----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC------------
Q 015965          267 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------  329 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~------------  329 (397)
                          ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+......            
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                2233468999999998754 55788999999999999999999999876554433322111100            


Q ss_pred             -----------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          330 -----------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       330 -----------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                                       ......++.++.+++.+||+.||++|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                             01123368899999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-39  Score=304.21  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=206.2

Q ss_pred             cccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCCC--hHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCce
Q 015965          115 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  186 (397)
                      +|++.+.||+|+||.||++..     .++.||||+++.....  ......+.+|+.+++++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            377889999999999999875     3466999998754321  22345688999999999 599999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999999999999876 4578999999999999999999999999999999999999999999999999987644332


Q ss_pred             c--ccCCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCCCCCCCCCCcH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~P~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      .  .....|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||.....    .+....+.  ...+..+..+++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTMSA  237 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCcccCH
Confidence            1  22346899999999987654  78899999999999999999999964322    12222222  223456677889


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .+.+++.+||+.||++|||+.++.+.|+..
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            999999999999999999998887777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.6e-39  Score=307.50  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=199.3

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChH------------HHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      ..+.+.||.|+||.||+|.+  .++.||||+++.......            ....+.+|+.++++++||||+++++++.
T Consensus        11 ~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   90 (335)
T PTZ00024         11 IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV   90 (335)
T ss_pred             hhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence            34567899999999999986  467899999875432221            0124778999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      .....|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||.++.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         91 EGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             cCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence            9999999999995 699999865 56789999999999999999999999999999999999999999999999999875


Q ss_pred             cccC---------------CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh
Q 015965          262 KAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       262 ~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~  325 (397)
                      ....               .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            5411               112233568899999998764 478899999999999999999999988776554443322


Q ss_pred             cCCCC--------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          326 KGLRP--------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       326 ~~~~~--------------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ....+                          ......+.++.+++.+||+.+|++||++.+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11000                          011345788999999999999999999999874

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=293.98  Aligned_cols=236  Identities=28%  Similarity=0.424  Sum_probs=204.8

Q ss_pred             eeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          122 VASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      ||.|+||.||++...  ++.+|+|++...... ......+..|+.++++++||||+++++.+......|++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999874  678999998765432 23456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCCCCCccc
Q 015965          199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW  277 (397)
Q Consensus       199 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~~gt~~y  277 (397)
                      .+++.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            999976 346899999999999999999999999999999999999999999999999999765443 234455789999


Q ss_pred             ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCC
Q 015965          278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD  357 (397)
Q Consensus       278 ~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps  357 (397)
                      +|||.+.+..++.++|+||||+++|+|++|..||......+....+..  .....+...+..+.+++.+||..||++||+
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999888899999999999999999999999987776554444444  345677778999999999999999999999


Q ss_pred             HHH
Q 015965          358 FSE  360 (397)
Q Consensus       358 ~~e  360 (397)
                      +.+
T Consensus       238 ~~~  240 (250)
T cd05123         238 SGG  240 (250)
T ss_pred             ccc
Confidence            944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-39  Score=309.94  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=205.3

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ..|++. ++|.+.+.||+|+||.||+|.+  +++.||||.++...........+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879           9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            346664 5799999999999999999986  4678999998765444444566889999999999999999999886543


Q ss_pred             ------ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          185 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       185 ------~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                            ..|+||||+. .+|..++   ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          88 SGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             cCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence                  4689999995 5777665   34689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC---------
Q 015965          259 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------  328 (397)
Q Consensus       259 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~---------  328 (397)
                      ++....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+.....         
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875432  2334567899999999866 4688999999999999999999999987765444333222100         


Q ss_pred             ------------CCCC--------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHH
Q 015965          329 ------------RPTI--------PKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIA  369 (397)
Q Consensus       329 ------------~~~~--------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l~  369 (397)
                                  .+..        ....++++.+++.+||+.||.+||++.+++.  .++.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                        0000        1246778999999999999999999999984  366653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.3e-40  Score=335.73  Aligned_cols=245  Identities=26%  Similarity=0.461  Sum_probs=195.7

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-------
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  184 (397)
                      .+|+.++.||+|+||.||+++.  +|+.||||.+.... +......+.+|+.+|.+|+|||||+++.+|.+..       
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            5688889999999999999975  78999999998776 5555677999999999999999999986542110       


Q ss_pred             --------------------------------------------------------------------------------
Q 015965          185 --------------------------------------------------------------------------------  184 (397)
Q Consensus       185 --------------------------------------------------------------------------------  184 (397)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015965          185 --------------------------------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN  232 (397)
Q Consensus       185 --------------------------------~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  232 (397)
                                                      .+||-||||+..+|.++++.....-.....|+++.+|+.||.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                            268999999988888888763221147789999999999999999999


Q ss_pred             cccCCCCCCcEEeCCCCceEEcccccccccc-------------------cCCcccCCCCCcccccccccCCC---CCCC
Q 015965          233 IIHRDLKAANLLMDENEVVKVADFGVARVKA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDH  290 (397)
Q Consensus       233 iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~---~~~~  290 (397)
                      ||||||||.||++++++.|||+|||+|+...                   ..+..+..+||..|+|||++.+.   .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999997511                   11234566899999999999665   4999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHhhhcCCCCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          291 KADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTI---PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       291 ~~Dv~slG~~l~ell~g~~P~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      |+|+||||++++||+.   ||. .+.....+.+.. .+.-|..   .....+.-+.+|+.|++.||.+||||.|+|.
T Consensus       798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            9999999999999986   454 344444444433 3333332   3334466789999999999999999999973

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.9e-38  Score=304.08  Aligned_cols=246  Identities=25%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-CCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  190 (397)
                      ++|++.+.||.|+||.||++..  .++.||||.+..........+.+.+|+.++++++||||+++++++.. ....|++|
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            6799999999999999999976  46779999887554444445678899999999999999999998865 45789999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+.....  ....
T Consensus        90 e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~  164 (328)
T cd07856          90 ELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTG  164 (328)
T ss_pred             ehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCC
Confidence            999 6799988864  5688889999999999999999999999999999999999999999999999875432  2334


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-----------------------c
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-----------------------K  326 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~-----------------------~  326 (397)
                      ..++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+..                       .
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            567889999998765 5789999999999999999999999987665322111110                       0


Q ss_pred             -CCCCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          327 -GLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       327 -~~~~~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                       .....     ....+++++.+++.+||+.+|++||++.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00001     113467899999999999999999999998643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-39  Score=310.89  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=205.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc-
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  185 (397)
                      |++. ++|++.+.||+|+||.||+|...  ++.||||++............+.+|+.++++++||||+++++++..... 
T Consensus        11 ~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          11 WEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             eccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            4443 57999999999999999999874  5779999987654444445678889999999999999999987765544 


Q ss_pred             -----eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          186 -----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       186 -----~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                           .++|+||+ +++|.+++..  ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence                 89999999 7799998875  578999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC----------
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------  329 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~----------  329 (397)
                      .....  .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+......          
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65432  345578899999999855 46889999999999999999999999877665444333221100          


Q ss_pred             ----------------C---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ----------------P---TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ----------------~---~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                      +   ......++++.+++.+||+.||.+|||+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                            0   011245889999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-39  Score=308.66  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=202.4

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC---
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP---  183 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  183 (397)
                      |.+. ++|.+.+.||+|+||.||++..  +++.||+|+++.........+.+.+|+.++++++||||+++++++...   
T Consensus        13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            3443 7799999999999999999975  567899999886544444456788899999999999999999987543   


Q ss_pred             ---CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          184 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       184 ---~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                         ...|++++++ |++|.+++..  ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence               3478888887 8899988864  468999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-----------
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-----------  328 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-----------  328 (397)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.....           
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            5432  2344578999999999866 5688999999999999999999999987665443332221100           


Q ss_pred             -------------CC-----CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          329 -------------RP-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       329 -------------~~-----~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                                   .+     ......++++.++|.+||+.||.+||++.+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                         00     0112357889999999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-38  Score=305.92  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=196.8

Q ss_pred             cccccceeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEec----CCc
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPS  185 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~  185 (397)
                      +|++.+.||+|+||.||++.+.    ++.||+|.+............+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999875    45799999875443444456788899999999 49999999987532    245


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      .|+++||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            78999998 5799998865 467899999999999999999999999999999999999999999999999999754432


Q ss_pred             C-----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-------------
Q 015965          266 G-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------  326 (397)
Q Consensus       266 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~-------------  326 (397)
                      .     ......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......++..             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1     1233478999999998765 56899999999999999999999999876543322221110             


Q ss_pred             -------------CCC---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          327 -------------GLR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       327 -------------~~~---~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                                   ...   +.....++..+.+++.+||+.||.+|||+.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence                         000   011234578899999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-38  Score=296.79  Aligned_cols=239  Identities=22%  Similarity=0.405  Sum_probs=192.8

Q ss_pred             cccccccee--eeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEecCCceEE
Q 015965          114 KHLKFGSKV--ASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       114 ~~~~~~~~l--g~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ++|.+.+.+  |+|+||.||++..  .+..+|+|++........       |+..... .+||||+++++.+..++..|+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            355666665  9999999999976  467799999875432221       2222221 269999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccCCc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~~~  267 (397)
                      ||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++.....  
T Consensus        87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            99999999999999774 4899999999999999999999999999999999999999988 9999999998755432  


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-hhh-cCCCCCCCCCCcHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQ-KGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~ll~  345 (397)
                       ....|+..|+|||++.+..++.++|+||||+++|+|++|..||........... ... .......+..+++.+.++|.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence             234689999999999998999999999999999999999999975543221111 111 12233455578999999999


Q ss_pred             HhchhCCCCCCC-HHHHHH
Q 015965          346 RCWQQDPALRPD-FSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps-~~ell~  363 (397)
                      +||+.+|.+||+ +.++++
T Consensus       243 ~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhccChhhCCchHHHHhc
Confidence            999999999996 688863

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=299.03  Aligned_cols=247  Identities=25%  Similarity=0.420  Sum_probs=205.2

Q ss_pred             ccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |++.+.||+|.||.||+|+..  ++.+|+|+++...........+.+|+.++++++|+||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999874  678999999876534444567888999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCCC
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  272 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~~  272 (397)
                      + ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.++...... ......
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            6 59999998755679999999999999999999999999999999999999999999999999997654432 233445


Q ss_pred             CCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-------------------CCC--
Q 015965          273 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------LRP--  330 (397)
Q Consensus       273 gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-------------------~~~--  330 (397)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+....                   ..+  
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            68889999998766 78999999999999999999999998776554443322110                   000  


Q ss_pred             ------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                            ......+..+.+++.+||..||++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                  011234678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-38  Score=306.86  Aligned_cols=245  Identities=23%  Similarity=0.378  Sum_probs=197.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--------
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--------  183 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------  183 (397)
                      .+|.+.+.||.|+||.||+|..  +++.||+|.+.....  ...+.+.+|+.++++++||||+++++.+...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            6799999999999999999987  467899999875433  3346688899999999999999999776543        


Q ss_pred             ------CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEccc
Q 015965          184 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADF  256 (397)
Q Consensus       184 ------~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~Df  256 (397)
                            ...|+||||++ ++|.+++..  +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+||
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                  35789999996 589888864  56899999999999999999999999999999999999974 567899999


Q ss_pred             ccccccccCC----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----
Q 015965          257 GVARVKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----  327 (397)
Q Consensus       257 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~----  327 (397)
                      |.++......    ......++..|+|||++.. ..++.++|||||||++|+|++|+.||...++.+.........    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997543221    1223467889999998644 568889999999999999999999998776655444332210    


Q ss_pred             -------------------CCCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 -------------------LRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 -------------------~~~~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                         ..+.     .....+.++.+++.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                               0000     12346788999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.9e-38  Score=327.46  Aligned_cols=146  Identities=28%  Similarity=0.490  Sum_probs=132.9

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.++||+|+||.||+|.+.  ++.||||+++... ........+.+|+.+++.++||||+++++.+.....+||||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67899999999999999999986  7789999997543 23445577889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      ||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999976 4578999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=317.56  Aligned_cols=253  Identities=26%  Similarity=0.466  Sum_probs=206.4

Q ss_pred             ccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------ceEEE
Q 015965          118 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------SLCIV  189 (397)
Q Consensus       118 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv  189 (397)
                      ..+.||+|+||.||+|+.  .|+.||||.++... .....+...+|+++|++++|||||+++++-++..      ...+|
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            347899999999999975  67889999998765 3334577889999999999999999998755433      35799


Q ss_pred             EEeccCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC--CCC--ceEEcccccccccc
Q 015965          190 TEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENE--VVKVADFGVARVKA  263 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~--~~~--~vkl~DfG~a~~~~  263 (397)
                      ||||.||+|...|++..  ..+++..++.++.++..||.|||++||+||||||.||++-  ++|  ..||+|||.|+..+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            99999999999998653  4699999999999999999999999999999999999994  334  58999999999999


Q ss_pred             cCCcccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHhhhcC-----------
Q 015965          264 QSGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL----QAAVGVVQKG-----------  327 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~----~~~~~~~~~~-----------  327 (397)
                      ++....+.+||..|.+||++. .+.|+..+|.|||||++|++.||..||......    +....+..+.           
T Consensus       176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~  255 (732)
T KOG4250|consen  176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE  255 (732)
T ss_pred             CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc
Confidence            999999999999999999998 488999999999999999999999999543222    2222222111           


Q ss_pred             --------CCCCCCCCCcHH----HHHHHHHhchhCCCCCC--CHHHHHHHHHHHHHH
Q 015965          328 --------LRPTIPKNSQPK----LAELLERCWQQDPALRP--DFSEIIEILQQIAKE  371 (397)
Q Consensus       328 --------~~~~~~~~~~~~----l~~ll~~cl~~dp~~Rp--s~~ell~~L~~l~~~  371 (397)
                              ...+.|...++.    +...+..+|..+|++|-  .+.+.-..+.++++.
T Consensus       256 eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  256 ENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             cCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence                    111234444444    45678888999999998  888888888888765

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=264.59  Aligned_cols=248  Identities=23%  Similarity=0.389  Sum_probs=210.5

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      +|.-.++||+|.||+||+|+.  +++.||+|.++.+..+.......++|+-+++.++|.|||++++....++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455668999999999999976  456799999987766665566788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~  271 (397)
                      | ...|..+....++.+....+..++.|+++|+.|+|++++.|||+||.|+||+.+|.+|++|||+++.+..+- -.+..
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            9 679999999999999999999999999999999999999999999999999999999999999999776653 46677


Q ss_pred             CCCcccccccccCCC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCC------C------------C
Q 015965          272 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR------P------------T  331 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~------~------------~  331 (397)
                      +.|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+-.....++...-..      |            .
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            889999999998665 58899999999999999998 88888888776666665432111      0            1


Q ss_pred             CC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ~~---------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .|         +.....-++++++.+.-+|.+|.++++.++
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11         122334579999999999999999988754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=306.94  Aligned_cols=238  Identities=23%  Similarity=0.357  Sum_probs=200.4

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ...|.+...+|.|+|+.|-.+..  +++..++|++.....+      ..+|+.++.. -+||||+++.+.+.+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence            46788888899999999998876  5677999999866222      2346655444 4699999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe-CCCCceEEcccccccccccCCcc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili-~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      ||++.|+-|.+.+...+  .....+..|+.+|+.++.|||++|+|||||||+|||+ +..++++|+|||.++.....  .
T Consensus       395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C  470 (612)
T ss_pred             ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence            99999998888876632  2236777899999999999999999999999999999 69999999999999876655  4


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ...+-|..|.|||++...+|+.++||||||++||+|++|+.||..-.....+   ..+...+.+...+|+..++|+++||
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i~~~~~s~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRIQMPKFSECVSDEAKDLLQQLL  547 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH---HHhhcCCccccccCHHHHHHHHHhc
Confidence            4556788999999999999999999999999999999999999876655333   3333455666899999999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      +.||.+||++.+++.
T Consensus       548 ~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  548 QVDPALRLGADEIGA  562 (612)
T ss_pred             cCChhhCcChhhhcc
Confidence            999999999999863

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=285.73  Aligned_cols=240  Identities=23%  Similarity=0.426  Sum_probs=199.2

Q ss_pred             ceeeeeCCceEEEEE--ECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          120 SKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +.||+|+|+.|--+.  .++..+|||++.+..  .....++.+|++++.+++ |+||++++++|+++...|+|||.|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            579999999998764  478899999998763  334678899999999986 999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ceEEcccccccccccC--------
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQS--------  265 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~vkl~DfG~a~~~~~~--------  265 (397)
                      +|...+++ +..+++..+.++..+|+.||.|||.+||.||||||+|||....+   -||||||.+..-....        
T Consensus       162 plLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            99999988 56799999999999999999999999999999999999997654   5899999987532221        


Q ss_pred             CcccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHhhhc
Q 015965          266 GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGVVQK  326 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--------------~~~~~~~~~~  326 (397)
                      ....+.+|+..|||||+..     ...|+.++|.||||+++|-|++|.+||.+.-.              .+.+..-++.
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            1234568999999999862     34589999999999999999999999964321              2333344444


Q ss_pred             CCCCCCC----CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          327 GLRPTIP----KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       327 ~~~~~~~----~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +. ..+|    ..++.+.+++++.++..|+.+|.++.+++.
T Consensus       321 Gk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  321 GK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            42 2233    457899999999999999999999999876

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=286.90  Aligned_cols=248  Identities=21%  Similarity=0.388  Sum_probs=210.5

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHH-HHHHHHHHhc-CCCCCeeeeeeEEec
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKE-FAQEVFIMRK-VRHKNVVQFIGACTK  182 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~-~~~E~~~l~~-l~h~niv~~~~~~~~  182 (397)
                      ..|.+...+|.++++||+|+|+.|.+++..  .+.+|+|+++++..+.+..-. ...|-.+..+ -+||.+|-++..|+.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            467888899999999999999999998764  466999999988776543322 3445555544 469999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ++.+++|.||++||+|.-++++ +.+++++.+..+...|+.||.|||++|||+||||.+|||++.+|++||.|+|+++..
T Consensus       323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999999999988876 578999999999999999999999999999999999999999999999999999865


Q ss_pred             cc-CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHh-hhcCCCCCCC
Q 015965          263 AQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-------LTPLQAAVGV-VQKGLRPTIP  333 (397)
Q Consensus       263 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~-------~~~~~~~~~~-~~~~~~~~~~  333 (397)
                      -. ....++.+|||.|+|||++.+..|....|+|+||++|+||+.|+.||+-       .+.......+ +.+.  ..+|
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--irip  479 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIP  479 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccc
Confidence            44 4456788999999999999999999999999999999999999999952       2223333333 3333  3478


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCC
Q 015965          334 KNSQPKLAELLERCWQQDPALRPD  357 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps  357 (397)
                      ..++-....+++..|++||.+|..
T Consensus       480 rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcC
Confidence            888888999999999999999964

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=292.98  Aligned_cols=255  Identities=31%  Similarity=0.524  Sum_probs=209.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhc--CCCCCeeeeeeEEecCC----
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----  184 (397)
                      .+...+++.+.||+|.||.||+|+..++.||||++..     .....|..|-+|.+.  ++|+||++|+++-....    
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            3456678889999999999999999999999999873     335668888888775  57999999999876544    


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEeCCCCceEEcc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVVKVAD  255 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~iiHrDlkp~Nili~~~~~vkl~D  255 (397)
                      .+.||+||.+.|||.+||..  ..+++....+++..|++||+|||+.         .|+|||||..|||+..|+..-|+|
T Consensus       282 eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            78999999999999999986  7899999999999999999999963         699999999999999999999999


Q ss_pred             cccccccccC---CcccCCCCCcccccccccCCCC-CC-----CchhHHHHHHHHHHHHhCCC------------CCC--
Q 015965          256 FGVARVKAQS---GVMTAETGTYRWMAPEVIEHKP-YD-----HKADVFSFGIVLWELLTGKL------------PYE--  312 (397)
Q Consensus       256 fG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slG~~l~ell~g~~------------P~~--  312 (397)
                      ||+|......   +.....+||.+|||||++.+.- +.     .+.||||+|.+||||++...            ||+  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999866543   2333478999999999997653 22     25899999999999998543            232  


Q ss_pred             ---CCChHHHHHHhhhcCCCCCCCCCC-----cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          313 ---YLTPLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       313 ---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                         ..+-.++-.-++++..||.+|...     ...+.+.++.||+.|++.|.|+.=+-+.+.++....
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence               112234445567788888887543     356899999999999999999999999998886543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=265.27  Aligned_cols=218  Identities=31%  Similarity=0.469  Sum_probs=189.1

Q ss_pred             ccccCcccccccceeeeeCCceE--EEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhc-CCCCCeeeeeeEEecCC
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPP  184 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~V--y~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~  184 (397)
                      .+++..+++.-+..||+|+||.|  |+-...|+-.|+|.++... +...+++.++|+.+..+ ..+|.+|.|||+..++.
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            47888899999999999999986  4555678889999998654 45557788889987554 46999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      .++|.||.| ..||..+..+   ..+.+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|+||+||||.+.
T Consensus       119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999999 6788877643   367899999999999999999999986 89999999999999999999999999998


Q ss_pred             ccccCCcccCCCCCcccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcC
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKG  327 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~~l~ell~g~~P~~~-~~~~~~~~~~~~~~  327 (397)
                      ...++-..+-..|...|||||.+.    ...|+.++||||||+++.||.+++.||+. .++.+.+..++...
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            887777777788999999999984    44799999999999999999999999976 57888887777654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-38  Score=301.56  Aligned_cols=245  Identities=21%  Similarity=0.345  Sum_probs=205.1

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .++.+-|..++.||-|+||+|.++..  +...||+|.+.+.. ........+..|..||..-+.+.||++|..|.+.+++
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            56677888899999999999999864  45569999887543 3444556788899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc---
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA---  263 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~---  263 (397)
                      |+||+|++||++..+|-+ -+.|.+..+..++.++..|+++.|+.|+|||||||+|||||.+|+|||.|||+++-+.   
T Consensus       705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999999999987 5889999999999999999999999999999999999999999999999999985211   


Q ss_pred             ------cCC----------------------------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHH
Q 015965          264 ------QSG----------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE  303 (397)
Q Consensus       264 ------~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  303 (397)
                            .+.                                  .-...+||+-|+|||++....|+..+|+||.|++|||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                  000                                  0011369999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 015965          304 LLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPALRP  356 (397)
Q Consensus       304 ll~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ll~~cl~~dp~~Rp  356 (397)
                      |+.|++||-..++.+...+++.+..  ......+++++..++|.++.. +++.|.
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            9999999999888887777655433  333445688899888887654 455554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=289.58  Aligned_cols=250  Identities=32%  Similarity=0.642  Sum_probs=203.1

Q ss_pred             ccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhc--CCCCCeeeeeeEEecCC----ceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~  187 (397)
                      .+..+.+.||+|.||+||+|.|.|+.||||++....     ...+.+|.+|.+.  |+|+||+.|+++-....    .++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            678899999999999999999999999999987432     3456777777664  68999999999865443    489


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                      ||++|.+.|||+|||..  ..++....++++..++.||++||..        .|.|||||..|||+..++..-|+|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999999999999986  7899999999999999999999953        5999999999999999999999999999


Q ss_pred             cccccC-----CcccCCCCCcccccccccCCCC----CC--CchhHHHHHHHHHHHHhC----------CCCCCCCChH-
Q 015965          260 RVKAQS-----GVMTAETGTYRWMAPEVIEHKP----YD--HKADVFSFGIVLWELLTG----------KLPYEYLTPL-  317 (397)
Q Consensus       260 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dv~slG~~l~ell~g----------~~P~~~~~~~-  317 (397)
                      ......     ......+||.+|||||++...-    ++  ..+||||||.++||+...          ++||.+.-+. 
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            654432     2345668999999999985431    21  258999999999999862          3688654332 


Q ss_pred             ----HHHHHhhhcCCCCCCCCCCc-----HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          318 ----QAAVGVVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       318 ----~~~~~~~~~~~~~~~~~~~~-----~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                          ++..-+..+.+||.+|....     ..+..+|+.||..||..|.|+--+.+.|.++.+
T Consensus       444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence                22222345567888776543     457789999999999999999999999988865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-37  Score=281.42  Aligned_cols=219  Identities=22%  Similarity=0.266  Sum_probs=182.4

Q ss_pred             eCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHHHHH
Q 015965          125 GSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL  202 (397)
Q Consensus       125 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l  202 (397)
                      |.||.||++.+  +++.||+|.++...       .+.+|...+....||||+++++.+......+++|||++|++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            88999999987  56779999987542       2334555555667999999999999999999999999999999998


Q ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCcccccccc
Q 015965          203 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV  282 (397)
Q Consensus       203 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~  282 (397)
                      .+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+......  .....++..|+|||.
T Consensus        77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            76 356899999999999999999999999999999999999999999999999987654332  233456788999999


Q ss_pred             cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 015965          283 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS  359 (397)
Q Consensus       283 ~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~  359 (397)
                      +.+..++.++|+||+|+++|+|++|..|+......      ........+|..+++.+.+++.+||+.||.+||++.
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            98888999999999999999999999887543211      111122346677889999999999999999999863

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-38  Score=282.40  Aligned_cols=249  Identities=23%  Similarity=0.377  Sum_probs=194.9

Q ss_pred             ccccccceeeeeCCceEEEEEEC------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-CCce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  186 (397)
                      ..|+....||+|.||.||++...      ...+|||.++.+......-....+|+.+++.++||||+.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            56889999999999999999543      2369999998764333333456789999999999999999998876 7889


Q ss_pred             EEEEEeccCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC----CceEEccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGV  258 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~----~~vkl~DfG~  258 (397)
                      ++++||.+ -+|.+.++.++    ..++...+..++.||+.|+.|||++-|+||||||.|||+..+    |.|||+|||+
T Consensus       104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            99999995 58988886542    368999999999999999999999999999999999999877    8999999999


Q ss_pred             ccccccCCc----ccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hH-----HHHH
Q 015965          259 ARVKAQSGV----MTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT-------PL-----QAAV  321 (397)
Q Consensus       259 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~-------~~-----~~~~  321 (397)
                      +|.+...-.    ....+-|.+|+|||.+.+. .|+.+.|||+.||++.||++-.+.|.+..       |.     ..+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            998765422    2233569999999998765 58999999999999999999988884321       11     1111


Q ss_pred             HhhhcCC------------------------CCC--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          322 GVVQKGL------------------------RPT--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       322 ~~~~~~~------------------------~~~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .++-...                        ...        ....-++...+|+.+||+.||.+|.|+.+.++
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            1111000                        000        00112445789999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=281.20  Aligned_cols=262  Identities=25%  Similarity=0.507  Sum_probs=223.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .+...+++....+-+|.||.||+|.|..       +.|-+|.++... +.-....+++|.-++..+.|||+.++.+++..
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            4445667777889999999999996643       347777776442 33345678999999999999999999998754


Q ss_pred             -CCceEEEEEeccCCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEc
Q 015965          183 -PPSLCIVTEFMSGGSVYDYLHKLKG-------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA  254 (397)
Q Consensus       183 -~~~~~lv~E~~~g~sL~~~l~~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~  254 (397)
                       ....++++.++.-|+|..++..+++       .++..++..++.|++.||+|||+.|+||.||..+|.+|++.-+|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             4567888999999999999985532       46777888999999999999999999999999999999999999999


Q ss_pred             ccccccccccC---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCC
Q 015965          255 DFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP  330 (397)
Q Consensus       255 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~  330 (397)
                      |=.++|..-+.   ..-.....+..||+||.+.+..|+.++|+||||++||||+| |+.||...+|.++.. .++.+.|.
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkdGyRl  517 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKDGYRL  517 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhcccee
Confidence            99999854433   22334456789999999999999999999999999999999 999999999988764 46778899


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ..|.+||++|..+|..||...|++||+++|+...|.++..+++
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999877664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.4e-36  Score=274.49  Aligned_cols=236  Identities=35%  Similarity=0.574  Sum_probs=202.7

Q ss_pred             CCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHHHHHH
Q 015965          126 SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH  203 (397)
Q Consensus       126 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~  203 (397)
                      +||.||+|.+.  ++.+|+|++........ ...+.+|+..+++++|+||+++++.+......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999885  47899999886543322 5789999999999999999999999998899999999999999999997


Q ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCccccccccc
Q 015965          204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI  283 (397)
Q Consensus       204 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~  283 (397)
                      .. ..++...++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.............++..|++||.+
T Consensus        80 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            63 33899999999999999999999999999999999999999999999999999877665555667789999999999


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCC--CcHHHHHHHHHhchhCCCCCCCHHHH
Q 015965          284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCWQQDPALRPDFSEI  361 (397)
Q Consensus       284 ~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~cl~~dp~~Rps~~el  361 (397)
                      .+..++.++|+||||+++|+|++|..||......+.................  ++.++.+++.+||..+|++||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            8888999999999999999999999999874444444444444433322222  88899999999999999999999999


Q ss_pred             HH
Q 015965          362 IE  363 (397)
Q Consensus       362 l~  363 (397)
                      ++
T Consensus       239 ~~  240 (244)
T smart00220      239 LQ  240 (244)
T ss_pred             hh
Confidence            75

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.3e-37  Score=331.50  Aligned_cols=244  Identities=23%  Similarity=0.412  Sum_probs=193.1

Q ss_pred             cccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      .+...+.||+|+||.||+|.+  .+..||||.++.....      ...|+..+++++|||||+++++|.++...|+||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            456677899999999999986  5678999998743221      12458889999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCcEEeCCCCceEEcccccccccccCCccc
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      +++|+|.++++.    +++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.......   ..
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~  836 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT  836 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence            999999999964    789999999999999999999   6799999999999999998887775 665543322   12


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhh---------cCCCCCC------C
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQ---------KGLRPTI------P  333 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-~~~~~~~~---------~~~~~~~------~  333 (397)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+         ....+..      +
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            346889999999999999999999999999999999999998532110 00111010         0011111      1


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .....++.+++.+||+.||++||++.++++.|+++.+..
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            122345778999999999999999999999999886643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=302.58  Aligned_cols=247  Identities=32%  Similarity=0.533  Sum_probs=210.3

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEec-----CCc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK-----PPS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-----~~~  185 (397)
                      +.|.|.+.||.|.+|.||+++.  .++..|+|++....   +..+++..|.++|+.+. |||++.++|++..     ++.
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            4567779999999999998864  67889999988654   33456778888988775 9999999998843     467


Q ss_pred             eEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ++||||||.|||..|++... ...+.+..+..|++.++.|+.+||.+.++|||||-.|||++.++.|||+|||++.....
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            99999999999999999755 45799999999999999999999999999999999999999999999999999875543


Q ss_pred             -CCcccCCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-CCCCCCCc
Q 015965          265 -SGVMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQ  337 (397)
Q Consensus       265 -~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~  337 (397)
                       -+...+.+|||.|||||++...     .|+.++|+||||++-.||--|.+|+..+.+..+.+.+-+.... ...|...+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs  255 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS  255 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence             3456678999999999998543     5788999999999999999999999999998888776544321 12256678


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .++.++|..||.+|.++||+..++++
T Consensus       256 ~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  256 KKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             HHHHHHHHHHHhhccccCcchhhhcc
Confidence            99999999999999999999999874

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=281.56  Aligned_cols=245  Identities=25%  Similarity=0.412  Sum_probs=197.8

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--C----CeeeeeeEEecCC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--K----NVVQFIGACTKPP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~  184 (397)
                      ..+|.+.+.+|+|.||.|-.+.+.  +..||||+++..   ....+..+-|+++|+++.+  |    -+|++.++|.-.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            578999999999999999998764  467999999843   3344556679999999953  2    3788889999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC----------------
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----------------  247 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~----------------  247 (397)
                      +.|||+|.+ |.|+++++... -.+++...+..++.||+.++.|||+.+++|-||||+|||+.+                
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999999999 88999999763 346899999999999999999999999999999999999942                


Q ss_pred             ----CCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH---H
Q 015965          248 ----NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA---A  320 (397)
Q Consensus       248 ----~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~---~  320 (397)
                          +-.|+|+|||.|+...+.  .+..+.|.-|.|||++.+-+++.++||||+||||+|+++|...|...++.+-   -
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM  321 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM  321 (415)
T ss_pred             ccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence                126999999999876554  3666889999999999999999999999999999999999999976654331   1


Q ss_pred             HHhhh--------c---------C----------------CCCCCC--------CCCcHHHHHHHHHhchhCCCCCCCHH
Q 015965          321 VGVVQ--------K---------G----------------LRPTIP--------KNSQPKLAELLERCWQQDPALRPDFS  359 (397)
Q Consensus       321 ~~~~~--------~---------~----------------~~~~~~--------~~~~~~l~~ll~~cl~~dp~~Rps~~  359 (397)
                      ..++.        +         +                ..+..|        .....+|.+||++||..||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            11111        0         0                000011        11234689999999999999999999


Q ss_pred             HHHH
Q 015965          360 EIIE  363 (397)
Q Consensus       360 ell~  363 (397)
                      |++.
T Consensus       402 EAL~  405 (415)
T KOG0671|consen  402 EALS  405 (415)
T ss_pred             HHhc
Confidence            9874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.2e-36  Score=259.04  Aligned_cols=243  Identities=20%  Similarity=0.375  Sum_probs=199.2

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCC--ce
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SL  186 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~  186 (397)
                      ..++|++.+++|+|.|++||.|..  .++.++||++++..     .+.+.+|+.||+.|+ ||||+++++...++.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            457899999999999999999974  67889999998643     567899999999998 999999999987753  46


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEcccccccccccC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~~~  265 (397)
                      .+|+||+.+.+.....    ..++...+..++.+++.||.|+|+.||+|||+||.||+||. ...++|+|+|+|.+..+.
T Consensus       111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            7999999887666554    34788899999999999999999999999999999999995 457999999999999888


Q ss_pred             CcccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHhh-------------------
Q 015965          266 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVV-------------------  324 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~-~~~~~~~~~~~~-------------------  324 (397)
                      ......+.+..|--||.+. -+.|+.+-|+|||||++..|+..+.||- +.++.+...++.                   
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            7777778889999999984 4568999999999999999999888883 333322222221                   


Q ss_pred             --------hcCCC--------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          325 --------QKGLR--------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       325 --------~~~~~--------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                              ....+        +....-.+++..+|+.++|..|-.+|+||+|.+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                    11111        1111234689999999999999999999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-37  Score=268.37  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=200.0

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-------
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-------  182 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  182 (397)
                      ..+.|.-..+||+|.||+||+++.  .++.||+|++--+..........++|+.+|..++|+|++.+++.|..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            446777788999999999999865  45678888654322222233557789999999999999999988743       


Q ss_pred             -CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          183 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       183 -~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                       ...+|+||.+| ..+|.-.|.....+++...+.+++.++..||.|+|++.|+|||+||+||||+.+|.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence             23489999999 4589989988778899999999999999999999999999999999999999999999999999987


Q ss_pred             cccCC-----cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc------CCC
Q 015965          262 KAQSG-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK------GLR  329 (397)
Q Consensus       262 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~------~~~  329 (397)
                      +....     ..+..+.|.+|.+||.+.+ ..|+++.|||..||+|.||.++.+-+.+.+..+.+..+..-      ...
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            65432     2344466999999999865 56999999999999999999999999887776654432210      000


Q ss_pred             --------------CCCC-------------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --------------PTIP-------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --------------~~~~-------------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                    ++.+             -.-.++..+|+.++|..||.+|++++++++
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                          0011             111357889999999999999999999874

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=277.95  Aligned_cols=249  Identities=20%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChH-----HHHHHHHHHHHHhcCCCCCeeeeeeEEe-cCC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-----MQKEFAQEVFIMRKVRHKNVVQFIGACT-KPP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~  184 (397)
                      .++|-++..||+|+|++||++.+  ..+.||||+-.......+     ..+...+|..|.+.|+||.||++|+++. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            36788889999999999999976  457799999765543332     3455778999999999999999999985 566


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEeC---CCCceEEcccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD---ENEVVKVADFGVA  259 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nili~---~~~~vkl~DfG~a  259 (397)
                      .+|-|+|||+|.+|+-||.. ...+++..+..|+.||+.||.||...  -|||-||||.|||+-   ..|.+||.|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            78999999999999999987 46689999999999999999999976  599999999999995   4578999999999


Q ss_pred             cccccCCc--------ccCCCCCcccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---hh
Q 015965          260 RVKAQSGV--------MTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG---VV  324 (397)
Q Consensus       260 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~---~~  324 (397)
                      +++.....        .+...||++|.+||.+.-    ...+.++||||+|+++|.++.|+.||...-..+.+..   ++
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            98775432        334579999999999732    2467899999999999999999999976544333221   11


Q ss_pred             hcC-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          325 QKG-LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       325 ~~~-~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                      ... ...+..+.++++..+||++||+..-++|....++.
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            111 11222345789999999999999999999887764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=285.69  Aligned_cols=254  Identities=19%  Similarity=0.279  Sum_probs=184.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE------------------CCcceEEEEecCCCCCh------------HHHHHHH
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY------------------CSQDVAIKVLKPERINS------------DMQKEFA  159 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~------------~~~~~~~  159 (397)
                      ....++|.+.++||+|+||.||+|.+                  .++.||||.++......            ...+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            34678999999999999999999964                  23569999987542211            0112234


Q ss_pred             HHHHHHhcCCCCCe-----eeeeeEEec--------CCceEEEEEeccCCCHHHHHHhccC-------------------
Q 015965          160 QEVFIMRKVRHKNV-----VQFIGACTK--------PPSLCIVTEFMSGGSVYDYLHKLKG-------------------  207 (397)
Q Consensus       160 ~E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~E~~~g~sL~~~l~~~~~-------------------  207 (397)
                      .|+.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...+                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            47777777776554     667776643        3468999999999999999864221                   


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC--CCCCccccccc
Q 015965          208 ----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA--ETGTYRWMAPE  281 (397)
Q Consensus       208 ----~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~--~~gt~~y~aPE  281 (397)
                          .+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||+++..........  ..+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                235667888999999999999999999999999999999999999999999975543322222  24589999999


Q ss_pred             ccCCCC--------------------CC--CchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHH-----------hhhcC
Q 015965          282 VIEHKP--------------------YD--HKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVG-----------VVQKG  327 (397)
Q Consensus       282 ~~~~~~--------------------~~--~~~Dv~slG~~l~ell~g~~-P~~~~~~~~~~~~-----------~~~~~  327 (397)
                      ++....                    |.  .+.|+||+||++++|++|.+ ||...........           .....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            975332                    11  24799999999999999876 7764322211111           11112


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCC---CCCCCHHHHHH
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDP---ALRPDFSEIIE  363 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp---~~Rps~~ell~  363 (397)
                      .........++...+|+.+||..+|   .+|+|+.|+++
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            2223345678899999999999866   68999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.8e-34  Score=292.04  Aligned_cols=246  Identities=16%  Similarity=0.217  Sum_probs=169.2

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeE----
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA----  179 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~----  179 (397)
                      .+..++|.+.++||+|+||.||+|++.      +..||||.++.....    +.+..|  .++...+.++..++..    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            445678999999999999999999874      467999987643211    111111  1112222222222221    


Q ss_pred             --EecCCceEEEEEeccCCCHHHHHHhccCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 015965          180 --CTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL  238 (397)
Q Consensus       180 --~~~~~~~~lv~E~~~g~sL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~l~~LH~~~iiHrDl  238 (397)
                        ......+++||||+++++|.+++......                   .....+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              24556789999999999999998753211                   112346679999999999999999999999


Q ss_pred             CCCcEEeCC-CCceEEcccccccccccC--CcccCCCCCcccccccccCCC----------------------CCCCchh
Q 015965          239 KAANLLMDE-NEVVKVADFGVARVKAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDHKAD  293 (397)
Q Consensus       239 kp~Nili~~-~~~vkl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  293 (397)
                      ||+|||++. ++.+||+|||+++.....  .......+|+.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 579999999999754332  233456789999999976322                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc----------CCCCC----------CCCCCcHHHHHHHHHhchhCCC
Q 015965          294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK----------GLRPT----------IPKNSQPKLAELLERCWQQDPA  353 (397)
Q Consensus       294 v~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~----------~~~~~----------~~~~~~~~l~~ll~~cl~~dp~  353 (397)
                      ||||||+||||+++..|+...  .......+..          ...+.          ..........+||.+||+.||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999987765421  1111111110          00000          0111233456899999999999


Q ss_pred             CCCCHHHHHH
Q 015965          354 LRPDFSEIIE  363 (397)
Q Consensus       354 ~Rps~~ell~  363 (397)
                      +|||+.++++
T Consensus       440 kR~ta~e~L~  449 (566)
T PLN03225        440 QRISAKAALA  449 (566)
T ss_pred             cCCCHHHHhC
Confidence            9999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=292.23  Aligned_cols=251  Identities=25%  Similarity=0.426  Sum_probs=196.7

Q ss_pred             cccceeeeeCCce-EEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEecc
Q 015965          117 KFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       117 ~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      .-.+.+|.|+-|+ ||+|.+.++.||||.+-.+.     .....+|+.+|+..+ |||||++++.-.+....||..|.| 
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            3345689999987 89999999999999876432     345678999999885 999999999999999999999999 


Q ss_pred             CCCHHHHHHhc--cC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---C--CceEEcccccccccccCC
Q 015965          195 GGSVYDYLHKL--KG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---N--EVVKVADFGVARVKAQSG  266 (397)
Q Consensus       195 g~sL~~~l~~~--~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~--~~vkl~DfG~a~~~~~~~  266 (397)
                      ..+|.+++...  +. .......+.++.|++.||++||+.+||||||||.||||+.   +  ..++|+|||+++....+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            67999999873  11 1111345778899999999999999999999999999975   2  479999999998655432


Q ss_pred             ----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCC-CCCCCCcHHH
Q 015965          267 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKL  340 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  340 (397)
                          ......||.+|+|||++....-+.++|||||||++|+.++ |..||...-..+.  .++...... .+......+.
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA  743 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA  743 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence                2445579999999999998888889999999999999999 5999976543332  222221110 1111111289


Q ss_pred             HHHHHHhchhCCCCCCCHHHHH------------HHHHHHHHHhchh
Q 015965          341 AELLERCWQQDPALRPDFSEII------------EILQQIAKEVGEE  375 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell------------~~L~~l~~~~~~~  375 (397)
                      .+||.+|++++|..||+|.+++            +.|+++-+++..+
T Consensus       744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e  790 (903)
T KOG1027|consen  744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKE  790 (903)
T ss_pred             HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhh
Confidence            9999999999999999999996            5677776666544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=264.59  Aligned_cols=132  Identities=24%  Similarity=0.432  Sum_probs=113.3

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-----C---CCeeeeeeEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----H---KNVVQFIGAC  180 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~  180 (397)
                      +...+|.+.++||.|-|++||++.+.  ++.||+|+.+..   ....+..+.||.+|++++     |   ..||++++.|
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            44588999999999999999999874  567999998843   345566788999999885     2   4799999988


Q ss_pred             ec----CCceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeC
Q 015965          181 TK----PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD  246 (397)
Q Consensus       181 ~~----~~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~  246 (397)
                      ..    ..++|||+|++ |.+|..++.... ..++...+..|+.||+.||.|||.. ||||-||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            54    45799999999 899999997653 4699999999999999999999975 999999999999995

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=261.86  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-----ceEE
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLCI  188 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  188 (397)
                      .+..+.||.|+||.||-.++  .++.||+|.+.....+-...+.+.+|+.+|...+|.|++..++....+.     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34457899999999999876  6788999998765544455678999999999999999999998776543     3678


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC--C
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--G  266 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~--~  266 (397)
                      ++|.| ..+|...+-. ...++.+.+.-++.||++||.|||+.||.||||||.|+|++.+..+||||||+++.....  .
T Consensus       135 ~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            88988 4467666654 577899999999999999999999999999999999999999999999999999976543  4


Q ss_pred             cccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh---------------------
Q 015965          267 VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV---------------------  324 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~---------------------  324 (397)
                      .|+..+-|..|.|||++.+. .|+.+.||||.||++.||+..+..|...++.+...-+.                     
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            57777889999999999775 59999999999999999999999998777655443222                     


Q ss_pred             --hcCCCC-CCC--------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          325 --QKGLRP-TIP--------KNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       325 --~~~~~~-~~~--------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                        +.+.++ ..+        ..-..+...++.+++.+||+.|.+..+.+..
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence              222221 111        1223467788999999999999988877654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=258.20  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=201.7

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      +.+|.-++.+|.|.- .|.-+-+  .++.||+|.+.....+....+...+|..++..++|+||++++.++....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456777788898887 5555533  6789999988776666666778889999999999999999999987554      


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..|+|||+| ..+|.+.+.   ..+....+..+..|++.|+.|||+.||+||||||+||++..+..+||.|||+++....
T Consensus        95 e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            479999999 679999886   3467888999999999999999999999999999999999999999999999998877


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-----------------  327 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-----------------  327 (397)
                      .-.++.++.|..|.|||++.+..|...+||||+||++.||++|+.-|.+.+..+...++.+.-                 
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            767888899999999999988889999999999999999999999997655433322222110                 


Q ss_pred             ----------------C-----CC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 ----------------L-----RP--TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ----------------~-----~~--~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                      +     +.  ..++.-...+++++.+||-.||++|.+++++|.
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                            0     00  011122356889999999999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.7e-35  Score=274.99  Aligned_cols=247  Identities=24%  Similarity=0.395  Sum_probs=204.0

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC------CCeeeeeeEEecC
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKP  183 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~  183 (397)
                      -.++|.+....|+|-|++|.+|.+  .++.||||++...   .-+.+.=+.|+.+|++|+.      -++++++..|...
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            346777777889999999999987  4678999999853   4456677889999999963      4789999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR  260 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~  260 (397)
                      +++|||+|-+ ..+|.++|.+...  .+....+..|+.|++.||..|-.+||+|.||||+|||+++. ..+||||||.|.
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999999999 7899999988643  57888999999999999999999999999999999999975 578999999997


Q ss_pred             ccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-----------cC--
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-----------KG--  327 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~-----------~~--  327 (397)
                      ....+ ..+.+..+..|.|||++.|.+|++..|+||+||+||||+||+..|++.++.+++.-.+.           ++  
T Consensus       586 ~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF  664 (752)
T KOG0670|consen  586 FASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF  664 (752)
T ss_pred             ccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence            66654 34555667889999999999999999999999999999999999999888776543221           00  


Q ss_pred             ------------------------------CCC------------CCCCC---CcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          328 ------------------------------LRP------------TIPKN---SQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       328 ------------------------------~~~------------~~~~~---~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                                                    ..|            ..|..   .-..|.+|+.+||..||++|.|..+.|
T Consensus       665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL  744 (752)
T KOG0670|consen  665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL  744 (752)
T ss_pred             hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence                                          001            01111   124688999999999999999999876


Q ss_pred             H
Q 015965          363 E  363 (397)
Q Consensus       363 ~  363 (397)
                      .
T Consensus       745 ~  745 (752)
T KOG0670|consen  745 K  745 (752)
T ss_pred             c
Confidence            4

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.9e-32  Score=241.53  Aligned_cols=209  Identities=37%  Similarity=0.686  Sum_probs=186.1

Q ss_pred             eeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHH
Q 015965          122 VASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY  199 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~  199 (397)
                      ||+|++|.||++...  ++.+++|++....... ....+.+|+..++.++|++|+++++++......+++||+++|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999987  7889999988664332 3467889999999999999999999999989999999999989999


Q ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEcccccccccccCC-cccCCCCCccc
Q 015965          200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSG-VMTAETGTYRW  277 (397)
Q Consensus       200 ~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~~~~-~~~~~~gt~~y  277 (397)
                      +++......++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            999875457899999999999999999999999999999999999999 8999999999997655432 23445678899


Q ss_pred             ccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 015965          278 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP  356 (397)
Q Consensus       278 ~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rp  356 (397)
                      ++||.+... .++.++|+|++|+++++|                                 ..+.+++.+|++.||.+||
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~  206 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRP  206 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCc
Confidence            999999877 788999999999999999                                 6899999999999999999


Q ss_pred             CHHHHHHH
Q 015965          357 DFSEIIEI  364 (397)
Q Consensus       357 s~~ell~~  364 (397)
                      ++.++++.
T Consensus       207 ~~~~l~~~  214 (215)
T cd00180         207 SAKEILEH  214 (215)
T ss_pred             CHHHHhhC
Confidence            99998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=280.68  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=215.8

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|.++.++|+|+||.||++++  .++..|+|+++.+..  +...-..+|+.+++.++|||||.+++.+.....+++.||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            6788999999999999999976  567899999997643  234567789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      ||.||+|.+.-+- .+.+++.++..+++..++|+.|||+.|=+|||||-.||++++.|.||++|||.+-..... .....
T Consensus        93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            9999999997654 688999999999999999999999999999999999999999999999999998544332 33456


Q ss_pred             CCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC---CCCCcHHHHHHH
Q 015965          271 ETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAELL  344 (397)
Q Consensus       271 ~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ll  344 (397)
                      +.||+.|||||+.   ....|...+|||++|++..|+-.-++|.-...+.++.+-..+.++.|..   +...++.+.+|+
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fv  251 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFV  251 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHH
Confidence            7899999999986   4567999999999999999999999999888998888877666665443   345788999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      +.|+..+|++||++..++.
T Consensus       252 K~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  252 KGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHhcCCCccCCChhhhee
Confidence            9999999999999998764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-31  Score=239.44  Aligned_cols=212  Identities=33%  Similarity=0.580  Sum_probs=181.6

Q ss_pred             ccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |.+.+.||.|++|.||++...  ++.+++|.+...... ...+.+.+|+..+++++|+|++++++.+......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            456789999999999999885  478999998865433 24678889999999999999999999999989999999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--cccCC
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAE  271 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--~~~~~  271 (397)
                      ++++|.+++......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......  .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999998743338999999999999999999999999999999999999999999999999998765543  33455


Q ss_pred             CCCccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcCC
Q 015965          272 TGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGL  328 (397)
Q Consensus       272 ~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~P~~~-~~~~~~~~~~~~~~~  328 (397)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++.....+....+.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            788899999999 777888899999999999999999999977 555545555554443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-31  Score=236.96  Aligned_cols=263  Identities=20%  Similarity=0.327  Sum_probs=220.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  187 (397)
                      +-.-.|+++++||+|+||+++.|+.  .++.||||.-......    -.+..|.+..+.|. .++|+++|.+.....+..
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            4445799999999999999999974  7899999985533322    33556777777775 699999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-----CCceEEccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARVK  262 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-----~~~vkl~DfG~a~~~  262 (397)
                      ||||++ |.||.|++.-+...|+...+..+|.|++.-++|+|++.+|+|||||+|+||..     ...|.|+|||+|+..
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 99999999999999999999999999999999999999999999999999974     346999999999876


Q ss_pred             ccCC--------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCC--
Q 015965          263 AQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLR--  329 (397)
Q Consensus       263 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~--  329 (397)
                      .++.        ......||.+||+-.-..+...+.+.|+-|||-++++.|-|.+||.++..   .+.+.++-.....  
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            6543        23455799999999999999999999999999999999999999988753   3444443322211  


Q ss_pred             -CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchhhHH
Q 015965          330 -PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE  378 (397)
Q Consensus       330 -~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~~~~  378 (397)
                       ..+...+|.++...++-.-..+..+-|+++-+..++.+++..++.....
T Consensus       260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg  309 (449)
T KOG1165|consen  260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDG  309 (449)
T ss_pred             HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence             1234568899999999999999999999999999999999988765433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=261.93  Aligned_cols=198  Identities=27%  Similarity=0.450  Sum_probs=172.4

Q ss_pred             ccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHH------HHHHHHHHHHhcCC---CCCeeeeeeEEec
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ------KEFAQEVFIMRKVR---HKNVVQFIGACTK  182 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~------~~~~~E~~~l~~l~---h~niv~~~~~~~~  182 (397)
                      .+|..++.+|.|+||.|+++.++.  ..|+||.+.+++.-.+..      -.+-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            568999999999999999998854  459999988775433221      12556999999998   9999999999999


Q ss_pred             CCceEEEEEec-cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          183 PPSLCIVTEFM-SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       183 ~~~~~lv~E~~-~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ++++||+||-. +|-+|.+++.. +..+++..+..|+.|++.|+++||+.||||||||-+||.++.+|-+||+|||.+..
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            99999999976 35589999976 57799999999999999999999999999999999999999999999999999853


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCC
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEY  313 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~P~~~  313 (397)
                       ..++....++||..|.|||++.+..|- ..-|||++|++||.++....||..
T Consensus       720 -~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 -TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence             446677888999999999999998875 457999999999999999989853

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-31  Score=227.61  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=218.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC-CCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~  186 (397)
                      .+....|+++++||+|+||.+|+|..  .+..||||+-......+    .+..|..+.+.|++ ..|+.+..++.+....
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            45567899999999999999999976  67889999976543332    35678889988875 7888888888888889


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKA  263 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~~  263 (397)
                      .+||+.+ |.||.+.+.-+...++..+++.++-|++.-++|+|.+++|||||||+|+|+.-   ...+.++|||+|+..-
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999999 99999999999999999999999999999999999999999999999999973   4579999999997654


Q ss_pred             cCC--------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCC--
Q 015965          264 QSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRP--  330 (397)
Q Consensus       264 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~--  330 (397)
                      +..        .....+||.+|.+-....+...+.+.|+-|+|.+|.++.-|.+||.+...   .+.+..+.......  
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            432        22345799999999888888899999999999999999999999998754   34455555544332  


Q ss_pred             -CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          331 -TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       331 -~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                       ......|.++...+..|-..--++-|++.-+.+.+.-++..+.
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence             2446789999999999999999999999999999888876654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-30  Score=243.23  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=206.4

Q ss_pred             cccccceeeeeCCceEEEEEECCc---ceEEEEecCCCCChHHHHHHHHHHHHHhcCC----CCCeeeeeeEE-ecCCce
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCSQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVR----HKNVVQFIGAC-TKPPSL  186 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~  186 (397)
                      +|++.++||+|+||.||++.....   .+|+|+.........  ..+..|+.++..+.    .+++..+++.+ ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            799999999999999999997654   589998775432211  14667888888876    26899999998 577789


Q ss_pred             EEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-----CceEEccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVAR  260 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-----~~vkl~DfG~a~  260 (397)
                      |+||+.+ |.+|.++..... +.++..++..++.|++.+|.+||+.|++||||||+|++++..     ..+.|.|||+++
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999999 999999886655 789999999999999999999999999999999999999865     469999999998


Q ss_pred             --cccc-CC-------c-ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--
Q 015965          261 --VKAQ-SG-------V-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--  327 (397)
Q Consensus       261 --~~~~-~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~--  327 (397)
                        .... .+       . .....||..|+++.+..+...+.+.|+||+++++.+++.|.+||.............+..  
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              3211 11       1 223459999999999999999999999999999999999999998766433222222221  


Q ss_pred             -CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          328 -LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       328 -~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                       .........+.++..++..+-..+...+|.+..+...|+++....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence             1111345567889999999999999999999999999988877653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=8.2e-31  Score=278.56  Aligned_cols=192  Identities=17%  Similarity=0.233  Sum_probs=143.9

Q ss_pred             CCC-CCeeeeeeEE-------ecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 015965          168 VRH-KNVVQFIGAC-------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK  239 (397)
Q Consensus       168 l~h-~niv~~~~~~-------~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk  239 (397)
                      ++| +||+++++++       .....++++|||+ +++|.+++......+++..++.++.||+.||+|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5777777776       2334577889988 779999998756679999999999999999999999999999999


Q ss_pred             CCcEEeCC-------------------CCceEEcccccccccccC-----------------CcccCCCCCccccccccc
Q 015965          240 AANLLMDE-------------------NEVVKVADFGVARVKAQS-----------------GVMTAETGTYRWMAPEVI  283 (397)
Q Consensus       240 p~Nili~~-------------------~~~vkl~DfG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~  283 (397)
                      |+||||+.                   ++.+||+|||+++.....                 .......||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999954                   445666777766532110                 001123589999999999


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       284 ~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+..|+.++|||||||+||||++|..|+.....  ....+.... .+.......+....++.+||+++|.+||++.++++
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            999999999999999999999999988754321  111111111 22211223456789999999999999999999974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-30  Score=227.06  Aligned_cols=253  Identities=31%  Similarity=0.640  Sum_probs=219.1

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++.+++.+..+|.....|+.|+|+|.+.+++.|+++.........+.|.+|.-.|+-..||||+.++++|..++++.++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            45667788889999999999999999999999999987766666678899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCceEE--ccccccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKV--ADFGVARVKAQ  264 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~vkl--~DfG~a~~~~~  264 (397)
                      ..||+.|||+..++...+ ..+..++.+++.++++||+|||+..  |----|....|+||++-+.+|  +|--++..   
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---  342 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence            999999999999987543 4677889999999999999999974  334468899999999876665  34333311   


Q ss_pred             CCcccCCCCCcccccccccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                         .....-.|.||+||.+..++-+   .++|+|||++++|||.|...||...++.+--+++.-+++++.+|+.+++.+.
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence               1122346899999999877654   4689999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .|+.-|++.||.+||.|..++-.|+++
T Consensus       420 klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            999999999999999999999988876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1e-29  Score=221.21  Aligned_cols=164  Identities=24%  Similarity=0.374  Sum_probs=133.9

Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCc
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY  275 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~  275 (397)
                      |+|.+++......+++..++.++.||+.||.|||+.+      ||+|||++.++.+|+  ||+++.....    ...||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            6899999876677999999999999999999999998      999999999999999  9999765443    236899


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC------CCCCCcH--HHHHHHHHh
Q 015965          276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------IPKNSQP--KLAELLERC  347 (397)
Q Consensus       276 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~l~~ll~~c  347 (397)
                      .|||||++.+..++.++|||||||++|||++|..||..................+.      .+...+.  ++.+++.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976554332222222221111      1122333  699999999


Q ss_pred             chhCCCCCCCHHHHHHHHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      |+.||.+||++.++++.+..+..+
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HhcccccccCHHHHHHHHHHHHHH
Confidence            999999999999999988777544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=225.84  Aligned_cols=248  Identities=19%  Similarity=0.306  Sum_probs=186.4

Q ss_pred             ccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeee-EEecCCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG-ACTKPPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-~~~~~~~~~lv  189 (397)
                      +.|.|.+.||.|.||.+-++++.+  +.+++|.+.....   ..++|.+|..---.| .|.||+.-|+ +|+..+.++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            678999999999999999998854  5699998876533   256788887554444 4899998876 56777788899


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC--CCCceEEcccccccccccCCc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~--~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +||++.|+|.+-+..  ..+-+....+++.|+++|+.|||++++||||||.+||||-  +.-.|||||||..+..+..-.
T Consensus       101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            999999999987764  5678888999999999999999999999999999999994  344899999999875443211


Q ss_pred             ccCCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHh--hhcCCCCCCC---CCC
Q 015965          268 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGV--VQKGLRPTIP---KNS  336 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~--~~~~~~~~~~---~~~  336 (397)
                        ..--+..|.+||+....     ...+.+|+|.||+++|.+++|.+||....- ...+.+.  ..++..+..|   ..+
T Consensus       179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence              11235568899986432     245679999999999999999999974221 1112221  2233333344   456


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ++.+..+.++-+..+|++|=-..+..+.-...
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence            88999999999999999995444444443333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=4.4e-30  Score=238.98  Aligned_cols=242  Identities=23%  Similarity=0.379  Sum_probs=188.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  187 (397)
                      ..|+..++||.|+|++||+++..     .+.||+|.+.....    ...+..|+++|..+. +.||+++.+.+..++..+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            56888999999999999999753     45699999876533    245788999999886 899999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEccccccccccc--
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQ--  264 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~--  264 (397)
                      +|+||++.....++...    ++...+..+++.++.||.++|++|||||||||.|+|.+ ..+.-.|+|||+|.....  
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999999888888765    67889999999999999999999999999999999998 467889999999861100  


Q ss_pred             ------C--------------------------C-----------cccCCCCCcccccccccCC-CCCCCchhHHHHHHH
Q 015965          265 ------S--------------------------G-----------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIV  300 (397)
Q Consensus       265 ------~--------------------------~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~  300 (397)
                            .                          +           ......||++|.|||++.. ...+.++||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                  0                          0           0011259999999999854 457889999999999


Q ss_pred             HHHHHhCCCCCCCCCh-HHHHHHhh---------------------h--------------cCC-------------CC-
Q 015965          301 LWELLTGKLPYEYLTP-LQAAVGVV---------------------Q--------------KGL-------------RP-  330 (397)
Q Consensus       301 l~ell~g~~P~~~~~~-~~~~~~~~---------------------~--------------~~~-------------~~-  330 (397)
                      +..+++++.||-.... ...+..++                     +              ..+             .. 
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            9999999999932211 11111000                     0              000             00 


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ......+..+.+|+.+|++.||.+|.|+++.|.
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            011234558999999999999999999999874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=5.4e-26  Score=214.05  Aligned_cols=248  Identities=30%  Similarity=0.497  Sum_probs=204.8

Q ss_pred             ccccceeeeeCCceEEEEEECCcceEEEEecCCCCChH-HHHHHHHHHHHHhcCCCC-CeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+.+++.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            667789999999999999887 7899999987765543 577899999999999988 7999999997777789999999


Q ss_pred             cCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccCC----
Q 015965          194 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG----  266 (397)
Q Consensus       194 ~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~~----  266 (397)
                      .++++.+++....  ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......    
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999997776533  2789999999999999999999999999999999999999988 79999999997555433    


Q ss_pred             ---cccCCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCC----CCC
Q 015965          267 ---VMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRP----TIP  333 (397)
Q Consensus       267 ---~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~----~~~  333 (397)
                         ......||..|+|||.+.+   ..++...|+||+|++++++++|..||.....   .......+.....+    ...
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS  240 (384)
T ss_pred             ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence               2456789999999999987   5788899999999999999999999877663   23333333332222    112


Q ss_pred             CCC----cHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          334 KNS----QPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       334 ~~~----~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                      ...    ...+.+++.+|+..+|..|.+..+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            221    2579999999999999999988877654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2e-26  Score=220.59  Aligned_cols=163  Identities=19%  Similarity=0.197  Sum_probs=128.1

Q ss_pred             cCcccccccceeeeeCCceEEEEEE---CCcceEEEEecCCCC---ChHHHHHHHHHHHHHhcCCCCCeee-eeeEEecC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTKP  183 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~  183 (397)
                      .-.++|.+.+.||+|+||+||+|.+   .++.+|||++.....   .......|.+|+.+|++++|+|++. +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            3447799999999999999999976   345689998764321   2334567999999999999999985 4432    


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDl-kp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +..|+||||++|++|.. +..    ..   ...++.|++.+|.|||+.||+|||| ||+|||++.++.+||+|||+++..
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            45799999999999963 211    11   1467899999999999999999999 999999999999999999999865


Q ss_pred             ccCCc---------ccCCCCCcccccccccCC
Q 015965          263 AQSGV---------MTAETGTYRWMAPEVIEH  285 (397)
Q Consensus       263 ~~~~~---------~~~~~gt~~y~aPE~~~~  285 (397)
                      .....         .....+++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            54321         123467888999999853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=225.89  Aligned_cols=234  Identities=26%  Similarity=0.418  Sum_probs=195.9

Q ss_pred             eeeeeCCceEEEE-----EECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEecc
Q 015965          121 KVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       121 ~lg~G~~g~Vy~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      .+|.|+||.|+++     .+.+.-+|+|+.++.............|..++..++ ||.+|++...++.+..+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3799999999865     345667999998876543333335667888898887 9999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCC
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  274 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  274 (397)
                      ||.|...+.+ ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++........   +||
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence            9999888876 466888888999999999999999999999999999999999999999999999876654333   999


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  354 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~  354 (397)
                      ..|||||+++  .+...+|.||||+++++|++|..||..    +....+...  .+..|...+...++++.+++..+|.+
T Consensus       157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhhCHHH
Confidence            9999999998  577889999999999999999999987    333344332  45678888999999999999999999


Q ss_pred             CCCH--HHHHHHHH
Q 015965          355 RPDF--SEIIEILQ  366 (397)
Q Consensus       355 Rps~--~ell~~L~  366 (397)
                      |...  ..+.+..+
T Consensus       229 rLg~~~~~~~eik~  242 (612)
T KOG0603|consen  229 RLGAGPDGVDEIKQ  242 (612)
T ss_pred             HhccCcchhHHHhc
Confidence            9855  44444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.2e-25  Score=228.55  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=187.0

Q ss_pred             cccceeeeeCCceEEEEEEC--CcceEEEEec----CCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          117 KFGSKVASGSYGDLYRGTYC--SQDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       117 ~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .....+|.|++|.|+.....  .+.++.|...    +..........+..|..+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977766542  2333444332    22222222333777888888999999988777666655555559


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      |||++ +|...+.. .+.++...+--++.|++.|++|||+.||.|||+|++|++++.+|.+||+|||.+.......    
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99998 99998876 3578888999999999999999999999999999999999999999999999997655443    


Q ss_pred             -cccCCCCCcccccccccCCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhhcCC------CCCCCCCCc
Q 015965          267 -VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGL------RPTIPKNSQ  337 (397)
Q Consensus       267 -~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~ell~g~~P~~~~~~~~~~-~~~~~~~~------~~~~~~~~~  337 (397)
                       .....+|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......+.. ........      ...+...++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence             3445689999999999999999985 79999999999999999999654433221 01000000      111234567


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ...+.+|.+||+.||.+|.|+.++++
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhh
Confidence            78899999999999999999999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.7e-24  Score=193.48  Aligned_cols=173  Identities=14%  Similarity=0.198  Sum_probs=136.6

Q ss_pred             CcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChH-HHHH------HHHHHHHHhcCCCCCeeeeeeEEecC-
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVRHKNVVQFIGACTKP-  183 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~-  183 (397)
                      -..+|++.+.||.|+||.||+....++.+|||++++...... ....      +.+|+..+.++.||+|+.+..++... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            357899999999999999999888888999999987654332 1122      57899999999999999998875532 


Q ss_pred             -------CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          184 -------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       184 -------~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                             ...+|+|||++|.+|.++..     +++    ....+++.++..||+.|++|||+||+||+++.+| ++|+||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                   35789999999999988732     233    2456999999999999999999999999999988 999999


Q ss_pred             ccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHH
Q 015965          257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL  305 (397)
Q Consensus       257 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell  305 (397)
                      |..+.........           .+.....|+.++|+||||+++..+.
T Consensus       179 g~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            9886553322111           1334455778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=5.8e-24  Score=187.26  Aligned_cols=141  Identities=16%  Similarity=0.174  Sum_probs=109.0

Q ss_pred             cceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHH------------------------HHHHHHHHHHHhcCCCCCe
Q 015965          119 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM------------------------QKEFAQEVFIMRKVRHKNV  173 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni  173 (397)
                      ...||+|+||.||+|.. .++.||||+++........                        .....+|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999987 5788999999865322111                        1123359999999988776


Q ss_pred             eeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcEEeCCCCceE
Q 015965          174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       174 v~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      ........  ...+|||||++|+++...... ...++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            43332222  224899999988777655333 46789999999999999999999 799999999999999998 47899


Q ss_pred             Ecccccccccc
Q 015965          253 VADFGVARVKA  263 (397)
Q Consensus       253 l~DfG~a~~~~  263 (397)
                      |+|||+|....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999996443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=194.02  Aligned_cols=198  Identities=23%  Similarity=0.351  Sum_probs=152.9

Q ss_pred             CCCCeeeeeeEEecC---------------------------CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHH
Q 015965          169 RHKNVVQFIGACTKP---------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV  221 (397)
Q Consensus       169 ~h~niv~~~~~~~~~---------------------------~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi  221 (397)
                      +|||||++.++|.+.                           ..+|+||..+ ..+|..++-.  ...+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence            499999999876432                           3579999988 5699999865  456777888899999


Q ss_pred             HHHHHHHHhCCcccCCCCCCcEEeC--CCC--ceEEcccccccccccCC-------cccCCCCCcccccccccCCCC---
Q 015965          222 SKGMNYLHQNNIIHRDLKAANLLMD--ENE--VVKVADFGVARVKAQSG-------VMTAETGTYRWMAPEVIEHKP---  287 (397)
Q Consensus       222 ~~~l~~LH~~~iiHrDlkp~Nili~--~~~--~vkl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---  287 (397)
                      ++|+.|||++||.|||+|.+|||+.  +|+  .+.|+|||.+-.....+       .....-|.-.-||||+....+   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999994  333  68999999874222211       122234788899999986543   


Q ss_pred             ---CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          288 ---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       288 ---~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                         --.++|.|+.|.+-||+++...||.............++..-|..|..+++.+++++...|+.||.+|++..-.-..
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence               12379999999999999999999976333222223345556788999999999999999999999999998776666


Q ss_pred             HHHHH
Q 015965          365 LQQIA  369 (397)
Q Consensus       365 L~~l~  369 (397)
                      |+-.+
T Consensus       511 l~LsL  515 (598)
T KOG4158|consen  511 LNLSL  515 (598)
T ss_pred             HHHHH
Confidence            65443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=5.7e-25  Score=224.63  Aligned_cols=243  Identities=18%  Similarity=0.250  Sum_probs=183.3

Q ss_pred             cccccceeeeeCCceEEEEEECCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      ++...+.||++.|=+|.++++....|+||++-+...  +-....+.++|++ ...+++||++++.-+...+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            678889999999999999998887899999865432  2222344445555 5667899999999888888888999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc----cCCcc
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA----QSGVM  268 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~----~~~~~  268 (397)
                      . .-+|+|.+.. +.-+..-....|+.||+.|+.-+|..||+|||||.+||||+.-+.+.|+||..-+..-    .+...
T Consensus       103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            9 6699999976 4557777888899999999999999999999999999999999999999998664211    11111


Q ss_pred             ----cCCCCCcccccccccCCC----------C-CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC-CCC-
Q 015965          269 ----TAETGTYRWMAPEVIEHK----------P-YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG-LRP-  330 (397)
Q Consensus       269 ----~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~-~~~-  330 (397)
                          .+...-.+|+|||.+...          + .+++.||||+||+++||++ |++||....-    ......+ ..+ 
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRSGNADDPE  256 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhccCccCHH
Confidence                122334579999997431          2 6678999999999999999 8999952211    1111000 000 


Q ss_pred             -CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 015965          331 -TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       331 -~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~  364 (397)
                       -+..-.+..++.++..|++.||.+|.+|++.|+.
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             0011223479999999999999999999999876

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=2.4e-23  Score=191.44  Aligned_cols=233  Identities=17%  Similarity=0.289  Sum_probs=152.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCC----------CCeeeeeeEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH----------KNVVQFIGAC  180 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~  180 (397)
                      ..+..++.||.|+++.||.+++.  ++.+|+|+...... .....+.+.+|......+.+          -.++--++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            35677889999999999999985  58899998754432 23346677777766655432          1222222222


Q ss_pred             e---------cC---C-----ceEEEEEeccCCCHHHHHHhc---cCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 015965          181 T---------KP---P-----SLCIVTEFMSGGSVYDYLHKL---KGV---FKLPSLLKVAIDVSKGMNYLHQNNIIHRD  237 (397)
Q Consensus       181 ~---------~~---~-----~~~lv~E~~~g~sL~~~l~~~---~~~---l~~~~~~~i~~qi~~~l~~LH~~~iiHrD  237 (397)
                      .         ..   .     +.+++|+-+ -++|.+++...   ...   +.......+..|+++.+++||+.|++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence            1         11   1     347788888 66888886532   111   22333455668999999999999999999


Q ss_pred             CCCCcEEeCCCCceEEcccccccccccCCcccCCCCCcccccccccCC--------CCCCCchhHHHHHHHHHHHHhCCC
Q 015965          238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKL  309 (397)
Q Consensus       238 lkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~ell~g~~  309 (397)
                      |+|+|++++.+|.++|+||+...........  ...+..|.+||....        ..++.+.|.|+||+++|.|.||..
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999999999999987655443221  345578999998743        357889999999999999999999


Q ss_pred             CCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 015965          310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  355 (397)
Q Consensus       310 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R  355 (397)
                      ||....+......    .+.  ....+|+.++.||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~--~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFS--RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence            9987654322111    111  222788999999999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4.5e-23  Score=180.67  Aligned_cols=182  Identities=14%  Similarity=0.137  Sum_probs=139.8

Q ss_pred             ccceeeeeCCceEEEEEECCcceEEEEecCCCCChH--HHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEecc
Q 015965          118 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       118 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      ....|++|+||+||.+...+.+++.+.+........  ....+.+|+.+|+++. |+++++++++    ...|++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            346899999999999888888888777765543211  2235789999999996 5889999886    34699999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEeCCCCceEEcccccccccccCCcc-----
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARVKAQSGVM-----  268 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDl-kp~Nili~~~~~vkl~DfG~a~~~~~~~~~-----  268 (397)
                      |.+|.+.+..        ....++.|++.++.++|++||+|||| ||+|||++.++.++|+|||++.........     
T Consensus        82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             CccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            9998764421        12357789999999999999999999 799999999999999999999855443310     


Q ss_pred             ---------cCCCCCcccccccccCCC-CCC-CchhHHHHHHHHHHHHhCCCCC
Q 015965          269 ---------TAETGTYRWMAPEVIEHK-PYD-HKADVFSFGIVLWELLTGKLPY  311 (397)
Q Consensus       269 ---------~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~ell~g~~P~  311 (397)
                               .-...++.|++|+...-- ..+ ...++++.|+.+|.++|+..|.
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence                     011357778888764322 333 5679999999999999988775

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=9.4e-23  Score=179.90  Aligned_cols=141  Identities=16%  Similarity=0.175  Sum_probs=110.8

Q ss_pred             ccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChH------------------------HHHHHHHHHHHHhcCCCCC
Q 015965          118 FGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSD------------------------MQKEFAQEVFIMRKVRHKN  172 (397)
Q Consensus       118 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~n  172 (397)
                      +.+.||+|+||.||+|... ++.||||+++.......                        ....+.+|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            3578999999999999874 88999999986532100                        0122457899999999998


Q ss_pred             eeeeeeEEecCCceEEEEEeccCCCHHHH-HHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCc
Q 015965          173 VVQFIGACTKPPSLCIVTEFMSGGSVYDY-LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEV  250 (397)
Q Consensus       173 iv~~~~~~~~~~~~~lv~E~~~g~sL~~~-l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~  250 (397)
                      +.....+...  ..||||||++|+++... +.  ...++...+..++.|++.++.++|+ .||+||||||+||+++ ++.
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            7444333332  24899999988755443 33  3567888999999999999999999 9999999999999999 889


Q ss_pred             eEEcccccccccc
Q 015965          251 VKVADFGVARVKA  263 (397)
Q Consensus       251 vkl~DfG~a~~~~  263 (397)
                      ++|+|||+++...
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=3.1e-22  Score=207.95  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=191.5

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC---CCCeeeeeeEEec
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK  182 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  182 (397)
                      ..+++....|.|.+.||.|+||.||+|.. .++.||+|+-++.....-.     -=.+++.+|+   -+.|..+..++.-
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHcc
Confidence            34688889999999999999999999975 4677999998876543221     1123344444   2456666666666


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-------CCceEEcc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVAD  255 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-------~~~vkl~D  255 (397)
                      .+..++|+||.+.|+|.++++. ...+++..+..++.||+..++.||..+|||+||||+|+||..       .--++|+|
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            6778999999999999999984 567899999999999999999999999999999999999942       33699999


Q ss_pred             ccccc---ccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----
Q 015965          256 FGVAR---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----  328 (397)
Q Consensus       256 fG~a~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----  328 (397)
                      ||.+.   .+.+.......++|-.+-.+|+..|+++++.+|.|.|+.+++-||.|+.-           . +..+.    
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q-~~~g~~~~~  912 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------E-VKNGSSWMV  912 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------H-hcCCcceec
Confidence            99985   33444455667889999999999999999999999999999999999631           1 22221    


Q ss_pred             CCCCCCCCcH-HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          329 RPTIPKNSQP-KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       329 ~~~~~~~~~~-~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ...++..... -...+...+|+.|-..=|...+|...|+.++.+.-.
T Consensus       913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~  959 (974)
T KOG1166|consen  913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT  959 (974)
T ss_pred             cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence            1112333322 345778888885555558889999999888876643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=5.8e-21  Score=171.16  Aligned_cols=136  Identities=23%  Similarity=0.399  Sum_probs=115.7

Q ss_pred             ceeeeeCCceEEEEEECCcceEEEEecCCCCChH------HHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      +.||+|++|.||+|.+.+..+++|+.........      ....+.+|+.++..+.|++|+....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5799999999999999999999998775433211      1245788999999999999877776666777889999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      +|++|.+++....    . ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.++.
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986521    2 7888999999999999999999999999999999 78899999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.86  E-value=5.3e-22  Score=202.91  Aligned_cols=204  Identities=28%  Similarity=0.411  Sum_probs=152.9

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|..++.|-.|+||.||..+++  .+.+|+|+-+..        -+++-  ++.....|.+|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------lilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------hhhhc--cccccCCccee----------------
Confidence            367888999999999999999765  678999653311        11111  23333334333                


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                           |+-...+.. -++++...        +.+++|||+.||+|||+||+|++|+.-|++|+.|||+++...-..    
T Consensus       136 -----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 222222222 34555443        778999999999999999999999999999999999986422110    


Q ss_pred             ------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CCCCCCC
Q 015965          267 ------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIP  333 (397)
Q Consensus       267 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~-~~~~~~~  333 (397)
                                  .....+||+.|+|||++..+.|...+|+|++|+++||.+.|+.||.+.++.+..-.++.. ...++-.
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d  281 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED  281 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence                        111237999999999999999999999999999999999999999999998776655533 2344456


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCC
Q 015965          334 KNSQPKLAELLERCWQQDPALRP  356 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rp  356 (397)
                      ...+++.++++.++|+.+|..|.
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhc
Confidence            67789999999999999999996

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-21  Score=188.96  Aligned_cols=207  Identities=31%  Similarity=0.570  Sum_probs=167.7

Q ss_pred             HhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCcE
Q 015965          165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-IHRDLKAANL  243 (397)
Q Consensus       165 l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-iHrDlkp~Ni  243 (397)
                      |+.+.|.|+.+++|.+.+++..++|.+||..|+|.|.+......+++.....+.++|+.||.|||...| .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999999999998877778888888999999999999998866 9999999999


Q ss_pred             EeCCCCceEEcccccccccccC---CcccCCCCCcccccccccCCCC-------CCCchhHHHHHHHHHHHHhCCCCCCC
Q 015965          244 LMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKP-------YDHKADVFSFGIVLWELLTGKLPYEY  313 (397)
Q Consensus       244 li~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~ell~g~~P~~~  313 (397)
                      +++..-.+||+|||+.......   .......-...|.|||.+....       .+.+.|+||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421   1112223456799999986641       45679999999999999999999975


Q ss_pred             C----ChHHHHHHhhh---cCCCCCCCC--CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          314 L----TPLQAAVGVVQ---KGLRPTIPK--NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       314 ~----~~~~~~~~~~~---~~~~~~~~~--~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .    .+.+.+..+..   ..++|.+..  ..++++..++++||..+|.+||++.++...+..+...
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            2    23334444333   224555442  3556899999999999999999999998888777653

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=4.3e-21  Score=170.83  Aligned_cols=134  Identities=16%  Similarity=0.222  Sum_probs=104.5

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-----CCCCeeeeeeEEecCC---ceE-EE
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPP---SLC-IV  189 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv  189 (397)
                      .+.||+|+||.||..... ...+||++.....  ...+.+.+|+.+++.+     .||||+++++++.++.   .++ +|
T Consensus         7 ~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPED-AQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEECCCC-cCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            468999999999973222 3347888875432  2346789999999999     5799999999998863   334 78


Q ss_pred             EEe--ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCcEEeCC----CCceEEcccccc
Q 015965          190 TEF--MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM-NYLHQNNIIHRDLKAANLLMDE----NEVVKVADFGVA  259 (397)
Q Consensus       190 ~E~--~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~iiHrDlkp~Nili~~----~~~vkl~DfG~a  259 (397)
                      |||  +.+++|.+++.+  +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.    ++.++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  557999999965  346655  35678888777 9999999999999999999974    337999995444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=3.5e-20  Score=164.58  Aligned_cols=133  Identities=20%  Similarity=0.361  Sum_probs=108.7

Q ss_pred             eeeeeCCceEEEEEECCcceEEEEecCCCCC-h-----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc
Q 015965          121 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-S-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      .||+|+||.||+|.+.+..+++|+....... .     .....+.+|+.+++.++|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            3899999999999999999999996643221 1     123567789999999998876544444555667899999999


Q ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          195 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       195 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      |++|.+++.....        .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||.++..
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998765211        7899999999999999999999999999999 889999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=4.2e-21  Score=184.35  Aligned_cols=167  Identities=26%  Similarity=0.472  Sum_probs=133.3

Q ss_pred             ceEEEEEeccCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ++||.|++|...+|.+|+...  ....+....+.++.|++.|++|   +|.+|||+||.||+...+..+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            578999999999999999643  2356777889999999999999   99999999999999999999999999998765


Q ss_pred             ccCC-------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCC
Q 015965          263 AQSG-------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK  334 (397)
Q Consensus       263 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  334 (397)
                      ....       .++..+||..||+||.+.+..|+.++||||||++|+|++. =..+++    .......++.+..|+...
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEFL  482 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHHh
Confidence            5544       5677899999999999999999999999999999999998 222221    112222333333332222


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDF  358 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~  358 (397)
                      .-.++-..|+.+++.+.|.+||++
T Consensus       483 ~d~p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  483 QDYPEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             hcCcHHHHHHHHhcCCCcccCchH
Confidence            233566799999999999999944

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=4.4e-20  Score=168.07  Aligned_cols=142  Identities=16%  Similarity=0.189  Sum_probs=111.1

Q ss_pred             cccccceeeeeCCceEEEEE---ECCcceEEEEecCCCCCh----------------------HHHHHHHHHHHHHhcCC
Q 015965          115 HLKFGSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR  169 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~---~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~  169 (397)
                      -|.+.+.||+|+||.||+|.   ..++.||||+++......                      .....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998   367889999987543210                      01233568999999997


Q ss_pred             CC--CeeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEeC
Q 015965          170 HK--NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMD  246 (397)
Q Consensus       170 h~--niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~Nili~  246 (397)
                      +.  .++++++.    ...++||||++|.+|...... ...+....+..++.||+.++.+||+.| |+||||||+||+++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            53  34445543    235899999999888765432 244566677899999999999999999 99999999999999


Q ss_pred             CCCceEEccccccccc
Q 015965          247 ENEVVKVADFGVARVK  262 (397)
Q Consensus       247 ~~~~vkl~DfG~a~~~  262 (397)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999998643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.82  E-value=1.7e-19  Score=183.66  Aligned_cols=136  Identities=21%  Similarity=0.337  Sum_probs=114.0

Q ss_pred             ccccceeeeeCCceEEEEEECCcceEEEEecCCCC-Ch-----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      |...+.||+|+||+||+|.+.+..+++|+...... ..     .....+.+|+.+++.++|++++..+.++..+...++|
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            35578999999999999999888877776432211 11     1235688999999999999998877777777778999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      |||++|++|.+++.         ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999885         246789999999999999999999999999999 678899999999965

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=2.8e-19  Score=158.78  Aligned_cols=137  Identities=19%  Similarity=0.240  Sum_probs=107.7

Q ss_pred             ccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCCh--------------------HHHHHHHHHHHHHhcCCCCC--
Q 015965          116 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHKN--  172 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~n--  172 (397)
                      |.+.+.||+|+||.||++.. .++.||||+++......                    .....+.+|..++.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            67778999999999999987 57889999977543110                    01123667899999888774  


Q ss_pred             eeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceE
Q 015965          173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       173 iv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      ++..++.    ...++||||++|++|.+....       .....++.+++.++.++|+.||+||||||+||++++++.++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            4444432    345899999999998765421       34567889999999999999999999999999999999999


Q ss_pred             Ecccccccccc
Q 015965          253 VADFGVARVKA  263 (397)
Q Consensus       253 l~DfG~a~~~~  263 (397)
                      |+|||.+....
T Consensus       166 liDfg~~~~~~  176 (198)
T cd05144         166 IIDWPQMVSTD  176 (198)
T ss_pred             EEECCccccCC
Confidence            99999996443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=4.6e-18  Score=149.36  Aligned_cols=137  Identities=21%  Similarity=0.304  Sum_probs=98.3

Q ss_pred             cceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHH----------------------HHHHHHHhcCCCCC--e
Q 015965          119 GSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEF----------------------AQEVFIMRKVRHKN--V  173 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~h~n--i  173 (397)
                      .+.||+|+||.||+|... ++.||||++++...........                      ..|...+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            578999999999999876 7889999987653322111111                      34556666554432  4


Q ss_pred             eeeeeEEecCCceEEEEEeccCCCHH-HHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCce
Q 015965          174 VQFIGACTKPPSLCIVTEFMSGGSVY-DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVV  251 (397)
Q Consensus       174 v~~~~~~~~~~~~~lv~E~~~g~sL~-~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~v  251 (397)
                      ++.++.    ...++||||++|+.+. ..+.....   ......++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            444443    2358999999985332 11221111   15678899999999999999 9999999999999999 8999


Q ss_pred             EEcccccccccc
Q 015965          252 KVADFGVARVKA  263 (397)
Q Consensus       252 kl~DfG~a~~~~  263 (397)
                      +|+|||.++...
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=1.5e-17  Score=151.65  Aligned_cols=136  Identities=14%  Similarity=0.162  Sum_probs=107.2

Q ss_pred             ceee-eeCCceEEEEEECCcceEEEEecCCCC-----------ChHHHHHHHHHHHHHhcCCCCCe--eeeeeEEecCCc
Q 015965          120 SKVA-SGSYGDLYRGTYCSQDVAIKVLKPERI-----------NSDMQKEFAQEVFIMRKVRHKNV--VQFIGACTKPPS  185 (397)
Q Consensus       120 ~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~  185 (397)
                      ..|| .|+.|+||.++..+..++||.+.....           .......+.+|+.++.+++|++|  +..+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4687 889999999988899999998754221           11233568889999999998875  667766433222


Q ss_pred             ----eEEEEEeccC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          186 ----LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       186 ----~~lv~E~~~g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                          .++|||+++| .+|.+++..  ..++..    .+.+|+.++.+||++||+||||||+|||++.++.++|+|||.++
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence                2599999997 689988864  345544    35789999999999999999999999999999999999999986


Q ss_pred             c
Q 015965          261 V  261 (397)
Q Consensus       261 ~  261 (397)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            4

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=7.4e-20  Score=186.34  Aligned_cols=249  Identities=25%  Similarity=0.404  Sum_probs=196.8

Q ss_pred             ccccccceeeeeCCceEEEEEECC---cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  189 (397)
                      ..|.+.+.||+|+|+.|-.....+   ..+|+|.+...............|..+-+.+. |+|++.+++....+...+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777889999999988775532   33666666554433444455666888888887 99999999999999999999


Q ss_pred             EEeccCCCHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEeCCCC-ceEEccccccccccc-C
Q 015965          190 TEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQ-S  265 (397)
Q Consensus       190 ~E~~~g~sL~~~l-~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~-~  265 (397)
                      ++|..|+++.+.+ .......+....-.++.|+..++.|+| ..++.|+|+||+|.+++..+ .++++|||+|..... .
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9999999999988 442226777788899999999999999 99999999999999999999 999999999986655 3


Q ss_pred             C---cccCCCC-CcccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhhcCC--CCCCCCCCc
Q 015965          266 G---VMTAETG-TYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGL--RPTIPKNSQ  337 (397)
Q Consensus       266 ~---~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~-~~~~~~~~--~~~~~~~~~  337 (397)
                      +   .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||......... ........  ........+
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSIS  259 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCC
Confidence            2   3345578 99999999998854 456789999999999999999999765443322 22222211  244556778


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                      ....+++.+++..+|..|.+.+++.
T Consensus       260 ~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  260 DQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             hhhhhcccccccCCchhcccccccc
Confidence            8899999999999999999988863

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=1.9e-17  Score=139.22  Aligned_cols=132  Identities=17%  Similarity=0.219  Sum_probs=113.6

Q ss_pred             ccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeeeEEecCCceEEEEEeccC
Q 015965          118 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       118 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.+.||.|.++.||++...+..+++|.......    ...+.+|+.+++.++|  .++++++.+....+..+++|||++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            357899999999999999888999999876533    4568889999999986  5899999988887889999999988


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      .++..+        +......++.+++.++.+||..   +++|+|++|+||++++.+.++++|||.++.
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777643        4556677889999999999985   799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.4e-16  Score=154.35  Aligned_cols=245  Identities=23%  Similarity=0.302  Sum_probs=188.9

Q ss_pred             cccccccceeee--eCCceEEEEEE----CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCc
Q 015965          113 PKHLKFGSKVAS--GSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS  185 (397)
Q Consensus       113 ~~~~~~~~~lg~--G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  185 (397)
                      ...+.+.+.+|+  |.+|.||.+..    .+..+|+|.-+...........=.+|+...++++ |+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345677788999  99999998765    4566899875443332222333445666666675 9999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCcEEeCCC-CceEEccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR  260 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~  260 (397)
                      +|+-+|++ +.+|..+.+.....++...++....+...    |+.++|+.+++|-|+||.||++..+ ...+++|||+..
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            99999999 78999998876667899999999999999    9999999999999999999999999 889999999998


Q ss_pred             ccccCCccc------CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHhhhcC-CCCC
Q 015965          261 VKAQSGVMT------AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--TPLQAAVGVVQKG-LRPT  331 (397)
Q Consensus       261 ~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~--~~~~~~~~~~~~~-~~~~  331 (397)
                      .........      ...|...|++||..++- ++...|+|++|.++.+-.++..+...-  +....    .+.. ...+
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----~r~~~ip~e  346 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----LRQGYIPLE  346 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccc----cccccCchh
Confidence            766554211      22578899999998765 788999999999999998876554322  11110    1111 1223


Q ss_pred             CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +....+.++...+..|++.+|..|++++.++.
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            34455677888999999999999999887653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.63  E-value=3.3e-14  Score=140.66  Aligned_cols=141  Identities=17%  Similarity=0.255  Sum_probs=98.2

Q ss_pred             ceeeeeCCceEEEEEE-CCcceEEEEecCCCCCh---H-------------------------HH----------HHHHH
Q 015965          120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D-------------------------MQ----------KEFAQ  160 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~---~-------------------------~~----------~~~~~  160 (397)
                      +.||+|++|.||+|+. .|+.||||+.++.....   +                         ..          -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999987 68899999998653110   0                         00          02455


Q ss_pred             HHHHHhcCC----CCCeeeeeeEE-ecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHH-HHHHHHhCCcc
Q 015965          161 EVFIMRKVR----HKNVVQFIGAC-TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK-GMNYLHQNNII  234 (397)
Q Consensus       161 E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~-~l~~LH~~~ii  234 (397)
                      |+..+.+++    +.+-+.+-.++ ......+|||||++|++|.++.........   ...++.+++. .+..+|..|++
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence            666555553    22222222222 223446899999999999988754222222   3446666665 46889999999


Q ss_pred             cCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          235 HRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       235 HrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      |+|++|.||+++.++.++++|||++....
T Consensus       280 H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       280 HADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999986543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=7.2e-14  Score=140.11  Aligned_cols=142  Identities=17%  Similarity=0.230  Sum_probs=91.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC----------------------------h----HHHHH--
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN----------------------------S----DMQKE--  157 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----------------------------~----~~~~~--  157 (397)
                      ..|.. +.||+|++|.||+|+..  |+.||||+.++....                            .    +..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34555 68999999999999874  789999999865210                            0    11111  


Q ss_pred             ----HHHHHHHHhcCC----CCCeeeeeeEEec-CCceEEEEEeccCCCHHHHHHhccCC-----CCHHHHHHHHHHHHH
Q 015965          158 ----FAQEVFIMRKVR----HKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKGV-----FKLPSLLKVAIDVSK  223 (397)
Q Consensus       158 ----~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~E~~~g~sL~~~l~~~~~~-----l~~~~~~~i~~qi~~  223 (397)
                          +.+|+..+.+++    +.+.+.+-.++.+ ....+|||||+.|+.+.++-.-....     +....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                344444444442    3332332222222 34568999999999998753211122     3333333344444  


Q ss_pred             HHHHHHhCCcccCCCCCCcEEeCCCC----ceEEcccccccccc
Q 015965          224 GMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  263 (397)
Q Consensus       224 ~l~~LH~~~iiHrDlkp~Nili~~~~----~vkl~DfG~a~~~~  263 (397)
                           ...|++|+|+||.||+++.++    .++++|||++...+
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 468999999999999999888    99999999986543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=3.6e-13  Score=133.57  Aligned_cols=162  Identities=16%  Similarity=0.253  Sum_probs=126.1

Q ss_pred             CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHH
Q 015965          136 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL  215 (397)
Q Consensus       136 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~  215 (397)
                      .+.+|.|.+.+....  .......+-+..|+.++||||++++..+...+.+|||+|.+  ..|..++.+.    ....+.
T Consensus        36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----~~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----GKEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----HHHHHH
Confidence            466788887775432  33345667888999999999999999999999999999998  4788888763    366777


Q ss_pred             HHHHHHHHHHHHHH-hCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc-cCCCCCcccccccccCCCCCCCchh
Q 015965          216 KVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKAD  293 (397)
Q Consensus       216 ~i~~qi~~~l~~LH-~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~D  293 (397)
                      .-+.||+.||.||| ..+++|++|.-..|+++..|..||++|.++........+ ....---.|..|+.+....  -..|
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence            78899999999997 678999999999999999999999999998654433221 1111223456666654333  3469


Q ss_pred             HHHHHHHHHHHHhC
Q 015965          294 VFSFGIVLWELLTG  307 (397)
Q Consensus       294 v~slG~~l~ell~g  307 (397)
                      .|.||+++|+++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.52  E-value=4e-14  Score=122.13  Aligned_cols=127  Identities=17%  Similarity=0.204  Sum_probs=97.1

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe-eeeeeEEecCCceEEEEEeccCCC
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGS  197 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~g~s  197 (397)
                      .+.|+.|.++.||+++..++.+++|+......   ....+.+|+.+++.+.+.++ ++++....  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            35789999999999999999999999765431   12345678888888865554 44555433  34589999999988


Q ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCcEEeCCCCceEEccccccc
Q 015965          198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-----IHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       198 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-----iHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      +.+.  .    .   ....++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~--~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTE--D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            7643  0    1   113456799999999999985     9999999999999 6789999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=1.7e-14  Score=148.57  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=189.9

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      +....+.+.+.+.+-+|+++.++.++-.  +...++|+.+.... .....+....+-.++-..++|.++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            4556677888889999999999987542  34455555443211 11112233344444444556777777666556677


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc-c
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-Q  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~-~  264 (397)
                      .+++++|+.|++|...++.. +..+......+...+..+.+|||+..++|+|++|.|+++..+++.++.|||...... .
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            89999999999999999874 456666777888899999999999999999999999999999999999998432100 0


Q ss_pred             --------------------C-----------CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015965          265 --------------------S-----------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY  313 (397)
Q Consensus       265 --------------------~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~  313 (397)
                                          .           .......||+.|.+||...+......+|+|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                0           011233689999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 015965          314 LTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQQDPALRPDFS  359 (397)
Q Consensus       314 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~  359 (397)
                      ..+.+....+..... .+.-+...+.+.++++.+.+..+|.+|..+.
T Consensus      1038 ~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            998887766654432 3455667789999999999999999997765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=2e-13  Score=119.57  Aligned_cols=137  Identities=17%  Similarity=0.201  Sum_probs=99.0

Q ss_pred             ceeeeeCCceEEEEEEC--------CcceEEEEecCCCCC--------------------hHHHHHHH----HHHHHHhc
Q 015965          120 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERIN--------------------SDMQKEFA----QEVFIMRK  167 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~--------------------~~~~~~~~----~E~~~l~~  167 (397)
                      ..||.|--+.||.|...        +..+|||+.+....+                    ....+.+.    +|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999754        267999988642110                    11122233    79999998


Q ss_pred             CCC--CCeeeeeeEEecCCceEEEEEeccCCCHHH-HHHhccCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcE
Q 015965          168 VRH--KNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANL  243 (397)
Q Consensus       168 l~h--~niv~~~~~~~~~~~~~lv~E~~~g~sL~~-~l~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~iiHrDlkp~Ni  243 (397)
                      +..  -+++..+++    ...+|||||+.+..+.. .+..  ..++......+..+++.+|..| |+.|+||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            863  456666654    35689999996643321 2222  2355566777889999999998 899999999999999


Q ss_pred             EeCCCCceEEcccccccccc
Q 015965          244 LMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       244 li~~~~~vkl~DfG~a~~~~  263 (397)
                      +++ ++.+.|+|||.+....
T Consensus       157 L~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE-CCcEEEEECCCceeCC
Confidence            997 4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=6.9e-13  Score=112.67  Aligned_cols=134  Identities=21%  Similarity=0.325  Sum_probs=102.3

Q ss_pred             ceeeeeCCceEEEEEECCcceEEEEecC-CCCChHH-----HHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          120 SKVASGSYGDLYRGTYCSQDVAIKVLKP-ERINSDM-----QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~-~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      ..+++|+-+.+|.+.+.+.++++|.=.+ ....+..     .....+|+.++.+++--.|.--+=+..+++...|+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            3578999999999999888888886433 2223322     244667999999887555544444455667778999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +|..|.+++...        ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++...
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999999763        244666677777889999999999999999998765 999999999743

>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

Probab=99.47  E-value=2.2e-13  Score=97.17  Aligned_cols=67  Identities=67%  Similarity=1.026  Sum_probs=64.6

Q ss_pred             CeeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHH
Q 015965            1 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV   67 (397)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~   67 (397)
                      ||||++.+.|+|+|+++++.+|+..||||..|.+|++.+|+.+|.|+|..|..++.+.|++++++..
T Consensus         1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~   67 (68)
T cd04928           1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI   67 (68)
T ss_pred             CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence            7999999999999999999999999999999999999999999999999999999999999998753

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=8.1e-14  Score=127.03  Aligned_cols=189  Identities=21%  Similarity=0.364  Sum_probs=137.9

Q ss_pred             hcCCCCCeeeeeeEEecC-----CceEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC--Cccc
Q 015965          166 RKVRHKNVVQFIGACTKP-----PSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN--NIIH  235 (397)
Q Consensus       166 ~~l~h~niv~~~~~~~~~-----~~~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~--~iiH  235 (397)
                      -++-|.|||+++.++.+.     ....+++|||..|+|..+|++.   ...+......+|+.||+.||.|||+.  -|+|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            345699999999988654     4578999999999999999754   34577888899999999999999998  4999


Q ss_pred             CCCCCCcEEeCCCCceEEcccccccc-----cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 015965          236 RDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP  310 (397)
Q Consensus       236 rDlkp~Nili~~~~~vkl~DfG~a~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P  310 (397)
                      +++..+.|++..+|.||+.---....     ...........+-+.|.+||.=.....+.++|||+||++..+|..|..-
T Consensus       202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq  281 (458)
T KOG1266|consen  202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ  281 (458)
T ss_pred             CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence            99999999999999999864222111     0111123344678899999987666677789999999999999887653


Q ss_pred             CC-CCCh---HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          311 YE-YLTP---LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       311 ~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                      -. ..+.   .+...... .++.       ...-++++.+|++..|..||++++++
T Consensus       282 ~tnseS~~~~ee~ia~~i-~~le-------n~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  282 STNSESKVEVEENIANVI-IGLE-------NGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             cCCCcceeehhhhhhhhe-eecc-------CccccCcCcccccCCCCCCcchhhhh
Confidence            21 1111   11111111 1111       12235678999999999999999886

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=8e-14  Score=136.78  Aligned_cols=243  Identities=22%  Similarity=0.217  Sum_probs=179.5

Q ss_pred             cccccccceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  188 (397)
                      ..+|..+..||.|.|+.|+.....   +-.|++|..............-..|+.+...+. |.+++..+..|......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            357888899999999999987543   345888877765544443444556777776664 8999999988888888899


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEcccccccccccCCc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~~~~~~~~  267 (397)
                      --||++++++...+ .....+.+...+++..|++.++.++|+..++|+|++|+||++..+ +..++.|||......-. .
T Consensus       344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-~  421 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-S  421 (524)
T ss_pred             chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-c
Confidence            99999999887666 234567888899999999999999999999999999999999876 78899999988642211 1


Q ss_pred             ccCCCCCcccc--cccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          268 MTAETGTYRWM--APEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       268 ~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      . ......+++  +|.......+..+.|+||||..+.+..+|.. ++....     ...++.+..+..+. ....+..+.
T Consensus       422 ~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~~i~~~~~p~~~~-~~~~~q~~~  494 (524)
T KOG0601|consen  422 G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SLTIRSGDTPNLPG-LKLQLQVLL  494 (524)
T ss_pred             c-cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----ceeeecccccCCCc-hHHhhhhhh
Confidence            1 122233344  5566677788899999999999999999764 222111     11122232333333 337899999


Q ss_pred             HHhchhCCCCCCCHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~  364 (397)
                      ..++.+++..||.+.++...
T Consensus       495 kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             hhhcCCccccchhhhhhccc
Confidence            99999999999999886543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.40  E-value=3.2e-11  Score=113.82  Aligned_cols=252  Identities=17%  Similarity=0.286  Sum_probs=171.9

Q ss_pred             ccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeee--------eeeEEecCCce
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ--------FIGACTKPPSL  186 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------~~~~~~~~~~~  186 (397)
                      ...++.||+|+-+.+|-.-.-... +-|+.........  .   +.+..|... .||-+-.        ++|. ......
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i   85 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI   85 (637)
T ss_pred             cCCCccccCCccceeeecchhhch-hheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence            445678999999999964333333 4466554322111  1   122333333 3553322        1111 122236


Q ss_pred             EEEEEeccCCCH-HHHHH-----hccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          187 CIVTEFMSGGSV-YDYLH-----KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       187 ~lv~E~~~g~sL-~~~l~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      .+.|..++|..- ..+++     +.-....++.+++.+..|+.+...||..|.+-+|++++|+|+++++.|.|.|-..-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            788888877532 22221     112347889999999999999999999999999999999999999999999977665


Q ss_pred             ccccCCcccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCC-------ChHHHHHH-----
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTG-KLPYEYL-------TPLQAAVG-----  322 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g-~~P~~~~-------~~~~~~~~-----  322 (397)
                      ....+......+|...|.+||.-.     +..-+...|.|.||+++++++.| +.||.+.       ++.++...     
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            555566667788999999999854     44556779999999999999985 9999654       23332111     


Q ss_pred             ---hhhcCCCCC----CCCCCcHHHHHHHHHhchhC--CCCCCCHHHHHHHHHHHHHHhch
Q 015965          323 ---VVQKGLRPT----IPKNSQPKLAELLERCWQQD--PALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       323 ---~~~~~~~~~----~~~~~~~~l~~ll~~cl~~d--p~~Rps~~ell~~L~~l~~~~~~  374 (397)
                         ..+.+.++.    ....+++.+..+..+|+..-  +.-|||++..+..|.++.+++..
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence               011122221    11346789999999999654  67899999999999999988864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=5.1e-12  Score=106.99  Aligned_cols=145  Identities=23%  Similarity=0.281  Sum_probs=107.7

Q ss_pred             ccceeeeeCCceEEEEEECCcceEEEEecCCC-CCh-----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          118 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPER-INS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       118 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ....|-+|+-+.|+++.+.|+...||.-.+.. ..+     -...+..+|+++|.++.--.|.--.=++.+....+|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            34678899999999999999999998643222 111     234567889999999875444333333455566789999


Q ss_pred             eccC-CCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ceEEccccccccc
Q 015965          192 FMSG-GSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK  262 (397)
Q Consensus       192 ~~~g-~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~vkl~DfG~a~~~  262 (397)
                      |++| .++.+++..... .........++.+|-..+.-||.++|||+||..+||++..++   .+.++|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9976 378888765433 333334478899999999999999999999999999997654   3589999998644

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.31  E-value=1.1e-11  Score=111.42  Aligned_cols=139  Identities=19%  Similarity=0.288  Sum_probs=104.2

Q ss_pred             ceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeeeEEecC---CceEEEEEec
Q 015965          120 SKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP---PSLCIVTEFM  193 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~E~~  193 (397)
                      +.|+.|.++.||+++..+ +.+++|+....... .....+.+|+.+++.+.+  .++++++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998776 88999997654321 124567889999999876  3457777776653   2578999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  230 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------------  230 (397)
                      +|.++.+.+..  ..++......++.+++.+|..||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888765421  345666666666777777776663                                           


Q ss_pred             -------------CCcccCCCCCCcEEeCC--CCceEEcccccccc
Q 015965          231 -------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARV  261 (397)
Q Consensus       231 -------------~~iiHrDlkp~Nili~~--~~~vkl~DfG~a~~  261 (397)
                                   ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         24699999999999998  67789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.24  E-value=1.6e-10  Score=106.75  Aligned_cols=139  Identities=14%  Similarity=0.059  Sum_probs=99.1

Q ss_pred             eeeeCCceEEEEEECCcceEEEEecCCCCCh---------HHHHHHHHHHHHHhcCCCCCe--eeeeeEEec-----CCc
Q 015965          122 VASGSYGDLYRGTYCSQDVAIKVLKPERINS---------DMQKEFAQEVFIMRKVRHKNV--VQFIGACTK-----PPS  185 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~-----~~~  185 (397)
                      +-......|++.++.|+.+.||.........         .....+.+|...+.++...+|  +..+.++..     ...
T Consensus        30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~  109 (268)
T PRK15123         30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT  109 (268)
T ss_pred             EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence            3333334577888888899999764432111         011147788888887753333  334444432     234


Q ss_pred             eEEEEEeccCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-------CCceEEccc
Q 015965          186 LCIVTEFMSGG-SVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVADF  256 (397)
Q Consensus       186 ~~lv~E~~~g~-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-------~~~vkl~Df  256 (397)
                      .+||||++++. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||++.       +..+.|+||
T Consensus       110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            68999999876 899998642 244566677889999999999999999999999999999975       468999999


Q ss_pred             cccc
Q 015965          257 GVAR  260 (397)
Q Consensus       257 G~a~  260 (397)
                      +.++
T Consensus       190 ~r~~  193 (268)
T PRK15123        190 HRAQ  193 (268)
T ss_pred             Cccc
Confidence            9885

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=3.9e-10  Score=98.47  Aligned_cols=127  Identities=20%  Similarity=0.272  Sum_probs=82.4

Q ss_pred             eEEEEEE-CCcceEEEEecCCCCCh------------------------HHHHHHHHHHHHHhcCCCC--CeeeeeeEEe
Q 015965          129 DLYRGTY-CSQDVAIKVLKPERINS------------------------DMQKEFAQEVFIMRKVRHK--NVVQFIGACT  181 (397)
Q Consensus       129 ~Vy~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~  181 (397)
                      .||.|.. .+..+|||+.+....+-                        .......+|...|.++..-  ++++.+.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4888876 56789999887431110                        1123467799999999865  466676543 


Q ss_pred             cCCceEEEEEecc--CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          182 KPPSLCIVTEFMS--GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY-LHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       182 ~~~~~~lv~E~~~--g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                         ..+|||||++  |..+..+...   .++......++.+++..+.. +|+.||+|+||.+.||+++++ .+.|+|||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               3589999998  5555443322   12234566677888886655 579999999999999999987 899999998


Q ss_pred             ccccc
Q 015965          259 ARVKA  263 (397)
Q Consensus       259 a~~~~  263 (397)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            86443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.10  E-value=4.7e-09  Score=101.74  Aligned_cols=210  Identities=17%  Similarity=0.220  Sum_probs=152.1

Q ss_pred             ceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----CCceEEEEEeccC-CCHHH
Q 015965          128 GDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIVTEFMSG-GSVYD  200 (397)
Q Consensus       128 g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~E~~~g-~sL~~  200 (397)
                      .+.|++..  +|..|++|.++..+...  ......-+++|+++.|+|+|++.+++..    +..+++|++|.++ ++|++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45777754  67779999985433221  1223345789999999999999998863    4568999999875 58888


Q ss_pred             HHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          201 YLHKL--------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       201 ~l~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +.-..              ..+.++..+|.++.||..||.++|+.|...+-|.|.+|+++.+-.++|+..|...+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            65321              2357889999999999999999999999999999999999988899999888876544332


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                            +       |-+.+   -.+-|.=.||.+++.|.||..- |......+....        .+....+.++++++.
T Consensus       448 ------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v~  503 (655)
T KOG3741|consen  448 ------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVVE  503 (655)
T ss_pred             ------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHHH
Confidence                  0       11111   1256999999999999999642 222222222111        234567789999999


Q ss_pred             HhchhCCCCCCCHHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~~  364 (397)
                      -....++++ -+..+++..
T Consensus       504 yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  504 YLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHhcCccc-ccHHHHHHH
Confidence            999999987 677887754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.02  E-value=2.1e-09  Score=96.87  Aligned_cols=137  Identities=19%  Similarity=0.243  Sum_probs=102.2

Q ss_pred             ccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCCh--------------------HHHHHHHHHHHHHhcCCCC--C
Q 015965          116 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHK--N  172 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~--n  172 (397)
                      ..++..||-|--+.||.|... +.++|||.-+....+.                    -......+|..+|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            467789999999999999874 7889999765432211                    1123466789999988754  6


Q ss_pred             eeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceE
Q 015965          173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       173 iv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      +++.++    .+..++||||++|..|+..-      ++....-.++..|+.-+.-+-..||||+|+++-||+++++|.+.
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            666654    34578999999987766432      23344555666777777666699999999999999999999999


Q ss_pred             Eccccccccc
Q 015965          253 VADFGVARVK  262 (397)
Q Consensus       253 l~DfG~a~~~  262 (397)
                      ++||-.+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999877543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=2.7e-09  Score=95.24  Aligned_cols=106  Identities=17%  Similarity=0.278  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHhcCCCCC--eeeeeeEEecC----CceEEEEEeccCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Q 015965          156 KEFAQEVFIMRKVRHKN--VVQFIGACTKP----PSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL  228 (397)
Q Consensus       156 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~E~~~g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~L  228 (397)
                      ....+|...+..+..-+  .+..+++....    ...++|||++++. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            34667777777665332  34455554432    2358999999885 79999876322 66777888999999999999


Q ss_pred             HhCCcccCCCCCCcEEeCCCC---ceEEccccccccc
Q 015965          229 HQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK  262 (397)
Q Consensus       229 H~~~iiHrDlkp~Nili~~~~---~vkl~DfG~a~~~  262 (397)
                      |..||+|+|+++.|||++.++   .+.++||+.++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999887   8999999988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.95  E-value=5.4e-08  Score=97.44  Aligned_cols=139  Identities=19%  Similarity=0.277  Sum_probs=93.6

Q ss_pred             ceeeeeCCceEEEEEEC-CcceEEEEecCCCCCh---H-------------------------HH----------HHHHH
Q 015965          120 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS---D-------------------------MQ----------KEFAQ  160 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~---~-------------------------~~----------~~~~~  160 (397)
                      ..|+++|-|.||+|+.. |+.||||+.++.....   +                         ..          -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57999999999999986 8999999998653210   0                         00          12444


Q ss_pred             HHHHHhcCC-----CCCe--eeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 015965          161 EVFIMRKVR-----HKNV--VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG-MNYLHQNN  232 (397)
Q Consensus       161 E~~~l~~l~-----h~ni--v~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~-l~~LH~~~  232 (397)
                      |...+.+++     .+++  ++++  ++-.+.-.|+|||++|-.+.+........++...+   +..++++ +..+-..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHHhcC
Confidence            555555543     2332  3333  22234568999999999999885433345553333   3333333 23344589


Q ss_pred             cccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          233 IIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       233 iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ++|.|.+|.||+++.+|.+.+.|||.+...+
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999999986543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.90  E-value=5.8e-10  Score=111.47  Aligned_cols=144  Identities=19%  Similarity=0.302  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccccccCCc-----c-----cCCCCCcccccccccCCCC
Q 015965          219 IDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-----M-----TAETGTYRWMAPEVIEHKP  287 (397)
Q Consensus       219 ~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-----~-----~~~~gt~~y~aPE~~~~~~  287 (397)
                      .+.+.|+.|+|.. ++||+.|.|++|.++.++.+||+.|+++.....+..     .     ........|.|||.+.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3444899999976 899999999999999999999999999864433111     0     0112456799999999988


Q ss_pred             CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh--hcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       288 ~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                      .+.++|+||+|+++|.+.. |+.-+.............  ........+..+|+++++-+.+++..++.-||++.++.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            8899999999999999995 555554432222111111  11112234578899999999999999999999776654

>PRK09902 hypothetical protein; Provisional

Probab=98.86  E-value=4.7e-08  Score=86.13  Aligned_cols=140  Identities=12%  Similarity=0.064  Sum_probs=102.1

Q ss_pred             eeeeCCceEEEEEECCcceEEEEecCCC----CChHHHHHHHHHHHHHhcCCCC--CeeeeeeEEec--C--CceEEEEE
Q 015965          122 VASGSYGDLYRGTYCSQDVAIKVLKPER----INSDMQKEFAQEVFIMRKVRHK--NVVQFIGACTK--P--PSLCIVTE  191 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~--~--~~~~lv~E  191 (397)
                      -|+|+.+-|++-...++.+-+|.-....    ..+.....|.+|...++++..-  .+++.......  +  -.-+||+|
T Consensus        26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            4678888899988888888888654211    0022356799999999988632  24444422111  1  12579999


Q ss_pred             eccC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc--eEEcccccccc
Q 015965          192 FMSG-GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV  261 (397)
Q Consensus       192 ~~~g-~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~--vkl~DfG~a~~  261 (397)
                      -++| -+|.+++.+. ....+......++.+++..+.-||+.|+.|+|+.+.||+++.++.  |+++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8854 4899888652 234566677889999999999999999999999999999986677  99999987753

>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

Probab=98.84  E-value=1.9e-08  Score=73.90  Aligned_cols=50  Identities=42%  Similarity=0.691  Sum_probs=47.2

Q ss_pred             CeeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecC
Q 015965            1 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG   50 (397)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~   50 (397)
                      +.||.+.+.|+|+||++++.+|++.|+||..|.+|.+.+|+.+|+|.|..
T Consensus         1 ~~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~   50 (73)
T cd04900           1 GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLD   50 (73)
T ss_pred             CEEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEEC
Confidence            47999999999999999999999999999999999998999999999854

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.74  E-value=1.3e-07  Score=83.70  Aligned_cols=140  Identities=16%  Similarity=0.193  Sum_probs=92.3

Q ss_pred             cCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChH-HHHH------HHHHHHHHhcCC---CCCeeeeeeEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVR---HKNVVQFIGAC  180 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~---h~niv~~~~~~  180 (397)
                      +-..+|++.+++-......|.+-...++.+++|..+......+ ....      ..+.+..+.+++   ......++-+.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3346777777777777777888888999999999876532211 1111      122333333332   22333333322


Q ss_pred             ec-----CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcc
Q 015965          181 TK-----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD  255 (397)
Q Consensus       181 ~~-----~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~D  255 (397)
                      ..     ....+++|||++|..|.+...     +++    .++..+.+++.-||+.|++|+|..|.|+++++++ ++++|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence            22     234568999999988876542     222    2456677889999999999999999999999655 99999


Q ss_pred             ccccc
Q 015965          256 FGVAR  260 (397)
Q Consensus       256 fG~a~  260 (397)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=1.6e-07  Score=84.90  Aligned_cols=134  Identities=17%  Similarity=0.242  Sum_probs=84.7

Q ss_pred             ceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC--eeeeeeEEecCCceEEEEEeccCCC
Q 015965          120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEFMSGGS  197 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~E~~~g~s  197 (397)
                      ..||.|..+.||+.  .+..+++|+......    .....+|.++++.+..-+  +++.+.++...+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984  366788898775331    234678999998886433  4677888777777889999998863


Q ss_pred             -HHHHH---------------------Hhcc-CCCCHHHHH-HHHH----------HHHH-HHHHHHh----CCcccCCC
Q 015965          198 -VYDYL---------------------HKLK-GVFKLPSLL-KVAI----------DVSK-GMNYLHQ----NNIIHRDL  238 (397)
Q Consensus       198 -L~~~l---------------------~~~~-~~l~~~~~~-~i~~----------qi~~-~l~~LH~----~~iiHrDl  238 (397)
                       +...+                     +... ...+..... .+..          .+.. ...+|.+    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     1100 011111111 1100          1111 1222221    24789999


Q ss_pred             CCCcEEeCCCCceEEccccccc
Q 015965          239 KAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       239 kp~Nili~~~~~vkl~DfG~a~  260 (397)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.62  E-value=2.9e-07  Score=78.10  Aligned_cols=136  Identities=19%  Similarity=0.245  Sum_probs=98.9

Q ss_pred             ccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCee-eeeeEEecCCceEEEEEe
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV-QFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~E~  192 (397)
                      -..+..+.||+|.+|.||+|.|.+..+|+|+-+.+..    ...+..|+++|..+.-.++. ++|.+..+    ++.|||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            3455667899999999999999999999999775533    45688899999999876664 45544433    456999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCcEEeCCCCceEEcccccccccccC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK-AANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk-p~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +.|.+|.++-...    +...+    ..++..---|-..||-|+.|. |...++..++.+.|+||..|+....+
T Consensus        94 i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p  159 (201)
T COG2112          94 IDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP  159 (201)
T ss_pred             hcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence            9998998876431    22333    344444445677899999997 55555555568999999999855443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=3.8e-07  Score=81.70  Aligned_cols=135  Identities=18%  Similarity=0.178  Sum_probs=87.2

Q ss_pred             eeeeCCceEEEEEE-CCcceEEEEecCCCCChHHH-----------------H---H--HHHHHHHHhcCC--CCCeeee
Q 015965          122 VASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQ-----------------K---E--FAQEVFIMRKVR--HKNVVQF  176 (397)
Q Consensus       122 lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~-----------------~---~--~~~E~~~l~~l~--h~niv~~  176 (397)
                      |.+|--+.||+|.. .+..+|+|+.+.........                 +   .  ...|...|+++.  +-.+++-
T Consensus        56 istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~P  135 (268)
T COG1718          56 ISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEP  135 (268)
T ss_pred             ecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence            44455556999875 57889999987543221110                 0   0  223555555553  2233344


Q ss_pred             eeEEecCCceEEEEEeccCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEc
Q 015965          177 IGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVA  254 (397)
Q Consensus       177 ~~~~~~~~~~~lv~E~~~g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~  254 (397)
                      +.+.    ...|||||+... .-.-.|..  -.+.......+..++++.|.-|-. .++||+||+.-|||+. ++.+.|+
T Consensus       136 i~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI  208 (268)
T COG1718         136 IAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII  208 (268)
T ss_pred             eeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence            4332    247999999432 11111211  123333677788899999988887 8999999999999999 8899999


Q ss_pred             ccccccccc
Q 015965          255 DFGVARVKA  263 (397)
Q Consensus       255 DfG~a~~~~  263 (397)
                      |||.|....
T Consensus       209 D~~QaV~~~  217 (268)
T COG1718         209 DVSQAVTID  217 (268)
T ss_pred             ECccccccC
Confidence            999986554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.58  E-value=4.3e-07  Score=81.94  Aligned_cols=139  Identities=21%  Similarity=0.287  Sum_probs=84.2

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC--CeeeeeeEEec---CCceEEEEEec
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACTK---PPSLCIVTEFM  193 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~E~~  193 (397)
                      ++.|+.|..+.||+.+..+..+++|.....    .....+.+|..+++.+...  .+++++.....   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            367999999999999998889999997643    3456777888888887533  35666664422   23468999999


Q ss_pred             cCCCHHH----------------HH---HhccCC---CCHHH---------HHHH------------HHHHHH-HHHHHH
Q 015965          194 SGGSVYD----------------YL---HKLKGV---FKLPS---------LLKV------------AIDVSK-GMNYLH  229 (397)
Q Consensus       194 ~g~sL~~----------------~l---~~~~~~---l~~~~---------~~~i------------~~qi~~-~l~~LH  229 (397)
                      +|..+..                .+   +.....   +....         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   111100   01000         0000            111222 233333


Q ss_pred             -------hCCcccCCCCCCcEEeC-CCCceEEcccccccc
Q 015965          230 -------QNNIIHRDLKAANLLMD-ENEVVKVADFGVARV  261 (397)
Q Consensus       230 -------~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a~~  261 (397)
                             ...++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                   24699999999999999 666678999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.52  E-value=9.9e-07  Score=80.74  Aligned_cols=135  Identities=18%  Similarity=0.169  Sum_probs=84.9

Q ss_pred             eeeeeCC-ceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEeccCCCH
Q 015965          121 KVASGSY-GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSV  198 (397)
Q Consensus       121 ~lg~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~g~sL  198 (397)
                      .|-.|.+ ..||+....+..+.+|+.....     ...+.+|+.+++.+. +--+++++++....+..++|||+++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3455655 6799998777788888876442     234667888887774 34466788877766678999999999877


Q ss_pred             HHHH-------------------HhccC---CCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 015965          199 YDYL-------------------HKLKG---VFKLP--SLLKVAI--------------------DVSKGMNYLH-----  229 (397)
Q Consensus       199 ~~~l-------------------~~~~~---~l~~~--~~~~i~~--------------------qi~~~l~~LH-----  229 (397)
                      ....                   +....   .+...  .......                    .+...+..|-     
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   11000   01000  0000000                    0111122221     


Q ss_pred             --hCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          230 --QNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       230 --~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                        ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              2348999999999999998888999999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.50  E-value=5.2e-07  Score=66.70  Aligned_cols=47  Identities=28%  Similarity=0.492  Sum_probs=43.9

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecC
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG   50 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~   50 (397)
                      +.+.+.|+|+||++++.+|++.|+||..|..+.|.+|+.+|+|.|..
T Consensus         3 ~ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d   49 (76)
T cd04927           3 LKLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITD   49 (76)
T ss_pred             EEEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeC
Confidence            56788999999999999999999999999999999999999999943

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=7.9e-07  Score=88.92  Aligned_cols=140  Identities=19%  Similarity=0.273  Sum_probs=92.4

Q ss_pred             ceeeeeCCceEEEEEE-CCcceEEEEecCCCCCh---HH--------------------------HH------HHHHHHH
Q 015965          120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---DM--------------------------QK------EFAQEVF  163 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~---~~--------------------------~~------~~~~E~~  163 (397)
                      +.||.-+.|.||+|+. .|+.||||+-++.....   +.                          .+      +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5699999999999986 46779999988653211   00                          01      2444554


Q ss_pred             HHhcC----CCCC------eeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015965          164 IMRKV----RHKN------VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI  233 (397)
Q Consensus       164 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i  233 (397)
                      ...+.    .|-+      |+++|-.+.  ..-.|+||||+|..+.|.-.-.+..++...+..-+.+...  +-|=..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence            44433    3444      555554333  3468999999999887764433455666644444333332  22335689


Q ss_pred             ccCCCCCCcEEeCC----CCceEEcccccccccc
Q 015965          234 IHRDLKAANLLMDE----NEVVKVADFGVARVKA  263 (397)
Q Consensus       234 iHrDlkp~Nili~~----~~~vkl~DfG~a~~~~  263 (397)
                      +|+|-+|.||++..    ++.+.+.|||+.....
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            99999999999984    6689999999986544

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.46  E-value=2.6e-06  Score=74.68  Aligned_cols=99  Identities=17%  Similarity=0.306  Sum_probs=80.2

Q ss_pred             HHHHHHhcCCC-CCeeeeeeEEecCCceEEEEEeccCCCHHHH---HHhccCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 015965          160 QEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---NN  232 (397)
Q Consensus       160 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~---l~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~  232 (397)
                      .|..+++.+++ +++++++|+|.+    ++++||...+++...   +.. -...++..+.+++.+++..+.+|+.   ..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            57888888886 699999999964    679999976665421   111 1235899999999999999999997   35


Q ss_pred             cccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          233 IIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       233 iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +.-.|++|+|+-+++++.+|++|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999999875443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.46  E-value=4.2e-06  Score=73.29  Aligned_cols=127  Identities=19%  Similarity=0.305  Sum_probs=92.6

Q ss_pred             ccccccceeeeeCC-ceEEEEEECCcceEEEEecC---CCC-------Ch---------HHHHHHHHHHHHHhcCC---C
Q 015965          114 KHLKFGSKVASGSY-GDLYRGTYCSQDVAIKVLKP---ERI-------NS---------DMQKEFAQEVFIMRKVR---H  170 (397)
Q Consensus       114 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~vavK~~~~---~~~-------~~---------~~~~~~~~E~~~l~~l~---h  170 (397)
                      .++++++.||.|.- |.||+++..++.+|+|+++.   ...       ..         ....-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78899999999999 99999999999999999331   110       00         12234778888777665   4


Q ss_pred             CCe--eeeeeEEec------------------CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Q 015965          171 KNV--VQFIGACTK------------------PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ  230 (397)
Q Consensus       171 ~ni--v~~~~~~~~------------------~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~  230 (397)
                      .++  |+++|+..=                  .....||.||++...          .++    ..-+.+|.+-|..+|+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILHK  182 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHHH
Confidence            566  999998621                  112468888886543          122    2345677778888999


Q ss_pred             CCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          231 NNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       231 ~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                      .||+-+|+++.|..   +  -+|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc---C--CEEEecccC
Confidence            99999999999986   2  389999975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.42  E-value=1.2e-06  Score=92.77  Aligned_cols=231  Identities=18%  Similarity=0.201  Sum_probs=160.8

Q ss_pred             eeeeCCceEEEEEECCc------ceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc----eEEEE
Q 015965          122 VASGSYGDLYRGTYCSQ------DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----LCIVT  190 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~~~------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~  190 (397)
                      +..-.+|+|+..++.-+      ++-++.-..... .+.......-|...+.+..|+|++.++.+......    ..+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            44556788888776321      122221110100 11222334457778889999999999988755432    23455


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC---cEEeCCCCceEEc--ccccccccccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA---NLLMDENEVVKVA--DFGVARVKAQS  265 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~---Nili~~~~~vkl~--DfG~a~~~~~~  265 (397)
                      ++++..++...++. -+.++...++.+..++..|+.|+|+....|.-+...   +..++.++.+.++  ||+.++.....
T Consensus       266 ~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~  344 (1351)
T KOG1035|consen  266 EICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN  344 (1351)
T ss_pred             hhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence            78888888888876 578899999999999999999999996666655555   4555666777777  99999887777


Q ss_pred             CcccCCCCCcccccccccCCCCCCCc--hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHK--ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~--~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .......-+..|.+||......++.+  .|+|.+|.....+..|..+-.....       .    ....+......+.+.
T Consensus       345 ~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------~----~~~l~~~~~~~~~d~  413 (1351)
T KOG1035|consen  345 EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------P----VSLLDVLSTSELLDA  413 (1351)
T ss_pred             ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------h----hhhhccccchhhhhh
Confidence            66666677788889999877766654  7999999999999887644211110       0    111222233378899


Q ss_pred             HHHhchhCCCCCCCHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~  364 (397)
                      ..+|+..++++|+++.+++..
T Consensus       414 ~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  414 LPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhcchhhhhccchhhhhhc
Confidence            999999999999999998754

>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.42  E-value=1.1e-06  Score=64.65  Aligned_cols=45  Identities=40%  Similarity=0.536  Sum_probs=41.9

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      |.+.+.|+|+||+.++.+|++.|+||..|+.+ |.+|..+|+|.|.
T Consensus         3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~   47 (74)
T cd04925           3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVR   47 (74)
T ss_pred             EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEE
Confidence            57888999999999999999999999999999 5699999999984

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.39  E-value=4.4e-08  Score=97.36  Aligned_cols=186  Identities=22%  Similarity=0.215  Sum_probs=131.4

Q ss_pred             ccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC-eeeeeeEEecCCceEEEEEecc
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFMS  194 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~E~~~  194 (397)
                      +....-+++|+++.+++.+.    .|-|.+........  ....-++++|.+++||| .+..++-++.++...++|+++.
T Consensus       244 s~~fh~fvK~altknpKkRp----taeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRP----TAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCC----Chhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            33445578999999997544    33333332221111  33445789999999999 7777777778888999999997


Q ss_pred             CC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCC
Q 015965          195 GG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG  273 (397)
Q Consensus       195 g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~g  273 (397)
                      ++ +-..-.....-.+-..+...+...-+++++++|+.-=+|+|    ||+..+ +.++..||+...............+
T Consensus       318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~  392 (829)
T KOG0576|consen  318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIG  392 (829)
T ss_pred             CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCC
Confidence            76 22111111111233334455666777899999998778998    777665 6799999999876665555667789


Q ss_pred             CcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015965          274 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE  312 (397)
Q Consensus       274 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~  312 (397)
                      |+.|+|||+.....+....|.|++|.--.+|--|-+|-.
T Consensus       393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            999999999999999999999999987666766766653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.33  E-value=1.4e-05  Score=70.56  Aligned_cols=130  Identities=21%  Similarity=0.373  Sum_probs=92.5

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCC--------------CChHHHHHHHHHHHHHhcCC------CCCeeeeee
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPER--------------INSDMQKEFAQEVFIMRKVR------HKNVVQFIG  178 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~niv~~~~  178 (397)
                      ...||+|+.-.||.-- .+....||++++..              ......++..+|+.-...+.      +..|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            3579999998898743 34457899988765              11112345566665555554      789999999


Q ss_pred             EEecCCceEEEEEeccC------CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC--C-
Q 015965          179 ACTKPPSLCIVTEFMSG------GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--E-  249 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g------~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~--~-  249 (397)
                      +.+++.-..+|+|.+..      .+|.+++..  +.++. .   +...+-.-..||-..+|+.+|++|.||++...  + 
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            99999889999998753      378888854  44555 3   33344455578889999999999999999632  2 


Q ss_pred             -ceEEcc
Q 015965          250 -VVKVAD  255 (397)
Q Consensus       250 -~vkl~D  255 (397)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             477776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.32  E-value=6.7e-06  Score=88.28  Aligned_cols=144  Identities=16%  Similarity=0.304  Sum_probs=91.1

Q ss_pred             cceeeeeCCceEEEEEECC----cceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCe--eeeeeEEecC---CceEE
Q 015965          119 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNV--VQFIGACTKP---PSLCI  188 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l  188 (397)
                      .+.++.|.+..+|+.+..+    ..+++|......... ....+.+|..+|+.+. |+++  ++++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3678999999999887654    367888765432211 2356889999999986 6654  7888888764   45789


Q ss_pred             EEEeccCCCHHH--------------------HH---HhccCC---C-----C----HHHHHHHHHH-------------
Q 015965          189 VTEFMSGGSVYD--------------------YL---HKLKGV---F-----K----LPSLLKVAID-------------  220 (397)
Q Consensus       189 v~E~~~g~sL~~--------------------~l---~~~~~~---l-----~----~~~~~~i~~q-------------  220 (397)
                      ||||++|..+.+                    .+   +.....   +     +    ...+..|..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998864321                    11   111100   0     0    1122222111             


Q ss_pred             --HHHHHHHHHh-----------CCcccCCCCCCcEEeCCC--CceEEcccccccccc
Q 015965          221 --VSKGMNYLHQ-----------NNIIHRDLKAANLLMDEN--EVVKVADFGVARVKA  263 (397)
Q Consensus       221 --i~~~l~~LH~-----------~~iiHrDlkp~Nili~~~--~~vkl~DfG~a~~~~  263 (397)
                        +...+.+|..           ..+||+|+++.||+++.+  ..+-|.||+++...+
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence              2233556632           259999999999999853  346799999986543

>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.18  E-value=7.8e-06  Score=59.71  Aligned_cols=64  Identities=23%  Similarity=0.354  Sum_probs=51.4

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEe---cCCCc---hhHHHHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---EETEQLRAALEKEVL   68 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vv---d~~~~---~~~~~l~~~l~~~~~   68 (397)
                      |.+.+.|+|+||..++.+|+++|++|.-|+. +|..+...|+|-|   +|.+.   +..+.++++|...+.
T Consensus         4 veV~~~DRpGLL~~i~~~l~~~~l~I~~A~I-~T~gera~D~FyV~d~~g~kl~~~~~~~~l~~~L~~al~   73 (75)
T cd04897           4 VTVQCRDRPKLLFDVVCTLTDMDYVVFHATI-DTDGDDAHQEYYIRHKDGRTLSTEGERQRVIKCLEAAIE   73 (75)
T ss_pred             EEEEeCCcCcHHHHHHHHHHhCCeEEEEEEE-eecCceEEEEEEEEcCCCCccCCHHHHHHHHHHHHHHHh
Confidence            6789999999999999999999999999998 8888899999988   44332   234566666665543

This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.17  E-value=1e-05  Score=73.63  Aligned_cols=73  Identities=15%  Similarity=0.218  Sum_probs=46.3

Q ss_pred             ceeeeeCCc-eEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC---CeeeeeeEEecC---CceEEEEEe
Q 015965          120 SKVASGSYG-DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACTKP---PSLCIVTEF  192 (397)
Q Consensus       120 ~~lg~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~E~  192 (397)
                      +.|+.|+.. .||+.   +..+++|+.+...    ....+.+|..+++.+...   .++++++.+...   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457767666 48875   4567888755321    234688899998877532   345555544332   235889999


Q ss_pred             ccCCCHH
Q 015965          193 MSGGSVY  199 (397)
Q Consensus       193 ~~g~sL~  199 (397)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.14  E-value=9.2e-06  Score=58.87  Aligned_cols=45  Identities=31%  Similarity=0.507  Sum_probs=42.3

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      |.+.+.|+|+||..++++|.++||+|.-|+. +|..+...|+|-|.
T Consensus         4 iev~a~DRpGLL~~i~~~l~~~gl~I~~AkI-sT~Gerv~DvFyV~   48 (72)
T cd04895           4 VKVDSARKPGILLEAVQVLTDLDLCITKAYI-SSDGGWFMDVFHVT   48 (72)
T ss_pred             EEEEECCcCCHHHHHHHHHHHCCcEEEEEEE-eecCCeEEEEEEEE
Confidence            5688999999999999999999999999999 99999999999984

This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.08  E-value=1.7e-05  Score=57.92  Aligned_cols=62  Identities=21%  Similarity=0.221  Sum_probs=49.2

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccc--cCCCceeeeEEecCCCc-----hhHHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS--TVDGYSLDVFVVDGWPY-----EETEQLRAALEKE   66 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~--t~~g~~l~~~vvd~~~~-----~~~~~l~~~l~~~   66 (397)
                      |-+.+.|+|+||.++..++.++|++|+-|+. +  |..+...|+|.||....     +..+.+++++...
T Consensus         3 lev~a~DRpGLL~~i~~~l~~~~l~i~~AkI-~~~T~Gerv~D~Fyv~~~g~kl~d~~~~~~L~~~L~~~   71 (75)
T cd04896           3 LQIRCVDQKGLLYDILRTSKDCNIQISYGRF-SSKVKGYREVDLFIVQSDGKKIMDPKKQAALCARLREE   71 (75)
T ss_pred             EEEEeCCcccHHHHHHHHHHHCCeEEEEEEE-ecCcccCEEEEEEEEeCCCCccCCHHHHHHHHHHHHHH
Confidence            4578999999999999999999999999998 6  77777889999976442     3345566666554

This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK10593 hypothetical protein; Provisional

Probab=98.02  E-value=6.4e-05  Score=70.97  Aligned_cols=76  Identities=13%  Similarity=0.089  Sum_probs=57.0

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC---CCeeeeeeEEecC---CceEEEEEe
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKP---PSLCIVTEF  192 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~E~  192 (397)
                      .+.||.|..+.||+....+..+.+|..+... .   ...+..|...|+.+.-   -.++++++.+...   +..+||||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            4579999999999988766678888855311 1   2467889999988853   3678888877543   568999999


Q ss_pred             ccCCCH
Q 015965          193 MSGGSV  198 (397)
Q Consensus       193 ~~g~sL  198 (397)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998764

>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.95  E-value=3.9e-05  Score=56.05  Aligned_cols=46  Identities=26%  Similarity=0.465  Sum_probs=42.3

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      +|++.+.|+|++|.+++.+|++.|+||..|..|. .+|+.+++|.|.
T Consensus         3 ri~V~~~D~~Gll~~i~~~l~~~~lnI~sa~i~t-~~~~~~d~f~v~   48 (72)
T cd04926           3 RLELRTEDRVGLLSDVTRVFRENGLTVTRAEIST-QGDMAVNVFYVT   48 (72)
T ss_pred             EEEEEECCccCHHHHHHHHHHHCCcEEEEEEEec-CCCeEEEEEEEE
Confidence            7899999999999999999999999999999975 488999999884

This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.86  E-value=6.9e-06  Score=76.24  Aligned_cols=135  Identities=19%  Similarity=0.256  Sum_probs=94.7

Q ss_pred             ccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHH--------------------HHHHHHHHHHHhcCCC--CC
Q 015965          116 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDM--------------------QKEFAQEVFIMRKVRH--KN  172 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~--------------------~~~~~~E~~~l~~l~h--~n  172 (397)
                      +.+++.||-|--+.||.+-+. |++.++|+-+..+.+...                    .-...+|...|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            566788999999999998775 788888876543322110                    1124457777777652  22


Q ss_pred             eeeeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceE
Q 015965          173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       173 iv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vk  252 (397)
                      +++.++    .+..|+|||++.|..|...-+-    ...+   .+...+..-+--|-.+|+||+|.+-=||++++++.++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            444443    3457999999999888765422    2222   3444555566678899999999999999999999999


Q ss_pred             Ecccccccc
Q 015965          253 VADFGVARV  261 (397)
Q Consensus       253 l~DfG~a~~  261 (397)
                      ++||-.+..
T Consensus       243 vIDFPQmvS  251 (465)
T KOG2268|consen  243 VIDFPQMVS  251 (465)
T ss_pred             EeechHhhc
Confidence            999987643

>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold

Probab=97.86  E-value=3.6e-05  Score=54.82  Aligned_cols=63  Identities=33%  Similarity=0.410  Sum_probs=51.1

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |.|++...|+|++|..++++|++-|+||..++.++..++ ...++++......+.+.+.+++++
T Consensus         1 ~~v~v~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~   63 (66)
T PF01842_consen    1 YRVRVIVPDRPGILADVTEILADHGINIDSISQSSDKDG-VGIVFIVIVVDEEDLEKLLEELEA   63 (66)
T ss_dssp             EEEEEEEETSTTHHHHHHHHHHHTTEEEEEEEEEEESST-TEEEEEEEEEEGHGHHHHHHHHHH
T ss_pred             CEEEEEcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCC-ceEEEEEEECCCCCHHHHHHHHHc
Confidence            679999999999999999999999999999999999885 333444434455677777777765

ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.84  E-value=2.6e-06  Score=92.22  Aligned_cols=232  Identities=11%  Similarity=0.047  Sum_probs=148.8

Q ss_pred             eEEEEEECCc---ceEEEEecCC---CCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEEEEEeccCCCHHH
Q 015965          129 DLYRGTYCSQ---DVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYD  200 (397)
Q Consensus       129 ~Vy~~~~~~~---~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~E~~~g~sL~~  200 (397)
                      ..+++++-++   .+.+|+.+..   .......+....|+..++...|+++.....-...  ....+..++|+.+|.+.+
T Consensus      1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~ 1320 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFS 1320 (2724)
T ss_pred             eeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHH
Confidence            3445554322   2455665532   2223334456667777777889988877654432  234688999999999999


Q ss_pred             HHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC-----CcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCC
Q 015965          201 YLHKLKG---VFKLPSLLKVAIDVSKGMNYLHQN-----NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE  271 (397)
Q Consensus       201 ~l~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~-----~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~  271 (397)
                      .+-+.-.   .+....+.....+.+.+..-+|+.     -.+|+++|+-|.+|..+..+|++++|+.+.... .......
T Consensus      1321 iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~ 1400 (2724)
T KOG1826|consen 1321 IIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLE 1400 (2724)
T ss_pred             HHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhh
Confidence            9865322   233333333334446666666654     269999999999999999999999999984433 2334456


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhC
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  351 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  351 (397)
                      .+++.|++|++.+.-.++.++|+|..|+.+|....|..+|....... ..++++.+..-.++...|.+.-.....++-..
T Consensus      1401 l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~-Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K 1479 (2724)
T KOG1826|consen 1401 LCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPA-LKGIIDNHTFFSIEKLKPGDANVEALHRLLWK 1479 (2724)
T ss_pred             hCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHH-HcCcccccccccccccCCCcccHHHHHHHHHH
Confidence            78899999999999889999999999999999988887764222111 11222222222344443444444555555556


Q ss_pred             CCCCCCHHHH
Q 015965          352 PALRPDFSEI  361 (397)
Q Consensus       352 p~~Rps~~el  361 (397)
                      ..+||.-...
T Consensus      1480 ~~~rp~q~is 1489 (2724)
T KOG1826|consen 1480 YMERPGQYIS 1489 (2724)
T ss_pred             hhhcchhhhh
Confidence            6667755444

>PRK05231 homoserine kinase; Provisional

Probab=97.76  E-value=0.00075  Score=64.31  Aligned_cols=137  Identities=15%  Similarity=0.215  Sum_probs=75.0

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC--CeeeeeeE------EecCCceEEEE
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGA------CTKPPSLCIVT  190 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~  190 (397)
                      .+.|+.|....+|+.+..+..+++|+.. . ...   .....|+.+++.|...  .+++.+..      ....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            3557778878899988777789999876 2 222   2223344444444211  12333321      12245578999


Q ss_pred             EeccCCCHH-----------HHH---HhccCCC--------C--H-HHHH-H-----------HHHH-HHHHHHHHH---
Q 015965          191 EFMSGGSVY-----------DYL---HKLKGVF--------K--L-PSLL-K-----------VAID-VSKGMNYLH---  229 (397)
Q Consensus       191 E~~~g~sL~-----------~~l---~~~~~~l--------~--~-~~~~-~-----------i~~q-i~~~l~~LH---  229 (397)
                      ||++|..+.           ..+   +.....+        .  + .... .           .+.+ +...++.+.   
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            999887431           111   1111101        1  0 0000 0           1111 111222332   


Q ss_pred             ----hCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          230 ----QNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       230 ----~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                          ..++||+|+.|.||+++.+...-|+||+.+.
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                2389999999999999977666899999885

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.00023  Score=64.60  Aligned_cols=72  Identities=13%  Similarity=0.193  Sum_probs=46.8

Q ss_pred             ceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC-eeeeeeEEecCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      +.|..|-...+|+....   ++.|++|+.......   .....+|+.+++.+...+ .+++++.+.    -.++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence            56778888899998765   467999986643211   122346888888775333 344554432    2479999998


Q ss_pred             CCH
Q 015965          196 GSV  198 (397)
Q Consensus       196 ~sL  198 (397)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.75  E-value=0.0004  Score=65.37  Aligned_cols=137  Identities=19%  Similarity=0.226  Sum_probs=83.4

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC--eeeeeeE------EecCCceEEEE
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA------CTKPPSLCIVT  190 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  190 (397)
                      .+.|..|....+|+....+..+++|+...  ..   ......|+.+++.+.+.+  +++++..      ....+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            35677788789999887778899998764  12   234556777777764322  4444432      12345578999


Q ss_pred             EeccCCCHHH-----------HH---HhccCCCC--------HHHHHH------------HHHHHHHHHHHHHh------
Q 015965          191 EFMSGGSVYD-----------YL---HKLKGVFK--------LPSLLK------------VAIDVSKGMNYLHQ------  230 (397)
Q Consensus       191 E~~~g~sL~~-----------~l---~~~~~~l~--------~~~~~~------------i~~qi~~~l~~LH~------  230 (397)
                      +|++|..+..           .+   +.....+.        ......            ....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876421           11   11100000        000000            11112333444443      


Q ss_pred             -CCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          231 -NNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       231 -~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                       .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             479999999999999998878999999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.74  E-value=0.00024  Score=65.46  Aligned_cols=133  Identities=14%  Similarity=0.136  Sum_probs=78.1

Q ss_pred             eeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe-eeeeeEEecCCceEEEEEeccCCCHHH
Q 015965          122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGSVYD  200 (397)
Q Consensus       122 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~g~sL~~  200 (397)
                      +..|-...+|+.+..++.+++|+........  .....+|..+++.+...++ ++++....    -++||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            4567778899988778889999855432111  0124678888888764333 34444432    368999999876532


Q ss_pred             --------------HH---Hhcc---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccCCCCCCc
Q 015965          201 --------------YL---HKLK---GVFKLP-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKAAN  242 (397)
Q Consensus       201 --------------~l---~~~~---~~l~~~-~~~~i~~qi---------~~~l~~LH~--------~~iiHrDlkp~N  242 (397)
                                    .+   +...   ..++.. .+..+..++         ...+..+-.        ..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                          11   1111   011111 111221111         111222221        258999999999


Q ss_pred             EEeCCCCceEEcccccccc
Q 015965          243 LLMDENEVVKVADFGVARV  261 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~  261 (397)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998853

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.73  E-value=0.0005  Score=65.23  Aligned_cols=138  Identities=22%  Similarity=0.280  Sum_probs=81.4

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC--CeeeeeeEE------ecCCceEEEE
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGAC------TKPPSLCIVT  190 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~  190 (397)
                      .+.++.|....+|+.+..+..+++|+..... ..   .....|..+++.|...  .+++++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            4667888778899987767788999876432 11   2344556666666422  234444321      1234578999


Q ss_pred             EeccCCCHH-----------HH---HHhccCCCC--------HHH---HH------------HHHHHHHHHHHHHHh---
Q 015965          191 EFMSGGSVY-----------DY---LHKLKGVFK--------LPS---LL------------KVAIDVSKGMNYLHQ---  230 (397)
Q Consensus       191 E~~~g~sL~-----------~~---l~~~~~~l~--------~~~---~~------------~i~~qi~~~l~~LH~---  230 (397)
                      +|++|..+.           ..   ++.....++        ...   ..            .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431           11   111111110        000   00            001123334555542   


Q ss_pred             ----CCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          231 ----NNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       231 ----~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                          .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                589999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.68  E-value=0.00088  Score=65.47  Aligned_cols=75  Identities=13%  Similarity=0.021  Sum_probs=52.2

Q ss_pred             ceeeeeCCceEEEEEECCc--ceEEEEecCCCC----C-hHHHHHHHHHHHHHhcCC---CCCeeeeeeEEecCCceEEE
Q 015965          120 SKVASGSYGDLYRGTYCSQ--DVAIKVLKPERI----N-SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~----~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  189 (397)
                      +.||-|.+..||++...+.  .++||.-.+...    . .-....+..|...|+.+.   ...+++++.+.  +...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence            5789999999999988653  799998543211    0 112456667888887763   34677787763  3557899


Q ss_pred             EEeccCC
Q 015965          190 TEFMSGG  196 (397)
Q Consensus       190 ~E~~~g~  196 (397)
                      |||+++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999764

>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD

Probab=97.60  E-value=0.00035  Score=50.27  Aligned_cols=48  Identities=40%  Similarity=0.598  Sum_probs=43.1

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCC
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW   51 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~   51 (397)
                      +|++.+.|+|++|+.++.+|++.|+||..+..+..-+ ...++|.+++.
T Consensus         2 ~l~i~~~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~-~~~~~~~v~~~   49 (70)
T cd04873           2 VVEVYAPDRPGLLADITRVLADLGLNIHDARISTTGE-RALDVFYVTDS   49 (70)
T ss_pred             EEEEEeCCCCCHHHHHHHHHHHCCCeEEEEEEeecCC-EEEEEEEEECC
Confidence            6899999999999999999999999999999987755 88888888653

This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t

>PRK05092 PII uridylyl-transferase; Provisional

Probab=97.58  E-value=0.00017  Score=78.51  Aligned_cols=65  Identities=34%  Similarity=0.493  Sum_probs=53.7

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEe---cCCCc---hhHHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---EETEQLRAALEKE   66 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vv---d~~~~---~~~~~l~~~l~~~   66 (397)
                      .||+|.+.|+|+||++++.+|+..|+||..|..|.+.+|+.+|+|.|   ++.+.   +..+.++.+|+..
T Consensus       733 t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~~L~~~  803 (931)
T PRK05092        733 TEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAKAIEDA  803 (931)
T ss_pred             EEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHHHHH
Confidence            48999999999999999999999999999999999999999999988   45432   2344455555543

>PRK04374 PII uridylyl-transferase; Provisional

Probab=97.54  E-value=0.0002  Score=76.73  Aligned_cols=49  Identities=24%  Similarity=0.313  Sum_probs=46.9

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecC
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG   50 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~   50 (397)
                      -||++.+.|+|+|+++++.+|+..|+||..|.+|.+.+|+.+|+|.|..
T Consensus       691 ~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ld~f~V~~  739 (869)
T PRK04374        691 LEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAIFDVFEVLP  739 (869)
T ss_pred             EEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEEEEEEEEeC
Confidence            4899999999999999999999999999999999999999999999954

>PRK03059 PII uridylyl-transferase; Provisional

Probab=97.53  E-value=0.00023  Score=76.46  Aligned_cols=48  Identities=29%  Similarity=0.540  Sum_probs=46.3

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      -||++.+.|+|+|+++++.+|+..||||..|.+|.+.+|+.+|+|.|.
T Consensus       679 ~~v~i~~~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ld~f~V~  726 (856)
T PRK03059        679 LQVMVYTPDQPDLFARICGYFDRAGFSILDARVHTTRHGYALDTFQVL  726 (856)
T ss_pred             EEEEEEecCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeEEEEEEEe
Confidence            489999999999999999999999999999999999999999999994

>PRK00275 glnD PII uridylyl-transferase; Provisional

Probab=97.53  E-value=0.00023  Score=76.81  Aligned_cols=47  Identities=21%  Similarity=0.446  Sum_probs=45.9

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      ||++.+.|+|+|++.++.+|+..||||..|.+|++.+|+.+|+|.|.
T Consensus       706 ~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~  752 (895)
T PRK00275        706 QIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVL  752 (895)
T ss_pred             EEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEe
Confidence            79999999999999999999999999999999999999999999994

>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains

Probab=97.52  E-value=0.00043  Score=51.19  Aligned_cols=63  Identities=24%  Similarity=0.319  Sum_probs=48.5

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVL   68 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~~   68 (397)
                      ||+.+.|+|++.+++|++|++.|.||.+...|. ..|...-...++.. ....++++++++....
T Consensus         4 ltv~g~Dr~GiVa~vs~~la~~g~nI~d~~q~~-~~~~F~m~~~~~~~-~~~~~~l~~~l~~~~~   66 (77)
T cd04893           4 ISALGTDRPGILNELTRAVSESGCNILDSRMAI-LGTEFALTMLVEGS-WDAIAKLEAALPGLAR   66 (77)
T ss_pred             EEEEeCCCChHHHHHHHHHHHcCCCEEEceeeE-EcCEEEEEEEEEec-cccHHHHHHHHHHHHH
Confidence            799999999999999999999999999999988 55544444444432 2356777777776443

This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.47  E-value=0.00092  Score=63.14  Aligned_cols=143  Identities=20%  Similarity=0.315  Sum_probs=84.2

Q ss_pred             eeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeeeEEecCC--ceEEEEEeccCC
Q 015965          121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPP--SLCIVTEFMSGG  196 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~E~~~g~  196 (397)
                      .+-.|..-.+|.....++.+++. ...............+|..+++.+.-  --+...++.|.++.  ..+.||+|++|.
T Consensus        32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe  110 (321)
T COG3173          32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE  110 (321)
T ss_pred             eccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence            33333333455555557778888 33223333445667788888887753  33455666776655  679999999883


Q ss_pred             CH------------------HHHHHhc---c-------C---CCCHHHHHHHHH--------------HHHHHHHHHHhC
Q 015965          197 SV------------------YDYLHKL---K-------G---VFKLPSLLKVAI--------------DVSKGMNYLHQN  231 (397)
Q Consensus       197 sL------------------~~~l~~~---~-------~---~l~~~~~~~i~~--------------qi~~~l~~LH~~  231 (397)
                      .+                  .+.|...   +       +   ......+..+..              .+..-..+++.+
T Consensus       111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            11                  1122111   0       0   001111112222              222334555543


Q ss_pred             --------CcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          232 --------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       232 --------~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                              .++|+|+.+.|++++.++.+-|.||+++...++
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                    489999999999999999999999999975543

>TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase

Probab=97.47  E-value=0.00063  Score=73.49  Aligned_cols=66  Identities=29%  Similarity=0.443  Sum_probs=53.8

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecC---CCch---hHHHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG---WPYE---ETEQLRAALEKEV   67 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~---~~~~---~~~~l~~~l~~~~   67 (397)
                      .||++.+.|+|+||++++.+|+..||||..|.+|.|.+|+.+|+|.|..   .+..   ..+.+++++...+
T Consensus       669 t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L  740 (850)
T TIGR01693       669 TEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELLQGLVDVL  740 (850)
T ss_pred             EEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCCCCCCCcHHHHHHHHHHHHHHH
Confidence            4899999999999999999999999999999999999999999999943   2221   2344555555544

This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.42  E-value=0.00069  Score=64.04  Aligned_cols=73  Identities=15%  Similarity=0.273  Sum_probs=46.0

Q ss_pred             ceeeeeCCceEEEEEEC--------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC-eeeeeeEEecCCceEEEE
Q 015965          120 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  190 (397)
                      +.|..|-...+|+.+..        ++.+++|+.......   .....+|..+++.+...+ .+++++.+..    .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            44566667788888764        367999997654211   234567777777775333 3455555532    3589


Q ss_pred             EeccCCCHH
Q 015965          191 EFMSGGSVY  199 (397)
Q Consensus       191 E~~~g~sL~  199 (397)
                      ||++|.++.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

Probab=97.42  E-value=0.00062  Score=49.10  Aligned_cols=45  Identities=36%  Similarity=0.572  Sum_probs=40.3

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      |.+.+.|+|++|.+++.++++.|+||..+..... .++.++.|.+.
T Consensus         3 l~v~~~d~~gll~~i~~~l~~~~~~I~~~~~~~~-~~~~~~~f~i~   47 (70)
T cd04899           3 LELTALDRPGLLADVTRVLAELGLNIHSAKIATL-GERAEDVFYVT   47 (70)
T ss_pred             EEEEEcCCccHHHHHHHHHHHCCCeEEEEEEEec-CCEEEEEEEEE
Confidence            6788999999999999999999999999998654 56999999874

This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase)

Probab=97.42  E-value=0.00075  Score=49.42  Aligned_cols=66  Identities=26%  Similarity=0.275  Sum_probs=48.3

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCch--hHHHHHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEVLK   69 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~--~~~~l~~~l~~~~~~   69 (397)
                      |++.+.|+|++++++|..|++.|.||...+.+....+.-+-+.+.-.|+..  +.++++++|+.-...
T Consensus         2 i~v~g~D~~Giv~~it~~l~~~g~nI~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~l~~~l~~l~~~   69 (74)
T cd04875           2 LTLSCPDRPGIVAAVSGFLAEHGGNIVESDQFVDPDSGRFFMRVEFELEGFDLSREALEAAFAPVAAE   69 (74)
T ss_pred             EEEEcCCCCCHHHHHHHHHHHcCCCEEeeeeeecCCCCeEEEEEEEEeCCCCCCHHHHHHHHHHHHHH
Confidence            689999999999999999999999999998886333322222111235543  688899888875543

This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein

Probab=97.35  E-value=0.0012  Score=50.20  Aligned_cols=67  Identities=18%  Similarity=0.231  Sum_probs=50.5

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCC-chhHHHHHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP-YEETEQLRAALEKEVLK   69 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~-~~~~~~l~~~l~~~~~~   69 (397)
                      |-|++.+.|+|++++++|..|++-|.||.+...+....-+.+ .++++... ..+.++++++++.-..+
T Consensus         2 ~vl~i~g~D~pGiva~vt~~la~~g~nI~~~~~~~~~~~f~~-~~~v~~~~~~~~~~~L~~~l~~l~~~   69 (88)
T cd04872           2 AVITVVGKDRVGIVAGVSTKLAELNVNILDISQTIMDGYFTM-IMIVDISESNLDFAELQEELEELGKE   69 (88)
T ss_pred             EEEEEEcCCCCCHHHHHHHHHHHcCCCEEechhHhhCCccEE-EEEEEeCCCCCCHHHHHHHHHHHHHH
Confidence            568999999999999999999999999999999875333333 33444322 34678888888875444

This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK01759 glnD PII uridylyl-transferase; Provisional

Probab=97.30  E-value=0.00058  Score=73.42  Aligned_cols=47  Identities=30%  Similarity=0.543  Sum_probs=45.7

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      ||++.+.|+|+||++++.+|+..||||..|.+|.+.+|+.+|+|.|.
T Consensus       679 ~V~V~~~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~alD~F~V~  725 (854)
T PRK01759        679 EIFIYCQDQANLFLKVVSTIGAKKLSIHDAQIITSQDGYVLDSFIVT  725 (854)
T ss_pred             EEEEEecCCccHHHHHHHHHHHCCCeEEEEEEEEccCCEEEEEEEEe
Confidence            89999999999999999999999999999999999999999999993

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	397
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-60
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-60
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-50
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-49
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-48
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-48
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-48
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-48
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-48
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-48
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-48
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-47
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-47
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-47
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-47
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-47
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-47
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-47
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-46
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-46
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-46
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-46
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-46
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-46
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-46
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-45
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-45
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-45
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-45
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-45
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-45
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-45
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-45
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-45
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-45
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-45
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-45
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-45
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-45
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-45
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-45
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-45
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-44
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-44
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-44
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-44
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-44
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-44
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-44
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-44
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-44
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-44
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-44
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-44
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-44
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-43
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-43
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-43
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-43
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-43
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-43
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-43
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-43
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-43
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-43
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-43
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-43
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-43
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-43
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-43
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-43
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-42
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-42
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-42
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-42
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-42
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-42
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-42
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-42
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-41
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-41
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-41
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-41
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-41
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-40
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-40
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-39
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-38
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-38
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-38
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-38
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-38
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-38
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-38
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-38
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-38
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-38
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-38
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-38
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-38
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-38
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-38
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-38
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-38
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-38
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-38
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-38
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-38
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-38
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-38
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-38
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-38
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-38
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-37
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-37
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-37
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-37
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-36
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-36
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-36
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-36
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-36
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-36
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-36
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-36
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-36
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-36
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-36
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-36
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-36
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-36
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-36
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-36
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-36
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-36
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-35
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-35
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-35
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-35
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-35
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-35
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-35
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-35
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-35
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-35
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-35
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-35
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-35
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-35
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-35
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-35
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-35
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-35
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-35
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-35
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-35
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-35
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-35
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-35
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-35
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-35
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-35
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-35
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-35
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-35
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-35
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-35
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-35
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-35
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-35
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-35
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-35
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-35
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-35
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-35
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-34
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-34
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-34
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-34
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-34
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-34
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-34
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-34
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-34
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-34
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-34
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-34
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-34
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-34
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-33
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-33
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-33
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-33
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-33
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-33
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-33
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-33
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-33
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-33
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-33
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-33
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-33
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-33
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-33
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-33
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-33
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-33
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-33
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-33
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-33
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-33
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-33
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-33
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-33
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-33
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-33
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-32
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-32
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-32
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-32
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-32
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-32
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-32
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-32
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-32
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-32
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-32
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-32
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-32
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-32
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-32
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-32
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-32
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-32
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-32
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-32
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-32
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-32
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-32
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-32
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-32
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-32
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-32
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-32
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-32
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-31
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-31
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-31
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-31
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-31
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-31
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-31
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-31
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-31
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-30
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-30
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-30
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-30
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-30
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-30
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-30
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-30
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-30
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-30
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-30
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-30
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-30
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-30
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-30
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-30
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-30
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-30
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-30
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-30
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-30
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-30
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-30
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-30
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-30
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-30
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-30
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-30
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-30
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-30
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-30
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-30
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-30
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-30
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-30
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-30
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-30
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-29
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-29
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-29
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-29
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-29
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-29
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-29
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-29
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-29
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-29
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-29
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-29
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-29
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-29
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-28
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-28
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-28
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-28
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-28
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-28
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-28
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-27
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-27
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-27
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-27
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-27
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-27
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-27
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-27
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-27
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-27
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-27
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-27
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-27
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-27
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-27
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-27
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-26
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-26
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-26
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-26
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-25
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-25
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-25
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-25
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-25
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-25
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-25
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-25
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-25
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-25
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-25
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-25
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-25
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-25
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-25
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-25
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-25
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-25
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-25
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-25
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-25
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-25
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-25
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-25
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-25
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-25
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-25
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-25
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-25
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-25
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-25
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-24
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-24
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-24
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-24
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-24
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-24
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-24
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-24
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-24
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-24
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-24
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-24
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-24
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-24
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-24
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-24
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-24
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-24
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-24
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-24
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-24
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-24
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-23
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-23
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-23
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-23
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-23
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-23
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-23
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-22
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-22
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-22
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-22
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-22
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-21
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-21
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-21
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-21
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-20
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-20
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-20
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-20
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-19
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-19
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-19
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-19
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-19
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-18
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-18
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-18
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-17
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-17
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-17
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-17
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-17
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-17
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-17
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-17
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-17
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-17
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-16
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-16
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-15
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-15
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-15
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-15
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-15
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-15
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-15
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-15
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-15
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-15
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-15
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-15
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-15
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-14
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-13
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-13
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-13
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-13
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-13
3soa_A	444	Full-Length Human Camkii Length = 444		6e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-11
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-11
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-11
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-11

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  227 bits (579), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 117/272 (43%), Positives = 175/272 (64%), Gaps = 6/272 (2%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           DG D+ +I    L    K+ +GS+G ++R  +   DVA+K+L  +  +++   EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL--LKVAIDV 221
           IM+++RH N+V F+GA T+PP+L IVTE++S GS+Y  LHK     +L     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 222 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT-AETGTYRWM 278
           +KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DFG++R+KA   + +    GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWM 206
Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           APEV+  +P + K+DV+SFG++LWEL T + P+  L P Q    V  K  R  IP+N  P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           ++A ++E CW  +P  RP F+ I+++L+ + K
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  227 bits (579), Expect = 8e-60,   Method: Compositional matrix adjust.
 Identities = 116/272 (42%), Positives = 177/272 (65%), Gaps = 6/272 (2%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           DG D+ +I    L    K+ +GS+G ++R  +   DVA+K+L  +  +++   EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL--LKVAIDV 221
           IM+++RH N+V F+GA T+PP+L IVTE++S GS+Y  LHK     +L     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 222 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT-AETGTYRWM 278
           +KGMNYLH  N  I+HR+LK+ NLL+D+   VKV DFG++R+KA + + + +  GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           APEV+  +P + K+DV+SFG++LWEL T + P+  L P Q    V  K  R  IP+N  P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           ++A ++E CW  +P  RP F+ I+++L+ + K
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  194 bits (493), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 167/277 (60%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 61  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 119
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAP
Sbjct: 120 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 239
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N   ++  L+  C ++    RP F  I+  ++++A+
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 166/277 (59%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N   ++  L+  C ++    RP F  I+  ++++A+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 102/277 (36%), Positives = 164/277 (59%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D  D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  T  P L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N   ++  L+  C ++    RP F  I+  ++++A+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/278 (37%), Positives = 168/278 (60%), Gaps = 12/278 (4%)
Query: 103 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 162
           +D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMA 279
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 280 PEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK- 334
           PEVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 335 --NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/278 (37%), Positives = 168/278 (60%), Gaps = 12/278 (4%)
Query: 103 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 162
           +D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMA 279
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 280 PEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK- 334
           PEVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 335 --NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 167/277 (60%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 25  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 84  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 142
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAP
Sbjct: 143 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 262
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 263 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 299

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 167/277 (60%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRK 167
           W IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMK 59
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           + H  +VQ  G C +   +C+VTEFM  G + DYL   +G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 284
           L +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFS 178
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQI 237
Query: 344 LERCWQQDPALRPDFSEIIEILQQIAK 370
           +  CW++ P  RP FS ++  L +IA+
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 160/271 (59%), Gaps = 10/271 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVF 163
           G+  W IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  
Sbjct: 1   GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAE 57
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +M K+ H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
           GM YL +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +P
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASP 176
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           EV     Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTH 235
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           + +++  CW++ P  RP FS ++  L +IA+
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/275 (37%), Positives = 166/275 (60%), Gaps = 12/275 (4%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++
Sbjct: 2   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM
Sbjct: 61  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEV 282
           +YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAPEV
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 283 I---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---N 335
           I   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 239
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
               +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 166/277 (59%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 166/277 (59%), Gaps = 12/277 (4%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 18  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 77  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 135
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 136 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 334
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 255
Query: 335 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 256 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 292

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/274 (37%), Positives = 165/274 (60%), Gaps = 12/274 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           K RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI 283
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 284 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---NS 336
              +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 156/265 (58%), Gaps = 10/265 (3%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDP  L F  ++ SG +G ++ G + ++D VAIK +K   ++ D   +F +E  +M K+ 
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED---DFIEEAEVMMKLS 80
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 81  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 286
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 199
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 258
Query: 346 RCWQQDPALRPDFSEIIEILQQIAK 370
            CW++ P  RP FS ++  L +IA+
Sbjct: 259 HCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 164/274 (59%), Gaps = 12/274 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           K RH N++ F+G  T  P L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI 283
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 284 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---NS 336
              +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 103/276 (37%), Positives = 166/276 (60%), Gaps = 15/276 (5%)
Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 163
           D +  WEI+   +   +++ SGS+G +Y+G +   DVA+K+LK      +  + F  EV 
Sbjct: 26  DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           ++RK RH N++ F+G  TK  +L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 280
           GM+YLH  NIIHRD+K+ N+ + E   VK+ DFG+A VK++ SG    E  TG+  WMAP
Sbjct: 144 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 281 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----PTIP 333
           EVI   ++ P+  ++DV+S+GIVL+EL+TG+LPY ++      + +V +G        + 
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263
Query: 334 KNSQPKLAELLERCWQQDPALRPDFSEI---IEILQ 366
           KN    +  L+  C ++    RP F +I   IE+LQ
Sbjct: 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 164/274 (59%), Gaps = 12/274 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           K RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI 283
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 284 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---NS 336
              +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 157/265 (59%), Gaps = 10/265 (3%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 60
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 286
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 346 RCWQQDPALRPDFSEIIEILQQIAK 370
            CW++ P  RP FS ++  L +IA+
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 156/264 (59%), Gaps = 10/264 (3%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 60
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 286
           + ++IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 346 RCWQQDPALRPDFSEIIEILQQIA 369
            CW++ P  RP FS ++  L  IA
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAAIA 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 157/265 (59%), Gaps = 10/265 (3%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 286
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 346 RCWQQDPALRPDFSEIIEILQQIAK 370
            CW++ P  RP FS ++  L +IA+
Sbjct: 237 HCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 98/269 (36%), Positives = 155/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAP 179
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  + P Q    +++K  R   P+    K
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 101/265 (38%), Positives = 154/265 (58%), Gaps = 14/265 (5%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 71
Query: 169 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 226
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 187
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
            K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 246
Query: 344 LERCWQQDPALRPDFSEIIEILQQI 368
           ++ CW  D A+RP F ++ E L+ I
Sbjct: 247 MKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 101/265 (38%), Positives = 154/265 (58%), Gaps = 14/265 (5%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 169 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 226
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 117 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 172
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
            K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 231
Query: 344 LERCWQQDPALRPDFSEIIEILQQI 368
           ++ CW  D A+RP F ++ E L+ I
Sbjct: 232 MKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 156/274 (56%), Gaps = 12/274 (4%)
Query: 102 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 159
           P+   D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF 
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 61
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVA 218
           +E  +M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 121
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 275
             +S  M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           +W APE + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 239
Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
               K+ EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 155/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G +G++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  + P Q    +++K  R   P+    K
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 14/265 (5%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 62
Query: 169 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 226
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 123 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 178
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + E+
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 237
Query: 344 LERCWQQDPALRPDFSEIIEILQQI 368
           ++ CW  D A+RP F ++ E L+ I
Sbjct: 238 MKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  + P Q    +++K  R   P+    K
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 186
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 75
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 194
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 253
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 254 VYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  177 bits (450), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 14/265 (5%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 243
Query: 169 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 226
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 359
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
            K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + ++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 344 LERCWQQDPALRPDFSEIIEILQQI 368
           ++ CW  D A RP F ++ E L+ I
Sbjct: 419 MKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 155/274 (56%), Gaps = 12/274 (4%)
Query: 102 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 159
           P+   D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF 
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 58
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVA 218
           +E  +M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 275
             +S  M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPI 177
Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           +W APE + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 236
Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
               K+ EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 237 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 63
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 182
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 241
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 152/269 (56%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 81
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT  P   IVTE+M  G++ DYL +  +       LL +A  +S 
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN VVKVADFG++R+       TA  G     +W AP
Sbjct: 142 AMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 200
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++KG R   P+   PK
Sbjct: 201 ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYDLLEKGYRMEQPEGCPPK 259
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CW+  PA RP F+E  +  + +
Sbjct: 260 VYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 183
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 269
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHR+L A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 447
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 308
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHR+L A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 427
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 486
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 151/274 (55%), Gaps = 20/274 (7%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRK 167
           EID   L     +  G +G +YR  +   +VA+K  +  P+   S   +   QE  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGM 225
           ++H N++   G C K P+LC+V EF  GG     L+++    ++P   L+  A+ +++GM
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGP----LNRVLSGKRIPPDILVNWAVQIARGM 118
Query: 226 NYLHQNNI---IHRDLKAANLLMDE--------NEVVKVADFGVARVKAQSGVMTAETGT 274
           NYLH   I   IHRDLK++N+L+ +        N+++K+ DFG+AR   ++  M+A  G 
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           Y WMAPEVI    +   +DV+S+G++LWELLTG++P+  +  L  A GV    L   IP 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                 A+L+E CW  DP  RP F+ I++ L  I
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 153/269 (56%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 153/269 (56%), Gaps = 12/269 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 150/262 (57%), Gaps = 12/262 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 280
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 340 LAELLERCWQQDPALRPDFSEI 361
           + EL+  CWQ +P+ RP F+EI
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 161/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 170/297 (57%), Gaps = 26/297 (8%)
Query: 78  HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 158 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 136 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 206 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 261
Query: 195 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 253
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321
Query: 254 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 309
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 322 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 381 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 170/297 (57%), Gaps = 26/297 (8%)
Query: 78  HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 158 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 136 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 206 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 261
Query: 195 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 253
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321
Query: 254 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 309
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 322 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 381 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 169/297 (56%), Gaps = 26/297 (8%)
Query: 78  HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 159 HRLTNVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 206
Query: 136 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 207 NGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 262
Query: 195 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 253
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 263 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 322
Query: 254 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 309
           ADFG+ R+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 323 ADFGLGRL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381
Query: 310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           PY  +   +  +  V++G R   P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 382 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVF 163
           G   WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  
Sbjct: 6   GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 62
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +M  + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV +
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 281
            M YL     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PE
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 182
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
           V+ +  +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+
Sbjct: 183 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 241
Query: 341 AELLERCWQQDPALRPDF----SEIIEILQQ 367
             ++  CW +    RP F    S I++++ +
Sbjct: 242 YTIMYSCWHEKADERPTFKILLSNILDVMDE 272

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 170/297 (57%), Gaps = 26/297 (8%)
Query: 78  HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 241 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 136 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 289 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 344
Query: 195 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 253
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 404
Query: 254 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 309
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 405 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 464 PYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVF 163
           G   WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 71
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +M  + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV +
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 281
            M YL     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PE
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 191
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
           V+ +  +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250
Query: 341 AELLERCWQQDPALRPDF----SEIIEILQQ 367
             ++  CW +    RP F    S I++++ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 285
           L     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
             +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 345 ERCWQQDPALRPDF----SEIIEIL 365
             CW +    RP F    S I++++
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVM 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 161/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVF 163
           G   WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 71
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +M  + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV +
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 281
            M YL     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PE
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPE 191
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
           V+ +  +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250
Query: 341 AELLERCWQQDPALRPDF----SEIIEILQQ 367
             ++  CW +    RP F    S I++++ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 154/267 (57%), Gaps = 12/267 (4%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 59
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M Y
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 285
           L     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
             +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 238
Query: 345 ERCWQQDPALRPDF----SEIIEILQQ 367
             CW +    RP F    S I++++ +
Sbjct: 239 YSCWHEKADERPTFKILLSNILDVMDE 265

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 154/267 (57%), Gaps = 12/267 (4%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 285
           L     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
             +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 345 ERCWQQDPALRPDF----SEIIEILQQ 367
             CW +    RP F    S I++++ +
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVMDE 266

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS G + D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/297 (35%), Positives = 169/297 (56%), Gaps = 26/297 (8%)
Query: 78  HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 158 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 136 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IV E+MS
Sbjct: 206 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMS 261
Query: 195 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 253
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321
Query: 254 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 309
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 322 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 381 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 58
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ G
Sbjct: 59  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 176
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 235
Query: 341 AELLERCWQQDPALRPDFSEIIEILQ 366
            +L+ +CW++DP  RP F  +   L+
Sbjct: 236 HDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 57
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ G
Sbjct: 58  KKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 116
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 117 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 175
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 234
Query: 341 AELLERCWQQDPALRPDFSEIIEILQ 366
            +L+ +CW+++P  RP F  +   L+
Sbjct: 235 HDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 60
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ G
Sbjct: 61  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 120 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 178
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 237
Query: 341 AELLERCWQQDPALRPDFSEIIEILQ 366
            +L+ +CW+++P  RP F  +   L+
Sbjct: 238 HDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 159/275 (57%), Gaps = 12/275 (4%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 156
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 215
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS G + D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 331
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 104/315 (33%), Positives = 168/315 (53%), Gaps = 22/315 (6%)
Query: 69  KLERQGWPS------HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV 122
           +LE +G+PS      H  S+     + +G+     H  +P D    W ++ + L  G ++
Sbjct: 69  RLEGEGFPSIPLLIDHLLSTQQPLTKKSGVV---LHRAVPKDK---WVLNHEDLVLGEQI 122
Query: 123 ASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
             G++G+++ G   + +  VA+K  + E +  D++ +F QE  I+++  H N+V+ IG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           T+   + IV E + GG    +L       ++ +LL++  D + GM YL     IHRDL A
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVFS 296
            N L+ E  V+K++DFG++R +A  GV  A  G      +W APE + +  Y  ++DV+S
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 297 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           FGI+LWE  + G  PY  L+  Q     V+KG R   P+     +  L+E+CW  +P  R
Sbjct: 301 FGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359
Query: 356 PDFSEIIEILQQIAK 370
           P FS I + LQ I K
Sbjct: 360 PSFSTIYQELQSIRK 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 104/315 (33%), Positives = 168/315 (53%), Gaps = 22/315 (6%)
Query: 69  KLERQGWPS------HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV 122
           +LE +G+PS      H  S+     + +G+     H  +P D    W ++ + L  G ++
Sbjct: 69  RLEGEGFPSIPLLIDHLLSTQQPLTKKSGVV---LHRAVPKDK---WVLNHEDLVLGEQI 122
Query: 123 ASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
             G++G+++ G   + +  VA+K  + E +  D++ +F QE  I+++  H N+V+ IG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
           T+   + IV E + GG    +L       ++ +LL++  D + GM YL     IHRDL A
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 241 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVFS 296
            N L+ E  V+K++DFG++R +A  GV  A  G      +W APE + +  Y  ++DV+S
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 297 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           FGI+LWE  + G  PY  L+  Q     V+KG R   P+     +  L+E+CW  +P  R
Sbjct: 301 FGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359
Query: 356 PDFSEIIEILQQIAK 370
           P FS I + LQ I K
Sbjct: 360 PSFSTIYQELQSIRK 374

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 157/264 (59%), Gaps = 12/264 (4%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M+K
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 58
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 226
           +RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ GM 
Sbjct: 59  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 283
           Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE  
Sbjct: 118 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 176
Query: 284 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
            +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L +
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 235
Query: 343 LLERCWQQDPALRPDFSEIIEILQ 366
           L+ +CW++DP  RP F  +   L+
Sbjct: 236 LMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+M+ GS+ D+L    G + +LP L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEWTARQGAKFPIKWTAPE 182
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 341 AELLERCWQQDPALRPDFSEIIEILQ 366
            +L+ +CW+++P  RP F  +   L+
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+M+ GS+ D+L    G + +LP L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 182
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 341 AELLERCWQQDPALRPDFSEIIEILQ 366
            +L+ +CW+++P  RP F  +   L+
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 160/266 (60%), Gaps = 12/266 (4%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           DVWEI  + L+   ++ +G +G+++ GT+  +  VAIK LKP  ++ +    F +E  IM
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIM 58
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           +K++H  +VQ     ++ P + IVTE+M+ GS+ D+L   +G   KLP+L+ +A  V+ G
Sbjct: 59  KKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 117
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N IHRDL++AN+L+    + K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYIERMNYIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPE 176
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL+T G++PY  +   +  +  V++G R   P++    L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISL 235
Query: 341 AELLERCWQQDPALRPDFSEIIEILQ 366
            EL+  CW++DP  RP F  +   L+
Sbjct: 236 HELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 152/265 (57%), Gaps = 12/265 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKP 287
               +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYS 236
Query: 347 CWQQDPALRPDF----SEIIEILQQ 367
           CW +    RP F    S I++++ +
Sbjct: 237 CWHEKADERPTFKILLSNILDVMDE 261

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 154/264 (58%), Gaps = 10/264 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 237
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-LPSLLKVAIDVSKG 224
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G  + LP L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I    +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L 
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 415
Query: 342 ELLERCWQQDPALRPDFSEIIEIL 365
            ++ RCW+  P  RP F  I  +L
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 154/264 (58%), Gaps = 10/264 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 64
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-LPSLLKVAIDVSKG 224
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G  + LP L+  +  +++G
Sbjct: 65  KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 124 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 183
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I    +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L 
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 242
Query: 342 ELLERCWQQDPALRPDFSEIIEIL 365
            ++ RCW+  P  RP F  I  +L
Sbjct: 243 NIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 154/262 (58%), Gaps = 16/262 (6%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 231
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-LPSLLKVAIDVSKG 224
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G  + LP L+  +  +++G
Sbjct: 232 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV A+  +        +W APE I 
Sbjct: 291 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPI--------KWTAPEAIN 342
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L  +
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 401
Query: 344 LERCWQQDPALRPDFSEIIEIL 365
           + RCW+  P  RP F  I  +L
Sbjct: 402 MMRCWKNRPEERPTFEYIQSVL 423

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 15/267 (5%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           ID K ++    V  G++G + +  + ++DVAIK ++ E      +K F  E+  + +V H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNH 61
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV--FKLPSLLKVAIDVSKGMNYL 228
            N+V+  GAC  P  +C+V E+  GGS+Y+ LH  + +  +     +   +  S+G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 229 HQ---NNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
           H      +IHRDLK  NLL+     V+K+ DFG A    Q+  MT   G+  WMAPEV E
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTH-MTNNKGSAAWMAPEVFE 177
Query: 285 HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              Y  K DVFS+GI+LWE++T + P++ +  P    +  V  G RP + KN    +  L
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 237
Query: 344 LERCWQQDPALRPDFSEIIEILQQIAK 370
           + RCW +DP+ RP   EI++I+  + +
Sbjct: 238 MTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 15/267 (5%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           ID K ++    V  G++G + +  + ++DVAIK ++ E      +K F  E+  + +V H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNH 60
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV--FKLPSLLKVAIDVSKGMNYL 228
            N+V+  GAC  P  +C+V E+  GGS+Y+ LH  + +  +     +   +  S+G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 229 HQ---NNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
           H      +IHRDLK  NLL+     V+K+ DFG A    Q+  MT   G+  WMAPEV E
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTH-MTNNKGSAAWMAPEVFE 176
Query: 285 HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              Y  K DVFS+GI+LWE++T + P++ +  P    +  V  G RP + KN    +  L
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 344 LERCWQQDPALRPDFSEIIEILQQIAK 370
           + RCW +DP+ RP   EI++I+  + +
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 152/264 (57%), Gaps = 9/264 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + +K   ++ +G +G+++ G Y  S  VA+K LKP  ++    + F +E  +M
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           + ++H  +V+     T+   + I+TE+M+ GS+ D+L   +G    LP L+  +  +++G
Sbjct: 63  KTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 122
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 123 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 182
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I    +  K+DV+SFGI+L+E++T GK+PY   T       + Q G R    +N   +L 
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ-GYRMPRVENCPDELY 241
Query: 342 ELLERCWQQDPALRPDFSEIIEIL 365
           ++++ CW++    RP F  +  +L
Sbjct: 242 DIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 64
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 65  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 124 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 242
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 243 QLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 63
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 64  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 122
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 241
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 242 QLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 57
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 58  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 116
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 235
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 236 QLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 70
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 71  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 129
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 130 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 248
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 249 QLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 67
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 68  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 126
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 127 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 245
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 246 QLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 72
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 73  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 131
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 132 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 250
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 251 QLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 71
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 72  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 130
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 131 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 249
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 250 QLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 99/345 (28%), Positives = 170/345 (49%), Gaps = 31/345 (8%)
Query: 47  VVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT 106
           ++DG+       +  A +  +++ +++G  +  S    +  E  G++SH   +   +D  
Sbjct: 313 LIDGY----CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYA 368
Query: 107 DV--------------WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKP 147
           ++              +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K 
Sbjct: 369 EIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK- 427
Query: 148 ERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK 206
               SD  +E F QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K
Sbjct: 428 -NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK 485
Query: 207 GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 266
               L SL+  A  +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S 
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 267 VMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
              A  G    +WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G 
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGR 604
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           ++ G R  +P N  P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 153/265 (57%), Gaps = 10/265 (3%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G  G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 342 ELLERCWQQDPALRPDFSEIIEILQ 366
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 146/272 (53%), Gaps = 13/272 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVF 163
           EI P  +     + +G +G++Y+G   +        VAIK LK        + +F  E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAG 98
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           IM +  H N+++  G  +K   + I+TE+M  G++  +L +  G F +  L+ +   ++ 
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMA 279
           GM YL   N +HRDL A N+L++ N V KV+DFG++RV       T  T       RW A
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           PE I ++ +   +DV+SFGIV+WE++T G+ PY  L+     +  +  G R   P +   
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPS 277
Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            + +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 278 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WEI  + +K   K+ +G +G+++ G Y  S  VA+K LKP  ++    + F +E  +M+ 
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 63
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 226
           ++H  +V+     TK   + I+TEFM+ GS+ D+L   +G    LP L+  +  +++GM 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 124 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              +  K++V+SFGI+L+E++T GK+PY   T     +  + +G R    +N   +L ++
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNAD-VMSALSQGYRMPRMENCPDELYDI 242
Query: 344 LERCWQQDPALRPDFSEIIEIL 365
           ++ CW++    RP F  +  +L
Sbjct: 243 MKMCWKEKAEERPTFDYLQSVL 264

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-F 158
            T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKF 58
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
            QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--R 276
             +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPN 236
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 159
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 4   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 61
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 120
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 277
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 121 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 239
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 240 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 159
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 5   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 62
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 63  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 121
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 277
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 122 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 181
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 240
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 241 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 159
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 64
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 277
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 242
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-F 158
            T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKF 58
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
            QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--R 276
             +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPN 236
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 153/263 (58%), Gaps = 10/263 (3%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M++
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQ 60
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 226
           ++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++GM 
Sbjct: 61  LQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 284
           ++ + N IHR+L+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179
Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
           +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L +L
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQL 238
Query: 344 LERCWQQDPALRPDFSEIIEILQ 366
           +  CW++ P  RP F  +  +L+
Sbjct: 239 MRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-F 158
            T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKF 58
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
            QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--R 276
             +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPN 236
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 141/269 (52%), Gaps = 13/269 (4%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FAQEV 162
           +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F QE 
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEA 59
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
             MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A  +S
Sbjct: 60  LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAP 280
             + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +WMAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N  P 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPT 237
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 159
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 30  TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 87
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 88  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 146
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 277
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 147 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 206
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 265
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 266 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 98/345 (28%), Positives = 169/345 (48%), Gaps = 31/345 (8%)
Query: 47  VVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT 106
           ++DG+       +  A +  +++ +++G  +  S    +  E  G++SH   +   +D  
Sbjct: 313 LIDGY----CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYA 368
Query: 107 DV--------------WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKP 147
           ++              +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K 
Sbjct: 369 EIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK- 427
Query: 148 ERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK 206
               SD  +E F QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K
Sbjct: 428 -NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK 485
Query: 207 GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 266
               L SL+  A  +S  + YL     +HRD+ A N+L+   + VK+ DFG++R    S 
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST 545
Query: 267 VMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
              A  G    +WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G 
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGR 604
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           ++ G R  +P N  P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 153/281 (54%), Gaps = 25/281 (8%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W+I  + L+ G  +  G +G +Y G +   +VAI+++  ER N D  K F +EV   R+ 
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           RH+NVV F+GAC  PP L I+T    G ++Y  +   K V  +    ++A ++ KGM YL
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA---------ETGTYRWMA 279
           H   I+H+DLK+ N+  D  +VV + DFG+  +   SGV+ A         + G    +A
Sbjct: 147 HAKGILHKDLKSKNVFYDNGKVV-ITDFGLFSI---SGVLQAGRREDKLRIQNGWLCHLA 202
Query: 280 PEVI---------EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 330
           PE+I         +  P+   +DVF+ G + +EL   + P++   P +A +  +  G++P
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGMKP 261
Query: 331 TIPKNSQPK-LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            + +    K ++++L  CW  +   RP F++++++L+++ K
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 151/266 (56%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           ID K L F +K+     G+L++G +   D+ +KVLK    ++   ++F +E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 171 KNVVQFIGACTKPPSL--CIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNY 227
            NV+  +GAC  PP+    ++T +M  GS+Y+ LH+    V      +K A+D+++GM +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 228 LH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 285
           LH  +  I    L + ++++DE+   +++   V       G M A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 286 KPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
           KP D     AD++SF ++LWEL+T ++P+  L+ ++  + V  +GLRPTIP    P +++
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 343 LLERCWQQDPALRPDFSEIIEILQQI 368
           L++ C  +DPA RP F  I+ IL+++
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 145/261 (55%), Gaps = 8/261 (3%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           E+  + +    ++ SG +G +  G +  Q DVA+K++K   ++ D   EF QE   M K+
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKL 60
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H  +V+F G C+K   + IVTE++S G + +YL       +   LL++  DV +GM +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHK 286
             +  IHRDL A N L+D +  VKV+DFG+ R       +++    +  +W APEV  + 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            Y  K+DV++FGI++WE+ + GK+PY+  T  +  + V Q G R   P  +   + +++ 
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPHLASDTIYQIMY 239
Query: 346 RCWQQDPALRPDFSEIIEILQ 366
            CW + P  RP F +++  ++
Sbjct: 240 SCWHELPEKRPTFQQLLSSIE 260

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 141/273 (51%), Gaps = 13/273 (4%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-F 158
            T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKF 58
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
            QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--R 276
             +S  + YL     +HRD+ A N+L+   + VK+ DFG++R    S    A  G    +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPN 236
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 94/322 (29%), Positives = 160/322 (49%), Gaps = 33/322 (10%)
Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           P  R ++  S   DT M +     ++P D    WE     L  G  +  G +G +     
Sbjct: 45  PLVRITTRLSSTADTPMLAGVSEYELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 136 CSQD---------VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 185
              D         VA+K+LK +    D+  +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 103 VGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 186 LCIVTEFMSGGSVYDYLHKLK--------GVFKLP-------SLLKVAIDVSKGMNYLHQ 230
           L ++ E+ S G++ +YL   +         + ++P        L+     +++GM YL  
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG---TYRWMAPEVIEHKP 287
              IHRDL A N+L+ EN V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y H++DV+SFG+++WE+ T G  PY  + P++    ++++G R   P N   +L  ++  
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRD 340
Query: 347 CWQQDPALRPDFSEIIEILQQI 368
           CW   P+ RP F +++E L +I
Sbjct: 341 CWHAVPSQRPTFKQLVEDLDRI 362

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 153/296 (51%), Gaps = 18/296 (6%)
Query: 91  GMKSH--PYHLKIPNDGTDVW--EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VA 141
           GMK    P+  + PN+    +  EID   +K    + +G +G++  G           VA
Sbjct: 6   GMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA 65
Query: 142 IKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY 201
           IK LK        +++F  E  IM +  H NV+   G  TK   + I+TEFM  GS+  +
Sbjct: 66  IKTLK-SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 124
Query: 202 LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 261
           L +  G F +  L+ +   ++ GM YL   N +HRDL A N+L++ N V KV+DFG++R 
Sbjct: 125 LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 262 ---KAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
                     T+  G     RW APE I+++ +   +DV+S+GIV+WE+++ G+ PY  +
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           T  Q  +  +++  R   P +    L +L+  CWQ+D   RP F +I+  L ++ +
Sbjct: 245 TN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG+ARV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 153/271 (56%), Gaps = 22/271 (8%)
Query: 116 LKFGSKVASGSYGDLYRGTYCSQD--VAIK--VLKPERINSDMQ---KEFAQEVFIMRKV 168
           +++  ++  G +G +++G        VAIK  +L      ++M    +EF +EVFIM  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H N+V+  G    PP +  V EF+  G +Y  L       K    L++ +D++ G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 229 HQNN--IIHRDLKAANLLM---DENEVV--KVADFGVARVKAQSGVMTAETGTYRWMAPE 281
              N  I+HRDL++ N+ +   DEN  V  KVADFG+++    S  ++   G ++WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 282 VI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQ 337
            I  E + Y  KAD +SF ++L+ +LTG+ P++  +   ++    + ++GLRPTIP++  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 70
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 87
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 266
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 267 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 152/271 (56%), Gaps = 22/271 (8%)
Query: 116 LKFGSKVASGSYGDLYRGTYCSQD--VAIK--VLKPERINSDMQ---KEFAQEVFIMRKV 168
           +++  ++  G +G +++G        VAIK  +L      ++M    +EF +EVFIM  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H N+V+  G    PP +  V EF+  G +Y  L       K    L++ +D++ G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 229 HQNN--IIHRDLKAANLLM---DENEVV--KVADFGVARVKAQSGVMTAETGTYRWMAPE 281
              N  I+HRDL++ N+ +   DEN  V  KVADFG ++    S  ++   G ++WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS--VSGLLGNFQWMAPE 196
Query: 282 VI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQ 337
            I  E + Y  KAD +SF ++L+ +LTG+ P++  +   ++    + ++GLRPTIP++  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 97
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 276
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 277 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG+ RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 91/309 (29%), Positives = 155/309 (50%), Gaps = 33/309 (10%)
Query: 89  DTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--------- 139
           DT M +     ++P D    WE     L  G  +  G +G +        D         
Sbjct: 4   DTPMLAGVSEYELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT 61
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           VA+K+LK +    D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++
Sbjct: 62  VAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 199 YDYLHKLK--------GVFKLP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            +YL   +         + ++P        L+     +++GM YL     IHRDL A N+
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 180
Query: 244 LMDENEVVKVADFGVARVKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L+ EN V+K+ADFG+AR           T      +WMAPE +  + Y H++DV+SFG++
Sbjct: 181 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 240
Query: 301 LWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
           +WE+ T G  PY  + P++    ++++G R   P N   +L  ++  CW   P+ RP F 
Sbjct: 241 MWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 299
Query: 360 EIIEILQQI 368
           +++E L +I
Sbjct: 300 QLVEDLDRI 308

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSH 141
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 147/271 (54%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDVA--IKVLKPERINSDMQKEFAQEVFI 164
           E+D   +K    + +G +G++  G       +DVA  IK LK        +++F  E  I
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG-YTEKQRRDFLCEASI 97
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H NVV   G  T+   + IV EFM  G++  +L K  G F +  L+ +   ++ G
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV       V T   G    RW AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I+++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P +    
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAG 276
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ++ A RP F +I+ IL ++ +
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH 141
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++TEF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/312 (29%), Positives = 157/312 (50%), Gaps = 43/312 (13%)
Query: 91  GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VA 141
           GM +     ++P D    WE+    L  G  +  G++G +        D         VA
Sbjct: 48  GMLAGVSEYELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA 105
Query: 142 IKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 200
           +K+LK +    D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +
Sbjct: 106 VKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 201 YL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           YL               H  +       L+  A  V++GM YL     IHRDL A N+L+
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 246 DENEVVKVADFGVAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
            E+ V+K+ADFG+AR         K  +G +       +WMAPE +  + Y H++DV+SF
Sbjct: 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV-----KWMAPEALFDRIYTHQSDVWSF 279
Query: 298 GIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 356
           G++LWE+ T G  PY  + P++    ++++G R   P N   +L  ++  CW   P+ RP
Sbjct: 280 GVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 338
Query: 357 DFSEIIEILQQI 368
            F +++E L +I
Sbjct: 339 TFKQLVEDLDRI 350

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 141
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 151/290 (52%), Gaps = 20/290 (6%)
Query: 96  PYHLKIPNDGTDVW--EIDPKHLKFGSKVASGSYGDLYRGTY--------CSQDVAIKVL 145
           P+  + PN     +  EID   +K    +  G +G++  G          C   VAIK L
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC---VAIKTL 65
Query: 146 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL 205
           K    +   +++F  E  IM +  H N++   G  TK   + I+TE+M  GS+  +L K 
Sbjct: 66  KAGYTDKQ-RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 124
Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 265
            G F +  L+ +   +  GM YL   + +HRDL A N+L++ N V KV+DFG++RV    
Sbjct: 125 DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 266 --GVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
                T   G    RW APE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDV 243
Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           +  +++G R   P +    L +L+  CWQ++ + RP F +I+ +L ++ +
Sbjct: 244 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 16  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 74
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 75  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 134
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 253
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 254 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 12  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 70
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 71  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 130
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 249
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 250 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 15  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 73
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 74  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 133
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 252
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 253 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 66
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 126
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 245
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 203
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++TEF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++TEF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 70
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G +G +        D         VA+K+LK +    D+  +  
Sbjct: 19  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 77
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 78  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 256
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 257 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  TK   + IVTE M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G +G +        D         VA+K+LK +    D+  +  
Sbjct: 17  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 75
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 76  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 254
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 255 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 147/294 (50%), Gaps = 26/294 (8%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 16  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 210 -----------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                       L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL 194
Query: 259 AR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+++ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 147/276 (53%), Gaps = 20/276 (7%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLK---PERINSDMQKEFAQE 161
           EID  ++K    + +G +G++ RG   +       VAIK LK    ER     ++EF  E
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER----QRREFLSE 67
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             IM +  H N+++  G  T    + I+TEFM  G++  +L    G F +  L+ +   +
Sbjct: 68  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGI 127
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------ 275
           + GM YL + + +HRDL A N+L++ N V KV+DFG++R   ++     ET +       
Sbjct: 128 ASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           RW APE I  + +   +D +S+GIV+WE+++ G+ PY  ++  Q  +  +++  R   P 
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPP 246
Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           +    L +L+  CWQ+D   RP F +++  L ++ +
Sbjct: 247 DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 152/271 (56%), Gaps = 22/271 (8%)
Query: 116 LKFGSKVASGSYGDLYRGTYCSQD--VAIK--VLKPERINSDMQ---KEFAQEVFIMRKV 168
           +++  ++  G +G +++G        VAIK  +L      ++M    +EF +EVFIM  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H N+V+  G    PP +  V EF+  G +Y  L       K    L++ +D++ G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 229 HQNN--IIHRDLKAANLLM---DENEVV--KVADFGVARVKAQSGVMTAETGTYRWMAPE 281
              N  I+HRDL++ N+ +   DEN  V  KVADF +++    S  ++   G ++WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 282 VI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQ 337
            I  E + Y  KAD +SF ++L+ +LTG+ P++  +   ++    + ++GLRPTIP++  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 145/274 (52%), Gaps = 18/274 (6%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY--------CSQDVAIKVLKPERINSDMQKEFAQE 161
           EID   +K    +  G +G++  G          C   VAIK LK    +   +++F  E
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC---VAIKTLKAGYTDKQ-RRDFLSE 65
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             IM +  H N++   G  TK   + I+TE+M  GS+  +L K  G F +  L+ +   +
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 125
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRW 277
             GM YL   + +HRDL A N+L++ N V KV+DFG++RV         T   G    RW
Sbjct: 126 GSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
            APE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P + 
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDC 244
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              L +L+  CWQ++ + RP F +I+ +L ++ +
Sbjct: 245 PIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 145/274 (52%), Gaps = 18/274 (6%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY--------CSQDVAIKVLKPERINSDMQKEFAQE 161
           EID   +K    +  G +G++  G          C   VAIK LK    +   +++F  E
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC---VAIKTLKAGYTDKQ-RRDFLSE 59
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             IM +  H N++   G  TK   + I+TE+M  GS+  +L K  G F +  L+ +   +
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 119
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRW 277
             GM YL   + +HRDL A N+L++ N V KV+DFG++RV         T   G    RW
Sbjct: 120 GSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
            APE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P + 
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDC 238
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              L +L+  CWQ++ + RP F +I+ +L ++ +
Sbjct: 239 PIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 92/287 (32%), Positives = 147/287 (51%), Gaps = 14/287 (4%)
Query: 96  PYHLKIPNDGTDVW--EIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPE 148
           P+  + PN     +  EI+   +     + +G +G++  G           VAIK LK  
Sbjct: 2   PHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG 61
Query: 149 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 208
                 +++F  E  IM +  H N++   G  TK   + IVTE+M  GS+  +L K  G 
Sbjct: 62  -YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ 120
Query: 209 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--G 266
           F +  L+ +   +S GM YL     +HRDL A N+L++ N V KV+DFG++RV       
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 180
Query: 267 VMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
             T   G    RW APE I  + +   +DV+S+GIV+WE+++ G+ PY  +T  Q  +  
Sbjct: 181 AYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKA 239
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V++G R   P +    L +L+  CWQ++   RP F EI+ +L ++ +
Sbjct: 240 VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 123
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDV--AIKVLKPERINSDMQKEFAQEVFI 164
           EI+   +     + SG  G++  G       +DV  AIK LK        +++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASI 103
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  T+     IVTE+M  GS+  +L    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAP 280
           M YL     +HRDL A N+L+D N V KV+DFG++RV       +   T      RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I  + +   +DV+SFG+V+WE+L  G+ PY  +T  +  +  V++G R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CW +D A RP FS+I+ +L  + +
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 193 GLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDV--AIKVLKPERINSDMQKEFAQEVFI 164
           EI+   +     + SG  G++  G       +DV  AIK LK        +++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASI 103
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  T+     IVTE+M  GS+  +L    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 280
           M YL     +HRDL A N+L+D N V KV+DFG++RV         T   G    RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E I  + +   +DV+SFG+V+WE+L  G+ PY  +T  +  +  V++G R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           L +L+  CW +D A RP FS+I+ +L  + +
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 51  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 109
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 169
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 229
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 230 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++  + S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 16  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 210 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 194
Query: 257 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 195 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 254
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 255 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 159
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 160 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 210
            E+ +M+ + +HKN++  +GACT+   L ++  + S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 211 LP-------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 263
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 264 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 319
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 14/273 (5%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFI 164
           EID   +K    + +G +G++  G           VAIK LK        +++F  E  I
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASI 61
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H NV+   G  TK   + I+TEFM  GS+  +L +  G F +  L+ +   ++ G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGT---YRWM 278
           M YL   N +HR L A N+L++ N V KV+DFG++R           T+  G     RW 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 337
           APE I+++ +   +DV+S+GIV+WE+++ G+ PY  +T  Q  +  +++  R   P +  
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCP 240
Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             L +L+  CWQ+D   RP F +I+  L ++ +
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 146/295 (49%), Gaps = 27/295 (9%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     L  G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 15  RLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 74  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 133
Query: 210 ------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
                        L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 258 VAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEY 313
           +AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 314 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 146/292 (50%), Gaps = 24/292 (8%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     L  G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 210 ---------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 260
                     L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192
Query: 261 --VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 316
              K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +  
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 252
Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
           +  ++ +CW   P  RP F  + + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 146/292 (50%), Gaps = 24/292 (8%)
Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 152
           ++P D +  WE     L  G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 209
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 210 ---------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 260
                     L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192
Query: 261 --VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 316
              K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +  
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 252
Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 DEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFI 164
           EID  ++K    + +G +G++ RG   +       VAIK LK        ++EF  E  I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YTERQRREFLSEASI 68
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M +  H N+++  G  T    + I+TEFM  G++  +L    G F +  L+ +   ++ G
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------RWM 278
           M YL + + +HRDL A N+L++ N V KV+DFG++R   ++      T +       RW 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 337
           APE I  + +   +D +S+GIV+WE+++ G+ PY  ++  Q  +  +++  R   P +  
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 247
Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             L +L+  CWQ+D   RP F +++  L ++ +
Sbjct: 248 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 23/279 (8%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           +D   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 12  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 70
Query: 167 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 213
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 214 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
              LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T 
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 249
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              P N   ++ +L+ +CW++ P  RP F++I+  L ++
Sbjct: 250 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 23/279 (8%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           +D   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 80
Query: 167 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 213
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 214 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
              LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T 
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 259
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              P N   ++ +L+ +CW++ P  RP F++I+  L ++
Sbjct: 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 141/265 (53%), Gaps = 12/265 (4%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           ID K L F +K+     G+L++G +   D+ +KVLK    ++   ++F +E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 171 KNVVQFIGACTKPPSL--CIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNY 227
            NV+  +GAC  PP+    ++T +   GS+Y+ LH+    V      +K A+D ++G  +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAF 126
Query: 228 LH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 285
           LH  +  I    L + ++ +DE+   +++   V       G   A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA----WVAPEALQK 182
Query: 286 KPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
           KP D     AD +SF ++LWEL+T ++P+  L+  +    V  +GLRPTIP    P +++
Sbjct: 183 KPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSK 242
Query: 343 LLERCWQQDPALRPDFSEIIEILQQ 367
           L + C  +DPA RP F  I+ IL++
Sbjct: 243 LXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 140/274 (51%), Gaps = 20/274 (7%)
Query: 113 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 172
           P  L  G  +  G +G   + T+      + + +  R + + Q+ F +EV +MR + H N
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           V++FIG   K   L  +TE++ GG++   +  +   +     +  A D++ GM YLH  N
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV----KAQ-SGVMTAE----------TGTYRW 277
           IIHRDL + N L+ EN+ V VADFG+AR+    K Q  G+ + +           G   W
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKG-LRPTIPK 334
           MAPE+I  + YD K DVFSFGIVL E++ G++    +YL P     G+  +G L    P 
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYL-PRTMDFGLNVRGFLDRYCPP 246
Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           N  P    +  RC   DP  RP F ++   L+ +
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 11/255 (4%)
Query: 122 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           +  G +G++Y G Y +      +VA+K  K +    D +++F  E  IM+ + H ++V+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IG   + P+  I+ E    G +  YL + K   K+ +L+  ++ + K M YL   N +HR
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADV 294
           D+   N+L+   E VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 295 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           + F + +WE+L+ GK P+ +L   +  +GV++KG R   P    P L  L+ RCW  DP+
Sbjct: 198 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 256
Query: 354 LRPDFSEIIEILQQI 368
            RP F+E++  L  +
Sbjct: 257 DRPRFTELVCSLSDV 271

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 11/255 (4%)
Query: 122 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           +  G +G++Y G Y +      +VA+K  K +    D +++F  E  IM+ + H ++V+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IG   + P+  I+ E    G +  YL + K   K+ +L+  ++ + K M YL   N +HR
Sbjct: 91  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADV 294
           D+   N+L+   E VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 295 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           + F + +WE+L+ GK P+ +L   +  +GV++KG R   P    P L  L+ RCW  DP+
Sbjct: 210 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 268
Query: 354 LRPDFSEIIEILQQI 368
            RP F+E++  L  +
Sbjct: 269 DRPRFTELVCSLSDV 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 11/255 (4%)
Query: 122 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           +  G +G++Y G Y +      +VA+K  K +    D +++F  E  IM+ + H ++V+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IG   + P+  I+ E    G +  YL + K   K+ +L+  ++ + K M YL   N +HR
Sbjct: 75  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADV 294
           D+   N+L+   E VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 295 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           + F + +WE+L+ GK P+ +L   +  +GV++KG R   P    P L  L+ RCW  DP+
Sbjct: 194 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 252
Query: 354 LRPDFSEIIEILQQI 368
            RP F+E++  L  +
Sbjct: 253 DRPRFTELVCSLSDV 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 215
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 216 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 263
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 264 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 142/265 (53%), Gaps = 13/265 (4%)
Query: 116 LKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           LK    + SG++G +Y+G +  +       VAIK+L  E        EF  E  IM  + 
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMD 98
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H ++V+ +G C  P ++ +VT+ M  G + +Y+H+ K       LL   + ++KGM YL 
Sbjct: 99  HPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 286
           +  ++HRDL A N+L+     VK+ DFG+AR ++       A+ G    +WMA E I ++
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            + H++DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ 
Sbjct: 218 KFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMV 276
Query: 346 RCWQQDPALRPDFSEIIEILQQIAK 370
           +CW  D   RP F E+     ++A+
Sbjct: 277 KCWMIDADSRPKFKELAAEFSRMAR 301

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 142/265 (53%), Gaps = 13/265 (4%)
Query: 116 LKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           LK    + SG++G +Y+G +  +       VAIK+L  E        EF  E  IM  + 
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMD 75
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H ++V+ +G C  P ++ +VT+ M  G + +Y+H+ K       LL   + ++KGM YL 
Sbjct: 76  HPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 286
           +  ++HRDL A N+L+     VK+ DFG+AR ++       A+ G    +WMA E I ++
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 287 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
            + H++DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ 
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMV 253
Query: 346 RCWQQDPALRPDFSEIIEILQQIAK 370
           +CW  D   RP F E+     ++A+
Sbjct: 254 KCWMIDADSRPKFKELAAEFSRMAR 278

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 36  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 95
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 215
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 96  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 155
Query: 216 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 263
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 156 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 264 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 216 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 275
Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 276 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 34  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 93
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 215
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 153
Query: 216 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 263
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 264 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 215
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 216 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 263
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 264 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 215
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 216 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 263
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 264 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 320
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 147/279 (52%), Gaps = 23/279 (8%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           +D   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 19  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 77
Query: 167 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 213
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 214 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
              LL  A DV++GM+YL Q   IHR+L A N+L+ EN V K+ADFG++R +      T 
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 256
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              P N   ++ +L+ +CW++ P  RP F++I+  L ++
Sbjct: 257 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 262
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 92  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 210
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 211 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 269
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 270 ADSRPKFRELIIEFSKMAR 288

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 259
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           ++SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 88  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 146
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 206
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 207 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 265
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 266 ADSRPKFRELIIEFSKMAR 284

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           ++SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 107 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 165
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 225
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 226 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 284
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 285 ADSRPKFRELIIEFSKMAR 303

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 76  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 253
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 254 ADSRPKFRELIIEFSKMAR 272

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 262
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 262
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 261
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 61
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 182 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 237 FVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 142/280 (50%), Gaps = 29/280 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIM 165
           W I+    +    + SG+   + +  YC+   + VAIK +  E+  + M  E  +E+  M
Sbjct: 10  WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAM 67
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSLLKVA 218
            +  H N+V +  +      L +V + +SGGSV D +  +        GV    ++  + 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------T 272
            +V +G+ YLH+N  IHRD+KA N+L+ E+  V++ADFGV+   A  G +T         
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 273 GTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
           GT  WMAPEV+E  + YD KAD++SFGI   EL TG  PY    P++  +  +Q    P+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-PPS 246
Query: 332 IPKNSQPK---------LAELLERCWQQDPALRPDFSEII 362
           +    Q K           +++  C Q+DP  RP  +E++
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 70
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 191 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 246 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 70
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 191 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 246 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 66
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 187 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 242 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 142/280 (50%), Gaps = 29/280 (10%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIM 165
           W I+    +    + SG+   + +  YC+   + VAIK +  E+  + M  E  +E+  M
Sbjct: 5   WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSLLKVA 218
            +  H N+V +  +      L +V + +SGGSV D +  +        GV    ++  + 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------T 272
            +V +G+ YLH+N  IHRD+KA N+L+ E+  V++ADFGV+   A  G +T         
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 273 GTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
           GT  WMAPEV+E  + YD KAD++SFGI   EL TG  PY    P++  +  +Q    P+
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-PPS 241
Query: 332 IPKNSQPK---------LAELLERCWQQDPALRPDFSEII 362
           +    Q K           +++  C Q+DP  RP  +E++
Sbjct: 242 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 63
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 239 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + +++GMNYL    ++H
Sbjct: 79  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 197
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 198 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 256
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 257 ADSRPKFRELIIEFSKMAR 275

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 67
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 188 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 243 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 69
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 69
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 98
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 219 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 274 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 318

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 134/246 (54%), Gaps = 7/246 (2%)
Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +     V ++ G
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 92
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 150
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 151 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 210
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 211 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 269
Query: 358 FSEIIE 363
             E+++
Sbjct: 270 AKELLK 275

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 135/246 (54%), Gaps = 7/246 (2%)
Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +     V ++ G
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 87
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 297
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 205
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           GI   EL  G+ P+  L P++  + ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 206 GITAIELARGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 358 FSEIIE 363
             E+++
Sbjct: 265 AKELLK 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 140/257 (54%), Gaps = 8/257 (3%)
Query: 111 IDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +DP+ L     K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQ 61
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
                V ++ G+  K   L I+ E++ GGS  D L    G      +  +  ++ KG++Y
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDY 119
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHK 286
           LH    IHRD+KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+  
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
            YD KAD++S GI   EL  G+ P+  L P++  + ++ K   PT+  N    L E +E 
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEA 238
Query: 347 CWQQDPALRPDFSEIIE 363
           C  ++P+ RP   E+++
Sbjct: 239 CLNKEPSFRPTAKELLK 255

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           ++SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 134/246 (54%), Gaps = 7/246 (2%)
Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +     V ++ G
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 297
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 131 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 358 FSEIIE 363
             E+++
Sbjct: 250 AKELLK 255

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 83  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 202 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 260
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 261 ADSRPKFRELIIEFSKMAR 279

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 86  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 204
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 205 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 263
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 264 ADSRPKFRELIIEFSKMAR 282

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 262
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 83  LLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 202 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 260
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 261 ADSRPKFRELIIEFSKMAR 279

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 261
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 135/261 (51%), Gaps = 16/261 (6%)
Query: 122 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ 175
           +  G +G +Y G Y  Q       AIK L   RI    Q E F +E  +MR + H NV+ 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 176 FIGACTKPPSLC-IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
            IG    P  L  ++  +M  G +  ++   +    +  L+   + V++GM YL +   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----RWMAPEVIEHKPYD 289
           HRDL A N ++DE+  VKVADFG+AR        + +   +     +W A E ++   + 
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 290 HKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
            K+DV+SFG++LWELLT G  PY ++ P      + Q G R   P+     L +++++CW
Sbjct: 207 TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSLYQVMQQCW 265
Query: 349 QQDPALRPDFSEIIEILQQIA 369
           + DPA+RP F  ++  ++QI 
Sbjct: 266 EADPAVRPTFRVLVGEVEQIV 286

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 32/286 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 63
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 213
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 214 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L   +++A +++ GM YL+ N  +HRDL A N  + E+  VK+ DFG+ R         K
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 367
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 239 FVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAI  L+ E  +    KE   E ++M  V + +V +
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELR-EATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 116 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 174
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 175 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 234
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 235 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 293
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 294 ADSRPKFRELIIEFSKMAR 312

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 132/257 (51%), Gaps = 27/257 (10%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K+LK E  ++DMQ +F +E  +M +  + N+V+ +G C     +C++ E+M+ G + 
Sbjct: 80  VAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 200 DYLHKLK--GVFKL----------------PSL-----LKVAIDVSKGMNYLHQNNIIHR 236
           ++L  +    V  L                P L     L +A  V+ GM YL +   +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKAD 293
           DL   N L+ EN VVK+ADFG++R    +    A+       RWM PE I +  Y  ++D
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           V+++G+VLWE+ +  L   Y    +  +  V+ G     P+N   +L  L+  CW + PA
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 318
Query: 354 LRPDFSEIIEILQQIAK 370
            RP F  I  ILQ++ +
Sbjct: 319 DRPSFCSIHRILQRMCE 335

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 86  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 292
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 204
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 205 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 263
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E+I    ++A+
Sbjct: 264 ADSRPKFRELIIEFSKMAR 282

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 147/277 (53%), Gaps = 12/277 (4%)
Query: 92  MKSHPYHLKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPE 148
           M   P  +++P    ++   DP+ L     ++  GS+G++++G      Q VAIK++  E
Sbjct: 2   MAHSPVAVQVPGMQNNI--ADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE 59
Query: 149 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-G 207
               +++    QE+ ++ +     V ++ G+  K   L I+ E++ GGS  D L      
Sbjct: 60  EAEDEIEDI-QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD 118
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
            F++ ++LK   ++ KG++YLH    IHRD+KAAN+L+ E   VK+ADFGVA     + +
Sbjct: 119 EFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175
Query: 268 -MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 326
                 GT  WMAPEVI+   YD KAD++S GI   EL  G+ P   + P++    ++ K
Sbjct: 176 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPK 234
Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
              PT+  +      E ++ C  +DP+ RP   E+++
Sbjct: 235 NNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 137/257 (53%), Gaps = 8/257 (3%)
Query: 111 IDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +DP+ L     ++  GS+G++Y+G   +  + VAIK++  E    +++    QE+ ++ +
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQ 73
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
                + ++ G+  K   L I+ E++ GGS  D L    G  +   +  +  ++ KG++Y
Sbjct: 74  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDY 131
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHK 286
           LH    IHRD+KAAN+L+ E   VK+ADFGVA     + +      GT  WMAPEVI+  
Sbjct: 132 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
            YD KAD++S GI   EL  G+ P   L P++  + ++ K   PT+         E +E 
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLFLIPKNSPPTLEGQHSKPFKEFVEA 250
Query: 347 CWQQDPALRPDFSEIIE 363
           C  +DP  RP   E+++
Sbjct: 251 CLNKDPRFRPTAKELLK 267

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 40  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 98
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 99  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 158
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++G   
Sbjct: 159 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 218
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 219 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 277
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 278 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 63  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 121
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++G   
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 300
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 121/198 (61%), Gaps = 12/198 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           G+K+  G +G +Y+G   +  VA+K L    +    +++++F QE+ +M K +H+N+V+ 
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 234
           +G  +    LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 289
           HRD+K+AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  E  P  
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP-- 213
Query: 290 HKADVFSFGIVLWELLTG 307
            K+D++SFG+VL E++TG
Sbjct: 214 -KSDIYSFGVVLLEIITG 230

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 22/283 (7%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 33  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 91
Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV---------FKL 211
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +              +L
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTA 270
             LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S  +  
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 271 ETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 327
                  +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +V+ G
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 271
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 272 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 22/283 (7%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV---------FKL 211
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +              +L
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTA 270
             LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S  +  
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 271 ETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 327
                  +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +V+ G
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 279
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 120/198 (60%), Gaps = 12/198 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           G+K+  G +G +Y+G   +  VA+K L    +    +++++F QE+ +M K +H+N+V+ 
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 234
           +G  +    LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 289
           HRD+K+AN+L+DE    K++DFG+AR     AQ+ +     GT  +MAPE +  E  P  
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP-- 213
Query: 290 HKADVFSFGIVLWELLTG 307
            K+D++SFG+VL E++TG
Sbjct: 214 -KSDIYSFGVVLLEIITG 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 81
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K+ H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 82  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 260
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 95
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K+ H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 96  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 156 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 274
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 275 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 142/287 (49%), Gaps = 26/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-------- 212
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +   V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 213 -----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSG 266
                 LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 267 VMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
            +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 161
           WE   K+L  G  +  G +G + + T            VA+K+LK     S++ ++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSE 76
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV------------- 208
             ++++V H +V++  GAC++   L ++ E+   GS+  +L + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 209 ----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                       +  L+  A  +S+GM YL + +++HRDL A N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 259 AR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  +
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L+++
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 119/198 (60%), Gaps = 12/198 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           G+K+  G +G +Y+G   +  VA+K L    +    +++++F QE+ +M K +H+N+V+ 
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 234
           +G  +    LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 289
           HRD+K+AN+L+DE    K++DFG+AR     AQ  +     GT  +MAPE +  E  P  
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP-- 207
Query: 290 HKADVFSFGIVLWELLTG 307
            K+D++SFG+VL E++TG
Sbjct: 208 -KSDIYSFGVVLLEIITG 224

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 95
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 96  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 156 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 274
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 275 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 142/287 (49%), Gaps = 26/287 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-------- 212
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +   V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 213 -----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSG 266
                 LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 267 VMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
            +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 49  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 107
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 168 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 286
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 287 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 80
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 259
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 39  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 97
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 98  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 157
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 158 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 276
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 277 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 29  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 87
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 88  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 147
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 148 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 266
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 267 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 14  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 72
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 73  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 133 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 251
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 252 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 81
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 260
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 80
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 259
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 150/294 (51%), Gaps = 36/294 (12%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 161
           WE   K+L  G  +  G +G + + T            VA+K+LK     S++ ++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSE 76
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV------------- 208
             ++++V H +V++  GAC++   L ++ E+   GS+  +L + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 209 ----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                       +  L+  A  +S+GM YL +  ++HRDL A N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 259 AR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  +
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L+++
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 150/294 (51%), Gaps = 36/294 (12%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 161
           WE   K+L  G  +  G +G + + T            VA+K+LK     S++ ++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSE 76
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV------------- 208
             ++++V H +V++  GAC++   L ++ E+   GS+  +L + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 209 ----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                       +  L+  A  +S+GM YL +  ++HRDL A N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 259 AR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  +
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L+++
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 269
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 270 LKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVYSEQDELDF 95
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 96  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 156 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 274
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 275 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 267
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 268 LKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 83
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 262
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 263 LKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 265
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 266 LKCWHPKAEMRPSFSELVSRISAI 289

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 269
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 270 LKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 110
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 289
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 290 LKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHP 89
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 268
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 269 LKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 109
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 288
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 289 LKCWHPKAEMRPSFSELVSRISAI 312

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 142/292 (48%), Gaps = 32/292 (10%)
Query: 110 EIDPKH-----LKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEF 158
           E+DP H     LK    +  G +G  +L R    G    + VA+K LKPE   + +  + 
Sbjct: 12  EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DL 70
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
            +E+ I+R + H+N+V++ G CT+     + ++ EF+  GS+ +YL K K    L   LK
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 272
            A+ + KGM+YL     +HRDL A N+L++    VK+ DFG+ +     K    V     
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 190
Query: 273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--------GKLPYEYLTPLQAA---- 320
               W APE +    +   +DV+SFG+ L ELLT          L  + + P        
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 321 --VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             V  +++G R   P N   ++ +L+ +CW+  P+ R  F  +IE  + + K
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR  +  +   +  +TG     +WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 271
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 272 LKCWHPKAEMRPSFSELVSRISAI 295

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 158
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 81
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 213
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 269
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+A+   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 270 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 260
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 141/289 (48%), Gaps = 28/289 (9%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 205
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L               H  
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNP 159
Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQ 264
           +       LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 265 SGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
           S  +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +       
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 279
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            +V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 328

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 142/296 (47%), Gaps = 35/296 (11%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 161
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 26  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 84
Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------ 214
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +       PSL      
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 215 ----------------LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                           L  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 259 AR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           AR +   S  +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 264
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
                   +V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 265 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 320

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 271
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 272 LKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 96
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 275
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 276 LKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 137/259 (52%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG++G +Y+G +          VAIKVL+ E  +    KE   E ++M  V    V +
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    ++ +VT+ M  G + D++ + +G      LL   + ++KGM+YL    ++H
Sbjct: 84  LLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 292
           RDL A N+L+     VK+ DFG+AR +        A+ G    +WMA E I  + + H++
Sbjct: 143 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQS 202
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 352 PALRPDFSEIIEILQQIAK 370
              RP F E++    ++A+
Sbjct: 262 SECRPRFRELVSEFSRMAR 280

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 65
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 186 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 241 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 268
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 269 LKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHP 150
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 329
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 118 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 171
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 172 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 285
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 286 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK 188
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/335 (27%), Positives = 155/335 (46%), Gaps = 43/335 (12%)
Query: 65  KEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS 124
           K+  + E Q      + S  +E      + + Y LK        WE   ++L+FG  + S
Sbjct: 4   KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK--------WEFPRENLEFGKVLGS 55
Query: 125 GSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 176
           G++G +   T         S  VA+K+LK E+ +S  ++    E+ +M ++  H+N+V  
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNL 114
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSL 214
           +GACT    + ++ E+   G + +YL   +                       V     L
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 273
           L  A  V+KGM +L   + +HRDL A N+L+   +VVK+ DFG+AR + + S  +     
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234
Query: 274 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 330
               +WMAPE +    Y  K+DV+S+GI+LWE+ + G  PY  +        ++Q G + 
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294
Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
             P  +  ++  +++ CW  D   RP F  +   L
Sbjct: 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 141/291 (48%), Gaps = 32/291 (10%)
Query: 111 IDPKH-----LKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFA 159
           +DP H     LK    +  G +G  +L R    G    + VA+K LKPE   + +  +  
Sbjct: 1   VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DLK 59
Query: 160 QEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
           +E+ I+R + H+N+V++ G CT+     + ++ EF+  GS+ +YL K K    L   LK 
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 119
Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETG 273
           A+ + KGM+YL     +HRDL A N+L++    VK+ DFG+ +     K    V      
Sbjct: 120 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 274 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--------GKLPYEYLTPLQAA----- 320
              W APE +    +   +DV+SFG+ L ELLT          L  + + P         
Sbjct: 180 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 239
Query: 321 -VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            V  +++G R   P N   ++ +L+ +CW+  P+ R  F  +IE  + + K
Sbjct: 240 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 290

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 161/322 (50%), Gaps = 35/322 (10%)
Query: 77  SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGT 134
           S  S SPT E + +G++ H   ++ P   +D  V  I  + +    ++  G++G ++   
Sbjct: 5   SGSSLSPT-EGKGSGLQGHI--IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAE 61
Query: 135 YC-----SQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 186
            C      QD   VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L
Sbjct: 62  -CHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 187 CIVTEFMSGGSVYDYLHK--------------LKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            +V E+M  G +  +L                  G   L  LL VA  V+ GM YL   +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYD 289
            +HRDL   N L+ +  VVK+ DFG++R    +        T    RWM PE I ++ + 
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 290 HKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
            ++DV+SFG+VLWE+ T GK P+  L+  + A+  + +G     P+   P++  ++  CW
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCW 297
Query: 349 QQDPALRPDFSEIIEILQQIAK 370
           Q++P  R    ++   LQ +A+
Sbjct: 298 QREPQQRHSIKDVHARLQALAQ 319

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 69
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HR+L A N ++  +  VK+ DFG+ R         K
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 189
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 190 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 245 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 262
           L  ++++A +++ GM YL+    +HR+L A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 145/288 (50%), Gaps = 26/288 (9%)
Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRG---TYC-SQD---VAIKVLKPERINSDMQKEF 158
           T V  I   ++    ++  G++G ++       C  QD   VA+K LK    N+  +K+F
Sbjct: 5   TFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA--RKDF 62
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKL----- 211
            +E  ++  ++H+++V+F G C +   L +V E+M  G +  +L  H    V        
Sbjct: 63  HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122
Query: 212 -----PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 266
                  +L +A  ++ GM YL   + +HRDL   N L+ EN +VK+ DFG++R    + 
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 267 VMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 322
                  T    RWM PE I ++ +  ++DV+S G+VLWE+ T GK P+  L+     + 
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIE 241
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            + +G     P+    ++ EL+  CWQ++P +R +   I  +LQ +AK
Sbjct: 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 37/267 (13%)
Query: 122 VASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 178
           V +G+YG +Y+G +    Q  AIKV+    +  D ++E  QE+ +++K   H+N+  + G
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 179 ACTK--PPS----LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 231
           A  K  PP     L +V EF   GSV D +   KG   K   +  +  ++ +G+++LHQ+
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 232 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 287
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 288 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---- 341
             YD K+D++S GI   E+  G  P   + P++A            IP+N  P+L     
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 259
Query: 342 -----ELLERCWQQDPALRPDFSEIIE 363
                  +E C  ++ + RP   ++++
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 129/249 (51%), Gaps = 21/249 (8%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V E+M  G + 
Sbjct: 51  VAVKALK--EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 200 DYLHK--------------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
            +L                  G   L  LL VA  V+ GM YL   + +HRDL   N L+
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 168
Query: 246 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 302
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+VLW
Sbjct: 169 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 228
Query: 303 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           E+ T GK P+  L+  + A+  + +G     P+   P++  ++  CWQ++P  R    ++
Sbjct: 229 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287
Query: 362 IEILQQIAK 370
              LQ +A+
Sbjct: 288 HARLQALAQ 296

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 129/249 (51%), Gaps = 21/249 (8%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V E+M  G + 
Sbjct: 45  VAVKALK--EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 200 DYLHK--------------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
            +L                  G   L  LL VA  V+ GM YL   + +HRDL   N L+
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 162
Query: 246 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 302
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+VLW
Sbjct: 163 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 222
Query: 303 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           E+ T GK P+  L+  + A+  + +G     P+   P++  ++  CWQ++P  R    ++
Sbjct: 223 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281
Query: 362 IEILQQIAK 370
              LQ +A+
Sbjct: 282 HARLQALAQ 290

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 133/247 (53%), Gaps = 12/247 (4%)
Query: 121 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           ++  G++G + +G Y  +    DVAIKVLK     +D + E  +E  IM ++ +  +V+ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRL 75
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           IG C +  +L +V E   GG ++ +L   +    + ++ ++   VS GM YL + N +HR
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 237 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKA 292
           DL A N+L+      K++DFG+++ + A     TA +      +W APE I  + +  ++
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WE L+ G+ PY+ +   +  +  +++G R   P    P+L  L+  CW   
Sbjct: 195 DVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYK 253
Query: 352 PALRPDF 358
              RPDF
Sbjct: 254 WEDRPDF 260

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 145/294 (49%), Gaps = 29/294 (9%)
Query: 103 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQ 155
           + G  V  I  + +    ++  G++G ++         T     VA+K LK   + +  +
Sbjct: 4   HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--R 61
Query: 156 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------------ 203
           K+F +E  ++  ++H+++V+F G C     L +V E+M  G +  +L             
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 204 ---KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 260
              + KG   L  +L +A  ++ GM YL   + +HRDL   N L+  N +VK+ DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 261 VKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 316
               +        T    RWM PE I ++ +  ++DV+SFG++LWE+ T GK P+  L+ 
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            +  +  + +G     P+    ++ +++  CWQ++P  R +  EI +IL  + K
Sbjct: 242 TE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 147/286 (51%), Gaps = 25/286 (8%)
Query: 82  SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ--- 138
           SP S+PE+   K     L +  D   + +I+         +  G++G + +G Y  +   
Sbjct: 317 SPFSDPEELKDKK----LFLKRDNLLIADIE---------LGCGNFGSVRQGVYRMRKKQ 363
Query: 139 -DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
            DVAIKVLK     +D + E  +E  IM ++ +  +V+ IG C +  +L +V E   GG 
Sbjct: 364 IDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           ++ +L   +    + ++ ++   VS GM YL + N +HR+L A N+L+      K++DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 258 VAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           +++ + A     TA +      +W APE I  + +  ++DV+S+G+ +WE L+ G+ PY+
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541
Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
            +   +  +  +++G R   P    P+L  L+  CW      RPDF
Sbjct: 542 KMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDF 586

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 140/247 (56%), Gaps = 5/247 (2%)
Query: 121 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS+G   L + T   +   IK +   R++S  ++E  +EV ++  ++H N+VQ+  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
           +  +  SL IV ++  GG ++  ++  KGV F+   +L   + +   + ++H   I+HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           +K+ N+ + ++  V++ DFG+ARV  +   +  A  GT  +++PE+ E+KPY++K+D+++
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 356
            G VL+EL T K  +E    ++  V  +  G  P +  +    L  L+ + ++++P  RP
Sbjct: 211 LGCVLYELCTLKHAFE-AGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 357 DFSEIIE 363
             + I+E
Sbjct: 270 SVNSILE 276

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 114 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           ++LK    +  G +G +    YC         + VA+K LK +      +  + QE+ I+
Sbjct: 31  RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDIL 87
Query: 166 RKVRHKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           R + H++++++ G C      SL +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 145
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 279
           GM YLH  + IHRDL A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA 205
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVG---------VVQ 325
           PE ++   + + +DV+SFG+ L+ELLT        P ++L  +  A G         +++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           +G R   P     ++  L++ CW+ + + RP F  +I IL+ +
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 115/198 (58%), Gaps = 12/198 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           G+K   G +G +Y+G   +  VA+K L    +    +++++F QE+ +  K +H+N+V+ 
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 234
           +G  +    LC+V  +   GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI 146
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 289
           HRD+K+AN+L+DE    K++DFG+AR     AQ    +   GT  + APE +  E  P  
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITP-- 204
Query: 290 HKADVFSFGIVLWELLTG 307
            K+D++SFG+VL E++TG
Sbjct: 205 -KSDIYSFGVVLLEIITG 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG +G +++G +  +       V IKV++ +      Q      +  +  + H ++V+
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 97
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    SL +VT+++  GS+ D++ + +G      LL   + ++KGM YL ++ ++H
Sbjct: 98  LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 156
Query: 236 RDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT-YRWMAPEVIEHKPYDHKA 292
           R+L A N+L+     V+VADFGVA +       ++ +E  T  +WMA E I    Y H++
Sbjct: 157 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 216
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY  L  L     +++KG R   P+     +  ++ +CW  D
Sbjct: 217 DVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMID 275
Query: 352 PALRPDFSEIIEILQQIAK 370
             +RP F E+     ++A+
Sbjct: 276 ENIRPTFKELANEFTRMAR 294

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 133/269 (49%), Gaps = 22/269 (8%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 165
           ID   L  G  +  G +G +  G    +D     VA+K +K +  +    +EF  E   M
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 166 RKVRHKNVVQFIGACTKP-----PSLCIVTEFMSGGSVYDYL--HKLKGVFK---LPSLL 215
           +   H NV++ +G C +      P   ++  FM  G ++ YL   +L+   K   L +LL
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 274
           K  +D++ GM YL   N +HRDL A N ++ ++  V VADFG+++ K  SG    +    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-KIYSGDYYRQGRIA 209
Query: 275 ---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 330
               +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY  +         +  G R 
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHGHRL 268
Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFS 359
             P++   +L E++  CW+ DP  RP FS
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 122 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           + SG +G +++G +  +       V IKV++ +      Q      +  +  + H ++V+
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 79
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +G C    SL +VT+++  GS+ D++ + +G      LL   + ++KGM YL ++ ++H
Sbjct: 80  LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 138
Query: 236 RDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT-YRWMAPEVIEHKPYDHKA 292
           R+L A N+L+     V+VADFGVA +       ++ +E  T  +WMA E I    Y H++
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 198
Query: 293 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           DV+S+G+ +WEL+T G  PY  L  L     +++KG R   P+     +  ++ +CW  D
Sbjct: 199 DVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMID 257
Query: 352 PALRPDFSEIIEILQQIAK 370
             +RP F E+     ++A+
Sbjct: 258 ENIRPTFKELANEFTRMAR 276

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 32/282 (11%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEV 162
           E+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF  E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEA 70
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---------LPS 213
            +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         L  
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQS 265
           ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K   
Sbjct: 131 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 324
           G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q    V+
Sbjct: 191 GLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245
Query: 325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
             G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 155/304 (50%), Gaps = 28/304 (9%)
Query: 75  WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGS 126
           W + +     + P DT +   PY         D  EI PK +    K+         SG+
Sbjct: 331 WAADKGPQREALPMDTEVYESPY--------ADPEEIRPKEVYLDRKLLTLEDKELGSGN 382
Query: 127 YGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 182
           +G + +G Y      + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +
Sbjct: 383 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 441
Query: 183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
             S  +V E    G +  YL + + V K  +++++   VS GM YL ++N +HRDL A N
Sbjct: 442 AESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 500
Query: 243 LLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFG 298
           +L+      K++DFG+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG
Sbjct: 501 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 560
Query: 299 IVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           +++WE  + G+ PY  +   +    +++KG R   P     ++ +L+  CW  D   RP 
Sbjct: 561 VLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG 619
Query: 358 FSEI 361
           F+ +
Sbjct: 620 FAAV 623

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 145/262 (55%), Gaps = 15/262 (5%)
Query: 106 TDVWEIDPKHLKFGSKV--ASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEV 162
           +D+ E D ++ + G +V    G+YG +Y G   S  V I + + PER +S   +   +E+
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEI 70
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAID 220
            + + ++HKN+VQ++G+ ++   + I  E + GGS+   L    G  K    ++      
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVA-RVKAQSGVMTAETGTYRWM 278
           + +G+ YLH N I+HRD+K  N+L++  + V+K++DFG + R+   +      TGT ++M
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 279 APEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIP 333
           APE+I+  P  Y   AD++S G  + E+ TGK P+  L   QAA   VG+ +  + P IP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIP 248
Query: 334 KNSQPKLAELLERCWQQDPALR 355
           ++   +    + +C++ DP  R
Sbjct: 249 ESMSAEAKAFILKCFEPDPDKR 270

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 114 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           ++LK    +  G +G +    YC         + VA+K LK +      +  + QE+ I+
Sbjct: 14  RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKAD-CGPQHRSGWKQEIDIL 70
Query: 166 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           R + H++++++ G C      SL +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 128
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 279
           GM YLH  + IHR+L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVG---------VVQ 325
           PE ++   + + +DV+SFG+ L+ELLT        P ++L  +  A G         +++
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           +G R   P     ++  L++ CW+ + + RP F  +I IL+ +
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 155/304 (50%), Gaps = 28/304 (9%)
Query: 75  WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGS 126
           W + +     + P DT +   P+         D  EI PK +    K+         SG+
Sbjct: 330 WAADKGPQREALPMDTEVFESPF--------ADPEEIRPKEVYLDRKLLTLEDKELGSGN 381
Query: 127 YGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 182
           +G + +G Y      + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +
Sbjct: 382 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 440
Query: 183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
             S  +V E    G +  YL + + V K  +++++   VS GM YL ++N +HRDL A N
Sbjct: 441 AESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 499
Query: 243 LLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFG 298
           +L+      K++DFG+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG
Sbjct: 500 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 559
Query: 299 IVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 357
           +++WE  + G+ PY  +   +    +++KG R   P     ++ +L+  CW  D   RP 
Sbjct: 560 VLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG 618
Query: 358 FSEI 361
           F+ +
Sbjct: 619 FAAV 622

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 114 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           ++LK    +  G +G +    YC         + VA+K LK +      +  + QE+ I+
Sbjct: 14  RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKAD-CGPQHRSGWKQEIDIL 70
Query: 166 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           R + H++++++ G C      SL +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 128
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 279
           GM YLH  + IHR+L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 129 GMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVG---------VVQ 325
           PE ++   + + +DV+SFG+ L+ELLT        P ++L  +  A G         +++
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           +G R   P     ++  L++ CW+ + + RP F  +I IL+ +
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 142/281 (50%), Gaps = 33/281 (11%)
Query: 114 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           ++LK    +  G +G +    YC         + VA+K LK E     ++  + +E+ I+
Sbjct: 8   RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALK-EGCGPQLRSGWQREIEIL 64
Query: 166 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           R + H+++V++ G C      S+ +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGLAQLLLFAQQICE 122
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 279
           GM YLH  + IHR L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 123 GMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 182
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT----GKLPYEYLTPL----QAAVGV------VQ 325
           PE ++   + + +DV+SFG+ L+ELLT     + P+   T L    Q  + V      ++
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 242
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           +G R   P     ++  L++ CW+ + + RP F  ++ ILQ
Sbjct: 243 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 142/281 (50%), Gaps = 33/281 (11%)
Query: 114 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           ++LK    +  G +G +    YC         + VA+K LK E     ++  + +E+ I+
Sbjct: 9   RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALK-EGCGPQLRSGWQREIEIL 65
Query: 166 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           R + H+++V++ G C      S+ +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGLAQLLLFAQQICE 123
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 279
           GM YLH  + IHR L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 124 GMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 183
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT----GKLPYEYLTPL----QAAVGV------VQ 325
           PE ++   + + +DV+SFG+ L+ELLT     + P+   T L    Q  + V      ++
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 243
Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
           +G R   P     ++  L++ CW+ + + RP F  ++ ILQ
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 63/170 (37%), Positives = 99/170 (58%), Gaps = 8/170 (4%)
Query: 207 GVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-- 260
           G +K P     L+  +  V++GM +L     IHRDL A N+L+ EN VVK+ DFG+AR  
Sbjct: 190 GFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 261 VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 318
            K    V   +T    +WMAPE I  K Y  K+DV+S+G++LWE+ + G  PY  +   +
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                +++G+R   P+ S P++ +++  CW +DP  RP F+E++E L  +
Sbjct: 310 DFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 150/290 (51%), Gaps = 28/290 (9%)
Query: 89  DTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGSYGDLYRGTY----C 136
           DT +   PY         D  EI PK +    K+         SG++G + +G Y     
Sbjct: 2   DTEVYESPY--------ADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV 53
Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 196
            + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +  S  +V E    G
Sbjct: 54  VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 112
Query: 197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
            +  YL + + V K  +++++   VS GM YL ++N +HRDL A N+L+      K++DF
Sbjct: 113 PLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 171
Query: 257 GVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 311
           G+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG+++WE  + G+ PY
Sbjct: 172 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 312 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
             +   +    +++KG R   P     ++ +L+  CW  D   RP F+ +
Sbjct: 232 RGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 150/290 (51%), Gaps = 28/290 (9%)
Query: 89  DTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGSYGDLYRGTY----C 136
           DT +   PY         D  EI PK +    K+         SG++G + +G Y     
Sbjct: 2   DTEVYESPY--------ADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV 53
Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 196
            + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +  S  +V E    G
Sbjct: 54  VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 112
Query: 197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
            +  YL + + V K  +++++   VS GM YL ++N +HRDL A N+L+      K++DF
Sbjct: 113 PLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 171
Query: 257 GVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 311
           G+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG+++WE  + G+ PY
Sbjct: 172 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 312 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
             +   +    +++KG R   P     ++ +L+  CW  D   RP F+ +
Sbjct: 232 RGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 110 EIDPKHLKFGSKV--------ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKE 157
           EI PK +    K+         SG++G + +G Y      + VA+K+LK E  +  ++ E
Sbjct: 13  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 72
Query: 158 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
              E  +M+++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++
Sbjct: 73  LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIEL 130
Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY 275
              VS GM YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 276 --RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI 332
             +W APE I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGC 249
Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEI 361
           P     ++ +L+  CW  D   RP F+ +
Sbjct: 250 PAGCPREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 110 EIDPKHLKFGSKV--------ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKE 157
           EI PK +    K+         SG++G + +G Y      + VA+K+LK E  +  ++ E
Sbjct: 5   EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 158 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
              E  +M+++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIEL 122
Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY 275
              VS GM YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 276 --RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI 332
             +W APE I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGC 241
Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEI 361
           P     ++ +L+  CW  D   RP F+ +
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 111 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 281
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 341 AELLERCWQQDPALRPDFSEI 361
            +L+  CW  D   RP F+ +
Sbjct: 244 YDLMNLCWTYDVENRPGFAAV 264

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 111 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 60
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 61  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 118
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 281
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 237
Query: 341 AELLERCWQQDPALRPDFSEI 361
            +L+  CW  D   RP F+ +
Sbjct: 238 YDLMNLCWTYDVENRPGFAAV 258

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 111 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 120
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 281
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 239
Query: 341 AELLERCWQQDPALRPDFSEI 361
            +L+  CW  D   RP F+ +
Sbjct: 240 YDLMNLCWTYDVENRPGFAAV 260

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 111 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 281
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 341 AELLERCWQQDPALRPDFSEI 361
            +L+  CW  D   RP F+ +
Sbjct: 244 YDLMNLCWTYDVENRPGFAAV 264

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 142/258 (55%), Gaps = 15/258 (5%)
Query: 110 EIDPKHLKFGSKV--ASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMR 166
           E D ++ + G +V    G+YG +Y G   S  V I + + PER +S   +   +E+ + +
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHK 60
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKG 224
            ++HKN+VQ++G+ ++   + I  E + GGS+   L    G  K    ++      + +G
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 225 MNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEV 282
           + YLH N I+HRD+K  N+L++  + V+K++DFG + R+   +      TGT ++MAPE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 180
Query: 283 IEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIPKNSQ 337
           I+  P  Y   AD++S G  + E+ TGK P+  L   QAA   VG+ +  + P IP++  
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMS 238
Query: 338 PKLAELLERCWQQDPALR 355
            +    + +C++ DP  R
Sbjct: 239 AEAKAFILKCFEPDPDKR 256

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 23/279 (8%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 165
           I  +    G  +  G +G +       +D     VA+K+LK + I S   +EF +E   M
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 166 RKVRHKNVVQFIGACTKP------PSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SL 214
           ++  H +V + +G   +       P   ++  FM  G ++ +L   +     F LP  +L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----TA 270
           ++  +D++ GM YL   N IHRDL A N ++ E+  V VADFG++R K  SG       A
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-KIYSGDYYRQGCA 198
Query: 271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 329
                +W+A E +    Y   +DV++FG+ +WE++T G+ PY  +   +    ++  G R
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GGNR 257
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              P     ++ +L+ +CW  DP  RP F+ +   L+ I
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 127/248 (51%), Gaps = 10/248 (4%)
Query: 121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GSYG +Y+  +    Q VAIK +    + SD+Q E  +E+ IM++    +VV++ G
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQ-EIIKEISIMQQCDSPHVVKYYG 91
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +  K   L IV E+   GSV D +           +  +     KG+ YLH    IHRD+
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           KA N+L++     K+ADFGVA ++           GT  WMAPEVI+   Y+  AD++S 
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALR 355
           GI   E+  GK PY  + P++ A+ ++     PT   P+       + +++C  + P  R
Sbjct: 212 GITAIEMAEGKPPYADIHPMR-AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
Query: 356 PDFSEIIE 363
              +++++
Sbjct: 271 ATATQLLQ 278

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 114 KHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q++F +E+ I++ 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKA 64
Query: 168 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +    +V++ G    P  P L +V E++  G + D+L + +       LL  +  + KGM
Sbjct: 65  LHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 281
            YL     +HRDL A N+L++    VK+ADFG+A++    K    V         W APE
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV---------VQKG 327
            +    +  ++DV+SFG+VL+EL T          E+L  +     V         +++G
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 244
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
            R   P     ++ EL++ CW   P  RP FS +
Sbjct: 245 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 136/291 (46%), Gaps = 29/291 (9%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 158
           G+D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDF 58
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
            +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 272
               + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V     
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA-------- 319
               W APE +    +   +DV+SFG+VL+EL T        P E++  +          
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 320 --AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 136/291 (46%), Gaps = 29/291 (9%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 158
           G+D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDF 58
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
            +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----GVMTAET 272
               + KGM YL     IHRDL   N+L++    VK+ DFG+ +V  Q      V     
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA-------- 319
               W APE +    +   +DV+SFG+VL+EL T        P E++  +          
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 320 --AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 73
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 131
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 132 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 191
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 250
Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC + D   R    E+I+
Sbjct: 251 LNRCLEMDVEKRGSAKELIQ 270

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 68
Query: 182 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 231
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 232 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 283
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 284 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 322
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 245
Query: 323 VVQKGLRPTIPKNSQPK-----LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 246 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 298

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 93
Query: 182 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 231
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 232 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 283
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 284 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 322
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 270
Query: 323 VVQKGLRPTIPKNSQPK-----LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 271 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 323

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 137/295 (46%), Gaps = 29/295 (9%)
Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDM 154
           +P    ++ + + +HLKF  ++  G++G +    Y        + VA+K L  +    + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEH 72
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLP 212
            ++F +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVM 268
            LL+    + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V 
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---- 319
                   W APE +    +   +DV+SFG+VL+EL T        P E++  +      
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 320 ------AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                  + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 157/331 (47%), Gaps = 54/331 (16%)
Query: 88  EDTGMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIK 143
           E T +K   Y +     G+     V     + +     +  G +G+++RG +  ++VA+K
Sbjct: 12  EGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVK 71
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVY 199
           +       S  ++    E++    +RH+N++ FI A  K       L +V+++   GS++
Sbjct: 72  IFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 128
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVV 251
           DYL++      +  ++K+A+  + G+ +LH           I HRDLK+ N+L+ +N   
Sbjct: 129 DYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186
Query: 252 KVADFGVARVKAQSGVMTAE------TGTYRWMAPEVIE------HKPYDHKADVFSFGI 299
            +AD G+A V+  S   T +       GT R+MAPEV++      H     +AD+++ G+
Sbjct: 187 CIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245
Query: 300 VLWEL-----LTG-----KLPYEYLTPLQAAVG-----VVQKGLRPTIPKNSQPK----- 339
           V WE+     + G     +LPY  L P   +V      V ++ LRP IP   Q       
Sbjct: 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 305
Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           +A+++  CW  + A R     I + L Q+++
Sbjct: 306 MAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 137/295 (46%), Gaps = 29/295 (9%)
Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDM 154
           +P    ++ + + +HLKF  ++  G++G +    Y        + VA+K L  +    + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEH 72
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLP 212
            ++F +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVM 268
            LL+    + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V 
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---- 319
                   W APE +    +   +DV+SFG+VL+EL T        P E++  +      
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 320 ------AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                  + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 67
Query: 182 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 231
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 232 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 283
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 284 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 322
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 323 VVQKGLRPTIPKNSQPK-----LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 123/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VAIK++   ++N    ++  +EV IM+ + H N+V+    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L ++ E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL+R    +P  R   
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 259
Query: 359 SEIIE 363
            +I++
Sbjct: 260 EQIMK 264

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 70
Query: 182 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 231
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 232 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 283
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 284 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 322
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 247
Query: 323 VVQKGLRPTIPKNSQPK-----LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 248 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 300

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 144/288 (50%), Gaps = 14/288 (4%)
Query: 81  SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQD 139
           SSP  EP+    +     L++  D  D     P+ +L    K+  GS G +   T  S  
Sbjct: 2   SSPQREPQRVSHEQFRAALQLVVDPGD-----PRSYLDNFIKIGEGSTGIVCIATVRSSG 56
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
             + V K +      ++    EV IMR  +H+NVV+   +      L +V EF+ GG++ 
Sbjct: 57  KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 116
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-V 258
           D +   +       +  V + V + ++ LH   +IHRD+K+ ++L+  +  VK++DFG  
Sbjct: 117 DIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 174
Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 318
           A+V  +        GT  WMAPE+I   PY  + D++S GI++ E++ G+ PY    PL+
Sbjct: 175 AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 234
Query: 319 AAVGVVQKGLRPTIPKN---SQPKLAELLERCWQQDPALRPDFSEIIE 363
            A+ +++  L P + KN     P L   L+R   +DPA R   +E+++
Sbjct: 235 -AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 280

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 73
Query: 182 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 231
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 232 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 283
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 284 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 322
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 250
Query: 323 VVQKGLRPTIPKNSQPK-----LAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 251 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 303

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 134/274 (48%), Gaps = 28/274 (10%)
Query: 114 KHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q++F +E+ I++ 
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKA 67
Query: 168 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +    +V++ G    P   SL +V E++  G + D+L + +       LL  +  + KGM
Sbjct: 68  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 127
Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 281
            YL     +HRDL A N+L++    VK+ADFG+A++    K    V         W APE
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 187
Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV---------VQKG 327
            +    +  ++DV+SFG+VL+EL T          E+L  + +   V         +++G
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEG 247
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
            R   P     ++ EL++ CW   P  RP FS +
Sbjct: 248 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 26/270 (9%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 162
           D WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 37  DFWEI-------IGELGDGAFGKVYK----AQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V     
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 280
             +NYLH N IIHRDLKA N+L   +  +K+ADFGV+  K    +   ++  GT  WMAP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 204
Query: 281 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 333
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQP 263
Query: 334 KNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                   + L++C +++   R   S++++
Sbjct: 264 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 26/270 (9%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 162
           D WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 37  DFWEI-------IGELGDGAFGKVYK----AQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V     
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 280
             +NYLH N IIHRDLKA N+L   +  +K+ADFGV+  K    +   ++  GT  WMAP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDSFIGTPYWMAP 204
Query: 281 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 333
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQP 263
Query: 334 KNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                   + L++C +++   R   S++++
Sbjct: 264 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 123/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VAIK++   ++N    ++  +EV IM+ + H N+V+    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L ++ E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 138
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +      G +    G+  + APE+ + K YD  + DV+S G
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL+R    +P  R   
Sbjct: 199 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 256
Query: 359 SEIIE 363
            +I++
Sbjct: 257 EQIMK 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 31/286 (10%)
Query: 102 PNDGTDVWEIDPKHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQ 155
           P D T   E   +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q
Sbjct: 2   PQDPTIFEE---RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQ 56
Query: 156 KEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 213
           ++F +E+ I++ +    +V++ G    P   SL +V E++  G + D+L + +       
Sbjct: 57  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 116
Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMT 269
           LL  +  + KGM YL     +HRDL A N+L++    VK+ADFG+A++    K    V  
Sbjct: 117 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 176
Query: 270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV- 323
                  W APE +    +  ++DV+SFG+VL+EL T          E+L  +     V 
Sbjct: 177 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 236
Query: 324 --------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
                   +++G R   P     ++ EL++ CW   P  RP FS +
Sbjct: 237 ALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 130
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 190
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC + D   R    E+++
Sbjct: 250 LNRCLEMDVEKRGSAKELLQ 269

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 73
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 131
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHR++K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 132 FLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 191
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 250
Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC + D   R    E+I+
Sbjct: 251 LNRCLEMDVEKRGSAKELIQ 270

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 28/277 (10%)
Query: 111 IDPKHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
            + +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q++F +E+ I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 77
Query: 165 MRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
           ++ +    +V++ G    P   SL +V E++  G + D+L + +       LL  +  + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 278
           KGM YL     +HRDL A N+L++    VK+ADFG+A++    K    V         W 
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV---------V 324
           APE +    +  ++DV+SFG+VL+EL T          E+L  +     V         +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           ++G R   P     ++ EL++ CW   P  RP FS +
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 143/287 (49%), Gaps = 14/287 (4%)
Query: 82  SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQDV 140
           SP  EP+    +     L++  D  D     P+ +L    K+  GS G +   T  S   
Sbjct: 1   SPQREPQRVSHEQFRAALQLVVDPGD-----PRSYLDNFIKIGEGSTGIVCIATVRSSGK 55
Query: 141 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 200
            + V K +      ++    EV IMR  +H+NVV+   +      L +V EF+ GG++ D
Sbjct: 56  LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 115
Query: 201 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VA 259
            +   +       +  V + V + ++ LH   +IHRD+K+ ++L+  +  VK++DFG  A
Sbjct: 116 IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 173
Query: 260 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 319
           +V  +        GT  WMAPE+I   PY  + D++S GI++ E++ G+ PY    PL+ 
Sbjct: 174 QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK- 232
Query: 320 AVGVVQKGLRPTIPKN---SQPKLAELLERCWQQDPALRPDFSEIIE 363
           A+ +++  L P + KN     P L   L+R   +DPA R   +E+++
Sbjct: 233 AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 278

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 130
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC   D   R    E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 137/270 (50%), Gaps = 26/270 (9%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 162
           D WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 37  DFWEI-------IGELGDGAFGKVYK----AQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V     
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 280
             +NYLH N IIHRDLKA N+L   +  +K+ADFGV+  K    +   +   GT  WMAP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDXFIGTPYWMAP 204
Query: 281 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 333
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQP 263
Query: 334 KNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                   + L++C +++   R   S++++
Sbjct: 264 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 17/280 (6%)
Query: 93  KSHPY-HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN 151
           KS  Y H++   D  +VWEI         ++  G++G +Y+               E  +
Sbjct: 4   KSREYEHVRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETKS 56
Query: 152 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
            +  +++  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      
Sbjct: 57  EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE 116
Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 270
           P +  V   + + +N+LH   IIHRDLKA N+LM     +++ADFGV+    ++     +
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 271 ETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 325
             GT  WMAPEV+     +  PYD+KAD++S GI L E+   + P+  L P++  + +  
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA- 235
Query: 326 KGLRPTI--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           K   PT+  P     +  + L+    ++P  RP  ++++E
Sbjct: 236 KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 133/278 (47%), Gaps = 28/278 (10%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 162
           EI    ++F  ++    +G +Y+G          +Q VAIK LK ++    +++EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 63
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 207
            +  +++H NVV  +G  TK   L ++  + S G ++++L                 +K 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQ 264
             + P  + +   ++ GM YL  ++++H+DL   N+L+ +   VK++D G+ R       
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
             ++       RWMAPE I +  +   +D++S+G+VLWE+ + G  PY   +       +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
             + + P  P +    +  L+  CW + P+ RP F +I
Sbjct: 244 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 133/278 (47%), Gaps = 28/278 (10%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 162
           EI    ++F  ++    +G +Y+G          +Q VAIK LK ++    +++EF  E 
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 80
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 207
            +  +++H NVV  +G  TK   L ++  + S G ++++L                 +K 
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQ 264
             + P  + +   ++ GM YL  ++++H+DL   N+L+ +   VK++D G+ R       
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 323
             ++       RWMAPE I +  +   +D++S+G+VLWE+ + G  PY   +       +
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260
Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
             + + P  P +    +  L+  CW + P+ RP F +I
Sbjct: 261 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 112 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 166
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 130
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR 190
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 343
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 344 LERCWQQDPALRPDFSEIIE 363
           L RC   D   R    E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 63
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 10  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 67
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 248 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 296

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 8   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 65
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 246 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 34  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 91
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 2   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 59
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 240 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 7   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 64
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 245 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 293

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 60
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 9   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 66
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 247 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 132/253 (52%), Gaps = 7/253 (2%)
Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHK 171
           H   G  +  G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++++     + P  + +V E++SGG ++DY+ K  G        ++   +  G++Y H++
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY-DH 290
            ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 291 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 350
           + D++S G++L+ LL G LP++    +      +  G+  T P+   P +  LL+   Q 
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYT-PQYLNPSVISLLKHMLQV 253
Query: 351 DPALRPDFSEIIE 363
           DP  R    +I E
Sbjct: 254 DPMKRATIKDIRE 266

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 9/257 (3%)
Query: 112 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 21  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 80
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V + ++ LH 
Sbjct: 81  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHA 138
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +        GT  WMAPE+I   PY 
Sbjct: 139 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN---SQPKLAELLER 346
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P + KN     P L   L+R
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDR 256
Query: 347 CWQQDPALRPDFSEIIE 363
              +DPA R   +E+++
Sbjct: 257 LLVRDPAQRATAAELLK 273

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 1   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 58
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 143/287 (49%), Gaps = 14/287 (4%)
Query: 82  SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQDV 140
           SP  EP+    +     L++  D  D     P+ +L    K+  GS G +   T  S   
Sbjct: 46  SPQREPQRVSHEQFRAALQLVVDPGD-----PRSYLDNFIKIGEGSTGIVCIATVRSSGK 100
Query: 141 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 200
            + V K +      ++    EV IMR  +H+NVV+   +      L +V EF+ GG++ D
Sbjct: 101 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 160
Query: 201 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VA 259
            +   +       +  V + V + ++ LH   +IHRD+K+ ++L+  +  VK++DFG  A
Sbjct: 161 IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218
Query: 260 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 319
           +V  +        GT  WMAPE+I   PY  + D++S GI++ E++ G+ PY    PL+ 
Sbjct: 219 QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK- 277
Query: 320 AVGVVQKGLRPTIPKN---SQPKLAELLERCWQQDPALRPDFSEIIE 363
           A+ +++  L P + KN     P L   L+R   +DPA R   +E+++
Sbjct: 278 AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 9/257 (3%)
Query: 112 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 17  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V + ++ LH 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHA 134
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +        GT  WMAPE+I   PY 
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN---SQPKLAELLER 346
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P + KN     P L   L+R
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDR 252
Query: 347 CWQQDPALRPDFSEIIE 363
              +DPA R   +E+++
Sbjct: 253 LLVRDPAQRATAAELLK 269

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        + A  G   + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 359 SEIIE 363
            +I++
Sbjct: 259 EQIMK 263

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 157
           H++   D  +VWEI         ++  G++G +Y+               E  + +  ++
Sbjct: 2   HVRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 54
Query: 158 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
           +  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      P +  V
Sbjct: 55  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 114
Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYR 276
              + + +N+LH   IIHRDLKA N+LM     +++ADFGV+    ++     +  GT  
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 277 WMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
           WMAPEV+     +  PYD+KAD++S GI L E+   + P+  L P++  + +  K   PT
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPT 233
Query: 332 I--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           +  P     +  + L+    ++P  RP  ++++E
Sbjct: 234 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 267

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 6   DPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 63
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ EF+  GS+ +YL K K       LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 274
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 165
           W+   + LK   ++  G+YG + +  +    Q +A+K ++   ++   QK+   ++  +M
Sbjct: 17  WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVM 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHK-LKGVFKLPSLLKVAIDVS 222
           R      +VQF GA  +     I  E MS      Y Y++  L  V     L K+ +   
Sbjct: 76  RSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 223 KGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           K +N+L +N  IIHRD+K +N+L+D +  +K+ DFG++     S   T + G   +MAPE
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 282 VIE----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 337
            I+     + YD ++DV+S GI L+EL TG+ PY     +   +  V KG  P +  + +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 338 ----PKLAELLERCWQQDPALRPDFSEIIE 363
               P     +  C  +D + RP + E+++
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 134/255 (52%), Gaps = 11/255 (4%)
Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHK 171
           H   G  +  G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++++     + P    +V E++SGG ++DY+ K   V ++ +  ++   +   ++Y H++
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRH 130
Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH- 290
            ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 291 KADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
           + D++S G++L+ LL G LP+  E++  L   +    +G    IP+     +A LL    
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPEYLNRSVATLLMHML 246
Query: 349 QQDPALRPDFSEIIE 363
           Q DP  R    +I E
Sbjct: 247 QVDPLKRATIKDIRE 261

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 9/257 (3%)
Query: 112 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 170
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 207
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V + ++ LH 
Sbjct: 208 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHA 265
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +        GT  WMAPE+I   PY 
Sbjct: 266 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN---SQPKLAELLER 346
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P + KN     P L   L+R
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDR 383
Query: 347 CWQQDPALRPDFSEIIE 363
              +DPA R   +E+++
Sbjct: 384 LLVRDPAQRATAAELLK 400

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 359 SEIIE 363
            +I++
Sbjct: 259 EQIMK 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 359 SEIIE 363
            +I++
Sbjct: 259 EQIMK 263

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 134/255 (52%), Gaps = 11/255 (4%)
Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHK 171
           H   G  +  G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++++     + P    +V E++SGG ++DY+ K   V ++ +  ++   +   ++Y H++
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRH 130
Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH- 290
            ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 291 KADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
           + D++S G++L+ LL G LP+  E++  L   +    +G    IP+     +A LL    
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPEYLNRSVATLLMHML 246
Query: 349 QQDPALRPDFSEIIE 363
           Q DP  R    +I E
Sbjct: 247 QVDPLKRATIKDIRE 261

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVA-HGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 133
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 134 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 193
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 194 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 251
Query: 359 SEIIE 363
            +I++
Sbjct: 252 EQIMK 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 131/262 (50%), Gaps = 9/262 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 161
           G+  W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S    A  GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE 179
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 237
Query: 342 ELLERCWQQDPALRPDFSEIIE 363
           +L+ R  + +P+ RP   E++E
Sbjct: 238 DLISRLLKHNPSQRPMLREVLE 259

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 157
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRDHRDVAVKVLR-----ADLARD 52
Query: 158 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 207
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
                  ++V  D  + +N+ HQN IIHRD+K AN+L+     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGN 171
Query: 268 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 320
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA++++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 359 SEIIE 363
            +I++
Sbjct: 259 EQIMK 263

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 141/292 (48%), Gaps = 50/292 (17%)
Query: 123 ASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 182
           A G +G +++    ++ VA+K+  P +     Q E+  EV+ +  ++H+N++QFIGA  +
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 183 PPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------- 231
             S    L ++T F   GS+ D+L     V     L  +A  +++G+ YLH++       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 232 ---NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIE 284
               I HRD+K+ N+L+  N    +ADFG+A +K ++G    +T    GT R+MAPEV+E
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 285 -----HKPYDHKADVFSFGIVLWELLTGKLPY-----EYLTPLQAAVG-----------V 323
                 +    + D+++ G+VLWEL +          EY+ P +  +G           V
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV 266
Query: 324 VQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V K  RP +    Q       L E +E CW  D   R     + E + Q+ +
Sbjct: 267 VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 157
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRLHRDVAVKVLR-----ADLARD 52
Query: 158 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 207
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 268 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 320
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 157
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRLHRDVAVKVLR-----ADLARD 52
Query: 158 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 207
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 268 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 320
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKV 192
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 251 SQRPXLREVLE 261

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 4   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 61
Query: 161 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----GVMTAETGT 274
             + KGM YL     IHR+L   N+L++    VK+ DFG+ +V  Q      V       
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 319
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 242 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA++++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 358
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 359 SEIIE 363
            +I++
Sbjct: 259 EQIMK 263

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 125/246 (50%), Gaps = 12/246 (4%)
Query: 122 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G +   T+    Q VA+K +  + +  SDM     +E+  ++ +RH ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
             T P  + +V E+ +GG ++DY+ + K + +     +    +   + Y H++ I+HRDL
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRHKIVHRDL 134
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 297
           K  NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 298 GIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           GIVL+ +L G+LP+  E++  L   V          +P    P    L+ R    DP  R
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKVN----SCVYVMPDFLSPGAQSLIRRMIVADPMQR 250
Query: 356 PDFSEI 361
               EI
Sbjct: 251 ITIQEI 256

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 161
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE 176
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 342 ELLERCWQQDPALRPDFSEIIE 363
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 161
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE 176
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 342 ELLERCWQQDPALRPDFSEIIE 363
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 122 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           +  G +G +Y+G       VA+K LK ER     + +F  EV ++    H+N+++  G C
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN---NII 234
             P    +V  +M+ GSV   L +    +     P   ++A+  ++G+ YLH +    II
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           HRD+KAAN+L+DE     V DFG+A++       V  A  GT   +APE +       K 
Sbjct: 165 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKT 224
Query: 293 DVFSFGIVLWELLTGKLPYEY-----------------LTPLQAAVGVVQKGLRPTIPKN 335
           DVF +G++L EL+TG+  ++                  L   +    +V   L+      
Sbjct: 225 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 284
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
              +L ++   C Q  P  RP  SE++ +L+
Sbjct: 285 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 145
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 204
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 205 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 262
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 263 SQRPMLREVLE 273

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 127
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 186
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 187 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 244
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 245 SQRPMLREVLE 255

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 100/184 (54%), Gaps = 2/184 (1%)
Query: 130 LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 189
           L R     ++VA+K++   ++NS   ++  +EV I + + H N+V+         +L +V
Sbjct: 32  LARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLV 91
Query: 190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLKA NLL+D + 
Sbjct: 92  XEYASGGEVFDYLVA-HGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADX 150
Query: 250 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFGIVLWELLTGK 308
            +K+ADFG +        + A  G   + APE+ + K YD  + DV+S G++L+ L++G 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210
Query: 309 LPYE 312
           LP++
Sbjct: 211 LPFD 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 132
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 192 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 249
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 250 SQRPMLREVLE 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 161
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE 176
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 342 ELLERCWQQDPALRPDFSEIIE 363
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 25/244 (10%)
Query: 91  GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI 150
           G+     H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+    
Sbjct: 13  GLVPRGSHMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRLHRDVAVKVLR---- 63
Query: 151 NSDMQKE------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYD 200
            +D+ ++      F +E      + H  +V     G    P  P   IV E++ G ++ D
Sbjct: 64  -ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 122
Query: 201 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 260
            +H  +G       ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR
Sbjct: 123 IVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 181
Query: 261 VKAQSGVMTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
             A SG    +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P
Sbjct: 182 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241
Query: 317 LQAA 320
           +  A
Sbjct: 242 VSVA 245

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 154
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 213
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  Q     + + +  T P        +L+ R  + +P
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANT-YQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 271
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 272 SQRPMLREVLE 282

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 157
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRDHRDVAVKVLR-----ADLARD 52
Query: 158 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 207
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 268 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 320
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 145/293 (49%), Gaps = 54/293 (18%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGAC 180
           V  G YG+++RG++  ++VA+K+        D +  F + E++    +RH+N++ FI + 
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 181 T----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 229
                    L ++T +   GS+YDYL          S L++ + ++ G+ +LH       
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 230 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 283
            +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R+MAPEV+
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 284 EHK----PYDH--KADVFSFGIVLWE----LLTGKLPYEYLTP-------------LQAA 320
           +       +D   + D+++FG+VLWE    +++  +  +Y  P             ++  
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 278
Query: 321 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQI 368
           V V Q+  RP IP    S P    LA+L++ CW Q+P+ R     I + L +I
Sbjct: 279 VCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 128
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S    A  GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 146/293 (49%), Gaps = 54/293 (18%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGAC 180
           V  G YG+++RG++  ++VA+K+      + D +  F + E++    +RH+N++ FI + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 181 T----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 229
                    L ++T +   GS+YDYL          S L++ + ++ G+ +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 230 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 283
            +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R+MAPEV+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 284 EHK----PYDH--KADVFSFGIVLWE----LLTGKLPYEYLTP-------------LQAA 320
           +       +D   + D+++FG+VLWE    +++  +  +Y  P             ++  
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 321 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQI 368
           V V Q+  RP IP    S P    LA+L++ CW Q+P+ R     I + L +I
Sbjct: 250 VCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 146/293 (49%), Gaps = 54/293 (18%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGAC 180
           V  G YG+++RG++  ++VA+K+      + D +  F + E++    +RH+N++ FI + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 181 T----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 229
                    L ++T +   GS+YDYL          S L++ + ++ G+ +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 230 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 283
            +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R+MAPEV+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 284 EHK----PYDH--KADVFSFGIVLWE----LLTGKLPYEYLTP-------------LQAA 320
           +       +D   + D+++FG+VLWE    +++  +  +Y  P             ++  
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 321 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQI 368
           V V Q+  RP IP    S P    LA+L++ CW Q+P+ R     I + L +I
Sbjct: 250 VCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 263
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 264 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 305 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 192
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 128
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLYRGTYCSQD--VAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y      +   +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 125
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 184
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 185 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 242
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 243 SQRPMLREVLE 253

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 130/253 (51%), Gaps = 20/253 (7%)
Query: 121 KVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 177
           K+  GS G   L R  +  + VA+K++    +    ++E    EV IMR  +H NVV+  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +      L ++ EF+ GG++ D + +++       +  V   V + + YLH   +IHRD
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 238 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           +K+ ++L+  +  VK++DFG  A++           GT  WMAPEVI    Y  + D++S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQ---PKLAELLERCWQQ 350
            GI++ E++ G+ PY   +P+QA      K LR + P   KNS    P L + LER   +
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 351 DPALRPDFSEIIE 363
           DP  R    E+++
Sbjct: 282 DPQERATAQELLD 294

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 263
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 264 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 314 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 263
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 264 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 263
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 264 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 312 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 133/272 (48%), Gaps = 14/272 (5%)
Query: 99  LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDM 154
           LK P+     ++ DP+ L F    ++  GS+G +Y  R    S+ VAIK +      S+ 
Sbjct: 38  LKDPDVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 96
Query: 155 Q-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 213
           + ++  +EV  ++K+RH N +Q+ G   +  +  +V E+  G S  D L   K   +   
Sbjct: 97  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 155
Query: 214 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 273
           +  V     +G+ YLH +N+IHRD+KA N+L+ E  +VK+ DFG A + A +       G
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VG 212
Query: 274 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 330
           T  WMAPEVI   +   YD K DV+S GI   EL   K P   +  + A   + Q     
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 272
Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
               +        ++ C Q+ P  RP  SE++
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVL 303

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG +   A S   T  +GT  ++ PE+IE + +D K 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKV 188
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 247 SQRPMLREVLE 257

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 53/279 (18%)
Query: 123 ASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 182
           A G +G +++    +  VA+K+  P +     Q E  +E+F    ++H+N++QFI A  +
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIF-PLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKR 80
Query: 183 PPSL----CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN------ 231
             +L     ++T F   GS+ DYL   KG +     L  VA  +S+G++YLH++      
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 232 -----NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEV 282
                +I HRD K+ N+L+  +    +ADFG+A V+ + G    +T    GT R+MAPEV
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 283 IE-----HKPYDHKADVFSFGIVLWELLT----GKLPY-EYLTPLQAAVG---------- 322
           +E      +    + D+++ G+VLWEL++       P  EY+ P +  +G          
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQE 256
Query: 323 -VVQKGLRPTIPKN--SQPKLAEL---LERCWQQDPALR 355
            VV K +RPTI  +    P LA+L   +E CW  D   R
Sbjct: 257 VVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 247 SQRPMLREVLE 257

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 203
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 53  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 106
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 262
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 107 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 225
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 226 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 203
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 55  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 108
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 262
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 109 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 168
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 169 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 227
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 228 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKK 128
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S    A  GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  Q     + + +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANT-YQDTYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 203
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 77  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 130
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 262
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 131 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 190
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 191 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 249
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 250 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 203
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 59  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 112
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 262
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 113 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 172
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 173 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 231
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 232 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 128
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 203
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 55  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 108
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 262
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 109 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 168
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 169 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 227
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 228 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 144 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 203
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 79  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 132
Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 262
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 251
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 362
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 252 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 104/194 (53%), Gaps = 4/194 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G++    L R     ++VA+K++   ++N    ++  +EV IM+ + H N+V+    
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLK 141
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 298
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 142 AENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 299 IVLWELLTGKLPYE 312
           ++L+ L++G LP++
Sbjct: 202 VILYTLVSGSLPFD 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+A+FG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 161
           G+  W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE 179
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 237
Query: 342 ELLERCWQQDPALRPDFSEIIE 363
           +L+ R  + +P+ RP   E++E
Sbjct: 238 DLISRLLKHNPSQRPMLREVLE 259

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 10/213 (4%)
Query: 121 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+ SG+YG+  L R      + AIK+++   +++    +  +EV +++ + H N+++   
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 179 ACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                 +  +V E   GG ++D  +H++K  F       +   V  G+ YLH++NI+HRD
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 238 LKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 294
           LK  NLL++  E   ++K+ DFG++ V      M    GT  ++APEV+  K YD K DV
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDV 220
Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 327
           +S G++L+ LL G  P+   T  Q  +  V+KG
Sbjct: 221 WSIGVILFILLAGYPPFGGQTD-QEILRKVEKG 252

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 133/287 (46%), Gaps = 25/287 (8%)
Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQ---KEFAQEV 162
           D  + + +HLKF  ++  G++G +    Y   QD   +V+  +++    +   ++F +E+
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 65
Query: 163 FIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
            I++ ++H N+V++ G C      +L ++ E++  GS+ DYL           LL+    
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ 125
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYR 276
           + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V         
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA----------AV 321
           W APE +    +   +DV+SFG+VL+EL T        P E++  +             +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 246 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 119/233 (51%), Gaps = 25/233 (10%)
Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 157
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRDHRDVAVKVLR-----ADLARD 52
Query: 158 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 207
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 268 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 130
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+A+FG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 189
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 247
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 248 SQRPMLREVLE 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 129/262 (49%), Gaps = 9/262 (3%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 161
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE 176
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 342 ELLERCWQQDPALRPDFSEIIE 363
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 122/248 (49%), Gaps = 11/248 (4%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 177
           ++  GS+G +Y  R    S+ VAIK +      S+ + ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
           G   +  +  +V E+  G S  D L   K   +   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADV 294
           +KA N+L+ E  +VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 354
           +S GI   EL   K P   +  + A   + Q         +        ++ C Q+ P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 355 RPDFSEII 362
           RP  SE++
Sbjct: 258 RPT-SEVL 264

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 27/271 (9%)
Query: 122 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           +  G +G +Y+G       VA+K LK ER     + +F  EV ++    H+N+++  G C
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN---NII 234
             P    +V  +M+ GSV   L +    +     P   ++A+  ++G+ YLH +    II
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           HRD+KAAN+L+DE     V DFG+A++       V  A  G    +APE +       K 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKT 216
Query: 293 DVFSFGIVLWELLTGKLPYEY-----------------LTPLQAAVGVVQKGLRPTIPKN 335
           DVF +G++L EL+TG+  ++                  L   +    +V   L+      
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
              +L ++   C Q  P  RP  SE++ +L+
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 190
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 124/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKV 192
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 130
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 189
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 247
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 248 SQRPMLREVLE 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 188
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 247 SQRPMLREVLE 257

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 13/261 (4%)
Query: 112 DPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           D + LKF  ++  GS+  +Y+G  T  + +VA   L+  ++    ++ F +E   ++ ++
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ 83
Query: 170 HKNVVQFIGA--CTKPPSLCIV--TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           H N+V+F  +   T     CIV  TE  + G++  YL + K V K+  L      + KG+
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGL 142
Query: 226 NYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
            +LH     IIHRDLK  N+ +      VK+ D G+A +K ++    A  GT  + APE 
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFXAPEX 201
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLA 341
            E K YD   DV++FG    E  T + PY            V  G++P +  K + P++ 
Sbjct: 202 YEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 342 ELLERCWQQDPALRPDFSEII 362
           E++E C +Q+   R    +++
Sbjct: 261 EIIEGCIRQNKDERYSIKDLL 281

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR 154
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 213
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           D++S G++ +E L GK P+E  T  Q     + + +  T P        +L+ R  + +P
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANT-YQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 271
Query: 353 ALRPDFSEIIE 363
           + RP   E++E
Sbjct: 272 SQRPMLREVLE 282

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 135/287 (47%), Gaps = 52/287 (18%)
Query: 114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
           K ++   ++  G YG+++ G +  + VA+KV    E  +   + E  Q V +    RH+N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM----RHEN 92
Query: 173 VVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           ++ FI A  K       L ++T++   GS+YDYL          S+LK+A     G+ +L
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHL 150
Query: 229 HQN--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM------TAETGT 274
           H           I HRDLK+ N+L+ +N    +AD G+A VK  S             GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTRVGT 209
Query: 275 YRWMAPEVI-EHKPYDH-----KADVFSFGIVLWEL----LTG------KLPYEYLTPLQ 318
            R+M PEV+ E    +H      AD++SFG++LWE+    ++G      +LPY  L P  
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 319 AAVG-----VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALR 355
            +       V  K LRP+ P          ++ +L+  CW  +PA R
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 130/249 (52%), Gaps = 14/249 (5%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  + +V E+ +G  ++DY+ +   + +  +  +    +   + Y H++ I+HRDL
Sbjct: 76  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKIVHRDL 133
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 297
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 134 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 193
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 354
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 194 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 248
Query: 355 RPDFSEIIE 363
           R    EI++
Sbjct: 249 RISIHEIMQ 257

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 128/249 (51%), Gaps = 14/249 (5%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  + +V E+ +G  ++DY+ + +         +    +   + Y H++ I+HRDL
Sbjct: 72  VIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 129
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 297
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 130 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 189
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 354
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 190 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 244
Query: 355 RPDFSEIIE 363
           R    EI++
Sbjct: 245 RISIHEIMQ 253

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 128/249 (51%), Gaps = 14/249 (5%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  + +V E+ +G  ++DY+ + +         +    +   + Y H++ I+HRDL
Sbjct: 81  VIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 138
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 297
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 139 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 354
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 199 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 253
Query: 355 RPDFSEIIE 363
           R    EI++
Sbjct: 254 RISIHEIMQ 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 128/249 (51%), Gaps = 14/249 (5%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  + +V E+ +G  ++DY+ + +         +    +   + Y H++ I+HRDL
Sbjct: 82  VIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 139
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 297
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 140 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 199
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 354
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 200 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 254
Query: 355 RPDFSEIIE 363
           R    EI++
Sbjct: 255 RISIHEIMQ 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 119/237 (50%), Gaps = 8/237 (3%)
Query: 122 VASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           + +GS+G   L R  +  +  A+KVLK E +    Q E    E  ++  V H  +++  G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  + ++ +++ GG ++  L K +  F  P     A +V   + YLH  +II+RDL
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDL 132
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 298
           K  N+L+D+N  +K+ DFG A  K    V     GT  ++APEV+  KPY+   D +SFG
Sbjct: 133 KPENILLDKNGHIKITDFGFA--KYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFG 190
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           I+++E+L G  P+     ++    ++   LR   P      + +LL R   +D + R
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 112 DPK-HLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRK 167
           DP+ +L    K+  GS G +   T  +  + VA+K +    +    ++E    EV IMR 
Sbjct: 42  DPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRD 98
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
             H NVV    +      L +V EF+ GG++ D +   +       +  V + V + ++Y
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSY 156
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           LH   +IHRD+K+ ++L+  +  +K++DFG  A+V  +        GT  WMAPEVI   
Sbjct: 157 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL 216
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 319
           PY  + D++S GI++ E++ G+ PY    PLQA
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 249

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 124/248 (50%), Gaps = 7/248 (2%)
Query: 119 GSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N+++
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
             G       + ++ E+   G+VY  L KL   F          +++  ++Y H   +IH
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           RD+K  NLL+  N  +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 194
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           S G++ +E L G  P+E  T  +    + +  +  T P        +L+ R  + + + R
Sbjct: 195 SLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 356 PDFSEIIE 363
              +E++E
Sbjct: 253 LTLAEVLE 260

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 122 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                S  IV E  +GG ++D + K K  F      ++   V  G+ Y+H++NI+HRDLK
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 240 AANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
             N+L++  E    +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWS 207
Query: 297 FGIVLWELLTGKLPY 311
            G++L+ LL+G  P+
Sbjct: 208 AGVILYILLSGTPPF 222

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 129/260 (49%), Gaps = 17/260 (6%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIK-VLKPERINSDMQKEFAQEVFI 164
           + +I  +  K   K+  G    +Y    T  +  VAIK +  P R   +  K F +EV  
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
             ++ H+N+V  I    +     +V E++ G ++ +Y+    G   + + +     +  G
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDG 123
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE--TGTYRWMAPEV 282
           + + H   I+HRD+K  N+L+D N+ +K+ DFG+A+  +++ +       GT ++ +PE 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------LRPTIPKN 335
            + +  D   D++S GIVL+E+L G+ P+   T +  A+  +Q         +R  IP++
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 336 SQPKLAELLERCWQQDPALR 355
               L+ ++ R  ++D A R
Sbjct: 244 ----LSNVILRATEKDKANR 259

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 15/260 (5%)
Query: 112 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 168
           D     F   + SG++G   L R     + VA+K + +   I+ ++Q+E        R +
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH----RSL 73
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           RH N+V+F      P  L I+ E+ SGG +Y+ +    G F           +  G++Y 
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYC 132
Query: 229 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           H   I HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  +
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 287 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQ--PKLA 341
            YD K ADV+S G+ L+ +L G  P+E     +     +Q+   ++ +IP + +  P+  
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252
Query: 342 ELLERCWQQDPALRPDFSEI 361
            L+ R +  DPA R    EI
Sbjct: 253 HLISRIFVADPATRISIPEI 272

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 122 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                S  IV E  +GG ++D + K K  F      ++   V  G+ Y+H++NI+HRDLK
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 240 AANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
             N+L++  E    +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWS 207
Query: 297 FGIVLWELLTGKLPY 311
            G++L+ LL+G  P+
Sbjct: 208 AGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 122 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                S  IV E  +GG ++D + K K  F      ++   V  G+ Y+H++NI+HRDLK
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 240 AANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
             N+L++  E    +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWS 207
Query: 297 FGIVLWELLTGKLPY 311
            G++L+ LL+G  P+
Sbjct: 208 AGVILYILLSGTPPF 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 114 KHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVR 169
           K   F   + SG++ +++  +     +  A+K +K  P   +S ++ E A    +++K++
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIA----VLKKIK 64
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H+N+V             +V + +SGG ++D + + +GV+       V   V   + YLH
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLH 123
Query: 230 QNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           +N I+HRDLK  NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  K
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQK 182
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
           PY    D +S G++ + LL G  P+
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 112 DPKHLKFGSKVASGSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQ 160
           DP   +    +  GS+G ++      G+   Q  A+KVLK       +R+ + M+++   
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--- 78
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
              I+ +V H  +V+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 79  ---ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 279
           ++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           PEV+  + +   AD +SFG++++E+LTG LP++     +    +++  L   +P+   P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPE 252
Query: 340 LAELLERCWQQDPALR 355
              LL   ++++PA R
Sbjct: 253 AQSLLRMLFKRNPANR 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 112 DPKHLKFGSKVASGSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQ 160
           DP   +    +  GS+G ++      G+   Q  A+KVLK       +R+ + M+++   
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--- 79
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
              I+ +V H  +V+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 80  ---ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 135
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 279
           ++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           PEV+  + +   AD +SFG++++E+LTG LP++     +    +++  L   +P+   P+
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPE 253
Query: 340 LAELLERCWQQDPALR 355
              LL   ++++PA R
Sbjct: 254 AQSLLRMLFKRNPANR 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 112 DPKHLKFGSKVASGSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQ 160
           DP   +    +  GS+G ++      G+   Q  A+KVLK       +R+ + M+++   
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--- 78
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
              I+ +V H  +V+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 79  ---ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 279
           ++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           PEV+  + +   AD +SFG++++E+LTG LP++     +    +++  L   +P+   P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPE 252
Query: 340 LAELLERCWQQDPALR 355
              LL   ++++PA R
Sbjct: 253 AQSLLRMLFKRNPANR 268

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 123/248 (49%), Gaps = 7/248 (2%)
Query: 119 GSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N+++
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
             G       + ++ E+   G+VY  L KL   F          +++  ++Y H   +IH
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           RD+K  NLL+  N  +K+ADFG + V A S       GT  ++ PE+IE + +D K D++
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLW 194
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           S G++ +E L G  P+E  T  +    + +  +  T P        +L+ R  + + + R
Sbjct: 195 SLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 356 PDFSEIIE 363
              +E++E
Sbjct: 253 LTLAEVLE 260

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 138/268 (51%), Gaps = 25/268 (9%)
Query: 112 DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKP------ERINSDMQKEFAQ 160
           DP H +    +  GS+G ++     ++       A+KVLK       +R+ + M+++   
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD--- 82
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
              I+  V H  VV+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 83  ---ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 138
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMA 279
           ++ G+++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           PEV+  + + H AD +S+G++++E+LTG LP++     +    +++  L   +P+    +
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKL--GMPQFLSTE 256
Query: 340 LAELLERCWQQDPALR----PDFSEIIE 363
              LL   ++++PA R    PD +E I+
Sbjct: 257 AQSLLRALFKRNPANRLGSGPDGAEEIK 284

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 114 KHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           K  +F   + +G++ +  L       +  A+K + P++     +     E+ ++RK++H+
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCI-PKKALKGKESSIENEIAVLRKIKHE 80
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           N+V        P  L +V + +SGG ++D + + KG +       +   V   + YLH+ 
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVE-KGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 232 NIIHRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
            I+HRDLK  NLL    DE   + ++DFG+++++ +  VM+   GT  ++APEV+  KPY
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY 199
Query: 289 DHKADVFSFGIVLWELLTGKLPY 311
               D +S G++ + LL G  P+
Sbjct: 200 SKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 10/259 (3%)
Query: 111 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 164
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 154
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 283
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL 214
Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 272
Query: 344 LERCWQQDPALRPDFSEII 362
           + R    DP LRP  +E++
Sbjct: 273 IRRMLHADPTLRPSVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 10/259 (3%)
Query: 111 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 164
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 154
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 283
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL 214
Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 272
Query: 344 LERCWQQDPALRPDFSEII 362
           + R    DP LRP  +E++
Sbjct: 273 IRRMLHADPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 10/259 (3%)
Query: 111 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 164
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 20  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 79
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 80  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 138
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVI 283
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A      G    +  GT  ++APEV+
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 198
Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 256
Query: 344 LERCWQQDPALRPDFSEII 362
           + R    DP LRP  +E++
Sbjct: 257 IRRMLHADPTLRPSVAELL 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 10/259 (3%)
Query: 111 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 164
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 154
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVI 283
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A      G    +  GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 214
Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
             K +  + D++S G +L+ LL GK P+E     +  + + +     ++P++  P  + L
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASAL 272
Query: 344 LERCWQQDPALRPDFSEII 362
           + R    DP LRP  +E++
Sbjct: 273 IRRMLHADPTLRPSVAELL 291

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 32/267 (11%)
Query: 122 VASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           +  G +G +Y+G       VA+K   PE  +S   +EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL-------LKVAIDVSKGMNYLHQNNI 233
            +   + ++ ++M  G++  +L+       LP++       L++ I  ++G++YLH   I
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYG----SDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDH 290
           IHRD+K+ N+L+DEN V K+ DFG+++   + G   +     GT  ++ PE         
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 291 KADVFSFGIVLWELLTGK------LPYEYLTPLQAAV-----GVVQKGLRPTIPKNSQP- 338
           K+DV+SFG+VL+E+L  +      LP E +   + AV     G +++ + P +    +P 
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 339 ---KLAELLERCWQQDPALRPDFSEII 362
              K  +   +C       RP   +++
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 129/256 (50%), Gaps = 8/256 (3%)
Query: 113 PKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKV 168
           P    F   +  GS+G +    + +++V  A+KVL+ + I    +++   ++   +++ V
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           +H  +V    +      L  V ++++GG ++ +L + +  F  P     A +++  + YL
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL 155
Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP 287
           H  NI++RDLK  N+L+D    + + DFG+ +   +    T+   GT  ++APEV+  +P
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLE 345
           YD   D +  G VL+E+L G  P+      +    ++ K   L+P I  +++  L  LL+
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 275
Query: 346 RCWQQDPALRPDFSEI 361
           +   +    + DF EI
Sbjct: 276 KDRTKRLGAKDDFMEI 291

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 32/267 (11%)
Query: 122 VASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 180
           +  G +G +Y+G       VA+K   PE  +S   +EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL-------LKVAIDVSKGMNYLHQNNI 233
            +   + ++ ++M  G++  +L+       LP++       L++ I  ++G++YLH   I
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYG----SDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKA---QSGVMTAETGTYRWMAPEVIEHKPYDH 290
           IHRD+K+ N+L+DEN V K+ DFG+++      Q+ +     GT  ++ PE         
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 291 KADVFSFGIVLWELLTGK------LPYEYLTPLQAAV-----GVVQKGLRPTIPKNSQP- 338
           K+DV+SFG+VL+E+L  +      LP E +   + AV     G +++ + P +    +P 
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 339 ---KLAELLERCWQQDPALRPDFSEII 362
              K  +   +C       RP   +++
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 125/258 (48%), Gaps = 31/258 (12%)
Query: 122 VASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           + +G++G   L R    ++ VA+K + + E+I+ ++++E        R +RH N+V+F  
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
               P  L IV E+ SGG +++ +    G F           +  G++Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYAHAMQVAHRDL 141
Query: 239 KAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
           K  N L+D +    +K+ADFG ++         +  GT  ++APEV+  K YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQ----------PKLAEL 343
           S G+ L+ +L G  P+E   P +       K  R TI +  N Q          P+   L
Sbjct: 202 SCGVTLYVMLVGAYPFE--DPEEP------KNFRKTIHRILNVQYAIPDYVHISPECRHL 253
Query: 344 LERCWQQDPALRPDFSEI 361
           + R +  DPA R    EI
Sbjct: 254 ISRIFVADPAKRISIPEI 271

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 126/268 (47%), Gaps = 31/268 (11%)
Query: 112 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 168
           D    +    + SG++G   L R    ++ VA+K + + E+I+ ++++E        R +
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 71
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           RH N+V+F      P  L IV E+ SGG +++ +    G F           +  G++Y 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 130
Query: 229 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           H   + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 287 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQ------ 337
            YD K ADV+S G+ L+ +L G  P+E   P +       K  R TI +  N Q      
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEP------KNFRKTIHRILNVQYAIPDY 242
Query: 338 ----PKLAELLERCWQQDPALRPDFSEI 361
               P+   L+ R +  DPA R    EI
Sbjct: 243 VHISPECRHLISRIFVADPAKRISIPEI 270

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 123/250 (49%), Gaps = 15/250 (6%)
Query: 122 VASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           + SG++G   L R    ++ VA+K + + E+I +++++E        R +RH N+V+F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
               P  L IV E+ SGG +++ +    G F           +  G++Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 239 KAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
           K  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK--NSQPKLAELLERCWQQD 351
           S G+ L+ +L G  P+E     +     + +   ++  IP   +  P+   L+ R +  D
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD 261
Query: 352 PALRPDFSEI 361
           PA R    EI
Sbjct: 262 PAKRISIPEI 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 121 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQK-EFAQEVFIMRKVRHKNVVQFI 177
           K+ SG+YG+  L +      + AIK++K   + +         EV +++++ H N+++  
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  +  +V E   GG ++D +  L+  F       +   V  G  YLH++NI+HRD
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 238 LKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 294
           LK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K DV
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 188
Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 327
           +S G++L+ LL G  P+   T  Q  +  V+KG
Sbjct: 189 WSCGVILYILLCGYPPFGGQTD-QEILKRVEKG 220

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 175
Query: 239 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 176 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 234
Query: 296 SFGIVLWELLTGKLPY 311
           S G++L+ LL+G  P+
Sbjct: 235 STGVILYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 176
Query: 239 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 177 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 235
Query: 296 SFGIVLWELLTGKLPY 311
           S G++L+ LL+G  P+
Sbjct: 236 STGVILYILLSGCPPF 251

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VAIK +  E +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKEALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 256
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYR-----GTYCSQDVAIKVLKPERI--NSDMQKEFAQEV 162
           +I P+  +    +  G YG +++     G    +  A+KVLK   I  N+        E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            I+ +V+H  +V  I A      L ++ E++SGG ++  L + +G+F   +      ++S
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEIS 131
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPE 281
             + +LHQ  II+RDLK  N++++    VK+ DFG+ +     G +T    GT  +MAPE
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++    ++   D +S G +++++LTG  P+
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 239 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 296 SFGIVLWELLTGKLPY 311
           S G++L+ LL+G  P+
Sbjct: 212 STGVILYILLSGCPPF 227

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYR-----GTYCSQDVAIKVLKPERI--NSDMQKEFAQEV 162
           +I P+  +    +  G YG +++     G    +  A+KVLK   I  N+        E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            I+ +V+H  +V  I A      L ++ E++SGG ++  L + +G+F   +      ++S
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEIS 131
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPE 281
             + +LHQ  II+RDLK  N++++    VK+ DFG+ +     G +T    GT  +MAPE
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++    ++   D +S G +++++LTG  P+
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+M GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+M GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 121 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQK-EFAQEVFIMRKVRHKNVVQFI 177
           K+ SG+YG+  L +      + AIK++K   + +         EV +++++ H N+++  
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  +  +V E   GG ++D +  L+  F       +   V  G  YLH++NI+HRD
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 238 LKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 294
           LK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K DV
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 205
Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 327
           +S G++L+ LL G  P+   T  Q  +  V+KG
Sbjct: 206 WSCGVILYILLCGYPPFGGQTD-QEILKRVEKG 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 25/267 (9%)
Query: 115 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ----KEFAQEVFIMRKV 168
           H + G ++ SG +  +   R     ++ A K +K  R++S  +    +E  +EV I+R++
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMN 226
           RH N++           + ++ E +SGG ++D+L + + + +      LK  +D   G++
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVH 122
Query: 227 YLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
           YLH   I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLRPTIPKNS 336
           + ++P   +AD++S G++ + LL+G  P+      E LT + A    V          N+
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA----VNYDFDEEYFSNT 238
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIE 363
                + + R   +DP  R   ++ +E
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLE 265

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 137 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 197 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDL 158
Query: 239 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 159 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 217
Query: 296 SFGIVLWELLTGKLPY 311
           S G++L+ LL+G  P+
Sbjct: 218 STGVILYILLSGCPPF 233

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 135 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 194
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 195 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 111/198 (56%), Gaps = 10/198 (5%)
Query: 122 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 175
           +  GS+G +     +GT   +  AIK+LK + +  + D++    ++  +    +   + Q
Sbjct: 27  LGKGSFGKVMLADRKGT--EELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQ 84
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                     L  V E+++GG +  ++ ++ G FK P  +  A ++S G+ +LH+  II+
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+++D    +K+ADFG+ +     GV T E  GT  ++APE+I ++PY    D 
Sbjct: 144 RDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 295 FSFGIVLWELLTGKLPYE 312
           +++G++L+E+L G+ P++
Sbjct: 204 WAYGVLLYEMLAGQPPFD 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VAIK +  E +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKEALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 256
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VAIK +  E +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 256
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 25/267 (9%)
Query: 115 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ----KEFAQEVFIMRKV 168
           H + G ++ SG +  +   R     ++ A K +K  R++S  +    +E  +EV I+R++
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMN 226
           RH N++           + ++ E +SGG ++D+L + + + +      LK  +D   G++
Sbjct: 73  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVH 129
Query: 227 YLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
           YLH   I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE+
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLRPTIPKNS 336
           + ++P   +AD++S G++ + LL+G  P+      E LT + A    V          N+
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA----VNYDFDEEYFSNT 245
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIE 363
                + + R   +DP  R   ++ +E
Sbjct: 246 SELAKDFIRRLLVKDPKRRMXIAQSLE 272

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 148/309 (47%), Gaps = 18/309 (5%)
Query: 54  EETEQLRAALEKEVLKLERQGWPS--HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 111
           EE E+   A++     L++Q       RS SP+   +++G +     L  P     + E 
Sbjct: 94  EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPS---DNSGAEEMEVSLAKPKHRVTMNEF 150
Query: 112 DPKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV 168
           +  +LK    +  G++G   L +     +  A+K+LK E I + D       E  +++  
Sbjct: 151 E--YLKL---LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           RH  +     +      LC V E+ +GG ++ +L + + VF          ++   ++YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL 264
Query: 229 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHK 286
           H + N+++RDLK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
            Y    D +  G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL  
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSG 382
Query: 347 CWQQDPALR 355
             ++DP  R
Sbjct: 383 LLKKDPKQR 391

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 148/309 (47%), Gaps = 18/309 (5%)
Query: 54  EETEQLRAALEK--EVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 111
           EE E+   A++   + LK + +     RS SP+   +++G +     L  P     + E 
Sbjct: 97  EEREEWTTAIQTVADGLKKQEEEEMDFRSGSPS---DNSGAEEMEVSLAKPKHRVTMNEF 153
Query: 112 DPKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV 168
           +  +LK    +  G++G   L +     +  A+K+LK E I   D       E  +++  
Sbjct: 154 E--YLKL---LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           RH  +     +      LC V E+ +GG ++ +L + + VF          ++   ++YL
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL 267
Query: 229 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHK 286
           H + N+++RDLK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E  
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
            Y    D +  G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL  
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSG 385
Query: 347 CWQQDPALR 355
             ++DP  R
Sbjct: 386 LLKKDPKQR 394

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 54/295 (18%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA- 179
           V  G YG+++RG +  + VA+K+      + D Q  F + E++    +RH N++ FI + 
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFS----SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 180 ---CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 229
                    L ++T +   GS+YD+L +     +    L++A+  + G+ +LH       
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQR--QTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 230 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 283
            +  I HRD K+ N+L+  N    +AD G+A + +Q             GT R+MAPEV+
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 284 EHKPYDHK------ADVFSFGIVLWELLTGKL----------PYEYLTP-------LQAA 320
           + +            D+++FG+VLWE+    +          P+  + P       ++  
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKV 249
Query: 321 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           V V Q+   PTIP    + P    LA+++  CW  +P+ R     I + LQ+I+ 
Sbjct: 250 VCVDQQT--PTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISN 302

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 128/267 (47%), Gaps = 25/267 (9%)
Query: 115 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ----KEFAQEVFIMRKV 168
           H + G ++ SG +  +   R     ++ A K +K  R+ S  +    +E  +EV I+R++
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMN 226
           RH N++           + ++ E +SGG ++D+L + + + +      LK  +D   G++
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVH 143
Query: 227 YLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
           YLH   I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE+
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLRPTIPKNS 336
           + ++P   +AD++S G++ + LL+G  P+      E LT + A    V          N+
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA----VNYDFDEEYFSNT 259
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIE 363
                + + R   +DP  R   ++ +E
Sbjct: 260 SELAKDFIRRLLVKDPKRRMXIAQSLE 286

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 120/242 (49%), Gaps = 10/242 (4%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 180 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 294
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 295 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D  
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 354 LR 355
            R
Sbjct: 435 RR 436

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 120/242 (49%), Gaps = 10/242 (4%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 180 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 294
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 373
Query: 295 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D  
Sbjct: 374 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 433
Query: 354 LR 355
            R
Sbjct: 434 RR 435

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 27/227 (11%)
Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEF 158
           +P      WE+         ++ +G +G + R  +    + VAIK  + E ++   ++ +
Sbjct: 8   LPTQTCGPWEMK-------ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 59
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSL---------CIVTEFMSGGSVYDYLHKLKGVF 209
             E+ IM+K+ H NVV    A   P  L          +  E+  GG +  YL++ +   
Sbjct: 60  CLEIQIMKKLNHPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116
Query: 210 KLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQ 264
            L    +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
             + T   GT +++APE++E K Y    D +SFG + +E +TG  P+
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 27/227 (11%)
Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEF 158
           +P      WE+         ++ +G +G + R  +    + VAIK  + E ++   ++ +
Sbjct: 9   LPTQTCGPWEMK-------ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 60
Query: 159 AQEVFIMRKVRHKNVVQFIGACTKPPSL---------CIVTEFMSGGSVYDYLHKLKGVF 209
             E+ IM+K+ H NVV    A   P  L          +  E+  GG +  YL++ +   
Sbjct: 61  CLEIQIMKKLNHPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 117
Query: 210 KLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQ 264
            L    +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q
Sbjct: 118 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
             + T   GT +++APE++E K Y    D +SFG + +E +TG  P+
Sbjct: 178 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VAIK +  + +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 256
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 120/242 (49%), Gaps = 10/242 (4%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 180 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 294
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 295 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D  
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 354 LR 355
            R
Sbjct: 435 RR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 120/242 (49%), Gaps = 10/242 (4%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 180 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 294
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 295 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D  
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 354 LR 355
            R
Sbjct: 435 RR 436

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 122/250 (48%), Gaps = 15/250 (6%)
Query: 122 VASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           + SG++G   L R    ++ VA+K + + E+I+ ++++E        R +RH N+V+F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
               P  L IV E+ SGG +++ +    G F           +  G++Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 239 KAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
           K  N L+D +    +K+  FG ++         +  GT  ++APEV+  K YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK--NSQPKLAELLERCWQQD 351
           S G+ L+ +L G  P+E     +     + +   ++  IP   +  P+   L+ R +  D
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD 261
Query: 352 PALRPDFSEI 361
           PA R    EI
Sbjct: 262 PAKRISIPEI 271

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 130/264 (49%), Gaps = 11/264 (4%)
Query: 115 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRH 170
           + +   K+  G + ++YR   C  D     LK  +I    ++  + +  +E+ +++++ H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
            NV+++  +  +   L IV E    G +     +  K K +    ++ K  + +   + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHK 286
           +H   ++HRD+K AN+ +    VVK+ D G+ R   +++    +  GT  +M+PE I   
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 287 PYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELL 344
            Y+ K+D++S G +L+E+   + P Y     L +    +++   P +P +    +L +L+
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 345 ERCWQQDPALRPDFSEIIEILQQI 368
             C   DP  RPD + + ++ +++
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRM 295

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAID 220
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 279
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 335
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 336 SQPKLAELLERCWQQDPALRPDFSE 360
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAID 220
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 279
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 335
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 336 SQPKLAELLERCWQQDPALRPDFSE 360
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAID 220
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 279
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 335
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 336 SQPKLAELLERCWQQDPALRPDFSE 360
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAID 220
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 279
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 335
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 336 SQPKLAELLERCWQQDPALRPDFSE 360
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 127/266 (47%), Gaps = 37/266 (13%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG--- 178
           + SG +G +++  +   D    V+K  + N++  +   +EV  + K+ H N+V + G   
Sbjct: 19  IGSGGFGQVFKAKH-RIDGKTYVIKRVKYNNEKAE---REVKALAKLDHVNIVHYNGCWD 74
Query: 179 -------------ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSK 223
                        + +K   L I  EF   G++  ++ K +G  KL  +L + +   ++K
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQITK 133
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 283
           G++Y+H   +I+RDLK +N+ + + + VK+ DFG+       G      GT R+M+PE I
Sbjct: 134 GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 284 EHKPYDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
             + Y  + D+++ G++L ELL    T     ++ T L+  +          I      K
Sbjct: 194 SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI----------ISDIFDKK 243
Query: 340 LAELLERCWQQDPALRPDFSEIIEIL 365
              LL++   + P  RP+ SEI+  L
Sbjct: 244 EKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  GSY    R  + + ++   V   ++   D  +E      ++R  +H N++       
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + +VTE M GG + D + + K  F       V   ++K + YLH   ++HRDLK +
Sbjct: 87  DGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145
Query: 242 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV+E + YD   D++S
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWS 205
Query: 297 FGIVLWELLTGKLPY 311
            G++L+ +LTG  P+
Sbjct: 206 LGVLLYTMLTGYTPF 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 130
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 191 SCGIVLTAMLAGELPWD 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 121/250 (48%), Gaps = 15/250 (6%)
Query: 122 VASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           + SG++G   L R    ++ VA+K + + E+I+ ++++E        R +RH N+V+F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
               P  L IV E+ SGG +++ +    G F           +  G++Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 239 KAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
           K  N L+D +    +K+  FG ++            GT  ++APEV+  K YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK--NSQPKLAELLERCWQQD 351
           S G+ L+ +L G  P+E     +     + +   ++  IP   +  P+   L+ R +  D
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD 261
Query: 352 PALRPDFSEI 361
           PA R    EI
Sbjct: 262 PAKRISIPEI 271

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 154
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+DE   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 211
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 212 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 119/239 (49%), Gaps = 8/239 (3%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L +     +  A+K+LK E I + D       E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRD 237
           +      LC V E+ +GG ++ +L + + VF          ++   ++YLH + N+++RD
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 135 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 194
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
            G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 195 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 119/239 (49%), Gaps = 8/239 (3%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L +     +  A+K+LK E I + D       E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRD 237
           +      LC V E+ +GG ++ +L + + VF          ++   ++YLH + N+++RD
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 137 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 196
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
            G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 197 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 119/239 (49%), Gaps = 8/239 (3%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G   L +     +  A+K+LK E I + D       E  +++  RH  +     
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRD 237
           +      LC V E+ +GG ++ +L + + VF          ++   ++YLH + N+++RD
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 136 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 195
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
            G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 196 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 50/279 (17%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG--- 178
           + SG +G +++  +   D    V++  + N++  +   +EV  + K+ H N+V + G   
Sbjct: 20  IGSGGFGQVFKAKH-RIDGKTYVIRRVKYNNEKAE---REVKALAKLDHVNIVHYNGCWD 75
Query: 179 --------------------------ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 212
                                     + +K   L I  EF   G++  ++ K +G  KL 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLD 134
Query: 213 SLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
            +L + +   ++KG++Y+H   +IHRDLK +N+ + + + VK+ DFG+       G  T 
Sbjct: 135 KVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQK 326
             GT R+M+PE I  + Y  + D+++ G++L ELL    T     ++ T L+  +     
Sbjct: 195 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI----- 249
Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
                I      K   LL++   + P  RP+ SEI+  L
Sbjct: 250 -----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 8/196 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 178
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+ +   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                    +V E  +GG ++D +   K  F      ++   V  G+ Y H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYXHKNKIVHRDL 152
Query: 239 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           K  NLL++   ++  +++ DFG++     S     + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 296 SFGIVLWELLTGKLPY 311
           S G++L+ LL+G  P+
Sbjct: 212 STGVILYILLSGCPPF 227

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 105/196 (53%), Gaps = 6/196 (3%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +  GS+G +        D   A+K+LK + +  + D++    ++  +    +   + Q  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                   L  V E+++GG +  ++ ++ G FK P  +  A +++ G+ +L    II+RD
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+++D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 297 FGIVLWELLTGKLPYE 312
           FG++L+E+L G+ P+E
Sbjct: 528 FGVLLYEMLAGQAPFE 543

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 105/196 (53%), Gaps = 6/196 (3%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +  GS+G +        D   A+K+LK + +  + D++    ++  +    +   + Q  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                   L  V E+++GG +  ++ ++ G FK P  +  A +++ G+ +L    II+RD
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+++D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 297 FGIVLWELLTGKLPYE 312
           FG++L+E+L G+ P+E
Sbjct: 207 FGVLLYEMLAGQAPFE 222

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 108/197 (54%), Gaps = 8/197 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I   + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 240 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 295
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 296 SFGIVLWELLTGKLPYE 312
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I + V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 162
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 219
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 220 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 102/195 (52%), Gaps = 6/195 (3%)
Query: 122 VASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +  GS+G ++   +   +Q  AIK LK + +  + D++    ++  +     H  +    
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  +L  V E+++GG +  ++      F L      A ++  G+ +LH   I++RD
Sbjct: 86  CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRD 144
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+L+D++  +K+ADFG+ +        T E  GT  ++APE++  + Y+H  D +S
Sbjct: 145 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWS 204
Query: 297 FGIVLWELLTGKLPY 311
           FG++L+E+L G+ P+
Sbjct: 205 FGVLLYEMLIGQSPF 219

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 153
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 210
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 211 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFAEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 10/234 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVD 276

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK  +  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGATWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 14/271 (5%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 162
           G   +E+    L+   ++  G+YG  +  R     Q +A+K ++   +NS  QK    ++
Sbjct: 42  GNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDL 100
Query: 163 FI-MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAI 219
            I MR V     V F GA  +   + I  E M       Y   +     +P   L K+A+
Sbjct: 101 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 160
Query: 220 DVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 278
            + K + +LH   ++IHRD+K +N+L++    VK+ DFG++     S   T + G   +M
Sbjct: 161 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 279 APEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIP 333
           APE I      K Y  K+D++S GI + EL   + PY+ + TP Q    VV++   P +P
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLP 279
Query: 334 KNS-QPKLAELLERCWQQDPALRPDFSEIIE 363
            +    +  +   +C +++   RP + E+++
Sbjct: 280 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 121 KVASGSYGD--LYRGTYCSQDVAIKVLKPERI--------NSDMQK---EFAQEVFIMRK 167
           K+ SG+YG+  L +      + AIKV+K  +         N +++K   E   E+ +++ 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKG 224
           + H N+++            +VTEF  GG +++ +   HK    F       +   +  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSG 158
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           + YLH++NI+HRD+K  N+L++       +K+ DFG++   ++   +    GT  ++APE
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218
Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           V++ K Y+ K DV+S G++++ LL G  P+
Sbjct: 219 VLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 101/177 (57%), Gaps = 6/177 (3%)
Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           VA+K++  +R   D  +   +E+ I + + H+NVV+F G   +     +  E+ SGG ++
Sbjct: 34  VAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
           D +    G+ + P   +    +  G+ YLH   I HRD+K  NLL+DE + +K++DFG+A
Sbjct: 93  DRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 260 ---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYE 312
              R   +  ++    GT  ++APE+++ + +  +  DV+S GIVL  +L G+LP++
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIISKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++++  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  GSY +  R  + + ++   V   ++   D  +E      ++R  +H N++       
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYD 91
Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + +VTE M GG + D + + K  F       V   + K + YLH   ++HRDLK +
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPS 150
Query: 242 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D++S
Sbjct: 151 NILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWS 210
Query: 297 FGIVLWELLTGKLPY 311
            GI+L+ +L G  P+
Sbjct: 211 LGILLYTMLAGYTPF 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  GSY +  R  + + ++   V   ++   D  +E      ++R  +H N++       
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYD 91
Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + +VTE M GG + D + + K  F       V   + K + YLH   ++HRDLK +
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPS 150
Query: 242 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D++S
Sbjct: 151 NILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWS 210
Query: 297 FGIVLWELLTGKLPY 311
            GI+L+ +L G  P+
Sbjct: 211 LGILLYTMLAGYTPF 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 13/230 (5%)
Query: 138 QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
           Q  A+K++   +  S      ++  +E  I   ++H ++V+ +   +    L +V EFM 
Sbjct: 50  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 195 GGSV-YDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEV- 250
           G  + ++ + +    F     +       + + + Y H NNIIHRD+K  N+L+   E  
Sbjct: 110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENS 169
Query: 251 --VKVADFGVARVKAQSGVMTA-ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
             VK+ DFGVA    +SG++     GT  +MAPEV++ +PY    DV+  G++L+ LL+G
Sbjct: 170 APVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 308 KLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPALR 355
            LP+ Y T  +   G+++    + P    +      +L+ R    DPA R
Sbjct: 230 CLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           +  GSY    R  + + +    V   ++   D  +E      ++R  +H N++       
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + +VTE   GG + D + + K  F       V   ++K + YLH   ++HRDLK +
Sbjct: 87  DGKYVYVVTELXKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145
Query: 242 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV+E + YD   D++S
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWS 205
Query: 297 FGIVLWELLTGKLPY 311
            G++L+  LTG  P+
Sbjct: 206 LGVLLYTXLTGYTPF 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 7/231 (3%)
Query: 119 GSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKNVVQ 175
           G  +  G +G++Y  R       +A+KVL   ++  + ++ +  +E+ I   +RH N+++
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 79
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                     + ++ EF   G +Y  L K  G F          +++  ++Y H+  +IH
Sbjct: 80  MYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIH 138
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           RD+K  NLLM     +K+ADFG + V A S       GT  ++ PE+IE K +D K D++
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLW 197
Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELL 344
             G++ +E L G  P++  +  +    +V   L+  P +   S+  +++LL
Sbjct: 198 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 248

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    + E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG+A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 235
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 144
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 145 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 204
Query: 295 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 345
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 205 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSMSVKAASVLK 262
Query: 346 RCWQQDPALR 355
               +DP  R
Sbjct: 263 SFLNKDPKER 272

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT   +APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           G +   G YG L+       +V +KVL  ++ + +  + F +   +M K+ HK++V   G
Sbjct: 27  GVRREVGDYGQLHE-----TEVLLKVL--DKAHRNYSESFFEAASMMSKLSHKHLVLNYG 79
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
            C       +V EF+  GS+  YL K K    +   L+VA  ++  M++L +N +IH ++
Sbjct: 80  VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139
Query: 239 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 289
            A N+L+   E         +K++D G++       ++        W+ PE IE+ K  +
Sbjct: 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLN 196
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
              D +SFG  LWE+ +G    + L+ L +   +     R  +P     +LA L+  C  
Sbjct: 197 LATDKWSFGTTLWEICSGG--DKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMD 254
Query: 350 QDPALRPDFSEIIEILQQI 368
            +P  RP F  II  L  +
Sbjct: 255 YEPDHRPSFRAIIRDLNSL 273

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 235
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 129
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 130 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 189
Query: 295 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 345
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 190 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 247
Query: 346 RCWQQDPALR 355
               +DP  R
Sbjct: 248 SFLNKDPKER 257

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 235
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 133
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 295 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 345
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 251
Query: 346 RCWQQDPALR 355
               +DP  R
Sbjct: 252 SFLNKDPKER 261

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++AP +I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 122 VASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +  GS+G ++   +   +Q  AIK LK + +  + D++    ++  +     H  +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  +L  V E+++GG +  ++      F L      A ++  G+ +LH   I++RD
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRD 143
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 296
           LK  N+L+D++  +K+ADFG+ +        T    GT  ++APE++  + Y+H  D +S
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWS 203
Query: 297 FGIVLWELLTGKLPY 311
           FG++L+E+L G+ P+
Sbjct: 204 FGVLLYEMLIGQSPF 218

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 122/256 (47%), Gaps = 16/256 (6%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVFIMRKVRHKNVVQFIG 178
           + +GSYG   +    S D  I V K     S  + E      EV ++R+++H N+V++  
Sbjct: 14  IGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 179 ACT--KPPSLCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN- 232
                   +L IV E+  GG   SV     K +       +L+V   ++  +   H+ + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 233 ----IIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKP 287
               ++HRDLK AN+ +D  + VK+ DFG+AR+    +    A  GT  +M+PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 347
           Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E++ R 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 348 WQQDPALRPDFSEIIE 363
                  RP   EI+E
Sbjct: 252 LNLKDYHRPSVEEILE 267

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 178
           +  GSY    L R     +  A++V+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 179 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 235
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 176
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 294
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236
Query: 295 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 345
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 294
Query: 346 RCWQQDPALR 355
               +DP  R
Sbjct: 295 SFLNKDPKER 304

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 6/203 (2%)
Query: 115 HLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH 170
           + +F   +  GS+G   L R        A+KVLK + I  + D++    ++  +     H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
             + Q       P  L  V EF++GG +  ++ K +  F        A ++   + +LH 
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHD 142
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYD 289
             II+RDLK  N+L+D     K+ADFG+ +    +GV TA   GT  ++APE+++   Y 
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 290 HKADVFSFGIVLWELLTGKLPYE 312
              D ++ G++L+E+L G  P+E
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           G +   G YG L+       +V +KVL  ++ + +  + F +   +M K+ HK++V   G
Sbjct: 27  GVRREVGDYGQLHE-----TEVLLKVL--DKAHRNYSESFFEAASMMSKLSHKHLVLNYG 79
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
            C       +V EF+  GS+  YL K K    +   L+VA  ++  M++L +N +IH ++
Sbjct: 80  VCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNV 139
Query: 239 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 289
            A N+L+   E         +K++D G++       ++        W+ PE IE+ K  +
Sbjct: 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLN 196
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
              D +SFG  LWE+ +G    + L+ L +   +     R  +P     +LA L+  C  
Sbjct: 197 LATDKWSFGTTLWEICSGG--DKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMD 254
Query: 350 QDPALRPDFSEIIEILQQI 368
            +P  RP F  II  L  +
Sbjct: 255 YEPDHRPSFRAIIRDLNSL 273

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 178
           + +GS+G   L +        A+K+L  +++    + E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 239 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           K  NL++D+   ++V DFG+A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 16/256 (6%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVFIMRKVRHKNVVQFIG 178
           + +GSYG   +    S D  I V K     S  + E      EV ++R+++H N+V++  
Sbjct: 14  IGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 179 ACT--KPPSLCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN- 232
                   +L IV E+  GG   SV     K +       +L+V   ++  +   H+ + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 233 ----IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP 287
               ++HRDLK AN+ +D  + VK+ DFG+AR+         E  GT  +M+PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 347
           Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E++ R 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 348 WQQDPALRPDFSEIIE 363
                  RP   EI+E
Sbjct: 252 LNLKDYHRPSVEEILE 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 114/228 (50%), Gaps = 7/228 (3%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G +G++Y  R       +A+KVL   ++  + ++ +  +E+ I   +RH N+++   
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  + ++ EF   G +Y  L K  G F          +++  ++Y H+  +IHRD+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 298
           K  NLLM     +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G
Sbjct: 141 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELL 344
           ++ +E L G  P++  +  +    +V   L+  P +   S+  +++LL
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 16/256 (6%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVFIMRKVRHKNVVQFIG 178
           + +GSYG   +    S D  I V K     S  + E      EV ++R+++H N+V++  
Sbjct: 14  IGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 179 ACT--KPPSLCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN- 232
                   +L IV E+  GG   SV     K +       +L+V   ++  +   H+ + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 233 ----IIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKP 287
               ++HRDLK AN+ +D  + VK+ DFG+AR+    +       GT  +M+PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 347
           Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E++ R 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 348 WQQDPALRPDFSEIIE 363
                  RP   EI+E
Sbjct: 252 LNLKDYHRPSVEEILE 267

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 6/252 (2%)
Query: 116 LKFGSKVASGSYGDLYRG--TYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 172
            K G+ +  GS+  +YR    +   +VAIK++ K     + M +    EV I  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++          + +V E    G +  YL      F           +  GM YLH + 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           I+HRDL  +NLL+  N  +K+ADFG+A ++K          GT  +++PE+     +  +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
           +DV+S G + + LL G+ P++  T       VV       +P     +  +L+ +  +++
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLSIEAKDLIHQLLRRN 250
Query: 352 PALRPDFSEIIE 363
           PA R   S +++
Sbjct: 251 PADRLSLSSVLD 262

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 127/257 (49%), Gaps = 15/257 (5%)
Query: 112 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRK 167
           DPK +  G  V+S     ++R T     V I  +  ER++ +  +E  +    E  I+R+
Sbjct: 97  DPKDV-IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 168 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           V  H +++  I +      + +V + M  G ++DYL + K          +   + + ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVS 214
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 284
           +LH NNI+HRDLK  N+L+D+N  ++++DFG +        +    GT  ++APE+++  
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 285 ----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP 338
               H  Y  + D+++ G++L+ LL G  P+ +   +     +++   + + P+  +   
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSS 334
Query: 339 KLAELLERCWQQDPALR 355
            + +L+ R  Q DP  R
Sbjct: 335 TVKDLISRLLQVDPEAR 351

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 113 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 169
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 9   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 68
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 69  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 127
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 286
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 340
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 239
Query: 341 AELLERCWQQDPALR 355
            +L+E+    D   R
Sbjct: 240 RDLVEKLLVLDATKR 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 113 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 169
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 6   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 65
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 66  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 124
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 286
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 340
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 236
Query: 341 AELLERCWQQDPALR 355
            +L+E+    D   R
Sbjct: 237 RDLVEKLLVLDATKR 251

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 123/255 (48%), Gaps = 14/255 (5%)
Query: 121 KVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFI 177
           ++  G+YG  +  R     Q +A+K ++   +NS  QK    ++ I MR V     V F 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NII 234
           GA  +   + I  E M       Y   +     +P   L K+A+ + K + +LH   ++I
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDH 290
           HRD+K +N+L++    VK+ DFG++           + G   +MAPE I      K Y  
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 291 KADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCW 348
           K+D++S GI + EL   + PY+ + TP Q    VV++   P +P +    +  +   +C 
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFTSQCL 251
Query: 349 QQDPALRPDFSEIIE 363
           +++   RP + E+++
Sbjct: 252 KKNSKERPTYPELMQ 266

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 113 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 169
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 7   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 66
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 125
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 286
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 340
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 237
Query: 341 AELLERCWQQDPALR 355
            +L+E+    D   R
Sbjct: 238 RDLVEKLLVLDATKR 252

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 113 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 169
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 8   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 67
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 68  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 126
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 286
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 340
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 238
Query: 341 AELLERCWQQDPALR 355
            +L+E+    D   R
Sbjct: 239 RDLVEKLLVLDATKR 253

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 124/254 (48%), Gaps = 11/254 (4%)
Query: 118 FGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           F  K+ SG++GD++     S  +   IK +  +R    M+ +   E+ +++ + H N+++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNIIK 84
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN---YLHQNN 232
                    ++ IV E   GG + + +   +   K  S   VA  + + MN   Y H  +
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 233 IIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           ++H+DLK  N+L  +   +  +K+ DFG+A +       T   GT  +MAPEV + +   
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT 203
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-KNSQPKLAELLERCW 348
            K D++S G+V++ LLTG LP+   +  +       K     +  +   P+  +LL++  
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQML 263
Query: 349 QQDPALRPDFSEII 362
            +DP  RP  ++++
Sbjct: 264 TKDPERRPSAAQVL 277

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 83/150 (55%), Gaps = 1/150 (0%)
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV-YDYLHKLKGVFKLPSLLKVAIDVS 222
           I+ KV  + VV    A     +LC+V   M+GG + +   H  +  F     +  A ++ 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
            G+  LH+  I++RDLK  N+L+D++  ++++D G+A    +   +    GT  +MAPEV
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           ++++ Y    D ++ G +L+E++ G+ P++
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     +  GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 83/150 (55%), Gaps = 1/150 (0%)
Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV-YDYLHKLKGVFKLPSLLKVAIDVS 222
           I+ KV  + VV    A     +LC+V   M+GG + +   H  +  F     +  A ++ 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
            G+  LH+  I++RDLK  N+L+D++  ++++D G+A    +   +    GT  +MAPEV
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           ++++ Y    D ++ G +L+E++ G+ P++
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 212
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 268
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 269 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     A  GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 212
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 268
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 269 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 212
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 268
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 269 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 212
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 268
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 269 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 212
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 268
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 269 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 120 SKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           S++  G+   +YR   C Q       A+KVLK     +  +K    E+ ++ ++ H N++
Sbjct: 59  SELGRGATSIVYR---CKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +       P  + +V E ++GG ++D + + KG +           + + + YLH+N I+
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 235 HRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           HRDLK  NLL      +  +K+ADFG++++     +M    GT  + APE++    Y  +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 292 ADVFSFGIVLWELLTGKLPY 311
            D++S GI+ + LL G  P+
Sbjct: 231 VDMWSVGIITYILLCGFEPF 250

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 128/303 (42%), Gaps = 67/303 (22%)
Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--V 168
           +D  +LK    +  G YG +Y+G+   + VA+KV          ++ F  E  I R   +
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLM 64
Query: 169 RHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDY--LHKLKGVFKLPSLLKVAIDV 221
            H N+ +FI    +  +       +V E+   GS+  Y  LH    V    S  ++A  V
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV----SSCRLAHSV 120
Query: 222 SKGMNYLHQN---------NIIHRDLKAANLLMDENEVVKVADFGVA---------RVKA 263
           ++G+ YLH            I HRDL + N+L+  +    ++DFG++         R   
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 264 QSGVMTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWE-------LLTGKL 309
           +     +E GT R+MAPEV+E        +    + D+++ G++ WE       L  G+ 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 310 PYEYLTPLQAAVG-----------VVQKGLRPTIP----KNSQP--KLAELLERCWQQDP 352
             EY    Q  VG           V ++  RP  P    +NS     L E +E CW QD 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 353 ALR 355
             R
Sbjct: 301 EAR 303

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 34/274 (12%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           V  GSYG +   R     + VAIK       +  ++K   +E+ +++++RH+N+V  +  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
           C K     +V EF+   ++ D L           + K    +  G+ + H +NIIHRD+K
Sbjct: 93  CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151
Query: 240 AANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPE-VIEHKPYDHKADVFSF 297
             N+L+ ++ VVK+ DFG AR  A  G V   E  T  + APE ++    Y    DV++ 
Sbjct: 152 PENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211
Query: 298 GIVLWELLTGKLPY------EYLTPLQAAVGV-------------VQKGLR-PTIPKNS- 336
           G ++ E+  G+  +      + L  +   +G              V  G+R P I +   
Sbjct: 212 GCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREP 271
Query: 337 ----QPKLAE----LLERCWQQDPALRPDFSEII 362
                PKL+E    L ++C   DP  RP  +E++
Sbjct: 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 212
           ++E  +EV I+R+V H N++           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 268
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 269 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           WE+ PK     + V SG+YG +         + VAIK L     +    K   +E+ +++
Sbjct: 20  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 167 KVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAI 219
            ++H+NV+  +   T   SL       +V  FM        L K+ G+ F    +  +  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGLKFSEEKIQYLVY 133
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 279
            + KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRA 191
Query: 280 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           PEVI     Y+   D++S G ++ E+LTGK
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     +  GT ++++PE++  K   
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 265
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 266 VEKLLVLDATKR 277

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           WE+ PK     + V SG+YG +         + VAIK L     +    K   +E+ +++
Sbjct: 38  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 96
Query: 167 KVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAI 219
            ++H+NV+  +   T   SL       +V  FM        L K+ G+ F    +  +  
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGMEFSEEKIQYLVY 151
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 279
            + KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRA 209
Query: 280 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           PEVI     Y+   D++S G ++ E+LTGK
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 13/230 (5%)
Query: 138 QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
           Q  A+K++   +  S      ++  +E  I   ++H ++V+ +   +    L +V EFM 
Sbjct: 52  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 111
Query: 195 GGSV-YDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEV- 250
           G  + ++ + +    F     +       + + + Y H NNIIHRD+K   +L+   E  
Sbjct: 112 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 171
Query: 251 --VKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
             VK+  FGVA    +SG V     GT  +MAPEV++ +PY    DV+  G++L+ LL+G
Sbjct: 172 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231
Query: 308 KLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPALR 355
            LP+ Y T  +   G+++    + P    +      +L+ R    DPA R
Sbjct: 232 CLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 280

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     +  GT ++++PE++  K   
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 261
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 262 VEKLLVLDATKR 273

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 112/230 (48%), Gaps = 13/230 (5%)
Query: 138 QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 194
           Q  A+K++   +  S      ++  +E  I   ++H ++V+ +   +    L +V EFM 
Sbjct: 50  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 195 GGSV-YDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEV- 250
           G  + ++ + +    F     +       + + + Y H NNIIHRD+K   +L+   E  
Sbjct: 110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 169
Query: 251 --VKVADFGVARVKAQSGVMTA-ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
             VK+  FGVA    +SG++     GT  +MAPEV++ +PY    DV+  G++L+ LL+G
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 308 KLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPALR 355
            LP+ Y T  +   G+++    + P    +      +L+ R    DPA R
Sbjct: 230 CLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRW 194
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 265
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 266 VEKLLVLDATKR 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRW 194
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRW 194
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 269
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 270 VEKLLVLDATKR 281

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 261
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 262 VEKLLVLDATKR 273

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 246
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 247 VEKLLVLDATKR 258

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 114/246 (46%), Gaps = 9/246 (3%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
             +D+++ G ++++L+ G  P+           +++  L    P+   PK  +L+E+   
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLVEKLLV 270
Query: 350 QDPALR 355
            D   R
Sbjct: 271 LDATKR 276

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 75  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 133
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYDHKA 292
           +K +N+L++    +K+ DFGV      SG +  E      GT  +M+PE ++   Y  ++
Sbjct: 134 VKPSNILVNSRGEIKLCDFGV------SGQLIDEMANEFVGTRSYMSPERLQGTHYSVQS 187
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQD 351
           D++S G+ L E+  G+ P   +   +    +V +   P +P      +  + + +C  ++
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP-PPKLPSAVFSLEFQDFVNKCLIKN 246
Query: 352 PALRPDFSEII 362
           PA R D  +++
Sbjct: 247 PAERADLKQLM 257

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 133
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVAT 191
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+ +G+Y  +Y+G   +  V +  LK  +++S+        +E+ +M++++H+N+V+   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYV-ALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DVSKGMNYLHQNN 232
                  L +V EFM    +  Y+   + V   P  L++ +       + +G+ + H+N 
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDH 290
           I+HRDLK  NLL+++   +K+ DFG+AR         ++E  T  + AP+V+   + Y  
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188
Query: 291 KADVFSFGIVLWELLTGK 308
             D++S G +L E++TGK
Sbjct: 189 SIDIWSCGCILAEMITGK 206

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 100/179 (55%), Gaps = 5/179 (2%)
Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 196
           +Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     +V + ++GG
Sbjct: 56  TQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKV 253
            +++ +   +  +           + + +N++HQ++I+HRDLK  NLL+    +   VK+
Sbjct: 116 ELFEDI-VAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKL 174
Query: 254 ADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G++L+ LL G  P+
Sbjct: 175 ADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 21/252 (8%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 290 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 343
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P    PK  +L
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPAAFFPKARDL 267
Query: 344 LERCWQQDPALR 355
           +E+    D   R
Sbjct: 268 VEKLLVLDATKR 279

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 126/249 (50%), Gaps = 8/249 (3%)
Query: 120 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 91  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 149
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 150 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 208
Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS-QPKLAELLERCWQQDPA 353
           G+ L E+  G+ P    +   A   ++   +    P +P      +  + + +C  ++PA
Sbjct: 209 GLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 268
Query: 354 LRPDFSEII 362
            R D  +++
Sbjct: 269 ERADLKQLM 277

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 133
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 191
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 129
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVAT 187
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 114/246 (46%), Gaps = 9/246 (3%)
Query: 116 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 172
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
             +D+++ G ++++L+ G  P+           +++  L    P+   PK  +L+E+   
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLVEKLLV 270
Query: 350 QDPALR 355
            D   R
Sbjct: 271 LDATKR 276

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKXQKLTDDHV 127
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 185
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCAKLTDDHV 123
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 146
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 204
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 132
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 190
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 96  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 150 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 207
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 124/251 (49%), Gaps = 11/251 (4%)
Query: 116 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKN 172
            + G  +  G +G++Y  R       VA+KVL   +I  + ++ +  +E+ I   + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +++          + ++ E+   G +Y  L K    F       +  +++  + Y H   
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQK-SCTFDEQRTATIMEELADALMYCHGKK 143
Query: 233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + ++ K 
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQ 350
           D++  G++ +ELL G  P+E  +  +    +V+  L+   ++P  +Q  +++LL    + 
Sbjct: 203 DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLL----RH 258
Query: 351 DPALRPDFSEI 361
           +P+ R   +++
Sbjct: 259 NPSERLPLAQV 269

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNVVQ 175
           KV  G+YG +Y+    ++D   +++  +RI  D + E       +E+ +++++ H N+V 
Sbjct: 28  KVGEGTYGVVYK----AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            I        L +V EFM    +   L + K   +   +      + +G+ + HQ+ I+H
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIE-HKPYDHK 291
           RDLK  NLL++ +  +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 292 ADVFSFGIVLWELLTGK 308
            D++S G +  E++TGK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 38  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 90
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       +VT  M        L+KL     L + 
Sbjct: 91  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYLVTHLMGAD-----LYKLLKTQHLSND 144
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 145 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 138
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 196
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNVVQ 175
           KV  G+YG +Y+    ++D   +++  +RI  D + E       +E+ +++++ H N+V 
Sbjct: 28  KVGEGTYGVVYK----AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            I        L +V EFM    +   L + K   +   +      + +G+ + HQ+ I+H
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 236 RDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIE-HKPYDHK 291
           RDLK  NLL++ +  +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 292 ADVFSFGIVLWELLTGK 308
            D++S G +  E++TGK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 123
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 122 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           + SG+ G +         ++VAIK L     N    K   +E+ +M+ V HKN++  +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 180 CTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK---------- 223
            T   SL       IV E M                 L  ++++ +D  +          
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDAN--------------LSQVIQMELDHERMSYLLYQMLV 137
Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 283
           G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  + APEVI
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 284 EHKPYDHKADVFSFGIVLWELLTG 307
               Y    D++S G+++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S + SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 132
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 190
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 25/236 (10%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +         + I V K  R    +   K   +E+ ++
Sbjct: 46  IWEV-PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 105 KHMKHENVIGLLDVFTPATSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 158
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 159 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 216
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
           + APE++ +   Y+   D++S G ++ ELLTG+     L P    +  +Q+ +R T
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT----LFPGTDHINQLQQIMRLT 268

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 308
           + APE+ +    Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 88  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 142 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 199
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 106/192 (55%), Gaps = 20/192 (10%)
Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 195
           SQ+ A+K++  E+    ++    +EV ++ + + H+NV++ I    +     +V E M G
Sbjct: 38  SQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95
Query: 196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEV--VK 252
           GS+  ++HK +   +L + + V  DV+  +++LH   I HRDLK  N+L +  N+V  VK
Sbjct: 96  GSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVK 154
Query: 253 VADFGVARVKAQSG----VMTAE----TGTYRWMAPEVI-----EHKPYDHKADVFSFGI 299
           + DFG+      +G    + T E     G+  +MAPEV+     E   YD + D++S G+
Sbjct: 155 ICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 300 VLWELLTGKLPY 311
           +L+ LL+G  P+
Sbjct: 215 ILYILLSGYPPF 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 133
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 191
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 18/180 (10%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT E  T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 78  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 132 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 194
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 99  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 153 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 210
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 82  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 136 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 193
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 78  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 132 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 95  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 149 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 206
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 88  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 142 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 199
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 88  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 142 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 199
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 132
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 190
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 241
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPS 155
Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G+++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIM 215
Query: 302 WELLTG 307
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 78  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 132 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKXQKLTDDHV 127
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 185
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 96  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 150 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 207
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 20/214 (9%)
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
           QE+ I++K+ H NVV+ +     P    L +V E ++ G V + +  LK + +  +    
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYF 143
Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYR 276
             D+ KG+ YLH   IIHRD+K +NLL+ E+  +K+ADFGV+   K    +++   GT  
Sbjct: 144 Q-DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA 202
Query: 277 WMAPEVIE--HKPYDHKA-DVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPT 331
           +MAPE +    K +  KA DV++ G+ L+  + G+ P+  E +  L + +    K     
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI----KSQALE 258
Query: 332 IPKNSQPKLAE----LLERCWQQDPALRPDFSEI 361
            P   QP +AE    L+ R   ++P  R    EI
Sbjct: 259 FP--DQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 81  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 135 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 192
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 16  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 75  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 128
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 129 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 186
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 124
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 182
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 87  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 141 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 198
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 73  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 127 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 184
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 72  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 183
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 122 VASGSYGDLYRGTY--CSQDVAIKV------LKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           +  G+  +++RG +       AIKV      L+P     D+Q    +E  +++K+ HKN+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP----VDVQ---MREFEVLKKLNHKNI 69
Query: 174 VQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLH 229
           V+   I   T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 230 QNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 284
           +N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E 
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 285 -------HKPYDHKADVFSFGIVLWELLTGKLPY 311
                   K Y    D++S G+  +   TG LP+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 15  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 74  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 127
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 128 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 185
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYL-HQ 230
           +VQ  G       + I  E M  G+  + L K ++G      L K+ + + K + YL  +
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE----HK 286
           + +IHRD+K +N+L+DE   +K+ DFG++             G   +MAPE I+     K
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 287 P-YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNS--QPKLAE 342
           P YD +ADV+S GI L EL TG+ PY+   T  +    V+Q+   P +P +         
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPGHMGFSGDFQS 262
Query: 343 LLERCWQQDPALRPDFSEIIE 363
            ++ C  +D   RP +++++E
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLE 283

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL-REIKI 78
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 132
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  + V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 27  IWEV-PERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 137
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 138 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 195
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 90/179 (50%), Gaps = 5/179 (2%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGG 196
           Q+ A K LK  R   D + E   E+ ++   +    V+           + ++ E+ +GG
Sbjct: 55  QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 197 SVYDY-LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VK 252
            ++   L +L  +     ++++   + +G+ YLHQNNI+H DLK  N+L+        +K
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 253 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           + DFG++R    +  +    GT  ++APE++ + P     D+++ GI+ + LLT   P+
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 78
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 132
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           VWE+ P+ L+    V SG+YG +         Q VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   S+       +VT  M           L  + K  +L     
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA--------DLNNIVKCQALSDEHV 133
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT    T
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVAT 191
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
             + APE++ +   Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 245

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 122 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  G +G +++   T     +A K++K   +    ++E   E+ +M ++ H N++Q   A
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDA 154
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRD 237
                 + +V E++ GG ++D +  +   + L  L  +     + +G+ ++HQ  I+H D
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 238 LKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           LK  N+L    +   +K+ DFG+AR       +    GT  ++APEV+ +       D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 296 SFGIVLWELLTGKLPY 311
           S G++ + LL+G  P+
Sbjct: 273 SVGVIAYMLLSGLSPF 288

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL 184
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 96  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  
Sbjct: 150 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVATRW 207
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 115 HLKFGSKVASGSYGDLYRGT--YCSQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHK 171
           H     ++ +G++G ++R T      + A K V+ P   + +  +   +E+  M  +RH 
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHP 108
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
            +V    A      + ++ EFMSGG +++ +            ++    V KG+ ++H+N
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 232 NIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           N +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 290 HKADVFSFGIVLWELLTGKLPY 311
           +  D++S G++ + LL+G  P+
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPF 250

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 127/255 (49%), Gaps = 14/255 (5%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 298 GIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLR---PTIPKNS-QPKLAELLERC 347
           G+ L E+  G+ P       E   P  A   ++   +    P +P      +  + + +C
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 249
Query: 348 WQQDPALRPDFSEII 362
             ++PA R D  +++
Sbjct: 250 LIKNPAERADLKQLM 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 115 HLKFGSKVASGSYGDLYRGT--YCSQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHK 171
           H     ++ +G++G ++R T      + A K V+ P   + +  +   +E+  M  +RH 
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHP 214
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
            +V    A      + ++ EFMSGG +++ +            ++    V KG+ ++H+N
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 232 NIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
           N +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 290 HKADVFSFGIVLWELLTGKLPY 311
           +  D++S G++ + LL+G  P+
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPF 356

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 78
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKCQHLSNDHICY 132
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKSQKLTDDHV 127
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+ R       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYVAT 185
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 26  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 78
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 79  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 132
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 133 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 192
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 252

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQK----------EFAQEVFIMRKVR 169
           + +  GS+G+          V I V K  RI    +K           F QE+ IM+ + 
Sbjct: 15  NTIGRGSWGE----------VKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H N+++          + +V E  +GG +++ +   K VF+     ++  DV   + Y H
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCH 123
Query: 230 QNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           + N+ HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK----NSQPKLAE 342
            Y  + D +S G++++ LL G  P+   T  +  + + +     T P+    N  P+   
Sbjct: 184 -YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAES 240
Query: 343 LLERCWQQDPALR 355
           L+ R   + P  R
Sbjct: 241 LIRRLLTKSPKQR 253

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 16  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 68
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 69  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 122
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 123 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 182
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 183 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 23  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 79
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 80  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 133
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 24  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 80
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 81  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 134
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 250

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 15  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 71
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 72  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 125
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 241

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 78
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 132
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 16  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 72
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 73  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 126
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T   
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 122 VASGSYGDLYRGTY--CSQDVAIKV------LKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           +  G+  +++RG +       AIKV      L+P     D+Q    +E  +++K+ HKN+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP----VDVQ---MREFEVLKKLNHKNI 69
Query: 174 VQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLH 229
           V+   I   T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 230 QNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 284
           +N I+HR++K  N++     D   V K+ DFG AR            GT  ++ P++ E 
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYER 189
Query: 285 -------HKPYDHKADVFSFGIVLWELLTGKLPY 311
                   K Y    D++S G+  +   TG LP+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 178 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 226
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKASIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 281
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 282 -VIEHKPYDHKADVFSFGIVLWELLT 306
            ++  + Y    D++  G ++ E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D+G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 20  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 72
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 73  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 126
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 127 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQK----------EFAQEVFIMRKVR 169
           + +  GS+G+          V I V K  RI    +K           F QE+ IM+ + 
Sbjct: 32  NTIGRGSWGE----------VKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H N+++          + +V E  +GG +++ +   K VF+     ++  DV   + Y H
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCH 140
Query: 230 QNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           + N+ HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 200
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK----NSQPKLAE 342
            Y  + D +S G++++ LL G  P+   T  +  + + +     T P+    N  P+   
Sbjct: 201 -YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAES 257
Query: 343 LLERCWQQDPALR 355
           L+ R   + P  R
Sbjct: 258 LIRRLLTKSPKQR 270

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 38  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 90
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 91  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 144
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 145 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 204
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 120/233 (51%), Gaps = 17/233 (7%)
Query: 114 KHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           K+ K G K+  GSYG ++  R     Q VAIK       +  ++K   +E+ ++++++H 
Sbjct: 4   KYEKIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLH 229
           N+V  +    +   L +V E+     +++     +GV   P  L  +I     + +N+ H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV---PEHLVKSITWQTLQAVNFCH 119
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPE-VIEHKP 287
           ++N IHRD+K  N+L+ ++ V+K+ DFG AR +   S     E  T  + +PE ++    
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG---VVQKGLRPTIPKNSQ 337
           Y    DV++ G V  ELL+G +P   L P ++ V    +++K L   IP++ Q
Sbjct: 180 YGPPVDVWAIGCVFAELLSG-VP---LWPGKSDVDQLYLIRKTLGDLIPRHQQ 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 90/164 (54%), Gaps = 7/164 (4%)
Query: 150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 209
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+   L + K   
Sbjct: 53  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 109
Query: 210 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 266
           ++P   L KV+I V +G+ YL + + I+HRD+K +N+L++    +K+ DFGV+     S 
Sbjct: 110 RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 168
Query: 267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
           +  +  GT  +MAPE ++   Y  ++D++S G+ L EL  G+ P
Sbjct: 169 MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR 189
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 190 --APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 241
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 155
Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 302 WELLTG 307
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 241
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPS 155
Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 302 WELLTG 307
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           VWE+ P+ L+    V SG+YG +         Q VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   S+       +VT  M           L  + K  +L     
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA--------DLNNIVKSQALSDEHV 133
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT    T
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVAT 191
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
             + APE++ +   Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 245

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR 189
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 190 --APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 241
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 155
Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 302 WELLTG 307
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 20  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 72
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+   RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 73  EIKILLAFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 126
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 127 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFL 186
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 298 GIVLWELLTGKLP 310
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 72  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR 185
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 --APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 134 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 192
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 193 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 251
Query: 298 GIVLWELLTGKLP 310
           G+ L E+  G+ P
Sbjct: 252 GLSLVEMAVGRYP 264

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 99  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 298 GIVLWELLTGKLP 310
           G+ L E+  G+ P
Sbjct: 217 GLSLVEMAVGRYP 229

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 131
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 252 RRLLVKDPKKR 262

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 131
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 252 RRLLVKDPKKR 262

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 298 GIVLWELLTGKLP 310
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 118/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK    +  G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK---QILNGVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 298 GIVLWELLTGKLP 310
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 120 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 237
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 298 GIVLWELLTGKLP 310
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 105/192 (54%), Gaps = 20/192 (10%)
Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 195
           SQ+ A+K++  E+    ++    +EV ++ + + H+NV++ I    +     +V E M G
Sbjct: 38  SQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95
Query: 196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEV--VK 252
           GS+  ++HK +   +L + + V  DV+  +++LH   I HRDLK  N+L +  N+V  VK
Sbjct: 96  GSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVK 154
Query: 253 VADF----GVARVKAQSGVMTAE----TGTYRWMAPEVI-----EHKPYDHKADVFSFGI 299
           + DF    G+      S + T E     G+  +MAPEV+     E   YD + D++S G+
Sbjct: 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 300 VLWELLTGKLPY 311
           +L+ LL+G  P+
Sbjct: 215 ILYILLSGYPPF 226

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAI+ + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL-R 74
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 178 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 226
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 281
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 282 -VIEHKPYDHKADVFSFGIVLWELLT 306
            ++  + Y    D++  G ++ E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           VWE+ P+ L+    V SG+YG +         Q VA+K L     +    +   +E+ ++
Sbjct: 15  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 73
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   S+       +VT  M           L  + K  +L     
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA--------DLNNIVKCQALSDEHV 125
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT    T
Sbjct: 126 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVAT 183
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
             + APE++ +   Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 237

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 99  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  
Sbjct: 153 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVATRW 210
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 8/166 (4%)
Query: 153 DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
           ++++   +EV I+RKV  H N++Q            +V + M  G ++DYL + K     
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 123
Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 271
               K+   + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        + + 
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV 183
Query: 272 TGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPY 311
            GT  ++APE+IE      H  Y  + D++S G++++ LL G  P+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 95/178 (53%), Gaps = 5/178 (2%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     +V + ++GG 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVA 254
           +++ +   +  +           + + +N+ H N I+HRDLK  NLL+    +   VK+A
Sbjct: 90  LFEDI-VAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 255 DFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           DFG+A  V+          GT  +++PEV+   PY    D+++ G++L+ LL G  P+
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 178 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 226
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 281
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 282 -VIEHKPYDHKADVFSFGIVLWELLT 306
            ++  + Y    D++  G ++ E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 241
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 155
Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 302 WELLTG 307
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 95/178 (53%), Gaps = 5/178 (2%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     +V + ++GG 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVA 254
           +++ +   +  +           + + +N+ H N I+HRDLK  NLL+    +   VK+A
Sbjct: 90  LFEDI-VAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 255 DFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           DFG+A  V+          GT  +++PEV+   PY    D+++ G++L+ LL G  P+
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 178 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 226
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 83  EICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 281
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 139 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 198
Query: 282 -VIEHKPYDHKADVFSFGIVLWELLT 306
            ++  + Y    D++  G ++ E+ T
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 121 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDM---QKEFAQEVFIMRKVRHKNVVQFI 177
           ++ SG++G ++R   C +    +V   + IN+     +     E+ IM ++ H  ++   
Sbjct: 58  ELGSGAFGVVHR---CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
            A      + ++ EF+SGG ++D +           ++       +G+ ++H+++I+H D
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 238 LKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           +K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P     D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 296 SFGIVLWELLTGKLPY 311
           + G++ + LL+G  P+
Sbjct: 235 AIGVLGYVLLSGLSPF 250

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 216
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 217 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DF +AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYVAT 185
Query: 275 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 104
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 105 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 122 VASGSYGDLY--RGTYCSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           +  G +  +Y  R    +Q VAIK +K          + +   +E+ +++++ H N++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-KGMNYLHQNNIIH 235
           + A     ++ +V +FM   +  + + K   +   PS +K  + ++ +G+ YLHQ+ I+H
Sbjct: 78  LDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI-EHKPYDHKAD 293
           RDLK  NLL+DEN V+K+ADFG+A+               RW  APE++   + Y    D
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVD 195
Query: 294 VFSFGIVLWELLTGKLPY 311
           +++ G +L ELL  ++P+
Sbjct: 196 MWAVGCILAELLL-RVPF 212

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 160
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 20  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 72
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 213
           E+ I+   RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 73  EIKILLAFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 126
Query: 214 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 268
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 127 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 269 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 117/236 (49%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 78
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 132
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +    
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 63
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 64  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 121
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 117/236 (49%), Gaps = 28/236 (11%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFI 164
           V+++ P++    S +  G+YG +    Y + +   VAIK + P    +  Q+   +E+ I
Sbjct: 23  VFDVGPRYTNL-SYIGEGAYG-MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKI 79
Query: 165 MRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS--LLK 216
           + + RH+N++  I    + P++       IV + M        L+KL     L +  +  
Sbjct: 80  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY 133
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAET 272
               + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +    
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 273 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
            T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 251
            M      +    ++       +  +   +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 252 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 63
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 64  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 121
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 4   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 62
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 63  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 120
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 180
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 63
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 64  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 121
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 11  PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 69
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 70  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 127
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 187
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
                  L +V EF+S   + D++    L G+  LP +      + +G+ + H + ++HR
Sbjct: 73  VIHTENKLYLVFEFLSM-DLKDFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 237 DLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 294
           DLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 295 FSFGIVLWELLTGK 308
           +S G +  E++T +
Sbjct: 191 WSLGCIFAEMVTRR 204

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 8/166 (4%)
Query: 153 DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
           ++++   +EV I+RKV  H N++Q            +V + M  G ++DYL + K     
Sbjct: 52  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 110
Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 271
               K+   + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +   
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 170
Query: 272 TGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPY 311
            GT  ++APE+IE      H  Y  + D++S G++++ LL G  P+
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 8/166 (4%)
Query: 153 DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
           ++++   +EV I+RKV  H N++Q            +V + M  G ++DYL + K     
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 123
Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 271
               K+   + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 272 TGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPY 311
            GT  ++APE+IE      H  Y  + D++S G++++ LL G  P+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+  FG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 119 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 172
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 230
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 345 ERCWQQDPALR 355
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
                  L +V EF+S   + D++    L G+  LP +      + +G+ + H + ++HR
Sbjct: 72  VIHTENKLYLVFEFLSM-DLKDFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 237 DLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 294
           DLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D+
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 295 FSFGIVLWELLTGK 308
           +S G +  E++T +
Sbjct: 190 WSLGCIFAEMVTRR 203

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCH 221
Query: 308 KL 309
           K+
Sbjct: 222 KI 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 308 KLPY 311
           K+ +
Sbjct: 222 KILF 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 308 KL 309
           K+
Sbjct: 222 KI 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 308 KLPY 311
           K+ +
Sbjct: 222 KILF 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 139 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 255
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 256 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 139 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 32  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 255
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 92  FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 150
Query: 256 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 151 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 122 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           + SG+ G +     T    +VA+K L     N    K   +E+ +++ V HKN++  +  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 180 CTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
            T   +L       +V E M   ++   +H      ++  LL   +    G+ +LH   I
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQML---CGIKHLHSAGI 145
Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 293
           IHRDLK +N+++  +  +K+ DFG+AR  + + +MT    T  + APEVI    Y    D
Sbjct: 146 IHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVD 205
Query: 294 VFSFGIVLWELLTGKLPYE 312
           ++S G ++ EL+ G + ++
Sbjct: 206 IWSVGCIMGELVKGSVIFQ 224

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 139 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 255
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 256 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           +  +N V+ + A  K  +L I  E+   G++YD +H      +     ++   + + ++Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------------VKAQSGVMTAET 272
           +H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 273 GTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKG 327
           GT  ++A EV++    Y+ K D++S GI+ +E++    TG      L  L++    V   
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSIE 247
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRP 356
             P    N      +++      DP  RP
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 216
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYVATRW 187
Query: 277 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 97/193 (50%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+++ H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLSFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 96
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 97  VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 155 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 308 KL 309
           K+
Sbjct: 215 KI 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 308 KL 309
           K+
Sbjct: 222 KI 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 139 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 255
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 116 FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 256 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 6/203 (2%)
Query: 111 IDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           +D ++ +   K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
            H N+V+ +        L +V EF+      +     L G+  LP +      + +G+ +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAF 122
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEH 285
            H + ++HRDLK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 286 KPYDHKADVFSFGIVLWELLTGK 308
           K Y    D++S G +  E++T +
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 221
Query: 308 KL 309
           K+
Sbjct: 222 KI 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 55  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 114
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 251
            M      +    ++       +  +   +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 115 LMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 170
Query: 252 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL 309
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  K+
Sbjct: 171 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 228

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 19/198 (9%)
Query: 122 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NV 173
           +  GS+G + +       Q VA+K+++ E+      ++ A+E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           +  +   T    +C+  E +S  ++Y+ +  +K +G F LP + K A  + + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKN 219
Query: 232 NIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
            IIH DLK  N+L+ +     +KV DFG +  + Q      ++  YR  APEVI    Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYG 277
Query: 290 HKADVFSFGIVLWELLTG 307
              D++S G +L ELLTG
Sbjct: 278 MPIDMWSLGCILAELLTG 295

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAI+++   +        +D      
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVE 188
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 189 TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 246
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 195
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 196 SLGCIFAEMVTRR 208

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 19/198 (9%)
Query: 122 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NV 173
           +  GS+G + +       Q VA+K+++ E+      ++ A+E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           +  +   T    +C+  E +S  ++Y+ +  +K +G F LP + K A  + + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKN 219
Query: 232 NIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
            IIH DLK  N+L+ +     +KV DFG +  + Q      ++  YR  APEVI    Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYG 277
Query: 290 HKADVFSFGIVLWELLTG 307
              D++S G +L ELLTG
Sbjct: 278 MPIDMWSLGCILAELLTG 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 141
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 142 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 308 KL 309
           K+
Sbjct: 260 KI 261

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 191
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 103
Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 251
            M      +    ++       +  +   +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 104 LMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 252 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL 309
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  K+
Sbjct: 160 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 6/192 (3%)
Query: 121 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+Y  +Y+G     D  VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                 SL +V E++    +  YL     +  + ++      + +G+ Y H+  ++HRDL
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126
Query: 239 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFS 296
           K  NLL++E   +K+ADFG+AR K+  +     E  T  +  P++ +    Y  + D++ 
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186
Query: 297 FGIVLWELLTGK 308
            G + +E+ TG+
Sbjct: 187 VGCIFYEMATGR 198

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 113 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 159
           PK L+        + SG+ G++   +    C + VAI+++   +        +D      
Sbjct: 144 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVE 202
Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 203 TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 260
Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 320
Query: 277 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
                  L +V EF+    + D++    L G+  LP +      + +G+ + H + ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKDFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 237 DLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 294
           DLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D+
Sbjct: 128 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 295 FSFGIVLWELLTGK 308
           +S G +  E++T +
Sbjct: 188 WSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 195
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 196 SLGCIFAEMVTRR 208

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 102
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 103 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 161 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 220
Query: 308 KL 309
           K+
Sbjct: 221 KI 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 308 KL 309
           K+
Sbjct: 222 KI 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 141
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 142 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 308 KL 309
           K+
Sbjct: 260 KI 261

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 104
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 105 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 308 KL 309
           K+
Sbjct: 223 KI 224

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 96
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 97  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 308 KL 309
           K+
Sbjct: 215 KI 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +++       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  L +V EF     +  Y     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 239 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 296
           K  NLL++ N  +K+ADFG+AR         +AE  T  +  P+V+   K Y    D++S
Sbjct: 128 KPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 297 FGIVLWELLTGKLP 310
            G +  EL     P
Sbjct: 188 AGCIFAELANAARP 201

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 104
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 105 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 308 KL 309
           K+
Sbjct: 223 KI 224

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 97
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 98  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 308 KL 309
           K+
Sbjct: 216 KI 217

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 97
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 98  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 308 KL 309
           K+
Sbjct: 216 KI 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 101/208 (48%), Gaps = 7/208 (3%)
Query: 110 EIDPKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER-INSDMQKEFAQEVFIMR 166
           +++  H +    +  GS+G   + +     +  A+K +  ++ +  +  +   +E+ IM+
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
            + H  +V    +      + +V + + GG +  +L +    FK  ++     ++   ++
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALD 129
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           YL    IIHRD+K  N+L+DE+  V + DF +A +  +   +T   GT  +MAPE+   +
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189
Query: 287 P---YDHKADVFSFGIVLWELLTGKLPY 311
               Y    D +S G+  +ELL G+ PY
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 308 KL 309
           K+
Sbjct: 222 KI 223

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 18/180 (10%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 52  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 105
Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 247
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 106 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 163
Query: 248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
           +  +K+ DFG+AR    S +M     T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 164 DCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+S     +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMT- 269
           L + I +++ + +LH   ++HRDLK +N+    ++VVKV DFG+     Q      V+T 
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 270 --------AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA- 320
                    + GT  +M+PE I    Y HK D+FS G++L+ELL     Y + T ++   
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMERVR 281
Query: 321 -VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
            +  V+    P +     P+   +++      P  RP+ ++IIE
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 95/180 (52%), Gaps = 9/180 (5%)
Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 196
           +Q  A+K++  +R+ ++ QKE      +     H N+V+            +V E ++GG
Sbjct: 36  NQAFAVKIIS-KRMEANTQKEITA---LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91
Query: 197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENEV--VKV 253
            +++ + K K  F       +   +   ++++H   ++HRDLK  NLL  DEN+   +K+
Sbjct: 92  ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 254 ADFGVARVKA-QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
            DFG AR+K   +  +     T  + APE++    YD   D++S G++L+ +L+G++P++
Sbjct: 151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+S     +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 120 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 173
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 174 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMN 226
           V+    CT     +   L +V E +    +  YL K+   GV    ++  +   + +G++
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQLLRGLD 134
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           +LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    D++S G +  E+   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 120/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E M     ++D++ + +G  +          V + + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 129
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 188
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 240
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 241 WCLALRPSDRPTFEEI 256

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 120 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 173
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 174 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMN 226
           V+    CT     +   L +V E +    +  YL K+   GV    ++  +   + +G++
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQLLRGLD 134
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           +LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    D++S G +  E+   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 120 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 173
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 174 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMN 226
           V+    CT     +   L +V E +    +  YL K+   GV    ++  +   + +G++
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQLLRGLD 134
Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           +LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    D++S G +  E+   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 122 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           + SG+ G +     T    +VA+K L     N    K   +E+ +++ V HKN++  +  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 180 CTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
            T   +L       +V E M   ++   +H      ++  LL     +  G+ +LH   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGI 147
Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 293
           IHRDLK +N+++  +  +K+ DFG+AR    + +MT    T  + APEVI    Y    D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVD 207
Query: 294 VFSFGIVLWELLTGKLPYE 312
           ++S G ++ EL+ G + ++
Sbjct: 208 IWSVGCIMGELVKGCVIFQ 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 14/267 (5%)
Query: 109 WEIDPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI-M 165
           +E+    L+   ++  G+YG  +  R     Q  A+K ++   +NS  QK    ++ I  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNSQEQKRLLXDLDISX 87
Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSK 223
           R V     V F GA  +   + I  E         Y   +     +P   L K+A+ + K
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 224 GMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
            + +LH   ++IHRD+K +N+L++    VK  DFG++           + G   + APE 
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPER 207
Query: 283 I----EHKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS- 336
           I      K Y  K+D++S GI   EL   + PY+ + TP Q    VV++   P +P +  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKF 266
Query: 337 QPKLAELLERCWQQDPALRPDFSEIIE 363
             +  +   +C +++   RP + E+ +
Sbjct: 267 SAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 116/237 (48%), Gaps = 32/237 (13%)
Query: 109 WEIDPKHLKFGSKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 162
           +++ P++ +    +  G+YG      D  R T     VAIK + P    +  Q+   +E+
Sbjct: 39  FDVGPRYTQL-QYIGEGAYGMVSSAYDHVRKT----RVAIKKISPFEHQTYCQRTL-REI 92
Query: 163 FIMRKVRHKNVV---QFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LL 215
            I+ + RH+NV+     + A T      + IV + M        L+KL    +L +  + 
Sbjct: 93  QILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETD-----LYKLLKSQQLSNDHIC 147
Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAE 271
                + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+AR+       +G +T  
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 272 TGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 324
             T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 19/198 (9%)
Query: 122 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NV 173
           +  G +G + +       Q VA+K+++ E+      ++ A+E+ I+  +R +      NV
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           +  +   T    +C+  E +S  ++Y+ +  +K +G F LP + K A  + + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKN 219
Query: 232 NIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
            IIH DLK  N+L+ +     +KV DFG +  + Q      ++  YR  APEVI    Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYR--APEVILGARYG 277
Query: 290 HKADVFSFGIVLWELLTG 307
              D++S G +L ELLTG
Sbjct: 278 MPIDMWSLGCILAELLTG 295

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 96/184 (52%), Gaps = 17/184 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     ++ + ++GG 
Sbjct: 48  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 107
Query: 198 VYD------YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---EN 248
           +++      Y  +      +  +L+  +       + HQ  ++HRDLK  NLL+    + 
Sbjct: 108 LFEDIVAREYYSEADASHCIQQILEAVL-------HCHQMGVVHRDLKPENLLLASKLKG 160
Query: 249 EVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
             VK+ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G++L+ LL G
Sbjct: 161 AAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220
Query: 308 KLPY 311
             P+
Sbjct: 221 YPPF 224

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 70/131 (53%), Gaps = 5/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L I+ E M GG ++  +  +    F      ++  D+   + +LH +NI HRD+K  NL
Sbjct: 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159
Query: 244 LMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L    E   V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVI 218
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 219 MYILLCGFPPF 229

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 70/131 (53%), Gaps = 5/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L I+ E M GG ++  +  +    F      ++  D+   + +LH +NI HRD+K  NL
Sbjct: 81  CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 140
Query: 244 LMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L    E   V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G++
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVI 199
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 200 MYILLCGFPPF 210

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 121 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +++       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
                  L +V EF     +  Y     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 239 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 296
           K  NLL++ N  +K+A+FG+AR         +AE  T  +  P+V+   K Y    D++S
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 297 FGIVLWELLTGKLP 310
            G +  EL     P
Sbjct: 188 AGCIFAELANAGRP 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+  ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+  ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 191 SLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 191 SLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 131 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 191 SLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           +  +N V+ + A  K  +L I  E+    ++YD +H      +     ++   + + ++Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------------VKAQSGVMTAET 272
           +H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 273 GTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKG 327
           GT  ++A EV++    Y+ K D++S GI+ +E++    TG      L  L++    V   
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSIE 247
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRP 356
             P    N      +++      DP  RP
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 133 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 192
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 193 SLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 179 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 238 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 295
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 296 SFGIVLWELLTGK 308
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 174
           +++  G+YG +Y  R  +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 175 QFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNY 227
           + +  C    +     + +V E +    +  YL K      LP  ++  +     +G+++
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDF 127
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +     T  + APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    D++S G +  E+   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 179 ACTKPPSLCIVTE--------FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
                  L +V E        FM   +       L G+  LP +      + +G+ + H 
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASA-------LTGI-PLPLIKSYLFQLLQGLAFCHS 120
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPY 288
           + ++HRDLK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 289 DHKADVFSFGIVLWELLTGK 308
               D++S G +  E++T +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 121 KVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                 L +V E +    +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEVIE-HKPYDHKADV 294
             NLL++    +K+ADFG+AR     G+     T E  T  + AP+V+   K Y    D+
Sbjct: 128 PQNLLINREGELKIADFGLARA---FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
           +S G +  E++ G       TPL   V    + +R
Sbjct: 185 WSVGCIFAEMVNG-------TPLFPGVSEADQLMR 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 121 KVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                 L +V E +    +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEVI-EHKPYDHKADV 294
             NLL++    +K+ADFG+AR     G+     T E  T  + AP+V+   K Y    D+
Sbjct: 128 PQNLLINREGELKIADFGLARA---FGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 295 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
           +S G +  E++ G       TPL   V    + +R
Sbjct: 185 WSVGCIFAEMVNG-------TPLFPGVSEADQLMR 212

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 121 KVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                 L +V E +    +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 240 AANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEVI-EHKPYDHKADV 294
             NLL++    +K+ADFG+AR     G+     T E  T  + AP+V+   K Y    D+
Sbjct: 128 PQNLLINREGELKIADFGLARA---FGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 295 FSFGIVLWELLTG 307
           +S G +  E++ G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 66/283 (23%)
Query: 105 GTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKP------ERINSDMQKE 157
           G  + E+  K HLK    +  GSYG + R    +Q  AI+ +K        +IN    + 
Sbjct: 18  GGSLLELQKKYHLK--GAIGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER 74
Query: 158 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
              EV +M+K+ H N+ +          +C+V E   GG + D L+    VF   S  K 
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN----VFIDDSTGKC 130
Query: 218 AIDVSK-------------------------------------------GMNYLHQNNII 234
           A+DV K                                            ++YLH   I 
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190
Query: 235 HRDLKAANLLMDENEV--VKVADFGVAR--VKAQSGV---MTAETGTYRWMAPEVIE--H 285
           HRD+K  N L   N+   +K+ DFG+++   K  +G    MT + GT  ++APEV+   +
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL 328
           + Y  K D +S G++L  LL G +P+  +        V+ K L
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 174
           +++  G+YG +Y  R  +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 175 QFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNY 227
           + +  C    +     + +V E +    +  YL K      LP  ++  +     +G+++
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDF 127
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +     T  + APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    D++S G +  E+   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 122 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
           V SG+YG +           VAIK L     +    K   +E+ +++ +RH+NV+  +  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 180 CTKPPSLCIVTEF-----MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
            T   +L   T+F       G  +   + H+  G  ++  L+   +   KG+ Y+H   I
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML---KGLRYIHAAGI 149
Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKA 292
           IHRDLK  NL ++E+  +K+ DFG+AR +A S  M     T  + APEVI +   Y    
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLAR-QADSE-MXGXVVTRWYRAPEVILNWMRYTQTV 207
Query: 293 DVFSFGIVLWELLTGK 308
           D++S G ++ E++TGK
Sbjct: 208 DIWSVGCIMAEMITGK 223

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 29/283 (10%)
Query: 111 IDPKHLKFGSKVASG--SYGDLYRGTYCSQDVAIK-VLKPERINSDMQKEFAQEVFIMRK 167
           ID KH  F  K+  G  SY DL  G +     A+K +L  E+ +   ++E  +E  + R 
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRL 82
Query: 168 VRHKNVVQFIGACTKPPSL----CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAID 220
             H N+++ +  C +         ++  F   G++++ + +LK          +L + + 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-----VARVKAQSGVMT-----A 270
           + +G+  +H     HRDLK  N+L+ +     + D G        V+     +T     A
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 271 ETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV-VQK 326
           +  T  + APE+     H   D + DV+S G VL+ ++ G+ PY+ +     +V + VQ 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262
Query: 327 GLR-PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            L  P  P++S   L +LL      DP  RP    ++  L+ +
Sbjct: 263 QLSIPQSPRHSS-ALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 174
           +++  G+YG +Y  R  +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 175 QFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNY 227
           + +  C    +     + +V E +    +  YL K      LP  ++  +     +G+++
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDF 127
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +     T  + APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    D++S G +  E+   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 125
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 236
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 237 WCLALRPSDRPTFEEI 252

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 269
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 268
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 269
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 268
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 13/104 (12%)
Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--------- 265
           L + + +++ + +LH   ++HRDLK +N+    ++VVKV DFG+     Q          
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 266 ----GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
                  T + GT  +M+PE I    Y HK D+FS G++L+ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 48/296 (16%)
Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDV------AIKVLKPERINSDMQKEFAQEVF 163
           E+    L+    +A G +  +Y     +QDV      A+K L       +  +   QEV 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYE----AQDVGSGREYALKRLLSN--EEEKNRAIIQEVC 77
Query: 164 IMRKVR-HKNVVQFIGAC--------TKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLP 212
            M+K+  H N+VQF  A         T      ++TE +  G + ++L K+  +G     
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCD 136
Query: 213 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARV--------- 261
           ++LK+     + + ++H+    IIHRDLK  NLL+     +K+ DFG A           
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 262 KAQSGVMTAE----TGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYL 314
            AQ   +  E      T  +  PE+I+   + P   K D+++ G +L+ L   + P+E  
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ-DPALRPDFSEIIEILQQIA 369
             L+     +  G     P ++Q  +   L R   Q +P  R   +E++  LQ+IA
Sbjct: 257 AKLR-----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 10  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 128
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 187
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 239
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 240 WCLALRPSDRPTFEEI 255

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HLIR 268
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 120/248 (48%), Gaps = 15/248 (6%)
Query: 122 VASGSYGDLY-----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN-V 173
           + +G+YG ++      G    +  A+KVLK   I   +   +    E  ++  +R    +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V    A      L ++ ++++GG ++ +L + +   +    + V  ++   + +LH+  I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGI 180
Query: 234 IHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVIE--HKPYD 289
           I+RD+K  N+L+D N  V + DFG+++  V  ++       GT  +MAP+++      +D
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 347
              D +S G++++ELLTG  P+       +   + ++ L+  P  P+       +L++R 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300
Query: 348 WQQDPALR 355
             +DP  R
Sbjct: 301 LMKDPKKR 308

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HLIR 269
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 125
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 236
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 237 WCLALRPSDRPTFEEI 252

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HLIR 269
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 94  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 153
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 154 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 213
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 214 MYILLCGYPPF 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 125
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 236
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 237 WCLALRPSDRPTFEEI 252

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 130
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 189
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 241
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 242 WCLALRPSDRPTFEEI 257

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 93  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 152
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 153 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 212
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 213 MYILLCGYPPF 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 95  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 154
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 155 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 214
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 215 MYILLCGYPPF 225

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 130
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 189
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 241
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 242 WCLALRPSDRPTFEEI 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 129
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 188
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 240
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 241 WCLALRPSDRPTFEEI 256

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 186 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 245 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 302 WELLTGKLPY 311
           + LL G  P+
Sbjct: 254 YILLCGYPPF 263

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 268
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 88  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 147
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 148 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 207
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 208 MYILLCGYPPF 218

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 103 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 162
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 163 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 222
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 223 MYILLCGYPPF 233

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 146
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 147 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 206
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 207 MYILLCGYPPF 217

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 130
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 189
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 241
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 242 WCLALRPSDRPTFEEI 257

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A      L +V E+M GG + + +       K         +V   ++ +H   +IHRD+
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 200
Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 292
           K  N+L+D++  +K+ADFG      ++G++  +T  GT  +++PEV++ +     Y  + 
Sbjct: 201 KPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGREC 260
Query: 293 DVFSFGIVLWELLTGKLPY 311
           D +S G+ L+E+L G  P+
Sbjct: 261 DWWSVGVFLFEMLVGDTPF 279

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 186 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 245 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259
Query: 302 WELLTGKLPY 311
           + LL G  P+
Sbjct: 260 YILLCGYPPF 269

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 149 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 208
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 209 MYILLCGYPPF 219

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 145
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 204
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 256
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 257 WCLALRPSDRPTFEEI 272

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 149 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 208
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 209 MYILLCGYPPF 219

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 34  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 93
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 94  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 152
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 211
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 263
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 264 WCLALRPSDRPTFEEI 279

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 144
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 203
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 255
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 256 WCLALRPSDRPTFEEI 271

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 172
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 231
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 283
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 284 WCLALRPSDRPTFEEI 299

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 59  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 118
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 119 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 177
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 236
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 288
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 289 WCLALRPSDRPTFEEI 304

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 145
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 204
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 256
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 257 WCLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 164
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 223
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 275
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 276 WCLALRPSDRPTFEEI 291

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 144
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 203
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 255
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 256 WCLALRPSDRPTFEEI 271

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 121 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 179 ACTKPPSLCIVTE--------FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
                  L +V E        FM   +       L G+  LP +      + +G+ + H 
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASA-------LTGI-PLPLIKSYLFQLLQGLAFCHS 124
Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPY 288
           + ++HRDLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 289 DHKADVFSFGIVLWELLTGK 308
               D++S G +  E++T +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 172
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 231
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 283
Query: 346 RCWQQDPALRPDFSEI 361
            C    P+ RP F EI
Sbjct: 284 WCLALRPSDRPTFEEI 299

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 185 SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
            L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NL
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 146
Query: 244 LMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 147 LYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 206
Query: 301 LWELLTGKLPY 311
           ++ LL G  P+
Sbjct: 207 MYILLCGYPPF 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVR---HK 171
           +++  G+YG +Y  R  +    VA+K ++          +     +EV ++R++    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 172 NVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKG 224
           NVV+ +  C    +     + +V E +    +  YL K      LP  ++  +     +G
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRG 132
Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
           +++LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +T    T  + APEV+ 
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192
Query: 285 HKPYDHKADVFSFGIVLWELLTGK 308
              Y    D++S G +  E+   K
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 21/256 (8%)
Query: 117 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 171 --KNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 145
Query: 228 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 285
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 204
Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 256
Query: 346 RCWQQDPALRPDFSEI 361
            C    P  RP F EI
Sbjct: 257 WCLALRPXDRPTFEEI 272

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 95/184 (51%), Gaps = 17/184 (9%)
Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           Q+ A  ++  +++++   ++  +E  I R ++H N+V+   + ++     ++ + ++GG 
Sbjct: 37  QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96
Query: 198 VYD------YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---EN 248
           +++      Y  +      +  +L+  +       + HQ  ++HR+LK  NLL+    + 
Sbjct: 97  LFEDIVAREYYSEADASHCIQQILEAVL-------HCHQMGVVHRNLKPENLLLASKLKG 149
Query: 249 EVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 307
             VK+ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G++L+ LL G
Sbjct: 150 AAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
Query: 308 KLPY 311
             P+
Sbjct: 210 YPPF 213

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 127 YGDLYRGTY---------CS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
           Y D+ +G +         C+  + A K++  +++++   ++  +E  I R ++H N+V+ 
Sbjct: 9   YEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 177 IGACTKPPSLCIVTEFMSGGSVYD------YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
             + ++     +V + ++GG +++      Y  +      +  +L+  +       + HQ
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ 121
Query: 231 NNIIHRDLKAANLLMD---ENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHK 286
             ++HRDLK  NLL+    +   VK+ADFG+A  V+          GT  +++PEV+  +
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
            Y    D+++ G++L+ LL G  P+
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPF 206

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           +KN+++ I          +V E + GGS+  ++ K K  F      +V  DV+  +++LH
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH 128
Query: 230 QNNIIHRDLKAANLLMDENEV---VKVADF----GVARVKAQSGVMTAE----TGTYRWM 278
              I HRDLK  N+L +  E    VK+ DF    G+    + + + T E     G+  +M
Sbjct: 129 TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 279 APEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPY 311
           APEV+E        YD + D++S G+VL+ +L+G  P+
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 4/130 (3%)
Query: 186 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 245 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D +S G++ 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIX 253
Query: 302 WELLTGKLPY 311
           + LL G  P+
Sbjct: 254 YILLCGYPPF 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           +  +N V+   A  K  +L I  E+    ++YD +H      +     ++   + + ++Y
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------------VKAQSGVMTAET 272
           +H   IIHR+LK  N+ +DE+  VK+ DFG+A+               +   S  +T+  
Sbjct: 132 IHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 273 GTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKG 327
           GT  ++A EV++    Y+ K D +S GI+ +E +    TG      L  L++    V   
Sbjct: 192 GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRS----VSIE 247
Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRP 356
             P    N      +++      DP  RP
Sbjct: 248 FPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHR 236
           A      L +V E+M GG     L  L   + +P         +V   ++ +H    IHR
Sbjct: 142 AFQDDRYLYMVMEYMPGGD----LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDH 290
           D+K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 257
Query: 291 KADVFSFGIVLWELLTGKLPY 311
           + D +S G+ L+E+L G  P+
Sbjct: 258 ECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHR 236
           A      L +V E+M GG     L  L   + +P         +V   ++ +H    IHR
Sbjct: 137 AFQDDRYLYMVMEYMPGGD----LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDH 290
           D+K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252
Query: 291 KADVFSFGIVLWELLTGKLPY 311
           + D +S G+ L+E+L G  P+
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 122 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHR 236
           A      L +V E+M GG     L  L   + +P         +V   ++ +H    IHR
Sbjct: 142 AFQDDRYLYMVMEYMPGGD----LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDH 290
           D+K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 257
Query: 291 KADVFSFGIVLWELLTGKLPY 311
           + D +S G+ L+E+L G  P+
Sbjct: 258 ECDWWSVGVFLYEMLVGDTPF 278

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 118 FGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
            G  +  GSYG     L   T C + V I   K  R   + +    +E+ ++R++RHKNV
Sbjct: 9   MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 174 VQFIGAC--TKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           +Q +      +   + +V E+   G   + D + + +  F +         +  G+ YLH
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLH 126
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVIE-- 284
              I+H+D+K  NLL+     +K++  GVA      A         G+  +  PE+    
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 285 HKPYDHKADVFSFGIVLWELLTGKLPYE--YLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
                 K D++S G+ L+ + TG  P+E   +  L   +G   KG    IP +  P L++
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG---KGSY-AIPGDCGPPLSD 242
Query: 343 LLERCWQQDPALRPDFSEI 361
           LL+   + +PA R    +I
Sbjct: 243 LLKGMLEYEPAKRFSIRQI 261

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 34/269 (12%)
Query: 121 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           ++  GS+G+++R      G  C+ + V ++V +            A+E+     +    +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR------------AEELMACAGLTSPRI 147
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V   GA  + P + I  E + GGS+   L K +G       L       +G+ YLH   I
Sbjct: 148 VPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRI 206
Query: 234 IHRDLKAANLLM-DENEVVKVADFGVARVKAQSG----VMTAE--TGTYRWMAPEVIEHK 286
           +H D+KA N+L+  +     + DFG A      G    ++T +   GT   MAPEV+  +
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYE--YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
             D K DV+S   ++  +L G  P+   +  PL   +      +R  IP +  P  A+ +
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAI 325
Query: 345 ERCWQQDPALRPDFSE----IIEILQQIA 369
           +   +++P  R   +E    +   LQQ+ 
Sbjct: 326 QEGLRKEPIHRVSAAELGGKVNRALQQVG 354

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 34/269 (12%)
Query: 121 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           ++  GS+G+++R      G  C+ + V ++V +            A+E+     +    +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR------------AEELMACAGLTSPRI 128
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V   GA  + P + I  E + GGS+   L K +G       L       +G+ YLH   I
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRI 187
Query: 234 IHRDLKAANLLM-DENEVVKVADFGVARVKAQSG----VMTAE--TGTYRWMAPEVIEHK 286
           +H D+KA N+L+  +     + DFG A      G    ++T +   GT   MAPEV+  +
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 287 PYDHKADVFSFGIVLWELLTGKLPYE--YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 344
             D K DV+S   ++  +L G  P+   +  PL   +      +R  IP +  P  A+ +
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAI 306
Query: 345 ERCWQQDPALRPDFSE----IIEILQQIA 369
           +   +++P  R   +E    +   LQQ+ 
Sbjct: 307 QEGLRKEPIHRVSAAELGGKVNRALQQVG 335

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 39/200 (19%)
Query: 136 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 179
           C + VAIK +    + +D Q  K   +E+ I+R++ H N+V+               +G+
Sbjct: 35  CDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 234
            T+  S+ IV E+M           L  V +   LL+         + +G+ Y+H  N++
Sbjct: 91  LTELNSVYIVQEYMET--------DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVL 142
Query: 235 HRDLKAANLLMD-ENEVVKVADFGVARVK----AQSGVMTAETGTYRWMAPE-VIEHKPY 288
           HRDLK ANL ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P  ++    Y
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202
Query: 289 DHKADVFSFGIVLWELLTGK 308
               D+++ G +  E+LTGK
Sbjct: 203 TKAIDMWAAGCIFAEMLTGK 222

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 157 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY------LHKLKGVFK 210
           +F  E+ I+  ++++  +   G  T    + I+ E+M   S+  +      L K    F 
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 211 LPSLLKVAI-DVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 268
              ++K  I  V    +Y+H + NI HRD+K +N+LMD+N  VK++DFG +       + 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI- 207
Query: 269 TAETGTYRWMAPEVIEHK-PYD-HKADVFSFGIVLWELLTGKLPY 311
               GTY +M PE   ++  Y+  K D++S GI L+ +    +P+
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 120 SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 177
           +K+  G+YG++Y+   T  ++ VAIK ++ E     +     +EV ++++++H+N+++  
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
                   L ++ E+ +   +  Y+ K   V  +  +      +  G+N+ H    +HRD
Sbjct: 100 SVIHHNHRLHLIFEY-AENDLKKYMDKNPDV-SMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 238 LKAANLLM-----DENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEV-IEHKP 287
           LK  NLL+      E  V+K+ DFG+AR     G+     T E  T  +  PE+ +  + 
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 288 YDHKADVFSFGIVLWELL 305
           Y    D++S   +  E+L
Sbjct: 215 YSTSVDIWSIACIWAEML 232

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 121 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 174
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 16  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 72
Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 132
Query: 232 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 271
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 133 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 188
Query: 272 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 189 EGDSRFLANEVLQEN-YTHLPKADIFALALTVV-CAAGAEP---LPRNGDQWHEIRQGRL 243
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRP 356
           P IP+    +  ELL+     DP  RP
Sbjct: 244 PRIPQVLSQEFTELLKVMIHPDPERRP 270

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 121 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 174
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 18  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 232 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 271
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 190
Query: 272 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 191 EGDSRFLANEVLQEN-YTHLPKADIFALALTVV-CAAGAEP---LPRNGDQWHEIRQGRL 245
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRP 356
           P IP+    +  ELL+     DP  RP
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRP 272

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 121 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 174
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 14  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 70
Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 71  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 130
Query: 232 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 271
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 131 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 186
Query: 272 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 187 EGDSRFLANEVLQEN-YTHLPKADIFALALTVVX-AAGAEP---LPRNGDQWHEIRQGRL 241
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRP 356
           P IP+    +  ELL+     DP  RP
Sbjct: 242 PRIPQVLSQEFTELLKVMIHPDPERRP 268

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 121 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 174
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 16  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 72
Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 132
Query: 232 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 271
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 133 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 188
Query: 272 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 189 EGDSRFLANEVLQEN-YTHLPKADIFALALTVV-CAAGAEP---LPRNGDQWHEIRQGRL 243
Query: 330 PTIPKNSQPKLAELLERCWQQDPALRP 356
           P IP+    +  ELL+     DP  RP
Sbjct: 244 PRIPQVLSQEFTELLKVMIHPDPERRP 270

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 121 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           +V  GS+G+++R      G  C+ + V ++V + E            E+     +    +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------------ELVACAGLSSPRI 112
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V   GA  + P + I  E + GGS+   + ++ G       L       +G+ YLH   I
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 234 IHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGV----MTAE--TGTYRWMAPEVIEHK 286
           +H D+KA N+L+  +     + DFG A      G+    +T +   GT   MAPEV+  K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
           P D K D++S   ++  +L G  P+
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 121 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           +V  GS+G+++R      G  C+ + V ++V + E            E+     +    +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------------ELVACAGLSSPRI 128
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V   GA  + P + I  E + GGS+   + ++ G       L       +G+ YLH   I
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRI 187
Query: 234 IHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGV----MTAE--TGTYRWMAPEVIEHK 286
           +H D+KA N+L+  +     + DFG A      G+    +T +   GT   MAPEV+  K
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
           P D K D++S   ++  +L G  P+
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 120/255 (47%), Gaps = 33/255 (12%)
Query: 130 LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKV-RHKNVVQFIGACT-KPPSL 186
           +YRG + ++DVA+K + PE  +      FA +EV ++R+   H NV+++   CT K    
Sbjct: 41  VYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYF--CTEKDRQF 92
Query: 187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 246
             +   +   ++ +Y+ +          + +    + G+ +LH  NI+HRDLK  N+L+ 
Sbjct: 93  QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152
Query: 247 ENEV-----VKVADFGVARVKA--------QSGVMTAETGTYRWMAPEVIEHKPYD---H 290
                      ++DFG+ +  A        +SGV     GT  W+APE++     +   +
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV----PGTEGWIAPEMLSEDCKENPTY 208
Query: 291 KADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA-ELLERCW 348
             D+FS G V + +++ G  P+      QA + +    L    P+  +  +A EL+E+  
Sbjct: 209 TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMI 268
Query: 349 QQDPALRPDFSEIIE 363
             DP  RP    +++
Sbjct: 269 AMDPQKRPSAKHVLK 283

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 128/286 (44%), Gaps = 29/286 (10%)
Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKV--LKPERINSDMQKEFAQ 160
           G+ V  + P + + G K+  G++G+L  G   Y ++ VAIK+  +K       ++  F +
Sbjct: 1   GSGVLMVGP-NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK 59
Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           ++     +     V + G C K  ++  V E + G S+ D        F L ++L +AI 
Sbjct: 60  QLGSGDGIPQ---VYYFGPCGKYNAM--VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQ 113
Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARV----KAQSGVMTAE 271
           +   M Y+H  N+I+RD+K  N L+        +V+ + DFG+A+     + +  +   E
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYRE 173
Query: 272 ----TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE-----YLTPLQAAVG 322
               TGT R+M+      K    + D+ + G +    L G LP++      L      +G
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
Query: 323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
             ++     +   + P++A  L    + D   +PD+  + ++   +
Sbjct: 234 DTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 92
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 210
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 232
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 81
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 199
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 99
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 217
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 88
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 206
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 116 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA----QEVFIMRKVR 169
            +  S +  G+YG +   T+    + VAIK ++P       +  FA    +E+ I++  +
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-----KPLFALRTLREIKILKHFK 67
Query: 170 HKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDV 221
           H+N++  I    +P S      + I+ E M        LH++     L    +       
Sbjct: 68  HENIIT-IFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQT 121
Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-----------MTA 270
            + +  LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S             MT 
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 271 ETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELL 305
              T  + APEV +    Y    DV+S G +L EL 
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 129 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 188
           +L R     + V ++ +  E  +++M      E+ + +   H N+V +         L +
Sbjct: 28  NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 87
Query: 189 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 246
           VT FM+ GS  D +  H + G+ +L ++  +   V K ++Y+H    +HR +KA+++L+ 
Sbjct: 88  VTSFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 146
Query: 247 ENEVVKVADFG-----VARVKAQSGVMTAETGTYR---WMAPEVIEH--KPYDHKADVFS 296
            +  V ++        ++  + Q  V      + +   W++PEV++   + YD K+D++S
Sbjct: 147 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 206
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAV---------------------------GVVQKGLR 329
            GI   EL  G +P++ +   Q  +                            V   GL 
Sbjct: 207 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 266
Query: 330 PTI------PKNS-----------QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK 370
            ++      P N             P     +E+C Q++P  RP  S ++     +QI +
Sbjct: 267 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 326

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 92
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 210
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 121 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           ++  GS+G+++R      G  C+ + V ++V + E            E+     +    +
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------------ELVACAGLSSPRI 126
Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V   GA  + P + I  E + GGS+   + ++ G       L       +G+ YLH   I
Sbjct: 127 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRI 185
Query: 234 IHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGV----MTAE--TGTYRWMAPEVIEHK 286
           +H D+KA N+L+  +     + DFG A      G+    +T +   GT   MAPEV+  K
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
           P D K D++S   ++  +L G  P+
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 129 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 188
           +L R     + V ++ +  E  +++M      E+ + +   H N+V +         L +
Sbjct: 44  NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103
Query: 189 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 246
           VT FM+ GS  D +  H + G+ +L ++  +   V K ++Y+H    +HR +KA+++L+ 
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 162
Query: 247 ENEVVKVADFG-----VARVKAQSGVMTAETGTYR---WMAPEVIEH--KPYDHKADVFS 296
            +  V ++        ++  + Q  V      + +   W++PEV++   + YD K+D++S
Sbjct: 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 297 FGIVLWELLTGKLPYEYLTPLQAAV---------------------------GVVQKGLR 329
            GI   EL  G +P++ +   Q  +                            V   GL 
Sbjct: 223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 282
Query: 330 PTI------PKNS-----------QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK 370
            ++      P N             P     +E+C Q++P  RP  S ++     +QI +
Sbjct: 283 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 84
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 202
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 203 DYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 120 SKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHK 171
           S + SG++G ++       +++V +K +K E++  D   E         E+ I+ +V H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLH 229
           N+++ +          +V E    GS  D    +    +L   L   I   +   + YL 
Sbjct: 90  NIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 289
             +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+   PY 
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 290 H-KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVG---VVQKGLRPTIPKNSQP------ 338
             + +++S G+ L+ L+  + P+ E    ++AA+    +V K L   +    QP      
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRT 267
Query: 339 KLAELLERCWQQDPALRPDFS 359
            L +L+   W   P    D++
Sbjct: 268 TLEKLVTDPWVTQPVNLADYT 288

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 93
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 211
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 212 DYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 122 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEVFIMRKVRHKNVVQFIGA 179
           +  GSYG +Y     + +  + + K  R+  D+   K   +E+ I+ +++   +++    
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLHQNNI 233
              P  L    E      + D    LK +FK P  L       +  ++  G N++H++ I
Sbjct: 94  II-PDDLLKFDELYIVLEIAD--SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGI 150
Query: 234 IHRDLKAANLLMDENEVVKVADFGVARV-----------------------KAQSGVMTA 270
           IHRDLK AN L++++  VKV DFG+AR                        K     +T+
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 271 ETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT 306
              T  + APE+I   + Y    D++S G +  ELL 
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 108
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 226
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 85
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 203
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 232
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 122 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 175
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 159
Query: 176 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 230
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 231 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 286
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 220 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 277
Query: 287 PYDHKADVFSFGIVLWELLTGK 308
            Y    DV+S G VL ELL G+
Sbjct: 278 DYTSSIDVWSAGCVLAELLLGQ 299
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	397
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-161
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-152
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-151
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-151
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-150
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-149
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-147
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-144
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-142
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-124
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-120
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-119
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-118
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-115
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-103
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-92
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-92
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-91
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-91
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-91
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-90
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-90
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-89
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-89
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-89
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-88
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-88
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-87
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-87
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-87
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-86
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-86
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-86
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-86
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-85
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-85
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-85
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-85
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-84
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-84
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-83
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-81
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-81
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-81
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-81
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-81
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-81
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-81
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-80
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-80
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-80
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-80
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-80
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-80
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-80
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-80
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-79
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-79
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-79
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-79
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-78
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-78
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-78
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-77
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-71
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-65
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-65
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-63
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-62
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-62
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-61
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-61
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-61
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-60
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-59
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-57
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-57
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-57
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-57
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-56
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-56
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-56
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-56
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-56
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-55
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-55
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-55
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-55
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-54
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-54
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-54
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-53
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-50
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-50
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-49
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-48
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-48
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-48
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-46
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-45
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-45
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-44
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-43
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-43
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-42
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-40
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-39
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-39
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-39
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-38
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-38
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-38
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-38
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-38
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-38
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-37
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-37
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-36
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-36
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-36
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-36
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-35
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-35
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-35
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-35
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-35
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-34
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-34
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-34
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-34
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-34
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-33
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-33
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-32
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-32
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-30
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-30
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-30
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-30
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-29
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-29
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-28
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-28
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-28
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-28
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-27
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-27
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-27
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-27
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-27
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-27
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-27
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-25
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-25
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-25
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-24
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-23
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-23
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-20
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-19
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-18
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1u8s_A	192	Glycine cleavage system transcriptional repressor,	3e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  454 bits (1170), Expect = e-161
 Identities = 117/300 (39%), Positives = 182/300 (60%), Gaps = 8/300 (2%)

Query: 78  HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 137
           H    P S+ +    ++  +   +  D     +I    L    K+ +GS+G ++R  +  
Sbjct: 4   HHHHHPMSDYDIPTTENLYFQGAMDGD---DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
            DVA+K+L  +  +++   EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 198 VYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKV 253
           +Y  LHK     +L     L +A DV+KGMNYLH  N  I+HR+LK+ NLL+D+   VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 254 ADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
            DFG++R+KA + +   +  GT  WMAPEV+  +P + K+DV+SFG++LWEL T + P+ 
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 372
            L P Q    V  K  R  IP+N  P++A ++E CW  +P  RP F+ I+++L+ + K  
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  430 bits (1108), Expect = e-152
 Identities = 101/289 (34%), Positives = 164/289 (56%), Gaps = 12/289 (4%)

Query: 93  KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS 152
           K H +H     D  D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L       
Sbjct: 3   KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTP 61

Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 212
              + F  EV ++RK RH N++ F+G  T P  L IVT++  G S+Y +LH  +  F++ 
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK 120

Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMT 269
            L+ +A   ++GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++   S    
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180

Query: 270 AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 326
             +G+  WMAPEVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240

Query: 327 GLR----PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           G        +  N   ++  L+  C ++    RP F  I+  ++++A+E
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  428 bits (1103), Expect = e-151
 Identities = 92/304 (30%), Positives = 137/304 (45%), Gaps = 17/304 (5%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
               P  L  G  +  G +G   + T+      + + +  R + + Q+ F +EV +MR +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H NV++FIG   K   L  +TE++ GG++   +  +   +     +  A D++ GM YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA---------------QSGVMTAETG 273
           H  NIIHRDL + N L+ EN+ V VADFG+AR+                          G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 274 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV-VQKGLRPTI 332
              WMAPE+I  + YD K DVFSFGIVL E++          P     G+ V+  L    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK-EKSSGGFLSV 391
           P N  P    +  RC   DP  RP F ++   L+ +   +        + E+   GF   
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304

Query: 392 LRRG 395
            RRG
Sbjct: 305 YRRG 308

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  425 bits (1095), Expect = e-150
 Identities = 95/274 (34%), Positives = 147/274 (53%), Gaps = 16/274 (5%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIM 165
           + EID   L     +  G +G +YR  +   +VA+K  + +     S   +   QE  + 
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
             ++H N++   G C K P+LC+V EF  GG +   L   +       L+  A+ +++GM
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118

Query: 226 NYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADFGVARVKAQSGVMTAETGT 274
           NYLH      IIHRDLK++N+L+ +        N+++K+ DFG+AR   ++  M+A  G 
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177

Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           Y WMAPEVI    +   +DV+S+G++LWELLTG++P+  +  L  A GV    L   IP 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                 A+L+E CW  DP  RP F+ I++ L  I
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  421 bits (1084), Expect = e-149
 Identities = 83/271 (30%), Positives = 149/271 (54%), Gaps = 12/271 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
             ID K L F +K+     G+L++G +   D+ +KVLK    ++   ++F +E   +R  
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 169 RHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 225
            H NV+  +GAC  PP+    ++T +M  GS+Y+ LH+    V      +K A+D+++GM
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 226 NYLH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 283
            +LH  +  I    L + ++++DE+   +++   V                  W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180

Query: 284 EHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
           + KP D     AD++SF ++LWEL+T ++P+  L+ ++  + V  +GLRPTIP    P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           ++L++ C  +DPA RP F  I+ IL+++  +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  419 bits (1078), Expect = e-147
 Identities = 83/305 (27%), Positives = 150/305 (49%), Gaps = 19/305 (6%)

Query: 83  PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAI 142
           P         +S P      +     W+I  + L+ G  +  G +G +Y G +   +VAI
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAI 60

Query: 143 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 202
           +++  ER N D  K F +EV   R+ RH+NVV F+GAC  PP L I+T    G ++Y  +
Sbjct: 61  RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120

Query: 203 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 262
              K V  +    ++A ++ KGM YLH   I+H+DLK+ N+  D    V + DFG+  + 
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSIS 179

Query: 263 A------QSGVMTAETGTYRWMAPEVI---------EHKPYDHKADVFSFGIVLWELLTG 307
                  +   +  + G    +APE+I         +  P+   +DVF+ G + +EL   
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239

Query: 308 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK-LAELLERCWQQDPALRPDFSEIIEILQ 366
           + P++        +  +  G++P + +    K ++++L  CW  +   RP F++++++L+
Sbjct: 240 EWPFKTQPAEA-IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

Query: 367 QIAKE 371
           ++ K 
Sbjct: 299 KLPKR 303

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  410 bits (1056), Expect = e-144
 Identities = 85/285 (29%), Positives = 150/285 (52%), Gaps = 22/285 (7%)

Query: 102 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ---- 155
               + +  +    +++  ++  G +G +++G        VAIK L       + +    
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 156 -KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 214
            +EF +EVFIM  + H N+V+  G    PP   +V EF+  G +Y  L       K    
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124

Query: 215 LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGV 267
           L++ +D++ G+ Y+   N  I+HRDL++ N+ +   +       KVADFG+++    S  
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182

Query: 268 MTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--GV 323
           ++   G ++WMAPE I  E + Y  KAD +SF ++L+ +LTG+ P++  +  +      +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            ++GLRPTIP++  P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  407 bits (1047), Expect = e-142
 Identities = 94/285 (32%), Positives = 149/285 (52%), Gaps = 15/285 (5%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           +  ID K ++    V  G++G + +  + ++DVAIK ++ E      +K F  E+  + +
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGM 225
           V H N+V+  GAC  P  +C+V E+  GGS+Y+ LH  + +        +   +  S+G+
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 226 NYLHQ---NNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
            YLH      +IHRDLK  NLL+     V+K+ DFG A        MT   G+  WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKL 340
           V E   Y  K DVFS+GI+LWE++T + P++ +  P    +  V  G RP + KN    +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSS 385
             L+ RCW +DP+ RP   EI++I+  + +     +E  +     
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  361 bits (928), Expect = e-124
 Identities = 81/307 (26%), Positives = 137/307 (44%), Gaps = 48/307 (15%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           V     K ++   ++  G YG+++ G +  + VA+KV       S  ++    E++    
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87

Query: 168 VRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +RH+N++ FI A  K       L ++T++   GS+YDYL          S+LK+A     
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145

Query: 224 GMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 270
           G+ +LH        +  I HRDLK+ N+L+ +N    +AD G+A                
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 271 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 314
             GT R+M PEV++      H      AD++SFG++LWE+             +LPY  L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 315 TPLQAAVG-----VVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEI 364
            P   +       V  K LRP+ P          ++ +L+  CW  +PA R     + + 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 365 LQQIAKE 371
           L ++++ 
Sbjct: 326 LAKMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  350 bits (899), Expect = e-120
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           + +     V  G YG+++RG++  ++VA+K+       S  ++    E++    +RH+N+
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENI 64

Query: 174 VQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           + FI +          L ++T +   GS+YDYL          S L++ + ++ G+ +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLH 122

Query: 230 --------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYR 276
                   +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 277 WMAPEVIEHKP------YDHKADVFSFGIVLWELLTG----------KLPYEYLTPLQAA 320
           +MAPEV++            + D+++FG+VLWE+             K P+  + P   +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 321 V-----GVVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                  V     RP IP           LA+L++ CW Q+P+ R     I + L +I
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  345 bits (888), Expect = e-118
 Identities = 79/309 (25%), Positives = 145/309 (46%), Gaps = 48/309 (15%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           V     + +     +  G +G+++RG +  ++VA+K+       S  ++    E++    
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92

Query: 168 VRHKNVVQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           +RH+N++ FI A  K       L +V+++   GS++DYL++      +  ++K+A+  + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150

Query: 224 GMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 270
           G+ +LH           I HRDLK+ N+L+ +N    +AD G+A     +          
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 271 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 314
             GT R+MAPEV++      H     +AD+++ G+V WE+             +LPY  L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 315 TPLQAAVG-----VVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEI 364
            P   +V      V ++ LRP IP   Q       +A+++  CW  + A R     I + 
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 365 LQQIAKEVG 373
           L Q++++ G
Sbjct: 331 LSQLSQQEG 339

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  339 bits (870), Expect = e-115
 Identities = 82/309 (26%), Positives = 139/309 (44%), Gaps = 48/309 (15%)

Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           GT+        L+     A G +G +++    ++ VA+K+   +        +   EV+ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYS 71

Query: 165 MRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           +  ++H+N++QFIGA  +  S    L ++T F   GS+ D+L     V     L  +A  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129

Query: 221 VSKGMNYLHQN----------NIIHRDLKAANLLMDENEVVKVADFGVARVK---AQSGV 267
           +++G+ YLH++           I HRD+K+ N+L+  N    +ADFG+A        +G 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 268 MTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPY-----EYLTPL 317
              + GT R+MAPEV+E      +    + D+++ G+VLWEL +          EY+ P 
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 318 QAAVG-----------VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEI 361
           +  +G           VV K  RP +    Q       L E +E CW  D   R     +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 362 IEILQQIAK 370
            E + Q+ +
Sbjct: 310 GERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  309 bits (792), Expect = e-103
 Identities = 75/320 (23%), Positives = 130/320 (40%), Gaps = 63/320 (19%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE--VFIMR 166
             +D  +LK    +  G YG +Y+G+   + VA+KV        + Q  F  E  ++ + 
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA----NRQ-NFINEKNIYRVP 62

Query: 167 KVRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
            + H N+ +FI    +  +       +V E+   GS+  YL          S  ++A  V
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120

Query: 222 SKGMNYLH---------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--------- 263
           ++G+ YLH         +  I HRDL + N+L+  +    ++DFG++             
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 264 QSGVMTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELL---TGKLPYEY 313
           +     +E GT R+MAPEV+E        +    + D+++ G++ WE+    T   P E 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

Query: 314 LTPLQAA---------------VGVVQKGLRPTIPKN------SQPKLAELLERCWQQDP 352
           +   Q A               V V ++  RP  P+       +   L E +E CW QD 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300

Query: 353 ALRPDFSEIIEILQQIAKEV 372
             R       E + ++    
Sbjct: 301 EARLTAQXAEERMAELMMIW 320

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  286 bits (734), Expect = 3e-94
 Identities = 93/272 (34%), Positives = 147/272 (54%), Gaps = 10/272 (3%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D W ++ + L  G ++  G++G+++ G     +  VA+K  + E +  D++ +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           +++  H N+V+ IG CT+   + IV E + GG    +L       ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAP 280
           M YL     IHRDL A N L+ E  V+K++DFG++R     GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E + +  Y  ++DV+SFGI+LWE  + G  PY  L+  Q     V+KG R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDA 343

Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           +  L+E+CW  +P  RP FS I + LQ I K 
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  277 bits (712), Expect = 2e-92
 Identities = 96/267 (35%), Positives = 156/267 (58%), Gaps = 10/267 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           W IDP  L F  ++ SG +G ++ G + ++  VAIK ++     +  +++F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMK 59

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           + H  +VQ  G C +   +C+VTEFM  G + DYL   +G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 284
           L +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              Y  K+DV+SFG+++WE+ + GK+PYE  +     V  +  G R   P+ +   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQI 237

Query: 344 LERCWQQDPALRPDFSEIIEILQQIAK 370
           +  CW++ P  RP FS ++  L +IA+
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  277 bits (712), Expect = 3e-92
 Identities = 102/292 (34%), Positives = 162/292 (55%), Gaps = 14/292 (4%)

Query: 102 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 159
           PN   D WE++   +    K+  G YG++Y G +   S  VA+K LK    ++   +EF 
Sbjct: 3   PNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL 57

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVA 218
           +E  +M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +          LL +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 275
             +S  M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPI 176

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           +W APE + +  +  K+DV++FG++LWE+ T G  PY  +   Q    +++K  R   P+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPE 235

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSG 386
               K+ EL+  CWQ +P+ RP F+EI +  + + +E    +E  ++    G
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  277 bits (711), Expect = 4e-92
 Identities = 90/270 (33%), Positives = 150/270 (55%), Gaps = 10/270 (3%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
             WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K     S  + EF +E  +M
Sbjct: 17  GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVM 73

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
             + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 282
            YL     +HRDL A N L+++  VVKV+DFG++R        T+  G+    RW  PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192

Query: 283 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
           + +  +  K+D+++FG+++WE+ + GK+PYE  T        + +GLR   P  +  K+ 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY 251

Query: 342 ELLERCWQQDPALRPDFSEIIEILQQIAKE 371
            ++  CW +    RP F  ++  +  +  E
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  277 bits (711), Expect = 4e-92
 Identities = 94/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
             W ++ K LK    +  G +GD+  G Y    VA+K +K         + F  E  +M 
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69

Query: 167 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           ++RH N+VQ +G   +    L IVTE+M+ GS+ DYL      V     LLK ++DV + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M YL  NN +HRDL A N+L+ E+ V KV+DFG+ +        + +       +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 184

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            +  K +  K+DV+SFGI+LWE+ + G++PY  +  L+  V  V+KG +   P    P +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 243

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKE 371
            E+++ CW  D A+RP F ++ E L+ I   
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  274 bits (704), Expect = 3e-91
 Identities = 87/268 (32%), Positives = 145/268 (54%), Gaps = 10/268 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 167
            E+  + +    ++ SG +G +  G +  Q DVA+K++K     S  + EF QE   M K
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           + H  +V+F G C+K   + IVTE++S G + +YL       +   LL++  DV +GM +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 284
           L  +  IHRDL A N L+D +  VKV+DFG+ R         +  GT    +W APEV  
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 285 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
           +  Y  K+DV++FGI++WE+ + GK+PY+  T     V  V +G R   P  +   + ++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIYQI 237

Query: 344 LERCWQQDPALRPDFSEIIEILQQIAKE 371
           +  CW + P  RP F +++  ++ + ++
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLREK 265

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  275 bits (705), Expect = 4e-91
 Identities = 83/277 (29%), Positives = 140/277 (50%), Gaps = 12/277 (4%)

Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFA 159
           +    I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++      +F 
Sbjct: 10  SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           +EV  M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---Y 275
            V++GM YL     IHRDL A NLL+   ++VK+ DFG+ R +         +      +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
            W APE ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           +    +  ++ +CW   P  RP F  + + L +    
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  280 bits (718), Expect = 6e-91
 Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
             W ++ K LK    +  G +GD+  G Y    VA+K +K +       + F  E  +M 
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMT 241

Query: 167 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           ++RH N+VQ +G   +    L IVTE+M+ GS+ DYL      V     LLK ++DV + 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M YL  NN +HRDL A N+L+ E+ V KV+DFG+ +        + +       +W APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 356

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            +  K +  K+DV+SFGI+LWE+ + G++PY  +  L+  V  V+KG +   P    P +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 415

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKE 371
            ++++ CW  D A RP F ++ E L+ I   
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  273 bits (701), Expect = 1e-90
 Identities = 82/282 (29%), Positives = 140/282 (49%), Gaps = 11/282 (3%)

Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 159
           G   + I  + +     +  G +G++Y G Y +       VA+K  K +    D +++F 
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFM 61

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            E  IM+ + H ++V+ IG   + P   I+ E    G +  YL + K   K+ +L+  ++
Sbjct: 62  SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 277
            + K M YL   N +HRD+   N+L+   E VK+ DFG++R         A       +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
           M+PE I  + +   +DV+ F + +WE+L+ GK P+ +L      +GV++KG R   P   
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLPKPDLC 239

Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE 378
            P L  L+ RCW  DP+ RP F+E++  L  + +   +   E
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  280 bits (719), Expect = 1e-90
 Identities = 100/301 (33%), Positives = 164/301 (54%), Gaps = 12/301 (3%)

Query: 93  KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI 150
           K +   +   +   D WE++   +    K+  G YG++Y G +   S  VA+K LK    
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--- 255

Query: 151 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VF 209
           ++   +EF +E  +M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +      
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 210 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 269
               LL +A  +S  M YL + N IHR+L A N L+ EN +VKVADFG++R+       T
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYT 374

Query: 270 AETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
           A  G     +W APE + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLE 433

Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSS 385
           K  R   P+    K+ EL+  CWQ +P+ RP F+EI +  + + +E    +E  ++    
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 493

Query: 386 G 386
           G
Sbjct: 494 G 494

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  270 bits (692), Expect = 2e-89
 Identities = 88/268 (32%), Positives = 151/268 (56%), Gaps = 12/268 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK     S     F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLM 62

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G    +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I +  +  K+DV+SFGI+L E++T G++PY  +T     +  +++G R   P N   +L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEEL 239

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQI 368
            +L+  CW++ P  RP F  +  +L+  
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  271 bits (695), Expect = 5e-89
 Identities = 84/281 (29%), Positives = 144/281 (51%), Gaps = 16/281 (5%)

Query: 102 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 154
           PN    +   +     K    + SG++G +Y+G +  +       VAIK L+        
Sbjct: 4   PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61

Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 214
            KE   E ++M  V + +V + +G C     + ++T+ M  G + DY+ + K       L
Sbjct: 62  -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119

Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 273
           L   + ++KGMNYL    ++HRDL A N+L+   + VK+ DFG+A+ + A+     AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 274 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 330
               +WMA E I H+ Y H++DV+S+G+ +WEL+T G  PY+ +   +    +++KG R 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238

Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
             P      +  ++ +CW  D   RP F E+I    ++A++
Sbjct: 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  269 bits (690), Expect = 6e-89
 Identities = 88/275 (32%), Positives = 145/275 (52%), Gaps = 11/275 (4%)

Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 159
            T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K    +  ++++F 
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFL 64

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 277
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNC 242

Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
            P L  L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  269 bits (689), Expect = 3e-88
 Identities = 72/274 (26%), Positives = 137/274 (50%), Gaps = 15/274 (5%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQ-KEFAQE 161
                  L+    + SG +G +++G +  +       V IKV++ +  +     +     
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDH 65

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           +  +  + H ++V+ +G C     L +VT+++  GS+ D++ + +G      LL   + +
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWM 278
           +KGM YL ++ ++HR+L A N+L+     V+VADFGVA +          +      +WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 337
           A E I    Y H++DV+S+G+ +WEL+T G  PY  L   +    +++KG R   P+   
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICT 243

Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
             +  ++ +CW  D  +RP F E+     ++A++
Sbjct: 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  267 bits (686), Expect = 3e-88
 Identities = 79/286 (27%), Positives = 140/286 (48%), Gaps = 13/286 (4%)

Query: 107 DVWEIDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQE 161
               +D K L    K   SG++G + +G Y      + VA+K+LK E  +  ++ E   E
Sbjct: 9   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             +M+++ +  +V+ IG C       +V E    G +  YL +     K  +++++   V
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQV 126

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 277
           S GM YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T      +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
            APE I +  +  K+DV+SFG+++WE  + G+ PY  +        +++KG R   P   
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGC 245

Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKE 382
             ++ +L+  CW  D   RP F+ +   L+    +V  E       
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  267 bits (685), Expect = 1e-87
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 12/274 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQE 161
              EI+   +     + SG  G++  G           VAIK LK        +++F  E
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             IM +  H N+++  G  T+     IVTE+M  GS+  +L    G F +  L+ +   V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 277
             GM YL     +HRDL A N+L+D N V KV+DFG++R ++         TG     RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
            APE I  + +   +DV+SFG+V+WE+L  G+ PY  +T  +  +  V++G R   P   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGC 279

Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              L +L+  CW +D A RP FS+I+ +L  + +
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  267 bits (685), Expect = 2e-87
 Identities = 86/275 (31%), Positives = 146/275 (53%), Gaps = 13/275 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
              EI P  +     + +G +G++Y+G            VAIK LK        + +F  
Sbjct: 37  FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLG 95

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           E  IM +  H N+++  G  +K   + I+TE+M  G++  +L +  G F +  L+ +   
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 276
           ++ GM YL   N +HRDL A N+L++ N V KV+DFG++R ++         +G     R
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           W APE I ++ +   +DV+SFGIV+WE++T G+ PY  L+     +  +  G R   P +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPMD 274

Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
               + +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  270 bits (691), Expect = 7e-87
 Identities = 97/278 (34%), Positives = 155/278 (55%), Gaps = 12/278 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP    S   + F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G    LP L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV  +    TA  G     +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I    +  K+DV+SFGI+L E++T G++PY  ++     +  +++G R   P+N   +L
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEEL 414

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE 378
             ++ RCW+  P  RP F  I  +L         + EE
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEE 452

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  262 bits (673), Expect = 2e-86
 Identities = 76/284 (26%), Positives = 137/284 (48%), Gaps = 15/284 (5%)

Query: 107 DVWEIDPKHLKFG-SKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQK-EFAQ 160
               +   +L     ++  G++G + +G Y  +    DVAIKVLK           E  +
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 59

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           E  IM ++ +  +V+ IG C     L +V E   GG ++ +L   +    + ++ ++   
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 276
           VS GM YL + N +HRDL A N+L+      K++DFG+++ + A     TA +      +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           W APE I  + +  ++DV+S+G+ +WE L+ G+ PY+ +      +  +++G R   P  
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPE 237

Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 379
             P+L  L+  CW      RPDF  + + ++     +  + E  
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  262 bits (673), Expect = 3e-86
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 31/292 (10%)

Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 158
           G+D  + + +HLKF  ++  G++G +    Y        + VA+K L+      +  ++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDF 58

Query: 159 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
            +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT- 274
               + KGM YL     IHRDL   N+L++    VK+ DFG+ + +         +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 275 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT----------------GKLPYEYLTP 316
               W APE +    +   +DV+SFG+VL+EL T                G      +  
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
               + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 FH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  264 bits (676), Expect = 3e-86
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 28/303 (9%)

Query: 92  MKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVL 145
           M  H +H        D    + +HLK+ S++  G++G +    Y          VA+K L
Sbjct: 1   MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60

Query: 146 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLH 203
           +      D Q++F +E+ I++ +    +V++ G    P   SL +V E++  G + D+L 
Sbjct: 61  QHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ 118

Query: 204 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VK 262
           + +       LL  +  + KGM YL     +HRDL A N+L++    VK+ADFG+A+ + 
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

Query: 263 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 318
                            W APE +    +  ++DV+SFG+VL+EL T             
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238

Query: 319 AAVGV-------------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
             +G              +++G R   P     ++ EL++ CW   P  RP FS +   L
Sbjct: 239 RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

Query: 366 QQI 368
             +
Sbjct: 299 DML 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  263 bits (673), Expect = 8e-86
 Identities = 74/323 (22%), Positives = 137/323 (42%), Gaps = 31/323 (9%)

Query: 78  HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 135
           H       +   T        +    +  D  + + +HLKF  ++  G++G +    Y  
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64

Query: 136 ----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 189
                 + VA+K L+      +  ++F +E+ I++ ++H N+V++ G C      +L ++
Sbjct: 65  LQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122

Query: 190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            E++  GS+ DYL K K       LL+    + KGM YL     IHRDL   N+L++   
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182

Query: 250 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
            VK+ DFG+ + +         +        W APE +    +   +DV+SFG+VL+EL 
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

Query: 306 T----------------GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
           T                G      +      + +++   R   P     ++  ++  CW 
Sbjct: 243 TYIEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWN 301

Query: 350 QDPALRPDFSEIIEILQQIAKEV 372
            +   RP F ++   + QI  ++
Sbjct: 302 NNVNQRPSFRDLALRVDQIRDQM 324

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  266 bits (682), Expect = 1e-85
 Identities = 99/280 (35%), Positives = 156/280 (55%), Gaps = 12/280 (4%)

Query: 95  HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSD 153
                +      D WEI  + L+   K+  G +G+++ GT+     VAIK LKP    + 
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTM 221

Query: 154 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLP 212
             + F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G   +LP
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 280

Query: 213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 272
            L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 339

Query: 273 GT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 328
           G     +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G 
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGY 398

Query: 329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           R   P      L +L+ +CW+++P  RP F  +   L+  
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  263 bits (674), Expect = 2e-85
 Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 12/274 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQE 161
              E+D  ++     V +G +G++  G           VAIK LK        +++F  E
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGE 96

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             IM +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 277
           + GM YL     +HRDL A N+L++ N V KV+DFG+ R ++          G     RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 336
            +PE I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P + 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDC 275

Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
              L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  271 bits (695), Expect = 3e-85
 Identities = 100/357 (28%), Positives = 173/357 (48%), Gaps = 20/357 (5%)

Query: 28  NIQEAHAFST-VDGY----SLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSS 82
           ++  A   +  +DGY    +         P +E E+   ++ K     ++       S S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362

Query: 83  PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--- 139
            T +  +   +   Y   +P+     +EI  + ++ G  +  G +GD+++G Y S +   
Sbjct: 363 ETDDYAEIIDEEDTY--TMPST--RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418

Query: 140 --VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
             VAIK  K    +  ++++F QE   MR+  H ++V+ IG  T+ P + I+ E  + G 
Sbjct: 419 MAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGE 476

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           +  +L   K    L SL+  A  +S  + YL     +HRD+ A N+L+  N+ VK+ DFG
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536

Query: 258 VARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           ++R    S    A  G    +WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
                 +G ++ G R  +P N  P L  L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 597 KNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  267 bits (683), Expect = 8e-85
 Identities = 99/268 (36%), Positives = 155/268 (57%), Gaps = 12/268 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+     VAIK LKP    +   + F QE  +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G   +LP L+ +A  ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 281
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 493

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQI 368
            +L+ +CW+++P  RP F  +   L+  
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  258 bits (660), Expect = 4e-84
 Identities = 81/291 (27%), Positives = 139/291 (47%), Gaps = 29/291 (9%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 160
           D    + + LK    +  G +G +    Y        + VA+K LKPE    +   +  +
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKK 72

Query: 161 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 218
           E+ I+R + H+N+V++ G CT+     + ++ EF+  GS+ +YL K K    L   LK A
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--- 274
           + + KGM+YL     +HRDL A N+L++    VK+ DFG+ + ++      T +      
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT---------------GKLPYEYLTPLQA 319
             W APE +    +   +DV+SFG+ L ELLT                   +  +T  + 
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR- 251

Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            V  +++G R   P N   ++ +L+ +CW+  P+ R  F  +IE  + + K
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  258 bits (661), Expect = 5e-84
 Identities = 84/281 (29%), Positives = 144/281 (51%), Gaps = 16/281 (5%)

Query: 102 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 154
           PN    +   +     K    + SG++G +Y+G +  +       VAIK L+        
Sbjct: 4   PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61

Query: 155 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 214
            KE   E ++M  V + +V + +G C     + ++T+ M  G + DY+ + K       L
Sbjct: 62  -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119

Query: 215 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 273
           L   + ++KGMNYL    ++HRDL A N+L+   + VK+ DFG+A+ + A+     AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 274 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 330
               +WMA E I H+ Y H++DV+S+G+ +WEL+T G  PY+ +   +    +++KG R 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238

Query: 331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
             P      +  ++ +CW  D   RP F E+I    ++A++
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  254 bits (651), Expect = 5e-83
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY---------CSQDVAIKVLKPERINSDMQKEFA 159
            +I  + L F   +  G++  +++G              +V +KVL     + +  + F 
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFF 60

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           +   +M K+ HK++V   G C       +V EF+  GS+  YL K K    +   L+VA 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMD--------ENEVVKVADFGVARVKAQSGVMTAE 271
            ++  M++L +N +IH ++ A N+L+             +K++D G++            
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173

Query: 272 TGTY----RWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 325
                    W+ PE IE+ K  +   D +SFG  LWE+ + G  P   L   Q  +   +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232

Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              +  +P     +LA L+  C   +P  RP F  II  L  +
Sbjct: 233 DRHQ--LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  251 bits (643), Expect = 1e-81
 Identities = 78/294 (26%), Positives = 142/294 (48%), Gaps = 29/294 (9%)

Query: 103 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQ 155
           + G  V  I  + +    ++  G++G ++               VA+K LK        +
Sbjct: 4   HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR 61

Query: 156 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------------- 202
           K+F +E  ++  ++H+++V+F G C     L +V E+M  G +  +L             
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121

Query: 203 --HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 260
              + KG   L  +L +A  ++ GM YL   + +HRDL   N L+  N +VK+ DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

Query: 261 VKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 316
               +        T    RWM PE I ++ +  ++DV+SFG++LWE+ T GK P+  L+ 
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241

Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            +  +  + +G     P+    ++ +++  CWQ++P  R +  EI +IL  + K
Sbjct: 242 TE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  252 bits (645), Expect = 1e-81
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 21/293 (7%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 161
           +   I  +    G  +  G +G +       +D     VA+K+LK + I S   +EF +E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 162 VFIMRKVRHKNVVQFIGACTK------PPSLCIVTEFMSGGSVYDYLHKLK-----GVFK 210
              M++  H +V + +G   +       P   ++  FM  G ++ +L   +         
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135

Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
           L +L++  +D++ GM YL   N IHRDL A N ++ E+  V VADFG++R          
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 271 ETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 326
              +    +W+A E +    Y   +DV++FG+ +WE++T G+ PY  +   +     +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIG 254

Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 379
           G R   P     ++ +L+ +CW  DP  RP F+ +   L+ I   +   +  +
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  251 bits (643), Expect = 1e-81
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 20/281 (7%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 161
           +   ID   L  G  +  G +G +  G    +D     VA+K +K +  +    +EF  E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 162 VFIMRKVRHKNVVQFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKLK-----GVFKL 211
              M+   H NV++ +G C +      P   ++  FM  G ++ YL   +         L
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 271
            +LLK  +D++ GM YL   N +HRDL A N ++ ++  V VADFG+++           
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206

Query: 272 TGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 327
                  +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY  +   +     +  G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHG 265

Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
            R   P++   +L E++  CW+ DP  RP FS +   L+++
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  251 bits (642), Expect = 2e-81
 Identities = 83/312 (26%), Positives = 144/312 (46%), Gaps = 38/312 (12%)

Query: 95  HPYHLKIPNDG---------TDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQD 139
           H +H    + G          D      ++LK    +  G +G +    Y        + 
Sbjct: 3   HHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM 62

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGS 197
           VA+K LK +      +  + QE+ I+R + H++++++ G C      SL +V E++  GS
Sbjct: 63  VAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           + DYL +      L  LL  A  + +GM YLH  + IHRDL A N+L+D + +VK+ DFG
Sbjct: 122 LRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 258 VAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 312
           +A+ V                  W APE ++   + + +DV+SFG+ L+ELLT       
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239

Query: 313 YLTPLQAAVGV-------------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
             T     +G+             +++G R   P     ++  L++ CW+ + + RP F 
Sbjct: 240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE 299

Query: 360 EIIEILQQIAKE 371
            +I IL+ + ++
Sbjct: 300 NLIPILKTVHEK 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  250 bits (640), Expect = 7e-81
 Identities = 93/315 (29%), Positives = 154/315 (48%), Gaps = 29/315 (9%)

Query: 95  HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERI 150
           H +H K   D T    +D   +KF   +  G++G + +          D AIK +K E  
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYA 64

Query: 151 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------- 202
           + D  ++FA E+ ++ K+  H N++  +GAC     L +  E+   G++ D+L       
Sbjct: 65  SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 203 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 254
                   +          LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+A
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184

Query: 255 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 310
           DFG++R      V   +T      RWMA E + +  Y   +DV+S+G++LWE+++ G  P
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

Query: 311 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           Y  +T        + +G R   P N   ++ +L+ +CW++ P  RP F++I+  L ++ +
Sbjct: 242 YCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

Query: 371 EVGEENEERRKEKSS 385
           E          EK +
Sbjct: 301 ERKTYVNTTLYEKFT 315

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  250 bits (640), Expect = 7e-81
 Identities = 86/318 (27%), Positives = 150/318 (47%), Gaps = 30/318 (9%)

Query: 80  SSSPTSEPEDTGMKSHPYHLKIPN--DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 135
           S S  S  E  G     + ++ P       V  I  + +    ++  G++G ++      
Sbjct: 5   SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64

Query: 136 -----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 190
                    VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V 
Sbjct: 65  LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122

Query: 191 EFMSGGSVYDYL--------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           E+M  G +  +L                  G   L  LL VA  V+ GM YL   + +HR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182

Query: 237 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKAD 293
           DL   N L+ +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++D
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 242

Query: 294 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 352
           V+SFG+VLWE+ T GK P+  L+  + A+  + +G     P+   P++  ++  CWQ++P
Sbjct: 243 VWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREP 301

Query: 353 ALRPDFSEIIEILQQIAK 370
             R    ++   LQ +A+
Sbjct: 302 QQRHSIKDVHARLQALAQ 319

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  249 bits (637), Expect = 7e-81
 Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 14/273 (5%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 162
           V       + F   +  G +G +Y GT    D      A+K L     +     +F  E 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77

Query: 163 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
            IM+   H NV+  +G C +   S  +V  +M  G + +++        +  L+   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 276
           +KGM YL     +HRDL A N ++DE   VKVADFG+AR        +    T      +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           WMA E ++ + +  K+DV+SFG++LWEL+T G  PY  +         + +G R   P+ 
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 256

Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
               L E++ +CW     +RP FSE++  +  I
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  250 bits (640), Expect = 1e-80
 Identities = 88/322 (27%), Positives = 151/322 (46%), Gaps = 37/322 (11%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
            SH     + +P   G+       ++P D    WE     L  G  +  G++G +     
Sbjct: 3   SSHHHHHHSQDPMLAGVS----EYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEA 56

Query: 136 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 185
                     +  VA+K+LK +        +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 57  VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115

Query: 186 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           L ++ E+ S G++ +YL                  +       L+     +++GM YL  
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 287
              IHRDL A N+L+ EN V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y H++DV+SFG+++WE+ T G  PY  +   +    ++++G R   P N   +L  ++  
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD 294

Query: 347 CWQQDPALRPDFSEIIEILQQI 368
           CW   P+ RP F +++E L +I
Sbjct: 295 CWHAVPSQRPTFKQLVEDLDRI 316

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  249 bits (638), Expect = 1e-80
 Identities = 81/305 (26%), Positives = 144/305 (47%), Gaps = 32/305 (10%)

Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 152
           ++P D    WE     L FG  + +G++G +   T         +  VA+K+LK    + 
Sbjct: 11  QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHL 67

Query: 153 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--------- 202
             ++    E+ ++  +  H N+V  +GACT      ++TE+   G + ++L         
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 203 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 254
                      +    L  LL  +  V+KGM +L   N IHRDL A N+L+    + K+ 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 255 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 310
           DFG+AR          +       +WMAPE I +  Y  ++DV+S+GI LWEL + G  P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

Query: 311 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           Y  +        ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++   
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 371 EVGEE 375
           E    
Sbjct: 308 ESTNH 312

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  249 bits (638), Expect = 2e-80
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 30/306 (9%)

Query: 94  SHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQ 138
           +H +H   PN          +D+ E+  K++     +  G++G++Y G            
Sbjct: 2   AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61

Query: 139 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
            VA+K L  E  +   + +F  E  I+ K  H+N+V+ IG   +     I+ E M+GG +
Sbjct: 62  QVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120

Query: 199 YDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENE 249
             +L + +          +  LL VA D++ G  YL +N+ IHRD+ A N L+       
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180

Query: 250 VVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT 306
           V K+ DFG+AR   ++             +WM PE      +  K D +SFG++LWE+ +
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

Query: 307 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
            G +PY   +  +  +  V  G R   PKN    +  ++ +CWQ  P  RP+F+ I+E +
Sbjct: 241 LGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

Query: 366 QQIAKE 371
           +   ++
Sbjct: 300 EYCTQD 305

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  247 bits (634), Expect = 2e-80
 Identities = 79/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)

Query: 109 WEI--DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 161
             I  +         +  G +G +Y G Y  Q       AIK L        ++  F +E
Sbjct: 14  VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLRE 72

Query: 162 VFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
             +MR + H NV+  IG    P     ++  +M  G +  ++   +    +  L+   + 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY----- 275
           V++GM YL +   +HRDL A N ++DE+  VKVADFG+AR        + +   +     
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           +W A E ++   +  K+DV+SFG++LWELLT G  PY ++ P       + +G R   P+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPE 251

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                L +++++CW+ DPA+RP F  ++  ++QI
Sbjct: 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  250 bits (640), Expect = 3e-80
 Identities = 91/329 (27%), Positives = 153/329 (46%), Gaps = 33/329 (10%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           P  R ++  S   DT M +     ++P D    WE     L  G  +  G +G +     
Sbjct: 45  PLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEA 102

Query: 136 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 185
                     +  VA+K+LK +        +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 103 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161

Query: 186 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           L ++ E+ S G++ +YL                  +       L+     +++GM YL  
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 287
              IHRDL A N+L+ EN V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y H++DV+SFG+++WE+ T G  PY  +   +    ++++G R   P N   +L  ++  
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD 340

Query: 347 CWQQDPALRPDFSEIIEILQQIAKEVGEE 375
           CW   P+ RP F +++E L +I      E
Sbjct: 341 CWHAVPSQRPTFKQLVEDLDRILTLTTNE 369

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  250 bits (639), Expect = 3e-80
 Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 14/273 (5%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 162
           V       + F   +  G +G +Y GT    D      A+K L       ++  +F  E 
Sbjct: 83  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEG 141

Query: 163 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
            IM+   H NV+  +G C +   S  +V  +M  G + +++        +  L+   + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 276
           +KGM +L     +HRDL A N ++DE   VKVADFG+AR        +    T      +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           WMA E ++ + +  K+DV+SFG++LWEL+T G  PY  +         + +G R   P+ 
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 320

Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
               L E++ +CW     +RP FSE++  +  I
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  246 bits (630), Expect = 8e-80
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 28/285 (9%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQ 160
           + EI    ++F  ++    +G +Y+G          +Q VAIK LK +     +++EF  
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRH 61

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 205
           E  +  +++H NVV  +G  TK   L ++  + S G ++++L                 +
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 206 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 265
           K   + P  + +   ++ GM YL  ++++H+DL   N+L+ +   VK++D G+ R    +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 266 GVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
                   +    RWMAPE I +  +   +D++S+G+VLWE+ + G  PY   +     V
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VV 240

Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
            +++       P +    +  L+  CW + P+ RP F +I   L+
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  247 bits (632), Expect = 9e-80
 Identities = 82/282 (29%), Positives = 140/282 (49%), Gaps = 22/282 (7%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFK 210
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+             
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
           L  ++++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R   ++     
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 271 ETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 326
                   RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q  +  V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVME 255

Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
           G     P N    L EL+  CWQ +P +RP F EII  +++ 
Sbjct: 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  246 bits (631), Expect = 1e-79
 Identities = 93/325 (28%), Positives = 147/325 (45%), Gaps = 38/325 (11%)

Query: 82  SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------ 135
            P   P D   +  PY           WE     LK G  +  G++G +           
Sbjct: 2   DPDELPLDEHCERLPYD-------ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT 54

Query: 136 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-PSLCIVTEF 192
              + VA+K+LK E       +    E+ I+  +  H NVV  +GACTKP   L ++ EF
Sbjct: 55  ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113

Query: 193 MSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 237
              G++  YL                  K    L  L+  +  V+KGM +L     IHRD
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADV 294
           L A N+L+ E  VVK+ DFG+AR   +      +       +WMAPE I  + Y  ++DV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233

Query: 295 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           +SFG++LWE+ + G  PY  +   +     +++G R   P  + P++ + +  CW  +P+
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293

Query: 354 LRPDFSEIIEILQQIAKEVGEENEE 378
            RP FSE++E L  + +      ++
Sbjct: 294 QRPTFSELVEHLGNLLQA--NAQQD 316

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  255 bits (652), Expect = 2e-79
 Identities = 81/314 (25%), Positives = 145/314 (46%), Gaps = 14/314 (4%)

Query: 75  WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV-ASGSYGDLYRG 133
                   P   P DT +   P+             +   +L         G++G + +G
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKK-LFLKRDNLLIADIELGCGNFGSVRQG 355

Query: 134 TYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 189
            Y  +    DVAIKVLK     +D  +E  +E  IM ++ +  +V+ IG C     L +V
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLV 413

Query: 190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            E   GG ++ +L   +    + ++ ++   VS GM YL + N +HR+L A N+L+    
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473

Query: 250 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
             K++DFG+++ + A     TA +      +W APE I  + +  ++DV+S+G+ +WE L
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

Query: 306 T-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 364
           + G+ PY+ +      +  +++G R   P    P+L  L+  CW      RPDF  + + 
Sbjct: 534 SYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 592

Query: 365 LQQIAKEVGEENEE 378
           ++     +  + E 
Sbjct: 593 MRACYYSLASKVEG 606

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  247 bits (633), Expect = 3e-79
 Identities = 84/316 (26%), Positives = 147/316 (46%), Gaps = 22/316 (6%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           P ++ S   +    T    +       +  +D+ E+  K++     +  G++G++Y G  
Sbjct: 33  PEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92

Query: 136 -------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 188
                      VA+K L  E  +   + +F  E  I+ K  H+N+V+ IG   +     I
Sbjct: 93  SGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151

Query: 189 VTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
           + E M+GG +  +L + +          +  LL VA D++ G  YL +N+ IHRD+ A N
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211

Query: 243 LLMD---ENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFS 296
            L+       V K+ DFG+AR   ++G            +WM PE      +  K D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271

Query: 297 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           FG++LWE+ + G +PY   +  +  +  V  G R   PKN    +  ++ +CWQ  P  R
Sbjct: 272 FGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

Query: 356 PDFSEIIEILQQIAKE 371
           P+F+ I+E ++   ++
Sbjct: 331 PNFAIILERIEYCTQD 346

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  245 bits (627), Expect = 4e-79
 Identities = 82/303 (27%), Positives = 149/303 (49%), Gaps = 38/303 (12%)

Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 152
           KI  D    WE   K+L  G  +  G +G + + T            VA+K+LK E  + 
Sbjct: 11  KILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASP 67

Query: 153 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 202
              ++   E  ++++V H +V++  GAC++   L ++ E+   GS+  +L          
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 203 -------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
                        H  +    +  L+  A  +S+GM YL +  ++HRDL A N+L+ E  
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187

Query: 250 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 306
            +K++DFG++R   +       +      +WMA E +    Y  ++DV+SFG++LWE++T
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

Query: 307 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
            G  PY  + P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L
Sbjct: 248 LGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

Query: 366 QQI 368
           +++
Sbjct: 307 EKM 309

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  245 bits (628), Expect = 2e-78
 Identities = 93/322 (28%), Positives = 153/322 (47%), Gaps = 34/322 (10%)

Query: 77  SHRSSSPTSE-PEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
            H    PT+E     GM +     ++P D    WE+    L  G  +  G++G +     
Sbjct: 33  HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90

Query: 136 ---------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 185
                        VA+K+LK          +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 91  IGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149

Query: 186 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           L ++ E+ S G++ +YL               H  +       L+  A  V++GM YL  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 287
              IHRDL A N+L+ E+ V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y H++DV+SFG++LWE+ T G  PY  +   +    ++++G R   P N   +L  ++  
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRD 328

Query: 347 CWQQDPALRPDFSEIIEILQQI 368
           CW   P+ RP F +++E L +I
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRI 350

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  243 bits (623), Expect = 3e-78
 Identities = 84/303 (27%), Positives = 148/303 (48%), Gaps = 28/303 (9%)

Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINS 152
           ++P +  + WE    +L+FG  + +G++G +   T            VA+K+LK    ++
Sbjct: 34  QLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHA 90

Query: 153 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK- 210
           D ++    E+ IM  + +H+N+V  +GACT    + ++TE+   G + ++L +   V + 
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150

Query: 211 ------------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                          LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210

Query: 259 ARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           AR          +       +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +
Sbjct: 211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 374
                   +V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+E   
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330

Query: 375 ENE 377
           E +
Sbjct: 331 ERD 333

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  243 bits (622), Expect = 5e-78
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 37/303 (12%)

Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 152
           +   D    WE   ++L+FG  + SG++G +   T         S  VA+K+LK E+ +S
Sbjct: 33  EYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADS 89

Query: 153 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 211
             ++    E+ +M ++  H+N+V  +GACT    + ++ E+   G + +YL   +  F  
Sbjct: 90  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 212 PS----------------------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
                                   LL  A  V+KGM +L   + +HRDL A N+L+   +
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209

Query: 250 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 306
           VVK+ DFG+AR                  +WMAPE +    Y  K+DV+S+GI+LWE+ +
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

Query: 307 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
            G  PY  +        ++Q G +   P  +  ++  +++ CW  D   RP F  +   L
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

Query: 366 QQI 368
              
Sbjct: 330 GCQ 332

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  241 bits (617), Expect = 3e-77
 Identities = 87/337 (25%), Positives = 156/337 (46%), Gaps = 39/337 (11%)

Query: 72  RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP---NDGTDVWEIDPKHLKFGSKVASGSYG 128
                +   ++  SE     +  +P + ++P   N      E    ++++   +  G++G
Sbjct: 2   AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61

Query: 129 DLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
            +++              VA+K+LK E  ++DMQ +F +E  +M +  + N+V+ +G C 
Sbjct: 62  RVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKG-----------------------VFKLPSLLKVA 218
               +C++ E+M+ G + ++L  +                                L +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--- 275
             V+ GM YL +   +HRDL   N L+ EN VVK+ADFG++R    +    A+       
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           RWM PE I +  Y  ++DV+++G+VLWE+ + G  PY  +   +  +  V+ G     P+
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPE 299

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
           N   +L  L+  CW + PA RP F  I  ILQ++ + 
Sbjct: 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  224 bits (572), Expect = 3e-71
 Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 15/272 (5%)

Query: 101 IPNDGTDVWEIDP--KHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQK 156
           I    T    +    + LKF  ++  GS+  +Y+G  T  + +VA   L+  ++    ++
Sbjct: 11  IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70

Query: 157 EFAQEVFIMRKVRHKNVVQFIGA----CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 212
            F +E  +++ ++H N+V+F  +          + +VTE M+ G++  YL +   V K+ 
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIK 129

Query: 213 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMT 269
            L      + KG+ +LH     IIHRDLK  N+ +      VK+ D G+A +K  S    
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189

Query: 270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
              GT  +MAPE+ E K YD   DV++FG+ + E+ T + PY            V  G++
Sbjct: 190 -VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 330 P-TIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           P +  K + P++ E++E C +Q+   R    +
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  210 bits (536), Expect = 2e-65
 Identities = 60/311 (19%), Positives = 133/311 (42%), Gaps = 16/311 (5%)

Query: 79  RSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYC 136
           +S      P             +  +    + I         K+  G + ++YR      
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRI-------EKKIGRGQFSEVYRAACLLD 56

Query: 137 SQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 195
              VA+K ++   +     +    +E+ +++++ H NV+++  +  +   L IV E    
Sbjct: 57  GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116

Query: 196 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 252
           G +   +   K    +    ++ K  + +   + ++H   ++HRD+K AN+ +    VVK
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 176

Query: 253 VADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 311
           + D G+ R   +++    +  GT  +M+PE I    Y+ K+D++S G +L+E+   + P+
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

Query: 312 EY-LTPLQAAVGVVQKGLRPTIPKNSQ-PKLAELLERCWQQDPALRPDFSEIIEILQQIA 369
                 L +    +++   P +P +    +L +L+  C   DP  RPD + + ++ +++ 
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

Query: 370 KEVGEENEERR 380
                  E   
Sbjct: 297 ACTASSLEHHH 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  211 bits (538), Expect = 3e-65
 Identities = 75/277 (27%), Positives = 148/277 (53%), Gaps = 10/277 (3%)

Query: 95  HPYHLKIPNDGTDVWEIDPKHLK---FGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER 149
           H +H            +  + ++      K+  GS+G   L + T   +   IK +   R
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61

Query: 150 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 208
           ++S  ++E  +EV ++  ++H N+VQ+  +  +  SL IV ++  GG ++  ++  KGV 
Sbjct: 62  MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121

Query: 209 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 268
           F+   +L   + +   + ++H   I+HRD+K+ N+ + ++  V++ DFG+ARV   S V 
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVE 180

Query: 269 TAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 326
            A    GT  +++PE+ E+KPY++K+D+++ G VL+EL T K  +E  + ++  V  +  
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKIIS 239

Query: 327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           G  P +  +    L  L+ + ++++P  RP  + I+E
Sbjct: 240 GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  206 bits (526), Expect = 1e-63
 Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 19/299 (6%)

Query: 68  LKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSY 127
           L    + W S  +      PE    +      K+     +  E +   +    +V  GS+
Sbjct: 13  LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSF 71

Query: 128 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 185
           G+++R          A+K +        ++    +E+     +    +V   GA  + P 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           + I  E + GGS+   + K  G       L       +G+ YLH   I+H D+KA N+L+
Sbjct: 125 VNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183

Query: 246 DEN-EVVKVADFGVARVKAQSGVMTAET------GTYRWMAPEVIEHKPYDHKADVFSFG 298
             +     + DFG A      G+  +        GT   MAPEV+  KP D K D++S  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 299 IVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQQDPALRP 356
            ++  +L G  P+         + +  +      IP +  P  A+ ++   +++P  R 
Sbjct: 244 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  202 bits (517), Expect = 1e-62
 Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 8/250 (3%)

Query: 117 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNV 173
           +  S++  GSYG++++       +  A+K           +     EV    KV +H   
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V+   A  +   L + TE   G S+  +            +     D    + +LH   +
Sbjct: 120 VRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 293
           +H D+K AN+ +      K+ DFG+      +G    + G  R+MAPE+++   Y   AD
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAAD 237

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           VFS G+ + E+             Q    + Q  L P        +L  +L    + DP 
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294

Query: 354 LRPDFSEIIE 363
           LR     ++ 
Sbjct: 295 LRATAEALLA 304

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  202 bits (515), Expect = 1e-62
 Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 38/291 (13%)

Query: 111 IDPKHLK---FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D +          + SG +G +++  +    +   IK +K         ++  +EV  +
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58

Query: 166 RKVRHKNVVQFIGA----------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 208
            K+ H N+V + G                  +K   L I  EF   G++  ++ K +G  
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 209 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 268
                 L++   ++KG++Y+H   +I+RDLK +N+ + + + VK+ DFG+       G  
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 327
           T   GT R+M+PE I  + Y  + D+++ G++L ELL      +E               
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFTDL 231

Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEVGEEN 376
               I      K   LL++   + P  RP+ SEI+    + + + E  E +
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  199 bits (508), Expect = 2e-61
 Identities = 86/285 (30%), Positives = 131/285 (45%), Gaps = 43/285 (15%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           W I+    +    + SG+   +         + VAIK +  E+  + M  E  +E+  M 
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLK---VAI--- 219
           +  H N+V +  +      L +V + +SGGSV D   H +        +L    +A    
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------G 273
           +V +G+ YLH+N  IHRD+KA N+L+ E+  V++ADFGV+   A  G +T         G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 274 TYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 332
           T  WMAPEV+E  + YD KAD++SFGI   EL TG  PY    P++              
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLT 239

Query: 333 PKNSQPKLA-----------------ELLERCWQQDPALRPDFSE 360
            +N  P L                  +++  C Q+DP  RP  +E
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  199 bits (508), Expect = 2e-61
 Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 36/282 (12%)

Query: 92  MKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPE 148
           M   P    +P  G    + DP+ L     K+  GS+G++++G      + VAIK++  E
Sbjct: 1   MAHSPVQSGLP--GMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58

Query: 149 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 208
               +++ +  QE+ ++ +     V ++ G+  K   L I+ E++ GGS  D L    G 
Sbjct: 59  EAEDEIE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GP 115

Query: 209 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVK 262
                +  +  ++ KG++YLH    IHRD+KAAN+L+ E+  VK+ADFGVA      ++K
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175

Query: 263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
             + V     GT  WMAPEVI+   YD KAD++S GI   EL  G+ P+  L P++    
Sbjct: 176 RNTFV-----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF- 229

Query: 323 VVQKGLRPTIPKNSQPKLA--------ELLERCWQQDPALRP 356
                    IPKN+ P L         E +E C  ++P+ RP
Sbjct: 230 --------LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  199 bits (507), Expect = 2e-61
 Identities = 73/247 (29%), Positives = 127/247 (51%), Gaps = 11/247 (4%)

Query: 119 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 176
              +  G+YG +Y G   S    +AIK +     +S   +   +E+ + + ++HKN+VQ+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKV-AIDVSKGMNYLHQNNII 234
           +G+ ++   + I  E + GGS+   L    G  K     +      + +G+ YLH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 235 HRDLKAANLLMDENE-VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKP--YDH 290
           HRD+K  N+L++    V+K++DFG + R+   +      TGT ++MAPE+I+  P  Y  
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204

Query: 291 KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
            AD++S G  + E+ TGK P+ E   P  A   V    + P IP++   +    + +C++
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264

Query: 350 QDPALRP 356
            DP  R 
Sbjct: 265 PDPDKRA 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  195 bits (498), Expect = 4e-60
 Identities = 58/281 (20%), Positives = 119/281 (42%), Gaps = 35/281 (12%)

Query: 119 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 175
             K+ SG +G +++          AIK  K     S  ++   +EV+    + +H +VV+
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  +
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135

Query: 233 IIHRDLKAANLLMDEN-------------------EVVKVADFGVARVKAQSGVMTAETG 273
           ++H D+K +N+ +                       + K+ D G      +      E G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEG 192

Query: 274 TYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 332
             R++A EV+ E+  +  KAD+F+  + +      +               +++G  P I
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLPRI 248

Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKE 371
           P+    +  ELL+     DP  RP    +++  +L   +++
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  193 bits (492), Expect = 7e-59
 Identities = 80/273 (29%), Positives = 123/273 (45%), Gaps = 37/273 (13%)

Query: 107 DVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVF 163
           D     P+ +     K+  GSYG +Y+  +    Q VAIK +  E       +E  +E+ 
Sbjct: 21  DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEIS 76

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           IM++    +VV++ G+  K   L IV E+   GSV D +           +  +     K
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRW 277
           G+ YLH    IHRD+KA N+L++     K+ADFGVA        K  + +     GT  W
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFW 191

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 337
           MAPEVI+   Y+  AD++S GI   E+  GK PY  + P++A            IP N  
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---------MIPTNPP 242

Query: 338 PKLA----------ELLERCWQQDPALRPDFSE 360
           P             + +++C  + P  R   ++
Sbjct: 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  191 bits (487), Expect = 2e-58
 Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 46/289 (15%)

Query: 98  HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ 155
           H++   D  +VWEI         ++  G++G +Y+          A KV++ +  + +  
Sbjct: 10  HVRRDLDPNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEEL 60

Query: 156 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           +++  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      P + 
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 216 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMT 269
            V   + + +N+LH   IIHRDLKA N+LM     +++ADFGV+        K  S +  
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178

Query: 270 AETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 324
              GT  WMAPEV+        PYD+KAD++S GI L E+   + P+  L P++  +   
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--- 232

Query: 325 QKGLRPTIPKNSQPKLA----------ELLERCWQQDPALRPDFSEIIE 363
                  I K+  P L           + L+    ++P  RP  ++++E
Sbjct: 233 ------KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  191 bits (488), Expect = 1e-57
 Identities = 54/308 (17%), Positives = 124/308 (40%), Gaps = 21/308 (6%)

Query: 74  GWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG 133
           G     ++    +  D+         K  +   +   +  +      ++ SG    +++ 
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75

Query: 134 TYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVT 190
                Q  AIK +  E  ++     +  E+  + K++  +  +++          + +V 
Sbjct: 76  LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135

Query: 191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 250
           E      +  +L K K             ++ + ++ +HQ+ I+H DLK AN L+ +  +
Sbjct: 136 EC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-M 192

Query: 251 VKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP-----------YDHKADVFS 296
           +K+ DFG+A  ++  +  +  ++  G   +M PE I+                 K+DV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252

Query: 297 FGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
            G +L+ +  GK P+ + +  +     ++        P   +  L ++L+ C ++DP  R
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

Query: 356 PDFSEIIE 363
               E++ 
Sbjct: 313 ISIPELLA 320

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  189 bits (481), Expect = 2e-57
 Identities = 68/250 (27%), Positives = 121/250 (48%), Gaps = 20/250 (8%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  G+ G +Y     +  Q+VAI+ +  +      ++    E+ +MR+ ++ N+V ++ 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +      L +V E+++GGS+ D + +         +  V  +  + + +LH N +IHRD+
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142

Query: 239 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           K+ N+L+  +  VK+ DFG        + K  + V     GT  WMAPEV+  K Y  K 
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPKV 197

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 350
           D++S GI+  E++ G+ PY    PL+A   +   G  P +    +      + L RC + 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEM 256

Query: 351 DPALRPDFSE 360
           D   R    E
Sbjct: 257 DVEKRGSAKE 266

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (481), Expect = 3e-57
 Identities = 62/311 (19%), Positives = 125/311 (40%), Gaps = 33/311 (10%)

Query: 91  GMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKV 144
           G   H +H     +       +  ID KH  F  K+  G +  +    G +     A+K 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61

Query: 145 LKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVY 199
           +     +    +E A +E  + R   H N+++ +  C +         ++  F   G+++
Sbjct: 62  I---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 200 DYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
           + + +LK          +L + + + +G+  +H     HRDLK  N+L+ +     + D 
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178

Query: 257 GVARVK----------AQSGVMTAETGTYRWMAPEVIEHKPY---DHKADVFSFGIVLWE 303
           G                      A+  T  + APE+   + +   D + DV+S G VL+ 
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238

Query: 304 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEI 361
           ++ G+ PY+ +     +V +  +  + +IP++ +    L +LL      DP  RP    +
Sbjct: 239 MMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297

Query: 362 IEILQQIAKEV 372
           +  L+ +    
Sbjct: 298 LSQLEALQPPA 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  188 bits (479), Expect = 5e-57
 Identities = 76/265 (28%), Positives = 138/265 (52%), Gaps = 21/265 (7%)

Query: 125 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGACTK 182
           G +G +Y+G   +  VA+K L      +  +  ++F QE+ +M K +H+N+V+ +G  + 
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101

Query: 183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
              LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161

Query: 241 ANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 297
           AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  +    K+D++SF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSF 220

Query: 298 GIVLWELLTGKLPY----------EYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAELL 344
           G+VL E++TG              +    ++     ++  +   +      S   +  + 
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA 280

Query: 345 ERCWQQDPALRPDFSEIIEILQQIA 369
            +C  +    RPD  ++ ++LQ++ 
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEMT 305

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  187 bits (478), Expect = 7e-57
 Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 20/250 (8%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GS G +         + VA+K++         ++    EV IMR  +H NVV+   
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYK 109

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           +      L ++ EF+ GG++ D + +         +  V   V + + YLH   +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167

Query: 239 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           K+ ++L+  +  VK++DFG          K +S V     GT  WMAPEVI    Y  + 
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLYATEV 222

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 350
           D++S GI++ E++ G+ PY   +P+QA   +      P +  + +  P L + LER   +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVR 281

Query: 351 DPALRPDFSE 360
           DP  R    E
Sbjct: 282 DPQERATAQE 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  186 bits (475), Expect = 2e-56
 Identities = 59/289 (20%), Positives = 116/289 (40%), Gaps = 35/289 (12%)

Query: 124 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC- 180
            G +G     +      + AIK ++        +++  +EV  + K+ H  +V++  A  
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWL 73

Query: 181 -----------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNY 227
                      +    L I  +     ++ D+++    + +      L + + +++ + +
Sbjct: 74  EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------KAQSGVMTAETGT 274
           LH   ++HRDLK +N+    ++VVKV DFG+                       T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
             +M+PE I    Y HK D+FS G++L+ELL    P+         +  V+    P +  
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFT 250

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEVGEENEERRK 381
              P    +++      P  RP+   IIE  + + +         +R +
Sbjct: 251 QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  187 bits (478), Expect = 2e-56
 Identities = 52/265 (19%), Positives = 114/265 (43%), Gaps = 21/265 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--V 173
               ++ SG    +++      Q  AIK +  E  ++     +  E+  + K++  +  +
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           ++          + +V E      +  +L K K             ++ + ++ +HQ+ I
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGI 129

Query: 234 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP--- 287
           +H DLK AN L+ +  ++K+ DFG+A  ++  +  +  ++  GT  +M PE I+      
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 288 --------YDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQP 338
                      K+DV+S G +L+ +  GK P+ + +  +     ++        P   + 
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 248

Query: 339 KLAELLERCWQQDPALRPDFSEIIE 363
            L ++L+ C ++DP  R    E++ 
Sbjct: 249 DLQDVLKCCLKRDPKQRISIPELLA 273

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  184 bits (470), Expect = 5e-56
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 16/254 (6%)

Query: 124 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA-- 179
           +GSYG     R     + +  K L    +    ++    EV ++R+++H N+V++     
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQ-----N 231
                +L IV E+  GG +   + K            +L+V   ++  +   H+     +
Sbjct: 76  DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135

Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYD 289
            ++HRDLK AN+ +D  + VK+ DFG+AR+        A+T  GT  +M+PE +    Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYN 194

Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
            K+D++S G +L+EL     P+   +  +   G +++G    IP     +L E++ R   
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIITRMLN 253

Query: 350 QDPALRPDFSEIIE 363
                RP   EI+E
Sbjct: 254 LKDYHRPSVEEILE 267

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  185 bits (472), Expect = 5e-56
 Identities = 54/271 (19%), Positives = 114/271 (42%), Gaps = 21/271 (7%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           +  +      ++ SG    +++      Q  AIK +  E  ++     +  E+  + K++
Sbjct: 25  VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84

Query: 170 HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
             +  +++          + +V E      +  +L K K             ++ + ++ 
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHT 142

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 284
           +HQ+ I+H DLK AN L+ +  ++K+ DFG+A        S V  ++ GT  +M PE I+
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 285 HKP-----------YDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTI 332
                            K+DV+S G +L+ +  GK P+ + +  +     ++        
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           P   +  L ++L+ C ++DP  R    E++ 
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  185 bits (472), Expect = 7e-56
 Identities = 79/287 (27%), Positives = 135/287 (47%), Gaps = 19/287 (6%)

Query: 104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQE 161
                W+   + LK   ++  G+YG + +  +    Q +A+K ++   ++   QK+   +
Sbjct: 12  SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMD 70

Query: 162 V-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKV 217
           +  +MR      +VQF GA  +     I  E MS      Y      L  V     L K+
Sbjct: 71  LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130

Query: 218 AIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
            +   K +N+L +N  IIHRD+K +N+L+D +  +K+ DFG++     S   T + G   
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 190

Query: 277 WMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 332
           +MAPE I+     + YD ++DV+S GI L+EL TG+ PY     +   +  V KG  P +
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250

Query: 333 PKNSQ----PKLAELLERCWQQDPALRPDFSEIIE---ILQQIAKEV 372
             + +    P     +  C  +D + RP + E+++   IL    + V
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  186 bits (473), Expect = 1e-55
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 29/301 (9%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGT 134
           P+  +       +          LK P+     ++ DP+ L     ++  GS+G +Y   
Sbjct: 15  PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74

Query: 135 YCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 191
                + VAIK +      S +  ++  +EV  ++K+RH N +Q+ G   +  +  +V E
Sbjct: 75  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134

Query: 192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 251
           +   GS  D L   K   +   +  V     +G+ YLH +N+IHRD+KA N+L+ E  +V
Sbjct: 135 YC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 193

Query: 252 KVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 308
           K+ DFG A   +      +  GT  WMAPEVI   +   YD K DV+S GI   EL   K
Sbjct: 194 KLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

Query: 309 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---------ELLERCWQQDPALRPDFS 359
            P   +  + A            I +N  P L            ++ C Q+ P  RP   
Sbjct: 251 PPLFNMNAMSALY---------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301

Query: 360 E 360
            
Sbjct: 302 V 302

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  186 bits (474), Expect = 2e-55
 Identities = 51/329 (15%), Positives = 108/329 (32%), Gaps = 38/329 (11%)

Query: 77  SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG--SYGDLYRGT 134
           +H            GM S                 +    +  + +  G      +    
Sbjct: 2   AHHHHHHMENLYFQGMSSFL--------------PEGGCYELLTVIGKGFEDLMTVNLAR 47

Query: 135 YCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 192
           Y    + V ++ +  E  +++M      E+ + +   H N+V +         L +VT F
Sbjct: 48  YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107

Query: 193 MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 251
           M+ GS  D +           ++  +   V K ++Y+H    +HR +KA+++L+  +  V
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167

Query: 252 KVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVL 301
            ++             R +              W++PEV++   + YD K+D++S GI  
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
            EL  G +P++ +   Q  +              + P L +      ++           
Sbjct: 228 CELANGHVPFKDMPATQMLL---------EKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278

Query: 362 IEILQQIAKEVGEENEERRKEKSSGGFLS 390
             +   +       +             S
Sbjct: 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  182 bits (464), Expect = 5e-55
 Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 15/277 (5%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEV-FIMR 166
           E+    L+   ++  G+YG + +  +    Q +A+K ++   +NS  QK    ++   MR
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            V     V F GA  +   + I  E M       Y  +           L K+A+ + K 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 225 MNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 283
           + +LH   ++IHRD+K +N+L++    VK+ DFG++           + G   +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181

Query: 284 E----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QP 338
                 K Y  K+D++S GI + EL   + PY+        +  V +   P +P +    
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241

Query: 339 KLAELLERCWQQDPALRPDFSEIIE---ILQQIAKEV 372
           +  +   +C +++   RP + E+++        +K  
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  182 bits (463), Expect = 1e-54
 Identities = 69/301 (22%), Positives = 132/301 (43%), Gaps = 25/301 (8%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 165
           ++ +   L+   ++ SG+ G +++  +      +A+K ++    N +  K    ++  ++
Sbjct: 20  YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVL 78

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +      +VQ  G       + I  E M   +      +++G      L K+ + + K +
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-RMQGPIPERILGKMTVAIVKAL 137

Query: 226 NYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
            YL  ++ +IHRD+K +N+L+DE   +K+ DFG++             G   +MAPE I+
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197

Query: 285 -----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-- 337
                   YD +ADV+S GI L EL TG+ PY+        +  V +   P +P +    
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257

Query: 338 PKLAELLERCWQQDPALRPDFSEIIE------------ILQQIAKEVGEENEERRKEKSS 385
                 ++ C  +D   RP +++++E             +    K+V  + E  R   SS
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSGPSS 317

Query: 386 G 386
           G
Sbjct: 318 G 318

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  182 bits (464), Expect = 2e-54
 Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 9/272 (3%)

Query: 103 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ 160
                V E+     +  S++ +G+ G +++ ++      +A K++  E I   ++ +  +
Sbjct: 22  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIR 80

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           E+ ++ +     +V F GA      + I  E M GGS+   L K  G      L KV+I 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139

Query: 221 VSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 279
           V KG+ YL +   I+HRD+K +N+L++    +K+ DFGV+     S   +   GT  +M+
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMS 198

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           PE ++   Y  ++D++S G+ L E+  G+ P     P  A    +  G +        P 
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI---PPPDAKELELMFGCQVEGDAAETPP 255

Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
                 R   +          I E+L  I  E
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  181 bits (462), Expect = 3e-54
 Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 38/278 (13%)

Query: 112 DPKHL-KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           DP  + +    V +G+YG +Y+G +    Q  AIKV+       D ++E  QE+ +++K 
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKY 77

Query: 169 -RHKNVVQFIGA------CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAID 220
             H+N+  + GA            L +V EF   GSV D +   K    K   +  +  +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 279
           + +G+++LHQ+ +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMA
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 280 PEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           PEVI         YD K+D++S GI   E+  G  P   + P++A            IP+
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPR 248

Query: 335 NSQPKLA---------ELLERCWQQDPALRPDFSEIIE 363
           N  P+L            +E C  ++ + RP   ++++
Sbjct: 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  180 bits (458), Expect = 5e-54
 Identities = 58/278 (20%), Positives = 114/278 (41%), Gaps = 34/278 (12%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +  + +  G++G + +       +  AIK ++      +       EV ++  + H+ VV
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 175 QFIGA-------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           ++  A               K  +L I  E+   G++YD +H      +     ++   +
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---------------KAQSG 266
            + ++Y+H   IIHRDLK  N+ +DE+  VK+ DFG+A+                   S 
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 267 VMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 325
            +T+  GT  ++A EV++    Y+ K D++S GI+ +E++           +   +  V 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245

Query: 326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
               P    N      +++      DP  RP    ++ 
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  178 bits (453), Expect = 5e-53
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 30/270 (11%)

Query: 124 SGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGAC 180
            G +G +Y+G       VA+K   PE      Q  +EF  E+  +   RH ++V  IG C
Sbjct: 49  HGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104

Query: 181 TKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRD 237
            +   + ++ ++M  G++  +L+        +     L++ I  ++G++YLH   IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164

Query: 238 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE-VIEHKPYDHKAD 293
           +K+ N+L+DEN V K+ DFG+++   +     + T   GT  ++ PE  I+ +  + K+D
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSD 223

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQA------AVGVVQKG---------LRPTIPKNSQP 338
           V+SFG+VL+E+L  +       P +       AV     G         L   I   S  
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQI 368
           K  +   +C       RP   +++  L+  
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  171 bits (436), Expect = 1e-50
 Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 46/292 (15%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
                +  G+  +++RG +       AIKV         +  +  +E  +++K+ HKN+V
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70

Query: 175 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 230
           +       T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 231 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 284
           N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 285 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 329
                  K Y    D++S G+  +   TG LP+      +    V+ K +          
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 330 ------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                              ++ +  Q  L  +L    + D      F +   
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  172 bits (437), Expect = 6e-50
 Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 46/297 (15%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
                +  G+  +++RG +       AIKV         +  +  +E  +++K+ HKN+V
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70

Query: 175 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 230
           +       T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 231 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 284
           N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 285 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 329
                  K Y    D++S G+  +   TG LP+      +    V+ K +          
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 330 ------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                              ++ +  Q  L  +L    + D      F +       I
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 9e-49
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 51/324 (15%)

Query: 81  SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQ 138
           + P S    +G     +       G  V E+    L+    +A G +  +Y  +     +
Sbjct: 2   AGPGSLGGASGRDQSDF------VGQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54

Query: 139 DVAIK-VLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--------LCI 188
           + A+K +L       +  +   QEV  M+K+  H N+VQF  A +              +
Sbjct: 55  EYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111

Query: 189 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLL 244
           +TE    G + ++L   + +G     ++LK+     + + ++H+    IIHRDLK  NLL
Sbjct: 112 LTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170

Query: 245 MDENEVVKVADFGVARVKAQSGVMTAET-------------GTYRWMAPEVIE---HKPY 288
           +     +K+ DFG A   +     +                 T  +  PE+I+   + P 
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230

Query: 289 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLER 346
             K D+++ G +L+ L   + P+E    L+     +  G + +IP +         L+  
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLR-----IVNG-KYSIPPHDTQYTVFHSLIRA 284

Query: 347 CWQQDPALRPDFSEIIEILQQIAK 370
             Q +P  R   +E++  LQ+IA 
Sbjct: 285 MLQVNPEERLSIAEVVHQLQEIAA 308

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  166 bits (423), Expect = 1e-48
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 29/290 (10%)

Query: 121 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 179
            +  G +G +Y+G       VA+K LK ER     + +F  EV ++    H+N+++  G 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGF 95

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQN---NI 233
           C  P    +V  +M+ GSV   L  + +    L  P   ++A+  ++G+ YLH +    I
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           IHRD+KAAN+L+DE     V DFG+A++     + V TA  GT   +APE +       K
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 215

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQA-----------------AVGVVQKGLRPTIPK 334
            DVF +G++L EL+TG+  ++                           +V   L+     
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD 275

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKS 384
               +L ++   C Q  P  RP  SE++ +L+     + E  EE +KE+ 
Sbjct: 276 EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE--GDGLAERWEEWQKEEM 323

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  165 bits (419), Expect = 2e-48
 Identities = 71/260 (27%), Positives = 127/260 (48%), Gaps = 10/260 (3%)

Query: 111 IDPKHLK---FGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFI 164
           +DP+  +    G  +  G +   +  +     +  A K++    +     +++ + E+ I
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
            R + H++VV F G       + +V E     S+ +   K +     P        +  G
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG 127

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 283
             YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT  ++APEV+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
             K +  + DV+S G +++ LL GK P+E  + L+     ++K    +IPK+  P  A L
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN-EYSIPKHINPVAASL 245

Query: 344 LERCWQQDPALRPDFSEIIE 363
           +++  Q DP  RP  +E++ 
Sbjct: 246 IQKMLQTDPTARPTINELLN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  166 bits (422), Expect = 2e-48
 Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 12/295 (4%)

Query: 76  PSHRSSSPTSEPEDTGMKSH---PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYR 132
           P+         P      +    P   +IP    D      +    G  +  G +   + 
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59

Query: 133 GT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 189
            +     +  A K++    +     +++ + E+ I R + H++VV F G       + +V
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119

Query: 190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            E     S+ +   K +     P        +  G  YLH+N +IHRDLK  NL ++E+ 
Sbjct: 120 LELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178

Query: 250 VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 308
            VK+ DFG+A +V+          GT  ++APEV+  K +  + DV+S G +++ LL GK
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

Query: 309 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
            P+E  + L+     ++K    +IPK+  P  A L+++  Q DP  RP  +E++ 
Sbjct: 239 PPFE-TSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  160 bits (407), Expect = 1e-46
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 8/244 (3%)

Query: 125 GSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           GS+  +YR        +VAIK++ K     + M +    EV I  +++H ++++      
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + +V E    G +  YL      F           +  GM YLH + I+HRDL  +
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGI 299
           NLL+  N  +K+ADFG+A  + +       T  GT  +++PE+     +  ++DV+S G 
Sbjct: 142 NLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200

Query: 300 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 359
           + + LL G+ P++    ++  +  V       +P     +  +L+ +  +++PA R   S
Sbjct: 201 MFYTLLIGRPPFDT-DTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLS 258

Query: 360 EIIE 363
            +++
Sbjct: 259 SVLD 262

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  159 bits (405), Expect = 2e-46
 Identities = 70/260 (26%), Positives = 125/260 (48%), Gaps = 10/260 (3%)

Query: 125 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           G +G++Y  R       +A+KVL   ++  + ++ +  +EV I   +RH N+++  G   
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + ++ E+   G+VY  L K    F          +++  ++Y H   +IHRD+K  
Sbjct: 80  DATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           NLL+     +K+ADFG +     S       GT  ++ PE+IE + +D K D++S G++ 
Sbjct: 139 NLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           +E L GK P+E  T  Q     + +    T P        +L+ R  + +P+ RP   E+
Sbjct: 198 YEFLVGKPPFEANTY-QETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255

Query: 362 IE---ILQQIAKEVGEENEE 378
           +E   I    +K    +N+E
Sbjct: 256 LEHPWITANSSKPSNCQNKE 275

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  167 bits (425), Expect = 2e-46
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 14/236 (5%)

Query: 117 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +   ++ +G +G + R       + VAIK  + E    + ++ +  E+ IM+K+ H NVV
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 75

Query: 175 QFI------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMN 226
                              +  E+  GG +  YL++ +    L    +  +  D+S  + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 227 YLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 283
           YLH+N IIHRDLK  N+++       + K+ D G A+   Q  + T   GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E K Y    D +SFG + +E +TG  P+          G V++     I       
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  157 bits (400), Expect = 1e-45
 Identities = 60/242 (24%), Positives = 112/242 (46%), Gaps = 7/242 (2%)

Query: 125 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           G +G++Y  R       +A+KVL   ++    ++ +  +E+ I   +RH N+++      
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
               + ++ EF   G +Y  L K  G F          +++  ++Y H+  +IHRD+K  
Sbjct: 85  DRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           NLLM     +K+ADFG +         T   GT  ++ PE+IE K +D K D++  G++ 
Sbjct: 144 NLLMGYKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           +E L G  P++  +  +    +V   L+   P        +L+ +  +  P  R     +
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

Query: 362 IE 363
           +E
Sbjct: 261 ME 262

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (408), Expect = 2e-45
 Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 34/297 (11%)

Query: 81  SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQD 139
           SSP+ E +D             ++ T V  +          +  G+ G  +YRG + ++D
Sbjct: 3   SSPSLEQDD------------GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD 50

Query: 140 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           VA+K     RI  +      +EV ++R+   H NV+++           I  E     ++
Sbjct: 51  VAVK-----RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATL 104

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKV 253
            +Y+ +          + +    + G+ +LH  NI+HRDLK  N+L+            +
Sbjct: 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164

Query: 254 ADFGVARV----KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT 306
           +DFG+ +     +      +   GT  W+APE++     +   +  D+FS G V + +++
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

Query: 307 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA-ELLERCWQQDPALRPDFSEI 361
            G  P+      QA + +    L    P+  +  +A EL+E+    DP  RP    +
Sbjct: 225 EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  158 bits (400), Expect = 5e-45
 Identities = 57/173 (32%), Positives = 92/173 (53%), Gaps = 4/173 (2%)

Query: 203 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 262
              K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR  
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 263 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 318
            +      +       +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
                +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  + + 
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 15/156 (9%)

Query: 106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEF 158
              WE     LK G  +  G++G +        D       VA+K+LK E       +  
Sbjct: 14  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 72

Query: 159 AQEVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
             E+ I+  +  H NVV  +GACTKP   L ++ EF   G++  YL   +  F       
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 252
                 +G +Y+     I  DLK     +  ++   
Sbjct: 133 A--RFRQGKDYV---GAIPVDLKRRLDSITSSQSSA 163

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  156 bits (396), Expect = 1e-44
 Identities = 51/248 (20%), Positives = 100/248 (40%), Gaps = 18/248 (7%)

Query: 131 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 190
           ++       +  +       +       + ++  M     KN V  +   +    L I  
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140

Query: 191 EFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 248
           +     ++ D++++   +        L + I +++ + +LH   ++HRDLK +N+    +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200

Query: 249 EVVKVADFGVARV-------------KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
           +VVKV DFG+                       T + GT  +M+PE I    Y HK D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260

Query: 296 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           S G++L+ELL     +         +  V+    P +     P+   +++      P  R
Sbjct: 261 SLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

Query: 356 PDFSEIIE 363
           P+ ++IIE
Sbjct: 318 PEATDIIE 325

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  155 bits (393), Expect = 5e-44
 Identities = 54/314 (17%), Positives = 120/314 (38%), Gaps = 47/314 (14%)

Query: 117 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI---------------NSDMQKEFAQE 161
           +    +  G +  +      ++  A+K  +   +                     +F  E
Sbjct: 34  RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSL 214
           + I+  ++++  +   G  T    + I+ E+M   S+  +                +  +
Sbjct: 94  LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 215 LKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 273
             +   V    +Y+H + NI HRD+K +N+LMD+N  VK++DFG +        +    G
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRG 212

Query: 274 TYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYE----------------YLT 315
           TY +M PE   ++      K D++S GI L+ +    +P+                    
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272

Query: 316 PLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE---ILQQIAK 370
           PL     +     + +   N+    +  + L+   +++PA R    + ++   +     +
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332

Query: 371 EVGEENEERRKEKS 384
           ++ E ++E  K++ 
Sbjct: 333 DLREFSKELYKKRK 346

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  153 bits (388), Expect = 2e-43
 Identities = 72/242 (29%), Positives = 123/242 (50%), Gaps = 6/242 (2%)

Query: 125 GSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 182
           G++  +    +    ++VAIK++   ++N    ++  +EV IM+ + H N+V+       
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85

Query: 183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 242
             +L ++ E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLKA N
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAEN 144

Query: 243 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVL 301
           LL+D +  +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G++L
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 361
           + L++G LP++    L+     V +G +  IP         LL+R    +P  R    +I
Sbjct: 205 YTLVSGSLPFDGQN-LKELRERVLRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

Query: 362 IE 363
           ++
Sbjct: 263 MK 264

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  151 bits (385), Expect = 2e-43
 Identities = 67/266 (25%), Positives = 127/266 (47%), Gaps = 18/266 (6%)

Query: 119 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 175
             K+  G    +Y    T  +  VAIK +    R   +  K F +EV    ++ H+N+V 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            I    +     +V E++ G ++ +Y+    G   + + +     +  G+ + H   I+H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 293
           RD+K  N+L+D N+ +K+ DFG+A+  +++ +       GT ++ +PE  + +  D   D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------KGLRPTIPKNSQPKLAELLER 346
           ++S GIVL+E+L G+ P+   T +  A+  +Q         +R  IP      L+ ++ R
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP----QSLSNVILR 250

Query: 347 CWQQDPALRP-DFSEIIEILQQIAKE 371
             ++D A R     E+ + L  +  E
Sbjct: 251 ATEKDKANRYKTIQEMKDDLSSVLHE 276

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  150 bits (381), Expect = 3e-42
 Identities = 52/334 (15%), Positives = 115/334 (34%), Gaps = 67/334 (20%)

Query: 57  EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 116
           ++L   L      L     P   SS P +      + +    +K   +    +++  K +
Sbjct: 24  DKLIFKL------LSGLSKPV--SSYPNTFEWQCKLPA----IKPKTE----FQLGSKLV 67

Query: 117 KFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
                +  G++  +Y  T          Q   +KV KP     +      Q +  ++   
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLMERLKPSM 125

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGM 225
               ++F  A        +V E  S G++ + ++  K     V     ++  A+ +   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 226 NYLHQNNIIHRDLKAANLLM-----------DENEVVKVADFGVA---RVKAQSGVMTAE 271
             +H   IIH D+K  N ++           D +  + + D G +   ++  +  + TA+
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 331
             T  +   E++ +KP++++ D F     ++ +L G                        
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-------------------KV 286

Query: 332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 365
             +  + K   L  R    D      ++E   ++
Sbjct: 287 KNEGGECKPEGLFRRLPHLDM-----WNEFFHVM 315

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  148 bits (377), Expect = 5e-42
 Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 23/269 (8%)

Query: 119 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           G  +  G   +++        +DVA+KVL+ +   +      F +E      + H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 176 F--IGACTKPPSLC--IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
               G    P      IV E++ G ++ D +H  +G       ++V  D  + +N+ HQN
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN 135

Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKP 287
            IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++++PE      
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195

Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNSQPKLA 341
            D ++DV+S G VL+E+LTG+ P+   +P+  A   V+            +       L 
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----ADLD 251

Query: 342 ELLERCWQQDPALRP-DFSEIIEILQQIA 369
            ++ +   ++P  R    +E+   L ++ 
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVH 280

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  146 bits (370), Expect = 2e-41
 Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 7/243 (2%)

Query: 125 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH ++++     +
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
            P    +V E++SGG ++DY+ K  G  +     ++   +   ++Y H++ ++HRDLK  
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 300
           N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S G++
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           L+ LL G LP++    +      ++ G    IP+     +A LL    Q DP  R    +
Sbjct: 201 LYALLCGTLPFDDEH-VPTLFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKD 258

Query: 361 IIE 363
           I E
Sbjct: 259 IRE 261

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  143 bits (364), Expect = 2e-40
 Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 9/247 (3%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
            G+YG++         + VA+K++  +R   D  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
           +     +  E+ SGG ++D +         P   +    +  G+ YLH   I HRD+K  
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134

Query: 242 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 297
           NLL+DE + +K++DFG   V R   +  ++    GT  ++APE+++ + +     DV+S 
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE-LLERCWQQDPALRP 356
           GIVL  +L G+LP++  +         ++      P          LL +   ++P+ R 
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254

Query: 357 DFSEIIE 363
              +I +
Sbjct: 255 TIPDIKK 261

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  144 bits (365), Expect = 2e-40
 Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 44/284 (15%)

Query: 117 KFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI------------------------ 150
               ++  GSYG   L      +   A+KVL  +++                        
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75

Query: 151 NSDMQKEFAQEVFIMRKVRHKNVVQF---IGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 207
                ++  QE+ I++K+ H NVV+    +    +   L +V E ++ G V +       
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTL--K 132

Query: 208 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 267
                       D+ KG+ YLH   IIHRD+K +NLL+ E+  +K+ADFGV+     S  
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 268 MTAET-GTYRWMAPEVI--EHKPYD-HKADVFSFGIVLWELLTGKLPY--EYLTPLQAAV 321
           + + T GT  +MAPE +    K +     DV++ G+ L+  + G+ P+  E +  L +  
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK- 251

Query: 322 GVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE 363
             ++       P        L +L+ R   ++P  R    EI  
Sbjct: 252 --IKSQ-ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  141 bits (358), Expect = 3e-39
 Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 9/247 (3%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
            G+YG++         + VA+K++  +R   D  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
           +     +  E+ SGG ++D +         P   +    +  G+ YLH   I HRD+K  
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134

Query: 242 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 297
           NLL+DE + +K++DFG   V R   +  ++    GT  ++APE+++ + +     DV+S 
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194

Query: 298 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE-LLERCWQQDPALRP 356
           GIVL  +L G+LP++  +         ++      P          LL +   ++P+ R 
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254

Query: 357 DFSEIIE 363
              +I +
Sbjct: 255 TIPDIKK 261

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  142 bits (360), Expect = 4e-39
 Identities = 41/360 (11%), Positives = 101/360 (28%), Gaps = 51/360 (14%)

Query: 59  LRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 118
           +R  L++E   +      + +  +   E     +        + +  +       + LK 
Sbjct: 11  MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKL 66

Query: 119 GSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
              +  G    ++        +D A+KV       +    +   +  F   ++  ++  +
Sbjct: 67  VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 176 FIGAC--------------------------TKPPSLCIVTEFMSG-----GSVYDYLHK 204
                                              +  ++    S       S  D+++ 
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 205 LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 264
            +G   + +L  +   + +    L    ++H      NL +  +  + + D         
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 265 SGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 322
            G  ++   TY     E +      + H  + +  G+ ++ +    LP+  +TP      
Sbjct: 247 RGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 323 VVQKGLRPTIPKNSQPKLA-------ELLERCWQQDPALRPDFSEIIE--ILQQIAKEVG 373
                  P     +             L+ R    D   R    E +E     Q+  E+ 
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  141 bits (358), Expect = 5e-39
 Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 8/243 (3%)

Query: 125 GSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           GS+G +   T+    Q VA+K +  + +  SDM     +E+  ++ +RH ++++     T
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
            P  + +V E+ +GG ++DY+ + K         +    +   + Y H++ I+HRDLK  
Sbjct: 80  TPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 300
           NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S GIV
Sbjct: 138 NLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           L+ +L G+LP++    +      V       +P    P    L+ R    DP  R    E
Sbjct: 198 LYVMLVGRLPFDDEF-IPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255

Query: 361 IIE 363
           I  
Sbjct: 256 IRR 258

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (355), Expect = 8e-39
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 17/249 (6%)

Query: 119 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 175
              V  G  GD+Y    T   + VA+K++      +   +    +E     +++  +VV 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                     L +    ++G  +   L + +G    P  + +   +   ++  H     H
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATH 157

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 293
           RD+K  N+L+  ++   + DFG+A       +       GT  +MAPE        ++AD
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNSQPKLAELLERC 347
           +++   VL+E LTG  PY+    L      +         +RP IP         ++ R 
Sbjct: 218 IYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP----VAFDAVIARG 272

Query: 348 WQQDPALRP 356
             ++P  R 
Sbjct: 273 MAKNPEDRY 281

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  139 bits (353), Expect = 1e-38
 Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           +       +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           N+++         S  IV E  +GG ++D + K +  F      ++   V  G+ Y+H++
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 232 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 289 DHKADVFSFGIVLWELLTGKLP 310
           D K DV+S G++L+ LL+G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  143 bits (363), Expect = 1e-38
 Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 7/243 (2%)

Query: 125 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH ++++     +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
            P  + +V E++SGG ++DY+ K  G        ++   +  G++Y H++ ++HRDLK  
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 300
           N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S G++
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205

Query: 301 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 360
           L+ LL G LP++    +      +  G     P+   P +  LL+   Q DP  R    +
Sbjct: 206 LYALLCGTLPFDDDH-VPTLFKKICDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKD 263

Query: 361 IIE 363
           I E
Sbjct: 264 IRE 266

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  139 bits (352), Expect = 1e-38
 Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
               ++  G++  + R  + +   + A K++  +++++   ++  +E  I RK++H N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +   +  +     +V + ++GG +++ +   +  +           + + + Y H N I+
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 235 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           HR+LK  NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 292 ADVFSFGIVLWELLTGKLP 310
            D+++ G++L+ LL G  P
Sbjct: 188 VDIWACGVILYILLVGYPP 206

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  143 bits (363), Expect = 1e-38
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 7/203 (3%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           +  +   K+ SG+YG++          + AIK+++   +++    +  +EV +++ + H 
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           N+++         +  +V E   GG ++D +   +  F       +   V  G+ YLH++
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 232 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           NI+HRDLK  NLL+   +++ ++K+ DFG++ V      M    GT  ++APEV+  K Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKY 214

Query: 289 DHKADVFSFGIVLWELLTGKLPY 311
           D K DV+S G++L+ LL G  P+
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPF 237

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  143 bits (362), Expect = 2e-38
 Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           +       +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           N+++         S  IV E  +GG ++D + K +  F      ++   V  G+ Y+H++
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 232 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 289 DHKADVFSFGIVLWELLTGKLP 310
           D K DV+S G++L+ LL+G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  138 bits (351), Expect = 2e-38
 Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 19/261 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS--DMQKEFAQEVFIMRKVRHKN 172
             G  +  GSYG +            A+K+LK +++    + +    +E+ ++R++RHKN
Sbjct: 8   LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 173 VVQF---IGACTKPPSLCIVTEFMSGGS--VYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
           V+Q    +    K   + +V E+   G   + D +   +  F +         +  G+ Y
Sbjct: 68  VIQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEY 124

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 284
           LH   I+H+D+K  NLL+     +K++  GVA      A         G+  +  PE+  
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 285 -HKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
               +   K D++S G+ L+ + TG  P+E    +      + KG    IP +  P L++
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKG-SYAIPGDCGPPLSD 242

Query: 343 LLERCWQQDPALRPDFSEIIE 363
           LL+   + +PA R    +I +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQ 263

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  140 bits (354), Expect = 3e-38
 Identities = 68/250 (27%), Positives = 115/250 (46%), Gaps = 15/250 (6%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 181
           SG++G           + VA+K ++       + +   +E+   R +RH N+V+F     
Sbjct: 30  SGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
            P  L I+ E+ SGG +Y+ +    G F           +  G++Y H   I HRDLK  
Sbjct: 87  TPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145

Query: 242 NLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFG 298
           N L+D +    +K+ DFG ++         +  GT  ++APEV+  + YD   ADV+S G
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205

Query: 299 IVLWELLTGKLPYE---YLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPA 353
           + L+ +L G  P+E        +  +  +    + +IP + +  P+   L+ R +  DPA
Sbjct: 206 VTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDDIRISPECCHLISRIFVADPA 264

Query: 354 LRPDFSEIIE 363
            R    EI  
Sbjct: 265 TRISIPEIKT 274

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  139 bits (352), Expect = 3e-38
 Identities = 56/257 (21%), Positives = 109/257 (42%), Gaps = 19/257 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA------QEVFIMRKV 168
              S + SG++G ++        ++V +K +K E++  D   E         E+ I+ +V
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 169 RHKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
            H N+++ +          +V E   SG  ++ ++ +       P    +   +   + Y
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGY 145

Query: 228 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           L   +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+   P
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205

Query: 288 YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y   + +++S G+ L+ L+  + P+  L     A            P     +L  L+  
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--------AIHPPYLVSKELMSLVSG 257

Query: 347 CWQQDPALRPDFSEIIE 363
             Q  P  R    +++ 
Sbjct: 258 LLQPVPERRTTLEKLVT 274

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  138 bits (349), Expect = 7e-38
 Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 21/298 (7%)

Query: 77  SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 136
            H   S    P  + M                 E      + G  + SG +G +Y G   
Sbjct: 6   HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65

Query: 137 S--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCI 188
           S    VAIK ++ +RI+             EV +++KV      V++ +    +P S  +
Sbjct: 66  SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125

Query: 189 VTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 247
           + E       ++D++ + +G  +          V + + + H   ++HRD+K  N+L+D 
Sbjct: 126 ILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184

Query: 248 NEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELL 305
           N   +K+ DFG   +  +  V T   GT  +  PE I +  Y    A V+S GI+L++++
Sbjct: 185 NRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

Query: 306 TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
            G +P+E           + +G +    +    +   L+  C    P+ RP F EI  
Sbjct: 244 CGDIPFE-------HDEEIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  135 bits (343), Expect = 2e-37
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 10/205 (4%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
               F  K+ SG++GD++     S   +  IK +  +R    M++    E+ +++ + H 
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHP 80

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 228
           N+++         ++ IV E   GG + + +              + ++   +   + Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 229 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 285
           H  +++H+DLK  N+L      +  +K+ DFG+A +       T   GT  +MAPEV   
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-K 199

Query: 286 KPYDHKADVFSFGIVLWELLTGKLP 310
           +    K D++S G+V++ LLTG LP
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  139 bits (353), Expect = 3e-37
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 8/204 (3%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRH 170
              K    +  GS+G++         Q+ A+KV+ K +      ++   +EV +++++ H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
            N+++            +V E  +GG ++D +   +  F      ++   V  G+ Y+H+
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK 144

Query: 231 NNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           N I+HRDLK  NLL+    ++  +++ DFG++     S  M  + GT  ++APEV+ H  
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203

Query: 288 YDHKADVFSFGIVLWELLTGKLPY 311
           YD K DV+S G++L+ LL+G  P+
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  138 bits (350), Expect = 4e-37
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 168
                + SG+ G++         + VAI+++   +        +D       E+ I++K+
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H  +++            IV E M GG ++D +       K  +       +   + YL
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 255

Query: 229 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 284
           H+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+  
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315

Query: 285 --HKPYDHKADVFSFGIVLWELLTGKLP 310
                Y+   D +S G++L+  L+G  P
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  133 bits (338), Expect = 1e-36
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 9/202 (4%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
           ++    + +  GS+G++            A K +    +       F QE+ IM+ + H 
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHP 66

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           N+++          + +V E  +GG +++ +   K VF+     ++  DV   + Y H+ 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 232 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           N+ HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+    Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY 184

Query: 289 DHKADVFSFGIVLWELLTGKLP 310
             + D +S G++++ LL G  P
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  135 bits (343), Expect = 1e-36
 Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
               ++  G++  + R  + +   + A K++  +++++   ++  +E  I RK++H N+V
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +   +  +     +V + ++GG +++ +   +  +           + + + Y H N I+
Sbjct: 92  RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 235 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           HR+LK  NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY   
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210

Query: 292 ADVFSFGIVLWELLTGKLP 310
            D+++ G++L+ LL G  P
Sbjct: 211 VDIWACGVILYILLVGYPP 229

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  136 bits (344), Expect = 3e-36
 Identities = 59/287 (20%), Positives = 120/287 (41%), Gaps = 43/287 (14%)

Query: 114 KHLKFGSKVASGSYGDL-YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHK 171
             +     +  GS G + ++G++  + VA+K     R+  D       E+ ++ +   H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK-----RMLIDFCDIALMEIKLLTESDDHP 69

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------HKLKGVFKLPSLLKVAIDVSKGM 225
           NV+++  + T    L I  E     ++ D +       +   + K  + + +   ++ G+
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 226 NYLHQNNIIHRDLKAANLLMD-------------ENEVVKVADFGVARV-----KAQSGV 267
            +LH   IIHRDLK  N+L+              EN  + ++DFG+ +       +    
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 268 MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPY--EYLTPL 317
           +   +GT  W APE++E        +      D+FS G V + +L+ GK P+  +Y    
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248

Query: 318 QAAVGVVQ-KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
               G+     ++    ++   +  +L+ +    DP  RP   +++ 
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  138 bits (350), Expect = 3e-36
 Identities = 55/264 (20%), Positives = 95/264 (35%), Gaps = 28/264 (10%)

Query: 119 GSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
              +A G  G +Y         + V +K L     +++ Q     E   + +V H ++VQ
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 176 FI-----GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
                        P   IV E++ G S+            +   +   +++   ++YLH 
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS 200

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
             +++ DLK  N+++ E + +K+ D G        G +    GT  + APE++   P   
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TV 255

Query: 291 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK-LAELLERCWQ 349
             D+++ G  L  L                 G    GL    P          LL R   
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPEDDPVLKTYDSYGRLLRRAID 306

Query: 350 QDPALRP-DFSEIIEILQQIAKEV 372
            DP  R     E+   L  + +EV
Sbjct: 307 PDPRQRFTTAEEMSAQLTGVLREV 330

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  132 bits (335), Expect = 5e-36
 Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 23/260 (8%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR- 169
           + G  +  G +G ++ G   +    VAIKV+   R+              EV ++ KV  
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 170 ---HKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
              H  V++ +          +V E  +    ++DY+ + KG             V   +
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAI 152

Query: 226 NYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 284
            + H   ++HRD+K  N+L+D      K+ DFG   +       T   GT  +  PE I 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWIS 211

Query: 285 HKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
              Y    A V+S GI+L++++ G +P+E           + +      P +  P    L
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFE-------RDQEILEA-ELHFPAHVSPDCCAL 263

Query: 344 LERCWQQDPALRPDFSEIIE 363
           + RC    P+ RP   EI+ 
Sbjct: 264 IRRCLAPKPSSRPSLEEILL 283

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  132 bits (334), Expect = 8e-36
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNV 173
            F   + SG++ +++        +  A+K + K              E+ +++K++H+N+
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHENI 68

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V             +V + +SGG ++D + + +GV+       V   V   + YLH+N I
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 234 IHRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
           +HRDLK  NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  KPY  
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSK 186

Query: 291 KADVFSFGIVLWELLTGKLP 310
             D +S G++ + LL G  P
Sbjct: 187 AVDCWSIGVITYILLCGYPP 206

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  135 bits (341), Expect = 1e-35
 Identities = 43/200 (21%), Positives = 101/200 (50%), Gaps = 7/200 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +   ++  G++  + R       Q+ A  ++  +++++   ++  +E  I R ++H N+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +   + ++     ++ + ++GG +++ +   +  +           + + + + HQ  ++
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVV 132

Query: 235 HRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
           HR+LK  NLL+    +   VK+ADFG+A  V+ +        GT  +++PEV+   PY  
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192

Query: 291 KADVFSFGIVLWELLTGKLP 310
             D+++ G++L+ LL G  P
Sbjct: 193 PVDLWACGVILYILLVGYPP 212

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  132 bits (334), Expect = 1e-35
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 53/247 (21%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL---KPERINSDMQKEFAQEVFIMRKVRHK 171
                +  GSYG +            AIK++   K  +IN    +    EV +M+K+ H 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL---------------- 215
           N+ +          +C+V E   GG + D L+           +                
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 216 -----------------------KVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEV 250
                                   +   +   ++YLH   I HRD+K  N L   +++  
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208

Query: 251 VKVADFGVARV-----KAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWE 303
           +K+ DFG+++        +   MT + GT  ++APEV+   ++ Y  K D +S G++L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 304 LLTGKLP 310
           LL G +P
Sbjct: 269 LLMGAVP 275

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  132 bits (334), Expect = 2e-35
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 14/247 (5%)

Query: 69  KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG 128
            L  +       SS T+          P +    ++   +        +  S++  G+  
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL----SDFFEVESELGRGATS 67

Query: 129 DLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 186
            +YR       +  A+KVLK       ++     E+ ++ ++ H N+++       P  +
Sbjct: 68  IVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEIFETPTEI 123

Query: 187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM- 245
            +V E ++GG ++D + + KG +           + + + YLH+N I+HRDLK  NLL  
Sbjct: 124 SLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 246 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 303
               +  +K+ADFG++++     +M    GT  + APE++    Y  + D++S GI+ + 
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242

Query: 304 LLTGKLP 310
           LL G  P
Sbjct: 243 LLCGFEP 249

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  130 bits (330), Expect = 3e-35
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 168
                + SG+ G++         + VAIK++   +        +D       E+ I++K+
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
            H  +++            IV E M GG ++D +       K  +       +   + YL
Sbjct: 73  NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 130

Query: 229 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 284
           H+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+  
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

Query: 285 --HKPYDHKADVFSFGIVLWELLTGKLP 310
                Y+   D +S G++L+  L+G  P
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  129 bits (326), Expect = 6e-35
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
           + G ++ SG +  + +       ++ A K +K  R++S  +    +E  +EV I+R++RH
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
            N++           + ++ E +SGG ++D+L + K         +    +  G++YLH 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS 126

Query: 231 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++      N  +K+ DFG+A             GT  ++APE++ ++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 287 PYDHKADVFSFGIVLWELLTG 307
           P   +AD++S G++ + LL+G
Sbjct: 187 PLGLEADMWSIGVITYILLSG 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  130 bits (329), Expect = 8e-35
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 14/207 (6%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHK 171
           +    +  G +  + R       Q  A+K++   +  S      ++  +E  I   ++H 
Sbjct: 27  ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNY 227
           ++V+ +   +    L +V EFM G  +   + K +          VA    +     + Y
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRY 145

Query: 228 LHQNNIIHRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 283
            H NNIIHRD+K   +L+   + +  VK+  FGVA  +     V     GT  +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLP 310
           + +PY    DV+  G++L+ LL+G LP
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  130 bits (329), Expect = 1e-34
 Identities = 52/250 (20%), Positives = 114/250 (45%), Gaps = 18/250 (7%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
               + +     E+   +S     ++P+      E   +       +  G    + R  +
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFY-QKYDPKDVIGRGVSSVVRRCVH 115

Query: 136 CS--QDVAIKVLK------PERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 186
            +   + A+K+++            ++++   +E  I+R+V  H +++  I +      +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 246
            +V + M  G ++DYL + K          +   + + +++LH NNI+HRDLK  N+L+D
Sbjct: 176 FLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234

Query: 247 ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIV 300
           +N  ++++DFG +        +    GT  ++APE+++      H  Y  + D+++ G++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

Query: 301 LWELLTGKLP 310
           L+ LL G  P
Sbjct: 295 LFTLLAGSPP 304

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  129 bits (327), Expect = 1e-34
 Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 7/194 (3%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGAC 180
            G +  + +    S  Q+ A K LK  R   D + E   E+ ++   +    V+      
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98

Query: 181 TKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                + ++ E+ +GG ++     +L  +     ++++   + +G+ YLHQNNI+H DLK
Sbjct: 99  ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158

Query: 240 AANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
             N+L+        +K+ DFG++R    +  +    GT  ++APE++ + P     D+++
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218

Query: 297 FGIVLWELLTGKLP 310
            GI+ + LLT   P
Sbjct: 219 IGIIAYMLLTHTSP 232

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  128 bits (325), Expect = 1e-34
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 167
           +    +  G    + R  +    ++ A+K++      S       ++++   +EV I+RK
Sbjct: 20  EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 168 V-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           V  H N++Q            +V + M  G ++DYL + K         K+   + + + 
Sbjct: 80  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 138

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 284
            LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198

Query: 285 ----HKPYDHKADVFSFGIVLWELLTGKLP 310
               H  Y  + D++S G++++ LL G  P
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  133 bits (337), Expect = 1e-34
 Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 14/268 (5%)

Query: 52  PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD-VWE 110
           P E T  +    ++   +  R+G+                     Y   I         E
Sbjct: 93  PCEPTAPVLIPGDE---RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 111 IDPKHLK----FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 164
           I   H+        ++ +G++G ++R T  +   + A K +     +   ++   +E+  
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQT 207

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  +RH  +V    A      + ++ EFMSGG +++ +            ++    V KG
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267

Query: 225 MNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
           + ++H+NN +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLP 310
            E KP  +  D++S G++ + LL+G  P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  128 bits (325), Expect = 2e-34
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 170
             G ++ SG +  + +    S   + A K +K  +  +  +    +E  +EV I+R+V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
            NV+           + ++ E +SGG ++D+L + K              +  G+NYLH 
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133

Query: 231 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 287 PYDHKADVFSFGIVLWELLTGKLP 310
           P   +AD++S G++ + LL+G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  132 bits (334), Expect = 2e-34
 Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLK-----------PERINSDMQKEFAQ 160
           +      K+ SG+YG++      +   + AIKV+K             +      +E   
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
           E+ +++ + H N+++            +VTEF  GG +++ +   +  F       +   
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQ 154

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRW 277
           +  G+ YLH++NI+HRD+K  N+L+   +    +K+ DFG++   ++   +    GT  +
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 310
           +APEV+  K Y+ K DV+S G++++ LL G  P
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  128 bits (324), Expect = 2e-34
 Identities = 42/198 (21%), Positives = 88/198 (44%), Gaps = 7/198 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
                +  G +G ++R    S  +    K +K +  +  + K   +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
               +      L ++ EF+SG  +++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 235 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 293 DVFSFGIVLWELLTGKLP 310
           D++S G +++ LL+G  P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  129 bits (326), Expect = 3e-34
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRH 170
             G ++ SG +  + +    S   + A K +K            ++E  +EV I+R+V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
            N++           + ++ E +SGG ++D+L + K              +  G+NYLH 
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133

Query: 231 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 287 PYDHKADVFSFGIVLWELLTGKLP 310
           P   +AD++S G++ + LL+G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  129 bits (326), Expect = 5e-34
 Identities = 39/294 (13%), Positives = 91/294 (30%), Gaps = 50/294 (17%)

Query: 113 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRK-- 167
           P+ L  G+ +           T     +   + V    ER  S+  K+  +EV  +R   
Sbjct: 77  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 168 --------------------VRHKNVVQFIGACTKPPSLCIVTEF-------MSGGSVYD 200
                               V+     + I        + +++ F        +  +  +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 201 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
            L       K       L++ + V + +  LH   ++H  L+  ++++D+   V +  F 
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 258 VARVKAQSGVMTAETGTY---RWMAPEVIEHKP-----YDHKADVFSFGIVLWELLTGKL 309
               +  +  ++     +      A  ++              D ++ G+ ++ +    L
Sbjct: 257 HLV-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 310 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
           P      L  +  + +      IP      +  LLE   +     R    + +E
Sbjct: 316 PNTDDAALGGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  128 bits (324), Expect = 6e-34
 Identities = 45/299 (15%), Positives = 93/299 (31%), Gaps = 59/299 (19%)

Query: 113 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVR 169
           P+ L  G+ +           T     +   + V    ER  S+  K+  +EV  +R +R
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 170 -------------------------HKNVVQFIGACTKPPSLCIVTEFM----SGGSVYD 200
                                     K +++          L     +     +  +  +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 201 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
            L       K       L++ + V + +  LH   ++H  L+  ++++D+   V +  F 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 258 VARVKAQSGVMTAETGTYRWMAPEVI-----------EHKPYDHKADVFSFGIVLWELLT 306
                 + G     + +  +  PE+                     D ++ G+V++ +  
Sbjct: 252 HLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 307 GKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
             LP        AA+G  +   R    IP      +  LLE   +     R    + +E
Sbjct: 309 ADLPIT----KDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  128 bits (323), Expect = 1e-33
 Identities = 41/198 (20%), Positives = 93/198 (46%), Gaps = 6/198 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
               ++ SG++G ++R    +  +    K +         +     E+ IM ++ H  ++
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
               A      + ++ EF+SGG ++D +           ++       +G+ ++H+++I+
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171

Query: 235 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           H D+K  N++    +   VK+ DFG+A       ++   T T  + APE+++ +P     
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231

Query: 293 DVFSFGIVLWELLTGKLP 310
           D+++ G++ + LL+G  P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  126 bits (320), Expect = 1e-33
 Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQK----EFAQEVFIMRKVRH 170
             G ++ SG +  + +    S     A K +K  R  S  +     +  +EV I+++++H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
            NV+           + ++ E ++GG ++D+L + K         +    +  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 132

Query: 231 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192

Query: 287 PYDHKADVFSFGIVLWELLTGKLP 310
           P   +AD++S G++ + LL+G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  124 bits (314), Expect = 7e-33
 Identities = 47/194 (24%), Positives = 93/194 (47%), Gaps = 13/194 (6%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC 180
            GS+    +  +    Q  A+K+     I+  M+    +E+  ++    H N+V+     
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKI-----ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 240
                  +V E ++GG +++ + K K  F       +   +   ++++H   ++HRDLK 
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134

Query: 241 ANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 296
            NLL    ++N  +K+ DFG AR     +  +     T  + APE++    YD   D++S
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194

Query: 297 FGIVLWELLTGKLP 310
            G++L+ +L+G++P
Sbjct: 195 LGVILYTMLSGQVP 208

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  124 bits (312), Expect = 3e-32
 Identities = 51/247 (20%), Positives = 106/247 (42%), Gaps = 14/247 (5%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSK--------VASGSY 127
            S+   +     +     +    +  P    D   +  K     S         +  G +
Sbjct: 43  WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102

Query: 128 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 185
           G +++    +    +A K++K   +    ++E   E+ +M ++ H N++Q   A      
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKND 160

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           + +V E++ GG ++D +            +     + +G+ ++HQ  I+H DLK  N+L 
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220

Query: 246 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 303
              + + +K+ DFG+AR       +    GT  ++APEV+ +       D++S G++ + 
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM 280

Query: 304 LLTGKLP 310
           LL+G  P
Sbjct: 281 LLSGLSP 287

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  122 bits (309), Expect = 6e-32
 Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 15/202 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNV 173
           +    +  GSY    R  + +   + A+K++         +++  +E+ I+ +  +H N+
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           +           + +VTE M GG + D + + +  F       V   ++K + YLH   +
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 234 IHRDLKAANLLM----DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPY 288
           +HRDLK +N+L        E +++ DFG A+ ++A++G++     T  ++APEV+E + Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 289 DHKADVFSFGIVLWELLTGKLP 310
           D   D++S G++L+ +LTG  P
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTP 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  118 bits (298), Expect = 9e-31
 Identities = 58/241 (24%), Positives = 108/241 (44%), Gaps = 17/241 (7%)

Query: 125 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 179
           GS+  +       T  S++ AIK+L+   I  + +  +   E  +M ++ H   V+    
Sbjct: 41  GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                 L     +   G +  Y+ K  G F          ++   + YLH   IIHRDLK
Sbjct: 99  FQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157

Query: 240 AANLLMDENEVVKVADFGVA-RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 296
             N+L++E+  +++ DFG A  +  +S    A +  GT ++++PE++  K     +D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPAL 354
            G ++++L+ G  P+           + QK   L    P+   PK  +L+E+    D   
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273

Query: 355 R 355
           R
Sbjct: 274 R 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  122 bits (307), Expect = 1e-30
 Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 9/230 (3%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 200 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
            +++ + +  F     +  A ++  G+  LH+  I++RDLK  N+L+D++  ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 259 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 318
           A    +   +    GT  +MAPEV++++ Y    D ++ G +L+E++ G+ P++      
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 392

Query: 319 AAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR-----PDFSEI 361
               V +          +   P+   L  +   +DPA R         E+
Sbjct: 393 KREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  118 bits (298), Expect = 2e-30
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 8/234 (3%)

Query: 125 GSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 181
           GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   +  
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 241
              +L +V E+++GG ++ +L +  G F  P     A  +     YLH  ++I+RDLK  
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 242 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 301
           NLL+D+   ++V DFG A  K   G      GT   +APE+I  K Y+   D ++ G+++
Sbjct: 171 NLLIDQQGYIQVTDFGFA--KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
           +E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (304), Expect = 3e-30
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 9/223 (4%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A K L  +R+      + A  E  I+ KV  + +V    A      LC+V   M+GG + 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273

Query: 200 DYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
            +++ +      F+ P  +     +  G+ +LHQ NII+RDLK  N+L+D++  V+++D 
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333

Query: 257 GVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 314
           G+A V+ ++G    +   GT  +MAPE++  + YD   D F+ G+ L+E++  + P+   
Sbjct: 334 GLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

Query: 315 TPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 355
                   + Q+ L    T P    P   +  E   Q+DP  R
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  118 bits (299), Expect = 3e-30
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 9/228 (3%)

Query: 141 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+K +  ++     +     +E+ IM+ + H  +V    +      + +V + + GG + 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
            +L +    FK  ++     ++   ++YL    IIHRD+K  N+L+DE+  V + DF +A
Sbjct: 104 YHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

Query: 260 RVKAQSGVMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYL-- 314
            +  +   +T   GT  +MAPE+   +    Y    D +S G+  +ELL G+ PY     
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-PDFSEI 361
           T  +  V   +     T P     ++  LL++  + +P  R    S++
Sbjct: 223 TSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  118 bits (297), Expect = 7e-30
 Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 26/250 (10%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
           P+     P ++P     +  P              I   +      +  G  G + +   
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83

Query: 136 CS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCI 188
               +  A+K+L       D  K   +EV +  +  +  ++V+ +            L I
Sbjct: 84  KRTQEKFALKML------QDCPKAR-REVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136

Query: 189 VTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 243
           V E + GG ++  +   +G           ++K    + + + YLH  NI HRD+K  NL
Sbjct: 137 VMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENL 192

Query: 244 LM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 300
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

Query: 301 LWELLTGKLP 310
           ++ LL G  P
Sbjct: 253 MYILLCGYPP 262

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  116 bits (292), Expect = 1e-29
 Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 39/248 (15%)

Query: 78  HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 137
           H   S   E    G +   Y +      TD +++  + L  G     G  G +    +  
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAV------TDDYQLSKQVL--GL----GVNGKVLECFHRR 52

Query: 138 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCIVT 190
             Q  A+K+L           +  QEV    +     ++V  +            L I+ 
Sbjct: 53  TGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105

Query: 191 EFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           E M GG ++  + + +G           +++   D+   + +LH +NI HRD+K  NLL 
Sbjct: 106 ECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLY 161

Query: 246 ---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 302
              +++ V+K+ DFG A+ +     +     T  ++APEV+  + YD   D++S G++++
Sbjct: 162 TSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220

Query: 303 ELLTGKLP 310
            LL G  P
Sbjct: 221 ILLCGFPP 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  116 bits (293), Expect = 1e-29
 Identities = 56/226 (24%), Positives = 111/226 (49%), Gaps = 13/226 (5%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           A+KV+K E +N D   ++ Q E  +  +   H  +V           L  V E+++GG +
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
             ++ + +           + ++S  +NYLH+  II+RDLK  N+L+D    +K+ D+G+
Sbjct: 98  MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156

Query: 259 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
            +   + G  T+ T  GT  ++APE++  + Y    D ++ G++++E++ G+ P++ +  
Sbjct: 157 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

Query: 317 LQAAVGVVQKGL-------RPTIPKNSQPKLAELLERCWQQDPALR 355
                   +  L       +  IP++   K A +L+    +DP  R
Sbjct: 216 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (288), Expect = 3e-29
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 32/240 (13%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVL--KPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 178
            G++  +         Q+ A+K++  +P  I S +     +EV ++ + + H+NV++ I 
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLELIE 78

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
              +     +V E M GGS+  ++HK +  F       V  DV+  +++LH   I HRDL
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137

Query: 239 KAANLLM---DENEVVKVADFGVARV--------KAQSGVMTAETGTYRWMAPEVIE--- 284
           K  N+L    ++   VK+ DF +              +  +    G+  +MAPEV+E   
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197

Query: 285 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
                YD + D++S G++L+ LL+G        P     G      R       Q  L E
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGSDCGWDRGEACPACQNMLFE 251

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  115 bits (290), Expect = 6e-29
 Identities = 55/226 (24%), Positives = 111/226 (49%), Gaps = 13/226 (5%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           A++V+K E +N D   ++ Q E  +  +   H  +V           L  V E+++GG +
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
             ++ + +           + ++S  +NYLH+  II+RDLK  N+L+D    +K+ D+G+
Sbjct: 141 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199

Query: 259 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
            +   + G  T+ T  GT  ++APE++  + Y    D ++ G++++E++ G+ P++ +  
Sbjct: 200 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

Query: 317 LQAAVGVVQKGL-------RPTIPKNSQPKLAELLERCWQQDPALR 355
                   +  L       +  IP++   K A +L+    +DP  R
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  112 bits (283), Expect = 2e-28
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+K+L+ E I +  +      E  +++  RH  +     A      LC V E+ +GG ++
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
            +L + + VF          ++   + YLH  ++++RD+K  NL++D++  +K+ DFG+ 
Sbjct: 94  FHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

Query: 260 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 317
           +     G     T  GT  ++APEV+E   Y    D +  G+V++E++ G+LP+      
Sbjct: 153 KEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

Query: 318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-----PDFSEI 361
           +    ++ + +R   P+   P+   LL    ++DP  R      D  E+
Sbjct: 212 RLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  111 bits (281), Expect = 3e-28
 Identities = 52/174 (29%), Positives = 95/174 (54%), Gaps = 4/174 (2%)

Query: 141 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 200
           A+KVLK   +    +     E  I+ +V H  +V+   A      L ++ +F+ GG ++ 
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115

Query: 201 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 260
            L K + +F    +     +++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++
Sbjct: 116 RLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

Query: 261 VKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
                      +  GT  +MAPEV+  + +   AD +SFG++++E+LTG LP++
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  111 bits (280), Expect = 5e-28
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 6/216 (2%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+KVLK E +    Q E    E  ++  V H  +++  G       + ++ +++ GG ++
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
             L K    F  P     A +V   + YLH  +II+RDLK  N+L+D+N  +K+ DFG A
Sbjct: 95  SLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153

Query: 260 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 319
             K    V     GT  ++APEV+  KPY+   D +SFGI+++E+L G  P+     ++ 
Sbjct: 154 --KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

Query: 320 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
              ++   LR   P      + +LL R   +D + R
Sbjct: 212 YEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (280), Expect = 6e-28
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            V  GSYG + +       + VAIK       +  ++K   +E+ +++++RH+N+V  + 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
            C K     +V EF+   ++ D L           + K    +  G+ + H +NIIHRD+
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150

Query: 239 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKPYDHKADV 294
           K  N+L+ ++ VVK+ DFG AR  A    V   E  T  YR  APE++     Y    DV
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGKAVDV 208

Query: 295 FSFGIVLWELLTGK 308
           ++ G ++ E+  G+
Sbjct: 209 WAIGCLVTEMFMGE 222

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  114 bits (287), Expect = 8e-28
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 10/222 (4%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKN---VVQFIGACTKPPSLCIVTEFMSGG 196
           A+K L  +RI     +  A  E  ++  V   +   +V    A   P  L  + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 256
            ++ +L +  GVF    +   A ++  G+ ++H   +++RDLK AN+L+DE+  V+++D 
Sbjct: 278 DLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336

Query: 257 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT 315
           G+A          A  GT+ +MAPEV++    YD  AD FS G +L++LL G  P+    
Sbjct: 337 GLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQH 394

Query: 316 PLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 355
             +    + +  L     +P +  P+L  LLE   Q+D   R
Sbjct: 395 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (280), Expect = 8e-28
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 36/209 (17%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVRH 170
            +  G +  +Y+      +Q VAIK     +I    + E           E+ +++++ H
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIK-----KIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------K 223
            N++  + A     ++ +V +FM           L+ + K  SL+     +        +
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAP 280
           G+ YLHQ+ I+HRDLK  NLL+DEN V+K+ADFG+A+     +   T +  T  YR  AP
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--AP 181

Query: 281 EVIEH-KPYDHKADVFSFGIVLWELLTGK 308
           E++   + Y    D+++ G +L ELL   
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  113 bits (285), Expect = 1e-27
 Identities = 60/250 (24%), Positives = 116/250 (46%), Gaps = 12/250 (4%)

Query: 71  ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 130
             +        +   +      +     +   ++  +   +      F   +  GS+G +
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV 357

Query: 131 ----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPP 184
                +GT   +  A+K+LK + +  D   E    E  ++    +   + Q         
Sbjct: 358 MLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415

Query: 185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 244
            L  V E+++GG +  ++ +  G FK P  +  A +++ G+ +L    II+RDLK  N++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474

Query: 245 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLW 302
           +D    +K+ADFG+ +     GV T  T  GT  ++APE+I ++PY    D ++FG++L+
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533

Query: 303 ELLTGKLPYE 312
           E+L G+ P+E
Sbjct: 534 EMLAGQAPFE 543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  109 bits (275), Expect = 1e-27
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 121 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNVV 174
           K+  G+YG +Y+      +  A+K     +I  + + E       +E+ I+++++H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALK-----KIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
           +          L +V E +      D    L   +G  +  +     + +  G+ Y H  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 232 NIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKP 287
            ++HRDLK  NLL++    +K+ADFG+AR         T E  T  YR  AP+V+   K 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKK 177

Query: 288 YDHKADVFSFGIVLWELLTGK 308
           Y    D++S G +  E++ G 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  110 bits (277), Expect = 2e-27
 Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 6/176 (3%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           A+KVLK + I  D   E    E  I+     H  + Q       P  L  V EF++GG +
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
             ++ K    F        A ++   + +LH   II+RDLK  N+L+D     K+ADFG+
Sbjct: 112 MFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170

Query: 259 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
            +    +GV TA T  GT  ++APE+++   Y    D ++ G++L+E+L G  P+E
Sbjct: 171 CKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (273), Expect = 2e-27
 Identities = 32/263 (12%), Positives = 79/263 (30%), Gaps = 46/263 (17%)

Query: 119 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQ 175
                       ++   T   + VA+  + P+ +   D+ +E       + ++    V +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
            +          +V E++ GGS+ +              ++    ++   +  H+  +  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 295
                + + +  +  V +A                                  + + D+ 
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDIR 186

Query: 296 SFGIVLWELLTGKLPYE---YLTPLQAAVGVVQ------KGLRPTIPKNSQPKLAELLER 346
             G  L+ LL  + P       + L  A             +   IP     +++ +  R
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP----FQISAVAAR 242

Query: 347 CWQQDPALRPDFSEIIEILQQIA 369
             Q D  +R   S ++ ++QQ  
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQAT 264

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (277), Expect = 2e-27
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 37/214 (17%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-F----AQEVFIMRKVRHKNV 173
           K+  G++G++++       Q VA+K     ++  + +KE F     +E+ I++ ++H+NV
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHENV 78

Query: 174 VQFIGACT--------KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVS 222
           V  I  C            S+ +V +F      +D    L  +   F L  + +V   + 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--Y 275
            G+ Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q    T    T  Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 276 RWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           R   PE++   + Y    D++  G ++ E+ T  
Sbjct: 195 R--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  111 bits (280), Expect = 2e-27
 Identities = 74/319 (23%), Positives = 145/319 (45%), Gaps = 21/319 (6%)

Query: 54  EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 113
           EE E+   A++     L++Q   +       S  +++G +     L  P        +  
Sbjct: 94  EEREEWTTAIQTVADGLKKQ-AAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-----RVTM 147

Query: 114 KHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRH 170
              ++   +  G++G   L +     +  A+K+LK E I +  +      E  +++  RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH- 229
             +     +      LC V E+ +GG ++ +L + + VF          ++   ++YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS 266

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP 287
           + N+++RDLK  NL++D++  +K+ DFG+ +   + G     T  GT  ++APEV+E   
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLEDND 325

Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 347
           Y    D +  G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL   
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGL 383

Query: 348 WQQDPALR-----PDFSEI 361
            ++DP  R      D  EI
Sbjct: 384 LKKDPKQRLGGGSEDAKEI 402

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 3e-27
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
           K+  GSYG +++       Q VAIK       +  ++K   +E+ ++++++H N+V  + 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
              +   L +V E+    +V   L + +       +  +     + +N+ H++N IHRD+
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128

Query: 239 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVIEH-KPYDHKADV 294
           K  N+L+ ++ V+K+ DFG AR+    S     E  T  YR  +PE++     Y    DV
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYGPPVDV 186

Query: 295 FSFGIVLWELLTGK 308
           ++ G V  ELL+G 
Sbjct: 187 WAIGCVFAELLSGV 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  109 bits (274), Expect = 4e-27
 Identities = 55/177 (31%), Positives = 97/177 (54%), Gaps = 8/177 (4%)

Query: 141 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           A+KVLK   I  +  K+ A    E  I+ +V+H  +V  I A      L ++ E++SGG 
Sbjct: 49  AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           ++  L + +G+F   +      ++S  + +LHQ  II+RDLK  N++++    VK+ DFG
Sbjct: 108 LFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 258 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           + +     G +T  T  GT  +MAPE++    ++   D +S G +++++LTG  P+ 
Sbjct: 167 LCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  109 bits (275), Expect = 4e-27
 Identities = 58/338 (17%), Positives = 111/338 (32%), Gaps = 87/338 (25%)

Query: 91  GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKV 144
           GM++             +  +   +      ++SGSYG       C+        VAIK 
Sbjct: 1   GMQAKGEAAMRDLIAE-LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKR 53

Query: 145 LKPERINSDMQKEF-----AQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IV 189
           +     +             +    E+ ++    H N++  +                +V
Sbjct: 54  VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLV 112

Query: 190 TEFMSGGSVYDYLHKL--KGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDL 238
           TE M      D L ++       +           +L        G++ LH+  ++HRDL
Sbjct: 113 TELMR----TD-LAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHRDL 160

Query: 239 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVF 295
              N+L+ +N  + + DF +AR        T       YR  APE++ + K +    D++
Sbjct: 161 HPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMW 218

Query: 296 SFGIVLWELLTGK-------------LPYEYL-TPLQAAVGVVQ--------KGLRPTIP 333
           S G V+ E+   K                E + TP    V +          +     +P
Sbjct: 219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278

Query: 334 K--------NSQPKLAELLERCWQQDPALRPDFSEIIE 363
                     + P   +L+ +  + +P  R    + + 
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  108 bits (272), Expect = 5e-27
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)

Query: 121 KVASGSYGDLYRG---TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKN 172
           KV  G+YG +Y+        + VA+K     RI  D + E       +E+ +++++ H N
Sbjct: 28  KVGEGTYGVVYKAKDSQ--GRIVALK-----RIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           +V  I        L +V EFM      D    L + K   +   +      + +G+ + H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EH 285
           Q+ I+HRDLK  NLL++ +  +K+ADFG+AR         T E  T  YR  AP+V+   
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGS 194

Query: 286 KPYDHKADVFSFGIVLWELLTGK 308
           K Y    D++S G +  E++TGK
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  108 bits (273), Expect = 6e-27
 Identities = 54/176 (30%), Positives = 96/176 (54%), Gaps = 6/176 (3%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           A+K+LK + +  D   E    E  ++    +   + Q          L  V E+++GG +
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
             ++ +  G FK P  +  A +++ G+ +L    II+RDLK  N+++D    +K+ADFG+
Sbjct: 109 MYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167

Query: 259 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
            +     GV T  T  GT  ++APE+I ++PY    D ++FG++L+E+L G+ P+E
Sbjct: 168 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  110 bits (276), Expect = 7e-27
 Identities = 41/179 (22%), Positives = 84/179 (46%), Gaps = 8/179 (4%)

Query: 141 AIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+K+L    +    +   F +E  ++     K +     A     +L +V ++  GG + 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
             L K +             ++   ++ +HQ + +HRD+K  N+LMD N  +++ADFG  
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222

Query: 260 RVKAQSGVMTAET--GTYRWMAPEVIEHKP-----YDHKADVFSFGIVLWELLTGKLPY 311
               + G + +    GT  +++PE+++        Y  + D +S G+ ++E+L G+ P+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  107 bits (270), Expect = 7e-27
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 173
           K+  G+YG +++       + VA+K     R+  D   E       +E+ ++++++HKN+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
           V+          L +V EF       D   Y     G      +      + KG+ + H 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EHK 286
            N++HRDLK  NLL++ N  +K+A+FG+AR         +AE  T  YR   P+V+   K
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAK 177

Query: 287 PYDHKADVFSFGIVLWELLTGKLPY 311
            Y    D++S G +  EL     P 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  108 bits (273), Expect = 7e-27
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 10/220 (4%)

Query: 141 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 197
           AIK LK + +  D   E       V       H  +           +L  V E+++GG 
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVL-SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104

Query: 198 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
           +  ++      F L      A ++  G+ +LH   I++RDLK  N+L+D++  +K+ADFG
Sbjct: 105 LMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 258 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 315
           + +        T  T  GT  ++APE++  + Y+H  D +SFG++L+E+L G+ P+    
Sbjct: 164 MCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

Query: 316 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 355
             +    +         P+  + +  +LL + + ++P  R
Sbjct: 223 EEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (271), Expect = 9e-27
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 28/203 (13%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHKN 172
           K+  G+Y  +Y+G        VA+K ++       ++ E        +EV +++ ++H N
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           +V          SL +V E++      D   YL     +  + ++      + +G+ Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EH 285
           +  ++HRDLK  NLL++E   +K+ADFG+AR K+  +     E  T  YR   P+++   
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGS 175

Query: 286 KPYDHKADVFSFGIVLWELLTGK 308
             Y  + D++  G + +E+ TG+
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  106 bits (268), Expect = 1e-26
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVR- 169
           ++  G+YG +Y+    +    VA+K      +                  EV ++R++  
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 170 --HKNVVQFIGACT-----KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VA 218
             H NVV+ +  C      +   + +V E +      D   YL K          +K + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YR 276
               +G+++LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +T    T  YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 308
             APEV+    Y    D++S G +  E+   K
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  107 bits (269), Expect = 4e-26
 Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 12/229 (5%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 198
           A+KVL+ + I    +++    E  ++ + V+H  +V    +      L  V ++++GG +
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 199 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
           + +L + +  F  P     A +++  + YLH  NI++RDLK  N+L+D    + + DFG+
Sbjct: 127 FYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185

Query: 259 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 316
            +   +    T+ T  GT  ++APEV+  +PYD   D +  G VL+E+L G  P+     
Sbjct: 186 CKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244

Query: 317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR----PDFSEI 361
            +    ++ K L+  +  N       LLE   Q+D   R     DF EI
Sbjct: 245 AEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  104 bits (263), Expect = 8e-26
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 39/211 (18%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 173
           K+ +G+Y  +Y+G   +    VA+K +K +       +E       +E+ +M++++H+N+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHENI 65

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS----------- 222
           V+          L +V EFM         + LK      ++      +            
Sbjct: 66  VRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 223 -KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWM 278
            +G+ + H+N I+HRDLK  NLL+++   +K+ DFG+AR         ++E  T  YR  
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR-- 175

Query: 279 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           AP+V+   + Y    D++S G +L E++TGK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  104 bits (263), Expect = 1e-25
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 121 KVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-----QEVFIMRKVR--- 169
           ++  G+YG +++          VA+K     R+     +E       +EV ++R +    
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 170 HKNVVQFI-----GACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VAID 220
           H NVV+           +   L +V E +      D   YL K+         +K +   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWM 278
           + +G+++LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  YR  
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGK 308
           APEV+    Y    D++S G +  E+   K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (267), Expect = 1e-25
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 37/221 (16%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----E 161
            + +  ++ +    + SG+ G +         ++VAIK  K  R   +  +  A+    E
Sbjct: 57  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN--QTHAKRAYRE 111

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           + +M+ V HKN++  +   T   +L       +V E M      + L ++     +   L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQV-----IQMEL 161

Query: 216 K------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 269
                  +   +  G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221

Query: 270 AETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 308
               T  YR  APEVI    Y    D++S G ++ E++  K
Sbjct: 222 PYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  104 bits (262), Expect = 2e-25
 Identities = 65/307 (21%), Positives = 131/307 (42%), Gaps = 24/307 (7%)

Query: 76  PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG------- 128
                +S         + +  + L+  N      ++  ++ +    + +G+YG       
Sbjct: 16  GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRK 75

Query: 129 DLYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQ-EVFIMRKVRHKN-VVQFIGACTKPPS 185
                T   +  A+KVLK   I       E  + E  ++  +R    +V    A      
Sbjct: 76  ISGHDT--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133

Query: 186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 245
           L ++ ++++GG ++ +L + +  F    +     ++   + +LH+  II+RD+K  N+L+
Sbjct: 134 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192

Query: 246 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI--EHKPYDHKADVFSFGIVL 301
           D N  V + DFG+++         A    GT  +MAP+++      +D   D +S G+++
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252

Query: 302 WELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR---- 355
           +ELLTG  P+       +   + ++ L+  P  P+       +L++R   +DP  R    
Sbjct: 253 YELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 312

Query: 356 -PDFSEI 361
             D  EI
Sbjct: 313 PRDADEI 319

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  105 bits (264), Expect = 3e-25
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 40/211 (18%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            + +GS+G +Y+   C   + VAIK     ++  D + +  +E+ IMRK+ H N+V+ + 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN-RELQIMRKLDHCNIVR-LR 113

Query: 179 ACTKPPS-------LCIVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDV 221
                         L +V +++   +VY    H  +    LP          L +     
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR----- 167

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGT--YRWM 278
              + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+   +     +   +  YR  
Sbjct: 168 --SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR-- 223

Query: 279 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           APE+I     Y    DV+S G VL ELL G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  104 bits (262), Expect = 4e-25
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 43/255 (16%)

Query: 78  HRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 136
             S++P +  +   +      +K+  +DG    + +  +      + +GS+G +++    
Sbjct: 4   TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNC-KVIGNGSFGVVFQAKLV 62

Query: 137 -SQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPS-------LC 187
            S +VAIK     ++  D  K F   E+ IMR V+H NVV  + A             L 
Sbjct: 63  ESDEVAIK-----KVLQD--KRFKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLN 114

Query: 188 IVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRD 237
           +V E++   +VY    H  K    +P          LL+        + Y+H   I HRD
Sbjct: 115 LVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRD 166

Query: 238 LKAANLLMDENE-VVKVADFGVARVKAQSGVMTAE--TGTYRWMAPEVI-EHKPYDHKAD 293
           +K  NLL+D    V+K+ DFG A++        +   +  YR  APE+I     Y    D
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNID 224

Query: 294 VFSFGIVLWELLTGK 308
           ++S G V+ EL+ G+
Sbjct: 225 IWSTGCVMAELMQGQ 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  103 bits (258), Expect = 5e-25
 Identities = 45/218 (20%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 165
            W       +   K+  G Y +++     +  + V +K+LKP +     +K+  +E+ I+
Sbjct: 31  EWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 84

Query: 166 RKVR-HKNVVQ----FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI- 219
             +R   N++          ++ P+L +     +     D   +L       +L    I 
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPAL-VFEHVNN----TD-FKQL-----YQTLTDYDIR 133

Query: 220 ----DVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGT 274
               ++ K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A              +
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193

Query: 275 YRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGKLP 310
            R+   PE++ +++ YD+  D++S G +L  ++  K P
Sbjct: 194 -RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  103 bits (259), Expect = 6e-25
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 45/225 (20%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ----E 161
            + +  ++ +    + SG+ G +         ++VAIK  K  R   +  +  A+    E
Sbjct: 20  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN--QTHAKRAYRE 74

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLP--- 212
           + +M+ V HKN++  +   T   SL       IV E M      + L +   V ++    
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQ---VIQMELDH 126

Query: 213 --------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 264
                    +L        G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    
Sbjct: 127 ERMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179

Query: 265 SGVMTAETGTYRWM-APEVIEHKPYDHKADVFSFGIVLWELLTGK 308
           S +MT    T R+  APEVI    Y    D++S G ++ E++ G 
Sbjct: 180 SFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  104 bits (261), Expect = 6e-25
 Identities = 38/201 (18%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 125 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 179
           G++ ++     + T   Q  A+K++    +    +    + E  ++     + + Q   A
Sbjct: 72  GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129

Query: 180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 239
                 L +V E+  GG +   L K               ++   ++ +H+   +HRD+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189

Query: 240 AANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE-------HKPYDH 290
             N+L+D    +++ADFG        G + +    GT  +++PE+++          Y  
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249

Query: 291 KADVFSFGIVLWELLTGKLPY 311
           + D ++ G+  +E+  G+ P+
Sbjct: 250 ECDWWALGVFAYEMFYGQTPF 270

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  102 bits (256), Expect = 2e-24
 Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 35/220 (15%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 161
            WE+     +    V SG+YG +           VAIK  K  R      + FA+    E
Sbjct: 20  AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS--ELFAKRAYRE 74

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           + +++ +RH+NV+  +   T   +L       +V  FM      D L K   + K   L 
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGK---LMKHEKLG 126

Query: 216 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
           +  I      + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT 
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTG 184

Query: 271 ETGTYRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
              T RW  APEVI     Y    D++S G ++ E++TGK
Sbjct: 185 YVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (255), Expect = 2e-24
 Identities = 45/220 (20%), Positives = 98/220 (44%), Gaps = 43/220 (19%)

Query: 120 SKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---- 169
            K+  G +       D+   T+    VA+K+++    +    +    E+ ++++V     
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTH----VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 77

Query: 170 -------HKNVVQ------FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLL 215
                    ++++        G       + +V E + G ++   + K +     L  + 
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134

Query: 216 KVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------VVKVADFGVARVKAQSGVM 268
           +++  +  G++Y+H+   IIH D+K  N+LM+  +       +K+AD G A    +    
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 308
           + +T  YR  +PEV+   P+   AD++S   +++EL+TG 
Sbjct: 195 SIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  101 bits (254), Expect = 3e-24
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 33/221 (14%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           V+++ P++    S +  G+YG +           VAIK + P    +  Q+   +E+ I+
Sbjct: 22  VFDVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKIL 79

Query: 166 RKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
            + RH+N++         P++       IV + M      D L+K   + K   L    I
Sbjct: 80  LRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME----TD-LYK---LLKTQHLSNDHI 130

Query: 220 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTA 270
                 + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T 
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 271 ETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
              T  YR  APE++   K Y    D++S G +L E+L+ +
Sbjct: 191 YVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  100 bits (250), Expect = 1e-23
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 161
            WE+ PK     + V SG+YG +         + VAIK  K  R      + FA+    E
Sbjct: 19  AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQS--EIFAKRAYRE 73

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           + +++ ++H+NV+  +   T   SL       +V  FM      D L K+ G+      +
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKI 128

Query: 216 KVAI-DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 274
           +  +  + KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVT 186

Query: 275 YRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
            RW  APEVI     Y+   D++S G ++ E+LTGK
Sbjct: 187 -RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  100 bits (251), Expect = 1e-23
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 9/178 (5%)

Query: 141 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 199
           A+K+L    +       F   E  IM       VVQ   A      L +V E+M GG + 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157

Query: 200 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
           + +                 +V   ++ +H    IHRD+K  N+L+D++  +K+ADFG  
Sbjct: 158 NLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215

Query: 260 RVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPY 311
               + G++  +T  GT  +++PEV++ +     Y  + D +S G+ L+E+L G  P+
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 37/210 (17%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 173
           K+  G+YG++Y+       + VAIK     RI  + ++E       +EV ++++++H+N+
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIK-----RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS------KGMNY 227
           ++          L ++ E+          + LK        + + +  S       G+N+
Sbjct: 96  IELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 228 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKA-QSGVMTAETGT--YRWMA 279
            H    +HRDLK  NLL+  ++     V+K+ DFG+AR         T E  T  YR   
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--P 205

Query: 280 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           PE++   + Y    D++S   +  E+L   
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 48/218 (22%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA----QEVFIMRKVRHKNVV 174
               G++G +  G   S    VAIK     ++  D    F     Q +  +  + H N+V
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQD--PRFRNRELQIMQDLAVLHHPNIV 82

Query: 175 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---- 222
           Q + +              L +V E++      D LH+     +     +VA        
Sbjct: 83  Q-LQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR---CCRNYYRRQVAPPPILIKV 133

Query: 223 ------KGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETG 273
                 + +  LH    N+ HRD+K  N+L++  +  +K+ DFG A+  + S    A   
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193

Query: 274 T--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
           +  YR  APE+I  ++ Y    D++S G +  E++ G+
Sbjct: 194 SRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)

Query: 117 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 172
             G KV  G+YG +Y+         +D A+K ++   I+    +E    + ++R+++H N
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPN 79

Query: 173 VVQFIGACT--KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSK---- 223
           V+             + ++ ++      +D    +   +        +++   + K    
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135

Query: 224 ----GMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR-----VKAQSGVMTA 270
               G++YLH N ++HRDLK AN+L+     E   VK+AD G AR     +K  +  +  
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDP 194

Query: 271 ETGT--YRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 308
              T  YR  APE++    H  Y    D+++ G +  ELLT +
Sbjct: 195 VVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 35/220 (15%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ----E 161
           +WE+  ++ +  S V SG+YG +     T     VA+K  K  R         A+    E
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQS--IIHAKRTYRE 78

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 215
           + +++ ++H+NV+  +   T   SL       +VT  M      D L+    + K   L 
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNN---IVKCQKLT 130

Query: 216 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 270
              +      + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR    +  MT 
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTG 188

Query: 271 ETGTYRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
              T RW  APE++     Y+   D++S G ++ ELLTG+
Sbjct: 189 YVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 50/233 (21%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 160
           V+ I     +  S +  G+YG       CS       + VAIK ++P        +   +
Sbjct: 6   VYNISSDF-QLKSLLGEGAYG-----VVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-R 58

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 214
           E+ I++  +H+N++  I    +P S        I+ E M      D LH+   V     L
Sbjct: 59  EIKILKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQ----TD-LHR---VISTQML 109

Query: 215 LKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 261
               I        + +  LH +N+IHRDLK +NLL++ N  +KV DFG+AR+        
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 262 ---KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 308
                Q   M     T  YR  APEV+     Y    DV+S G +L EL   +
Sbjct: 170 SEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 47/208 (22%)

Query: 118 FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 174
               +  G  G + +       +  A+K+L       D  K   +EV +  +  +  ++V
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIV 74

Query: 175 QFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGM 225
           + +            L IV E + GG ++  +   +G           ++K    + + +
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAI 130

Query: 226 NYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
            YLH  NI HRD+K  NLL      N ++K+ DFG                     A E 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET 170

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLP 310
              + YD   D++S G++++ LL G  P
Sbjct: 171 T-GEKYDKSCDMWSLGVIMYILLCGYPP 197

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 64/311 (20%), Positives = 115/311 (36%), Gaps = 80/311 (25%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 160
            +++  ++      +  G  G        S       + VAIK +        ++    +
Sbjct: 6   GFDLGSRY-MDLKPLGCGGNG-----LVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL-R 57

Query: 161 EVFIMRKVRHKNVVQFIGACTKPPSLC--------------IVTEFMSGGSVYDYLHKLK 206
           E+ I+R++ H N+V+         S                IV E+M      D L    
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN-- 110

Query: 207 GVFKLPSLLKVAID-----VSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVAR 260
            V +   LL+         + +G+ Y+H  N++HRDLK ANL ++ E+ V+K+ DFG+AR
Sbjct: 111 -VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 261 V----KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK----- 308
           +     +  G ++    T  YR  +P ++     Y    D+++ G +  E+LTGK     
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227

Query: 309 --------LPYEYL-TPLQAAVGVVQKGLR------PTIPK--------NSQPKLAELLE 345
                   L  E +    +     +   +        T P             +  + LE
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287

Query: 346 RCWQQDPALRP 356
           +     P  R 
Sbjct: 288 QILTFSPMDRL 298

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 31/188 (16%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVTE 191
           Q VA+K+++         ++ A+E+ I+  +R +      NV+  +   T    +C+  E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179

Query: 192 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            +S  ++Y+ +  +K +G F LP + K A  + + ++ LH+N IIH DLK  N+L+ +  
Sbjct: 180 LLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237

Query: 250 --VVKVADFGVARVKAQSGVMTAETGT-------YRWMAPEVIEHKPYDHKADVFSFGIV 300
              +KV DFG       S     +          YR  APEVI    Y    D++S G +
Sbjct: 238 RSGIKVIDFG-------SSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCI 288

Query: 301 LWELLTGK 308
           L ELLTG 
Sbjct: 289 LAELLTGY 296

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 68/296 (22%)

Query: 61  AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 120
           ++ E    +    G     S S     +     S      +P   +D W+I  ++ +   
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD-WQIPDRY-EIRH 59

Query: 121 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-FAQ----EVFIMRKVRHKNV 173
            + +GSYG +         + VAIK     +I    +     +    E+ I+ ++ H +V
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 174 VQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DV 221
           V+ +     P  +       +V E        D   K   +F+ P  L          ++
Sbjct: 115 VK-VLDIVIPKDVEKFDELYVVLEIAD----SD-FKK---LFRTPVYLTELHIKTLLYNL 165

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------------- 261
             G+ Y+H   I+HRDLK AN L++++  VKV DFG+AR                     
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 262 --------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT 306
                   K     +T    T  YR  APE+I   + Y    DV+S G +  ELL 
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGCIFAELLN 279

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 80/312 (25%)

Query: 103 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQ 155
             G     +   +      +  GSYG                ++VAIK  K  R+  D  
Sbjct: 16  FQGIKNVHVPDNY-IIKHLIGRGSYG-----YVYLAYDKNTEKNVAIK--KVNRMFED-- 65

Query: 156 KEFAQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKL 205
               +    E+ I+ +++   +++       P  L       IV E        D L K 
Sbjct: 66  LIDCKRILREITILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIAD----SD-LKK- 118

Query: 206 KGVFKLPSLLK------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 259
             +FK P  L       +  ++  G N++H++ IIHRDLK AN L++++  VKV DFG+A
Sbjct: 119 --LFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 260 RV-----------------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKAD 293
           R                        K     +T+   T  YR  APE+I   + Y    D
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSID 234

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
           ++S G +  ELL     +                  P  P +S   L+         + +
Sbjct: 235 IWSTGCIFAELLNMLQSHINDPT----------NRFPLFPGSSCFPLSPDRNSKKVHEKS 284

Query: 354 LRPDFSEIIEIL 365
            R   + I  I+
Sbjct: 285 NRDQLNIIFNII 296

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 46/243 (18%), Positives = 91/243 (37%), Gaps = 72/243 (29%)

Query: 121 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQ-- 175
            + +GS+G +         +  A+K     ++  D    +   E+ IM+ + H N+++  
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHVNIIKLV 66

Query: 176 ------------------------------FIGACTKPPS------LCIVTEFMSGGSVY 199
                                              +   +      L ++ E++   +++
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125

Query: 200 DYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-EN 248
             L   ++    +P          L +        + ++H   I HRD+K  NLL++ ++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSKD 178

Query: 249 EVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELL 305
             +K+ DFG A+    S    A   +  YR  APE++     Y    D++S G V  EL+
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 306 TGK 308
            GK
Sbjct: 237 LGK 239

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 66/245 (26%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ- 160
             +  K+ +   K+  G+YG                + VA+K  K      +     AQ 
Sbjct: 5   RHVLRKY-ELVKKLGKGAYG-----IVWKSIDRRTGEVVAVK--KIFDAFQN--STDAQR 54

Query: 161 ---EVFIMRKVR-HKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPS 213
              E+ I+ ++  H+N+V  +    +  +   + +V ++M      D LH    V +   
Sbjct: 55  TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYME----TD-LHA---VIRANI 105

Query: 214 LLKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV------- 261
           L  V        + K + YLH   ++HRD+K +N+L++    VKVADFG++R        
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 262 ---------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWE 303
                               ++T    T  YR  APE++     Y    D++S G +L E
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGE 223

Query: 304 LLTGK 308
           +L GK
Sbjct: 224 ILCGK 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 19/183 (10%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPPSLCIVTE 191
           + VAIK++K          +   EV ++  +          +V           LC+V E
Sbjct: 80  EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136

Query: 192 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLM-- 245
            +S  ++YD L     +G   L    K A  +   + +L     +IIH DLK  N+L+  
Sbjct: 137 MLSY-NLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 246 DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 305
            +   +K+ DFG +    Q      ++  YR  +PEV+   PYD   D++S G +L E+ 
Sbjct: 195 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMH 252

Query: 306 TGK 308
           TG+
Sbjct: 253 TGE 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 48/206 (23%)

Query: 137 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 190
            + VA+K++K         +    E+ ++  +           VQ +        +CIV 
Sbjct: 40  GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96

Query: 191 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 248
           E + G S YD++  +     F+L  + K+A  + K +N+LH N + H DLK  N+L  ++
Sbjct: 97  ELL-GLSTYDFIKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154

Query: 249 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 282
           +                    +KV DFG       S     E  +       YR  APEV
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVSTRHYR--APEV 205

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGK 308
           I    +    DV+S G +L E   G 
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLGF 231

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 50/206 (24%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 190
             VA+K+++    N    +E A+ E+ +++K++ K        V           +CI  
Sbjct: 46  SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 191 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 248
           E + G + +++L  +  +  + LP +  +A  +   + +LH+N + H DLK  N+L   +
Sbjct: 102 ELL-GKNTFEFLKENNFQP-YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159

Query: 249 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 282
           E                    ++VADFG       S     E  T       YR   PEV
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEV 210

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGK 308
           I    +    DV+S G +L+E   G 
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRGF 236

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.8 bits (205), Expect = 4e-18
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 31/285 (10%)

Query: 115 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 171
             + G K+ SGS+GD+Y GT  +  ++VAIK+   E + +   +    E  I + ++   
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQ-LHIESKIYKMMQGGV 65

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
            +        +     +V E + G S+ D  +     F L ++L +A  +   + Y+H  
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 232 NIIHRDLKAANLLM---DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 278
           N IHRD+K  N LM    +  +V + DFG+A+    A++            TGT R+   
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 279 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP- 333
                IE    D   D+ S G VL     G LP++ L   T  Q    + +K +   I  
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241

Query: 334 --KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 376
             K    + A  L  C       +PD+S + ++ + +    G   
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 55/211 (26%)

Query: 138 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRH-----KNVVQFIGACTKPPSLCIVTE 191
           +  A+KV++    N       A+ E  I++K+++      N+V++ G       +C++ E
Sbjct: 61  KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116

Query: 192 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 249
            + G S+Y+ +  +   G F +  +    I++ K +NYL + ++ H DLK  N+L+D+  
Sbjct: 117 PL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174

Query: 250 V-------------------------VKVADFGVARVKAQSGVMTAETGT-------YRW 277
                                     +K+ DFG            ++          YR 
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGK 308
            APEVI +  +D  +D++SFG VL EL TG 
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 61/285 (21%), Positives = 118/285 (41%), Gaps = 30/285 (10%)

Query: 115 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 171
           + + G K+  G++G+L  G      + VAIK+   E + S   +    E    +++    
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLH-LEYRFYKQLGSGD 65

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
            + Q            +V E + G S+ D        F L ++L +AI +   M Y+H  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 232 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSG--VMTAE----TGTYRWM 278
           N+I+RD+K  N L+        +V+ + DF +A+  +  ++   +   E    TGT R+M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

Query: 279 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP 333
           +  +  H   +   + D+ + G +    L G LP++ L   T  +    +        I 
Sbjct: 185 S--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242

Query: 334 K--NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 376
               + P++A  L    + D   +PD+  + ++   +    G   
Sbjct: 243 VLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 71/258 (27%)

Query: 120 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-------- 169
            K+  G +  ++        + VA+KV+K         +    E+ +++ VR        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPN 99

Query: 170 HKNVVQFIGACT-KPPS---LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKG 224
            + VVQ +        +   +C+V E + G  +  ++ K       LP + K+   V +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 225 MNYLH-QNNIIHRDLKAANLLM-------------------------------------- 245
           ++YLH +  IIH D+K  N+L+                                      
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 246 -----------DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 294
                       E   VK+AD G A    +      +T  YR  + EV+    Y+  AD+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADI 276

Query: 295 FSFGIVLWELLTGKLPYE 312
           +S   + +EL TG   +E
Sbjct: 277 WSTACMAFELATGDYLFE 294

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 52/286 (18%), Positives = 107/286 (37%), Gaps = 31/286 (10%)

Query: 115 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 171
           H K G ++  GS+G ++ GT     Q VAIK    E   SD   +   E    + +    
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAP-QLRDEYRTYKLLAGCT 66

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
            +        +     +V + + G S+ D L      F + ++   A  +   +  +H+ 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 232 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM 278
           ++++RD+K  N L+         ++ V DFG+ +      +            +GT R+M
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

Query: 279 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP 333
           +  +  H   +   + D+ + G V    L G LP++ L   T  Q    + +K     + 
Sbjct: 186 S--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 334 ---KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 376
                   +  + +           PD+  +  +  ++ + +    
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 60/349 (17%), Positives = 114/349 (32%), Gaps = 56/349 (16%)

Query: 75  WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT 134
              H SS      E+   +S    L+    GT + +   +  K  S     + G LY   
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62

Query: 135 ----------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 184
                        Q  ++K+   +  +  +  E     F  R  +   V          P
Sbjct: 63  PTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQN---FFQRAAKPLQV-NKWKKLYSTP 115

Query: 185 SLCIVTEFMSGGSVYDY-----------LHKL-----KGVFKLPSLLKVAIDVSKGMNYL 228
            L I T    G     Y           L        K V    S+L+VA  +   + +L
Sbjct: 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175

Query: 229 HQNNIIHRDLKAANLLMDENEVVKV--ADFGVAR--------VKAQSGVMTAETGTYRWM 278
           H+N  +H ++ A N+ +D  +  +V  A +G A         V    G  +   G   ++
Sbjct: 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

Query: 279 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK-- 334
           +  +  HK      ++D+ S G  + + L G LP+    P    +   ++          
Sbjct: 236 S--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV 293

Query: 335 ------NSQPK-LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 376
                     + L + L+         +P ++ +   L+ + +++    
Sbjct: 294 GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 68/339 (20%), Positives = 126/339 (37%), Gaps = 51/339 (15%)

Query: 77  SHRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 135
            H  SS      +       Y   +P  +G  + +++      G K+ SG +G +Y    
Sbjct: 4   HHHHSSGVDLGTENL-----YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFP 58

Query: 136 --CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 193
               +  A  V+K E   +        E+   ++V  K+ ++      +   L I   + 
Sbjct: 59  TNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115

Query: 194 SGGSVY---DY--------------LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 236
           SG + +    Y              +    G FK  ++L++ I +   + Y+H+N  +H 
Sbjct: 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175

Query: 237 DLKAANLLMDENEVVKV--ADFGVARVKAQSGVM--------TAETGTYRWMAPEVIEHK 286
           D+KAANLL+      +V  AD+G++     +G              GT  + +  +  HK
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS--LDAHK 233

Query: 287 PYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAV--------GVVQKGLRPTIPKNS 336
                 ++DV   G  +   L GKLP+E       AV          + + +    P  S
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGS 293

Query: 337 QPK-LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 374
               +A+ L          +P++  + +IL      +G 
Sbjct: 294 SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 31/285 (10%)

Query: 115 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK 171
             + G K+ SGS+G++Y GT    +++VAIK+   E + +    +   E  I R ++   
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP-QLLYESKIYRILQGGT 63

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
            +        +     +V + + G S+ D  +       L ++L +A  +   + ++H  
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 232 NIIHRDLKAANLLMDENE---VVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 278
           + +HRD+K  N LM        V + DFG+A+      +            TGT R+   
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 279 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLP---YEYLTPLQAAVGVVQKGLRPTIP- 333
                IE    D   D+ S G VL   L G LP    +  T  Q    + +K +  +I  
Sbjct: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239

Query: 334 --KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 376
             +    + A     C       +PD+S +  + + +    G + 
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 54/301 (17%), Positives = 108/301 (35%), Gaps = 44/301 (14%)

Query: 117 KFGSKVASGSYGDLYRGT-YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
           K G  +  G +G +Y      S+ V        ++          E+   ++      +Q
Sbjct: 38  KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97

Query: 176 FIGACTKPPSLCI-------------------VTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
                 K   L +                   + +   G  +          F   ++L+
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQ 156

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV--ADFGVARVKAQSGVMTAE--- 271
           +++ +   + Y+H++  +H D+KA+NLL++     +V   D+G+A      GV  A    
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 272 -----TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 324
                 GT  + +  +  H       + D+   G  + + LTG LP+E        V   
Sbjct: 217 PKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274

Query: 325 QKGLRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 375
           +   R  I           N+  ++A+ +E     D   +P +  + +IL Q  K +G +
Sbjct: 275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334

Query: 376 N 376
           +
Sbjct: 335 D 335

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 7e-12
 Identities = 33/186 (17%), Positives = 63/186 (33%), Gaps = 48/186 (25%)

Query: 121 KVASGSYGDLYRGTYCSQDVAIKVL---KPERINSDMQK---EFAQEVFIMRKV------ 168
           K+  G +G++++       VAIK++    P+ +N   QK   E   E+ I +++      
Sbjct: 27  KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 169 ---RHKNVVQFIGAC----TKPPSLC--------------------------IVTEFMSG 195
              R +  +          + PP L                           IV EF  G
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVA 254
           G   D       +  L +   +   ++  +     +    HRDL   N+L+ +  + K+ 
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204

Query: 255 DFGVAR 260
                +
Sbjct: 205 YTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 3e-08
 Identities = 48/436 (11%), Positives = 120/436 (27%), Gaps = 118/436 (27%)

Query: 30  QEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK------------------LE 71
           +  + +  +     D FV +    +  +  ++ L KE +                   L 
Sbjct: 13  EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLL 72

Query: 72  RQG-----------------WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT-----DVW 109
            +                  +      +   +P            ++ ND       +V 
Sbjct: 73  SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132

Query: 110 EIDPKH--------LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 161
            + P          L+    V     G L  G      VA+ V    ++    Q +   +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVL--IDGVLGSGKTW---VALDVCLSYKV----QCKMDFK 183

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
           +F +           +  C  P ++  + + +      ++  +      +   +     +
Sbjct: 184 IFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH---SI 230

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWM 278
              +  L    +  +  +   L++      +     +    ++     + T       ++
Sbjct: 231 QAELRRL----LKSKPYENCLLVLLNVQNAKAWNAFNLS-CKIL----LTTRFKQVTDFL 281

Query: 279 APEVIEHKPYDHKADVFS-------FGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLR 329
           +     H   DH +   +           L +     LP E LT  P    + ++ + +R
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLPREVLTTNPR--RLSIIAESIR 338

Query: 330 --PTIPKNSQ----PKLAELLERCW-QQDPA-LRPDF-------------SEIIEIL-QQ 367
                  N +     KL  ++E      +PA  R  F             + ++ ++   
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398

Query: 368 IAKEVGEE--NEERRK 381
           + K       N+  + 
Sbjct: 399 VIKSDVMVVVNKLHKY 414

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 Length = 192

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 11/84 (13%), Positives = 27/84 (32%), Gaps = 2/84 (2%)

Query: 4  ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 63
          IT    D+P + +++  L+   G NI ++        ++L + +          ++   L
Sbjct: 9  ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLI--SGSPSNITRVETTL 66

Query: 64 EKEVLKLERQGWPSHRSSSPTSEP 87
               + +        S       
Sbjct: 67 PLLGQQHDLITMMKRTSPHDHQTH 90

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	397
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.19
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.98
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.79
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.66
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.42
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.21
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.61
1u8s_A	192	Glycine cleavage system transcriptional repressor,	97.51
1zpv_A	91	ACT domain protein; structural genomics, PSI, prot	97.43
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.39
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.39
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
2nyi_A	195	Unknown protein; protein structure initiative, PSI	97.23
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.22
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.17
2ko1_A	88	CTR148A, GTP pyrophosphokinase; homodimer, alpha+b	96.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.89
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.81
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.45
2f1f_A	164	Acetolactate synthase isozyme III small subunit; f	96.28
2nyi_A	195	Unknown protein; protein structure initiative, PSI	96.24
1u8s_A	192	Glycine cleavage system transcriptional repressor,	95.78
2pc6_A	165	Probable acetolactate synthase isozyme III (small;	95.76
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.74
3n0v_A	286	Formyltetrahydrofolate deformylase; formyl transfe	94.96
3obi_A	288	Formyltetrahydrofolate deformylase; structural gen	94.77
3lou_A	292	Formyltetrahydrofolate deformylase; structural gen	94.65
3o1l_A	302	Formyltetrahydrofolate deformylase; structural gen	94.62
3nrb_A	287	Formyltetrahydrofolate deformylase; N-terminal ACT	94.51
2fgc_A	193	Acetolactate synthase, small subunit; regulatory s	93.58
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	93.54
3p96_A	415	Phosphoserine phosphatase SERB; ssgcid, structural	93.41
1y7p_A	223	Hypothetical protein AF1403; structural genomics,	92.5
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.72
2jhe_A	190	Transcription regulator TYRR; aromatic hydrocarbon	88.04
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.71
2f06_A	144	Conserved hypothetical protein; structural genomic	87.15
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.82

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-64  Score=470.87  Aligned_cols=266  Identities=36%  Similarity=0.691  Sum_probs=230.2

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ....|+|+.+++++.++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.+ +
T Consensus        27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            456799999999999999999999999998754 69999998776677777889999999999999999999998865 5


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+|||||||+||+|.++++..++.+++..+..|+.||+.||+|||+++||||||||+|||+++++.+||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            68999999999999999988778899999999999999999999999999999999999999999999999999986543


Q ss_pred             C---CcccCCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-C---CCCC
Q 015965          265 S---GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-P---TIPK  334 (397)
Q Consensus       265 ~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~---~~~~  334 (397)
                      .   ......+||+.|||||++.+   .+|+.++|||||||+||||+||+.||...++.......+..+.. |   ..+.
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence            2   23455689999999999853   46899999999999999999999999988877666666655433 2   3567


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+++++.+|+.+||+.||++|||+.++++.|+.+...+
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            78999999999999999999999999999998876544

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-62  Score=466.04  Aligned_cols=260  Identities=31%  Similarity=0.583  Sum_probs=226.3

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  180 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  180 (397)
                      .+.++.++|.+.++||+|+||+||+|++.       ++.||||+++..  +....++|.+|+.+|++++|||||+++++|
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45788889999999999999999999874       466999999854  455567899999999999999999999999


Q ss_pred             ecCCceEEEEEeccCCCHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC
Q 015965          181 TKPPSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD  246 (397)
Q Consensus       181 ~~~~~~~lv~E~~~g~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~  246 (397)
                      .+++.+|||||||++|+|.+++++..              +.+++..++.|+.||+.||.|||+++||||||||+|||++
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            99999999999999999999997642              4689999999999999999999999999999999999999


Q ss_pred             CCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015965          247 ENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG  322 (397)
Q Consensus       247 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~  322 (397)
                      .++.+||+|||+++......   ......||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+....
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999998654332   2234579999999999999999999999999999999999 9999999988776655


Q ss_pred             hhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       323 ~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      + ..+.++..|..+++++.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus       273 i-~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          273 I-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             H-HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             H-HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            4 4556788899999999999999999999999999999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-62  Score=460.54  Aligned_cols=260  Identities=29%  Similarity=0.572  Sum_probs=229.7

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      +.|+.++|.+.++||+|+||+||+|++.       +..||||+++..  +....++|.+|+.+|++++|||||+++++|.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3677889999999999999999999874       456999999854  4555678999999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKL------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      +++.+|||||||+||+|.++++..            ...+++..++.++.||+.||.|||+++||||||||+|||++.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999763            24699999999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCCcc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 015965          250 VVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~  325 (397)
                      .+||+|||+|+........   ....||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+....+. 
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            9999999999865443222   23358999999999999999999999999999999998 999999998877766654 


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+.++..|..+|+++.+|+.+||+.||++|||+.++.+.|+++.+.
T Consensus       245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            4556778899999999999999999999999999999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-61  Score=457.49  Aligned_cols=258  Identities=27%  Similarity=0.542  Sum_probs=228.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      +++..+++++.++||+|+||+||+|.+.       ++.||||+++... .....++|.+|+.+|++++|||||+++|+|.
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            4677889999999999999999999873       4679999998653 3344578999999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD  246 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~  246 (397)
                      +++.+|||||||++|+|.++|...               ...+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999653               24689999999999999999999999999999999999999


Q ss_pred             CCCceEEcccccccccccC---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015965          247 ENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG  322 (397)
Q Consensus       247 ~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~  322 (397)
                      +++.+||+|||+++.....   .......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+....
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999865433   23345679999999999999999999999999999999998 8999999988776655


Q ss_pred             hhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       323 ~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      + ..+.+++.|..+|+++.+|+.+||+.||++||||.+|++.|++.
T Consensus       260 i-~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 I-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H-HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            4 45566778899999999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-61  Score=462.02  Aligned_cols=251  Identities=26%  Similarity=0.475  Sum_probs=221.8

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ..++|+++++||+|+||+||+|++.  ++.||||+++.........+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            3478999999999999999999874  78899999988777777778899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-c
Q 015965          190 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V  267 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~  267 (397)
                      ||||+||+|.+++...+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... .
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            99999999999997644 457999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+.... .+..+..+++++.+||.+|
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~  260 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVSQL  260 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHH
Confidence            345679999999999999999999999999999999999999999998888887776654 4556788999999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||++|||+.|+++
T Consensus       261 L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          261 FKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.2e-61  Score=461.70  Aligned_cols=265  Identities=32%  Similarity=0.625  Sum_probs=235.8

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCC-CCeeeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIG  178 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~  178 (397)
                      +.|+|..++|+++++||+|+||+||+|++.+       +.||||.++... .....+.|.+|+.+|++++| ||||++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            4699999999999999999999999998754       459999998654 34446789999999999976 89999999


Q ss_pred             EEecC-CceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          179 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       179 ~~~~~-~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      +|.++ ..+|||||||++|+|.++|+...               ..+++..+..++.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            99764 56899999999999999997632               348999999999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~  318 (397)
                      ||+++++.+||+|||+|+......   ......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998654432   2234568999999999999999999999999999999998 999999988777


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .....+..+.++..|..+++++.++|.+||+.||++|||+.++++.|+++++.-
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            777778888899999999999999999999999999999999999999998643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8e-61  Score=455.04  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=224.2

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ....+.|++.++||+|+||+||+|++.  ++.||||+++.+...       .+|+.+|++++|||||++++++.+++.+|
T Consensus        54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            334567899999999999999999974  678999999865432       46999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~~  266 (397)
                      ||||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+......
T Consensus       127 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999999999987 57899999999999999999999999999999999999999987 69999999998765432


Q ss_pred             c------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-CCCCCCCcHH
Q 015965          267 V------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPK  339 (397)
Q Consensus       267 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  339 (397)
                      .      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+...... ..++..++++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  285 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL  285 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence            1      12347999999999999999999999999999999999999999887776666666654432 2467889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      +.+||.+||+.||.+|||+.|+++.|...+++...
T Consensus       286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            99999999999999999999999999998887653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-61  Score=453.56  Aligned_cols=249  Identities=23%  Similarity=0.414  Sum_probs=222.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ..+++|++++.||+|+||+||+|++  +++.||||++++... .....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3457899999999999999999987  467899999975422 1223567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC--
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--  265 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~--  265 (397)
                      |||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus       109 ivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999999987 578999999999999999999999999999999999999999999999999999876433  


Q ss_pred             -CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          266 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       266 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                       ....+.+||+.|||||++.+..|+.++|||||||++|+|++|..||...+..+....+....  +.+|..+++++++||
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARDLV  265 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHHHH
Confidence             23456789999999999999999999999999999999999999999988888877776653  457788999999999


Q ss_pred             HHhchhCCCCCCCHHHHH
Q 015965          345 ERCWQQDPALRPDFSEII  362 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell  362 (397)
                      .+||+.||++|||+.|++
T Consensus       266 ~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGT
T ss_pred             HHHccCCHhHCcChHHHc
Confidence            999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.3e-60  Score=438.86  Aligned_cols=246  Identities=27%  Similarity=0.488  Sum_probs=204.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||+||+|.+  +++.||||++++.... ......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999987  4688999999765443 334567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+ +|+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........+
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            999 7899999987 57899999999999999999999999999999999999999999999999999988776666677


Q ss_pred             CCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+||+.|||||++.+..| +.++|||||||++|+|++|+.||...+..+....+...  .+.+|..+++++.+||.+||+
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLI  248 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSC
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcc
Confidence            899999999999998887 57999999999999999999999988877666665544  345778899999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.|+++
T Consensus       249 ~dP~~R~s~~eil~  262 (275)
T 3hyh_A          249 VNPLNRISIHEIMQ  262 (275)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHc
Confidence            99999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-61  Score=451.86  Aligned_cols=246  Identities=26%  Similarity=0.441  Sum_probs=213.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+++++|++++.||+|+||+||+|+.     .++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            56778999999999999999999986     3466999999865433333346888999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+|||||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999999987 57899999999999999999999999999999999999999999999999999986543


Q ss_pred             -CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          265 -SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       265 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                       .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...  .+.+|..+++++.+|
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSL  256 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHHHHH
Confidence             33455678999999999999999999999999999999999999999999988887777665  345778899999999


Q ss_pred             HHHhchhCCCCCCCH
Q 015965          344 LERCWQQDPALRPDF  358 (397)
Q Consensus       344 l~~cl~~dp~~Rps~  358 (397)
                      |.+||+.||++|||+
T Consensus       257 i~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          257 LRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHTCSSGGGSTTC
T ss_pred             HHHHcccCHHHCCCC
Confidence            999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.9e-60  Score=439.97  Aligned_cols=245  Identities=29%  Similarity=0.554  Sum_probs=214.3

Q ss_pred             ccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----CCceEEE
Q 015965          116 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIV  189 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  189 (397)
                      |++.++||+|+||+||+|.+.  +..||+|++..........+.|.+|+.+|++++|||||++++++..    +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            477889999999999999985  5679999998776666677889999999999999999999999865    3458999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeC-CCCceEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ||||+||+|.+++.+ .+.+++..+..|+.||+.||+|||++|  ||||||||+|||++ .++.+||+|||+|+.... .
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S  185 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-C
Confidence            999999999999987 578999999999999999999999998  99999999999997 479999999999986543 3


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-CCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ll~  345 (397)
                      .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...+........+..+.. +.++..+++++.+||.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            4456789999999999976 5999999999999999999999999877666555555555443 3456678899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||++|||+.|+++
T Consensus       265 ~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-60  Score=450.97  Aligned_cols=246  Identities=29%  Similarity=0.459  Sum_probs=218.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ..|++.++||+|+||+||+|++.  ++.||||+++......  .+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            56999999999999999999984  6789999997543322  3568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      ||+||+|.+++.+  +.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... .....
T Consensus       152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            9999999999975  67999999999999999999999999999999999999999999999999999876544 34567


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+..... ....+..+++++.+||.+||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            7999999999999999999999999999999999999999999888777766554321 223345689999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.|+++
T Consensus       310 ~dP~~R~ta~e~l~  323 (346)
T 4fih_A          310 RDPAQRATAAELLK  323 (346)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999865

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-58  Score=452.49  Aligned_cols=246  Identities=29%  Similarity=0.459  Sum_probs=219.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|++.++||+|+||.||+|.+.  ++.||||++.......  .+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            56999999999999999999984  6889999997654322  3568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      ||+||+|.+++..  +.+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... .....
T Consensus       229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            9999999999975  57999999999999999999999999999999999999999999999999999876544 34566


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..... ....+..+++++.+||.+||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            7899999999999999999999999999999999999999999888877766554321 233456789999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.|+++
T Consensus       387 ~dP~~R~ta~ell~  400 (423)
T 4fie_A          387 RDPAQRATAAELLK  400 (423)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.8e-57  Score=427.82  Aligned_cols=253  Identities=27%  Similarity=0.525  Sum_probs=206.8

Q ss_pred             ccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC----ceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  189 (397)
                      .+|.+.++||+|+||+||+|++.++.||||+++...   .....+..|+..+.+++|||||++++++.+++    .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            468889999999999999999999999999987432   22223345677778899999999999997654    47999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ||||+||+|.++++.  ..+++..+.+++.|++.||+|||++        +||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999976  5689999999999999999999987        999999999999999999999999999986


Q ss_pred             cccCCc-----ccCCCCCcccccccccCCC------CCCCchhHHHHHHHHHHHHhCCCCCC----------CC-----C
Q 015965          262 KAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYE----------YL-----T  315 (397)
Q Consensus       262 ~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~P~~----------~~-----~  315 (397)
                      ......     ....+||+.|||||++.+.      .|+.++|||||||+||||+||..||.          ..     .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            654322     2235799999999999764      36779999999999999999976653          22     1


Q ss_pred             hHHHHHHhhhcCCCCCCCCC-----CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          316 PLQAAVGVVQKGLRPTIPKN-----SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~-----~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      ..+....+.....+|.+|..     +++.+.+|+.+||+.||++|||+.|+++.|+++.++
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            22333444566677777654     335789999999999999999999999999988654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-56  Score=421.95  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=192.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-------
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  184 (397)
                      ++|++++.||+|+||+||+|++.  ++.||||+++... .....+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            46899999999999999999874  6789999997553 3445577999999999999999999999986544       


Q ss_pred             -----ceEEEEEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccc
Q 015965          185 -----SLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       185 -----~~~lv~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                           .+|||||||+||+|.+++.....  ..++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 37999999999999999976321  24556788999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-------------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 015965          258 VARVKAQSG-------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV  324 (397)
Q Consensus       258 ~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~  324 (397)
                      +|+......             ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||.............
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            998654432             2234579999999999999999999999999999999996   776432221222222


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          325 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       325 ~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .....|..+...++.+.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222222223344567889999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-55  Score=429.00  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=213.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec------CCc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  185 (397)
                      ++|+++++||+|+||+||+|.+  +++.||||+++.........+.+.+|+.+|++++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            6799999999999999999987  47889999998776666667789999999999999999999998754      357


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|||||||+ |+|.+++.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            899999995 689999976 578999999999999999999999999999999999999999999999999999865432


Q ss_pred             -----CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--------
Q 015965          266 -----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------  331 (397)
Q Consensus       266 -----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--------  331 (397)
                           ......+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+......+.        
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                 334567999999999998775 569999999999999999999999999888777666543221111        


Q ss_pred             ---------------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ---------------------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                           ....+++++.+||.+||..||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                 11346889999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-53  Score=434.67  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=224.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++++.||+|+||+||+|.+  +++.||||+++...  ....+.+.+|+.+|+.++|||||++++++.+...+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5799999999999999999987  46789999987643  3345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC--CceEEcccccccccccCCccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~--~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      ||+||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+.........
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            999999999997766789999999999999999999999999999999999999854  899999999999887776677


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCCCCCcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~~c  347 (397)
                      ..+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......  +..+..+++++.+||.+|
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~  394 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL  394 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            789999999999999999999999999999999999999999999988888777665433  233467899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |..||.+|||+.|+++
T Consensus       395 L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          395 LLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-52  Score=397.48  Aligned_cols=268  Identities=42%  Similarity=0.742  Sum_probs=230.9

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      .+.+++...+|++.+.||+|+||.||+|++.++.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            44578888999999999999999999999999999999998877677777889999999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      .++||||+++++|.+++....  ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999999997632  23899999999999999999999999  99999999999999999999999999975


Q ss_pred             cccCC-cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          262 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       262 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....+...+..+++++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            54332 23456799999999999999999999999999999999999999999988887777666667778889999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .+++.+||+.||.+|||+.++++.|+.+++...
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999987543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-52  Score=405.09  Aligned_cols=242  Identities=22%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  187 (397)
                      ++|++.++||+|+||+||+|+..     ++.||||.+.....    ...+.+|+.+|+.+ +|||||++++++.+.+++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            57999999999999999999763     46799999875432    34678899999988 5999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEcccccccccccC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQS-  265 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~~~~~~-  265 (397)
                      |||||++|++|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... 
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999999984    48999999999999999999999999999999999999876 89999999999754322 


Q ss_pred             ----------------------------CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 015965          266 ----------------------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT-  315 (397)
Q Consensus       266 ----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~-  315 (397)
                                                  ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||...+ 
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                        123345799999999999775 58999999999999999999999995433 


Q ss_pred             hHHHHHHhhhc----------------------------------------------------CCCCCCCCCCcHHHHHH
Q 015965          316 PLQAAVGVVQK----------------------------------------------------GLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       316 ~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~l~~l  343 (397)
                      ..+....+..-                                                    .........+++++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            32222221110                                                    00011224578999999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      |.+||+.||.+|||+.|+++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHCcCChhHCcCHHHHhc
Confidence            99999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-52  Score=427.37  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=211.2

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC----ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +..++|+++++||+|+||+||+|+.  +++.||||++++...    ..........++.+++.++|||||++++++.+++
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            4457899999999999999999987  467899999975321    1222233344577888899999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+||||||++||+|.+++.+ .+.+++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999987 57899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      . ...+.+||+.|||||++. +..|+.++|||||||+||||++|.+||...+   ..+....+..  ..+.+|..+++++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~S~~a  421 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPEL  421 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCccCCHHH
Confidence            3 345679999999999996 4679999999999999999999999997532   2233333333  2456788899999


Q ss_pred             HHHHHHhchhCCCCCCC-----HHHHHH
Q 015965          341 AELLERCWQQDPALRPD-----FSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps-----~~ell~  363 (397)
                      ++||.+||+.||.+|++     +.|+++
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            99999999999999998     677764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.9e-51  Score=389.77  Aligned_cols=248  Identities=28%  Similarity=0.493  Sum_probs=226.3

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.+.||+|+||.||+|.+  .++.||||++..........+.+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999987  5788999999877666667788999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            99999999999977 46799999999999999999999999999999999999999999999999999987776666778


Q ss_pred             CCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+....  ...|..+++++.+|+.+||+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~  250 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFYMSTDCENLLKRFLV  250 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHCC
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHCC
Confidence            8999999999999888775 78999999999999999999999988877777666553  34677889999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||.+|||+.|+++
T Consensus       251 ~dP~~R~t~~eil~  264 (328)
T 3fe3_A          251 LNPIKRGTLEQIMK  264 (328)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-51  Score=377.22  Aligned_cols=261  Identities=35%  Similarity=0.718  Sum_probs=231.3

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ...|.++.++|++.+.||+|+||.||+|.+ .++.||+|+++.....   .+.+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            456899999999999999999999999998 5667999999866544   356889999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||+++++|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999999999988777899999999999999999999999999999999999999999999999999976543


Q ss_pred             CC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          265 SG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       265 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ .....+..+..+++.+.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY  237 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHH
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hcCccCCCCCcCCHHHH
Confidence            32  2234457889999999998899999999999999999999 99999988877666554 44456677788899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      +++.+||+.||.+|||+.++++.|+++.+
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999865

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-50  Score=393.27  Aligned_cols=266  Identities=31%  Similarity=0.622  Sum_probs=232.0

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  176 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~  176 (397)
                      ..|++..++|++++.||+|+||.||+|++.+         ..||||+++... .......+.+|+.+++++ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3577888999999999999999999998632         349999998653 344567899999999999 89999999


Q ss_pred             eeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 015965          177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  241 (397)
Q Consensus       177 ~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~  241 (397)
                      ++++...+.+|+||||++||+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            999999999999999999999999998643               34889999999999999999999999999999999


Q ss_pred             cEEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015965          242 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  317 (397)
Q Consensus       242 Nili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~  317 (397)
                      |||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999998654332   2234467889999999999999999999999999999999 99999987765


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      +... .+..+.++..+..+++++.++|.+||+.||.+||++.++++.|+++++...+
T Consensus       313 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          313 ELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             GHHH-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence            5443 4555667778889999999999999999999999999999999999876643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3e-51  Score=398.61  Aligned_cols=264  Identities=34%  Similarity=0.653  Sum_probs=233.2

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+.|.++.++|++.+.||+|+||.||+|.+.  ++.||||+++.. ........|.+|+.+|++++||||+++++++...
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            4568999999999999999999999999985  678999999854 3445566799999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ...|+||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999999999998766679999999999999999999999999999999999999999999999999998644


Q ss_pred             cCCcc---cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          264 QSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       264 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      .....   ....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+... .+..+.+...|..++++
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  343 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPELCPDA  343 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-HHHTTCCCCCCTTCCHH
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence            33211   11235778999999998889999999999999999998 999999988766544 34556677788889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +.++|.+||+.||++|||+.++++.|+++.+.
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-50  Score=375.45  Aligned_cols=257  Identities=32%  Similarity=0.622  Sum_probs=233.8

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC--Cce
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL  186 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  186 (397)
                      +.++.++|++.+.||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++..+  ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            467778999999999999999999999999999999998776777778899999999999999999999999887  788


Q ss_pred             EEEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ++||||+++++|.+++..... .+++..++.++.||+.||.|||++|  |+||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999999987543 5899999999999999999999999  9999999999999999999999999875432


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCC---chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDH---KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                          .....||+.|+|||++.+..++.   ++||||||+++|+|++|..||...+..+..........++..+..+++++
T Consensus       165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                23457899999999998765555   79999999999999999999999998888888888888888999999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+++.+||+.||++|||+.++++.|+++.
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            99999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-50  Score=375.73  Aligned_cols=262  Identities=34%  Similarity=0.680  Sum_probs=230.6

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECCc-ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      ...|+++.++|++.+.||+|+||.||++.+.+. .||||+++.....   ...+.+|+.++++++||||+++++++.+..
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            456899999999999999999999999988654 6999999876544   356889999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999987677899999999999999999999999999999999999999999999999999976543


Q ss_pred             CC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          265 SG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       265 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....+...+..+++.+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-hcccCCCCCCcCCHHHH
Confidence            32  2233457889999999998899999999999999999998 99999998877666554 44556667788899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +++.+||+.||.+|||+.++++.|++++++
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            999999999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=385.10  Aligned_cols=263  Identities=34%  Similarity=0.601  Sum_probs=230.2

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .++..++|++.+.||+|+||.||+|.+.     +..||||+++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4678899999999999999999999873     2349999998653 445567899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ...|+||||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999999998767789999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          264 QSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       264 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ...    ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ....++..+..+++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  281 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRLPAPMGCPH  281 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCCCCCCCCcCH
Confidence            432    1223356788999999998899999999999999999999 99999988877766554 44556677888999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ++.+++.+||+.||.+|||+.++++.|+++++...
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            99999999999999999999999999999986543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-51  Score=384.98  Aligned_cols=264  Identities=33%  Similarity=0.535  Sum_probs=224.6

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      +.+..++|+++++||+|+||.||++.+.  ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            3567789999999999999999999985  677999988643  456678899999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999999999999877889999999999999999999999999999999999999999999999999997654332


Q ss_pred             cc---------------cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-hhhcCCCC
Q 015965          267 VM---------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQKGLRP  330 (397)
Q Consensus       267 ~~---------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~-~~~~~~~~  330 (397)
                      ..               ....||+.|+|||++.+..++.++||||||+++|+|++|..||....+...... ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            11               145799999999999999999999999999999999999999875432111000 00111122


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ..+..+++.+.+++.+||+.||++|||+.++++.|+++...+..
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            34667888999999999999999999999999999999887754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-50  Score=400.87  Aligned_cols=257  Identities=35%  Similarity=0.687  Sum_probs=227.9

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-c
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-S  185 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~  185 (397)
                      ..|+++.++|++.+.||+|+||.||+|.+.++.||||+++...    ..+.|.+|+.+|++++||||+++++++.... .
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            4588999999999999999999999999999999999998653    2467899999999999999999999987655 7


Q ss_pred             eEEEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      +|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987543 379999999999999999999999999999999999999999999999999985433


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+.... +..+.++..|..+++++.++
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCCTTCCHHHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence            2  223467899999999999999999999999999999998 9999998877665544 45566778889999999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      |.+||+.||.+|||+.++++.|+++.+
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-50  Score=378.34  Aligned_cols=264  Identities=36%  Similarity=0.736  Sum_probs=216.8

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +.+.+++..++|++.++||+|+||.||+|++.+ .||||+++.........+.+.+|+.++++++||||+++++++ ...
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            455679999999999999999999999998654 599999988776777778899999999999999999999965 456


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            78999999999999999987777899999999999999999999999999999999999999999999999999975443


Q ss_pred             ---CCcccCCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-C---CCCC
Q 015965          265 ---SGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-P---TIPK  334 (397)
Q Consensus       265 ---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~---~~~~  334 (397)
                         ........||+.|+|||++.   +..++.++||||||+++|+|++|..||......+.....+..... +   ..+.
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS  252 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence               22334457999999999986   667888999999999999999999999987766665555544332 2   2345


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      .+++++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            788999999999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.7e-50  Score=378.15  Aligned_cols=263  Identities=28%  Similarity=0.532  Sum_probs=221.0

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .++..++|++.++||+|+||.||++++      .++.||||+++..  .....+.+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            367778999999999999999999985      4577999999854  44556789999999999999999999999854


Q ss_pred             --CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          183 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       183 --~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                        ...+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              356899999999999999998876779999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHH
Q 015965          261 VKAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------------QAAV  321 (397)
Q Consensus       261 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---------------~~~~  321 (397)
                      ......    ......+|..|+|||++.+..++.++||||||+++|+|++|..||......               ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            654432    223345788899999999999999999999999999999999998643211               1222


Q ss_pred             HhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .......+...+..+++++.+++.+||+.||++|||+.++++.|+++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            3344555667788999999999999999999999999999999999987653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.2e-50  Score=372.13  Aligned_cols=263  Identities=32%  Similarity=0.600  Sum_probs=218.8

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      ..|++..++|++.+.||+|+||.||+|.+..     ..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            3478888999999999999999999998743     349999987543 3455678999999999999999999999985


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                       .+..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence             4678999999999999999987666899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          262 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       262 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...++..+..+++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~  244 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP  244 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence            654332  233456789999999998899999999999999999997 999999887766555443 3445667788999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+.+++.+||+.||++|||+.++++.|++++++.
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-49  Score=376.25  Aligned_cols=267  Identities=30%  Similarity=0.621  Sum_probs=236.6

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEE-------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      ...|++..++|++.+.||+|+||.||+|++       .++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            456889999999999999999999999986       23579999998653 334467799999999999 899999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG-----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  240 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp  240 (397)
                      +++...+..++||||+++++|.+++.....                 .+++..++.++.||+.||.|||++||+||||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            999999999999999999999999987533                 489999999999999999999999999999999


Q ss_pred             CcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015965          241 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  316 (397)
Q Consensus       241 ~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~  316 (397)
                      +||+++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999986554332   223456889999999998899999999999999999999 9999998877


Q ss_pred             HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ............++..+..+++++.+++.+||+.||.+|||+.++++.|++++.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            666777777777777788899999999999999999999999999999999988754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.6e-50  Score=382.84  Aligned_cols=250  Identities=24%  Similarity=0.451  Sum_probs=220.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|++.+.||+|+||.||+++..  ++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            35578999999999999999999874  67899999875321 1223456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CC
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~  266 (397)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus        82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999999999976 56799999999999999999999999999999999999999999999999999986433 33


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      .....+||+.|+|||++.+..++.++||||||+++|||++|..||...+..+....+....  ..+|..+++++.++|.+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            4556789999999999999999999999999999999999999999888777766666543  44677899999999999


Q ss_pred             hchhCCCCCC-----CHHHHHH
Q 015965          347 CWQQDPALRP-----DFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rp-----s~~ell~  363 (397)
                      ||+.||.+||     ++.++++
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHc
Confidence            9999999999     8999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=385.78  Aligned_cols=268  Identities=31%  Similarity=0.623  Sum_probs=235.9

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ  175 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  175 (397)
                      ...|++..++|.+.++||+|+||.||+|++.+         ..||||+++... .......+.+|+.+++++ +||||++
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            34578999999999999999999999998743         359999998653 445567899999999999 8999999


Q ss_pred             eeeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 015965          176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  240 (397)
Q Consensus       176 ~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp  240 (397)
                      +++++...+..++||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998753               3589999999999999999999999999999999


Q ss_pred             CcEEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015965          241 ANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  316 (397)
Q Consensus       241 ~Nili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~  316 (397)
                      +|||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998654432   2334467899999999999999999999999999999999 9999998876


Q ss_pred             HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchh
Q 015965          317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  375 (397)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~  375 (397)
                      .+... .+....++..+..+++++.+++.+||+.||.+|||+.++++.|++++......
T Consensus       300 ~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          300 EELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHH-HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHH-HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            65544 45556677788899999999999999999999999999999999998877643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.5e-50  Score=371.19  Aligned_cols=256  Identities=36%  Similarity=0.713  Sum_probs=217.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCC--hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +++.++|++.+.||+|+||.||+|.+.++.||||+++.....  ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            566789999999999999999999999999999998765332  223467889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEeCC--------CCceEEccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADF  256 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nili~~--------~~~vkl~Df  256 (397)
                      +||||+++++|.+++..  ..+++..++.++.|++.||.|||++|   |+||||||+||+++.        ++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999999864  67999999999999999999999999   999999999999986        778999999


Q ss_pred             ccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       257 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      |+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.................+..+
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9997654432 335579999999999999999999999999999999999999999998888888877777777888999


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4e-50  Score=387.26  Aligned_cols=266  Identities=32%  Similarity=0.626  Sum_probs=232.4

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      ...|++..++|++.+.||+|+||.||+|.+.+       +.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34688999999999999999999999998532       569999998653 344467799999999999 789999999


Q ss_pred             eEEecCCc-eEEEEEeccCCCHHHHHHhccC-------------------------------------------------
Q 015965          178 GACTKPPS-LCIVTEFMSGGSVYDYLHKLKG-------------------------------------------------  207 (397)
Q Consensus       178 ~~~~~~~~-~~lv~E~~~g~sL~~~l~~~~~-------------------------------------------------  207 (397)
                      +++...+. +++||||++||+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 8999999999999999976432                                                 


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC---cc
Q 015965          208 ----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM  268 (397)
Q Consensus       208 ----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~---~~  268 (397)
                                      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                            18899999999999999999999999999999999999999999999999998654332   23


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....||+.|+|||++.+..++.++||||||+++|+|++ |..||......+.....+.....+..+..+++++.+++.+|
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            34567899999999999999999999999999999998 99999988776777777777777788889999999999999


Q ss_pred             chhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          348 WQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      |+.||.+|||+.++++.|+++++..
T Consensus       333 l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHHHHHHHHh
Confidence            9999999999999999999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-49  Score=368.98  Aligned_cols=259  Identities=32%  Similarity=0.620  Sum_probs=229.2

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEECCc-ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+++..++|++.+.||+|+||.||++.+.+. .||+|+++.....   ...+.+|+.++++++||||+++++++......
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            3678889999999999999999999988654 6999999866544   35688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998866679999999999999999999999999999999999999999999999999998655443


Q ss_pred             c--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHH
Confidence            2  223456788999999999889999999999999999999 999999888777665543 444566677889999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      +.+||+.||.+|||+.++++.|+++.+
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            999999999999999999999988743

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-49  Score=365.61  Aligned_cols=259  Identities=36%  Similarity=0.728  Sum_probs=230.0

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .|.++.++|++.+.||+|+||.||++.+ .++.||+|+++.....   .+.+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            4789999999999999999999999998 4567999999876543   35688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++||||+++++|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99999999999999998877789999999999999999999999999999999999999999999999999997654321


Q ss_pred             --cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                        ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....++..+..+++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQI  237 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcCCcCCCCccCcHHHHHH
Confidence              2234467889999999998889999999999999999999 99999988776665554 4445666778889999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      +.+||+.||.+|||+.++++.|+++.+
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-49  Score=381.66  Aligned_cols=264  Identities=31%  Similarity=0.582  Sum_probs=229.1

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  180 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  180 (397)
                      .+++..++|++.+.||+|+||.||+|++.+       +.||||+++... .......+.+|+.++++++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            356778999999999999999999999864       679999998653 445567899999999999999999999999


Q ss_pred             ecCCceEEEEEeccCCCHHHHHHhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 015965          181 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD  237 (397)
Q Consensus       181 ~~~~~~~lv~E~~~g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrD  237 (397)
                      ...+..|+||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            99999999999999999999998642                       5689999999999999999999999999999


Q ss_pred             CCCCcEEeCCCCceEEcccccccccccC---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 015965          238 LKAANLLMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEY  313 (397)
Q Consensus       238 lkp~Nili~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~  313 (397)
                      |||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999999765432   22334568999999999998899999999999999999999 9999998


Q ss_pred             CChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          314 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .+..+....+. .+..+..+..+++++.+++.+||+.||.+|||+.++++.|+++.+...
T Consensus       280 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          280 MAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             SCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            88766655544 444556778899999999999999999999999999999999876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.9e-50  Score=398.01  Aligned_cols=305  Identities=23%  Similarity=0.373  Sum_probs=228.4

Q ss_pred             CCCchhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCCccccCcccccccceeeeeCCce
Q 015965           50 GWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD  129 (397)
Q Consensus        50 ~~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~ss~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~  129 (397)
                      ....+++++|..+++..+..++.+........+.++..... ......     ......+.+..++|++.++||+|+||.
T Consensus        90 ~~~~ee~e~W~~ai~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~y~~~~~lG~G~~g~  163 (446)
T 4ejn_A           90 VETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSG-AEEMEV-----SLAKPKHRVTMNEFEYLKLLGKGTFGK  163 (446)
T ss_dssp             CSSHHHHHHHHHHHHHHCCC----------------------------------------CCCGGGEEEEEEEEEETTEE
T ss_pred             cCCHHHHHHHHHHHHhhhhhhhcccccccccCCCCCccccc-cccccc-----cccCcccCCChHHcEEeEEEeeCcCEE
Confidence            45678899999999987755544432221111111100000 000000     011123356668899999999999999


Q ss_pred             EEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCCCHHHHHHhcc
Q 015965          130 LYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK  206 (397)
Q Consensus       130 Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~  206 (397)
                      ||++..  .++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++|++|.+++.. .
T Consensus       164 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~  242 (446)
T 4ejn_A          164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-E  242 (446)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-H
T ss_pred             EEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-c
Confidence            999987  467899999875422 233346688899999999999999999999999999999999999999999976 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcccCCCCCcccccccccC
Q 015965          207 GVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIE  284 (397)
Q Consensus       207 ~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~  284 (397)
                      +.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.
T Consensus       243 ~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  322 (446)
T 4ejn_A          243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE  322 (446)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC
Confidence            679999999999999999999998 9999999999999999999999999999986433 33455678999999999999


Q ss_pred             CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHH
Q 015965          285 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP-----DFS  359 (397)
Q Consensus       285 ~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rp-----s~~  359 (397)
                      +..++.++|||||||++|+|++|..||...+..+....+....  ..+|..+++++.+||.+||+.||.+||     ++.
T Consensus       323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~  400 (446)
T 4ejn_A          323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK  400 (446)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred             CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHH
Confidence            9999999999999999999999999999988877777666553  346778999999999999999999999     999


Q ss_pred             HHHH
Q 015965          360 EIIE  363 (397)
Q Consensus       360 ell~  363 (397)
                      ++++
T Consensus       401 ell~  404 (446)
T 4ejn_A          401 EIMQ  404 (446)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            9875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-50  Score=384.75  Aligned_cols=267  Identities=30%  Similarity=0.573  Sum_probs=230.4

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEE-------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      ...|++..++|++.+.||+|+||.||+|.+       .+..||||+++... .......+.+|+.+++++ +||||++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            346899999999999999999999999987       23469999998543 233456789999999999 899999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhccC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG----------------------VFKLPSLLKVAIDVSKGMNYLHQNNIIH  235 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH  235 (397)
                      +++...+..++||||+++++|.+++.....                      .+++..++.++.||+.||.|||++||+|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            999999999999999999999999986543                      3789999999999999999999999999


Q ss_pred             CCCCCCcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 015965          236 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY  311 (397)
Q Consensus       236 rDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~  311 (397)
                      |||||+|||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999976544322   223456889999999998899999999999999999998 99999


Q ss_pred             CCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          312 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ............+.....+..+..+++++.+++.+||+.||.+|||+.++++.|+.++....
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            98877777777777777888888999999999999999999999999999999999877654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-49  Score=386.05  Aligned_cols=263  Identities=33%  Similarity=0.608  Sum_probs=220.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+++.++|++.+.||+|+||.||+|++.     +..||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            4677889999999999999999999864     4569999998653 445567899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ...++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998866789999999999999999999999999999999999999999999999999998655


Q ss_pred             cCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          264 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       264 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+.... +..+.+...+..+++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~  277 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRLPPPMDCPA  277 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-HHTTEECCCCTTCBH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccccH
Confidence            4321    112245788999999999999999999999999999998 9999998887665544 444556667778999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ++.+++.+||+.||.+||++.++++.|+++++..+
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence            99999999999999999999999999999987543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2e-49  Score=371.76  Aligned_cols=270  Identities=29%  Similarity=0.536  Sum_probs=229.6

Q ss_pred             CccccCcccccccc-eeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          107 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       107 ~~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      ..+.++.++|++.+ .||+|+||.||+|.+.    ++.||||+++.........+.+.+|+.++++++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34567788999998 9999999999999653    46699999987765566678899999999999999999999999 


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            45678999999999999999987 46799999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          262 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       262 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      ......    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  245 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGC  245 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            544322    223356789999999988889999999999999999999 9999998877655444 4455567778889


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchhhHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER  379 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~  379 (397)
                      ++++.+++.+||+.||.+||++.++++.|++++......+.++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  288 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHH  288 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccccc
Confidence            9999999999999999999999999999999999888765543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-49  Score=382.62  Aligned_cols=249  Identities=22%  Similarity=0.391  Sum_probs=220.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +.|++++.||+|+||.||++...  ++.||+|+++......    ...+.+.+|+.+|++++||||+++++++.+...+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            67999999999999999999884  6789999998654322    13467899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC----ceEEcccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  263 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~----~vkl~DfG~a~~~~  263 (397)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999976 56799999999999999999999999999999999999998777    79999999998776


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLA  341 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  341 (397)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.......  ..+..+++++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            6655667789999999999999999999999999999999999999999988877776665543321  22357889999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +||.+||..||.+|||+.++++
T Consensus       251 ~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          251 DFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999984

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-49  Score=372.38  Aligned_cols=246  Identities=27%  Similarity=0.506  Sum_probs=217.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||||++.......  .+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            6799999999999999999976  56789999987553332  4568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      |++|++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence            9999999999976  468999999999999999999999999999999999999999999999999997655433 3445


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ..||+.|+|||++.+..++.++||||||+++|+|++|..||...++......+..... ....+..+++.+.+++.+||+
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  255 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE  255 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHcc
Confidence            6899999999999999999999999999999999999999998888776666554433 334566789999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.++++
T Consensus       256 ~dp~~Rps~~ell~  269 (297)
T 3fxz_A          256 MDVEKRGSAKELLQ  269 (297)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.3e-49  Score=382.17  Aligned_cols=249  Identities=21%  Similarity=0.405  Sum_probs=221.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++...........+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            67999999999999999999874  6789999998776666667789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC---CceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~---~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++........
T Consensus       109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~  187 (362)
T 2bdw_A          109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  187 (362)
T ss_dssp             CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred             cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence            9999999999976 4679999999999999999999999999999999999999865   45999999999877666556


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........+  ..+++++.+||.+
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  267 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS  267 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            66789999999999999999999999999999999999999999888777666665544332222  4578999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||++||++.++++
T Consensus       268 ~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          268 MLTVNPKKRITADQALK  284 (362)
T ss_dssp             HSCSSGGGSCCHHHHTT
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.7e-50  Score=380.34  Aligned_cols=264  Identities=29%  Similarity=0.462  Sum_probs=219.3

Q ss_pred             CCCCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          104 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ++...+.++.++|++.++||+|+||.||+|++.++.||||+++..   ......+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            445667899999999999999999999999999999999999743   23344566799999999999999999999875


Q ss_pred             Cc----eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCcEEeCCCC
Q 015965          184 PS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN----------NIIHRDLKAANLLMDENE  249 (397)
Q Consensus       184 ~~----~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~iiHrDlkp~Nili~~~~  249 (397)
                      ..    +++||||+++++|.+++..  ..+++..++.++.||+.||.|||+.          ||+||||||+|||++.++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            43    6999999999999999976  5699999999999999999999999          999999999999999999


Q ss_pred             ceEEcccccccccccCC---cccCCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC------
Q 015965          250 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLT------  315 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~P~~~~~------  315 (397)
                      .+||+|||+++......   ......||+.|+|||++.+.     .++.++||||||+++|+|++|+.||....      
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            99999999997654432   23345799999999999763     45668899999999999999999996532      


Q ss_pred             ----------hHHHHHHhhhcCCCCCCCCC-----CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          316 ----------PLQAAVGVVQKGLRPTIPKN-----SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       316 ----------~~~~~~~~~~~~~~~~~~~~-----~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                                .............++..+..     +++++.+|+.+||+.||++|||+.++++.|+++.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                      12222223333444444332     3456999999999999999999999999999987643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.4e-49  Score=372.68  Aligned_cols=263  Identities=29%  Similarity=0.599  Sum_probs=230.6

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeE
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA  179 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  179 (397)
                      ..|++..++|++.+.||+|+||.||++.+.       ++.||||+++... .....+.+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            457888999999999999999999999862       2679999998543 45556789999999999999999999999


Q ss_pred             EecCCceEEEEEeccCCCHHHHHHhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 015965          180 CTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR  236 (397)
Q Consensus       180 ~~~~~~~~lv~E~~~g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHr  236 (397)
                      +...+..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999999998643                       238899999999999999999999999999


Q ss_pred             CCCCCcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 015965          237 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE  312 (397)
Q Consensus       237 Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~  312 (397)
                      ||||+||+++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986544322   233467889999999998889999999999999999999 999999


Q ss_pred             CCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .....+... .+.....+..+..+++++.+++.+||+.||.+||++.++++.|++++..
T Consensus       255 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPERLFN-LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGGGHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHH-HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            887765543 3445556677888999999999999999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.4e-49  Score=394.43  Aligned_cols=261  Identities=34%  Similarity=0.664  Sum_probs=229.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+.|++..++|++.+.||+|+||.||+|.+. +..||||+++.....   .+.|.+|+.+|++++||||+++++++. ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            4568999999999999999999999999985 567999999865433   567999999999999999999999987 56


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      .+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            7899999999999999997543 368999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...  ......+|+.|+|||++....++.++||||||+++|||++ |..||...+..+....+ ..+.+...+..+++++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEEL  414 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTCCCCCCTTSCHHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHH
Confidence            322  1223456789999999998899999999999999999999 99999998887766554 4556777788999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .++|.+||+.||++|||+.++++.|+++...
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999988653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.7e-49  Score=369.60  Aligned_cols=260  Identities=25%  Similarity=0.446  Sum_probs=222.0

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +-.++|++.+.||+|+||.||++.+.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            33578999999999999999999874  67899999865443 4455678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999999999987 4679999999999999999999999999999999999999999999999999998654432 


Q ss_pred             -cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC---CCCCCCcHHHHH
Q 015965          267 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAE  342 (397)
Q Consensus       267 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~  342 (397)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+............   ..+..+++.+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence             2234579999999999999999999999999999999999999999988877766655543322   245678999999


Q ss_pred             HHHHhchhCCCCCC-CHHHHHHHHHHHHHH
Q 015965          343 LLERCWQQDPALRP-DFSEIIEILQQIAKE  371 (397)
Q Consensus       343 ll~~cl~~dp~~Rp-s~~ell~~L~~l~~~  371 (397)
                      ++.+||+.||.+|| ++.++.+.|++++.+
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            99999999999998 899999988887543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=382.15  Aligned_cols=264  Identities=30%  Similarity=0.552  Sum_probs=228.2

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  180 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  180 (397)
                      .+++..++|++.+.||+|+||.||+|.+.       ++.||||+++... .......+.+|+.++++++||||+++++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45677889999999999999999999853       3469999997543 445566789999999999999999999999


Q ss_pred             ecCCceEEEEEeccCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ce
Q 015965          181 TKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VV  251 (397)
Q Consensus       181 ~~~~~~~lv~E~~~g~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~v  251 (397)
                      ......++||||++|++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999998753      3589999999999999999999999999999999999999555   59


Q ss_pred             EEcccccccccccC---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 015965          252 KVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  327 (397)
Q Consensus       252 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~  327 (397)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +..+
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC
Confidence            99999999754322   22234467999999999998999999999999999999998 9999998887666554 4445


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .++..+..+++.+.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            5667788899999999999999999999999999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.2e-49  Score=375.79  Aligned_cols=267  Identities=30%  Similarity=0.593  Sum_probs=234.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  177 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~  177 (397)
                      ...|++..++|++.+.||+|+||.||+|.+.+       ..||+|+++... .......+.+|+.+++++ +||||++++
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34688999999999999999999999998743       359999998653 344567799999999999 899999999


Q ss_pred             eEEecCCceEEEEEeccCCCHHHHHHhc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 015965          178 GACTKPPSLCIVTEFMSGGSVYDYLHKL-------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  244 (397)
Q Consensus       178 ~~~~~~~~~~lv~E~~~g~sL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  244 (397)
                      +++...+..++||||+++++|.+++...             ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9999999999999999999999999754             245899999999999999999999999999999999999


Q ss_pred             eCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015965          245 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA  320 (397)
Q Consensus       245 i~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~  320 (397)
                      ++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            99999999999999986543322   223456889999999998899999999999999999998 99999988776767


Q ss_pred             HHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          321 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .........+..+..+++.+.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            77777777777788899999999999999999999999999999999987653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=387.84  Aligned_cols=249  Identities=19%  Similarity=0.362  Sum_probs=220.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++..  .++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            6799999999999999999987  56789999998776666667789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC---CCCceEEcccccccccccCC-c
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSG-V  267 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~---~~~~vkl~DfG~a~~~~~~~-~  267 (397)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... .
T Consensus        91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            9999999999987 56799999999999999999999999999999999999998   56789999999997655432 3


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC--CCCCcHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLE  345 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~  345 (397)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........  ...+++++.+||.
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  249 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN  249 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            45568999999999999999999999999999999999999999998887777776655443322  2478999999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+|||+.|+++
T Consensus       250 ~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          250 KMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHSCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhHCCCHHHHhc
Confidence            999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-48  Score=372.26  Aligned_cols=263  Identities=33%  Similarity=0.624  Sum_probs=225.0

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECCc------ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      +++..++|++.+.||+|+||.||+|.+...      .||||+++... .......+.+|+.++++++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            478889999999999999999999987432      39999998653 44456679999999999999999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      .+..++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999886778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          263 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       263 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+.++..+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDCP  276 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCB
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCcCCCcccCC
Confidence            44321    223356889999999999999999999999999999999 9999998877665544 34455666778899


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      +.+.+++.+||+.||.+||++.++++.|++++....
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            999999999999999999999999999999987554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6e-49  Score=367.43  Aligned_cols=267  Identities=36%  Similarity=0.662  Sum_probs=234.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+.|++..++|++.+.||+|+||.||+|.+.  +..||+|+++...   ...+.+.+|+.++++++||||+++++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3568999999999999999999999999986  6779999997543   2356789999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +..++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999999864 345899999999999999999999999999999999999999999999999999866


Q ss_pred             ccCCc--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          263 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       263 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      .....  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+++.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEK  240 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHH
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHH
Confidence            54332  223356889999999998899999999999999999999 9999988776655443 4455667778889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchhh
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN  376 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~~  376 (397)
                      +.+++.+||+.||.+|||+.++++.|++++.+.....
T Consensus       241 l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~  277 (288)
T 3kfa_A          241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD  277 (288)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence            9999999999999999999999999999998776443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-49  Score=376.09  Aligned_cols=247  Identities=19%  Similarity=0.315  Sum_probs=220.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++..   ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            67999999999999999999884  577999998744   3345668899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC--CCceEEcccccccccccCCccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~--~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      |++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~  161 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence            99999999999876668999999999999999999999999999999999999987  7899999999998776665566


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~c  347 (397)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........  ....+++++.+|+.+|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence            67899999999999998899999999999999999999999999888777777665543322  1246889999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |..||.+|||+.|+++
T Consensus       242 L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          242 LVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             cCCChhHCcCHHHHhc
Confidence            9999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.3e-49  Score=373.19  Aligned_cols=267  Identities=27%  Similarity=0.505  Sum_probs=213.2

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEECCc-----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .+.+..++|++.+.||+|+||.||+|.+...     .||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3467778999999999999999999986432     69999998776566667889999999999999999999999987


Q ss_pred             CCce------EEEEEeccCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCce
Q 015965          183 PPSL------CIVTEFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  251 (397)
Q Consensus       183 ~~~~------~lv~E~~~g~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~v  251 (397)
                      ....      ++||||+++++|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7655      99999999999999996542     258999999999999999999999999999999999999999999


Q ss_pred             EEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 015965          252 KVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  327 (397)
Q Consensus       252 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~  327 (397)
                      ||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.. .
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-G  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-T
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc-C
Confidence            9999999976544322   223456889999999999999999999999999999999 9999998887666555443 4


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchh
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  375 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~  375 (397)
                      ..+..+..+++++.+++.+||+.||.+|||+.++++.|++++......
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence            455677889999999999999999999999999999999998876543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=383.04  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=214.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  185 (397)
                      .+..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|+.+++.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            456678999999999999999999874  67899999875421 122345678899999988 69999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-  264 (397)
                      +|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999999987 46799999999999999999999999999999999999999999999999999985433 


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+....  ...|..+++++.++|
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  255 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLHEDATGIL  255 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence            234456689999999999999999999999999999999999999999998888777776653  446778999999999


Q ss_pred             HHhchhCCCCCCCH------HHHHH
Q 015965          345 ERCWQQDPALRPDF------SEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~------~ell~  363 (397)
                      .+||+.||.+||++      .++++
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999998      66654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-48  Score=365.32  Aligned_cols=255  Identities=33%  Similarity=0.673  Sum_probs=220.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHH-----HHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-----KEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .+..++|++.+.||+|+||.||+|.+  .++.||||++..........     +.+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45668899999999999999999998  46789999987654432221     678999999999999999999999976


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCc-----eEEcc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV-----VKVAD  255 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~-----vkl~D  255 (397)
                      ..  ++||||+++++|.+++......+++..++.++.|++.||.|||++|  |+||||||+||+++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            55  7999999999999999876778999999999999999999999999  999999999999988776     99999


Q ss_pred             cccccccccCCcccCCCCCccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHhhhcCCCCC
Q 015965          256 FGVARVKAQSGVMTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPT  331 (397)
Q Consensus       256 fG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~--~~~~~~~~~~~~~  331 (397)
                      ||+++....  ......||+.|+|||++  ....++.++||||||+++|+|++|..||.......  ..........++.
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            999975433  34556899999999998  45567889999999999999999999998765433  3445556677788


Q ss_pred             CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          332 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       332 ~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .+..+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            8899999999999999999999999999999999763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-48  Score=364.18  Aligned_cols=263  Identities=29%  Similarity=0.576  Sum_probs=225.6

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECCc-----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      ..|.+..++|++.+.||+|+||.||+|.+.+.     .||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            34677889999999999999999999987432     39999988653 3445678999999999999999999999987


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      + +..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            5 457899999999999999988777799999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          262 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       262 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +.....+..+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRLPKPDLCPP  241 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCCCCCTTCCH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCCCCCCCCCH
Confidence            55432  2234467889999999998899999999999999999998 9999987766555443 344455667778999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999997654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-49  Score=367.19  Aligned_cols=266  Identities=27%  Similarity=0.544  Sum_probs=231.9

Q ss_pred             ccccCcccccccc-eeeeeCCceEEEEEE----CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          108 VWEIDPKHLKFGS-KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       108 ~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .+.+..++|.+.+ .||+|+||.||+|.+    .+..||||+++... .....+.+.+|+.++++++||||+++++++. 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            3567778888887 999999999999986    35669999998653 4455678999999999999999999999994 


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      .+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            45699999999999999999876678999999999999999999999999999999999999999999999999999866


Q ss_pred             ccCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          263 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       263 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+.++..+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~  239 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  239 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HhcCCcCCCCCCcC
Confidence            44322    223456899999999988889999999999999999998 9999998877665544 44455677888999


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchhh
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN  376 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~~  376 (397)
                      +++.+++.+||+.||.+||++.++++.|++++.+.....
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            999999999999999999999999999999998876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-48  Score=363.37  Aligned_cols=264  Identities=31%  Similarity=0.621  Sum_probs=229.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+.|++..++|++.+.||+|+||.||+|.+.+ +.||||+++.....   .+.+.+|+.++++++||||+++++++.. +
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            46789999999999999999999999999865 47999999865433   4578899999999999999999998874 5


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            6899999999999999997543 368999999999999999999999999999999999999999999999999998665


Q ss_pred             cCCc--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ....  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+++++
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  239 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEEL  239 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCCCCcccccHHH
Confidence            4322  223456889999999998889999999999999999999 9999998887665554 34455666778899999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      .+++.+||+.||++|||+.++++.|++++.....
T Consensus       240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            9999999999999999999999999999887653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.7e-49  Score=383.17  Aligned_cols=246  Identities=22%  Similarity=0.399  Sum_probs=210.2

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  185 (397)
                      .+..++|+++++||+|+||.||++++.  ++.||||+++..... ......+.+|..+++++ +||||+++++++.+...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            556688999999999999999999885  567999999865433 23345578899999876 89999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc-cc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK-AQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~-~~  264 (397)
                      +|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ..
T Consensus       128 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999999987 467999999999999999999999999999999999999999999999999999863 33


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHhhhcCCCCCCCCC
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------LQ-AAVGVVQKGLRPTIPKN  335 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--------~~-~~~~~~~~~~~~~~~~~  335 (397)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.....        .+ ....+...  ...+|..
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~  284 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRS  284 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--CCCCCTT
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--ccCCCCc
Confidence            3445667899999999999999999999999999999999999999964321        12 22223332  4567788


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCH
Q 015965          336 SQPKLAELLERCWQQDPALRPDF  358 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~  358 (397)
                      +++++.+||.+||+.||.+||++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence            99999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-49  Score=397.30  Aligned_cols=263  Identities=36%  Similarity=0.687  Sum_probs=232.7

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+.|++...+|++.++||+|+||.||+|.+.  +..||||+++.....   .+.|.+|+.+|++++||||+++++++...
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4568999999999999999999999999986  577999999865433   46799999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ..+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999999999864 356899999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          263 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       263 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      .....  .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+... .+....+...+..++++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEK  447 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCCCTTCCHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence            44322  223356789999999998899999999999999999999 999999887665543 45566677788899999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +.+||.+||+.||.+|||+.++++.|++++++.
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            999999999999999999999999999886543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.4e-48  Score=371.78  Aligned_cols=267  Identities=31%  Similarity=0.615  Sum_probs=232.2

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ  175 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  175 (397)
                      ...|++..++|++.+.||+|+||.||+|.+.         +..||||+++... .......+.+|+.+++++ +||||++
T Consensus        27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            3458899999999999999999999999874         3569999998653 444567799999999999 8999999


Q ss_pred             eeeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 015965          176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  240 (397)
Q Consensus       176 ~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp  240 (397)
                      +++++...+..|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            9999999999999999999999999998643               2489999999999999999999999999999999


Q ss_pred             CcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015965          241 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  316 (397)
Q Consensus       241 ~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~  316 (397)
                      +||+++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            999999999999999999986554322   233457889999999988889999999999999999999 9999998876


Q ss_pred             HHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          317 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      .+.... +....++..+..+++++.+++.+||+.||.+|||+.++++.|+++++....
T Consensus       266 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          266 EELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHH-HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            655444 444556677888999999999999999999999999999999999886653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-48  Score=371.02  Aligned_cols=251  Identities=25%  Similarity=0.430  Sum_probs=210.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCCC--hHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .+..++|++.+.||+|+||.||+++.     .++.||||+++.....  ......+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            56678999999999999999999987     4677999999865432  2334568889999999999999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      .+.+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999999999976 467899999999999999999999999999999999999999999999999999754


Q ss_pred             ccC-CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          263 AQS-GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       263 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...  ....+..+++++.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~  249 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQEAR  249 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHHHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence            333 2344567999999999999999999999999999999999999999998887777666654  3456778899999


Q ss_pred             HHHHHhchhCCCCCC-----CHHHHHH
Q 015965          342 ELLERCWQQDPALRP-----DFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rp-----s~~ell~  363 (397)
                      ++|.+||..||.+||     ++.++++
T Consensus       250 ~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          250 DLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            999999999999999     6777764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=372.54  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=219.0

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++......    .....+.+|+.++++++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            57999999999999999999984  6789999987654321    12567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC----ceEEcccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  263 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~----~vkl~DfG~a~~~~  263 (397)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999976 56799999999999999999999999999999999999999887    89999999998776


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLA  341 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  341 (397)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.......  ..+..+++.+.
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  249 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence            5555666789999999999999999999999999999999999999999888777666655433221  12356789999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +|+.+||+.||.+|||+.++++
T Consensus       250 ~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          250 DFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-48  Score=369.34  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=209.7

Q ss_pred             CcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      -.++|++.++||+|+||+||+|.+ .++.||+|+++...........+.+|+.++++++||||+++++++......++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999998 5677999999876555555677899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  177 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT  177 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence            9996 5899998876777999999999999999999999999999999999999999999999999999865433 3345


Q ss_pred             CCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC-----------------
Q 015965          270 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-----------------  331 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~-----------------  331 (397)
                      ...||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+.                 
T Consensus       178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT  257 (311)
T ss_dssp             CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred             CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence            5678999999999876 5689999999999999999999999987766554444332111100                 


Q ss_pred             -----------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 -----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 -----------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                 ....+++++.+||.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                       12346789999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-48  Score=365.87  Aligned_cols=249  Identities=23%  Similarity=0.394  Sum_probs=209.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      ++|++.+.||+|+||.||+|.+. ++.||+|+++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999884 67899999976644433346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~  271 (397)
                      +++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            965 999999887788999999999999999999999999999999999999999999999999999865432 233455


Q ss_pred             CCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC----------------C----
Q 015965          272 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------------P----  330 (397)
Q Consensus       272 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~----------------~----  330 (397)
                      .||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......                +    
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            78999999999976 45899999999999999999999999988876665554431100                0    


Q ss_pred             -------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 -------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 -------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                             .....+++++.+|+.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   112457899999999999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.4e-48  Score=360.80  Aligned_cols=250  Identities=20%  Similarity=0.385  Sum_probs=223.5

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999874  678999999877666666788999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc---eEEcccccccccccCCc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSGV  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~---vkl~DfG~a~~~~~~~~  267 (397)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++........
T Consensus        85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            99999999999876 467999999999999999999999999999999999999986655   99999999987776666


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC--CCCCcHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLE  345 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~  345 (397)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........  ...+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            66778999999999999999999999999999999999999999988887777666555443322  2478899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcccChhhCCCHHHHhc
Confidence            999999999999999976

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-49  Score=381.69  Aligned_cols=266  Identities=20%  Similarity=0.303  Sum_probs=215.4

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHH---------HHHHHHHHHHHhcCCCCC
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKN  172 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~n  172 (397)
                      .++..++|++.+.||+|+||.||+|.+.       ++.||||++.........         ...+.+|+..++.++|||
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             ECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             eccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            3456679999999999999999999874       367999998765321110         012445667788899999


Q ss_pred             eeeeeeEEecC----CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC--
Q 015965          173 VVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--  246 (397)
Q Consensus       173 iv~~~~~~~~~----~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~--  246 (397)
                      |+++++++...    ...||||||+ |++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++  
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            99999998764    4589999999 9999999988667899999999999999999999999999999999999999  


Q ss_pred             CCCceEEcccccccccccCCc--------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015965          247 ENEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ  318 (397)
Q Consensus       247 ~~~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~  318 (397)
                      .++.+||+|||+++.......        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            889999999999976544322        133459999999999999999999999999999999999999998643322


Q ss_pred             HHHHhhhcCCCCC---------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchh
Q 015965          319 AAVGVVQKGLRPT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  375 (397)
Q Consensus       319 ~~~~~~~~~~~~~---------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~  375 (397)
                      ...........+.         .+..+++++.+++..||+.||.+||++.++++.|++++++.+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            2221111111111         12577899999999999999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.4e-49  Score=380.18  Aligned_cols=248  Identities=25%  Similarity=0.429  Sum_probs=210.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHH-HhcCCCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~  185 (397)
                      .+..++|++.+.||+|+||.||++++.  ++.||||+++..... ......+.+|..+ ++.++||||+++++++.+...
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            456688999999999999999999985  567999999765432 2334556777776 577899999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-  264 (397)
                      +|+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999999987 46799999999999999999999999999999999999999999999999999986433 


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+....  ...+..+++++.+||
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Confidence            334556789999999999999999999999999999999999999999988888777776653  346678999999999


Q ss_pred             HHhchhCCCCCCCHHH
Q 015965          345 ERCWQQDPALRPDFSE  360 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~e  360 (397)
                      .+||+.||.+||++.+
T Consensus       271 ~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHTCSSGGGSTTTTT
T ss_pred             HHHcccCHHhCCCCCC
Confidence            9999999999999753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-48  Score=367.70  Aligned_cols=267  Identities=28%  Similarity=0.514  Sum_probs=221.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  180 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  180 (397)
                      ...+.++.++|.+.+.||+|+||.||+|.+..     ..||+|+++.........+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34567888999999999999999999998643     3699999987766666678899999999999999999999999


Q ss_pred             ecCC-----ceEEEEEeccCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc
Q 015965          181 TKPP-----SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  250 (397)
Q Consensus       181 ~~~~-----~~~lv~E~~~g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~  250 (397)
                      ....     ..++||||+++++|.+++...     ...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            7754     359999999999999998532     356999999999999999999999999999999999999999999


Q ss_pred             eEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhc
Q 015965          251 VKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK  326 (397)
Q Consensus       251 vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~  326 (397)
                      +||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-Hc
Confidence            9999999997654332   2233457889999999999999999999999999999999 99999988776655544 34


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       327 ~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ..++..+..+++++.+++.+||+.||.+|||+.++++.|+++++.+.
T Consensus       265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            44667778899999999999999999999999999999999988764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-48  Score=389.69  Aligned_cols=262  Identities=36%  Similarity=0.660  Sum_probs=226.1

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+.|++..++|++.++||+|+||.||+|.+.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.. .
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            45689999999999999999999999999875 56999999875433   3578999999999999999999999876 6


Q ss_pred             ceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            789999999999999999754 3569999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...  ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.... +..+.++..+..+++.+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL  410 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTSCHHH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            332  1223456789999999998899999999999999999999 9999999887766555 44566777788999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .++|.+||+.||++|||+.++++.|+++....
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            99999999999999999999999999886543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-48  Score=367.50  Aligned_cols=259  Identities=30%  Similarity=0.552  Sum_probs=221.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+....|++.+.||+|+||.||++.+      .++.||||+++.... ......+.+|+.++++++||||+++++++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            55667899999999999999999985      457799999986542 22346789999999999999999999999876


Q ss_pred             --CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          184 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       184 --~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                        ..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              668999999999999999987778899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHHHh
Q 015965          262 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--------------TPLQAAVGV  323 (397)
Q Consensus       262 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~--------------~~~~~~~~~  323 (397)
                      .....    ......||..|+|||++.+..++.++||||||+++|+|++|..|+...              .........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            65443    233456888999999999988999999999999999999999876322              223334444


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       324 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .....+...+..+++++.+++.+||+.||.+|||+.++++.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            5556677788899999999999999999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.6e-49  Score=381.15  Aligned_cols=252  Identities=23%  Similarity=0.400  Sum_probs=216.5

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      ..+..++|++.+.||+|+||.||++.+.  ++.||+|++..... .......+.+|+.+|+.++|||||++++++.+...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4677789999999999999999999874  56799999874321 12234678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999999986 567999999999999999999999999999999999999999999999999999877766


Q ss_pred             CcccCCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCCCCCCCCcHH
Q 015965          266 GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ......+||+.|+|||++.   +..|+.++|||||||++|+|++|..||.....   .+....+..  .....|..++++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~  246 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQE  246 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHH
Confidence            6677889999999999996   34689999999999999999999999975432   222222222  244567789999


Q ss_pred             HHHHHHHhchhCCCCCCC-HHHHHH
Q 015965          340 LAELLERCWQQDPALRPD-FSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps-~~ell~  363 (397)
                      +.+||.+||+.||.+||+ +.++++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999999999999999998 666653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-48  Score=364.11  Aligned_cols=259  Identities=36%  Similarity=0.688  Sum_probs=219.4

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-C
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-P  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~  184 (397)
                      ...|.++.++|++.+.||+|+||.||++++.++.||||+++...    ..+.+.+|+.++++++||||+++++++... +
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            34578889999999999999999999999999999999988543    346788999999999999999999987554 4


Q ss_pred             ceEEEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            78999999999999999976432 38999999999999999999999999999999999999999999999999997554


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                      ..  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+.+
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  245 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYE  245 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHH
T ss_pred             cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCcccCCHHHHH
Confidence            33  233467899999999998899999999999999999998 9999988776555444 4445567778889999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      ++.+||+.||.+|||+.++++.|+++...
T Consensus       246 li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          246 VMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-48  Score=371.32  Aligned_cols=248  Identities=26%  Similarity=0.453  Sum_probs=219.4

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|++.+.||+|+||.||+++..  ++.||+|+++..... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            34578999999999999999999874  678999998753211 122456788999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  .
T Consensus        83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--V  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--C
T ss_pred             EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--c
Confidence            99999999999999987 46799999999999999999999999999999999999999999999999999986543  2


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....  ..+|..+++++.++|.+|
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            345689999999999999999999999999999999999999999988887777776654  346778899999999999


Q ss_pred             chhCCCCCC-----CHHHHHH
Q 015965          348 WQQDPALRP-----DFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rp-----s~~ell~  363 (397)
                      |..||.+||     ++.++++
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHT
T ss_pred             hccCHHHcCCCcCCCHHHHhc
Confidence            999999999     8888873

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-48  Score=370.23  Aligned_cols=266  Identities=32%  Similarity=0.621  Sum_probs=230.9

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  178 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  178 (397)
                      ..|++..++|++.+.||+|+||.||+|.+.       ++.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            467888899999999999999999999853       3669999998653 344557799999999999 6899999999


Q ss_pred             EEecCC-ceEEEEEeccCCCHHHHHHhccCC---------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          179 ACTKPP-SLCIVTEFMSGGSVYDYLHKLKGV---------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       179 ~~~~~~-~~~lv~E~~~g~sL~~~l~~~~~~---------------l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      ++...+ .+++||||+++++|.+++......               +++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987754 489999999999999999875332               8899999999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~  318 (397)
                      |+++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999999976543321   223457889999999999999999999999999999998 999998877666


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .....+..+..+..+..+++++.+++.+||+.||.+|||+.++++.|+++++...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            6666666666777788899999999999999999999999999999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.1e-48  Score=372.07  Aligned_cols=245  Identities=22%  Similarity=0.399  Sum_probs=211.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCce
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  186 (397)
                      +..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|+.+++++ +||||+++++++.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            45578999999999999999999985  57799999986544 344566788999999987 899999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-C
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-S  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~  265 (397)
                      |+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999999976 46799999999999999999999999999999999999999999999999999986432 3


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHhhhcCCCCCCCCCC
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---------TPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~---------~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||...         ........+...  ...+|..+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCCC
Confidence            3455678999999999999999999999999999999999999999753         112222233332  34567889


Q ss_pred             cHHHHHHHHHhchhCCCCCCCH
Q 015965          337 QPKLAELLERCWQQDPALRPDF  358 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~  358 (397)
                      ++++.++|.+||+.||.+||++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence            9999999999999999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-48  Score=376.26  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=217.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  185 (397)
                      .+..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|..+++.+ +||||+++++++.+...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            456678999999999999999999985  46799999875421 112245688899999988 79999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-  264 (397)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999999986 46799999999999999999999999999999999999999999999999999986433 


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+....  ..+|..+++++.+||
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC  252 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence            334456789999999999999999999999999999999999999999988887777776653  456778999999999


Q ss_pred             HHhchhCCCCCCC-----HHHHHH
Q 015965          345 ERCWQQDPALRPD-----FSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps-----~~ell~  363 (397)
                      .+||..||.+||+     +.++++
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999995     466653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.7e-48  Score=366.69  Aligned_cols=263  Identities=31%  Similarity=0.573  Sum_probs=228.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG  178 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  178 (397)
                      .+.|++..++|++.+.||+|+||.||+|.+.       ++.||||++.... .......+.+|+.++++++||||+++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4568899999999999999999999999764       4679999998543 3444567999999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      ++......++||||+++++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            9999999999999999999999997642         4578999999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 015965          250 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~  325 (397)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999997654332   1223456889999999998899999999999999999999 8999998887766655444


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                       ...+..+..+++.+.+++.+||+.||.+|||+.++++.|++++.
T Consensus       256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             34456678899999999999999999999999999999987644

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.2e-48  Score=361.30  Aligned_cols=249  Identities=22%  Similarity=0.361  Sum_probs=211.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.++||+|+||+||+|.+  .++.||||+++...........+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5799999999999999999998  46779999998776666666789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |++ ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus        82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            996 5777777766788999999999999999999999999999999999999999999999999999865433 33455


Q ss_pred             CCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcCCC-------------------
Q 015965          271 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLR-------------------  329 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~P-~~~~~~~~~~~~~~~~~~~-------------------  329 (397)
                      ..||+.|+|||++.+.. ++.++||||||+++|+|++|..| |...+..+....+......                   
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            68899999999997765 89999999999999999987777 5555554444443321110                   


Q ss_pred             --------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                              ......+++++.+|+.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                    0122357899999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=397.81  Aligned_cols=264  Identities=27%  Similarity=0.542  Sum_probs=226.0

Q ss_pred             ccccCcccccccc-eeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          108 VWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       108 ~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .|.+..+++.+.+ +||+|+||.||+|.+.    +..||||+++.... ....+.+.+|+.+|++++|||||++++++..
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            4556667777777 8999999999999873    34599999986532 3345789999999999999999999999987


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                       +.+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             5699999999999999999876778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          263 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       263 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+.... +..+.++..+..++
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  565 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCCCCTTCC
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCC
Confidence            43321    122345789999999998999999999999999999998 9999999887665544 45566777888999


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      +++.+||.+||+.||++||++.++++.|++++.....
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999887754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-49  Score=377.48  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=216.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCc
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  185 (397)
                      .+..++|++.+.||+|+||.||+|++.  ++.||||+++.... .......+..|..+++.+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            456678999999999999999999984  67799999975321 112245677899998876 89999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-  264 (397)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            9999999999999999987 46799999999999999999999999999999999999999999999999999986433 


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...  .+..|..+++++.+||
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL  249 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence            23455678999999999999999999999999999999999999999988887777666554  3456778999999999


Q ss_pred             HHhchhCCCCCCCHH-HHH
Q 015965          345 ERCWQQDPALRPDFS-EII  362 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~-ell  362 (397)
                      .+||..||.+||++. +++
T Consensus       250 ~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGG
T ss_pred             HHHhcCCHhHcCCChHHHH
Confidence            999999999999997 664

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-48  Score=371.47  Aligned_cols=259  Identities=30%  Similarity=0.608  Sum_probs=219.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--Ccc----eEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+..++|++.+.||+|+||.||+|.+.  ++.    ||+|.++... .....+.+.+|+.++++++||||+++++++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            456788999999999999999999874  333    5888776432 233357799999999999999999999999875


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                       ..++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             4789999999999999998877889999999999999999999999999999999999999999999999999998655


Q ss_pred             cCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          264 QSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       264 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.. ..+....+...+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence            4332   223456889999999999999999999999999999999 99999987765544 445555566778889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +.+++.+||+.||.+||++.++++.|+.+...
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999998654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=375.34  Aligned_cols=274  Identities=28%  Similarity=0.567  Sum_probs=222.6

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      ...|++..++|++.+.||+|+||.||+|.+.+ .+|+|+++.........+.+.+|+.++++++||||+++++++...+.
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            45678899999999999999999999999865 59999998765444444567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  264 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-  264 (397)
                      .++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.... 
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999999999987666799999999999999999999999999999999999998 68999999999865432 


Q ss_pred             -----CCcccCCCCCcccccccccCC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC
Q 015965          265 -----SGVMTAETGTYRWMAPEVIEH---------KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP  330 (397)
Q Consensus       265 -----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~  330 (397)
                           ........||+.|+|||++.+         ..++.++||||||+++|+|++|..||...........+.......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 122334568999999999864         457889999999999999999999999888776666554443333


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhchhhHHHhh
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK  381 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~~~  381 (397)
                      ..+..+++++.+++.+||+.||.+|||+.++++.|+++.+.......++..
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~  313 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF  313 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence            334468889999999999999999999999999999998766544343333

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=365.84  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=210.1

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh------------------------HHHHHHHHHHHH
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------------------------DMQKEFAQEVFI  164 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~  164 (397)
                      +..++|++.+.||+|+||.||+|.+  .++.||||++.......                        ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3457899999999999999999987  46779999987653211                        123568899999


Q ss_pred             HhcCCCCCeeeeeeEEec--CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          165 MRKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       165 l~~l~h~niv~~~~~~~~--~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      +++++||||+++++++..  ...+|+||||+++++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999999986  567899999999999988654  3579999999999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCC-cccCCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~  318 (397)
                      ||++.++.+||+|||+++...... ......||+.|+|||++.+..   ++.++||||||+++|+|++|..||.......
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            999999999999999998655432 344568999999999997765   3778999999999999999999999887766


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ....+............+++++.++|.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            666655555444445678999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-48  Score=369.71  Aligned_cols=263  Identities=29%  Similarity=0.519  Sum_probs=224.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe--
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--  181 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--  181 (397)
                      -++.++|++.+.||+|+||.||++++      .++.||||++...  .....+.+.+|+.++++++||||+++++++.  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            46678999999999999999999985      4567999999864  3455677999999999999999999999886  


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      .....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            44568999999999999999988667899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHh
Q 015965          262 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGV  323 (397)
Q Consensus       262 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~--------------~~~~~~~  323 (397)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....              .......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            54432    22344688899999999998899999999999999999999999854322              2334445


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       324 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      .....++..+..+++++.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            566667778889999999999999999999999999999999999876654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-48  Score=377.89  Aligned_cols=262  Identities=20%  Similarity=0.375  Sum_probs=217.7

Q ss_pred             ccccCcccccccceeeee--CCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          108 VWEIDPKHLKFGSKVASG--SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+..+.++|++.++||+|  +||.||++.+.  ++.||||+++...........+.+|+.++++++||||+++++++...
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            345667899999999999  99999999985  67899999987766667778899999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999999999764 366999999999999999999999999999999999999999999999999988643


Q ss_pred             ccC--------CcccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----
Q 015965          263 AQS--------GVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----  328 (397)
Q Consensus       263 ~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----  328 (397)
                      ...        .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||...+..+..........    
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            322        12233478999999999987  6799999999999999999999999987665544443322111    


Q ss_pred             ----------------------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HH
Q 015965          329 ----------------------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQ  366 (397)
Q Consensus       329 ----------------------------------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~--L~  366 (397)
                                                              ....+..+++++.+||.+||+.||.+|||+.|+++.  |+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                    012345678899999999999999999999999843  44


Q ss_pred             HHH
Q 015965          367 QIA  369 (397)
Q Consensus       367 ~l~  369 (397)
                      ++.
T Consensus       339 ~~~  341 (389)
T 3gni_B          339 QIK  341 (389)
T ss_dssp             GC-
T ss_pred             HHh
Confidence            443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.4e-48  Score=374.32  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=218.6

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            4478999999999999999999984  67899999875321 11224678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      ||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            9999999999999987 467999999999999999999999999999999999999999999999999999865432  3


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...+|..+++++.++|.+||
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHh
Confidence            4568999999999999999999999999999999999999999998887777776665  34567789999999999999


Q ss_pred             hhCCCCCCC-----HHHHHH
Q 015965          349 QQDPALRPD-----FSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps-----~~ell~  363 (397)
                      +.||.+||+     +.++++
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHT
T ss_pred             hcCHHhccCCccCCHHHHHh
Confidence            999999998     777754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.6e-48  Score=363.70  Aligned_cols=260  Identities=18%  Similarity=0.276  Sum_probs=221.1

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||+|.+  .++.||||++......    ..+.+|+.+++.+ +|+|++++++++......
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            34557899999999999999999995  5778999998754322    3477899999999 799999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc-----eEEcccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARV  261 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~-----vkl~DfG~a~~  261 (397)
                      ++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 99999999886677999999999999999999999999999999999999987776     99999999986


Q ss_pred             cccCCc--------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhhcC---
Q 015965          262 KAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKG---  327 (397)
Q Consensus       262 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~---~~~~~~~~~~~~---  327 (397)
                      ......        .....||+.|+|||++.+..++.++||||||+++|+|++|..||....   ..+....+....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            554322        345579999999999999999999999999999999999999998743   333333332221   


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ..+.....+++++.+++.+||+.||++||++.++++.|++++++.+.
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            11223457889999999999999999999999999999999987764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-48  Score=377.10  Aligned_cols=248  Identities=19%  Similarity=0.369  Sum_probs=220.0

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++....  ......+.+|+.+|++++||||+++++++.+...+++|||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            67999999999999999999874  6779999987542  3345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC--CCceEEcccccccccccCCccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~--~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      |++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.........
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  208 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  208 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence            99999999999876668999999999999999999999999999999999999974  5789999999998776655555


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCCcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ll~~c  347 (397)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .+.....+++++.+||.+|
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  288 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  288 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence            66899999999999999999999999999999999999999999888777766655433  2334457899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||.+|||+.++++
T Consensus       289 L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          289 LQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             cCCChhHCcCHHHHhh
Confidence            9999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-48  Score=373.18  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=201.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ...++|++.+.||+|+||.||++..  .++.||||++......   ...+.+|+.+++.++||||+++++++.....+|+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            4457899999999999999999998  4678999999765433   2457899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc--eEEcccccccccccCC
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSG  266 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~--vkl~DfG~a~~~~~~~  266 (397)
                      ||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999999999976 467999999999999999999999999999999999999987765  9999999998655555


Q ss_pred             cccCCCCCcccccccccCCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~ell~g~~P~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....    ......+............+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            5566789999999999988888766 8999999999999999999987543    2333333333333334446889999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +||.+||+.||.+|||+.++++
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          253 HLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHHh
Confidence            9999999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=365.40  Aligned_cols=257  Identities=35%  Similarity=0.679  Sum_probs=216.1

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++.++|++.+.||+|+||.||++++.++.||||++...    ...+.+.+|+.++++++||||+++++++.+  ..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            467789999999999999999999999999999998743    335679999999999999999999998874  48999


Q ss_pred             EEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCcEEeCCCCc-eEEcccccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQ---NNIIHRDLKAANLLMDENEV-VKVADFGVARVKA  263 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nili~~~~~-vkl~DfG~a~~~~  263 (397)
                      |||++|++|.+++.....  .++...++.++.|++.||.|||+   +||+||||||+||+++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999986432  47889999999999999999999   89999999999999998886 7999999997544


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...........++..+..+++.+.+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred             cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence            32  33456999999999999999999999999999999999999999865432 2223334455567777889999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ++.+||+.||.+|||+.++++.|+++.+....
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            99999999999999999999999999776654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-48  Score=371.72  Aligned_cols=259  Identities=28%  Similarity=0.564  Sum_probs=219.5

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--Ccc----eEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+..++|++.+.||+|+||.||+|.+.  ++.    ||+|.+..... ......+.+|+.++++++||||+++++++.. 
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            456688999999999999999999874  333    77887754322 2223457789999999999999999998864 


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ...++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            56899999999999999998766789999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          264 QSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       264 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +....++..+..++++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-LEKGERLAQPQICTID  245 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-HHTTCBCCCCTTBCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCCCcCcHH
Confidence            432   2334567889999999998899999999999999999999 9999998776555443 4455566777888999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +.+++.+||+.||.+||++.++++.|+.+...
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999999988653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-48  Score=371.03  Aligned_cols=257  Identities=21%  Similarity=0.319  Sum_probs=217.4

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  188 (397)
                      ..++|++.+.||+|+||.||+|..  .++.||||++......    ..+.+|+.+++++ +||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            347899999999999999999986  5678999998755332    3478899999999 89999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc-----eEEcccccccccc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARVKA  263 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~-----vkl~DfG~a~~~~  263 (397)
                      ||||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++...
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 99999999887788999999999999999999999999999999999999998887     9999999998654


Q ss_pred             cCCc--------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCC--
Q 015965          264 QSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRP--  330 (397)
Q Consensus       264 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~--  330 (397)
                      ....        .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.   .+....+.......  
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            4322        2456899999999999999999999999999999999999999987543   22222222211111  


Q ss_pred             -CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          331 -TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       331 -~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                       .....+| ++.+++.+||+.||.+||++.++++.|+++.++.+.
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence             1123355 999999999999999999999999999999988764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.5e-49  Score=377.98  Aligned_cols=246  Identities=29%  Similarity=0.496  Sum_probs=212.5

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||||++...... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999998  5678999998743211 112356889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~  166 (336)
T 3h4j_B           89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT  166 (336)
T ss_dssp             CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred             ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence            999 7899999876 46799999999999999999999999999999999999999999999999999987776666677


Q ss_pred             CCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+  .......|..+++++.+||.+||+
T Consensus       167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~  244 (336)
T 3h4j_B          167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIV  244 (336)
T ss_dssp             CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred             ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHcC
Confidence            789999999999988876 68999999999999999999999765433221111  112345677889999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||.+|||+.|+++
T Consensus       245 ~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          245 ADPMQRITIQEIRR  258 (336)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             CChhHCcCHHHHHh
Confidence            99999999999974

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.3e-48  Score=366.96  Aligned_cols=262  Identities=29%  Similarity=0.551  Sum_probs=223.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .++...|+++++||+|+||.||++.+      .++.||||+++... .......+.+|+.++++++||||+++++++.+.
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            34545569999999999999999876      45779999998653 445567799999999999999999999999874


Q ss_pred             --CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          184 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       184 --~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                        ..+++||||+++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence              568999999999999999976  4599999999999999999999999999999999999999999999999999987


Q ss_pred             cccCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHh
Q 015965          262 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--------------QAAVGV  323 (397)
Q Consensus       262 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~--------------~~~~~~  323 (397)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......              ......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            65432    223446888999999999988999999999999999999999999653221              122334


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       324 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      +........+..+++++.+|+.+||+.||.+|||+.++++.|+++.+....
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            455667778889999999999999999999999999999999999887764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-47  Score=358.74  Aligned_cols=258  Identities=31%  Similarity=0.584  Sum_probs=220.9

Q ss_pred             cccccceeeeeCCceEEEEEECC--c---ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce-EE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL-CI  188 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~--~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l  188 (397)
                      .|++.++||+|+||.||+|.+.+  +   .||+|+++... .....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            46677999999999999998632  2   59999987543 344567899999999999999999999999876655 99


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC---
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---  265 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~---  265 (397)
                      ||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....   
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            99999999999999876778999999999999999999999999999999999999999999999999999754332   


Q ss_pred             --CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          266 --GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       266 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                        .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+... ..........+..+++.+.+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-HHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-HhhcCCCCCCCccchHHHHH
Confidence              22334567899999999999999999999999999999999 555666666554443 34455566677889999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ++.+||+.||.+|||+.++++.|+++++++..
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999988753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-48  Score=366.78  Aligned_cols=259  Identities=30%  Similarity=0.608  Sum_probs=217.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--Ccc----eEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+..++|++.++||+|+||.||+|.+.  ++.    ||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            456688999999999999999999874  444    4777766443 223357789999999999999999999999875


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      . .++|+||+.+++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 889999999999999998877889999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          264 QSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       264 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+... .+........+..++++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence            4322   223456889999999999999999999999999999999 999999887665544 34555566778889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +.+++.+||+.||.+||++.++++.|+++...
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            99999999999999999999999999999743

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=371.90  Aligned_cols=248  Identities=21%  Similarity=0.350  Sum_probs=214.2

Q ss_pred             cceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          119 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      .+.||+|+||.||+|..  .++.||+|+++...  ....+.+.+|+.++++++||||+++++++...+.+++||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            56899999999999987  46789999998643  344577999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe--CCCCceEEcccccccccccCCcccCCCCC
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGT  274 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili--~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  274 (397)
                      +|.+++......+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++............||
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt  251 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT  251 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSS
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCC
Confidence            9999998766779999999999999999999999999999999999999  56789999999999877666556667899


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHhchhCC
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQQDP  352 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl~~dp  352 (397)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........  ....+++++.+||.+||+.||
T Consensus       252 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  331 (373)
T 2x4f_A          252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK  331 (373)
T ss_dssp             CTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSG
T ss_pred             CcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCCh
Confidence            999999999999999999999999999999999999999888777777666543322  235688999999999999999


Q ss_pred             CCCCCHHHHHH--HHHHH
Q 015965          353 ALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       353 ~~Rps~~ell~--~L~~l  368 (397)
                      .+|||+.++++  .|.+.
T Consensus       332 ~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          332 SWRISASEALKHPWLSDH  349 (373)
T ss_dssp             GGSCCHHHHHHSHHHHCH
T ss_pred             hhCCCHHHHhcCcCcCCC
Confidence            99999999986  55544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.7e-48  Score=360.05  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=204.6

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      +++..++|++.+.||+|+||.||++.+  .++.||||+++.........+.+.++...++.++||||+++++++...+..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            467789999999999999999999998  577899999987654444445566666678899999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ++||||++ ++|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999996 588888754   356799999999999999999999998 9999999999999999999999999999876


Q ss_pred             ccCCcccCCCCCccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhhcCCCCCCCCCCc
Q 015965          263 AQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      ..........||+.|+|||++    .+..++.++||||||+++|+|++|..||... .+................+..++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            665555566899999999996    5667899999999999999999999999874 44455555555554444556789


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            99999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-47  Score=396.32  Aligned_cols=263  Identities=29%  Similarity=0.542  Sum_probs=224.8

Q ss_pred             ccccCcccccccc-eeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          108 VWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       108 ~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      .|.++...+.+.. +||+|+||.||+|.+.    ++.||||+++.........+++.+|+.+|++++|||||++++++..
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3555555565544 7999999999999763    3569999998766555567889999999999999999999999975


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                       ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       442 -~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          442 -ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             -CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence             458999999999999999976 567999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          263 AQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       263 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      ....    ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+.... +..+.++..+..++
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  598 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCP  598 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCC
Confidence            4432    1223356889999999999999999999999999999998 9999999887665544 45566777888999


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      +++.+||.+||+.||++||++.++++.|+++..++.
T Consensus       599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          599 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999999987764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-48  Score=369.16  Aligned_cols=262  Identities=32%  Similarity=0.598  Sum_probs=223.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--Ccc--eEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD--VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  184 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  184 (397)
                      .++.++|++.+.||+|+||.||+|.+.  +..  +|+|.++... .......+.+|+.+++++ +||||+++++++...+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            466789999999999999999999864  443  5999887532 333456789999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      ..|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997643               4699999999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCC
Q 015965          250 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~  328 (397)
                      .+||+|||+++............+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~  258 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY  258 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hhcCC
Confidence            999999999975444333445567899999999998889999999999999999998 9999998887665554 44455


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ++..+..+++++.+++.+||+.||.+|||+.++++.|++++.+..
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            666778899999999999999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.7e-49  Score=387.96  Aligned_cols=254  Identities=19%  Similarity=0.327  Sum_probs=218.1

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.++||+|+||+||+|++.  ++.||||+++..... ......+.+|+.+++.++||||+++++++.+...+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            455688999999999999999999985  467999998742111 11123378899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||++||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            99999999999999998867889999999999999999999999999999999999999999999999999997655443


Q ss_pred             c--ccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---CCCCCCC
Q 015965          267 V--MTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS  336 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~  336 (397)
                      .  ....+||+.|+|||++.     ...|+.++|||||||++|||++|..||...+..+....++....+   |.....+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence            3  23468999999999986     567899999999999999999999999999888877777654322   3333458


Q ss_pred             cHHHHHHHHHhchhCCCC--CCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPAL--RPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~--Rps~~ell~  363 (397)
                      ++++.+||.+||..+|++  ||++.++++
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            999999999999888887  999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-47  Score=360.76  Aligned_cols=258  Identities=31%  Similarity=0.565  Sum_probs=219.8

Q ss_pred             ccccccceeeeeCCceEEEEEECCc-----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe-cCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~  187 (397)
                      .+|++.++||+|+||.||+|.+...     .+|+|.++... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            5688999999999999999986432     38999987543 4455678999999999999999999999864 456789


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      +||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            9999999999999998767789999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          267 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                          ......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+. ....+..+..+++.+.
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  262 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLY  262 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHH
Confidence                2234467889999999999999999999999999999999 777887776655554433 3445566788899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      +++.+||+.||.+|||+.++++.|++++.++.
T Consensus       263 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            99999999999999999999999999988654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-48  Score=371.80  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=215.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ...++|++.+.||+|+||.||+|.+. ++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            34578999999999999999999874 6789999987653  33457799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          190 TEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      |||+++++|.+++....   ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... 
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999986542   35899999999999999999999999999999999999999999999999999764332 


Q ss_pred             --CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHhhh---------cCC
Q 015965          266 --GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA------AVGVVQ---------KGL  328 (397)
Q Consensus       266 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~------~~~~~~---------~~~  328 (397)
                        .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+.      ......         ...
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL  273 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred             ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence              122344689999999999888999999999999999999999999975443211      111010         111


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      ....+..+++.+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            1223334567899999999999999999999999999998753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-48  Score=364.88  Aligned_cols=256  Identities=27%  Similarity=0.478  Sum_probs=216.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  180 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  180 (397)
                      ++..++|++.+.||+|+||.||+|.+..         ..||+|+++...  ....+.+.+|+.++++++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            5677899999999999999999997643         459999987542  33457799999999999999999999999


Q ss_pred             ecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc--------eE
Q 015965          181 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VK  252 (397)
Q Consensus       181 ~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~--------vk  252 (397)
                      ..++..++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999999999886666999999999999999999999999999999999999998887        99


Q ss_pred             EcccccccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCC
Q 015965          253 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP  330 (397)
Q Consensus       253 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~  330 (397)
                      |+|||++......   ....||+.|+|||++.+ ..++.++||||||+++|+|++ |.+||........... ...  ..
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~--~~  235 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YED--RH  235 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHT--TC
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhc--cC
Confidence            9999998654332   23357889999999987 779999999999999999999 5666666555443332 222  34


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ..+...++++.+++.+||+.||.+|||+.++++.|+++++..+
T Consensus       236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            5566778899999999999999999999999999999977544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-48  Score=364.27  Aligned_cols=247  Identities=22%  Similarity=0.269  Sum_probs=206.8

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  188 (397)
                      -.++|++.++||+|+||+||+|.+.  ++.||||++............+..|+..+.++ +||||+++++++.+.+.+|+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3478999999999999999999984  67899999887655555555566666665554 89999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      ||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence            99999 78999999887778999999999999999999999999999999999999999999999999999877666566


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|..|+.....   ...+......+..+..+++++.+++.+||
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L  289 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMML  289 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence            66789999999999986 699999999999999999999666544322   22233333334455678999999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      +.||++|||+.++++
T Consensus       290 ~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          290 EPDPKLRATAEALLA  304 (311)
T ss_dssp             CSSTTTSCCHHHHHT
T ss_pred             CCChhhCcCHHHHHh
Confidence            999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.4e-49  Score=384.42  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=216.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.++||+|+||.||++++.  ++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            456688999999999999999999984  56799999864211 011123478899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||++||+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            999999999999999975  569999999999999999999999999999999999999999999999999998765543


Q ss_pred             c--ccCCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCCcH
Q 015965          267 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQP  338 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  338 (397)
                      .  ....+||+.|+|||++.+..    |+.++|||||||++|||++|..||...+..+....++....  ..+....+++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence            2  34668999999999997765    78999999999999999999999999888887777765432  2223347899


Q ss_pred             HHHHHHHHhchhCCCC--CCCHHHHHH
Q 015965          339 KLAELLERCWQQDPAL--RPDFSEIIE  363 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~--Rps~~ell~  363 (397)
                      ++.+||.+||..+|.+  ||++.++++
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            9999999999988988  999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-48  Score=375.89  Aligned_cols=259  Identities=30%  Similarity=0.554  Sum_probs=213.9

Q ss_pred             ccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-CCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  187 (397)
                      ..|++.+.||+|+||.||+|++.+     ..||+|.++... .....+.+.+|+.++++++||||+++++++.. ++..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            357788999999999999998632     248999987543 34556789999999999999999999998754 46789


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-  266 (397)
                      +||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999999999998766778999999999999999999999999999999999999999999999999997554322 


Q ss_pred             ----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          267 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       267 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                          ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+..+....+ ..+.++..+..+++.+.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHH
Confidence                1233457889999999999999999999999999999999 78899877665554443 34446667788999999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          342 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      +++.+||+.||++|||+.++++.|++++..+..
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999887653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-48  Score=393.27  Aligned_cols=262  Identities=36%  Similarity=0.660  Sum_probs=230.6

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+.|++..++|++.++||+|+||.||+|.+.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.+ .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            46799999999999999999999999999875 56999999875433   3578999999999999999999999876 6


Q ss_pred             ceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      .+||||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            789999999999999999754 3568999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...  ......++..|+|||++.+..++.++||||||++||||++ |..||......+.... +..+.+...+..+++++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL  493 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            321  1223456789999999998899999999999999999999 9999999887766555 44566777788999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+||.+||+.||++|||+.+|++.|++++...
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            99999999999999999999999999886544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.1e-48  Score=361.44  Aligned_cols=261  Identities=32%  Similarity=0.624  Sum_probs=219.2

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC---c--ceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      ..+..++|++.+.||+|+||.||+|++..   +  .||||+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            35677899999999999999999998632   2  489999886543 33556789999999999999999999999987


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +. .++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            54 89999999999999999887778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          263 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       263 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+......+..+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            54322    223457889999999998889999999999999999999 9999999988888777777666777778899


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      +++.+++.+||+.||.+|||+.++++.|+++..
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            999999999999999999999999999988754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.2e-48  Score=372.90  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=210.1

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC---ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      .++|++.+.||+|+||.||++.+.  ++.||||+++....   .....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            367999999999999999999874  67899999864211   1112467899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc---eEEcccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARV  261 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~---vkl~DfG~a~~  261 (397)
                      +||||++|++|.+++.+.   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999999888653   235899999999999999999999999999999999999986654   99999999987


Q ss_pred             cccCCc-ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcH
Q 015965          262 KAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQP  338 (397)
Q Consensus       262 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  338 (397)
                      ...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .+....+........  ....+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence            655433 345689999999999999999999999999999999999999998743 333334443322211  1256789


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+||.+||+.||++|||+.++++
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-47  Score=368.79  Aligned_cols=246  Identities=30%  Similarity=0.458  Sum_probs=217.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      +.|++.+.||+|+||.||+|..  .++.||||++...... ....+.+.+|+.++++++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4589999999999999999986  5678999999865433 344567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+. |+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....   ...
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~  209 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  209 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence            9996 689998877678899999999999999999999999999999999999999999999999999976543   235


Q ss_pred             CCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          271 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       271 ~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ..||+.|+|||++.   ...++.++||||||+++|+|++|..||...+..+....+.........+..+++.+.++|.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            67999999999984   567899999999999999999999999998887777776666555555677899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||++|||+.++++
T Consensus       290 l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             cccChhhCcCHHHHhh
Confidence            9999999999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=366.32  Aligned_cols=258  Identities=23%  Similarity=0.373  Sum_probs=214.4

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC--ce
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL  186 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~  186 (397)
                      +..++|++.+.||+|+||.||+|.+.  ++.||||+++...... ....+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            34578999999999999999999985  6789999998543222 2466789999999999999999999988765  78


Q ss_pred             EEEEEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe----CCCCceEEccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  260 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili----~~~~~vkl~DfG~a~  260 (397)
                      |+||||+++++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999999986433  38999999999999999999999999999999999999    778889999999998


Q ss_pred             ccccCCcccCCCCCcccccccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCC
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIE--------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGL  328 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~----~~~~~~~~~~~~  328 (397)
                      ............||+.|+|||++.        +..++.++|||||||++|+|++|..||.....    .+....+.....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            877666666778999999999985        57789999999999999999999999975432    233333332211


Q ss_pred             C-----------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          329 R-----------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       329 ~-----------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .                       ...+..+++.+.+++.+||+.||++|||+.|+++...+-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            0                       0122334678999999999999999999999988877653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=369.26  Aligned_cols=247  Identities=24%  Similarity=0.395  Sum_probs=197.1

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      -.++|++.+.||+|+||.||+|++.  ++.||||+++...    ..+.+.+|+.++++++||||+++++++......++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3467999999999999999999985  4679999998542    235688899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~~~~~  266 (397)
                      |||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++......
T Consensus       127 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          127 LELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             ECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            999999999999976 467999999999999999999999999999999999999975   8899999999998766555


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HhhhcCCC--CCCCCCCcHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLR--PTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~l~~l  343 (397)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+......  ......+++++.+|
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  285 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL  285 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence            5566789999999999999999999999999999999999999998766555333 33332222  22335688999999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      |.+||+.||++|||+.++++
T Consensus       286 i~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          286 VRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=382.30  Aligned_cols=253  Identities=17%  Similarity=0.301  Sum_probs=215.5

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||+++.  .++.||||++++... .......+.+|+.++..++||||+++++++.+...+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            45668899999999999999999998  467899999874321 111223478899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||++||+|.+++.+....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998766689999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--ccCCCCCcccccccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---CCCCCCC
Q 015965          267 V--MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---LRPTIPK  334 (397)
Q Consensus       267 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~---~~~~~~~  334 (397)
                      .  ....+||+.|+|||++.       ...|+.++|||||||++|||++|..||...+..+....++...   ..+..+.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            3  23458999999999986       4578999999999999999999999999988887777766432   2233446


Q ss_pred             CCcHHHHHHHHHhchhCCCCC---CCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALR---PDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~R---ps~~ell~  363 (397)
                      .+++++.+||.+||. +|.+|   |++.++++
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            799999999999999 99998   58888864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-48  Score=369.07  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=208.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            67999999999999999999874  67899999875432 2234668899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC---Ccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~---~~~  268 (397)
                      |++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            9999999999875 456999999999999999999999999999999999999999999999999999765432   223


Q ss_pred             cCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..................+++++.+|+.+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHH
Confidence            45689999999999987765 77899999999999999999999876554 22333333333333346788999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||.+|||+.|+++
T Consensus       245 ~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          245 ILVENPSARITIPDIKK  261 (323)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HccCChhhCcCHHHHhh
Confidence            99999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.8e-48  Score=384.96  Aligned_cols=250  Identities=26%  Similarity=0.521  Sum_probs=220.7

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|.+++.||+|+||.||+|.+.  ++.||||+++..... .+....+.+|+.+++.++||||+++++++.....+|
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34578999999999999999999874  788999998753211 123457889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999976 56799999999999999999999999999999999999999999999999999987766666


Q ss_pred             ccCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      ....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+...  ....|..+++++.+||.+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHHHH
Confidence            667789999999999988765 67999999999999999999999988776666665544  234567789999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||.+|||+.++++
T Consensus       250 ~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          250 MLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HcCCCchhCcCHHHHHh
Confidence            99999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.3e-48  Score=362.15  Aligned_cols=251  Identities=31%  Similarity=0.597  Sum_probs=205.4

Q ss_pred             cCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhc--CCCCCeeeeeeEEec----CC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTK----PP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~  184 (397)
                      +-.++|++.+.||+|+||.||+|++.++.||||++...     ....+.+|..++..  ++||||+++++++..    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            34578999999999999999999999999999998743     23445566666665  899999999998654    34


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                      ..++||||+++++|.++++.  ..+++..++.++.||+.||.|||        +.||+||||||+|||++.++.+||+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            58999999999999999964  57999999999999999999999        999999999999999999999999999


Q ss_pred             ccccccccCCc-----ccCCCCCcccccccccCCC------CCCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 015965          257 GVARVKAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTG----------KLPYEYLT  315 (397)
Q Consensus       257 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g----------~~P~~~~~  315 (397)
                      |+++.......     .....||+.|+|||++.+.      .++.++||||||+++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            99976554322     2334799999999999876      455789999999999999999          88886532


Q ss_pred             h----HHHHHH-hhhcCCCCCCCC-----CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          316 P----LQAAVG-VVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       316 ~----~~~~~~-~~~~~~~~~~~~-----~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      +    ...... ......++..+.     .+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2    222222 222333444442     2567899999999999999999999999999876

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.7e-47  Score=360.53  Aligned_cols=244  Identities=29%  Similarity=0.462  Sum_probs=213.0

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      .|...++||+|+||.||+|...  ++.||||+++.....  ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            3666789999999999999874  788999999765432  246788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~  271 (397)
                      ++|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus       124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999865  569999999999999999999999999999999999999999999999999997655432 34456


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHhch
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl~  349 (397)
                      .||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.... .+.  .+..+++++.+++.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHcc
Confidence            89999999999999999999999999999999999999999888776665544432 222  234578999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.++++
T Consensus       281 ~dp~~Rps~~ell~  294 (321)
T 2c30_A          281 RDPQERATAQELLD  294 (321)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.2e-47  Score=362.99  Aligned_cols=250  Identities=22%  Similarity=0.396  Sum_probs=219.1

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .++|++.+.||+|+||.||++.+.  ++.||+|+++......    ...+.+.+|+.++++++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            367999999999999999999884  6789999987654322    1356789999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC----ceEEccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVK  262 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~----~vkl~DfG~a~~~  262 (397)
                      ++||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999999999999976 56789999999999999999999999999999999999999887    7999999999877


Q ss_pred             ccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCCCCCcHHH
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKL  340 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  340 (397)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  +..+..+++.+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA  249 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence            6655556678999999999999999999999999999999999999999988877766655443222  11235688999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++.+||+.||++|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhc
Confidence            99999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=366.83  Aligned_cols=252  Identities=21%  Similarity=0.374  Sum_probs=214.3

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeeeEEecCCc
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPS  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~  185 (397)
                      ..+..++|++.+.||+|+||.||++.+. ++.||||+++...........+.+|+.+|++++|  |||+++++++.....
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            3567788999999999999999999874 5669999998776666677889999999999986  999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+|||+. +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus        84 ~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVMECG-NIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEECCC-SEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEeCC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99999954 8899999987 56799999999999999999999999999999999999997 678999999999865443


Q ss_pred             C---cccCCCCCcccccccccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCCCC
Q 015965          266 G---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRP  330 (397)
Q Consensus       266 ~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-~~~~~~~~~~~~~~~  330 (397)
                      .   ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||.... .......+.......
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            2   2335579999999999864           678899999999999999999999998754 334455555555666


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..+...++++.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            778888899999999999999999999999974

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-47  Score=372.33  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCC--ceE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SLC  187 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~  187 (397)
                      .++|++.+.||+|+||.||+|.+  .++.||||++............+.+|+.+++++. ||||+++++++..++  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            36899999999999999999987  4678999999876666666788899999999997 999999999997544  689


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc---
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---  264 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~---  264 (397)
                      +||||++ ++|.+++..  +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....   
T Consensus        88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9999996 699999876  5799999999999999999999999999999999999999999999999999975432   


Q ss_pred             -------------------CCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 015965          265 -------------------SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV  324 (397)
Q Consensus       265 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~  324 (397)
                                         .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               122344689999999999976 679999999999999999999999999888766655544


Q ss_pred             hcCCCCC---------------------------------------------CCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 015965          325 QKGLRPT---------------------------------------------IPKNSQPKLAELLERCWQQDPALRPDFS  359 (397)
Q Consensus       325 ~~~~~~~---------------------------------------------~~~~~~~~l~~ll~~cl~~dp~~Rps~~  359 (397)
                      .....|.                                             .+..+++++.+||.+||+.||.+|||+.
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            2211110                                             1236788999999999999999999999


Q ss_pred             HHHHH
Q 015965          360 EIIEI  364 (397)
Q Consensus       360 ell~~  364 (397)
                      |+++.
T Consensus       325 e~l~H  329 (388)
T 3oz6_A          325 DALKH  329 (388)
T ss_dssp             HHTTS
T ss_pred             HHhCC
Confidence            98753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-46  Score=356.26  Aligned_cols=263  Identities=21%  Similarity=0.420  Sum_probs=211.9

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCC-CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|++.+.||+|+||.||+|..  .++.||||+++... ........+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999987  46789999998643 3455667899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |||+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            9999999999998753   4568999999999999999999999999999999999999999999999999997654432


Q ss_pred             -cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||....  ..+....+......+..+..+++++.++
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  270 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  270 (310)
T ss_dssp             --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHH
T ss_pred             ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHH
Confidence             2334578999999999999999999999999999999999999997543  2333333333333444446789999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHHHHhchh
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIAKEVGEE  375 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~  375 (397)
                      +.+||+.||.+|||+.++++.|+++.......
T Consensus       271 i~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence            99999999999999999999999998776644

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=364.31  Aligned_cols=262  Identities=27%  Similarity=0.539  Sum_probs=223.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      .+..++|++++.||+|+||.||++++      .++.||||++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            56678899999999999999999985      4677999999864  345567899999999999999999999998764


Q ss_pred             C--ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          184 P--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       184 ~--~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      +  .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  78999999999999999988767799999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHHH
Q 015965          262 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---------------LQAAVG  322 (397)
Q Consensus       262 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---------------~~~~~~  322 (397)
                      ......    .....++..|+|||++.+..++.++||||||+++|+|++|..||.....               ......
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            654432    2234578889999999988899999999999999999999999863211               011223


Q ss_pred             hhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          323 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       323 ~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      .+....++..+..+++++.+++.+||+.||.+|||+.++++.|+++.+++.
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            344455666778899999999999999999999999999999999988764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-47  Score=353.45  Aligned_cols=246  Identities=24%  Similarity=0.406  Sum_probs=216.6

Q ss_pred             ccccccceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.+  ..||+|++.......  .+.+.+|+.++++++||||+++++++......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            679999999999999999999854  568999987643322  4678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili---~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.........
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence            9999999999876 4679999999999999999999999999999999999999   78899999999999877666666


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC--CCCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........  ...+++.+.+++.+
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR  244 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence            677899999999999765 899999999999999999999999998887777666554332221  12678999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||.+|||+.++++
T Consensus       245 ~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          245 LLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.9e-48  Score=364.90  Aligned_cols=256  Identities=27%  Similarity=0.450  Sum_probs=211.6

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce---
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL---  186 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  186 (397)
                      .++|++.+.||+|+||.||++.+  .++.||||+++.... .......+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36899999999999999999996  467899999987644 345567799999999999999999999998765543   


Q ss_pred             -EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          187 -CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       187 -~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                       |+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence             999999999999999986 467999999999999999999999999999999999999999999999999999765443


Q ss_pred             C----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHH
Q 015965          266 G----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPK  339 (397)
Q Consensus       266 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  339 (397)
                      .    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...........+.  ....++++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence            2    22334689999999999999999999999999999999999999999888777766665543322  23568899


Q ss_pred             HHHHHHHhchhCCCCCCCHH-HHHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFS-EIIEILQQIA  369 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~-ell~~L~~l~  369 (397)
                      +.+++.+||+.||.+||++. ++...|..+.
T Consensus       250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            99999999999999999655 4555565554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-47  Score=362.63  Aligned_cols=248  Identities=24%  Similarity=0.407  Sum_probs=197.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.++++++||||+++++++..++.+|+|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            57999999999999999999864  678999999765422 223568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          192 FMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      |++ ++|.+++....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            996 69999987643     45899999999999999999999999999999999999999999999999999865433 


Q ss_pred             CcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC----------------
Q 015965          266 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  328 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~----------------  328 (397)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....                
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence            23445689999999999976 4689999999999999999999999998887665554432110                


Q ss_pred             ----------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 ----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ----------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                      .+..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                            01122357889999999999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-47  Score=384.76  Aligned_cols=248  Identities=26%  Similarity=0.478  Sum_probs=216.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.++||+|+||+||++.+.  ++.||||+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            67999999999999999999984  6789999986533222235678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC---CCCceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~---~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++........
T Consensus       102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  180 (486)
T 3mwu_A          102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (486)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence            9999999999876 46799999999999999999999999999999999999995   4567999999999877666666


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+ .|+.++|||||||++|+|++|..||...+..+....+.........+  ..+++++.+||.+
T Consensus       181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  259 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK  259 (486)
T ss_dssp             -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred             CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence            67789999999999976 49999999999999999999999999988887777766654443333  4678999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||.+|||+.++++
T Consensus       260 ~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          260 MLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-47  Score=383.37  Aligned_cols=253  Identities=26%  Similarity=0.458  Sum_probs=216.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|+++++||+|+||.||+|.+.  +..||||+++...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            47999999999999999999984  6779999998765444345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++........
T Consensus       117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            9999999999876 467999999999999999999999999999999999999976   455999999999887766666


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+ .|+.++|||||||++|+|++|..||...+..+....+.........+  ..+++++.+||.+
T Consensus       196 ~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            77789999999999874 59999999999999999999999999998887777766654443322  5689999999999


Q ss_pred             hchhCCCCCCCHHHHHH--HHHHH
Q 015965          347 CWQQDPALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~--~L~~l  368 (397)
                      ||+.||.+|||+.++++  .|++.
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HCCCChhhCccHHHHhcCcccccC
Confidence            99999999999999984  35444

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=359.38  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999985  6789999998776666667788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            9999999988765 567999999999999999999999999999999999999999999999999999865533 33445


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-------------------CCCC
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------GLRP  330 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~-------------------~~~~  330 (397)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...                   ....
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            679999999999875 66899999999999999999999999988776554433221                   0000


Q ss_pred             CC----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 TI----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ~~----------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..          ...+++++.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00          1357889999999999999999999999974

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6e-47  Score=354.03  Aligned_cols=248  Identities=23%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|.+.++||+|+||.||++...  +..+|+|++....... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            67999999999999999999874  5779999987654322 25678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCceEEcccccccccccC
Q 015965          192 FMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       192 ~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili---~~~~~vkl~DfG~a~~~~~~  265 (397)
                      |+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            99999999998643   3679999999999999999999999999999999999999   45678999999999876665


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-CCCCCCcHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLAELL  344 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ll  344 (397)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+............ .....+++++.+++
T Consensus       181 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL  259 (285)
T ss_dssp             ------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred             ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence            55666789999999999864 58999999999999999999999999888766655544433222 22244789999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||+.||.+|||+.|+++
T Consensus       260 ~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          260 KQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.3e-47  Score=370.98  Aligned_cols=252  Identities=21%  Similarity=0.375  Sum_probs=214.5

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC--CCCeeeeeeEEecCCc
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS  185 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  185 (397)
                      ..+...+|++.+.||+|+||.||++.+. ++.||||++............+.+|+.+|++++  ||||+++++++...+.
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            4566678999999999999999999874 567999999877666667788999999999997  5999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus       131 ~~lv~E~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          131 IYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEEEC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEEec-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9999994 58899999987 45789999999999999999999999999999999999996 589999999999865443


Q ss_pred             C---cccCCCCCcccccccccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCCCC
Q 015965          266 G---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRP  330 (397)
Q Consensus       266 ~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-~~~~~~~~~~~~~~~  330 (397)
                      .   .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.... .......++......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            2   2345679999999999865           368899999999999999999999998754 334555555555566


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..+...++++.+||.+||+.||.+|||+.++++
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            677778899999999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.7e-47  Score=361.56  Aligned_cols=262  Identities=30%  Similarity=0.559  Sum_probs=222.6

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE-------CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      .++..++|++.+.||+|+||.||+|++       .++.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            467788999999999999999999984       34569999997443 4445667999999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceE
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVK  252 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vk  252 (397)
                      .....|+||||+++++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.   +..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753      35889999999999999999999999999999999999984   44699


Q ss_pred             EcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCC
Q 015965          253 VADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       253 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~  328 (397)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~  262 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSGG  262 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTTC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-HhcCC
Confidence            99999997543322   2233467899999999988899999999999999999998 9999998876655444 44455


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+..+..+++.+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            66778889999999999999999999999999999999886643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.4e-47  Score=353.25  Aligned_cols=254  Identities=24%  Similarity=0.450  Sum_probs=215.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++......    ...+.+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999985  6789999987654322    13567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC----ceEEcccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  263 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~----~vkl~DfG~a~~~~  263 (397)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999976 46799999999999999999999999999999999999998877    89999999998766


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCCCCCcHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA  341 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~  341 (397)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  +..+..+++.+.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            555555667999999999999999999999999999999999999999988877666554433221  112356789999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~--~L~~l  368 (397)
                      +++.+||..||.+|||+.++++  .++++
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999986  45554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=360.89  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=208.3

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC---ChHHHHHHHHHHHHHhcCC---CCCeeeeeeEEec
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK  182 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  182 (397)
                      +..++|++.++||+|+||+||+|.+  .++.||||+++....   .......+.+|+.+++.++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3457899999999999999999985  567899999874321   1111234566777776664   9999999999977


Q ss_pred             CC-----ceEEEEEeccCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          183 PP-----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       183 ~~-----~~~lv~E~~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                      ..     .+++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     4799999995 699999987533 4999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC-----
Q 015965          257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-----  331 (397)
Q Consensus       257 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~-----  331 (397)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+.     
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            999877666666677899999999999999999999999999999999999999998887776665543211110     


Q ss_pred             --------------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 --------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 --------------------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                          ....+++++.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                11357889999999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.5e-47  Score=382.28  Aligned_cols=249  Identities=24%  Similarity=0.429  Sum_probs=215.7

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh-----------HHHHHHHHHHHHHhcCCCCCeeeeeeE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-----------DMQKEFAQEVFIMRKVRHKNVVQFIGA  179 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~~  179 (397)
                      .++|+++++||+|+||+||+|.+.  ++.||||+++......           ...+.+.+|+.+|++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            367999999999999999999974  5779999997654321           234678899999999999999999999


Q ss_pred             EecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ceEEccc
Q 015965          180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADF  256 (397)
Q Consensus       180 ~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~vkl~Df  256 (397)
                      +.+...+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999976 46799999999999999999999999999999999999998776   6999999


Q ss_pred             ccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC--CC
Q 015965          257 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PK  334 (397)
Q Consensus       257 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~  334 (397)
                      |+++............||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+.........  ..
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            99988776666677789999999999875 5899999999999999999999999998888777776655433222  25


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++++.+||.+||+.||.+|||+.++++
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            78899999999999999999999999974

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-47  Score=363.42  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=202.1

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ..++|++.++||+|+||.||++.+  .++.||||+++...........+.+|+.++++++||||+++++++.....+|+|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            346899999999999999999986  467899999987665555567788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-----CCCceEEccccccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-----ENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-----~~~~vkl~DfG~a~~~~~  264 (397)
                      |||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++....
T Consensus       112 ~e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            99996 599999987 45799999999999999999999999999999999999994     455699999999986543


Q ss_pred             C-CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC----------
Q 015965          265 S-GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI----------  332 (397)
Q Consensus       265 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~----------  332 (397)
                      . .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+......+..          
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            3 334456789999999999774 4899999999999999999999999988877766665443111110          


Q ss_pred             ------------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          333 ------------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       333 ------------------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                        +..+++++.+||.+||+.||.+|||+.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                              0116789999999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.5e-47  Score=354.13  Aligned_cols=250  Identities=26%  Similarity=0.464  Sum_probs=214.2

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|++.+.||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.++++++||||+++++++.+....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            34578999999999999999999885  456999998643211 122456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus        86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence            99999999999999987 467999999999999999999999999999999999999999999999999998654332 3


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...  ....+..+++.+.+|+.+|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHH
Confidence            34567999999999999999999999999999999999999999988877666555443  3456778899999999999


Q ss_pred             chhCCCCCCCHHHHHHH
Q 015965          348 WQQDPALRPDFSEIIEI  364 (397)
Q Consensus       348 l~~dp~~Rps~~ell~~  364 (397)
                      |+.||.+|||+.++++.
T Consensus       242 l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCSSGGGSCCHHHHHHC
T ss_pred             hccChhhCCCHHHHhhC
Confidence            99999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7e-47  Score=361.88  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=220.0

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ..++|.+.+.||+|+||.||++.+.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3468999999999999999999985  56799999876533 34556778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cc
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GV  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~  267 (397)
                      ||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       119 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          119 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            9999999999999876 467999999999999999999999999999999999999999999999999999865433 23


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...  ....+..+++.+.++|.+|
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHH
Confidence            44567999999999999999999999999999999999999999988776666555544  3346778899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||++|||+.++++
T Consensus       276 l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          276 LQTDPTARPTINELLN  291 (335)
T ss_dssp             TCSSGGGSCCGGGGGG
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.3e-47  Score=383.06  Aligned_cols=250  Identities=24%  Similarity=0.450  Sum_probs=221.3

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      -.++|++.++||+|+||.||++..  .++.||||++...... ......+.+|+.++++++||||+++++++......|+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            346899999999999999999988  4678999998765432 2345678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCceEEcccccccccccC
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili---~~~~~vkl~DfG~a~~~~~~  265 (397)
                      ||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       104 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            9999999999999976 5679999999999999999999999999999999999999   56789999999999877666


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAEL  343 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l  343 (397)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+.........+  ..+++++.+|
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  261 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL  261 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence            66666789999999999976 59999999999999999999999999998888777776665443333  4688999999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      |.+||+.||.+|||+.++++
T Consensus       262 i~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          262 IRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHCCCChhHCcCHHHHhh
Confidence            99999999999999999974

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.8e-47  Score=380.28  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=204.3

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      .++|+++++||+|+||.||+|.+.  ++.||||++..........+.+.+|+.+|+.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999874  677999999876556666788999999999999999999999997654      


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+|+||||+++ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            46999999965 5776664   3589999999999999999999999999999999999999999999999999988776


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------  330 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--------------  330 (397)
                      .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....++.....+              
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            666777899999999999999999999999999999999999999999888766655544321111              


Q ss_pred             ------CCC---------CC-----------CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ------TIP---------KN-----------SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ------~~~---------~~-----------~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                            ...         ..           .++++.+||.+||..||++|||+.|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  000         00           1567999999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-46  Score=375.92  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----  182 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----  182 (397)
                      |.+. ++|++++.||+|+||.||+|.+  .++.||||++..........+.+.+|+.+|++++||||+++++++..    
T Consensus        49 ~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           49 WQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             CccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            4443 6899999999999999999976  46789999998766666667889999999999999999999999843    


Q ss_pred             -CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          183 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       183 -~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                       ...+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             cCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence             35689999998 6799999976 56799999999999999999999999999999999999999999999999999986


Q ss_pred             cccC----------------------------CcccCCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHh------
Q 015965          262 KAQS----------------------------GVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT------  306 (397)
Q Consensus       262 ~~~~----------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~------  306 (397)
                      ....                            ......+||+.|+|||++ .+..|+.++|||||||+||||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            5422                            123455789999999986 56679999999999999999998      


Q ss_pred             -----CCCCCCCCChH--------------------HHHHHhhh----------------------cCCC-------CCC
Q 015965          307 -----GKLPYEYLTPL--------------------QAAVGVVQ----------------------KGLR-------PTI  332 (397)
Q Consensus       307 -----g~~P~~~~~~~--------------------~~~~~~~~----------------------~~~~-------~~~  332 (397)
                           |.++|.+.+..                    .....+..                      ....       ...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 67777654310                    11111100                      0000       011


Q ss_pred             CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          333 PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       333 ~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ...+++++.+||.+||..||.+|||+.|+++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            2356899999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-47  Score=358.23  Aligned_cols=259  Identities=18%  Similarity=0.314  Sum_probs=210.2

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|++.+.||+|+||.||++.+.  ++.||||+++.... .....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            368999999999999999999874  67799999976543 334457799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC--c
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V  267 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~--~  267 (397)
                      |||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  .
T Consensus       113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            999999999999986 4679999999999999999999999999999999999999999999999999997654432  2


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCCCCCcHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLE  345 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~  345 (397)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||........... ......  ...+..+++++.+++.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~  270 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTVRPGIPVAFDAVIA  270 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-HHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-hccCCCCccccCCCCCHHHHHHHH
Confidence            3355799999999999999999999999999999999999999987765433322 222221  2345678899999999


Q ss_pred             HhchhCCCCCC-CHHHHHHHHHHHHHHhc
Q 015965          346 RCWQQDPALRP-DFSEIIEILQQIAKEVG  373 (397)
Q Consensus       346 ~cl~~dp~~Rp-s~~ell~~L~~l~~~~~  373 (397)
                      +||+.||++|| ++.++++.|++++....
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            99999999999 99999999998865543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=364.51  Aligned_cols=250  Identities=28%  Similarity=0.411  Sum_probs=209.3

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-  184 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  184 (397)
                      .|++. ++|++.+.||+|+||.||+|.+  .++.||||++..........+.+.+|+.+++.++||||+++++++.... 
T Consensus        20 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           20 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             EECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            45553 6899999999999999999987  4678999999776656666788999999999999999999999997753 


Q ss_pred             -----ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          185 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       185 -----~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                           .+|+||||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence                 469999999 8899999976  67999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---------
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------  329 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---------  329 (397)
                      +....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......         
T Consensus       176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          176 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            86543  3456789999999999876 67999999999999999999999999988776655444321111         


Q ss_pred             --------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                          .......++.+.+|+.+||..||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                1123467899999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.5e-48  Score=369.73  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC-----CcceEEEEecCCCCChH---------HHHHHHHHHHHHhcCCCCCee
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSD---------MQKEFAQEVFIMRKVRHKNVV  174 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv  174 (397)
                      .++..++|++.+.||+|+||.||+|.+.     +..+|||++........         ....+.+|+.+++.++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            3566789999999999999999999984     46799999876532111         112366788999999999999


Q ss_pred             eeeeEEec----CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-
Q 015965          175 QFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-  249 (397)
Q Consensus       175 ~~~~~~~~----~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-  249 (397)
                      ++++++..    ....|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            99999887    67899999999 99999999764 4899999999999999999999999999999999999998877 


Q ss_pred             -ceEEcccccccccccCC--------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015965          250 -VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA  320 (397)
Q Consensus       250 -~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~  320 (397)
                       .+||+|||+++......        ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             99999999997654322        124557999999999999999999999999999999999999999653221111


Q ss_pred             HHhhhcCCCCCCC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          321 VGVVQKGLRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       321 ~~~~~~~~~~~~~---------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      .........+.++         ..+++++.+++.+||+.||++||++.++++.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111111111222         27889999999999999999999999999998875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-46  Score=350.84  Aligned_cols=251  Identities=29%  Similarity=0.542  Sum_probs=215.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----C
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----P  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~  183 (397)
                      ..+...|++.+.||+|+||.||+|.+.  +..||+|++..........+.+.+|+.++++++||||+++++++..    .
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            345567899999999999999999884  4669999998776667777889999999999999999999998865    3


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeC-CCCceEEccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVAR  260 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~-~~~~vkl~DfG~a~  260 (397)
                      ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            558999999999999999976 467999999999999999999999999  99999999999998 78999999999997


Q ss_pred             ccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHH
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPK  339 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  339 (397)
                      ..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||................. ....+...+++
T Consensus       181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            54433 3345679999999999875 489999999999999999999999988666555544444433 33455677899


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+++.+||+.||.+|||+.++++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhh
Confidence            999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.9e-47  Score=357.29  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=211.1

Q ss_pred             ccccceeeeeCCceEEEEEECCcceEEEEecCCC--CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          116 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      |..++.||+|+||.||+|.+.++.||||++....  ......+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            4556899999999999999999999999987543  23445678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC---cc
Q 015965          194 SGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM  268 (397)
Q Consensus       194 ~g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~---~~  268 (397)
                      ++++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......   ..
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            999999999754  3468999999999999999999999999999999999999999999999999997654322   12


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh---hhc----------CCCCCCCCC
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV---VQK----------GLRPTIPKN  335 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~---~~~----------~~~~~~~~~  335 (397)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+   ...          ...+..+..
T Consensus       193 ~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST  271 (307)
T ss_dssp             SSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred             cccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence            345799999999998764 889999999999999999999999765432211111   110          111223334


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      .++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            56789999999999999999999999999998743

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.6e-47  Score=353.70  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=216.9

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe--cCCceEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCI  188 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l  188 (397)
                      .++|++.+.||+|+||.||++.+.  ++.||+|++..........+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            368999999999999999999884  677999999877666667788999999999999999999999874  4567899


Q ss_pred             EEEeccCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEeCCCCceEEccccccc
Q 015965          189 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      ||||+++++|.+++....   ..+++..++.++.||+.||.|||+.|     |+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997642   35999999999999999999999999     9999999999999999999999999997


Q ss_pred             ccccCCc-ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          261 VKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       261 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .+..+..+..++++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDE  243 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccCHH
Confidence            6544321 234468999999999999899999999999999999999999999887766555443 34455677889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEIL  365 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L  365 (397)
                      +.+++.+||+.||.+|||+.++++.+
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            99999999999999999999998643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.6e-47  Score=353.97  Aligned_cols=256  Identities=26%  Similarity=0.385  Sum_probs=214.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE-ecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||||++......    ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            6899999999999999999996  5678999998765433    3578899999999998876666655 5667789999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC---CCCceEEcccccccccccCCc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~---~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999 9999999987677899999999999999999999999999999999999994   788999999999986554322


Q ss_pred             --------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCC---CCCCC
Q 015965          268 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGL---RPTIP  333 (397)
Q Consensus       268 --------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~---~~~~~  333 (397)
                              .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   .+....+.....   .+..+
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence                    2455799999999999999999999999999999999999999986432   122222222111   11234


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ..+++++.+++.+||+.||.+|||+.++++.|+++.++.+.
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            67889999999999999999999999999999999887754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-46  Score=389.17  Aligned_cols=263  Identities=32%  Similarity=0.601  Sum_probs=226.8

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      ..+++..++|++.+.||+|+||.||+|.+..     ..||||.++... .....+.+.+|+.++++++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4567888899999999999999999998843     348999987543 4455678999999999999999999999985


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      + +..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            4 568999999999999999987666799999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          262 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       262 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. .+.++..+..+++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~  619 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP  619 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCCH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccccH
Confidence            654322  223456789999999998899999999999999999997 999999888776665544 4456667889999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .+.+++.+||+.||.+|||+.++++.|++++++.
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.6e-47  Score=350.96  Aligned_cols=251  Identities=26%  Similarity=0.501  Sum_probs=209.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            345578999999999999999999884  77899999874321 112245788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999999976 4678999999999999999999999999999999999999999999999999998766555


Q ss_pred             cccCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                      ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+...  ....+..+++++.+++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHH
Confidence            5556689999999999988765 57999999999999999999999887776655554433  33466778999999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCCCHHHHHh
Confidence            999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=368.93  Aligned_cols=257  Identities=18%  Similarity=0.260  Sum_probs=213.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC----------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeee----
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC----------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ----  175 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----  175 (397)
                      ....++|++.+.||+|+||.||+|.+.          ++.||||++...       ..+.+|+.++++++||||++    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence            444689999999999999999999874          578999998754       35778999999999999887    


Q ss_pred             -----------eeeEEec-CCceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          176 -----------FIGACTK-PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       176 -----------~~~~~~~-~~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                                 +++++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                       5667665 67889999999 99999999875 3679999999999999999999999999999999999


Q ss_pred             EEeCCCC--ceEEcccccccccccCC--------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015965          243 LLMDENE--VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE  312 (397)
Q Consensus       243 ili~~~~--~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~  312 (397)
                      ||++.++  .+||+|||+++......        ......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  99999999997654332        1234479999999999999999999999999999999999999998


Q ss_pred             CCC-hHHHHHHhhhc--CCCCCCC------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          313 YLT-PLQAAVGVVQK--GLRPTIP------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       313 ~~~-~~~~~~~~~~~--~~~~~~~------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ... ...........  ...+...      ..+++++.+++.+||+.||.+|||+.++++.|++++++.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            764 22222222211  1111111      24689999999999999999999999999999999988764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.7e-47  Score=361.84  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=200.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-------
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  184 (397)
                      ++|++.+.||+|+||.||+|++.  ++.||||+++... .....+.+.+|+.+|++++||||+++++++.+.+       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            57899999999999999999984  6789999998654 3334677999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEEEeccCCCHHHHHHhcc--CCCCHH
Q 015965          185 --------------------------------------------------SLCIVTEFMSGGSVYDYLHKLK--GVFKLP  212 (397)
Q Consensus       185 --------------------------------------------------~~~lv~E~~~g~sL~~~l~~~~--~~l~~~  212 (397)
                                                                        ..++||||++|++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999998642  235566


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-------------cccCCCCCccccc
Q 015965          213 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-------------VMTAETGTYRWMA  279 (397)
Q Consensus       213 ~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-------------~~~~~~gt~~y~a  279 (397)
                      .++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......             ......||+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            789999999999999999999999999999999999999999999998665432             2334579999999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 015965          280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS  359 (397)
Q Consensus       280 PE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~  359 (397)
                      ||++.+..++.++||||||+++|+|++|..|+..   .............+......++++.+++.+||+.||.+|||+.
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence            9999999999999999999999999998776421   1111122222222223344567899999999999999999999


Q ss_pred             HHHH
Q 015965          360 EIIE  363 (397)
Q Consensus       360 ell~  363 (397)
                      ++++
T Consensus       322 ~~l~  325 (332)
T 3qd2_B          322 DIIE  325 (332)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            9975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-46  Score=351.44  Aligned_cols=248  Identities=26%  Similarity=0.445  Sum_probs=219.3

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|++.+.||+|+||.||++.+.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999985  56799999876543 345567789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Ccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~  268 (397)
                      |||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            999999999998876 467999999999999999999999999999999999999999999999999999865433 234


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...  ....+..+++.+.+++.+||
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  250 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML  250 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHHHHc
Confidence            4567999999999999999999999999999999999999999988876666555443  34567788999999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015965          349 QQDPALRPDFSEIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~ell~  363 (397)
                      +.||++|||+.++++
T Consensus       251 ~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          251 QTDPTARPTINELLN  265 (294)
T ss_dssp             CSSGGGSCCGGGGGG
T ss_pred             ccChhhCcCHHHHhh
Confidence            999999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=354.99  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=191.6

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|++  .++.||||++..... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5799999999999999999987  567899999864321 1122467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  170 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY  170 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence            999999999999876678999999999999999999999999999999999999999999999999999765432 2233


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...  ....+..+++++.+++.+||+
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  248 (278)
T 3cok_A          171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLSIEAKDLIHQLLR  248 (278)
T ss_dssp             ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSCHHHHHHHHHHSC
T ss_pred             eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccCHHHHHHHHHHcc
Confidence            457899999999999999999999999999999999999999876654444333322  234567789999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.++++
T Consensus       249 ~dp~~Rps~~~~l~  262 (278)
T 3cok_A          249 RNPADRLSLSSVLD  262 (278)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             cCHhhCCCHHHHhc
Confidence            99999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=364.62  Aligned_cols=260  Identities=27%  Similarity=0.456  Sum_probs=206.1

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHH--HhcCCCCCeeeeeeEEec----
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI--MRKVRHKNVVQFIGACTK----  182 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~----  182 (397)
                      +.++.++|++.+.||+|+||.||+|++.++.||||+++...     ...+..|..+  +..++||||+++++.+..    
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            35677899999999999999999999999999999987432     2334444444  556899999999985532    


Q ss_pred             -CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEeCCCCceE
Q 015965          183 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVVK  252 (397)
Q Consensus       183 -~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~iiHrDlkp~Nili~~~~~vk  252 (397)
                       ...+++||||+++++|.+++..  ...++..++.++.||+.||.|||+.         ||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence             2357899999999999999976  4558899999999999999999999         999999999999999999999


Q ss_pred             EcccccccccccC---------CcccCCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCC-C
Q 015965          253 VADFGVARVKAQS---------GVMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLTGKLPYEYL-T  315 (397)
Q Consensus       253 l~DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~g~~P~~~~-~  315 (397)
                      |+|||+++.....         .......||+.|+|||++.+       ..++.++|||||||++|||++|..||... .
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999765432         12234579999999999977       45667899999999999999997665321 1


Q ss_pred             -----------------hHHHHHHhhhcCCCCCCCCC------CcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          316 -----------------PLQAAVGVVQKGLRPTIPKN------SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       316 -----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                                       .............++.++..      +++++.+||.+||+.||++|||+.++++.|++++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence                             11111222333445555544      3458999999999999999999999999999999877


Q ss_pred             chh
Q 015965          373 GEE  375 (397)
Q Consensus       373 ~~~  375 (397)
                      ...
T Consensus       321 ~~~  323 (336)
T 3g2f_A          321 ERN  323 (336)
T ss_dssp             CC-
T ss_pred             Hhc
Confidence            643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-46  Score=362.77  Aligned_cols=251  Identities=25%  Similarity=0.424  Sum_probs=213.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ++..++|++.+.||+|+||.||++.+.  ++.||+|+++... .....+.+.+|+.++++++||||+++++++...+..|
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            556688999999999999999999986  6789999998653 4555678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +||||++|++|.+++.. .+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999987 46799999999999999999999996 9999999999999999999999999999754332 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------------------
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-------------------------  321 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~-------------------------  321 (397)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...                         
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            2345579999999999999999999999999999999999999998765543221                         


Q ss_pred             -----------------HhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          322 -----------------GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       322 -----------------~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                       .+.........+..+++++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                             111122222223457899999999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.6e-47  Score=353.45  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=211.5

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEE-ecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||||++......    ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            6799999999999999999986  5678999987654322    3477899999999988877766655 6667789999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCceEEcccccccccccCCc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili---~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999 999999998777789999999999999999999999999999999999999   7889999999999986554322


Q ss_pred             --------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhhcCCC---CCCC
Q 015965          268 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLR---PTIP  333 (397)
Q Consensus       268 --------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---~~~~~~~~~~~~---~~~~  333 (397)
                              .....||+.|+|||++.+..++.++||||||+++|+|++|..||......   +....+......   +...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence                    23457999999999999999999999999999999999999999764322   222222222111   1223


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ..+++++.+++.+||+.||++|||+.++++.|++++++.+.
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            56789999999999999999999999999999999987763

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-47  Score=364.39  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=210.5

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCC---CChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|+++...   ......+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            378999999999999999999874  5679999986532   12344578999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc---------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 015965          188 IVTEFMSGGSVYDYLHKL---------------------------------------KGVFKLPSLLKVAIDVSKGMNYL  228 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~~l~~L  228 (397)
                      +||||++|++|.+++...                                       ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998521                                       11235778889999999999999


Q ss_pred             HhCCcccCCCCCCcEEeCCCC--ceEEcccccccccccCC-----cccCCCCCcccccccccCC--CCCCCchhHHHHHH
Q 015965          229 HQNNIIHRDLKAANLLMDENE--VVKVADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGI  299 (397)
Q Consensus       229 H~~~iiHrDlkp~Nili~~~~--~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~  299 (397)
                      |++||+||||||+||+++.++  .+||+|||+++......     ......||+.|+|||++.+  ..++.++||||||+
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  89999999998653321     2345679999999999965  67899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          300 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       300 ~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++|+|++|..||...+..+....+.........+  ..+++++.+||.+||+.||.+||++.++++
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999998888887777665543333  247899999999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=358.20  Aligned_cols=253  Identities=31%  Similarity=0.593  Sum_probs=207.9

Q ss_pred             cccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhc--CCCCCeeeeeeEEecC----Cce
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKP----PSL  186 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~  186 (397)
                      .++|++.+.||+|+||.||+|++.++.||||++....     ...+.+|..++..  ++||||+++++++...    ...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            4689999999999999999999999999999986431     2344455555554  4899999999999876    678


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEeCCCCceEEccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      |+||||+++++|.+++..  ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||+|||+
T Consensus       111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            999999999999999975  5799999999999999999999999        999999999999999999999999999


Q ss_pred             ccccccCCc-----ccCCCCCcccccccccCCCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 015965          259 ARVKAQSGV-----MTAETGTYRWMAPEVIEHKPYDHK------ADVFSFGIVLWELLTG----------KLPYEYLTP-  316 (397)
Q Consensus       259 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~~l~ell~g----------~~P~~~~~~-  316 (397)
                      ++.......     .....||+.|+|||++.+..++..      +||||||+++|||++|          ..||....+ 
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            975543322     224579999999999988777665      9999999999999999          777765322 


Q ss_pred             ----HHHHHHhhhcCCCCCCCC-----CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          317 ----LQAAVGVVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       317 ----~~~~~~~~~~~~~~~~~~-----~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                          ............++..+.     .+++++.+++.+||+.||.+|||+.++++.|+++.++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence                122222233444555543     56778999999999999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5e-47  Score=362.11  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=212.9

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      .+....++|++.+.||+|+||.||++.+.  ++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            34455689999999999999999999985  6789999998776666667778999999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      .|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999888887654 567999999999999999999999999999999999999999999999999999765443


Q ss_pred             -CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----------------
Q 015965          266 -GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------  327 (397)
Q Consensus       266 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~----------------  327 (397)
                       .......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....                
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             334456799999999999775 78999999999999999999999999887766554433210                


Q ss_pred             ---C-CCC---------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 ---L-RPT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ---~-~~~---------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                         . .+.         ....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0 000         11357899999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-46  Score=362.14  Aligned_cols=249  Identities=22%  Similarity=0.427  Sum_probs=216.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC--h----HHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCC
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN--S----DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  184 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  184 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++.....  .    ...+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            57999999999999999999984  788999999765421  1    2245688999999999 7999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..|+||||++|++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999976 46799999999999999999999999999999999999999999999999999987766


Q ss_pred             CCcccCCCCCcccccccccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCC
Q 015965          265 SGVMTAETGTYRWMAPEVIEH------KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNS  336 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~  336 (397)
                      ........||+.|+|||++.+      ..++.++||||||+++|+|++|..||...+.......+.........+  ..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            656667789999999999853      358889999999999999999999999887776666555544332222  467


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+.+++.+||+.||.+|||+.++++
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            889999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-46  Score=369.05  Aligned_cols=243  Identities=23%  Similarity=0.375  Sum_probs=195.1

Q ss_pred             cccccc-ceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHH-hcCCCCCeeeeeeEEec----CCc
Q 015965          114 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPS  185 (397)
Q Consensus       114 ~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~  185 (397)
                      ++|.+. +.||+|+||.||++.+.  ++.||||+++..       ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            456665 68999999999999884  677999998732       3466788876 45689999999998865    567


Q ss_pred             eEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV  261 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~  261 (397)
                      +|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            899999999999999998643 36999999999999999999999999999999999999997   78999999999987


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHhhhcCCCC--CCCCC
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ----AAVGVVQKGLRP--TIPKN  335 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~----~~~~~~~~~~~~--~~~~~  335 (397)
                      ..........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......    ....+.......  .....
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  293 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  293 (400)
T ss_dssp             CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred             cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence            665555667789999999999999999999999999999999999999997654321    222222222221  22256


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++++.+||.+||+.||++|||+.++++
T Consensus       294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          294 VSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.4e-48  Score=366.70  Aligned_cols=259  Identities=30%  Similarity=0.509  Sum_probs=211.4

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+.+..++|++.+.||+|+||.||+|.. .++.||||+++...... ....+.+|+.++++++||||+++++++..+...
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            4567778999999999999999999986 46789999988653221 123588999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999998643   3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccC--CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhc--------
Q 015965          261 VKAQS--GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQK--------  326 (397)
Q Consensus       261 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~----~~~~~~~~~~~--------  326 (397)
                      .....  .......||+.|+|||++.+..++.++||||||+++|+|++|..||....    ........+..        
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE  262 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence            65433  22344569999999999988889999999999999999999999995211    00001111111        


Q ss_pred             -----CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 015965          327 -----GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       327 -----~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~  367 (397)
                           ...+..+...++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                 11112223345789999999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=364.36  Aligned_cols=242  Identities=22%  Similarity=0.402  Sum_probs=210.7

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChH------HHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||||+++.......      ....+.+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            6799999999999999999986  467799999987643221      23457789999999999999999999999999


Q ss_pred             eEEEEEeccCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          186 LCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       186 ~~lv~E~~~g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            99999998766 99999976 46799999999999999999999999999999999999999999999999999987766


Q ss_pred             CCcccCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....      ...  .....+..+++++.+|
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE--AAIHPPYLVSKELMSL  254 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT--TCCCCSSCCCHHHHHH
T ss_pred             CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh--hccCCCcccCHHHHHH
Confidence            666666789999999999988876 7889999999999999999999976332      111  1234566789999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIEI  364 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~  364 (397)
                      +.+||+.||++|||+.++++.
T Consensus       255 i~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-46  Score=361.54  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=208.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-----CCCeeeeeeEEec
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----HKNVVQFIGACTK  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~  182 (397)
                      .+-.++|++.++||+|+||.||+|.+  .++.||||+++..   ......+..|+.+++.+.     ||||+++++++..
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            34457899999999999999999998  5677999999742   344566788999999986     9999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC--------------
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--------------  247 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~--------------  247 (397)
                      .+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 999999998653 45999999999999999999999999999999999999975              


Q ss_pred             -----------CCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015965          248 -----------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP  316 (397)
Q Consensus       248 -----------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~  316 (397)
                                 ++.+||+|||+++....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                       78999999999986443  23456899999999999999999999999999999999999999988776


Q ss_pred             HHHHHHhhhcCCCC------------------------CCC--------------------CCCcHHHHHHHHHhchhCC
Q 015965          317 LQAAVGVVQKGLRP------------------------TIP--------------------KNSQPKLAELLERCWQQDP  352 (397)
Q Consensus       317 ~~~~~~~~~~~~~~------------------------~~~--------------------~~~~~~l~~ll~~cl~~dp  352 (397)
                      .+....+.......                        ..+                    ...++.+.+||.+||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            55544332211000                        001                    1123778899999999999


Q ss_pred             CCCCCHHHHHH
Q 015965          353 ALRPDFSEIIE  363 (397)
Q Consensus       353 ~~Rps~~ell~  363 (397)
                      .+|||+.|+++
T Consensus       345 ~~Rpta~elL~  355 (360)
T 3llt_A          345 TLRPSPAELLK  355 (360)
T ss_dssp             GGSCCHHHHTT
T ss_pred             hhCCCHHHHhc
Confidence            99999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=360.80  Aligned_cols=261  Identities=21%  Similarity=0.355  Sum_probs=213.6

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe---
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT---  181 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---  181 (397)
                      ..+.++.++|++.+.||+|+||.||++..  .++.||||++...  .....+.+.+|+.++++++||||+++++++.   
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            45678889999999999999999999986  5678999998653  3455678999999999999999999999986   


Q ss_pred             -cCCceEEEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccc
Q 015965          182 -KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       182 -~~~~~~lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                       .....++||||+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence             334689999999999999999763   4679999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC----------cccCCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHh
Q 015965          258 VARVKAQSG----------VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGV  323 (397)
Q Consensus       258 ~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~P~~~~~~~-~~~~~~  323 (397)
                      +++......          ......||+.|+|||++.+..   ++.++||||||+++|+|++|..||...... ......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            987543211          112335799999999997654   788999999999999999999999532110 011122


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          324 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       324 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .........+..+++++.+++.+||+.||.+|||+.++++.|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            2333344455678999999999999999999999999999998874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.1e-47  Score=385.17  Aligned_cols=252  Identities=23%  Similarity=0.403  Sum_probs=216.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|++.+.||+|+||.||++..  +++.||||++..... .......+.+|+.+|++++||||+++++++.+...+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            5668899999999999999999988  467899999865321 1122456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997643 359999999999999999999999999999999999999999999999999998776665


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.....   .......+.. .....+..+++++.+|
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~~dL  419 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQARSL  419 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHHHHH
Confidence            56677999999999999999999999999999999999999999987532   2222222222 2445678899999999


Q ss_pred             HHHhchhCCCCCC-----CHHHHHH
Q 015965          344 LERCWQQDPALRP-----DFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rp-----s~~ell~  363 (397)
                      |.+||+.||.+||     ++.++++
T Consensus       420 I~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          420 CSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHhccCCHHHcCCCCCCCHHHHHh
Confidence            9999999999999     7888874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.8e-46  Score=348.33  Aligned_cols=243  Identities=23%  Similarity=0.381  Sum_probs=210.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++...........+.+|+..+..+ +||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67999999999999999999984  78899999987766666677889999999999 8999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-------------------
Q 015965          191 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------------  248 (397)
Q Consensus       191 E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-------------------  248 (397)
                      ||++|++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.+                   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999764   2679999999999999999999999999999999999999844                   


Q ss_pred             CceEEcccccccccccCCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC
Q 015965          249 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG  327 (397)
Q Consensus       249 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~  327 (397)
                      ..+||+|||.+......   ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+......    ......
T Consensus       171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~~~~  243 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----HEIRQG  243 (289)
T ss_dssp             CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----HHHHTT
T ss_pred             eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----HHHHcC
Confidence            47999999999765543   234699999999999766 5668999999999999999998877544322    223344


Q ss_pred             CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..+..+..+++++.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            556778889999999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=361.61  Aligned_cols=253  Identities=23%  Similarity=0.375  Sum_probs=205.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            57999999999999999999984  677999999754321 112245679999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            996 5999999887778999999999999999999999999999999999999999999999999999765433 23345


Q ss_pred             CCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC------------------
Q 015965          271 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------------  331 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~------------------  331 (397)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+.                  
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            578999999999876 5689999999999999999999999999887766555443211110                  


Q ss_pred             ----------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 015965          332 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       332 ----------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l  368 (397)
                                ....+++++.+||.+||+.||.+|||+.|+++  .|.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                      11346789999999999999999999999986  44444

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=360.36  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=206.9

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh---HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++......   .....+.+|+.++++++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            468999999999999999999874  6789999987643222   12346889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-C
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~  266 (397)
                      +||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999965 999999876677999999999999999999999999999999999999999999999999999865433 3


Q ss_pred             cccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--------------
Q 015965          267 VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------------  331 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--------------  331 (397)
                      ......||+.|+|||++.+. .++.++||||||+++|+|++|.+||...+..+....+......+.              
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            34556899999999999654 588999999999999999999999999887777666554211110              


Q ss_pred             ------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 ------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ------------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                  ....+++++.+||.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                        01456789999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=358.69  Aligned_cols=261  Identities=25%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEe--
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACT--  181 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--  181 (397)
                      ..+++...+|++.++||+|+||.||++.+  .++.||||++...  .......+.+|+.+++++. ||||+++++++.  
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            45678888999999999999999999998  6778999998644  3445677899999999996 999999999984  


Q ss_pred             ------cCCceEEEEEeccCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCce
Q 015965          182 ------KPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV  251 (397)
Q Consensus       182 ------~~~~~~lv~E~~~g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~~~~~v  251 (397)
                            ....+++||||+ +|+|.+++...  .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  334579999999 57999998753  457999999999999999999999999  9999999999999999999


Q ss_pred             EEcccccccccccCCcc-------------cCCCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015965          252 KVADFGVARVKAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT  315 (397)
Q Consensus       252 kl~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~  315 (397)
                      ||+|||+++........             ....||+.|+|||++   .+..++.++||||||+++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999865543211             144689999999998   56778899999999999999999999997654


Q ss_pred             hHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          316 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ....    .........+...++.+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus       258 ~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          258 KLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence            4332    333334445567778899999999999999999999999999999876554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-46  Score=350.64  Aligned_cols=250  Identities=23%  Similarity=0.430  Sum_probs=217.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||||++...... ......+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            345578999999999999999999985  456999998643211 11245688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      ++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            999999999999999987 467999999999999999999999999999999999999999999999999998654432 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...  ....+..+++++.+++.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCCCcCCHHHHHHHHH
Confidence            334567999999999999999999999999999999999999999988776666555443  345677889999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||.+||++.++++
T Consensus       246 ~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HSCSSGGGSCCHHHHHT
T ss_pred             HhhcCHhhCCCHHHHhh
Confidence            99999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-46  Score=350.72  Aligned_cols=248  Identities=33%  Similarity=0.583  Sum_probs=219.1

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .+.|++.+.||+|+||.||+|.+.  ++.||||+++..... ...+.+.+|+.++++++||||+++++++......|+||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            356999999999999999999874  678999999765432 33577899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-ccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~  269 (397)
                      ||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus       100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A          100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            99999999999865  679999999999999999999999999999999999999999999999999997655432 334


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhch
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+ .....+..+..+++.+.+++.+||+
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hcCCCCCCccccCHHHHHHHHHHcC
Confidence            567999999999999999999999999999999999999999988776655543 3444566778899999999999999


Q ss_pred             hCCCCCCCHHHHHHH
Q 015965          350 QDPALRPDFSEIIEI  364 (397)
Q Consensus       350 ~dp~~Rps~~ell~~  364 (397)
                      .||.+|||+.++++.
T Consensus       257 ~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          257 KEPSFRPTAKELLKH  271 (303)
T ss_dssp             SSGGGSCCHHHHTTC
T ss_pred             CChhhCcCHHHHhhC
Confidence            999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.8e-47  Score=360.01  Aligned_cols=251  Identities=20%  Similarity=0.375  Sum_probs=214.3

Q ss_pred             ccccccc-ceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEE
Q 015965          113 PKHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       113 ~~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  188 (397)
                      .+.|.+. +.||+|+||.||+|.+.  ++.||+|+++...........+.+|+.+++.+. ||||+++++++......++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            3567776 88999999999999885  678999999876555555678999999999995 6999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEccccccccccc
Q 015965          189 VTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQ  264 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~~~  264 (397)
                      ||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999988543 467999999999999999999999999999999999999987   78999999999987766


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--CCCCCCCCcHHHHH
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAE  342 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  342 (397)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....  .......+++.+.+
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            6555667899999999999999999999999999999999999999999888777666554433  33344678999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +|.+||+.||.+|||+.++++
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCChhhCcCHHHHhC
Confidence            999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-46  Score=351.83  Aligned_cols=246  Identities=24%  Similarity=0.456  Sum_probs=213.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||++++.  ++.||+|+++....  .....+.+|+.++++++||||+++++++......|+|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            67999999999999999999874  77899999985432  223568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili---~~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++..... ..
T Consensus        87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~  164 (304)
T 2jam_A           87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM  164 (304)
T ss_dssp             CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred             cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence            9999999999976 4679999999999999999999999999999999999999   77889999999999754432 23


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCCCCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  ...+..+++++.+++.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  244 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH  244 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence            3456899999999999999999999999999999999999999988877666665554332  23446789999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||..||.+|||+.++++
T Consensus       245 ~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          245 LLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHCSSTTTSCCHHHHHT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9e-47  Score=392.36  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=218.6

Q ss_pred             cccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCC
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  184 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  184 (397)
                      ..+..++|+++++||+|+||.||++.+.  ++.||||+++.... .......+..|..++..+ +||+|+++++++.+..
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            3566788999999999999999999985  46699999875321 112245678899999987 6999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+||||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999999987 46799999999999999999999999999999999999999999999999999986433


Q ss_pred             -CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          265 -SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       265 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                       .......+||+.|+|||++.+..|+.++||||||++||||++|..||...+..+....+....  ..+|..+++++.+|
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAI  572 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHH
Confidence             334556789999999999999999999999999999999999999999998888877776653  45778899999999


Q ss_pred             HHHhchhCCCCCCCH-----HHHHH
Q 015965          344 LERCWQQDPALRPDF-----SEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~-----~ell~  363 (397)
                      |.+||+.||.+||++     .++++
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhc
Confidence            999999999999987     66653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.7e-47  Score=351.31  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=212.8

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------  182 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  182 (397)
                      ..+|++.+.||+|+||.||+|.+.  ++.||+|+++...      ..+.+|+.++++++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            367999999999999999999985  7889999997543      346789999999999999999998754        


Q ss_pred             --------CCceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEE
Q 015965          183 --------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV  253 (397)
Q Consensus       183 --------~~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl  253 (397)
                              ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    34589999999999999999764 357999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC
Q 015965          254 ADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP  333 (397)
Q Consensus       254 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~  333 (397)
                      +|||+++............||+.|+|||++.+..++.++||||||+++|+|++|..||....  . ......   ....+
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~-~~~~~~---~~~~~  237 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--K-FFTDLR---DGIIS  237 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--H-HHHHHH---TTCCC
T ss_pred             CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--H-HHHHhh---ccccc
Confidence            99999987766655666789999999999999999999999999999999999998874221  1 111122   23356


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ..+++.+.+++.+||+.||.+|||+.++++.|..+.+...
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            6788999999999999999999999999999998865443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.6e-46  Score=360.69  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      .++|++.+.||+|+||.||+|.+  .++.||||++............+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999987  4677999999876656666778999999999999999999999997665      


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..|+||||++ ++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            6799999995 58888875   4589999999999999999999999999999999999999999999999999987665


Q ss_pred             CCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--------------
Q 015965          265 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------  330 (397)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--------------  330 (397)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+              
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            555566789999999999999999999999999999999999999999888766655544321111              


Q ss_pred             ------CC--------------CC------CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ------TI--------------PK------NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ------~~--------------~~------~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                            ..              +.      ..++++.+||.+||..||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                  00              00      11578999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-46  Score=349.64  Aligned_cols=249  Identities=26%  Similarity=0.476  Sum_probs=217.0

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.+.||+|+||.||++.+  .++.||||++............+.+|+.++++++||||+++++++......++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            36899999999999999999998  4678999998765444444677899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC---CceEEcccccccccccCCc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~---~~vkl~DfG~a~~~~~~~~  267 (397)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||+++.......
T Consensus       101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            99999999999876 4679999999999999999999999999999999999999754   4799999999987665544


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--CCCcHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLE  345 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~  345 (397)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........+  ..+++++.+++.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence            4555689999999999765 8999999999999999999999999888777666655544333332  568899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+|||+.++++
T Consensus       259 ~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          259 KMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcccChhhCcCHHHHhc
Confidence            999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-46  Score=359.29  Aligned_cols=254  Identities=30%  Similarity=0.601  Sum_probs=214.5

Q ss_pred             cccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhc--CCCCCeeeeeeEEecCC----ce
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL  186 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~  186 (397)
                      .++|++.+.||+|+||.||+|++.++.||||+++..     ....+.+|+.+++.  ++||||+++++++....    ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            478999999999999999999999999999998643     23567788888887  78999999999998876    78


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      |+||||+++++|.+++.+  ..+++..++.++.||+.||.|||        +.||+||||||+|||++.++.+||+|||+
T Consensus       116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            999999999999999976  56899999999999999999999        89999999999999999999999999999


Q ss_pred             ccccccCC-----cccCCCCCcccccccccCCCC------CCCchhHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 015965          259 ARVKAQSG-----VMTAETGTYRWMAPEVIEHKP------YDHKADVFSFGIVLWELLTG----------KLPYEYLTP-  316 (397)
Q Consensus       259 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g----------~~P~~~~~~-  316 (397)
                      ++......     ......||+.|+|||++.+..      ++.++||||||+++|+|++|          ..||....+ 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            97665443     234557999999999997652      33689999999999999999          789976432 


Q ss_pred             ----HHHHHHhhhcCCCCCCCC-----CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          317 ----LQAAVGVVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       317 ----~~~~~~~~~~~~~~~~~~-----~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                          ......+.....++.++.     .+++.+.+++.+||+.||.+|||+.++++.|+++.++.+
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence                233333344455555553     345689999999999999999999999999999987643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=375.85  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=215.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC--ce
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL  186 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~  186 (397)
                      ...++|++.++||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            34578999999999999999999985  678999999854322 22466789999999999999999999998755  67


Q ss_pred             EEEEEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe----CCCCceEEccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  260 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili----~~~~~vkl~DfG~a~  260 (397)
                      |+||||++|++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999999976432  39999999999999999999999999999999999999    777889999999998


Q ss_pred             ccccCCcccCCCCCcccccccccCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhcCC
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGL  328 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~ell~g~~P~~~~~----~~~~~~~~~~~~~  328 (397)
                      ............||+.|+|||++.+        ..++.++|||||||++|+|++|..||....    ..+....+.....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            7766666667789999999999865        567889999999999999999999996432    2333344333211


Q ss_pred             C-----------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          329 R-----------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       329 ~-----------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .                       ..++..+++.+.+++.+||+.||++||++.++++.++++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            0                       011123457899999999999999999999999999998764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=353.69  Aligned_cols=250  Identities=31%  Similarity=0.520  Sum_probs=209.7

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEec-----
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK-----  182 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----  182 (397)
                      ...++|++.+.||+|+||.||+|.+  .++.||||++......   ...+.+|+.+++++ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3457899999999999999999998  5788999998765332   35688999999998 79999999999876     


Q ss_pred             -CCceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          183 -PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       183 -~~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                       ...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             457899999999999999998643 579999999999999999999999999999999999999999999999999997


Q ss_pred             ccccC-CcccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCC
Q 015965          261 VKAQS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK  334 (397)
Q Consensus       261 ~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~  334 (397)
                      ..... .......||+.|+|||++.     +..++.++||||||+++|+|++|..||...........+.........+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            65432 2334557999999999986     56789999999999999999999999998888777666655554444567


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++.+.++|.+||..||.+||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            78999999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-46  Score=359.59  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=209.6

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-------
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------  183 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  183 (397)
                      .++|++.++||+|+||.||+|.+  .++.||||++............+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36899999999999999999998  467899999876655444456788999999999999999999998763       


Q ss_pred             -CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 -PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 -~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                       +.+|+||||++ ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence             46899999996 5888888776778999999999999999999999999999999999999999999999999999765


Q ss_pred             cc-----CCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--CCCCCCC
Q 015965          263 AQ-----SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPK  334 (397)
Q Consensus       263 ~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~--~~~~~~~  334 (397)
                      ..     ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+....  ..+....
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            42     223345678999999999876 568999999999999999999999999887766555443321  1111111


Q ss_pred             C----------------------------CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 N----------------------------SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~----------------------------~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .                            .++.+.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1                            2678999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-46  Score=379.40  Aligned_cols=246  Identities=25%  Similarity=0.411  Sum_probs=211.7

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|++.+.||+|+||.||++++  +++.||||+++..... ......+.+|+.++++++||||+++++++.....+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            4567899999999999999999998  4678999998753221 122456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      +||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999999764   24699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          265 SGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       265 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||....    ..+....+...  ....|..++++
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~  419 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA  419 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCHH
Confidence            433 334589999999999999999999999999999999999999997653    33344444433  34567889999


Q ss_pred             HHHHHHHhchhCCCCCCCH
Q 015965          340 LAELLERCWQQDPALRPDF  358 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~  358 (397)
                      +.+||.+||+.||.+||++
T Consensus       420 ~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHhccCCHhHCCCC
Confidence            9999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.4e-46  Score=349.06  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=217.8

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC---C----hHHHHHHHHHHHHHhcCC-CCCeeeeeeEEec
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---N----SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK  182 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  182 (397)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++....   .    ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999984  57899999976532   1    123466889999999996 9999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999999999999999999986 467999999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCcccCCCCCcccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCC--C
Q 015965          263 AQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--K  334 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~  334 (397)
                      ..........||+.|+|||++.      ...++.++||||||+++|+|++|..||...+..+....+.........+  .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            6665566678999999999984      4568899999999999999999999999888777666655554433322  4


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++.+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            67899999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-46  Score=359.70  Aligned_cols=243  Identities=24%  Similarity=0.438  Sum_probs=206.1

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++.+.||+|+||.||++.+.  ++.||||+++.....      ..+|+.++.++ +||||+++++++.+...+|+||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            67999999999999999999884  677999999865432      34677888777 7999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC----CceEEcccccccccccC-
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQS-  265 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~----~~vkl~DfG~a~~~~~~-  265 (397)
                      ||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++..... 
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            99999999999976 4679999999999999999999999999999999999998543    35999999999865443 


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHhhhcCCC--CCCCCCCcHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLR--PTIPKNSQPKL  340 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~l  340 (397)
                      ......+||+.|+|||++.+..++.++||||||+++|+|++|..||...   +..+....+......  ...+..+++++
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  254 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA  254 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence            3445668999999999998888999999999999999999999999753   344444444433322  22346789999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||.+||..||++|||+.++++
T Consensus       255 ~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          255 KDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-45  Score=365.89  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=200.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-----Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  186 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++.........+.+.+|+.+|++++||||+++++++...     ..+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            68999999999999999999874  56799999987666666678899999999999999999999998766     568


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             EEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             EEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence            99999994 699999976 5679999999999999999999999999999999999999999999999999998654332


Q ss_pred             -----------------------cccCCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCC-----------CC
Q 015965          267 -----------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKL-----------PY  311 (397)
Q Consensus       267 -----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~-----------P~  311 (397)
                                             .....+||+.|+|||++ ....|+.++|||||||++|||++|..           +|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f  263 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF  263 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence                                   23567899999999986 56679999999999999999998544           44


Q ss_pred             CCCCh-----------------HHHHHHh-----------------------hhc-CCCCC-----CCCCCcHHHHHHHH
Q 015965          312 EYLTP-----------------LQAAVGV-----------------------VQK-GLRPT-----IPKNSQPKLAELLE  345 (397)
Q Consensus       312 ~~~~~-----------------~~~~~~~-----------------------~~~-~~~~~-----~~~~~~~~l~~ll~  345 (397)
                      .+.+.                 ......+                       ... .....     ....+++++.+||.
T Consensus       264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  343 (432)
T 3n9x_A          264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE  343 (432)
T ss_dssp             CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            33221                 0111110                       000 00111     11457899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+|||+.|+++
T Consensus       344 ~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          344 SMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHhcCCcccCCCHHHHhc
Confidence            999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-46  Score=353.90  Aligned_cols=255  Identities=33%  Similarity=0.572  Sum_probs=196.8

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      .|.+..++|++.+.||+|+||.||+|.+  .++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            3678889999999999999999999976  578899999875432 2335678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKL-------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                      .++||||++|++|.+++...       .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999999999752       45689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC------cccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--
Q 015965          259 ARVKAQSG------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--  329 (397)
Q Consensus       259 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--  329 (397)
                      +.......      ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..................  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            97654322      2234579999999999865 56899999999999999999999999987776655444433211  


Q ss_pred             ------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                            +.....+++++.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  1233567899999999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=351.31  Aligned_cols=256  Identities=24%  Similarity=0.465  Sum_probs=199.1

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ...|.+..++|++.+.||+|+||.||+|.+.  ++.||||+++.........+.+.++..+++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            3456777889999999999999999999984  77899999987654444445556666788899999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +..++||||+ ++.+..+.....+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999999999 6677777766567899999999999999999999995 9999999999999999999999999999776


Q ss_pred             ccCCcccCCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCCCCCCC--C
Q 015965          263 AQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIP--K  334 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~~~~~~~~~~~--~  334 (397)
                      ..........||+.|+|||++.     ...++.++||||||+++|+|++|..||..... .+....+.. ...+..+  .
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~  254 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCCCSSS
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCCCccC
Confidence            6555555668999999999994     55688999999999999999999999987543 333333333 3333333  4


Q ss_pred             CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          335 NSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       335 ~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+++++.+++.+||+.||.+||++.++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            57899999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-46  Score=362.20  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=210.7

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-----
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-----  182 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  182 (397)
                      +...++|++++.||+|+||.||+|.+  .++.||||++......      ..+|+.+|+.++||||+++++++..     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            45567899999999999999999987  5678999998755322      2369999999999999999999843     


Q ss_pred             ---------------------------------CCceEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHH
Q 015965          183 ---------------------------------PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMN  226 (397)
Q Consensus       183 ---------------------------------~~~~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~  226 (397)
                                                       ...+++||||++ ++|.+.+..   ....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             334889999996 588887763   2567999999999999999999


Q ss_pred             HHHhCCcccCCCCCCcEEeC-CCCceEEcccccccccccCCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHH
Q 015965          227 YLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWEL  304 (397)
Q Consensus       227 ~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el  304 (397)
                      |||++||+||||||+|||++ .++.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 6889999999999877666666777899999999998765 499999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHhhhcCCC---------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCC
Q 015965          305 LTGKLPYEYLTPLQAAVGVVQKGLR---------------------------PTIPKNSQPKLAELLERCWQQDPALRPD  357 (397)
Q Consensus       305 l~g~~P~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps  357 (397)
                      ++|+.||.+.+..+....++.....                           ...+..+++++.+||.+||+.||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999998877766655432111                           1135568899999999999999999999


Q ss_pred             HHHHHH--HHHHHHH
Q 015965          358 FSEIIE--ILQQIAK  370 (397)
Q Consensus       358 ~~ell~--~L~~l~~  370 (397)
                      +.|+++  .++++..
T Consensus       316 ~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          316 PYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHTSGGGHHHHH
T ss_pred             HHHHhcCHHHHHHHh
Confidence            999983  4555544

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=359.18  Aligned_cols=257  Identities=16%  Similarity=0.243  Sum_probs=215.2

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEE-------ECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC---CCCeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQ  175 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~  175 (397)
                      ...+++..++|.+.++||+|+||.||+|.       ..++.||||+++...     ..++.+|+.+++.++   |+||++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            34567888999999999999999999993       356789999998542     346778888888887   899999


Q ss_pred             eeeEEecCCceEEEEEeccCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC----
Q 015965          176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----  247 (397)
Q Consensus       176 ~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~----  247 (397)
                      +++++...+..|+||||++||+|.+++...    ...+++..++.++.||+.||+|||++||+||||||+|||++.    
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            999999999999999999999999999753    457999999999999999999999999999999999999998    


Q ss_pred             -------CCceEEcccccccccc---cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015965          248 -------NEVVKVADFGVARVKA---QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL  317 (397)
Q Consensus       248 -------~~~vkl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~  317 (397)
                             ++.+||+|||+++...   ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999996533   333455678999999999999999999999999999999999999999543221


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCC-CCHHHHHHHHHHHHHHhc
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-PDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~R-ps~~ell~~L~~l~~~~~  373 (397)
                      ..  . ...   .......++.+.+++..|++.+|.+| |++.++.+.|++++....
T Consensus       292 ~~--~-~~~---~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          292 EC--K-PEG---LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             EE--E-ECS---CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ce--e-ech---hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence            00  0 000   11112346789999999999999999 689999999999887654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-45  Score=352.25  Aligned_cols=243  Identities=19%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             CcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEec--CCce
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSL  186 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~  186 (397)
                      ..++|++.+.||+|+||.||+|.+  .++.||||+++...     .+.+.+|+.++++++ ||||+++++++..  ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            357899999999999999999987  56789999997532     466889999999997 9999999999987  5678


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQS  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~  265 (397)
                      ++||||+++++|.+++..    +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999998854    89999999999999999999999999999999999999776 8999999999877666


Q ss_pred             CcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhh------------cC----
Q 015965          266 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQ------------KG----  327 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~-~~~~~~~~~~------------~~----  327 (397)
                      .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+..            ..    
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            66667789999999999877 679999999999999999999999995432 2222211110            00    


Q ss_pred             -------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 -------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 -------------------~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                         .....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                               011122337899999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-47  Score=371.36  Aligned_cols=252  Identities=16%  Similarity=0.199  Sum_probs=202.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCC-CChHHHHHHHHHH---HHHhcCCCCCeeeee------
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEV---FIMRKVRHKNVVQFI------  177 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~~~------  177 (397)
                      ....++|++.+.||+|+||.||+|.+  .++.||||+++... ......+.+.+|+   .++++++|||||+++      
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            33457899999999999999999985  47889999997543 2344567899999   555666899999998      


Q ss_pred             -eEEecCC-----------------ceEEEEEeccCCCHHHHHHhccCCCC-------HHHHHHHHHHHHHHHHHHHhCC
Q 015965          178 -GACTKPP-----------------SLCIVTEFMSGGSVYDYLHKLKGVFK-------LPSLLKVAIDVSKGMNYLHQNN  232 (397)
Q Consensus       178 -~~~~~~~-----------------~~~lv~E~~~g~sL~~~l~~~~~~l~-------~~~~~~i~~qi~~~l~~LH~~~  232 (397)
                       +++..++                 ..|+||||+ +|+|.+++... +.++       +..++.++.||+.||+|||++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence             6666553                 378999999 68999999864 2344       4788889999999999999999


Q ss_pred             cccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCcccccccccCCC-----------CCCCchhHHHHHHHH
Q 015965          233 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-----------PYDHKADVFSFGIVL  301 (397)
Q Consensus       233 iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l  301 (397)
                      |+||||||+|||++.++.+||+|||+++....  ......| +.|+|||++.+.           .++.++|||||||++
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999999985432  3455678 999999999887           899999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHHHHh
Q 015965          302 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEV  372 (397)
Q Consensus       302 ~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l~~~~  372 (397)
                      |+|++|..||...+.......+.      ..+..+++++.+||.+||+.||++|||+.++++  .++++.+.+
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            99999999997655433222211      123578899999999999999999999999986  566665544

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.1e-46  Score=355.79  Aligned_cols=256  Identities=30%  Similarity=0.504  Sum_probs=190.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHH-HHhcCCCCCeeeeeeEEec
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~  182 (397)
                      ...|.+..++|++.+.||+|+||.||+|.+.  ++.||||+++.... ......+.+|+. +++.++||||+++++++..
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            4568889999999999999999999999985  77899999986543 333445556655 7888999999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCceEEcccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                      .+..++||||+++ +|.+++..    ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            9999999999964 88888763    256799999999999999999999999 99999999999999999999999999


Q ss_pred             cccccccCCcccCCCCCccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCC-
Q 015965          258 VARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI-  332 (397)
Q Consensus       258 ~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~-  332 (397)
                      +++............||+.|+|||++    .+..++.++||||||+++|+|++|..||...............+..+.. 
T Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS  251 (327)
T ss_dssp             SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred             CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            99876655545556899999999998    5667899999999999999999999999875433222221222222222 


Q ss_pred             ---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          333 ---PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       333 ---~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                         ...+++.+.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               2468899999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.8e-46  Score=346.08  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=210.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            57999999999999999999884  67899999875433 2345778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC---Ccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~---~~~  268 (397)
                      |+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   ...
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            9999999998865 457999999999999999999999999999999999999999999999999999765432   223


Q ss_pred             cCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .................+++.+.+++.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence            45679999999999987765 678999999999999999999998765432 2222232222222335688999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||.+|||+.++++
T Consensus       245 ~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          245 ILVENPSARITIPDIKK  261 (276)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HCCCCchhCCCHHHHhc
Confidence            99999999999999865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-46  Score=369.97  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=198.3

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC------hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++......      ......+.+|+.+|++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            468999999999999999999874  578999998754321      1223358899999999999999999999865 4


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ceEEcccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARV  261 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~vkl~DfG~a~~  261 (397)
                      ..|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            58999999999999998875 56799999999999999999999999999999999999997544   599999999988


Q ss_pred             cccCCcccCCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC---CCCC
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPKN  335 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~  335 (397)
                      ...........||+.|+|||++.+   ..++.++||||||+++|+|++|..||............+..+....   ....
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            776666667789999999999853   5688899999999999999999999986544333333333332222   2256


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++.+.+|+.+||+.||.+|||+.++++
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            8899999999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8e-46  Score=350.96  Aligned_cols=245  Identities=24%  Similarity=0.411  Sum_probs=200.0

Q ss_pred             cccccc-ceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEE
Q 015965          114 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       114 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +.|++. +.||+|+||.||++.+  .++.||||+++....  .....+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            567774 7899999999999986  567899999976532  2346788999999885 799999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc---eEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~---vkl~DfG~a~~~~~~~  266 (397)
                      |||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++......
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            999999999999987 467999999999999999999999999999999999999998776   9999999987543221


Q ss_pred             --------cccCCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------------HH
Q 015965          267 --------VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTP---------------LQ  318 (397)
Q Consensus       267 --------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---------------~~  318 (397)
                              ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||.....               ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                    1234469999999999865     5688999999999999999999999976542               11


Q ss_pred             HHHHhhhcCCCCCCC----CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          319 AAVGVVQKGLRPTIP----KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~----~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ....+.....  ..+    ..+++++.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          249 LFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            2222222221  222    457899999999999999999999999976

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=348.46  Aligned_cols=250  Identities=30%  Similarity=0.473  Sum_probs=211.2

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ....++|++.+.||+|+||.||+|.+.  ++.||||++.....    ...+.+|+.++++++||||+++++++......|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            344578999999999999999999885  67899999986432    356889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-C
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~  266 (397)
                      +||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            999999999999999866778999999999999999999999999999999999999999999999999999765443 2


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~  345 (397)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..... ....+..+++.+.+++.
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence            33455799999999999999999999999999999999999999998887666554433321 12234567899999999


Q ss_pred             HhchhCCCCCCCHHHHHH
Q 015965          346 RCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~  363 (397)
                      +||+.||.+|||+.++++
T Consensus       261 ~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-46  Score=357.45  Aligned_cols=238  Identities=22%  Similarity=0.424  Sum_probs=182.7

Q ss_pred             cceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEeccC
Q 015965          119 GSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      .+.||+|+||.||++.+.  ++.||||++...     ....+.+|+.+++.+. ||||+++++++.+....|+||||++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            378999999999999984  678999998643     2456788999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---ceEEcccccccccccC-CcccCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQS-GVMTAE  271 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---~vkl~DfG~a~~~~~~-~~~~~~  271 (397)
                      ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..... ......
T Consensus        91 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  169 (325)
T 3kn6_A           91 GELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP  169 (325)
T ss_dssp             CBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence            999999987 56799999999999999999999999999999999999998766   8999999999865443 334556


Q ss_pred             CCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHhhhcCCCCC--CCCCCcHHHHH
Q 015965          272 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVVQKGLRPT--IPKNSQPKLAE  342 (397)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~l~~  342 (397)
                      .||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .+....+........  ....+++++.+
T Consensus       170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (325)
T 3kn6_A          170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD  249 (325)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHH
T ss_pred             CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHH
Confidence            789999999999999999999999999999999999999976433       233333322221111  11357899999


Q ss_pred             HHHHhchhCCCCCCCHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell  362 (397)
                      ||.+||+.||.+|||+.+++
T Consensus       250 li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          250 LIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHHHHHCCCTTTCCCTTTST
T ss_pred             HHHHHCCCChhHCCCHHHHh
Confidence            99999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.9e-46  Score=349.00  Aligned_cols=249  Identities=28%  Similarity=0.492  Sum_probs=210.9

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++.....  .....+.+|+.++++++||||+++++++...+..++||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            367999999999999999999985  67799999875432  23567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence            999999999999877788999999999999999999999999999999999999999999999999997543221 1233


Q ss_pred             CCCCCccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-CCCCCCCcHHHHHH
Q 015965          270 AETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAEL  343 (397)
Q Consensus       270 ~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  343 (397)
                      ...||+.|+|||++     .+..++.++||||||+++|+|++|..||...+.......+...... ...+..+++++.++
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  255 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF  255 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence            45799999999998     4677899999999999999999999999998887766665544322 22356678999999


Q ss_pred             HHHhchhCCCCCCCHHHHHH
Q 015965          344 LERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+||+.||.+|||+.++++
T Consensus       256 i~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          256 LKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHcccChhhCCCHHHHhc
Confidence            99999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.4e-46  Score=361.70  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=196.1

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-  183 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  183 (397)
                      ..|++. ++|++.+.||+|+||.||+|.+  .++.||||++..........+.+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            345555 7899999999999999999987  467899999987655666678899999999999999999999998754 


Q ss_pred             -----CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          184 -----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       184 -----~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                           ...|+|||++ +++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence                 5679999999 7899999865  6799999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-------
Q 015965          259 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------  330 (397)
Q Consensus       259 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-------  330 (397)
                      ++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......|       
T Consensus       179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9865432  455689999999999876 679999999999999999999999999887765554443211100       


Q ss_pred             --------------C--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 --------------T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 --------------~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                    .        .....++.+.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                          0        11356789999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=344.86  Aligned_cols=253  Identities=28%  Similarity=0.493  Sum_probs=211.0

Q ss_pred             cccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      +....+++.....||+|+||.||+|.+  .++.||||.++...  ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            445556666677999999999999997  45679999987653  33456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEcccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKA  263 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~  263 (397)
                      ++||||+++++|.+++....+  .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999999999999999987533  4568889999999999999999999999999999999987 8999999999997654


Q ss_pred             cC-CcccCCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCCCCCCCCCCcHH
Q 015965          264 QS-GVMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       264 ~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      .. .......||+.|+|||++.+..  ++.++||||||+++|+|++|..||....... ...........+..+..++++
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE  254 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence            32 2234557999999999997643  8899999999999999999999997654332 233333345567788889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+++.+||+.||++||++.++++
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhc
Confidence            999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-45  Score=368.70  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=215.2

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC-CCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|++.++||+|+||.||+|.+.  ++.||||+++.....    ..+.+|+.+++.++| ++|+.+..++......+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            368999999999999999999974  788999998765433    247789999999987 5566666667777888999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCceEEcccccccccccCC
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili---~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999 999999998777889999999999999999999999999999999999999   588999999999998655432


Q ss_pred             c--------ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCC---CCCC
Q 015965          267 V--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGL---RPTI  332 (397)
Q Consensus       267 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~~~---~~~~  332 (397)
                      .        .....||+.|+|||++.+..++.++|||||||+||+|++|..||.....   .+....+.....   ....
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            2        2256799999999999999999999999999999999999999987543   233333222221   1223


Q ss_pred             CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          333 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       333 ~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      +..+++++.+|+.+||+.||++||++.+|++.|++++...+
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            36778999999999999999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-46  Score=361.30  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=209.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEe
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT  181 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  181 (397)
                      .+..++|++.+.||+|+||.||+++.     .++.||||+++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            45568999999999999999999987     567899999875421  112234567799999999 6999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999986 46799999999999999999999999999999999999999999999999999976


Q ss_pred             cccC--CcccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhcCCCCCCC
Q 015965          262 KAQS--GVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIP  333 (397)
Q Consensus       262 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~~~----~~~~~~~~~~~~~~~~~~  333 (397)
                      ....  .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||....    .......+..  ..+..+
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC
Confidence            5432  22334579999999999975  457899999999999999999999997432    2222222222  245677


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 015965          334 KNSQPKLAELLERCWQQDPALRP-----DFSEIIEI  364 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rp-----s~~ell~~  364 (397)
                      ..+++.+.+||.+||..||.+||     ++.++++.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            88999999999999999999999     88888753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-46  Score=354.72  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=203.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC------hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++......      ......+.+|+.++++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            67999999999999999999884  577999999764321      122345889999999999999999999987755 


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc---eEEccccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK  262 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~---vkl~DfG~a~~~  262 (397)
                      .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            8999999999999999876 567999999999999999999999999999999999999987664   999999999876


Q ss_pred             ccCCcccCCCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---CCCCCCC
Q 015965          263 AQSGVMTAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS  336 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~  336 (397)
                      ..........||+.|+|||++   ....++.++||||||+++|+|++|..||............+..+..   +..+..+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  247 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence            554444456799999999997   3567899999999999999999999999765443222222222222   1223567


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++++.+++.+||+.||++||++.++++
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            899999999999999999999999984

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-45  Score=351.64  Aligned_cols=250  Identities=23%  Similarity=0.397  Sum_probs=209.6

Q ss_pred             cccccccceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcC---CCCCeeeeeeEEe-----
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----  181 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----  181 (397)
                      .++|++.+.||+|+||.||+|.+.   ++.||+|+++...........+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            368999999999999999999873   56799999875433222223455677776665   8999999999987     


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      .....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5567899999996 69999998753 358999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-----------
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-----------  329 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-----------  329 (397)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......           
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            766555556678999999999999999999999999999999999999999988877665555431100           


Q ss_pred             --------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                    ......+++.+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          1123567899999999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.4e-45  Score=347.49  Aligned_cols=254  Identities=21%  Similarity=0.374  Sum_probs=213.8

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC--CCCeeeeeeEEecC
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP  183 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~  183 (397)
                      ....+..++|++.+.||+|+||.||++.+. ++.||||++............+.+|+.++++++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            345777889999999999999999999874 567999999877666667788999999999997  59999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +..|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++...
T Consensus       101 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          101 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             CEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            999999995 58899999987 46789999999999999999999999999999999999996 4899999999997654


Q ss_pred             cCC---cccCCCCCcccccccccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCC
Q 015965          264 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGL  328 (397)
Q Consensus       264 ~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~~~~~~  328 (397)
                      ...   ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||..... ............
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            332   2234578999999999875           4688899999999999999999999987643 344445555555


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ....+...++++.+++.+||+.||.+||++.++++
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            66677788999999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.5e-45  Score=356.13  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=210.5

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ...|++. ++|.+.+.||+|+||.||+|.+.  ++.||||+++.........+.+.+|+.+++.++||||+++++++...
T Consensus        35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            3445555 68999999999999999999874  67899999987766666678899999999999999999999999877


Q ss_pred             Cce------EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccc
Q 015965          184 PSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       184 ~~~------~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                      +..      |+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence            655      99999995 68888773   459999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC------
Q 015965          258 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  330 (397)
Q Consensus       258 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~------  330 (397)
                      +++.....  .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+      
T Consensus       190 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          190 LARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            99765432  445678999999999977 779999999999999999999999999887766655544311111      


Q ss_pred             -----------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 -----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 -----------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                             ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                                   012456899999999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.3e-46  Score=358.16  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=201.6

Q ss_pred             CcccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCC---------ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERI---------NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      -.++|++.+.||+|+||.||+|.+ .++.||||++.....         .....+.+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            347899999999999999999976 467799999865332         2233477999999999999999999999984


Q ss_pred             c-----CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          182 K-----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       182 ~-----~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                      .     ...+|+||||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            3     335899999996 6999998876678999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-----
Q 015965          257 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----  330 (397)
Q Consensus       257 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-----  330 (397)
                      |+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+     
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99986666555666789999999999876 679999999999999999999999999887666555543321111     


Q ss_pred             -------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 -------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 -------------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                               ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                                     112456789999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-45  Score=363.61  Aligned_cols=244  Identities=25%  Similarity=0.330  Sum_probs=202.5

Q ss_pred             cccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------C
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  184 (397)
                      ..+|++.+.||+|+||.||+|++  .++.||||++.....      .+.+|+.+|++++||||+++++++...      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            35799999999999999999998  467899999875432      234699999999999999999988432      2


Q ss_pred             ceEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CceEEccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR  260 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-~~vkl~DfG~a~  260 (397)
                      .+++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            36799999965 77766643   35679999999999999999999999999999999999999965 678999999998


Q ss_pred             ccccCCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC----------
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------  329 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~----------  329 (397)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....++.....          
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            76665556677899999999998764 7999999999999999999999999988876665554431100          


Q ss_pred             --------CC---------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --------PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --------~~---------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                              +.         ++..+++++.+||.+||..||.+||++.|+++
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                    00         23456899999999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.9e-45  Score=354.58  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-----Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  186 (397)
                      .+|++.+.||+|+||.||++.+.  ++.||||++.... .......+.+|+.++++++||||+++++++...     ...
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            68999999999999999999874  5679999998543 344557799999999999999999999999765     368


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+. ++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            99999995 699999975  569999999999999999999999999999999999999999999999999998655432


Q ss_pred             c----ccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-----------
Q 015965          267 V----MTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------  330 (397)
Q Consensus       267 ~----~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-----------  330 (397)
                      .    .....||+.|+|||++. +..++.++||||||+++|+|++|..||...+..+....+......+           
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            2    34458999999999864 4568999999999999999999999998877655554443211110           


Q ss_pred             ------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                        .....+++++.+||.+||+.||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                              012457889999999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-45  Score=359.61  Aligned_cols=245  Identities=25%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             CcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC------
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  184 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  184 (397)
                      ...+|++.+.||+|+||.||+|++. +..+|+|.+......      ..+|+.+++.++||||+++++++....      
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            3467999999999999999999984 455899987644321      236999999999999999999985443      


Q ss_pred             ceEEEEEeccCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLH---KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVAR  260 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a~  260 (397)
                      .+++||||+++ ++.+.+.   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            37899999976 4444433   2356799999999999999999999999999999999999999 79999999999998


Q ss_pred             ccccCCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC----------
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------  329 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~----------  329 (397)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......          
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            77666666778899999999998664 5999999999999999999999999998876666554432100          


Q ss_pred             --------C---------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 --------P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 --------~---------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                              +         ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                    0         123457899999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-46  Score=362.59  Aligned_cols=257  Identities=14%  Similarity=0.126  Sum_probs=194.1

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh-HHHHHHHHHH---HHHhcCCCCCeeeee-------e
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEV---FIMRKVRHKNVVQFI-------G  178 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~E~---~~l~~l~h~niv~~~-------~  178 (397)
                      ...+|++.+.||+|+||.||+|.+.  ++.||||+++...... .....+.+|+   .+|+. +||||++++       +
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence            3456999999999999999999974  6779999999765533 4455677784   55555 799988755       4


Q ss_pred             EEecC-----------------CceEEEEEeccCCCHHHHHHhccCCCCHHHH------HHHHHHHHHHHHHHHhCCccc
Q 015965          179 ACTKP-----------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------LKVAIDVSKGMNYLHQNNIIH  235 (397)
Q Consensus       179 ~~~~~-----------------~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~iiH  235 (397)
                      ++..+                 ..+|+||||++ ++|.+++......++...+      +.++.||+.||+|||++||+|
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            44433                 23799999997 8999999876555666666      788899999999999999999


Q ss_pred             CCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015965          236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEY  313 (397)
Q Consensus       236 rDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~~  313 (397)
                      |||||+|||++.++.+||+|||+++.....  .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||..
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999865432  224567799999999987  7899999999999999999999999987


Q ss_pred             CChHHHHH-------HhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHHHHh
Q 015965          314 LTPLQAAV-------GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEV  372 (397)
Q Consensus       314 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l~~~~  372 (397)
                      ..+.....       ...........+..+++.+.+||.+||+.||++|||+.++++  .++++....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI  363 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence            64321100       000111122233578999999999999999999999999974  455554443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.1e-45  Score=360.07  Aligned_cols=245  Identities=26%  Similarity=0.406  Sum_probs=207.0

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcC------CCCCeeeeeeEEecCC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV------RHKNVVQFIGACTKPP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~  184 (397)
                      ..+|++.++||+|+||.||+|.+.  ++.||||+++..   ......+.+|+.+++.+      +|+||+++++++....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            467999999999999999999874  577999999753   34456677888888776      5789999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc--eEEcccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV  261 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~--vkl~DfG~a~~  261 (397)
                      .+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus       173 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          173 HICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             eEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            999999999 579999998754 45999999999999999999999999999999999999999887  99999999975


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC-----------
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------  330 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~-----------  330 (397)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+           
T Consensus       252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          252 EHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             TTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             cCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            443  3445689999999999999999999999999999999999999999887766554433210000           


Q ss_pred             ----------------------------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ----------------------------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ----------------------------------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                                                    .++...++++.+||.+||+.||.+|||+.|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence                                                          012234788999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=343.41  Aligned_cols=247  Identities=24%  Similarity=0.423  Sum_probs=207.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe--cCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~  187 (397)
                      ++|++.+.||+|+||.||++.+  .++.||+|+++....  .......+.+|+.++++++||||+++++++.  .....|
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            5799999999999999999987  456799999875421  1234567999999999999999999999984  456789


Q ss_pred             EEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc--
Q 015965          188 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--  264 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~--  264 (397)
                      +||||++++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....  
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999765 77777654 45799999999999999999999999999999999999999999999999999976543  


Q ss_pred             -CCcccCCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHH
Q 015965          265 -SGVMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  341 (397)
Q Consensus       265 -~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  341 (397)
                       ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||...+..+....+...  ....+..+++.+.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l~  241 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPLS  241 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHHH
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHHH
Confidence             22334557999999999997654  377999999999999999999999988776665555443  3456778899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++.+||+.||.+|||+.++++
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.3e-46  Score=357.55  Aligned_cols=250  Identities=21%  Similarity=0.387  Sum_probs=213.1

Q ss_pred             cCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCCh---------------HHHHHHHHHHHHHhcCCCCCeee
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS---------------DMQKEFAQEVFIMRKVRHKNVVQ  175 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~  175 (397)
                      +..++|++.+.||+|+||.||+|.+.++.||||++.......               .....+.+|+.++++++||||++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            445789999999999999999999988999999987432111               11267899999999999999999


Q ss_pred             eeeEEecCCceEEEEEeccCCCHHHH------HHhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCC
Q 015965          176 FIGACTKPPSLCIVTEFMSGGSVYDY------LHKL-KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDE  247 (397)
Q Consensus       176 ~~~~~~~~~~~~lv~E~~~g~sL~~~------l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~  247 (397)
                      +++++...+..|+||||+++++|.++      +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999998      5442 4679999999999999999999999 99999999999999999


Q ss_pred             CCceEEcccccccccccCCcccCCCCCcccccccccCCC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhh
Q 015965          248 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH-KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVV  324 (397)
Q Consensus       248 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~ell~g~~P~~~~~~-~~~~~~~~  324 (397)
                      ++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||..... .+....+.
T Consensus       188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            999999999999865443 44566899999999999877 6666 89999999999999999999988776 44444433


Q ss_pred             hcCCCCCCC-------------------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          325 QKGLRPTIP-------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       325 ~~~~~~~~~-------------------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ...  ...+                   ..+++++.+|+.+||+.||.+|||+.++++
T Consensus       267 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          267 TKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            322  2222                   568899999999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.2e-45  Score=349.48  Aligned_cols=249  Identities=27%  Similarity=0.437  Sum_probs=207.6

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      .|++. ++|.+.+.||+|+||.||+|.+.  ++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus        19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            34443 68999999999999999999874  6789999998766666667889999999999999999999999987654


Q ss_pred             ------eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          186 ------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       186 ------~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                            .|+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             cccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence                  499999996 68887764   35999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-----------  327 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~-----------  327 (397)
                      +.....  .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+....           
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            765432  345678999999999876 678999999999999999999999999887665544433210           


Q ss_pred             ---------------CC---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          328 ---------------LR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       328 ---------------~~---~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                     .+   ......+++++.+||.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                           01   1233467899999999999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-44  Score=348.10  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=205.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC-----Cce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  186 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            68999999999999999999985  6789999997542 344567788999999999999999999987654     678


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      |+||||+. ++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            99999995 699999876  579999999999999999999999999999999999999999999999999997654321


Q ss_pred             -----------cccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC----
Q 015965          267 -----------VMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----  330 (397)
Q Consensus       267 -----------~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~----  330 (397)
                                 ......||+.|+|||++. +..++.++||||||+++|+|++|..||...+..+....+......+    
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence                       123357899999999875 4678999999999999999999999999877655443332211000    


Q ss_pred             --------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 --------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 --------------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                                .....+++++.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                      012467899999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.3e-45  Score=341.34  Aligned_cols=244  Identities=24%  Similarity=0.449  Sum_probs=197.7

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec---------
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---------  182 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  182 (397)
                      ++|++.+.||+|+||.||+|.+  .++.||||+++.   .......+.+|+.++++++||||+++++++.+         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            5789999999999999999987  467899999864   23445778999999999999999999998754         


Q ss_pred             ----CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccc
Q 015965          183 ----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  258 (397)
Q Consensus       183 ----~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~  258 (397)
                          ....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                3467999999999999999987666788899999999999999999999999999999999999999999999999


Q ss_pred             ccccccC---------------CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015965          259 ARVKAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG  322 (397)
Q Consensus       259 a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~  322 (397)
                      ++.....               .......||+.|+|||++.+. .++.++||||||+++|+|++   ||...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9755421               123345789999999999765 68999999999999999998   5543222222222


Q ss_pred             hhhc---CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          323 VVQK---GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       323 ~~~~---~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .+..   ...+..+...++.+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2222   2334455677889999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-44  Score=349.50  Aligned_cols=250  Identities=20%  Similarity=0.216  Sum_probs=196.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc--
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--  185 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  185 (397)
                      ....++|++.+.||+|+||.||+|++.  ++.||||++......   ...+.+++..++.++||||+++++++.....  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            445578999999999999999999985  678999988654322   2346678888888999999999999865433  


Q ss_pred             -----eEEEEEeccCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEeCC-CCceEEc
Q 015965          186 -----LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMDE-NEVVKVA  254 (397)
Q Consensus       186 -----~~lv~E~~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nili~~-~~~vkl~  254 (397)
                           +++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence                 7899999965 66555442   3567899999999999999999999  999999999999999996 8999999


Q ss_pred             ccccccccccCCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-----
Q 015965          255 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-----  328 (397)
Q Consensus       255 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-----  328 (397)
                      |||+++............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.....     
T Consensus       175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            99999877766666677899999999998654 489999999999999999999999998887766655543211     


Q ss_pred             -------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 -------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 -------------------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                               .+..+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                                     11223346789999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=341.56  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe----------
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT----------  181 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------  181 (397)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++...  .....+.+.+|+.++++++||||+++++++.          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            68999999999999999999985  678999998754  3455678999999999999999999999874          


Q ss_pred             ----cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEccc
Q 015965          182 ----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADF  256 (397)
Q Consensus       182 ----~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~Df  256 (397)
                          .....|+||||++ ++|.+++..  +.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                3467899999996 699999964  6799999999999999999999999999999999999997 5679999999


Q ss_pred             ccccccccC----CcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--
Q 015965          257 GVARVKAQS----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--  329 (397)
Q Consensus       257 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--  329 (397)
                      |+++.....    .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            999865432    22334467999999998855 67899999999999999999999999988876655544432110  


Q ss_pred             ---------------------C-----CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ---------------------P-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ---------------------~-----~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                           +     ..+..+++++.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                                 0     112467899999999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.2e-44  Score=343.48  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=206.2

Q ss_pred             cCcccccccceeeeeCCceEEEEEE---CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC------CeeeeeeEEe
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACT  181 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~  181 (397)
                      +-.++|++.+.||+|+||.||++.+   .++.||||+++..   ......+.+|+.+++.++|+      +|+++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3347899999999999999999987   4577999999743   34456788999999988765      4999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-------------
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------------  247 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-------------  247 (397)
                      ..+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 899999997643 36899999999999999999999999999999999999987             


Q ss_pred             ------CCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015965          248 ------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV  321 (397)
Q Consensus       248 ------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~  321 (397)
                            ++.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  668999999999764432  345689999999999999999999999999999999999999998877655433


Q ss_pred             HhhhcCCC------------------------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 015965          322 GVVQKGLR------------------------------------------PTIPKNSQPKLAELLERCWQQDPALRPDFS  359 (397)
Q Consensus       322 ~~~~~~~~------------------------------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~  359 (397)
                      .+......                                          ...+...++++.+|+.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            22111000                                          011223467899999999999999999999


Q ss_pred             HHHH
Q 015965          360 EIIE  363 (397)
Q Consensus       360 ell~  363 (397)
                      |+++
T Consensus       325 ell~  328 (339)
T 1z57_A          325 EALK  328 (339)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=355.01  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=183.9

Q ss_pred             ccccc-cceeeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe--cCCce
Q 015965          114 KHLKF-GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSL  186 (397)
Q Consensus       114 ~~~~~-~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~  186 (397)
                      +.|.+ +++||+|+||.||+|.+.    ++.||||+++.....    ..+.+|+.+|++++||||+++++++.  ....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34655 568999999999999964    567999999865433    35778999999999999999999994  46779


Q ss_pred             EEEEEeccCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe----CCCCceEEc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVA  254 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili----~~~~~vkl~  254 (397)
                      |+||||+. ++|.+++....        ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99999995 68888876331        248999999999999999999999999999999999999    677899999


Q ss_pred             ccccccccccC----CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHH
Q 015965          255 DFGVARVKAQS----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAA  320 (397)
Q Consensus       255 DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~---------~~~  320 (397)
                      |||+++.....    .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......         +..
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999865432    233456799999999999874 5899999999999999999999999754431         222


Q ss_pred             HHhhhcCCCCC------------------------------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          321 VGVVQKGLRPT------------------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       321 ~~~~~~~~~~~------------------------------------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ..+...-..+.                                    .....++.+.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            22211100000                                    01123678999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-44  Score=353.49  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC--------CCCeeeeeeEEe-
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--------HKNVVQFIGACT-  181 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~-  181 (397)
                      .++|++.++||+|+||.||+|.+.  ++.||||+++..   ......+.+|+.+++.++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            478999999999999999999874  677999999743   344577889999999885        788999999987 


Q ss_pred             ---cCCceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCC-------
Q 015965          182 ---KPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE-------  249 (397)
Q Consensus       182 ---~~~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~~~~-------  249 (397)
                         ....+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++       
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence               556799999999 66777776553 36799999999999999999999998 999999999999999775       


Q ss_pred             ------------------------------------------ceEEcccccccccccCCcccCCCCCcccccccccCCCC
Q 015965          250 ------------------------------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP  287 (397)
Q Consensus       250 ------------------------------------------~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  287 (397)
                                                                .+||+|||+++.....  .....||+.|+|||++.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence                                                      7999999999865433  45568999999999999999


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHhhhc-CC--------------------------------
Q 015965          288 YDHKADVFSFGIVLWELLTGKLPYEYLTP------LQAAVGVVQK-GL--------------------------------  328 (397)
Q Consensus       288 ~~~~~Dv~slG~~l~ell~g~~P~~~~~~------~~~~~~~~~~-~~--------------------------------  328 (397)
                      ++.++|||||||++|+|++|..||...+.      ......+... +.                                
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            99999999999999999999999976542      1111111110 00                                


Q ss_pred             -------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 -------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 -------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                             ....+...++.+.+||.+||+.||++|||+.|+++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                   00112334577999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.4e-44  Score=344.50  Aligned_cols=243  Identities=22%  Similarity=0.375  Sum_probs=175.2

Q ss_pred             ccccccc-eeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----CCce
Q 015965          114 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSL  186 (397)
Q Consensus       114 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  186 (397)
                      ++|.+.+ .||+|+||.||+|.+.  ++.||||++...   ..   ...+....++.++||||+++++++..    ...+
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            6788855 6999999999999985  788999998743   22   12223344667799999999999875    4458


Q ss_pred             EEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVK  262 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~  262 (397)
                      ++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999999998753 36999999999999999999999999999999999999976   455999999999765


Q ss_pred             ccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh------cCCCCCCCCCC
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNS  336 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~------~~~~~~~~~~~  336 (397)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............      ..........+
T Consensus       182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3fhr_A          182 TQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV  260 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred             ccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence            432 33456789999999999888899999999999999999999999976654332211111      11122233578


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++++.+|+.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=353.91  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             CccccCcccccccceeeeeCCce-EEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCC
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  184 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  184 (397)
                      ..+.+...+|.+.+.||+|+||+ ||++...++.||||++......     .+.+|+.+|+++ +|||||++++++.+..
T Consensus        17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34677778899999999999998 5667778899999999764322     356799999999 7999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-----CceEEcccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVA  259 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-----~~vkl~DfG~a  259 (397)
                      ..|+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+     ..+||+|||++
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999999995 69999998766667777788999999999999999999999999999999532     35889999999


Q ss_pred             cccccC----CcccCCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCC-
Q 015965          260 RVKAQS----GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP-  330 (397)
Q Consensus       260 ~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~-  330 (397)
                      +.....    .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||......+............ 
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL  250 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence            865533    2334567999999999997   4567889999999999999999 999997665444333222211111 


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEII  362 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell  362 (397)
                      ..+...+..+.+||.+||+.||.+|||+.+++
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            11233456789999999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-43  Score=344.78  Aligned_cols=245  Identities=24%  Similarity=0.351  Sum_probs=203.4

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CC-----CeeeeeeEEecCC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK-----NVVQFIGACTKPP  184 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~  184 (397)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++..   ......+.+|+.+++.++ |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            478999999999999999999874  567999999743   344566778888888875 44     4999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEeC--CCCceEEcccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMD--ENEVVKVADFGVA  259 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nili~--~~~~vkl~DfG~a  259 (397)
                      ..|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999995 59999998754 56999999999999999999999  57999999999999995  4778999999999


Q ss_pred             cccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--------
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------  331 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--------  331 (397)
                      +....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+.        
T Consensus       209 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          209 CQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             EETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             eeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            86643  24466899999999999999999999999999999999999999998887666555443211000        


Q ss_pred             --------C------------------CC----------------------------CCcHHHHHHHHHhchhCCCCCCC
Q 015965          332 --------I------------------PK----------------------------NSQPKLAELLERCWQQDPALRPD  357 (397)
Q Consensus       332 --------~------------------~~----------------------------~~~~~l~~ll~~cl~~dp~~Rps  357 (397)
                              .                  +.                            ...+++.+||.+||+.||++|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence                    0                  00                            01147899999999999999999


Q ss_pred             HHHHHH
Q 015965          358 FSEIIE  363 (397)
Q Consensus       358 ~~ell~  363 (397)
                      +.|+++
T Consensus       367 a~e~L~  372 (382)
T 2vx3_A          367 PYYALQ  372 (382)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=338.45  Aligned_cols=244  Identities=25%  Similarity=0.462  Sum_probs=198.6

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh----HHHHHHHHHHHHHhcC----CCCCeeeeeeE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKV----RHKNVVQFIGA  179 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~~~~~  179 (397)
                      +.-.++|++.+.||+|+||.||+|.+  .++.||||+++......    .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44457899999999999999999987  56779999997654322    1233466789999888    89999999999


Q ss_pred             EecCCceEEEEEe-ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEcccc
Q 015965          180 CTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFG  257 (397)
Q Consensus       180 ~~~~~~~~lv~E~-~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG  257 (397)
                      +...+..++|||+ +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            9998999999999 789999999987 46799999999999999999999999999999999999999 88999999999


Q ss_pred             cccccccCCcccCCCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCC
Q 015965          258 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  336 (397)
Q Consensus       258 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (397)
                      +++..... ......||+.|+|||++.+..+. .++||||||+++|+|++|+.||.....      +...  ....+..+
T Consensus       186 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--~~~~~~~~  256 (312)
T 2iwi_A          186 SGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--ELHFPAHV  256 (312)
T ss_dssp             SCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--CCCCCTTS
T ss_pred             hhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--ccCCcccC
Confidence            99866543 34556799999999999776664 489999999999999999999975321      1222  33466788


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++++.+++.+||+.||++|||+.++++
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-44  Score=343.43  Aligned_cols=244  Identities=25%  Similarity=0.465  Sum_probs=206.6

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCC--CCCeeeeeeEEe
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACT  181 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~  181 (397)
                      +.-.++|++.+.||+|+||.||+|.+  .++.||||+++......    .....+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            44567899999999999999999987  46779999987653321    12245677999999996  599999999999


Q ss_pred             cCCceEEEEEeccC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCceEEcccccc
Q 015965          182 KPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVA  259 (397)
Q Consensus       182 ~~~~~~lv~E~~~g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~-~~~~vkl~DfG~a  259 (397)
                      .++..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999999999976 899999987 57799999999999999999999999999999999999999 7899999999999


Q ss_pred             cccccCCcccCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          260 RVKAQSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      +..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....      +...  ....+..+++
T Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~~~~  268 (320)
T 3a99_A          198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQRVSS  268 (320)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCCCSSCCCH
T ss_pred             cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--cccccccCCH
Confidence            866543 3445679999999999977665 6789999999999999999999975321      1221  2345677899


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++.+++.+||+.||++|||+.++++
T Consensus       269 ~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          269 ECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-43  Score=337.37  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=203.3

Q ss_pred             cccccccceeeeeCCceEEEEEEC--C-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC------eeeeeeEEecC
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--S-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTKP  183 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~  183 (397)
                      .++|++.+.||+|+||.||++.+.  + +.||+|+++..   ......+.+|+.++++++|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            478999999999999999999874  3 57999999743   344567888999999987665      99999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe-----------------
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-----------------  245 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili-----------------  245 (397)
                      +..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+                 
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence            9999999999 777877776543 579999999999999999999999999999999999999                 


Q ss_pred             --CCCCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 015965          246 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV  323 (397)
Q Consensus       246 --~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~  323 (397)
                        +.++.+||+|||+++....  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence              5678999999999976443  234568999999999999999999999999999999999999999987765543332


Q ss_pred             hhcCCC------------------------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 015965          324 VQKGLR------------------------------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEI  361 (397)
Q Consensus       324 ~~~~~~------------------------------------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~el  361 (397)
                      ......                                          .......++++.+||.+||+.||.+|||+.++
T Consensus       252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            211000                                          00111235689999999999999999999998


Q ss_pred             HH
Q 015965          362 IE  363 (397)
Q Consensus       362 l~  363 (397)
                      ++
T Consensus       332 l~  333 (355)
T 2eu9_A          332 LL  333 (355)
T ss_dssp             TT
T ss_pred             hc
Confidence            73

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-43  Score=343.04  Aligned_cols=248  Identities=20%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             ccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-----------CCCeeee
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQF  176 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~  176 (397)
                      .+..++|++.+.||+|+||.||+|++  .++.||||+++..   ......+.+|+.++++++           ||||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45667899999999999999999987  5678999999743   334567888999999886           8999999


Q ss_pred             eeEEecCC----ceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeC----
Q 015965          177 IGACTKPP----SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD----  246 (397)
Q Consensus       177 ~~~~~~~~----~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nili~----  246 (397)
                      ++++...+    .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987644    689999999 99999999874 34699999999999999999999998 999999999999994    


Q ss_pred             --CCCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HH
Q 015965          247 --ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP------LQ  318 (397)
Q Consensus       247 --~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~------~~  318 (397)
                        ..+.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              3448999999999765432  3456799999999999999999999999999999999999999976542      11


Q ss_pred             HHHHhhhc-C---------------------------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCH
Q 015965          319 AAVGVVQK-G---------------------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDF  358 (397)
Q Consensus       319 ~~~~~~~~-~---------------------------------------~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~  358 (397)
                      ....+... +                                       .....+..+++++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111110 0                                       0112334556889999999999999999999


Q ss_pred             HHHHH
Q 015965          359 SEIIE  363 (397)
Q Consensus       359 ~ell~  363 (397)
                      .++++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-42  Score=324.43  Aligned_cols=232  Identities=13%  Similarity=0.171  Sum_probs=193.2

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +-.++|++.+.||+|+||.||+|.+.  ++.||||+++..... ....+.+.+|+.++++++||||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34478999999999999999999985  678999999876543 455678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  267 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  267 (397)
                      +||||++|++|.+++..  + .....+..++.||+.||.|||++||+||||||+|||++.++.+||+++|.         
T Consensus       108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred             EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------
Confidence            99999999999999954  3 45667889999999999999999999999999999999999999985543         


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HhhhcCCCC--CCCCCCcHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV---GVVQKGLRP--TIPKNSQPKLAE  342 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~~  342 (397)
                                ++       +++.++||||||+++|+|++|+.||...+..+...   ........+  .....+++++.+
T Consensus       176 ----------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          176 ----------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             ----------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             ----------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                      22       37889999999999999999999998765432110   111111110  123578899999


Q ss_pred             HHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          343 LLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      ++.+||+.||++| |+.++++.|+++....
T Consensus       239 li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            9999999999999 9999999999986544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.7e-42  Score=343.08  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=187.3

Q ss_pred             ccccccceeeeeCCceEEE-EEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYR-GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|.+.+.||+|+||+||. +...++.||||++....     ...+.+|+.+++++ +||||+++++++.+...+|+|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            4456678899999999964 45678899999987432     34578899999876 89999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-------------CceE
Q 015965          192 FMSGGSVYDYLHKLKGV------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------EVVK  252 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~------l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~-------------~~vk  252 (397)
                      |+. ++|.+++......      .++..++.++.||+.||.|||++||+||||||+|||++.+             +.+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            995 6999999764221      1233457899999999999999999999999999999754             4899


Q ss_pred             EcccccccccccCC-----cccCCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015965          253 VADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA  319 (397)
Q Consensus       253 l~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~  319 (397)
                      |+|||+++......     ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||......+.
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            99999998665432     1234579999999999965       678999999999999999999 9999976554332


Q ss_pred             HHHhhhcCCCCCC-----CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          320 AVGVVQKGLRPTI-----PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       320 ~~~~~~~~~~~~~-----~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                        .+.........     +..+++++.+++.+||+.||.+|||+.++++
T Consensus       249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              22222222111     1234688999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.5e-43  Score=358.24  Aligned_cols=256  Identities=26%  Similarity=0.382  Sum_probs=206.9

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec------CCc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  185 (397)
                      ++|++.++||+|+||.||+|.+  .++.||||+++.. ........+.+|+.++++++||||+++++++..      ...
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            6799999999999999999986  4678999998865 345556789999999999999999999998765      667


Q ss_pred             eEEEEEeccCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCc---eEEccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVAR  260 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~---vkl~DfG~a~  260 (397)
                      .|+||||++|++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            8999999999999999986432  6899999999999999999999999999999999999997765   9999999998


Q ss_pred             ccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----------hhhcC---
Q 015965          261 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG----------VVQKG---  327 (397)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~----------~~~~~---  327 (397)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||...........          .....   
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            87766666677899999999999999999999999999999999999999976432211100          00000   


Q ss_pred             -----C----CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHH-----HHHHHHHHH
Q 015965          328 -----L----RPTIPKNSQPKLAELLERCWQQDPALRPDFSEI-----IEILQQIAK  370 (397)
Q Consensus       328 -----~----~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~el-----l~~L~~l~~  370 (397)
                           .    ....+..+++.+.+++.+||..||.+|||+.++     .+.++++++
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                 0    011223467899999999999999999999884     456666544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-42  Score=341.37  Aligned_cols=243  Identities=17%  Similarity=0.189  Sum_probs=189.0

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCC-CCee------------
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH-KNVV------------  174 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv------------  174 (397)
                      ....+|++.+.||+|+||+||+|.+.  ++.||||+++.... .....+.+.+|+.+++.++| +|..            
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456888999999999999999986  78899999884332 22335678999999999987 2211            


Q ss_pred             ---------eeeeEEec-----CCceEEEEEeccCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 015965          175 ---------QFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNII  234 (397)
Q Consensus       175 ---------~~~~~~~~-----~~~~~lv~E~~~g~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~ii  234 (397)
                               .+..++..     ...++++|+++ +++|.+++...      ...+++..++.++.||+.||.|||++||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                     11111111     22467788877 78999998532      34577888999999999999999999999


Q ss_pred             cCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCCccccccccc----------CCCCCCCchhHHHHHHHHHHH
Q 015965          235 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----------EHKPYDHKADVFSFGIVLWEL  304 (397)
Q Consensus       235 HrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~~l~el  304 (397)
                      ||||||+|||++.++.+||+|||+++.....  ....+| +.|+|||++          .+..++.++|||||||++|+|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999998765443  455678 999999999          666788899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          305 LTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       305 l~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ++|+.||...+..+....+..      ....+++++.+||.+||+.||++||++.++++
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999987655433222211      22467899999999999999999999888764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-42  Score=360.16  Aligned_cols=245  Identities=21%  Similarity=0.261  Sum_probs=201.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc--
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--  185 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  185 (397)
                      +-.++|++.+.||+|+||.||++.+.   ++.||||++.... .......+.+|+.++++++||||+++++++...+.  
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            33478999999999999999999874   5779999987542 34556778999999999999999999999987665  


Q ss_pred             ---eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          186 ---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       186 ---~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                         .||||||++|++|.+++..   .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence               7999999999999987754   79999999999999999999999999999999999999975 8999999999865


Q ss_pred             ccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC-CCCCCcHHHH
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-IPKNSQPKLA  341 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~  341 (397)
                      ...   ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.....         ...... .....++.+.
T Consensus       232 ~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~  298 (681)
T 2pzi_A          232 NSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYG  298 (681)
T ss_dssp             TCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHH
T ss_pred             ccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHH
Confidence            443   456799999999999765 48899999999999999999998864211         000000 0012357899


Q ss_pred             HHHHHhchhCCCCCC-CHHHHHHHHHHHHHHhc
Q 015965          342 ELLERCWQQDPALRP-DFSEIIEILQQIAKEVG  373 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rp-s~~ell~~L~~l~~~~~  373 (397)
                      ++|.+||+.||.+|| ++.++...|..++.+..
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  331 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV  331 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence            999999999999999 57788888888877654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-41  Score=317.12  Aligned_cols=222  Identities=23%  Similarity=0.409  Sum_probs=180.8

Q ss_pred             cccccc-ceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHH-hcCCCCCeeeeeeEEec----CCc
Q 015965          114 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPS  185 (397)
Q Consensus       114 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~  185 (397)
                      ++|.+. +.||+|+||.||++.+  .++.||||+++..       ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            456666 7899999999999987  4678999998742       3466788887 66789999999999876    667


Q ss_pred             eEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV  261 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~  261 (397)
                      .++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            899999999999999998753 36999999999999999999999999999999999999998   78999999999864


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCC----CC
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIP----KN  335 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~----~~  335 (397)
                      ..                     +..++.++||||||+++|+|++|..||..................  ...+    ..
T Consensus       170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (299)
T 3m2w_A          170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  228 (299)
T ss_dssp             CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTT
T ss_pred             cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhccc
Confidence            32                     235788999999999999999999999776544332222111111  1122    56


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++++.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          229 VSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            7899999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.2e-43  Score=333.60  Aligned_cols=240  Identities=16%  Similarity=0.237  Sum_probs=189.3

Q ss_pred             cCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCC------ChHHHHHHHHHHHHHhcCC---------CCCeee
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR---------HKNVVQ  175 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~  175 (397)
                      +..++|++.+.||+|+||+||+|+++++.||||+++....      .....+.+.+|+.+++.++         ||||++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            5568899999999999999999999999999999986532      2223467888998888885         777777


Q ss_pred             eeeEEe------------------------------cCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHH
Q 015965          176 FIGACT------------------------------KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM  225 (397)
Q Consensus       176 ~~~~~~------------------------------~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l  225 (397)
                      +.+++.                              ....+|+||||+++|++.+.+.+  +.+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            766542                              26789999999999977666643  6789999999999999999


Q ss_pred             HHHH-hCCcccCCCCCCcEEeCCCC--------------------ceEEcccccccccccCCcccCCCCCcccccccccC
Q 015965          226 NYLH-QNNIIHRDLKAANLLMDENE--------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE  284 (397)
Q Consensus       226 ~~LH-~~~iiHrDlkp~Nili~~~~--------------------~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~  284 (397)
                      .||| ++||+||||||+|||++.++                    .+||+|||+++.....    ..+||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999887                    8999999999876543    347999999999998


Q ss_pred             CCCCCCchhHHHHHHH-HHHHHhCCCCCCCCChHHHH-HHhhhcC-CCCC----CCCCCcHHHHHHHHHhchhCCCCCCC
Q 015965          285 HKPYDHKADVFSFGIV-LWELLTGKLPYEYLTPLQAA-VGVVQKG-LRPT----IPKNSQPKLAELLERCWQQDPALRPD  357 (397)
Q Consensus       285 ~~~~~~~~Dv~slG~~-l~ell~g~~P~~~~~~~~~~-~~~~~~~-~~~~----~~~~~~~~l~~ll~~cl~~dp~~Rps  357 (397)
                      +.. +.++|||||+++ .++++.|..||......... ..+.... ....    .+..+++++.+||.+||+.|     |
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            876 889999998777 77788899998542211111 1222111 1111    12346789999999999977     8


Q ss_pred             HHHHH
Q 015965          358 FSEII  362 (397)
Q Consensus       358 ~~ell  362 (397)
                      +.|++
T Consensus       325 a~e~l  329 (336)
T 2vuw_A          325 ATDLL  329 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.2e-34  Score=295.24  Aligned_cols=182  Identities=14%  Similarity=0.130  Sum_probs=130.9

Q ss_pred             eeeeCCceEEEE--EECCcceEEEEecCCCCC--------hHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCCceEEEE
Q 015965          122 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       122 lg~G~~g~Vy~~--~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      .+.|+.|.+..+  .+.++.+|||++......        ....++|.+|+.+|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456666655544  347899999999765322        12346799999999999 6999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      ||++|++|.+++.. .+.++..   +|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus       322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            99999999999987 4667654   57899999999999999999999999999999999999999999866543 3344


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK  308 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~  308 (397)
                      ..+||+.|||||++.+. +..++|+||+|+++++|.++.
T Consensus       398 t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          398 NLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence            56899999999999875 677899999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=4.8e-31  Score=267.33  Aligned_cols=184  Identities=20%  Similarity=0.251  Sum_probs=148.6

Q ss_pred             ccceeeeeCCceEEEEEECCcceEEEEecCCCCChH------HHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          118 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       118 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ..+.||+|+||.||++++.++.+++|..........      ..+.+.+|+.+|++++||||+++..++......|||||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            356899999999999998999999998765433211      23458999999999999999966665666777899999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc----
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----  267 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~----  267 (397)
                      |++|++|.+++..         +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++.......    
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            9999999999865         5689999999999999999999999999999998  999999999987654322    


Q ss_pred             ----ccCCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015965          268 ----MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYE  312 (397)
Q Consensus       268 ----~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~P~~  312 (397)
                          .....||+.|||||++..  ..|+..+|+|+..+-..+-+.++-+|.
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                235579999999999977  668888999999988888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.2e-26  Score=216.10  Aligned_cols=146  Identities=14%  Similarity=0.144  Sum_probs=116.6

Q ss_pred             ccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCCh----------------HHHHHHHHHHHHHhcCCCCCeeee
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS----------------DMQKEFAQEVFIMRKVRHKNVVQF  176 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~~  176 (397)
                      ..|.+++.||+|+||.||+|.+ .++.||||+++......                .....+.+|+.+|++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            3455669999999999999998 46789999997543211                13567899999999999  4 666


Q ss_pred             eeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccc
Q 015965          177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  256 (397)
Q Consensus       177 ~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~Df  256 (397)
                      .+++.. +..|+||||++|++|.+ +.       ......++.|++.||.|||++||+||||||+|||++ ++.+||+||
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            665543 56799999999999987 42       123557999999999999999999999999999999 999999999


Q ss_pred             ccccccccCCcccCCCCCcccccccccC
Q 015965          257 GVARVKAQSGVMTAETGTYRWMAPEVIE  284 (397)
Q Consensus       257 G~a~~~~~~~~~~~~~gt~~y~aPE~~~  284 (397)
                      |+++.            +..++|||.+.
T Consensus       237 G~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHH
T ss_pred             CCCeE------------CCCCCHHHHHH
Confidence            99963            34568899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.7e-22  Score=185.62  Aligned_cols=137  Identities=16%  Similarity=0.205  Sum_probs=107.6

Q ss_pred             ccccceeeeeCCceEEEEEE--CCcc--eEEEEecCCCCCh----------------------HHHHHHHHHHHHHhcCC
Q 015965          116 LKFGSKVASGSYGDLYRGTY--CSQD--VAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR  169 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~  169 (397)
                      |.+.+.||+|+||.||+|.+  .++.  ||||+++......                      .....+.+|+.+|+++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67789999999999999987  7888  9999986542111                      11235788999999998


Q ss_pred             CCCe--eeeeeEEecCCceEEEEEeccC-C----CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCC
Q 015965          170 HKNV--VQFIGACTKPPSLCIVTEFMSG-G----SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAA  241 (397)
Q Consensus       170 h~ni--v~~~~~~~~~~~~~lv~E~~~g-~----sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~  241 (397)
                      |+++  +.++..    ...+|||||+.+ |    +|.++...    .++..+..++.||+.+|.||| +.||+||||||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            8754  444432    357999999942 3    77766432    235567889999999999999 999999999999


Q ss_pred             cEEeCCCCceEEccccccccc
Q 015965          242 NLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       242 Nili~~~~~vkl~DfG~a~~~  262 (397)
                      |||++.  .++|+|||+|...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999998  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.1e-19  Score=174.63  Aligned_cols=135  Identities=16%  Similarity=0.210  Sum_probs=97.7

Q ss_pred             ccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCCh------------HHHHH--------HHHHHHHHhcCCCCCee
Q 015965          116 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS------------DMQKE--------FAQEVFIMRKVRHKNVV  174 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~------------~~~~~--------~~~E~~~l~~l~h~niv  174 (397)
                      |.+++.||.|+||.||+|.. .|+.||||+++....+.            .....        ..+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            78899999999999999986 57889999987532110            00011        23466666666544432


Q ss_pred             --eeeeEEecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC---
Q 015965          175 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---  249 (397)
Q Consensus       175 --~~~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~---  249 (397)
                        ..++.    ...+|||||++|++|.++.       ..+....++.||+.+|.+||+.|||||||||.|||++++|   
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence              22221    1347999999998886532       1223467889999999999999999999999999998776   


Q ss_pred             -------ceEEcccccccc
Q 015965          250 -------VVKVADFGVARV  261 (397)
Q Consensus       250 -------~vkl~DfG~a~~  261 (397)
                             .+.|+||+.+..
T Consensus       246 d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEE
T ss_pred             cccccccceEEEEeCCccc
Confidence                   389999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.2e-13  Score=126.44  Aligned_cols=138  Identities=12%  Similarity=0.090  Sum_probs=110.8

Q ss_pred             cccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEec
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      .|++...++.|+.+.||+....++.+++|+........  ...+.+|+.+++.+. +..++++++++...+..|+||||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            57777888889999999998778899999987532111  234778999998885 677889999998888899999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  230 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------------  230 (397)
                      +|.+|.+.+.      +......++.++..++..||+                                           
T Consensus        93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9999987531      122234678899999999998                                           


Q ss_pred             ----------------CCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          231 ----------------NNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       231 ----------------~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                                      ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                            448999999999999876667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.30  E-value=6.7e-12  Score=120.29  Aligned_cols=139  Identities=14%  Similarity=0.247  Sum_probs=106.1

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEec--CCCCChHHHHHHHHHHHHHhcCC--CCCeeeeeeEEecC---CceEEEEE
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP---PSLCIVTE  191 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~E  191 (397)
                      .+.|+.|.++.||+.+..+..+++|+..  ..... .....+.+|+.+++.+.  +..+++++.++.+.   +..|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999998888889999876  33211 12346788999999887  45678899888776   45899999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-----------------------------------------  230 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-----------------------------------------  230 (397)
                      |++|..+.+..   ...++......++.+++..|..||+                                         
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99988774311   2346777888899999999999997                                         


Q ss_pred             -----------------CCcccCCCCCCcEEeCCCCc--eEEcccccccc
Q 015965          231 -----------------NNIIHRDLKAANLLMDENEV--VKVADFGVARV  261 (397)
Q Consensus       231 -----------------~~iiHrDlkp~Nili~~~~~--vkl~DfG~a~~  261 (397)
                                       .+++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             36899999999999997753  69999999864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=3.6e-12  Score=115.90  Aligned_cols=132  Identities=12%  Similarity=0.128  Sum_probs=95.9

Q ss_pred             ccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC--eeeeeeEEecCCceEEEEEe
Q 015965          116 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       116 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~E~  192 (397)
                      +.+....+.|..+.||++... ++.+++|+.....     ...+.+|+.+++.+.+.+  ++++++++...+..++||||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            343333345666999998754 4679999976541     134678888888886544  56688888887889999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN----------------------------------------  232 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  232 (397)
                      ++|.+|.  ..    ...   ...++.+++..+..||+..                                        
T Consensus        97 i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998884  21    111   2246667777777777643                                        


Q ss_pred             ------------------cccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          233 ------------------IIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       233 ------------------iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                                        ++|+|++|.||+++.++.+.|+|||.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              99999999999998777777999999853

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.19  E-value=3.6e-11  Score=112.48  Aligned_cols=182  Identities=17%  Similarity=0.204  Sum_probs=121.3

Q ss_pred             ceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCC--eeeeeeEEecCC---ceEEEEEec
Q 015965          120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKN--VVQFIGACTKPP---SLCIVTEFM  193 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~E~~  193 (397)
                      +.++.|.+..||+.   ++.+++|+....    .....+.+|..+|+.+. +..  +++++.......   ..|+||+++
T Consensus        26 ~~~~~G~~n~v~~v---~~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEI---NRDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEES---TTSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEE---CCEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            46899999999986   367999986532    34567889999998874 322  445555443333   348899999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  230 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------------  230 (397)
                      +|.+|.+...   ..++......++.+++..+..||+                                           
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988875432   236677777788888888888885                                           


Q ss_pred             ---------------CCcccCCCCCCcEEeCC--CCceEEcccccccccccCCcccCCCCCccccccccc----CCCC-C
Q 015965          231 ---------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKP-Y  288 (397)
Q Consensus       231 ---------------~~iiHrDlkp~Nili~~--~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~-~  288 (397)
                                     ..++|+|++|.||++++  ++.+.|+||+.+...+.............-..|+..    .... .
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                           23799999999999998  567899999998754432111110000000122211    1100 0


Q ss_pred             ---------CCchhHHHHHHHHHHHHhCCCCC
Q 015965          289 ---------DHKADVFSFGIVLWELLTGKLPY  311 (397)
Q Consensus       289 ---------~~~~Dv~slG~~l~ell~g~~P~  311 (397)
                               ....++|+++.++|.+.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     11268999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.79  E-value=8.3e-08  Score=89.69  Aligned_cols=133  Identities=17%  Similarity=0.172  Sum_probs=92.5

Q ss_pred             ceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC---CeeeeeeEEe-cCCceEEEEEeccC
Q 015965          120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACT-KPPSLCIVTEFMSG  195 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~E~~~g  195 (397)
                      +.++.|....||+.   ++.+++|+-.    .......+.+|..+|+.+.+.   .+++++.++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45788888899987   7889999853    233456788999999998752   3566777664 44567899999999


Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---------------------------------------------  230 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~---------------------------------------------  230 (397)
                      .+|.+..-   ..++......++.++...|..||+                                             
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88876321   123333444444444444444443                                             


Q ss_pred             ---------------CCcccCCCCCCcEEeCC---CCc-eEEccccccccc
Q 015965          231 ---------------NNIIHRDLKAANLLMDE---NEV-VKVADFGVARVK  262 (397)
Q Consensus       231 ---------------~~iiHrDlkp~Nili~~---~~~-vkl~DfG~a~~~  262 (397)
                                     ..++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           24599999999999987   355 589999988643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.67  E-value=2.5e-07  Score=84.38  Aligned_cols=131  Identities=17%  Similarity=0.239  Sum_probs=93.3

Q ss_pred             eeeeeCCc-eEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEeccCC
Q 015965          121 KVASGSYG-DLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       121 ~lg~G~~g-~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      .+..|..| .||+....  +..+++|+-...     ....+.+|...|+.+. +--+++++.++.+++..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45556665 58987643  457999986532     3456888999988775 334778888888888899999999998


Q ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 015965          197 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------------------------------------------  231 (397)
Q Consensus       197 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------------------------------------------  231 (397)
                      ++.+.....     ......++.++...|..||+.                                             
T Consensus       106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            887765431     112233445555555555531                                             


Q ss_pred             -------------CcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          232 -------------NIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       232 -------------~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                                   .++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         278999999999999887778999998854

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.42  E-value=1.4e-06  Score=81.92  Aligned_cols=135  Identities=18%  Similarity=0.218  Sum_probs=78.0

Q ss_pred             ceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeee------EEecCCceEEEEE
Q 015965          120 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIG------ACTKPPSLCIVTE  191 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~E  191 (397)
                      +.|+.|..+.||+....+..+++|+....   .   ..+..|..+++.+..  -.+++++.      +....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45666778899999877777999998752   2   223344444444421  12333332      1123556789999


Q ss_pred             eccCCCHH-----------H---HHHhccCCC-------------CHHH-------------------------------
Q 015965          192 FMSGGSVY-----------D---YLHKLKGVF-------------KLPS-------------------------------  213 (397)
Q Consensus       192 ~~~g~sL~-----------~---~l~~~~~~l-------------~~~~-------------------------------  213 (397)
                      |++|.++.           .   .++.....+             .+..                               
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986432           1   122211111             1110                               


Q ss_pred             HHHHHHHHHHHHHHHH-------------hCCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          214 LLKVAIDVSKGMNYLH-------------QNNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       214 ~~~i~~qi~~~l~~LH-------------~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      +..+..++..++.+|+             ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111122334566665             3579999999999999888899999999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=1.4e-07  Score=89.90  Aligned_cols=79  Identities=14%  Similarity=0.084  Sum_probs=53.8

Q ss_pred             ccee-eeeCCceEEEEEEC--------CcceEEEEecCCC---CChHHHHHHHHHHHHHhcCCC---CCeeeeeeEEecC
Q 015965          119 GSKV-ASGSYGDLYRGTYC--------SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKP  183 (397)
Q Consensus       119 ~~~l-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~  183 (397)
                      .+.| +.|....+|+....        ++.+++|+.....   ...  ...+.+|+.+++.+..   -.+++++.++.+.
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            3567 78888999988765        6679999865432   100  1345678888777742   3567788877665


Q ss_pred             ---CceEEEEEeccCCCHH
Q 015965          184 ---PSLCIVTEFMSGGSVY  199 (397)
Q Consensus       184 ---~~~~lv~E~~~g~sL~  199 (397)
                         +..++||||++|.++.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3568999999886543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=1.5e-06  Score=84.05  Aligned_cols=76  Identities=12%  Similarity=-0.001  Sum_probs=48.4

Q ss_pred             cceeeeeCCceEEEEEE--CCcceEEEEecCCCC--Ch---HHHHHHHHHHHHHhcCCC--C-CeeeeeeEEecCCceEE
Q 015965          119 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NS---DMQKEFAQEVFIMRKVRH--K-NVVQFIGACTKPPSLCI  188 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l  188 (397)
                      .+.||.|.++.||+++.  .++.++||...+...  ..   .....+..|..+++.+..  + .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            35789999999999954  467899998764321  00   112345678888877642  3 34556654  3345689


Q ss_pred             EEEeccCC
Q 015965          189 VTEFMSGG  196 (397)
Q Consensus       189 v~E~~~g~  196 (397)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.21  E-value=2e-05  Score=68.65  Aligned_cols=139  Identities=14%  Similarity=0.171  Sum_probs=96.9

Q ss_pred             CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCCC
Q 015965          196 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  274 (397)
Q Consensus       196 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  274 (397)
                      -||.+.|...+.++++.++|.++.|.+.+|.-+- +..-..+=+.|..|++..+|.|.+.+ +.+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            4899999999999999999999999999987762 12212334457999999999988764 1110           123


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh----
Q 015965          275 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ----  350 (397)
Q Consensus       275 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~----  350 (397)
                      ..+.|||... ...+.+.=|||||+++|.-+-                   -++.+..+..+++.|..||..|..-    
T Consensus       101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d~  160 (229)
T 2yle_A          101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMANTVEAD  160 (229)
T ss_dssp             ------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTTCCC--
T ss_pred             cCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHhccccc
Confidence            3566888764 334678899999999998765                   2334456678899999999999865    


Q ss_pred             ---------------------CCCCCCCHHHHHHHHH
Q 015965          351 ---------------------DPALRPDFSEIIEILQ  366 (397)
Q Consensus       351 ---------------------dp~~Rps~~ell~~L~  366 (397)
                                           .+..|++++++++.=.
T Consensus       161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             ------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence                                 2457889998875543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.14  E-value=4e-06  Score=81.75  Aligned_cols=78  Identities=15%  Similarity=0.200  Sum_probs=48.3

Q ss_pred             HhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccCCCC--CcccccccccCCCCC---CCchhHHHHHHHHHH
Q 015965          229 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKPY---DHKADVFSFGIVLWE  303 (397)
Q Consensus       229 H~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~---~~~~Dv~slG~~l~e  303 (397)
                      +...++|+|++|.|||++.++ +.|+||+.+..............  ...|++|+......-   ....++......+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456899999999999999877 99999999875432211111111  134566655432111   112455677777777


Q ss_pred             HHhC
Q 015965          304 LLTG  307 (397)
Q Consensus       304 ll~g  307 (397)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=2.1e-05  Score=73.49  Aligned_cols=75  Identities=16%  Similarity=0.129  Sum_probs=60.1

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC---CCCeeeeeeEEecCCceEEEEEeccC
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVTEFMSG  195 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~E~~~g  195 (397)
                      .+.|+.|.+..+|+....+..+++|+....     ....+..|...|+.+.   ...+++++.++...+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            357899999999999877788999987632     1456788988888774   35688888888877889999999998


Q ss_pred             CCH
Q 015965          196 GSV  198 (397)
Q Consensus       196 ~sL  198 (397)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.78  E-value=6.4e-05  Score=69.58  Aligned_cols=133  Identities=18%  Similarity=0.213  Sum_probs=74.5

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe-eeeeeEEecCCceEEEEEec-cCC
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFM-SGG  196 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~-~g~  196 (397)
                      .+.|+.|....+|+.    +.+++|+.......   .....+|..+++.+...++ +++++..  +..-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            577889999999998    77999987753211   1112356766666542222 4555543  33457899999 665


Q ss_pred             CHHHH------------------HHhccCCCC-----HHHHHHHHH--------------HHHHHHHH----HH----hC
Q 015965          197 SVYDY------------------LHKLKGVFK-----LPSLLKVAI--------------DVSKGMNY----LH----QN  231 (397)
Q Consensus       197 sL~~~------------------l~~~~~~l~-----~~~~~~i~~--------------qi~~~l~~----LH----~~  231 (397)
                      +|...                  ++.....++     ...+..+..              .+...+..    +.    ..
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            54320                  111111111     111111111              11111111    11    12


Q ss_pred             CcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          232 NIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       232 ~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5567789999998854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.76  E-value=6.1e-05  Score=70.72  Aligned_cols=136  Identities=15%  Similarity=0.105  Sum_probs=71.3

Q ss_pred             eeeeeCCce-EEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeeeEEecCCceEEEEEeccCC
Q 015965          121 KVASGSYGD-LYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       121 ~lg~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      .|+.|.... +|+.... ++.+++|...+...     ..+..|+.+++.+..  -.+++++.+....  -+++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            455554443 6676653 66677776554321     123345555555532  2355666654333  37899999777


Q ss_pred             CHHHHHHhcc-------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH---
Q 015965          197 SVYDYLHKLK-------------------------GVFKLPSLL-------K-VA------------IDVSKGMNYL---  228 (397)
Q Consensus       197 sL~~~l~~~~-------------------------~~l~~~~~~-------~-i~------------~qi~~~l~~L---  228 (397)
                      ++.+++....                         ..+......       . +.            ..+...+..+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            7765443110                         011111110       0 00            0111222333   


Q ss_pred             ---HhCCcccCCCCCCcEEeCCC----CceEEcccccccccc
Q 015965          229 ---HQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKA  263 (397)
Q Consensus       229 ---H~~~iiHrDlkp~Nili~~~----~~vkl~DfG~a~~~~  263 (397)
                         +...++|||+.+.||+++.+    +.+.|+||+.+....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence               23479999999999999875    689999999986543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.61  E-value=0.00015  Score=67.59  Aligned_cols=139  Identities=14%  Similarity=0.153  Sum_probs=77.9

Q ss_pred             cceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC--eeeeeeE------EecCCceEEEE
Q 015965          119 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA------CTKPPSLCIVT  190 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  190 (397)
                      .+.|+.|....+|+....+..+++|+......    ...+..|+.+++.+...+  +++++..      ....+..+++|
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            35677888889999987777899999875311    123445666666553211  2333321      12234568999


Q ss_pred             EeccCCCHH-----------HH---HHhccCCC--------CHHHHHH---------------HHHHHHHHHHHHHh---
Q 015965          191 EFMSGGSVY-----------DY---LHKLKGVF--------KLPSLLK---------------VAIDVSKGMNYLHQ---  230 (397)
Q Consensus       191 E~~~g~sL~-----------~~---l~~~~~~l--------~~~~~~~---------------i~~qi~~~l~~LH~---  230 (397)
                      +|++|..+.           ..   ++.....+        .......               +...+...++.+..   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999886431           11   12111111        1000000               00113344555552   


Q ss_pred             ----CCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          231 ----NNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       231 ----~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                          .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                3699999999999999876678999998753

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5

Probab=97.51  E-value=0.00014  Score=62.73  Aligned_cols=64  Identities=17%  Similarity=0.277  Sum_probs=52.5

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV   67 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~   67 (397)
                      +.|++++.|+|+++++++++|++.|+||.++..|.+.+++.+ .++|+. +....++++++|....
T Consensus         7 ~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~~~   70 (192)
T 1u8s_A            7 LVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPLLG   70 (192)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHHHH
T ss_pred             EEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHHHH
Confidence            579999999999999999999999999999999998777777 555554 2346677777777644

>1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7

Probab=97.43  E-value=0.00043  Score=51.72  Aligned_cols=67  Identities=22%  Similarity=0.219  Sum_probs=52.7

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK   69 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~~~   69 (397)
                      +.|++.+.|+|++|+.++++|++.|.||.....+..- |...-.+.++....+..+++.++|++....
T Consensus         6 ~~l~v~~~DrpGila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~~~   72 (91)
T 1zpv_A            6 AIITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFGQT   72 (91)
T ss_dssp             EEEEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred             EEEEEEECCCCCHHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHHHH
Confidence            4689999999999999999999999999998887654 655555555543456788899888875544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.39  E-value=0.00035  Score=68.15  Aligned_cols=72  Identities=13%  Similarity=0.245  Sum_probs=48.1

Q ss_pred             cceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe-eeeeeEEecCCceEE
Q 015965          119 GSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCI  188 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~l  188 (397)
                      .+.|+.|....+|+....         ++.+++|+..... .   ...+.+|..+++.+...++ +++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            356888888999999864         3679999985321 1   1344578888887753333 566765542    38


Q ss_pred             EEEeccCCCH
Q 015965          189 VTEFMSGGSV  198 (397)
Q Consensus       189 v~E~~~g~sL  198 (397)
                      |+||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999987443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.39  E-value=0.00077  Score=61.76  Aligned_cols=78  Identities=14%  Similarity=0.109  Sum_probs=53.9

Q ss_pred             ccccccceeeeeCCceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC---CCeeeeeeEEecCCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv  189 (397)
                      .++.-++.+|.|..+.||+.+. +|+.|.+|+........  ...|..|...|+.+.-   --+++++.+.    .-++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3455567899999999999987 46789999866443221  2347788888887742   2345566543    24889


Q ss_pred             EEeccCCC
Q 015965          190 TEFMSGGS  197 (397)
Q Consensus       190 ~E~~~g~s  197 (397)
                      |||+.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.00084  Score=64.24  Aligned_cols=135  Identities=13%  Similarity=0.203  Sum_probs=79.4

Q ss_pred             ceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEE
Q 015965          120 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  189 (397)
                      +.|.-|-...+|+....         ++.+++|+.....   .....+.+|..+++.+. +.-.+++++.+.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            45766778889988763         3678999853321   11345568888888775 2223566766643    389


Q ss_pred             EEeccCCCHHH--------------HH---HhccC----CCC--HHHHHHHHHHHHH-------------------HHHH
Q 015965          190 TEFMSGGSVYD--------------YL---HKLKG----VFK--LPSLLKVAIDVSK-------------------GMNY  227 (397)
Q Consensus       190 ~E~~~g~sL~~--------------~l---~~~~~----~l~--~~~~~~i~~qi~~-------------------~l~~  227 (397)
                      |||++|.+|..              .|   +...-    ...  +..+.++..++-.                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998865431              11   11111    111  3445555544422                   2333


Q ss_pred             HH----h----CCcccCCCCCCcEEeCCC----CceEEcccccccc
Q 015965          228 LH----Q----NNIIHRDLKAANLLMDEN----EVVKVADFGVARV  261 (397)
Q Consensus       228 LH----~----~~iiHrDlkp~Nili~~~----~~vkl~DfG~a~~  261 (397)
                      |.    .    ..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32    2    258999999999999876    7899999998853

>2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria}

Probab=97.23  E-value=0.00029  Score=60.91  Aligned_cols=47  Identities=11%  Similarity=0.298  Sum_probs=42.6

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEec
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD   49 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd   49 (397)
                      ++|++++-|+|+|+++++++|++.|+||.+|..|.+.++|.+ .+.|+
T Consensus         6 ~~ltv~~~DrpGiva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~   52 (195)
T 2nyi_A            6 FVVSVAGSDRVGIVHDFSWALKNISANVESSRMACLGGDFAM-IVLVS   52 (195)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE
T ss_pred             EEEEEEeCCCCcHHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEE
Confidence            479999999999999999999999999999999998899988 44454

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.22  E-value=0.0023  Score=59.52  Aligned_cols=136  Identities=16%  Similarity=0.165  Sum_probs=76.9

Q ss_pred             eeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCC--CeeeeeeE-----EecCCceEEEEEe
Q 015965          121 KVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGA-----CTKPPSLCIVTEF  192 (397)
Q Consensus       121 ~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~E~  192 (397)
                      .++ |....||+.... ++.+++|+..+.....   ..+..|..+++.+...  .+++++..     ....+..+++|++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            466 777889988654 4579999987543332   3455677777666421  23444433     1123456789999


Q ss_pred             ccCCCHH-----H------H---HHhccC--------CCCHHHH----------------------HHHHHHHHHHHHHH
Q 015965          193 MSGGSVY-----D------Y---LHKLKG--------VFKLPSL----------------------LKVAIDVSKGMNYL  228 (397)
Q Consensus       193 ~~g~sL~-----~------~---l~~~~~--------~l~~~~~----------------------~~i~~qi~~~l~~L  228 (397)
                      ++|.++.     .      .   ++....        .......                      ...+.+++..+.-+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431     1      1   111100        1111110                      01111222222211


Q ss_pred             ----HhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          229 ----HQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       229 ----H~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                          ....++|+|+++.||+++ + .+.|+||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                234689999999999999 4 8999999987543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.17  E-value=0.00044  Score=65.81  Aligned_cols=72  Identities=11%  Similarity=0.135  Sum_probs=42.6

Q ss_pred             ceeeeeCCceEEEEEECC----------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC-eeeeeeEEecCCceEE
Q 015965          120 SKVASGSYGDLYRGTYCS----------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCI  188 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l  188 (397)
                      +.|+.|..-.+|+....+          +.+++|+......   .......|..+++.+...+ ++++++..  +  -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            467788888999988754          6788888654311   1112346777777665333 44666544  2  378


Q ss_pred             EEEeccCCCH
Q 015965          189 VTEFMSGGSV  198 (397)
Q Consensus       189 v~E~~~g~sL  198 (397)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A

Probab=96.90  E-value=0.0017  Score=47.85  Aligned_cols=61  Identities=18%  Similarity=0.175  Sum_probs=42.3

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL   63 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l   63 (397)
                      ..|++...|+|++|++++++|++.|.||........ ++...-.+.++....+..+++.+++
T Consensus         6 ~~l~v~~~Dr~G~L~~I~~~la~~~inI~~i~~~~~-~~~~~~~i~v~~~~~~~l~~l~~~L   66 (88)
T 2ko1_A            6 AGIRIVGEDKNGMTNQITGVISKFDTNIRTIVLNAK-DGIFTCNLMIFVKNTDKLTTLMDKL   66 (88)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHTTSSSCEEEEEEEEC-SSEEEEEEEEEESSHHHHHHHHHHH
T ss_pred             EEEEEEEECCCcHHHHHHHHHHHCCCCeEEEEEEEc-CCEEEEEEEEEECCHHHHHHHHHHH
Confidence            357889999999999999999999999998777543 3433334444443334444444444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.89  E-value=0.0053  Score=60.19  Aligned_cols=72  Identities=19%  Similarity=0.148  Sum_probs=46.7

Q ss_pred             ceeeeeCCceEEEEEECC--cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe-eeeeeEEecCCceEEEEEeccCC
Q 015965          120 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      +.|+.|-...+|+....+  ..+++|+........   ....+|..+++.+...++ +++++.+.  +  .+||||++|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            567888889999998876  779999875432110   112468888888765444 56777663  2  3599999875


Q ss_pred             CH
Q 015965          197 SV  198 (397)
Q Consensus       197 sL  198 (397)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.81  E-value=0.0058  Score=57.38  Aligned_cols=33  Identities=21%  Similarity=0.412  Sum_probs=28.6

Q ss_pred             CCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       231 ~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            468999999999999988889999998876433

>2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6

Probab=96.28  E-value=0.012  Score=48.91  Aligned_cols=63  Identities=22%  Similarity=0.243  Sum_probs=49.8

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC-CceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~-g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |.|.+-..|+|++|++++.++++-|.||.-..+..+.+ |.+-=.++|++ ..+..+++...+.+
T Consensus         4 ~~IsV~v~NrpGvLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~~-d~~~leqI~kqL~K   67 (164)
T 2f1f_A            4 RILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG-DEKVLEQIEKQLHK   67 (164)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES-CHHHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcHHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEec-cHHHHHHHHHHHcC
Confidence            88999999999999999999999999999888876664 76666777874 34455555555554

>2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria}

Probab=96.24  E-value=0.007  Score=52.13  Aligned_cols=68  Identities=19%  Similarity=0.107  Sum_probs=47.1

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC-CceeeeEEe----cCCCchhHHHHHHHHHHHHHHh
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVV----DGWPYEETEQLRAALEKEVLKL   70 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~-g~~l~~~vv----d~~~~~~~~~l~~~l~~~~~~~   70 (397)
                      |-|++++.|+|+++..+|.+|++.|+||.++..|..-. ...-++|.+    +.-...+ ++|+++|.....++
T Consensus        94 ~iltv~g~DrpGiva~Vt~~La~~g~nI~~~~~~t~~~~~~~~~~F~m~~~~~~~~~~~-~~l~~~l~~~a~~l  166 (195)
T 2nyi_A           94 YELYVEGPDSEGIVEAVTAVLAKKGANIVELETETLPAPFAGFTLFRMGSRVAFPFPLY-QEVVTALSRVEEEF  166 (195)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEEECSSTTCEEEEEEEEEEEEGGGH-HHHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCHHHHHHHHHHHcCCCEEEceeeecccccCCCCeEEEEEEEEcCCCcc-HHHHHHHHHHHHHc
Confidence            45899999999999999999999999999999985430 000123332    2112334 77888887655443

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5

Probab=95.78  E-value=0.025  Score=48.39  Aligned_cols=69  Identities=16%  Similarity=0.079  Sum_probs=48.3

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccC-------CCceeeeEEecCCCchhHHHHHHHHHHHHHHh
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL   70 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~-------~g~~l~~~vvd~~~~~~~~~l~~~l~~~~~~~   70 (397)
                      +-|++.+.|+|+++..++.+|++.|+||..+..|..-       .+...--+.++.....+.+++++++.....++
T Consensus        94 ~~l~v~~~D~~Gil~~v~~~l~~~~~nI~~~~~~t~~~~~~~~~~~~F~~~~~~~~~~~~~~~~l~~~l~~~~~~~  169 (192)
T 1u8s_A           94 VEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAISARVDSGCNLMQLQEEFDALCTAL  169 (192)
T ss_dssp             EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEEEEECTTSCHHHHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCccHHHHHHHHHHHcCCcHHHhhhhcccCCccCCCCCEEEEEEEEeCCCCCCHHHHHHHHHHHHHHh
Confidence            3478999999999999999999999999999998543       11111111223223346788888888755543

>2pc6_A Probable acetolactate synthase isozyme III (small; regulatory subunit, structural genomi protein structure initiative; HET: MSE; 2.50A {Nitrosomonas europaea atcc 19718} SCOP: d.58.18.6 d.58.18.6

Probab=95.76  E-value=0.025  Score=47.04  Aligned_cols=63  Identities=30%  Similarity=0.413  Sum_probs=48.7

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC-CceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~-g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |.|.+-..|+|++|++++.++++-|.||.-..+..+-+ |.+-=.++|++ ..+..+++...+.+
T Consensus         5 ~~IsV~veNrpGvL~rI~~lfs~rg~NI~Sl~v~~t~d~g~sritivV~~-d~~~leql~kQL~K   68 (165)
T 2pc6_A            5 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQITKQLNK   68 (165)
T ss_dssp             EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEE-CHHHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcHHHHHHHHHHHCCCcEEEEEEEecCCCCEEEEEEEEec-cHHHHHHHHHHhcC
Confidence            78999999999999999999999999999888876664 66666667774 34445555555543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.74  E-value=0.034  Score=53.84  Aligned_cols=72  Identities=13%  Similarity=0.175  Sum_probs=45.5

Q ss_pred             ceeeeeCCceEEEEEEC---------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC-CCeeeeeeEEecCCceEEE
Q 015965          120 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv  189 (397)
                      +.|..|....+|+....         ++.+++|+.......   .....+|..+++.+.. .-.+++++.+.    -++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            46777888889998876         577999986543211   1123467777776642 22355665432    3789


Q ss_pred             EEeccCCCH
Q 015965          190 TEFMSGGSV  198 (397)
Q Consensus       190 ~E~~~g~sL  198 (397)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

>3n0v_A Formyltetrahydrofolate deformylase; formyl transferase, ACT domain, structural genomics, joint C structural genomics, JCSG; HET: MSE; 2.25A {Pseudomonas putida}

Probab=94.96  E-value=0.057  Score=49.24  Aligned_cols=66  Identities=15%  Similarity=0.075  Sum_probs=48.7

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeeccccc-CCCceeeeEEecCCCchhHHHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPYEETEQLRAALEKEV   67 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t-~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~   67 (397)
                      +-||+++.|+|++..++|+.|++.|.||.+...|.. ..|...=...++.....+.++++++++.-.
T Consensus         9 ~vLtv~c~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~L~~~f~~la   75 (286)
T 3n0v_A            9 WILTADCPSMLGTVDVVTRYLFEQRCYVTEHHSFDDRQSGRFFIRVEFRQPDDFDEAGFRAGLAERS   75 (286)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEECCSSCCHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCCCHHHHHHHHHHHCCCCeeeeeeeccCCCCeeEEEEEEecCCCCCHHHHHHHHHHHH
Confidence            358999999999999999999999999999999842 234333333344322346788888887543

>3obi_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 1.95A {Rhodopseudomonas palustris}

Probab=94.77  E-value=0.05  Score=49.64  Aligned_cols=67  Identities=21%  Similarity=0.279  Sum_probs=49.6

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccC-CCceeeeEEecCCC-chhHHHHHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWP-YEETEQLRAALEKEVLK   69 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~-~g~~l~~~vvd~~~-~~~~~~l~~~l~~~~~~   69 (397)
                      -||+++.|+|++..++|+.|++.|.||.+...|.+. .|...=...++... ..+.++|+++++.-..+
T Consensus         8 iLtv~g~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~~L~~~f~~la~~   76 (288)
T 3obi_A            8 VLTLSCPDRAGIVSAVSTFLFENGQNILDAQQYNDTESGHFFMRVVFNAAAKVIPLASLRTGFGVIAAK   76 (288)
T ss_dssp             EEEEEEECCTTHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEEESSCCCCHHHHHHHHHHHHHH
T ss_pred             EEEEECCCCCCHHHHHHHHHHHCCCcEEeeeeeecCCCCceEEEEEEEcCCCCCCHHHHHHHHHHHHHH
Confidence            489999999999999999999999999999998543 45433333333221 23678888888764443

>3lou_A Formyltetrahydrofolate deformylase; structural genomics, JOI for structural genomics, JCSG, protein structure initiative hydrolase; HET: MSE; 1.90A {Burkholderia mallei}

Probab=94.65  E-value=0.057  Score=49.37  Aligned_cols=67  Identities=15%  Similarity=0.142  Sum_probs=48.7

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccc-cCCCceeeeEEecCC--C-chhHHHHHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGW--P-YEETEQLRAALEKEVLK   69 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~-t~~g~~l~~~vvd~~--~-~~~~~~l~~~l~~~~~~   69 (397)
                      -+|+++-|+|++..++|+.|++.|.||.++..|. ...|...=...++..  . ..+.++|+++++.-..+
T Consensus        12 vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~~~~L~~~f~~la~~   82 (292)
T 3lou_A           12 VLTLSCPSAAGQVAAVVGLLDRHRCYVDELTVFDDDLSARFFVRCVFHATDDADALRVDALRREFEPIAER   82 (292)
T ss_dssp             EEEEEEESCSCHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEEECC----CCHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCCCCHHHHHHHHHHHCCCCEEeeEEEecCCCCceEEEEEEEccCcccCCCHHHHHHHHHHHHHh
Confidence            4899999999999999999999999999999985 234433333333432  1 24678888888765444

>3o1l_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 2.20A {Pseudomonas syringae PV}

Probab=94.62  E-value=0.072  Score=48.88  Aligned_cols=67  Identities=15%  Similarity=0.175  Sum_probs=49.3

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeeccccc-CCCceeeeEEecCCC-chhHHHHHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWP-YEETEQLRAALEKEVLK   69 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t-~~g~~l~~~vvd~~~-~~~~~~l~~~l~~~~~~   69 (397)
                      =+|+++.|+|++...+|+.|++.|.||.++..|.. ..|...=...++... ..+.++|+++++.-..+
T Consensus        24 iLtv~c~DrpGIVa~VS~~La~~g~NI~d~~q~~d~~~g~FfMr~~~~~~~~~~~~~~L~~~l~~la~~   92 (302)
T 3o1l_A           24 RLVIACPDRVGIVAKVSNFLASHNGWITEASHHSDNLSGWFFMRHEIRADTLPFDLDGFREAFTPIAEE   92 (302)
T ss_dssp             EEEEEEECCTTHHHHHHHHHHHTTCCEEEEEEEEETTTTEEEEEEEEEGGGSSSCHHHHHHHHHHHHHH
T ss_pred             EEEEECCCCCCHHHHHHHHHHHCCCCEEEeeEEecCCCCeEEEEEEEecCCCCCCHHHHHHHHHHHHHH
Confidence            38999999999999999999999999999999853 245443333344211 23678888888765444

>3nrb_A Formyltetrahydrofolate deformylase; N-terminal ACT domain, structural genomics, joint center for structural genomics, JCSG; HET: MSE FLC; 2.05A {Pseudomonas putida}

Probab=94.51  E-value=0.05  Score=49.65  Aligned_cols=63  Identities=22%  Similarity=0.348  Sum_probs=44.6

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccC-CCceeeeEEecCCCchhHHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPYEETEQLRAALEKE   66 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~-~g~~l~~~vvd~~~~~~~~~l~~~l~~~   66 (397)
                      =+|+++.|+|++...+|+.|++.|.||.++..|.+. .|...=...++. +..+.++|+++++.-
T Consensus         9 vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~-~~~~~~~L~~~f~~l   72 (287)
T 3nrb_A            9 VLSLACQDAPGIVSEVSTFLFNNGANIVEAEQFNDEDSSKFFMRVSVEI-PVAGVNDFNSAFGKV   72 (287)
T ss_dssp             EEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEEC-CC---CHHHHHHHHH
T ss_pred             EEEEECCCCCCHHHHHHHHHHHCCCCEEeeeeeecCCCCeEEEEEEEEc-CCCCHHHHHHHHHHH
Confidence            379999999999999999999999999999999533 444333333343 222344777777653

>2fgc_A Acetolactate synthase, small subunit; regulatory subunit, structural genomi protein structure initiative; 2.30A {Thermotoga maritima} SCOP: d.58.18.6 d.58.18.6

Probab=93.58  E-value=0.11  Score=43.96  Aligned_cols=63  Identities=25%  Similarity=0.337  Sum_probs=47.8

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC-CceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~-g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |-|++..-|+|+.|++++.++++-|.||.--.+..|.+ |.+-=.++|++. ....+++...+.+
T Consensus        30 ~~LsVlVeN~pGvLaRItglfsrRG~NI~SLtV~~ted~gisRitIvV~g~-e~~ieqL~kQL~K   93 (193)
T 2fgc_A           30 HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKGD-DKTIEQIEKQAYK   93 (193)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHTTTCEEEEEEEEECSSTTEEEEEEEEEEC-TTHHHHHHHHHTT
T ss_pred             EEEEEEECCCChHHHHHHHHHHHCCceEEEEEeeccCCCCEEEEEEEEECC-HHHHHHHHHHhcC
Confidence            67888899999999999999999999998877766665 555556677754 3455556555543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=93.54  E-value=0.0082  Score=58.96  Aligned_cols=62  Identities=8%  Similarity=0.030  Sum_probs=18.0

Q ss_pred             cccceeeeeCCceEEEEEECC--cceEE------EEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          117 KFGSKVASGSYGDLYRGTYCS--QDVAI------KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       117 ~~~~~lg~G~~g~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      .+.++||   ||+||+|.+.+  .+||+      |..+......+....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456777   99999999865  47888      776655445555567889999999999999999887653

>3p96_A Phosphoserine phosphatase SERB; ssgcid, structural genomics, structural genomics center for infectious disease, hydrolas; 2.05A {Mycobacterium avium}

Probab=93.41  E-value=0.067  Score=51.49  Aligned_cols=65  Identities=23%  Similarity=0.330  Sum_probs=46.2

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCch--hHHHHHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEVLK   69 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~--~~~~l~~~l~~~~~~   69 (397)
                      =||+++.|||++.+.+|++|++.|.||.+..-+....-|.+-+ .++. +..  +.++++++++....+
T Consensus        14 ~lt~~g~Dr~Giv~~vs~~l~~~~~nI~d~~q~~~~~~f~~~~-~~~~-~~~~~~~~~l~~~l~~~~~~   80 (415)
T 3p96_A           14 LITVTGVDQPGVTATLFEVLSRHGVELLNVEQVVIRHRLTLGV-LVCC-PADVADGPALRHDVEAAIRK   80 (415)
T ss_dssp             EEEEEEECCTTHHHHHHHHHTTTTCEEEEEEEEEETTEEEEEE-EEEE-CHHHHTSHHHHHHHHHHHHH
T ss_pred             EEEEEcCCCCCHHHHHHHHHHHCCCCEEEeeeEEECCEeEEEE-EEEe-cCCcCCHHHHHHHHHHHHHH
Confidence            3899999999999999999999999999998875433233333 2332 222  347788888764333

>1y7p_A Hypothetical protein AF1403; structural genomics, protein structure initiative, PSI, alpha-beta-alpha sandwich; HET: RIP; 1.90A {Archaeoglobus fulgidus} SCOP: c.23.1.7 d.58.18.12

Probab=92.50  E-value=0.19  Score=43.24  Aligned_cols=60  Identities=25%  Similarity=0.391  Sum_probs=41.7

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccC----CCceeeeEEecCCCchhHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV----DGYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~----~g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      +|.+...|+|++|+.++++|++.+.||.-.+.+...    +|.+.=.+-++..   +.+++.+.+++
T Consensus         6 tL~I~a~DRpGLLsDIt~vLAe~kiNIltIn~~~~~kG~~ng~A~I~IEV~d~---~Le~LL~kLrk   69 (223)
T 1y7p_A            6 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGG---DFEKILERVKT   69 (223)
T ss_dssp             EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEEEEEECSS---CHHHHHHHHHT
T ss_pred             EEEEEEcCCCCHHHHHHHHHHHcCCCceEEEEEccccCCcCCEEEEEEEECCC---CHHHHHHHHhC
Confidence            678899999999999999999999999999998877    5544444433433   55666655543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.72  E-value=0.056  Score=51.84  Aligned_cols=29  Identities=24%  Similarity=0.469  Sum_probs=25.1

Q ss_pred             cccCCCCCCcEEe------CCCCceEEcccccccc
Q 015965          233 IIHRDLKAANLLM------DENEVVKVADFGVARV  261 (397)
Q Consensus       233 iiHrDlkp~Nili------~~~~~vkl~DfG~a~~  261 (397)
                      ++|+|+.+.|||+      ++++.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999998864

>2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli}

Probab=88.04  E-value=1.5  Score=36.26  Aligned_cols=59  Identities=17%  Similarity=0.245  Sum_probs=42.2

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      +|.+.+.|+++||+.++++|++.|.||.-...-..  |. +.+- +.....++...+...+..
T Consensus         2 ~~~v~~~dr~g~l~~i~~~l~~~~~ni~~~~~~~~--g~-i~~~-~~~~~~~~~~~L~~~l~~   60 (190)
T 2jhe_A            2 RLEVFCEDRLGLTRELLDLLVLRGIDLRGIEIDPI--GR-IYLN-FAELEFESFSSLMAEIRR   60 (190)
T ss_dssp             EEEEEECSCTTHHHHHHHHHHHTTCCEEEEEEETT--TE-EEEE-ECCCCHHHHHHHHHHHHH
T ss_pred             EEEEEEecCCcHHHHHHHHHHHcCCCeEEEEEecC--CE-EEEE-EEeCCHHHHHHHHHHHHc
Confidence            57889999999999999999999999999888433  54 3332 223444455555555543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.71  E-value=1.6  Score=37.68  Aligned_cols=122  Identities=9%  Similarity=0.109  Sum_probs=79.3

Q ss_pred             HHHHHhcCCCCCeeeeeeEEecCCceEEEEEecc-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 015965          161 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS-GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK  239 (397)
Q Consensus       161 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk  239 (397)
                      |+.+|. ..||+++.. .+-...+.+.+.++.-+ +.++.. +    ...+....++++.+|+....+++  .-+|--|.
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~  106 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLA  106 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCS
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEe
Confidence            333443 357888866 45555565655555443 223332 3    23688888999999998875444  34677899


Q ss_pred             CCcEEeCCCCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015965          240 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE  312 (397)
Q Consensus       240 p~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~  312 (397)
                      |+||+++.++.+++.-.|+....                +|.     .++...=+-.+=|++..+++++..|+
T Consensus       107 P~NL~f~~~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          107 PDELFFTRDGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGGEEECTTSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cceEEEcCCCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999999988765322                111     12222334457889999999988773

>2f06_A Conserved hypothetical protein; structural genomics hypothetical protein, PSI, protein struc initiative; HET: MSE HIS; 2.10A {Bacteroides thetaiotaomicron} SCOP: d.58.18.11 d.58.18.11

Probab=87.15  E-value=1.6  Score=34.93  Aligned_cols=38  Identities=18%  Similarity=0.318  Sum_probs=32.9

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD   39 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~   39 (397)
                      |.|++..-|+|+.|++++.+|++-|.||.--....+.+
T Consensus         7 ~~i~v~v~d~~G~l~~i~~~la~~~inI~~i~~~~~~~   44 (144)
T 2f06_A            7 KQLSIFLENKSGRLTEVTEVLAKENINLSALCIAENAD   44 (144)
T ss_dssp             EEEEEEECSSSSHHHHHHHHHHHTTCCEEEEEEEECSS
T ss_pred             EEEEEEecCCCcHHHHHHHHHHHCCCCEEEEEEEecCC
Confidence            78999999999999999999999999999866654433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.82  E-value=3.8  Score=35.41  Aligned_cols=149  Identities=15%  Similarity=0.203  Sum_probs=90.7

Q ss_pred             CCCCeeeeeeEEecCCceEEEEEeccCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCcEEeC
Q 015965          169 RHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMN-YLHQNNIIHRDLKAANLLMD  246 (397)
Q Consensus       169 ~h~niv~~~~~~~~~~~~~lv~E~~~g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~iiHrDlkp~Nili~  246 (397)
                      .||++..-+  -.+++.+.+.++.-+++ ++. .++    ..+....++++.+|+.... ++  ..-+|--|.|+||+++
T Consensus        48 ~~~~f~~~I--~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           48 VDPCIVRDI--DVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN  118 (219)
T ss_dssp             SCSSSEEEE--EECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred             cCCCCCeEE--EEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence            577773323  35556666666655333 333 333    3688888999988888665 44  3446778999999999


Q ss_pred             CCCceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc
Q 015965          247 ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK  326 (397)
Q Consensus       247 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~  326 (397)
                      .++.++|.-.|+-...                +|.-     .+...=+-.+=|++..++.++..|+      .+.. .-.
T Consensus       119 ~~~~p~i~hRGi~~~l----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe------~l~~-~le  170 (219)
T 4ano_A          119 RALEPFFLHVGVKESL----------------PPDE-----WDDERLLREVKATVLALTEGEYRFD------EYLK-FHE  170 (219)
T ss_dssp             TTCCEEESCCEETTTB----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH------HHHH-HTT
T ss_pred             CCCcEEEEEcCCcccC----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH------HHHh-HHh
Confidence            9999999988875322                2221     1222223347788888888877663      2222 111


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          327 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       327 ~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      ..      ..++    +....++.+     |+.++.+.|++-.
T Consensus       171 ~~------k~~~----f~~~I~~a~-----tleel~~~L~~~y  198 (219)
T 4ano_A          171 TL------KCSP----IAKELWQAD-----HLDAVLAVLEKWV  198 (219)
T ss_dssp             TS------CCCH----HHHHHHHCS-----SHHHHHHHHHHHH
T ss_pred             hh------cCCH----HHHHHHccC-----CHHHHHHHHHHHH
Confidence            11      1222    333444433     8888888888776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	397
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-92
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-84
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-78
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-78
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-77
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-76
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-75
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-75
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-74
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-74
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-74
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-73
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-73
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-73
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-72
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-72
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-71
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-71
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-71
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-70
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-70
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-69
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-67
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-67
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-67
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-66
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-65
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-65
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-65
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-63
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-62
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-60
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-59
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-59
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-57
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-56
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-54
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-52
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-52
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-51
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-46
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-46
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-45
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-43
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-39
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-17
d1ygya3	78	d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena	5e-05
d1u8sa1	86	d.58.18.5 (A:2-87) putative transcriptional repres	5e-05
d1sc6a3	84	d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena	6e-05
d1y7pa2	77	d.58.18.12 (A:2-78) Hypothetical protein AF1403, N	3e-04
d2pc6a2	77	d.58.18.6 (A:1-77) Acetolactate synthase small sub	6e-04
d1zpva1	83	d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Strepto	8e-04
d2f06a1	71	d.58.18.11 (A:71-141) Hypothetical protein BT0572	0.003
d2fgca2	78	d.58.18.6 (A:27-104) Acetolactate synthase small s	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  277 bits (709), Expect = 2e-92
 Identities = 97/276 (35%), Positives = 160/276 (57%), Gaps = 12/276 (4%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           K RH N++ F+G  T P  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMTAETGTYRWMAPEVI 283
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++   S      +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 284 EHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----PTIPKNS 336
             +   PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G        +  N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 372
              +  L+  C ++    RP F +I+  ++ +A+ +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (650), Expect = 8e-84
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 8/262 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 169 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 226
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ +  + +          +W APE +  K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175

Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
            +  K+DV+SFGI+LWE+ +         PL+  V  V+KG +   P    P + E+++ 
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235

Query: 347 CWQQDPALRPDFSEIIEILQQI 368
           CW  D A+RP F ++ E L+ I
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 3e-78
 Identities = 84/262 (32%), Positives = 145/262 (55%), Gaps = 8/262 (3%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDPK L F  ++ +G +G +  G +    DVAIK++K   ++   + EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKP 287
               +HRDL A N L+++  VVKV+DFG++R                 RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 288 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           +  K+D+++FG+++WE+ + GK+PYE  T  + A   + +GLR   P  +  K+  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 347 CWQQDPALRPDFSEIIEILQQI 368
           CW +    RP F  ++  +  +
Sbjct: 237 CWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 7e-78
 Identities = 86/263 (32%), Positives = 146/263 (55%), Gaps = 6/263 (2%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 169
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58

Query: 170 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 230 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP 287
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        ++       +W +PEV     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 347
           Y  K+DV+SFG+++WE+ +              V  +  G R   P+ +   + +++  C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 348 WQQDPALRPDFSEIIEILQQIAK 370
           W++ P  RP FS ++  L +IA+
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (607), Expect = 3e-77
 Identities = 80/266 (30%), Positives = 143/266 (53%), Gaps = 8/266 (3%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++      F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 224
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 282
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+    +           +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
           I +  +  K+DV+SFGI+L E++T              +  +++G R   P N   +L +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 343 LLERCWQQDPALRPDFSEIIEILQQI 368
           L+  CW++ P  RP F  +  +L+  
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 2e-76
 Identities = 93/266 (34%), Positives = 147/266 (55%), Gaps = 8/266 (3%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 165
           D WEI  + L+   K+  G +G+++ GT+     VAIK LKP  ++    + F QE  +M
Sbjct: 10  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVM 66

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 224
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G   +LP L+ +A  ++ G
Sbjct: 67  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 282
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+    +           +W APE 
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 342
             +  +  K+DV+SFGI+L EL T           +  +  V++G R   P      L +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 343 LLERCWQQDPALRPDFSEIIEILQQI 368
           L+ +CW+++P  RP F  +   L+  
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  234 bits (598), Expect = 1e-75
 Identities = 93/280 (33%), Positives = 154/280 (55%), Gaps = 8/280 (2%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 164
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +     +EF +E  +
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAV 66

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 223
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPE 281
            M YL + N IHRDL A N L+ EN +VKVADFG++R+                +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
            + +  +  K+DV++FG++LWE+ T  +       L     +++K  R   P+    K+ 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246

Query: 342 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK 381
           EL+  CWQ +P+ RP F+EI +  + + +E    +E  ++
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 7e-75
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 12/269 (4%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 164
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAP 280
           M YL     IHRDL A NLL+   ++VK+ DFG+ R          +       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 339
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 340 LAELLERCWQQDPALRPDFSEIIEILQQI 368
           +  ++ +CW   P  RP F  + + L + 
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 4e-74
 Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 35/292 (11%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 161
           WE   ++L+FG  + SG++G +          T  S  VA+K+LK E+ +S  ++    E
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSE 90

Query: 162 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------- 206
           + +M ++  H+N+V  +GACT    + ++ E+   G + +YL   +              
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 207 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                    V     LL  A  V+KGM +L   + +HRDL A N+L+   +VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 259 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 314
           AR                  +WMAPE +    Y  K+DV+S+GI+LWE+ + G  PY  +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 366
                   ++Q G +   P  +  ++  +++ CW  D   RP F  +   L 
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 7e-74
 Identities = 74/263 (28%), Positives = 132/263 (50%), Gaps = 13/263 (4%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
            D + LKF  ++  GS+  +Y+G       +VA   L+  ++    ++ F +E  +++ +
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 169 RHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           +H N+V+F  +          + +VTE M+ G++  YL +   V K+  L      + KG
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124

Query: 225 MNYLHQNN--IIHRDLKAAN-LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 281
           + +LH     IIHRDLK  N  +      VK+ D G+A +K ++    A  GT  +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKL 340
           + E K YD   DV++FG+ + E+ T + PY            V  G++P +  K + P++
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 341 AELLERCWQQDPALRPDFSEIIE 363
            E++E C +Q+   R    +++ 
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 9e-74
 Identities = 78/277 (28%), Positives = 138/277 (49%), Gaps = 13/277 (4%)

Query: 111 IDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 165
           +D K L    K   SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
           +++ +  +V+ IG C    S  +V E    G +  YL +     K  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 281
            YL ++N +HRDL A N+L+      K++DFG+++     +      T      +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREM 239

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 377
            +L+  CW  D   RP F+ +   L+    +V  E  
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 1e-73
 Identities = 68/258 (26%), Positives = 125/258 (48%), Gaps = 9/258 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 165
           W ++    + G  +  G +G++Y          +A+KVL   ++    ++ +  +EV I 
Sbjct: 3   WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 166 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
             +RH N+++  G       + ++ E+   G+VY  L K    F          +++  +
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANAL 119

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 285
           +Y H   +IHRD+K  NLL+     +K+ADFG +   A S   T   GT  ++ PE+IE 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 286 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 345
           + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236

Query: 346 RCWQQDPALRPDFSEIIE 363
           R  + +P+ RP   E++E
Sbjct: 237 RLLKHNPSQRPMLREVLE 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 2e-73
 Identities = 82/272 (30%), Positives = 141/272 (51%), Gaps = 11/272 (4%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEV 162
            EI P  +     + +G +G++Y+G   +        VAIK LK        + +F  E 
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEA 60

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
            IM +  H N+++  G  +K   + I+TE+M  G++  +L +  G F +  L+ +   ++
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 278
            GM YL   N +HRDL A N+L++ N V KV+DFG++RV       +   +      RW 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           APE I ++ +   +DV+SFGIV+WE++T      +       +  +  G R   P +   
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
            + +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 5e-73
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 13/279 (4%)

Query: 109 WEIDPKHLKFGS-KVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVF 163
             +   +L     ++  G++G + +G Y       DVAIKVLK         +E  +E  
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
           IM ++ +  +V+ IG C     L +V E   GG ++ +L   +    + ++ ++   VS 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMA 279
           GM YL + N +HRDL A N+L+      K++DFG+++      +     +A     +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 338
           PE I  + +  ++DV+S+G+ +WE L+ G+ PY+ +   +  +  +++G R   P    P
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPP 239

Query: 339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 377
           +L  L+  CW      RPDF  + + ++     +  + E
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 2e-72
 Identities = 84/270 (31%), Positives = 139/270 (51%), Gaps = 9/270 (3%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 163
           +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K    +  ++++F QE  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEAL 60

Query: 164 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 223
            MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A  +S 
Sbjct: 61  TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 224 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPE 281
            + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A       +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 282 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 341
            I  + +   +DV+ FG+ +WE+L   +           +G ++ G R  +P N  P L 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 342 ELLERCWQQDPALRPDFSEIIEILQQIAKE 371
            L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  226 bits (577), Expect = 2e-72
 Identities = 90/289 (31%), Positives = 147/289 (50%), Gaps = 16/289 (5%)

Query: 96  PYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPE 148
           P+  + PN+       EID   +K    + +G +G++  G           VAIK LK  
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 149 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 208
                 +++F  E  IM +  H NV+   G  TK   + I+TEFM  GS+  +L +  G 
Sbjct: 66  Y-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124

Query: 209 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 268
           F +  L+ +   ++ GM YL   N +HRDL A N+L++ N V KV+DFG++R        
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 269 TAET------GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 321
              T         RW APE I+++ +   +DV+S+GIV+WE+++ G+ PY  +T  Q  +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVI 243

Query: 322 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             +++  R   P +    L +L+  CWQ+D   RP F +I+  L ++ +
Sbjct: 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (573), Expect = 1e-71
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 32/301 (10%)

Query: 100 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINS 152
           ++P D    WE     L FG  + +G++G +   T            VA+K+LKP   + 
Sbjct: 11  QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HL 67

Query: 153 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----- 206
             ++    E+ ++  +  H N+V  +GACT      ++TE+   G + ++L + +     
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 207 ------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 254
                           L  LL  +  V+KGM +L   N IHRDL A N+L+    + K+ 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 255 DFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 310
           DFG+AR          +       +WMAPE I +  Y  ++DV+S+GI LWEL + G  P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

Query: 311 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           Y  +        ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++   
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 371 E 371
           E
Sbjct: 308 E 308

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 5e-71
 Identities = 72/264 (27%), Positives = 136/264 (51%), Gaps = 12/264 (4%)

Query: 110 EIDPK-HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 166
           +++P+   +   ++  G++G +Y+      S   A KV+  +  + +  +++  E+ I+ 
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILA 64

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
              H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V       +N
Sbjct: 65  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-- 283
           YLH N IIHRDLKA N+L   +  +K+ADFGV+    ++     +  GT  WMAPEV+  
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 284 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-KGLRPTIPKNSQPK 339
              + +PYD+KADV+S GI L E+   + P+  L P++  + + + +      P      
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 340 LAELLERCWQQDPALRPDFSEIIE 363
             + L++C +++   R   S++++
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQ 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 6e-71
 Identities = 81/282 (28%), Positives = 138/282 (48%), Gaps = 21/282 (7%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIM 165
            +D   +KF   +  G++G + +          D AIK +K    + D  ++FA E+ ++
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64

Query: 166 RKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK---------------LKGVF 209
            K+  H N++  +GAC     L +  E+   G++ D+L K                    
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 210 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 269
               LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 329
                 RWMA E + +  Y   +DV+S+G++LWE+++                 + +G R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 330 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 371
              P N   ++ +L+ +CW++ P  RP F++I+  L ++ +E
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  222 bits (567), Expect = 1e-70
 Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 27/305 (8%)

Query: 102 PNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ-KE 157
           P+     ++ DP+ L     ++  GS+G +Y        + VAIK +      S+ + ++
Sbjct: 2   PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61

Query: 158 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 217
             +EV  ++K+RH N +Q+ G   +  +  +V E+  G +        K   +   +  V
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120

Query: 218 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 277
                +G+ YLH +N+IHRD+KA N+L+ E  +VK+ DFG A + A +       GT  W
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYW 177

Query: 278 MAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 334
           MAPEVI       YD K DV+S GI   EL   K P   +  + A   + Q         
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237

Query: 335 NSQPKLAELLERCWQQDPALRPDFSEI---------------IEILQQIAKEVGE-ENEE 378
           +        ++ C Q+ P  RP    +               ++++Q+    V E +N +
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297

Query: 379 RRKEK 383
            RK K
Sbjct: 298 YRKMK 302

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  220 bits (561), Expect = 5e-70
 Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 34/295 (11%)

Query: 109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 161
            E    ++++   +  G++G +++              VA+K+LK E  ++DMQ +F +E
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQRE 66

Query: 162 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-------------- 207
             +M +  + N+V+ +G C     +C++ E+M+ G + ++L  +                
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 208 ---------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 258
                           L +A  V+ GM YL +   +HRDL   N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 259 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 315
           +R    +    A+       RWM PE I +  Y  ++DV+++G+VLWE+ +  L   Y  
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 316 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
             +  +  V+ G     P+N   +L  L+  CW + PA RP F  I  ILQ++ +
Sbjct: 247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 8e-70
 Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 14/260 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +    + +GSYG   +    S  + +  K L    +    ++    EV ++R+++H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 175 QFIGACTKPPS--LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH 229
           ++        +  L IV E+  GG +   + K    +       +L+V   ++  +   H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 230 Q-----NNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 283
           +     + ++HRDLK AN+ +D  + VK+ DFG+AR +   +    A  GT  +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
               Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEI 245

Query: 344 LERCWQQDPALRPDFSEIIE 363
           + R        RP   EI+E
Sbjct: 246 ITRMLNLKDYHRPSVEEILE 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 2e-69
 Identities = 80/281 (28%), Positives = 126/281 (44%), Gaps = 14/281 (4%)

Query: 109 WEIDPKHLK--FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 161
             I P  L   F   +  G +G +Y GT    D      A+K L     +     +F  E
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTE 78

Query: 162 VFIMRKVRHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 220
             IM+   H NV+  +G C +   S  +V  +M  G + +++        +  L+   + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 221 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTY 275
           V+KGM +L     +HRDL A N ++DE   VKVADFG+AR             T      
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 276 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 335
           +WMA E ++ + +  K+DV+SFG++LWEL+T   P             + +G R   P+ 
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

Query: 336 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 376
               L E++ +CW     +RP FSE++  +  I      E+
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 1e-67
 Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 9/257 (3%)

Query: 112 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 168
           DP K      K+  G+ G +Y     +  Q+VAI+ +  +      ++    E+ +MR+ 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMREN 74

Query: 169 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
           ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + +L
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL 132

Query: 229 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP 287
           H N +IHRD+K+ N+L+  +  VK+ DFG    +  +    +   GT  WMAPEV+  K 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 288 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER 346
           Y  K D++S GI+  E++ G+ PY    PL+A   +   G      P+       + L R
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 347 CWQQDPALRPDFSEIIE 363
           C   D   R    E+++
Sbjct: 253 CLDMDVEKRGSAKELLQ 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 5e-67
 Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 9/254 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
                +  G+YG++         + VA+K++  +R   D  +   +E+ I + + H+NVV
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVV 66

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +F G   +     +  E+ SGG ++D +         P   +    +  G+ YLH   I 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 235 HRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD-H 290
           HRD+K  NLL+DE + +K++DFG+A V     +  ++    GT  ++APE+++ + +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 291 KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
             DV+S GIVL  +L G+LP++  +   Q      +K       K        LL +   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245

Query: 350 QDPALRPDFSEIIE 363
           ++P+ R    +I +
Sbjct: 246 ENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 6e-67
 Identities = 88/297 (29%), Positives = 142/297 (47%), Gaps = 28/297 (9%)

Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 153
           +P D    WE     LK G  +  G++G +        D       VA+K+LK    +S+
Sbjct: 1   LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 154 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHK-------- 204
            +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL          
Sbjct: 60  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119

Query: 205 -------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 257
                   K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 258 VARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEY 313
           +AR   +      +       +WMAPE I  + Y  ++DV+SFG++LWE+ +    PY  
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

Query: 314 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
           +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  + +
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-66
 Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 31/296 (10%)

Query: 101 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERIN 151
           +P D    WE+    L  G  +  G++G +        D         VA+K+LK +   
Sbjct: 2   LPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59

Query: 152 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------- 203
            D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL        
Sbjct: 60  KDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 204 --------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 255
                     +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 256 FGVARVKAQSGVMTA---ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 312
           FG+AR                  +WMAPE +  + Y H++DV+SFG++LWE+ T      
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
              P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-66
 Identities = 79/271 (29%), Positives = 138/271 (50%), Gaps = 13/271 (4%)

Query: 111 IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFI 164
           +     K    + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64

Query: 165 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 224
           M  V + +V + +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KG
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 225 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE 281
           MNYL    ++HRDL A N+L+   + VK+ DFG+A++                 +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 282 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 340
            I H+ Y H++DV+S+G+ +WEL+T G  PY+ +        +++KG R   P      +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDV 242

Query: 341 AELLERCWQQDPALRPDFSEIIEILQQIAKE 371
             ++ +CW  D   RP F E+I    ++A++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 4e-65
 Identities = 65/299 (21%), Positives = 129/299 (43%), Gaps = 48/299 (16%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK 167
           E+     +  S++ +G+ G +++ ++      +A K++  E I   ++ +  +E+ ++ +
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60

Query: 168 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 227
                +V F GA      + I  E M GGS+   L K  G      L KV+I V KG+ Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119

Query: 228 LHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
           L + + I+HRD+K +N+L++    +K+ DFGV+  +    +  +  GT  +M+PE ++  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178

Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQ------- 337
            Y  ++D++S G+ L E+  G+ P        L+   G   +G     P   +       
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 338 ---------------------------------PKLAELLERCWQQDPALRPDFSEIIE 363
                                             +  + + +C  ++PA R D  +++ 
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  208 bits (530), Expect = 9e-65
 Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 12/265 (4%)

Query: 109 WEIDPKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 162
            EI   H+        ++ +G++G ++R T  +   + A K +     +   ++   +E+
Sbjct: 17  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 74

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
             M  +RH  +V    A      + ++ EFMSGG +++ +            ++    V 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 223 KGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 280
           KG+ ++H+NN +H DLK  N++     +  +K+ DFG+         +   TGT  + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 281 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--P 338
           EV E KP  +  D++S G++ + LL+G  P+      +    V            S    
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 339 KLAELLERCWQQDPALRPDFSEIIE 363
              + + +    DP  R    + +E
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALE 279

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (526), Expect = 9e-65
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 20/281 (7%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 159
           D WE+  + +    ++  GS+G +Y G             VAIK +       + + EF 
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEFL 71

Query: 160 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 210
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+             
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---V 267
           L  ++++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R   ++     
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 327
                   RWM+PE ++   +   +DV+SFG+VLWE+ T           +  +  V +G
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 328 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 368
                P N    L EL+  CWQ +P +RP F EII  +++ 
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  207 bits (527), Expect = 3e-64
 Identities = 49/255 (19%), Positives = 114/255 (44%), Gaps = 8/255 (3%)

Query: 115 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 172
           +     ++ SG++G ++R    +  +    K +         +     E+ IM ++ H  
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           ++    A      + ++ EF+SGG ++D +           ++       +G+ ++H+++
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147

Query: 233 IIHRDLKAANLLMDENE--VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
           I+H D+K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P   
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207

Query: 291 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCW 348
             D+++ G++ + LL+G  P+     L+    V +          S   P+  + ++   
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267

Query: 349 QQDPALRPDFSEIIE 363
           Q++P  R    + +E
Sbjct: 268 QKEPRKRLTVHDALE 282

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-63
 Identities = 72/303 (23%), Positives = 135/303 (44%), Gaps = 48/303 (15%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 173
           + +     +  G +G+++RG +  ++VA+K+        +       E++    +RH+N+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 59

Query: 174 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 229
           + FI A  K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117

Query: 230 Q--------NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTYR 276
                      I HRDLK+ N+L+ +N    +AD G+A     +            GT R
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 277 WMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--------- 321
           +MAPEV++      H     +AD+++ G+V WE+             Q            
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 322 ------GVVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 370
                  V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

Query: 371 EVG 373
           + G
Sbjct: 298 QEG 300

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (519), Expect = 1e-63
 Identities = 64/298 (21%), Positives = 136/298 (45%), Gaps = 23/298 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
            F   + +G++ ++         + VAIK +  + +    +     E+ ++ K++H N+V
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIV 70

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
                      L ++ + +SGG ++D + + KG +      ++   V   + YLH   I+
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 235 HRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           HRDLK  NLL   +DE+  + ++DFG+++++    V++   GT  ++APEV+  KPY   
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQ 349
            D +S G++ + LL G  P+      +    +++       P          + +    +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 350 QDPALRPDFSEIIE-------------ILQQIAKEVGEENEERRKEKSSGGFLSVLRR 394
           +DP  R    + ++             I Q +++++ ++N  + K K +    +V+R 
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI-KKNFAKSKWKQAFNATAVVRH 306

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-62
 Identities = 58/258 (22%), Positives = 114/258 (44%), Gaps = 9/258 (3%)

Query: 110 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD-MQKEFAQEVFIMR 166
           +  P+  KFG  +  GS+  +      +  ++ AIK+L+   I  +       +E  +M 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 167 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           ++ H   V+          L     +   G +  Y+ K  G F          ++   + 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALE 122

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVI 283
           YLH   IIHRDLK  N+L++E+  +++ DFG A+V +         +  GT ++++PE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 343
             K     +D+++ G ++++L+ G  P+           +++  L    P+   PK  +L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDL 240

Query: 344 LERCWQQDPALRPDFSEI 361
           +E+    D   R    E+
Sbjct: 241 VEKLLVLDATKRLGCEEM 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-62
 Identities = 51/280 (18%), Positives = 115/280 (41%), Gaps = 15/280 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
                +  G +G ++R    S  +    K +K +      Q    +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNIL 64

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
               +      L ++ EF+SG  +++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 235 HRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 350
           D++S G +++ LL+G  P+   T  Q    ++            +   +  + ++R   +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244

Query: 351 DPALRPDFSEII------EILQQIAKEVGEENEERRKEKS 384
           +   R   SE +      + +++++ +V    + RR   +
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  195 bits (496), Expect = 2e-60
 Identities = 60/265 (22%), Positives = 117/265 (44%), Gaps = 19/265 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 167
           +    +  G    + R  +    ++ A+K++      S       ++++   +EV I+RK
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 168 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
           V  H N++Q            +V + M  G ++DYL + K         K+   + + + 
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 284
            LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE  
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 285 ----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--P 338
               H  Y  + D++S G++++ LL G  P+ +   +     ++    +   P+      
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 339 KLAELLERCWQQDPALRPDFSEIIE 363
            + +L+ R     P  R    E + 
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALA 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 59/255 (23%), Positives = 118/255 (46%), Gaps = 10/255 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN 172
                +  GS+G ++   +    Q  AIK LK + +  + D++    ++  +     H  
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 173 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 232
           +           +L  V E+++GG +  ++      F L      A ++  G+ +LH   
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 233 IIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 291
           I++RDLK  N+L+D++  +K+ADFG+ +             GT  ++APE++  + Y+H 
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 292 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 351
            D +SFG++L+E+L G+ P+      +    +      P  P+  + +  +LL + + ++
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVRE 241

Query: 352 PALRPDFSEIIEILQ 366
           P  R       +I Q
Sbjct: 242 PEKRLGVRG--DIRQ 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 19/274 (6%)

Query: 113 PKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 165
           P HL    + G  +  G   +++        +DVA+KVL+ +          F +E    
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 166 RKVRHKNVVQFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
             + H  +V             P   IV E++ G ++ D +H  +G       ++V  D 
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADA 120

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRW 277
            + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 278 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 337
           ++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A   V++   P   ++  
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 338 --PKLAELLERCWQQDPALRP-DFSEIIEILQQI 368
               L  ++ +   ++P  R    +E+   L ++
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-57
 Identities = 60/259 (23%), Positives = 117/259 (45%), Gaps = 13/259 (5%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD----MQKEFAQEVFIMRKVRH 170
             G ++ SG +  + +    S     A K +K  R  S      +++  +EV I+++++H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
            NV+           + ++ E ++GG ++D+L + K         +    +  G+ YLH 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131

Query: 231 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 286
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 287 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 344
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 345 ERCWQQDPALRPDFSEIIE 363
            R   +DP  R    + ++
Sbjct: 252 RRLLVKDPKKRMTIQDSLQ 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 4e-56
 Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 23/280 (8%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           + G K+ SGS+GD+Y GT  +  ++VAIK+   +        +   E  I + ++    +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
             I  C       ++   + G S+ D  +     F L ++L +A  +   + Y+H  N I
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 235 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVI 283
           HRD+K  N LM    +  +V + DFG+A+    +              TGT R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 284 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------PTIPKNSQ 337
                  + D+ S G VL     G LP++ L          +   +        + K   
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 377
            + A  L  C       +PD+S + ++ + +    G   +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  181 bits (460), Expect = 1e-54
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 10/258 (3%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 170
           +  +    + +GS+G ++        +  A+KVLK E +    Q E    E  ++  V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
             +++  G       + ++ +++ GG ++  L K    F  P     A +V   + YLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 290
            +II+RDLK  N+L+D+N  +K+ DFG A+      V     GT  ++APEV+  KPY+ 
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 291 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 350
             D +SFGI+++E+L G  P+     ++    ++        P      + +LL R   +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238

Query: 351 DPALRPDFSE--IIEILQ 366
           D + R    +    ++  
Sbjct: 239 DLSQRLGNLQNGTEDVKN 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  181 bits (459), Expect = 4e-54
 Identities = 66/260 (25%), Positives = 121/260 (46%), Gaps = 12/260 (4%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ----EVFIMRKVRH 170
                +  G +G++Y        +  A+K L  +RI     +  A      + ++     
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
             +V    A   P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H 
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 289
             +++RDLK AN+L+DE+  V+++D G+A   ++     A  GT+ +MAPEV++    YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYD 184

Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTIPKNSQPKLAELLERCW 348
             AD FS G +L++LL G  P+       +  +  +   +   +P +  P+L  LLE   
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 349 QQDPALRPDFSE--IIEILQ 366
           Q+D   R         E+ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKE 264

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 8e-54
 Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 19/257 (7%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 169
           + G  + SG +G +Y G   S    VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 170 -HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 228
               V++ +    +P S  ++ E              +G  +          V + + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 229 HQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 287
           H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185

Query: 288 Y-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 346
           Y    A V+S GI+L++++ G +P+E+   +           +    +    +   L+  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRW 237

Query: 347 CWQQDPALRPDFSEIIE 363
           C    P+ RP F EI  
Sbjct: 238 CLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 46/287 (16%), Positives = 101/287 (35%), Gaps = 25/287 (8%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 171
            H K G ++  GS+G ++ GT     Q VAIK             +   E    + +   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGC 60

Query: 172 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 231
             +  +    +     ++   + G S+ D L      F + ++   A  +   +  +H+ 
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 232 NIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQSGV--------MTAETGTYRWM 278
           ++++RD+K  N L+         ++ V DFG+ +                   +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 279 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------PTI 332
           +      +    + D+ + G V    L G LP++ L          + G +        +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 333 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 379
                 +  + +           PD+  +  +  ++ + +    +E 
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-52
 Identities = 60/259 (23%), Positives = 121/259 (46%), Gaps = 9/259 (3%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRH 170
               +   +  G++G +      +  +  A+K+L+ E I + D       E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 171 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 230
             +     A      LC V E+ +GG ++ +L + + VF          ++   + YLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123

Query: 231 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYD 289
            ++++RD+K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 290 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 349
              D +  G+V++E++ G+LP+      +    ++ +      P+   P+   LL    +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241

Query: 350 QDPALRP--DFSEIIEILQ 366
           +DP  R     S+  E+++
Sbjct: 242 KDPKQRLGGGPSDAKEVME 260

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 9e-52
 Identities = 54/257 (21%), Positives = 105/257 (40%), Gaps = 24/257 (9%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 180
            G  G + +       +  A+K+L+          +  +EV +  +  +  ++V+ +   
Sbjct: 22  LGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVY 74

Query: 181 ----TKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                    L IV E + GG ++  +       F      ++   + + + YLH  NI H
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134

Query: 236 RDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 292
           RD+K  NLL      N ++K+ DFG A+       +T    T  ++APEV+  + YD   
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI------PKNSQPKLAELLER 346
           D++S G++++ LL G  P+     L  + G+  +                  ++  L+  
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254

Query: 347 CWQQDPALRPDFSEIIE 363
             + +P  R   +E + 
Sbjct: 255 LLKTEPTQRMTITEFMN 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 7e-51
 Identities = 55/286 (19%), Positives = 114/286 (39%), Gaps = 36/286 (12%)

Query: 114 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRK--- 167
           +  +  +++  G+YG +++        + VA+K ++ +     M     +EV ++R    
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 168 VRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 222
             H NVV+    CT   +     L +V E +            +      ++  +   + 
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 223 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 282
           +G+++LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 283 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----------- 331
           +    Y    D++S G +  E+   K  +   + +     ++     P            
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 332 --------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                            +      +LL +C   +PA R      + 
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-48
 Identities = 60/273 (21%), Positives = 118/273 (43%), Gaps = 34/273 (12%)

Query: 124 SGSYGDLYRGTYCS--QDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIG 178
            G +  +Y+    +  Q VAIK +K          + +   +E+ +++++ H N++  + 
Sbjct: 8   EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67

Query: 179 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 238
           A     ++ +V +FM    +   +     V     +    +   +G+ YLHQ+ I+HRDL
Sbjct: 68  AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126

Query: 239 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 296
           K  NLL+DEN V+K+ADFG+A+   + +   T +  T  + APE++   + Y    D+++
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186

Query: 297 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------------------- 331
            G +L ELL         + L     + +    PT                         
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246

Query: 332 -IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
            I   +   L +L++  +  +P  R   ++ ++
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-47
 Identities = 53/278 (19%), Positives = 106/278 (38%), Gaps = 31/278 (11%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +   K+  G+YG +Y+       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           + +        L +V EF+                 LP +      + +G+ + H + ++
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPY-DHKA 292
           HRDLK  NLL++    +K+ADFG+AR         T E  T  + APE++    Y     
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------------------- 331
           D++S G +  E++T +  +   + +     + +    P                      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 332 ------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                 +          LL +    DP  R      + 
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  159 bits (402), Expect = 1e-46
 Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 31/277 (11%)

Query: 117 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 175
               K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 176 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 235
                     L +V E +        L   +G  +  +     + +  G+ Y H   ++H
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123

Query: 236 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW-MAPEVIE-HKPYDHKAD 293
           RDLK  NLL++    +K+ADFG+AR                W  AP+V+   K Y    D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---------------------- 331
           ++S G +  E++ G   +  ++     + + +    P                       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243

Query: 332 -----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                  K       +LL +  + DP  R    + +E
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 3e-46
 Identities = 60/296 (20%), Positives = 119/296 (40%), Gaps = 44/296 (14%)

Query: 108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 165
           V+++ P++    S +  G+YG +           VAIK + P   +    +   +E+ I+
Sbjct: 3   VFDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKIL 60

Query: 166 RKVRHKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 221
            + RH+N++        P         +   + G  +Y  L           +      +
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQI 118

Query: 222 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRW 277
            +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 278 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 331
            APE++ +   Y    D++S G +L E+L+ +  +     L     ++     P+     
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 332 ------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                                   +  N+  K  +LL++    +P  R +  + + 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 8/243 (3%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNV 173
                + +GS+G +    +       A+K+L  +++    Q E    E  I++ V    +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 174 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 233
           V+   +     +L +V E+++GG ++ +L +  G F  P     A  +     YLH  ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 234 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 293
           I+RDLK  NLL+D+   ++V DFG A+     G      GT   +APE+I  K Y+   D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 294 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 353
            ++ G++++E+  G  P+    P+Q    +V    +   P +    L +LL    Q D  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 354 LRP 356
            R 
Sbjct: 279 KRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-45
 Identities = 62/284 (21%), Positives = 130/284 (45%), Gaps = 17/284 (5%)

Query: 99  LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSD 153
           L+  N      ++  ++ +    + +G+YG ++     S     +  A+KVLK   I   
Sbjct: 9   LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68

Query: 154 MQ--KEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 210
            +  +    E  ++  +R    +V    A      L ++ ++++GG ++ +L + +  F 
Sbjct: 69  AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFT 127

Query: 211 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 268
              +     ++   + +LH+  II+RD+K  N+L+D N  V + DFG+++  V  ++   
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187

Query: 269 TAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 326
               GT  +MAP+++      +D   D +S G++++ELLTG  P+       +   + ++
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247

Query: 327 GLR--PTIPKNSQPKLAELLERCWQQDPALRPDFSE--IIEILQ 366
            L+  P  P+       +L++R   +DP  R         EI +
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-45
 Identities = 64/293 (21%), Positives = 119/293 (40%), Gaps = 47/293 (16%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +  +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 175 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 226
             I  C    S        + +V +F          + L   F L  + +V   +  G+ 
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131

Query: 227 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 281
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q    T    T  +  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 282 VI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------- 331
           ++   + Y    D++  G ++ E+ T     +  T       + Q     T         
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 332 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                                      P   +L+++    DPA R D  + + 
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 55/279 (19%), Positives = 110/279 (39%), Gaps = 33/279 (11%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
           +   K+  G+YG +++       + VA+K ++ +  +  +     +E+ ++++++HKN+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 175 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 234
           +          L +V EF        +     G      +      + KG+ + H  N++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 235 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIE-HKPYDHKA 292
           HRDLK  NLL++ N  +K+A+FG+AR         +AE  T  +  P+V+   K Y    
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 293 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------------- 330
           D++S G +  EL     P      +   +  + + L                        
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 331 ------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                  +         +LL+   + +P  R    E ++
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-43
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 40/295 (13%)

Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 162
               WE+     +    V SG+YG +           VAIK L     +    K   +E+
Sbjct: 10  TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 163 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFM----SGGSVYDYLHKLKGVFKLPSLLKVA 218
            +++ +RH+NV+  +   T   +L   T+F       G+    L K         +  + 
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLV 127

Query: 219 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 278
             + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    T  + 
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYR 185

Query: 279 APEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------- 330
           APEVI     Y    D++S G ++ E++TGK  ++    L     +++    P       
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 331 ----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                                 +I  N+ P    LLE+    D   R    E + 
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-42
 Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 45/286 (15%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
                + +GS+G +Y+   C   + VAIK +  ++      +   +E+ IMRK+ H N+V
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIV 76

Query: 175 QFIGACTKPPS------LCIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMN 226
           +                L +V +++         H  + K    +  +      + + + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 227 YLHQNNIIHRDLKAANL-LMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP-EVIE 284
           Y+H   I HRD+K  NL L  +  V+K+ DFG A+   +     +   +  + AP  +  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196

Query: 285 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------- 331
              Y    DV+S G VL ELL G+  +   + +   V +++    PT             
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 332 --------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                             + P+   L  R  +  P  R    E   
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-39
 Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 53/307 (17%)

Query: 105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 162
           G   + +  K  +    + SG+ G +         ++VAIK L     N    K   +E+
Sbjct: 9   GDSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 163 FIMRKVRHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 216
            +M+ V HKN++  +   T   +      + +V E M           ++       +  
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123

Query: 217 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 276
           +   +  G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 277 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 331
           + APEVI    Y    D++S G ++ E++  K+ +     +     V+++   P      
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 332 -----------------------------------IPKNSQPKLAELLERCWQQDPALRP 356
                                                K    +  +LL +    DPA R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 357 DFSEIIE 363
              + ++
Sbjct: 304 SVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 1e-38
 Identities = 57/293 (19%), Positives = 116/293 (39%), Gaps = 40/293 (13%)

Query: 107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 164
            +WE+ P+  +  S V SG+YG +           VA+K L     +    K   +E+ +
Sbjct: 12  TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 165 MRKVRHKNVVQFIGACTKPPSLC-----IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           ++ ++H+NV+  +   T   SL       +   + G  + + +           +  +  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIY 128

Query: 220 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 279
            + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR      +       +    
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187

Query: 280 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------- 331
             ++    Y+   D++S G ++ ELLTG+  +     +     +++    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 332 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 363
                                +   + P   +LLE+    D   R   ++ + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  139 bits (350), Expect = 1e-38
 Identities = 52/310 (16%), Positives = 119/310 (38%), Gaps = 60/310 (19%)

Query: 105 GTDVWEIDPKHLKFGS--------KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDM 154
             + W+ +   +++G+        K+  G Y +++     +  + V +K+LKP +     
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----- 72

Query: 155 QKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKL 211
           +K+  +E+ I+  +R   N++        P S    +V E ++         +L      
Sbjct: 73  KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTD 128

Query: 212 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA 270
             +     ++ K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A           
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188

Query: 271 ETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL- 328
              +  +  PE+ ++++ YD+  D++S G +L  ++  K P+ +       +  + K L 
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 329 -----------------------------------RPTIPKNSQPKLAELLERCWQQDPA 353
                                                       P+  + L++  + D  
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 354 LRPDFSEIIE 363
            R    E +E
Sbjct: 309 SRLTAREAME 318

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 1e-26
 Identities = 47/317 (14%), Positives = 108/317 (34%), Gaps = 75/317 (23%)

Query: 117 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 174
               K+  G +  ++          VA+K+++ +++     +    E+ ++++V   +  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNT 72

Query: 175 QFIGACTKPP---------------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 219
           +                         + +V E +    +            L  + +++ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 220 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEV------VKVADFGVARVKAQSGVMTAET 272
            +  G++Y+H +  IIH D+K  N+LM+  +       +K+AD G A    +    +   
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190

Query: 273 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE-------------------- 312
            T  + +PEV+   P+   AD++S   +++EL+TG   +E                    
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 313 -----------------YLTPLQAAVGVVQKGLRPT---------IPKNSQPKLAELLER 346
                            +         + +    P            K+   ++++ L  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 347 CWQQDPALRPDFSEIIE 363
             Q DP  R D   ++ 
Sbjct: 311 MLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.0 bits (186), Expect = 8e-17
 Identities = 22/195 (11%), Positives = 58/195 (29%), Gaps = 32/195 (16%)

Query: 119 GSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQK--------EFAQEVFIMRKVR 169
           G  +  G    ++        +  +K  K    +    K         F+       +  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 170 HKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 225
            + + +  G             ++ E +    +Y          ++ +  +V   + + +
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEV 116

Query: 226 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 281
              +   I+H DL   N+L+ E   + + DF  +        +  +         + +  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS-- 173

Query: 282 VIEHKPYDHKADVFS 296
               + Y  + D+ S
Sbjct: 174 ----RTYRTEKDINS 184

>d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 39.0 bits (91), Expect = 5e-05
 Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 2/62 (3%)

Query: 2  HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWP-YEETEQL 59
            +     D+P  L ++  LL   G+NIQ A      +   +  +  +D     +    +
Sbjct: 4  INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63

Query: 60 RA 61
           A
Sbjct: 64 AA 65

>d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

 Score = 39.4 bits (92), Expect = 5e-05
 Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 2/62 (3%)

Query: 4  ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 63
          IT    D+P + +++  L+   G NI      +        + ++ G       ++   L
Sbjct: 8  ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65

Query: 64 EK 65
            
Sbjct: 66 PL 67

>d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Escherichia coli [TaxId: 562]

 Score = 38.9 bits (91), Expect = 6e-05
 Identities = 12/62 (19%), Positives = 29/62 (46%), Gaps = 2/62 (3%)

Query: 2  HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEET-EQL 59
            +    +++P +L+ L  + A+ G+NI   +  ++   GY +     D    E+  + +
Sbjct: 12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71

Query: 60 RA 61
          +A
Sbjct: 72 KA 73

>d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: AF1403 N-terminal domain-like
domain: Hypothetical protein AF1403, N-terminal domain
species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]

 Score = 37.0 bits (86), Expect = 3e-04
 Identities = 13/73 (17%), Positives = 32/73 (43%), Gaps = 3/73 (4%)

Query: 4  ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE-ETEQLRAA 62
          +    ++K  +L  LT ++A+ G NI  A  F    G      ++       + E++   
Sbjct: 4  LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILER 63

Query: 63 LEK--EVLKLERQ 73
          ++    ++++E +
Sbjct: 64 VKTFDYIIEIEEE 76

>d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Nitrosomonas europaea [TaxId: 915]

 Score = 36.1 bits (84), Expect = 6e-04
 Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 4/73 (5%)

Query: 2  HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 60
          H I+   +++   LS++  L +  G NI+      T D   S    V +G P E  EQ+ 
Sbjct: 3  HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQIT 61

Query: 61 AALEK--EVLKLE 71
            L K  EV+KL 
Sbjct: 62 KQLNKLIEVVKLI 74

>d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} Length = 83

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: SP0238-like
domain: UPF0237 protein SP0238
species: Streptococcus pneumoniae [TaxId: 1313]

 Score = 35.9 bits (83), Expect = 8e-04
 Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 4  ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 63
          IT    DK  +++ ++  +A++GLNI +       + +++   V      +    LR   
Sbjct: 5  ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDEKQDF-TYLRNEF 63

Query: 64 EK 65
          E 
Sbjct: 64 EA 65

>d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} Length = 71

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

 Score = 33.9 bits (78), Expect = 0.003
 Identities = 9/63 (14%), Positives = 27/63 (42%), Gaps = 6/63 (9%)

Query: 4  ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 63
          +  S  + P  L+++   L+  G+ I+  ++F+  +  +  V           ++    L
Sbjct: 2  VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANNN-VANVVIRPS-----NMDKCIEVL 55

Query: 64 EKE 66
          +++
Sbjct: 56 KEK 58

>d2fgca2 d.58.18.6 (A:27-104) Acetolactate synthase small subunit, IlvH {Thermotoga maritima [TaxId: 2336]} Length = 78

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Thermotoga maritima [TaxId: 2336]

 Score = 33.8 bits (78), Expect = 0.003
 Identities = 19/73 (26%), Positives = 32/73 (43%), Gaps = 4/73 (5%)

Query: 2  HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 60
          H ++    +KP ++ ++  L A  G NI       +   G S  V +V G   +  EQ+ 
Sbjct: 4  HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKG-DDKTIEQIE 62

Query: 61 AALEK--EVLKLE 71
              K  EV+K+ 
Sbjct: 63 KQAYKLVEVVKVT 75

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	397
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d1zpva1	83	UPF0237 protein SP0238 {Streptococcus pneumoniae [	97.69
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.68
d1u8sa1	86	putative transcriptional repressor VC2159 {Vibrio	97.61
d1u8sa2	93	putative transcriptional repressor VC2159 {Vibrio	97.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.68
d1ygya3	78	Phosphoglycerate dehydrogenase, regulatory (C-term	96.6
d1y7pa2	77	Hypothetical protein AF1403, N-terminal domain {Ar	96.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.24
d2f06a1	71	Hypothetical protein BT0572 {Bacteroides thetaiota	95.85
d1sc6a3	84	Phosphoglycerate dehydrogenase, regulatory (C-term	95.7
d2f06a2	70	Hypothetical protein BT0572 {Bacteroides thetaiota	94.89
d2f1fa1	76	Acetolactate synthase small subunit, IlvH {Escheri	93.08
d2pc6a2	77	Acetolactate synthase small subunit, IlvH {Nitroso	92.98
d2fgca2	78	Acetolactate synthase small subunit, IlvH {Thermot	92.16
d2qmwa2	80	Prephenate dehydratase C-terminal domain {Staphylo	86.24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-62  Score=452.26  Aligned_cols=264  Identities=36%  Similarity=0.710  Sum_probs=229.5

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCce
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  186 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  186 (397)
                      |.|+++.++|+++++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            4699999999999999999999999998654 69999998776666777889999999999999999999998765 568


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      ++||||++||+|.+++...+..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... 
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999999887788999999999999999999999999999999999999999999999999999865532 


Q ss_pred             --CcccCCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC----CCCCCC
Q 015965          266 --GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----TIPKNS  336 (397)
Q Consensus       266 --~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~----~~~~~~  336 (397)
                        .......||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.++.......+..+..+    ..+..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              23345679999999999864   358899999999999999999999999988776666655554332    356778


Q ss_pred             cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          337 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      ++++.+|+.+||+.||++|||+.++++.|+.+.+.+
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            999999999999999999999999999999887654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-60  Score=441.88  Aligned_cols=265  Identities=35%  Similarity=0.654  Sum_probs=233.8

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      ..+.|+++.++|++.++||+|+||+||+|.+.  ++.||||+++.....   .++|.+|+.+|++++|||||++++++.+
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            35679999999999999999999999999984  667999999865433   4579999999999999999999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      ++.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999999999999764 45789999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCc--ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          262 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       262 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ......  .....||+.|+|||++.+..|+.++|||||||++|||++|..||............+..+.++..+..++++
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK  244 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHH
Confidence            654432  233457899999999999999999999999999999999766655444455566667778888899999999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +.+|+.+||+.||++|||+.++++.|+.++++.
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            999999999999999999999999998876543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=433.29  Aligned_cols=256  Identities=35%  Similarity=0.717  Sum_probs=219.5

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      |++++|++++.||+|+||+||+|.+. ++.||||+++.....   .++|.+|+.++++++|||||++++++..++..++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            57789999999999999999999985 466999999865443   35799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  267 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--  267 (397)
                      |||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......  
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999999988778899999999999999999999999999999999999999999999999999986654432  


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      .....||+.|+|||++.+..|+.++||||||+++|||+| |.+||...+..+.... +..+.++..|..+++++.+|+.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHH
Confidence            234578999999999999999999999999999999999 5777777666555544 45567788889999999999999


Q ss_pred             hchhCCCCCCCHHHHHHHHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      ||+.||++|||++++++.|+++.+
T Consensus       238 cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-59  Score=436.44  Aligned_cols=260  Identities=33%  Similarity=0.605  Sum_probs=220.9

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC--c---ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +++.++|++.++||+|+||+||+|.+..  +   .||||.+.... .....+.|.+|+.+|++++|||||++++++..++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            5677899999999999999999998742  2   38888877543 4455678999999999999999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      .+|+||||++||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999999988777899999999999999999999999999999999999999999999999999986554


Q ss_pred             CCcc------cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCc
Q 015965          265 SGVM------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  337 (397)
Q Consensus       265 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (397)
                      ....      ....||+.|||||++.+..++.++|||||||++|||+| |..||...+..+.... +..+.++..+..++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCP  259 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccch
Confidence            3221      22357899999999999999999999999999999998 8999999888766555 45566777888999


Q ss_pred             HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          338 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       338 ~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +++.+|+.+||+.||++|||+.|+++.|+++++.
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            9999999999999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-59  Score=432.05  Aligned_cols=261  Identities=31%  Similarity=0.619  Sum_probs=228.8

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      .+.|+|+.++|++.++||+|+||+||+|.+.+ +.||||+++.....   .+.|.+|+.+|++++|||||++++++.+ +
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence            56799999999999999999999999999864 57999999865443   3579999999999999999999998865 5


Q ss_pred             ceEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      .+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+...
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence            6899999999999999876433 369999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          264 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       264 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...  ......||+.|||||++.+..++.++|||||||++|||+|| .+||...+..+.. ..+..+.++..|..+++++
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l  239 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEEL  239 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHH
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCCCCcccChHHH
Confidence            443  23445789999999999988999999999999999999995 5556666555544 4456677888899999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=424.53  Aligned_cols=253  Identities=33%  Similarity=0.670  Sum_probs=228.8

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      +++++|+++++||+|+||+||+|++.+ +.||||+++.....   .++|.+|+.++++++||||+++++++.+++.+++|
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            467899999999999999999999854 57999999876544   35799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc--
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  267 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--  267 (397)
                      |||+++|+|.+++......+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999999887778899999999999999999999999999999999999999999999999999986554332  


Q ss_pred             ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          268 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       268 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      .....||+.|+|||++.+..++.++||||||+++|||+| |+.||...+..+....+ ..+.++..|..+++++.+||.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCcccccHHHHHHHHH
Confidence            334678999999999999999999999999999999998 89999999987766654 4566888899999999999999


Q ss_pred             hchhCCCCCCCHHHHHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIEILQQ  367 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~~L~~  367 (397)
                      ||+.||++|||+.++++.|.+
T Consensus       237 cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHC
T ss_pred             HccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999998865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-59  Score=428.16  Aligned_cols=246  Identities=27%  Similarity=0.481  Sum_probs=219.9

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++++.||+|+||+||+|++.  ++.||||++..... .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999984  57799999874322 1223467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus        86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~  163 (263)
T d2j4za1          86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT  163 (263)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred             eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence            99999999999986 567999999999999999999999999999999999999999999999999999765543 3455


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..||+.|||||++.+..|+.++|||||||++|+|++|+.||...+..+....+...  .+.+|..+++++.+|+.+||+.
T Consensus       164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  241 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKH  241 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHccC
Confidence            68999999999999999999999999999999999999999998887777665544  4557788999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015965          351 DPALRPDFSEIIE  363 (397)
Q Consensus       351 dp~~Rps~~ell~  363 (397)
                      ||++|||+.|+++
T Consensus       242 dp~~R~t~~eil~  254 (263)
T d2j4za1         242 NPSQRPMLREVLE  254 (263)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             CHhHCcCHHHHHc
Confidence            9999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-58  Score=427.61  Aligned_cols=259  Identities=32%  Similarity=0.613  Sum_probs=222.4

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      +|++++|++.++||+|+||.||+|.+.+      ..||||.++... .......|.+|+.+|++++|||||++++++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            7888999999999999999999998753      259999997553 344456799999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +..++||||+.+++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999999998877889999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          264 QSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       264 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ...    ......||+.|||||++.+..++.++|||||||++|||++|..| |...+.. .....+..+.++..+..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccCCCCCchhhHH
Confidence            432    22334689999999999999999999999999999999996554 5555544 44555677788889999999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      ++.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999999999999998876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-59  Score=441.73  Aligned_cols=259  Identities=31%  Similarity=0.598  Sum_probs=228.3

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC--c-----ceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--Q-----DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  178 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  178 (397)
                      ..|+++.++|+++++||+|+||+||+|++.+  +     .||+|.+.... .......+.+|+.+|+++ +|||||++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4689999999999999999999999998743  2     48999987543 233456789999999988 8999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhcc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR  236 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHr  236 (397)
                      ++.+++.+|+||||++||+|.++++...                      +.+++..++.++.||+.||+|||++|||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999997643                      348899999999999999999999999999


Q ss_pred             CCCCCcEEeCCCCceEEcccccccccccCCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 015965          237 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE  312 (397)
Q Consensus       237 Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~  312 (397)
                      ||||+|||++.++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||++|||++ |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986554432   234467999999999999999999999999999999997 899999


Q ss_pred             CCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 015965          313 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  366 (397)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~  366 (397)
                      +.+..+....++..+.+++.|..+++++.+||.+||+.||++|||+.||++.|.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            988878888888888899999999999999999999999999999999999885

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-58  Score=429.47  Aligned_cols=263  Identities=28%  Similarity=0.549  Sum_probs=230.9

Q ss_pred             cccCcccccccce-eeeeCCceEEEEEEC----CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          109 WEIDPKHLKFGSK-VASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       109 ~~~~~~~~~~~~~-lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      +-+..++|.+.+. ||+|+||+||+|.+.    +..||||+++... .....+.|.+|+.+|++++|||||++++++.. 
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-   80 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   80 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence            3466678888884 999999999999763    2359999998653 45556789999999999999999999999976 


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +.+||||||++||+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            46899999999999999998767889999999999999999999999999999999999999999999999999998665


Q ss_pred             cCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          264 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       264 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||+| |..||...+..+.... +..+.++..|..+|+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPP  239 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCCTTCCH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCH
Confidence            4322    234468999999999998999999999999999999998 9999998887665544 556778888999999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ++.+||.+||+.||++|||+.++++.|+++..++..
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence            999999999999999999999999999998876654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=427.30  Aligned_cols=259  Identities=29%  Similarity=0.559  Sum_probs=221.5

Q ss_pred             cccccc-ceeeeeCCceEEEEEECC----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEE
Q 015965          114 KHLKFG-SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  188 (397)
Q Consensus       114 ~~~~~~-~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  188 (397)
                      ..+.+. ++||+|+||+||+|.+.+    +.||||+++....+....+.|.+|+.+|++++|||||+++++|..+ ..+|
T Consensus         6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~l   84 (277)
T d1xbba_           6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML   84 (277)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEE
T ss_pred             hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEE
Confidence            344443 469999999999998643    4699999987666666678899999999999999999999999764 5789


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCc-
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-  267 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~-  267 (397)
                      ||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        85 vmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             EEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            9999999999999986 56799999999999999999999999999999999999999999999999999986543322 


Q ss_pred             ---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 015965          268 ---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       268 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                         .....||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..+... .+..+.++..|..+|+++.+|
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~~~~l  242 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREMYDL  242 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHHHHH
Confidence               223468999999999999999999999999999999998 999999988766554 455667888899999999999


Q ss_pred             HHHhchhCCCCCCCHHHHHHHHHHHHHHhchh
Q 015965          344 LERCWQQDPALRPDFSEIIEILQQIAKEVGEE  375 (397)
Q Consensus       344 l~~cl~~dp~~Rps~~ell~~L~~l~~~~~~~  375 (397)
                      +.+||+.||++|||+.++++.|++...+.-++
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e  274 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  274 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence            99999999999999999999999988776543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=426.99  Aligned_cols=250  Identities=25%  Similarity=0.420  Sum_probs=211.5

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--CCceEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCI  188 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  188 (397)
                      .++|++.+.||+|+||+||+|++.  ++.||||+++.........+.+.+|+.+|++++|||||++++++.+  ...+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999874  6789999998877777777889999999999999999999999865  456899


Q ss_pred             EEEeccCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEeCCCCceEEccccccc
Q 015965          189 VTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      ||||++||+|.+++.+.   ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998643   467999999999999999999999976     9999999999999999999999999998


Q ss_pred             ccccCC-cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          261 VKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       261 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ...... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+... ..+.+|..++++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~  241 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDE  241 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHH
Confidence            765443 345678999999999999999999999999999999999999999998887776665544 345677889999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHH
Q 015965          340 LAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +.+||.+||+.||++|||+.|+++
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHh
Confidence            999999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-58  Score=427.54  Aligned_cols=246  Identities=27%  Similarity=0.507  Sum_probs=219.5

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++.++||+|+||+||+|.+  +++.||||+++......  .+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            4799999999999999999986  47889999987553322  4678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |++||+|.+++.+  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus        98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            9999999998865  57999999999999999999999999999999999999999999999999999876543 34456


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHHHHhch
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  349 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  349 (397)
                      .+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+..... ....+..+++++++||.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            6899999999999999999999999999999999999999999888777766665543 344567789999999999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015965          350 QDPALRPDFSEIIE  363 (397)
Q Consensus       350 ~dp~~Rps~~ell~  363 (397)
                      .||++|||+.|+++
T Consensus       256 ~dP~~R~s~~eil~  269 (293)
T d1yhwa1         256 MDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-58  Score=424.34  Aligned_cols=262  Identities=32%  Similarity=0.608  Sum_probs=222.0

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      +|+|+.++|++++.||+|+||.||+|.+..     ..||||.++... .....+.|.+|+.+|++++|||||++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            489999999999999999999999998753     237888876543 44556789999999999999999999999964


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                       +.+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             6789999999999999998887788999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          263 AQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       263 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....  ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..+....+ ..+.++..+..+|++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT  237 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHH
Confidence            5432  2334568999999999999999999999999999999998 89999998887766654 455667788999999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +.+||.+||+.||++|||+.+|++.|++++++.
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999997654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=425.33  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=210.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++++.||+|+||+||+|.+.  ++.||||+++.... .+..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            57999999999999999999974  67899999976532 2334678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC---Ccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~---~~~  268 (397)
                      |++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....   ...
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999965 567999999999999999999999999999999999999999999999999999865433   234


Q ss_pred             cCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      ...+||+.|||||++.+..+ +.++|||||||++|+|++|+.||....... .................+++++.+|+.+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  242 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  242 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence            56689999999999988876 578999999999999999999997765433 3333333333344446789999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||++|||+.|+++
T Consensus       243 ~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         243 ILVENPSARITIPDIKK  259 (271)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-58  Score=427.72  Aligned_cols=248  Identities=29%  Similarity=0.491  Sum_probs=218.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|++++.||+|+||+||+|.+.  ++.||||+++...  ....+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            45899999999999999999984  5679999997643  2335678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~  270 (397)
                      |++||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .....
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            99999999998876778999999999999999999999999999999999999999999999999999755433 23446


Q ss_pred             CCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC-CCCCCCCCcHHHHHHH
Q 015965          271 ETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELL  344 (397)
Q Consensus       271 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll  344 (397)
                      .+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||...++.+....+..... ....+..+++++.+||
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            78999999999983     55689999999999999999999999999988887777665432 2334567899999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||+.||++|||+.|+++
T Consensus       250 ~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-57  Score=428.02  Aligned_cols=248  Identities=22%  Similarity=0.443  Sum_probs=203.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      +.|++.+.||+|+||+||+|++.  ++.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            56999999999999999999884  6779999998654432 24568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC---CCCceEEcccccccccccCCcc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM  268 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~---~~~~vkl~DfG~a~~~~~~~~~  268 (397)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+++........
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999976 57899999999999999999999999999999999999995   5789999999999877766666


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHHHHHHHH
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLER  346 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ll~~  346 (397)
                      ...+||+.|||||++.+..|+.++|||||||++|+|++|..||...+..+....+.......  ..+..+++++.+||.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            77789999999999999999999999999999999999999999988888777776655433  3446789999999999


Q ss_pred             hchhCCCCCCCHHHHHH
Q 015965          347 CWQQDPALRPDFSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps~~ell~  363 (397)
                      ||+.||++|||+.|+++
T Consensus       247 ~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HccCCHhHCcCHHHHhc
Confidence            99999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=417.54  Aligned_cols=246  Identities=29%  Similarity=0.554  Sum_probs=213.2

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec----CCceEE
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCI  188 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l  188 (397)
                      .|++.++||+|+||+||+|.+.  ++.||+|++..........+.+.+|+.+|++++|||||++++++..    ...+|+
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            3577789999999999999985  5679999998776666667789999999999999999999999864    345899


Q ss_pred             EEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeC-CCCceEEcccccccccccC
Q 015965          189 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       189 v~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nili~-~~~~vkl~DfG~a~~~~~~  265 (397)
                      ||||++||+|.+++.+ ...+++..++.++.||+.||+|||++|  |+||||||+|||++ +++.+||+|||+++.....
T Consensus        90 vmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999999999977 467999999999999999999999998  99999999999996 5789999999999865433


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC-CCCCCCCcHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAELL  344 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ll  344 (397)
                       .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||............+..+.. +..+..+++++.+||
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  246 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII  246 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred             -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence             3446689999999999976 5999999999999999999999999877665555554444433 345667889999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||+.||++|||+.|+++
T Consensus       247 ~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         247 EGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHSCSSGGGSCCHHHHHT
T ss_pred             HHHccCCHhHCcCHHHHhC
Confidence            9999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=419.43  Aligned_cols=256  Identities=36%  Similarity=0.697  Sum_probs=221.9

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-CCce
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL  186 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  186 (397)
                      .|+++.++|+++++||+|+||.||+|.+.++.||||+++.+.    ..+.|.+|+.++++++||||+++++++.+ .+.+
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            389999999999999999999999999999999999997543    24678999999999999999999999865 4668


Q ss_pred             EEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          187 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      |+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999999997643 35899999999999999999999999999999999999999999999999999865433


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                        .....+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+..+.... +..+.+++++..+++++.+|+
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHHH
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHH
Confidence              334578999999999998999999999999999999998 7999988877766655 455678889999999999999


Q ss_pred             HHhchhCCCCCCCHHHHHHHHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIEILQQIAK  370 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~~L~~l~~  370 (397)
                      .+||+.||++|||+.++++.|+++.+
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=428.79  Aligned_cols=250  Identities=23%  Similarity=0.416  Sum_probs=219.1

Q ss_pred             cCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ..+++|++++.||+|+||+||+|.+.  ++.||||+++.... .....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            34578999999999999999999884  67899999875321 1223467899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC--
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--  265 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~--  265 (397)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.....  
T Consensus        85 ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999999999876 578999999999999999999999999999999999999999999999999999876533  


Q ss_pred             -CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 015965          266 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  344 (397)
Q Consensus       266 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  344 (397)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+...  .+.+|..+++++.+||
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  241 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLV  241 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence             2334568999999999999999999999999999999999999999998888777776654  3457788999999999


Q ss_pred             HHhchhCCCCCCCHHHHHH
Q 015965          345 ERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       345 ~~cl~~dp~~Rps~~ell~  363 (397)
                      .+||+.||++|||+.|+++
T Consensus       242 ~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         242 EKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HTTSCSSGGGSTTSGGGTC
T ss_pred             HHHccCCHhHCcCHHHHcC
Confidence            9999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-57  Score=423.53  Aligned_cols=246  Identities=29%  Similarity=0.437  Sum_probs=219.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC-hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ..|+++++||+|+||+||+|++.  ++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999874  567999999876543 344567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   ...
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCc
Confidence            99999998766654 57899999999999999999999999999999999999999999999999999986543   345


Q ss_pred             CCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHh
Q 015965          271 ETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  347 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  347 (397)
                      ..||+.|||||++.+   ..|+.++|||||||++|||++|..||...+..+....+......+..+..+++++.+||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            689999999999854   45899999999999999999999999999888888887777666666677899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||++|||+.|+++
T Consensus       251 L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             CcCChhHCcCHHHHHh
Confidence            9999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-57  Score=418.36  Aligned_cols=263  Identities=35%  Similarity=0.646  Sum_probs=222.5

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ..+.|+|+.++|++.+.||+|+||+||+|.+.+ +.||||+++.....   .+.|.+|+.+|++++|||||++++++.+ 
T Consensus         8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3           8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            467799999999999999999999999999855 56999999865443   3579999999999999999999999865 


Q ss_pred             CceEEEEEeccCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      +.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence            5689999999999999998654 457999999999999999999999999999999999999999999999999999866


Q ss_pred             ccCC--cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHhhhcCCCCCCCCCCcHH
Q 015965          263 AQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  339 (397)
Q Consensus       263 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (397)
                      ....  ......||+.|+|||++....++.++||||||+++|||++|.. ||......+. ...+..+.+++.+..++++
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~  242 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPES  242 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCCTTSCHH
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCCCCCcccCHH
Confidence            4432  3344578999999999999999999999999999999999654 4555554444 4445566777889999999


Q ss_pred             HHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          340 LAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       340 l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +.++|.+||+.||++|||+.+|++.|++.++..
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999999999998876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=427.87  Aligned_cols=255  Identities=25%  Similarity=0.449  Sum_probs=214.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ++..++|+++++||+|+||+||+|.+.  ++.||+|+++... .......+.+|+.+|++++|||||++++++.+++.+|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            566789999999999999999999984  6779999998653 3344577999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~  266 (397)
                      +||||++||+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999999987 4679999999999999999999997 59999999999999999999999999999865433 


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------------------------
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG------------------------  322 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~------------------------  322 (397)
                      .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+....                        
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            23456899999999999999999999999999999999999999976543221100                        


Q ss_pred             -----------------hhhcCCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHH
Q 015965          323 -----------------VVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQ  367 (397)
Q Consensus       323 -----------------~~~~~~~~~~~-~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~  367 (397)
                                       .......+..+ ...++++.+||.+||..||++|||+.|+++  .|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                             00111112222 246789999999999999999999999987  4544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-57  Score=418.20  Aligned_cols=258  Identities=32%  Similarity=0.620  Sum_probs=220.8

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC-----cceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      -|+.++|++.+.||+|+||+||+|++.+     ..||||+++.... .....+.|.+|+.+|++++|||||++++++.+ 
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            4667889999999999999999998743     2589999876544 34456789999999999999999999999976 


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +..++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            46899999999999999998877889999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCc----ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcH
Q 015965          264 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  338 (397)
Q Consensus       264 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (397)
                      ....    .....||+.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+...+.+++.+..+|+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            4422    223457889999999999999999999999999999998 89999999999988888888888889999999


Q ss_pred             HHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 015965          339 KLAELLERCWQQDPALRPDFSEIIEILQQI  368 (397)
Q Consensus       339 ~l~~ll~~cl~~dp~~Rps~~ell~~L~~l  368 (397)
                      ++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999999888764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-56  Score=429.40  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=223.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++++.||+|+||.||+|.+.  ++.||||++....  ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57999999999999999999874  6789999997543  3445778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC--CCCceEEcccccccccccCCccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~--~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      |++||+|.+++.+..+.+++..+..++.||+.||.|||++|||||||||+|||++  .++.+||+|||+++.........
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            9999999999976677899999999999999999999999999999999999996  46789999999999877766677


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~c  347 (397)
                      ...||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+........  ....+++++.+||.+|
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  263 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL  263 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            78999999999999999999999999999999999999999999888887777766544322  3356889999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||++|||+.|+++
T Consensus       264 L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         264 LLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=419.88  Aligned_cols=264  Identities=32%  Similarity=0.618  Sum_probs=222.2

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  178 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  178 (397)
                      +.|++..++|+++++||+|+||.||+|.+.+       +.||||+++... .....+.+.+|+.++.++ +|+||+.+++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            5689999999999999999999999998743       469999988553 334456777888777766 6899999999


Q ss_pred             EEecC-CceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 015965          179 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  242 (397)
Q Consensus       179 ~~~~~-~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  242 (397)
                      ++..+ ..+++||||+++|+|.+++....               ..+++..++.++.||+.||.|||++|||||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence            98664 46899999999999999997532               358899999999999999999999999999999999


Q ss_pred             EEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHH
Q 015965          243 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQ  318 (397)
Q Consensus       243 ili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~P~~~~~~~~  318 (397)
                      ||++.++.+||+|||+|+......   ......||+.|+|||++.+..++.++|||||||++|||++| .+||......+
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998654332   23345799999999999999999999999999999999985 67898887777


Q ss_pred             HHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          319 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .....+..+.++..|..+++++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            77777888888999999999999999999999999999999999999999764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=424.24  Aligned_cols=250  Identities=24%  Similarity=0.449  Sum_probs=222.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      +..++|++++.||+|+||.||+|++  +++.||||++++... .....+.+.+|+.+|++++||||+++++++.++..+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            4557899999999999999999987  467899999975422 1223567889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CC
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~  266 (397)
                      +||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus        82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999987 57899999999999999999999999999999999999999999999999999986544 33


Q ss_pred             cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHH
Q 015965          267 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  346 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  346 (397)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...  .+.+|..+++++.+||.+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHh
Confidence            455678999999999999999999999999999999999999999999887777666654  356788999999999999


Q ss_pred             hchhCCCCCCC-----HHHHHH
Q 015965          347 CWQQDPALRPD-----FSEIIE  363 (397)
Q Consensus       347 cl~~dp~~Rps-----~~ell~  363 (397)
                      ||+.||.+||+     +.++++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hccCCchhhcccccccHHHHHc
Confidence            99999999995     788875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=417.21  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=222.3

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  187 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  187 (397)
                      ++|++++.||+|+||+||+|.+.  ++.||||+++......    ...+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999984  6789999997654322    23577999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC----ceEEcccccccccc
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  263 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~----~vkl~DfG~a~~~~  263 (397)
                      |||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999977 46899999999999999999999999999999999999998776    59999999998877


Q ss_pred             cCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLA  341 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  341 (397)
                      .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.......  ..+..+++++.
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  248 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence            6666777889999999999999999999999999999999999999999988888777766544332  23467899999


Q ss_pred             HHHHHhchhCCCCCCCHHHHHH
Q 015965          342 ELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       342 ~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +||.+||+.||++|||+.|+++
T Consensus       249 ~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         249 DFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-56  Score=427.20  Aligned_cols=248  Identities=19%  Similarity=0.374  Sum_probs=224.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++++.||+|+||.||+|.+  +++.||||+++...  ......+.+|+.+|++++|||||++++++.++..+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5799999999999999999987  46789999988653  3335678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC--CCCceEEcccccccccccCCccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~--~~~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      |++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+.........
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9999999998877667899999999999999999999999999999999999998  67899999999999887776677


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCCCCCcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~~c  347 (397)
                      ...||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......  ...+..+++++.+||.+|
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  266 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  266 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            788999999999999999999999999999999999999999999888877777665443  234467899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |+.||.+|||+.|+++
T Consensus       267 L~~dp~~R~s~~eil~  282 (352)
T d1koba_         267 LQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=412.18  Aligned_cols=263  Identities=32%  Similarity=0.632  Sum_probs=227.6

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  176 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~  176 (397)
                      ..|+|+.++|++++.||+|+||.||+|+..+         ..||||+++... ......++.+|+..+.++ +|||||++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            3499999999999999999999999998633         259999998654 344467788898888887 79999999


Q ss_pred             eeEEecCCceEEEEEeccCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 015965          177 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  241 (397)
Q Consensus       177 ~~~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~  241 (397)
                      +++|.+++.+++||||+++|+|.+++....               ..+++..++.++.||+.||+|||++|||||||||+
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence            999999999999999999999999997543               35899999999999999999999999999999999


Q ss_pred             cEEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015965          242 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  317 (397)
Q Consensus       242 Nili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~  317 (397)
                      |||++.++.+||+|||+++......   ......||+.|+|||++.+..|+.++||||||+++|||++ |.+||...+..
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9999999999999999998665433   2334578999999999999999999999999999999998 79999888776


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      +.. ..+..+.++..|..+++++.+||.+||+.||.+|||+.|+++.|+++...
T Consensus       245 ~~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 ELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            554 55667788889999999999999999999999999999999999998653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-55  Score=413.56  Aligned_cols=259  Identities=31%  Similarity=0.587  Sum_probs=227.3

Q ss_pred             cccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEe
Q 015965          109 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  181 (397)
Q Consensus       109 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  181 (397)
                      |++..++|++.+.||+|+||+||+|++.+       +.||||+++... ..+..+.|.+|+.+|++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            57777899999999999999999999754       469999998543 4555678999999999999999999999999


Q ss_pred             cCCceEEEEEeccCCCHHHHHHhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 015965          182 KPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL  238 (397)
Q Consensus       182 ~~~~~~lv~E~~~g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDl  238 (397)
                      .....+++|||+++|+|.+++....                       ..+++..++.++.||+.||+|||++|||||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            9999999999999999999997532                       24888999999999999999999999999999


Q ss_pred             CCCcEEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCC
Q 015965          239 KAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEYL  314 (397)
Q Consensus       239 kp~Nili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~-~P~~~~  314 (397)
                      ||+|||++.++.+||+|||+|+......   ......||+.|+|||++.+..|+.++|||||||++|||++|. +||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999998654332   233557899999999999999999999999999999999985 688888


Q ss_pred             ChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          315 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      +..+.... +..+.++..|..+++++.+|+.+||+.||++||||.||++.|+++.
T Consensus       247 ~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 AHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            88777666 4455677888999999999999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=415.26  Aligned_cols=265  Identities=31%  Similarity=0.626  Sum_probs=237.2

Q ss_pred             CccccCcccccccceeeeeCCceEEEEEECC-------cceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeee
Q 015965          107 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  178 (397)
Q Consensus       107 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  178 (397)
                      ..|+++.++|+++++||+|+||.||+|++.+       +.||||+++... ......+|.+|+.+++++ +|||||++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3699999999999999999999999998733       469999998764 344566799999999999 6999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  241 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~  241 (397)
                      ++.+...+++||||+++|+|.++++...                 ..+++..+..++.||+.||.|||++||+||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999997642                 25889999999999999999999999999999999


Q ss_pred             cEEeCCCCceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015965          242 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  317 (397)
Q Consensus       242 Nili~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~  317 (397)
                      ||+++.++.+||+|||.++......   ......||+.|+|||++.+..++.++||||||+++|||++ |.+||...+..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998655432   2234578999999999999999999999999999999998 77788888877


Q ss_pred             HHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          318 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      +....++..+.++..+..+++++.+||.+||+.||++|||+.++++.|++.+.+.
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            7788888889999999999999999999999999999999999999999988764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=415.98  Aligned_cols=258  Identities=30%  Similarity=0.610  Sum_probs=221.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEECC--c----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTYCS--Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  184 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  184 (397)
                      +..++|+++++||+|+||+||+|.+..  +    .||+|.++... .....++|.+|+.+|++++|||||+++++|.++ 
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            345679999999999999999998743  2    48888887543 233457899999999999999999999999874 


Q ss_pred             ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc
Q 015965          185 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  264 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~  264 (397)
                      ..+++|||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            57888999999999999988788899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc---ccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHH
Q 015965          265 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  340 (397)
Q Consensus       265 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  340 (397)
                      ...   .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+. ...+..+.++..|..+++++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcccCHHH
Confidence            322   223468999999999999999999999999999999998 8999998876654 44566677888889999999


Q ss_pred             HHHHHHhchhCCCCCCCHHHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRPDFSEIIEILQQIAKE  371 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~  371 (397)
                      .+|+.+||+.||++|||+.++++.|..+.+.
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999887654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.1e-55  Score=406.88  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=217.5

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC----ce
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SL  186 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  186 (397)
                      ++|++.+.||+|+||+||+|++.  ++.||||+++.... +......+.+|+.+|++++|||||++++++....    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999974  77899999987654 3455677999999999999999999999987654    37


Q ss_pred             EEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-
Q 015965          187 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  265 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-  265 (397)
                      ||||||++|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+...... 
T Consensus        87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            899999999999999876 578999999999999999999999999999999999999999999999999998754432 


Q ss_pred             ---CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCCCCCcHHH
Q 015965          266 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKL  340 (397)
Q Consensus       266 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  340 (397)
                         ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...++.+.....+.....+  .....+|+++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence               23445579999999999999999999999999999999999999999999888877777665433  2346789999


Q ss_pred             HHHHHHhchhCCCCCC-CHHHHHHHHHHHH
Q 015965          341 AELLERCWQQDPALRP-DFSEIIEILQQIA  369 (397)
Q Consensus       341 ~~ll~~cl~~dp~~Rp-s~~ell~~L~~l~  369 (397)
                      .++|.+||+.||.+|| |+++++..|.++.
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            9999999999999999 8999988888764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-55  Score=415.17  Aligned_cols=245  Identities=26%  Similarity=0.459  Sum_probs=219.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++++.||+|+||+||+|++.  ++.||||+++.... .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999974  67899999875322 1223567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  ...
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~  160 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  160 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence            99999999998876 577899999999999999999999999999999999999999999999999999876433  456


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      .+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+..+....+....  ..+|..+++++.+++.+||..
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhh
Confidence            789999999999999999999999999999999999999999998888877776653  456788999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 015965          351 DPALRP-----DFSEIIE  363 (397)
Q Consensus       351 dp~~Rp-----s~~ell~  363 (397)
                      ||.+|+     |+.++++
T Consensus       239 dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccchhhHHHHHc
Confidence            999996     8999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=416.07  Aligned_cols=262  Identities=32%  Similarity=0.586  Sum_probs=226.0

Q ss_pred             ccCcccccccceeeeeCCceEEEEEECC--c--ceEEEEecCCCCChHHHHHHHHHHHHHhcC-CCCCeeeeeeEEecCC
Q 015965          110 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  184 (397)
Q Consensus       110 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  184 (397)
                      .|+.++|++.++||+|+||+||+|++.+  .  .||||.++... ..+..+.|.+|+.+|+++ +|||||++++++.+.+
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            5677999999999999999999998744  3  47788876443 233456799999999998 7999999999999999


Q ss_pred             ceEEEEEeccCCCHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          185 SLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       185 ~~~lv~E~~~g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      .+++||||++||+|.++++..               ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999753               25799999999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCC
Q 015965          250 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGL  328 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~P~~~~~~~~~~~~~~~~~~  328 (397)
                      .+||+|||+++............||+.|+|||.+.+..|+.++||||||+++|||++| .+||...+..+....+ ..+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i-~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-GGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH-HhcC
Confidence            9999999999876665555566799999999999999999999999999999999996 5688888877766554 4567


Q ss_pred             CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          329 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       329 ~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ++..+..+++++.+||.+||+.||++|||+.++++.|++++++..
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            888899999999999999999999999999999999999987554

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.5e-55  Score=402.90  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=220.4

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh-------HHHHHHHHHHHHHhcCC-CCCeeeeeeEEecC
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP  183 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  183 (397)
                      ++|++.+.||+|+||+||+|++  .++.||||+++......       ...+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6799999999999999999987  56789999987654321       23356889999999997 99999999999999


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      +.+||||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            999999999999999999976 5789999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCcccCCCCCcccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCC
Q 015965          264 QSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKN  335 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~  335 (397)
                      .........||+.|+|||++.      ...++.++||||+||++|+|++|+.||...+.......+......+.  ....
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            766667788999999999984      34578899999999999999999999999988777776666544332  3347


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +|+++.+|+.+||+.||++|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            8999999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=406.98  Aligned_cols=262  Identities=31%  Similarity=0.567  Sum_probs=230.3

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC-------CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeee
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG  178 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  178 (397)
                      .+.|+|+.++|+++++||+|+||+||+|.+.       ++.||||+++... .......|.+|+.++++++|||||++++
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            3569999999999999999999999999874       3569999998553 4455667999999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 015965          179 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  249 (397)
Q Consensus       179 ~~~~~~~~~lv~E~~~g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~  249 (397)
                      ++..+...++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            9999999999999999999999986532         3468889999999999999999999999999999999999999


Q ss_pred             ceEEcccccccccccCC---cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhh
Q 015965          250 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQ  325 (397)
Q Consensus       250 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~P~~~~~~~~~~~~~~~  325 (397)
                      ++||+|||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++| .+||...+..+....+. 
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-  249 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-  249 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence            99999999998654432   23344689999999999999999999999999999999997 68999888877776554 


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 015965          326 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  369 (397)
Q Consensus       326 ~~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~  369 (397)
                      .+.++..|..+++.+.++|.+||+.||++|||+.++++.|++.+
T Consensus       250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            45577788899999999999999999999999999998886653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-55  Score=416.14  Aligned_cols=245  Identities=25%  Similarity=0.388  Sum_probs=219.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCC-ChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  190 (397)
                      ++|++++.||+|+||.||+|.+.  ++.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+...+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999874  78899999874321 1223467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCCcccC
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  270 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  270 (397)
                      ||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....  ....
T Consensus       121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~  197 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWT  197 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCC
T ss_pred             ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--cccc
Confidence            99999999999977 46899999999999999999999999999999999999999999999999999986643  3456


Q ss_pred             CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhchh
Q 015965          271 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  350 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  350 (397)
                      ..||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....  +..+..+++++.+||.+||+.
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHhhh
Confidence            789999999999999999999999999999999999999999988888777776653  456778999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 015965          351 DPALRP-----DFSEIIE  363 (397)
Q Consensus       351 dp~~Rp-----s~~ell~  363 (397)
                      ||.+|+     |+.++++
T Consensus       276 dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccccccHHHHHc
Confidence            999994     8999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=411.54  Aligned_cols=247  Identities=19%  Similarity=0.312  Sum_probs=220.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|++++.||+|+||+||+|.+.  ++.||||+++...   .....+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            57999999999999999999874  6779999998653   234568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC--CceEEcccccccccccCCccc
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~--~~vkl~DfG~a~~~~~~~~~~  269 (397)
                      ||+||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++.........
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            999999999998766689999999999999999999999999999999999999854  489999999998776666666


Q ss_pred             CCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHh
Q 015965          270 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC  347 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~c  347 (397)
                      ...||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+........  .+..+++++.+||.+|
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence            77899999999999999999999999999999999999999999988887777766543322  2246899999999999


Q ss_pred             chhCCCCCCCHHHHHH
Q 015965          348 WQQDPALRPDFSEIIE  363 (397)
Q Consensus       348 l~~dp~~Rps~~ell~  363 (397)
                      |..||++|||+.|+++
T Consensus       242 L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         242 LVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-54  Score=403.75  Aligned_cols=256  Identities=29%  Similarity=0.516  Sum_probs=217.2

Q ss_pred             cccceeeeeCCceEEEEEECCc-----ceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec-CCceEEEE
Q 015965          117 KFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT  190 (397)
Q Consensus       117 ~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  190 (397)
                      .+.++||+|+||+||+|++...     .||||.++.. .+....++|.+|+.+|++++|||||+++|++.. ++..++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            3467899999999999987432     4899998753 345566889999999999999999999999865 56789999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC----
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~----  266 (397)
                      ||+++++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......    
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999999998777788899999999999999999999999999999999999999999999999998654332    


Q ss_pred             -cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHH
Q 015965          267 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  345 (397)
Q Consensus       267 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  345 (397)
                       ......||+.|+|||.+....++.++||||||+++|||++|..||............+..+.++..|..+++++.+|+.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             2223468999999999999999999999999999999999777765543333333445566788888999999999999


Q ss_pred             HhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          346 RCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       346 ~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      +||+.||++||++.|+++.|++++++..
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence            9999999999999999999999987543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=408.68  Aligned_cols=247  Identities=24%  Similarity=0.428  Sum_probs=216.1

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCC-ChHHHHHHHHHHHHH-hcCCCCCeeeeeeEEecCCceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv  189 (397)
                      ++|++++.||+|+||+||+|++  +++.||||++++... .....+.+..|+.++ +.++|||||++++++.+.+.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999998  567899999975321 112234566666665 478999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccccc-CCcc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVM  268 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~-~~~~  268 (397)
                      |||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999999999986 57799999999999999999999999999999999999999999999999999986543 3345


Q ss_pred             cCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHHHHHHhc
Q 015965          269 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  348 (397)
Q Consensus       269 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  348 (397)
                      ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...  .+.+|..+++++.+||.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L  238 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLF  238 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhc
Confidence            5568999999999999999999999999999999999999999998888777766544  46778889999999999999


Q ss_pred             hhCCCCCCCHH-HHHH
Q 015965          349 QQDPALRPDFS-EIIE  363 (397)
Q Consensus       349 ~~dp~~Rps~~-ell~  363 (397)
                      +.||.+||++. ++++
T Consensus       239 ~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CSSGGGSBTTBSCGGG
T ss_pred             ccCCCCCcCHHHHHHh
Confidence            99999999985 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-53  Score=410.10  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=209.8

Q ss_pred             CcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCC----hHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCc
Q 015965          112 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  185 (397)
Q Consensus       112 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  185 (397)
                      ..++|++++.||+|+||.||+|++.  ++.||||++.+....    ........+|+.+++.++|||||++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            3468999999999999999999984  678999998643221    1112233445788888899999999999999999


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus        82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999999987 577899999999999999999999999999999999999999999999999999866543


Q ss_pred             CcccCCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HhhhcCCCCCCCCCCcHHHHHH
Q 015965          266 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLRPTIPKNSQPKLAEL  343 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l  343 (397)
                       ......||+.|+|||++. +..|+.++|||||||++|||++|+.||...+...... ........+..+..+++++.+|
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  239 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence             345668999999999986 4579999999999999999999999998754332211 1122233556678899999999


Q ss_pred             HHHhchhCCCCCCC-----HHHHHH
Q 015965          344 LERCWQQDPALRPD-----FSEIIE  363 (397)
Q Consensus       344 l~~cl~~dp~~Rps-----~~ell~  363 (397)
                      |.+||+.||.+|||     +.++++
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHc
Confidence            99999999999999     788874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=395.69  Aligned_cols=249  Identities=21%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|+++++||+|+||+||+|++.  ++.||||+++...........+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999984  6789999998665444445778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-Cccc
Q 015965          192 FMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  269 (397)
Q Consensus       192 ~~~g~sL~~~l-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~  269 (397)
                      |+.+ ++.+++ ......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ....
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            9955 555555 444567999999999999999999999999999999999999999999999999999876543 3445


Q ss_pred             CCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC----------------CC-
Q 015965          270 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------------PT-  331 (397)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~----------------~~-  331 (397)
                      ...||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+....+......                .. 
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            568999999999987665 578999999999999999999999988876665554321100                00 


Q ss_pred             ----------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          332 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       332 ----------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                ....+++++.+|+.+||..||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                      11356789999999999999999999999976

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=404.70  Aligned_cols=243  Identities=23%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             ccccccc-eeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHh-cCCCCCeeeeeeEEec----CCc
Q 015965          114 KHLKFGS-KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTK----PPS  185 (397)
Q Consensus       114 ~~~~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~  185 (397)
                      ++|++.. .||+|+||.||+|.+  +++.||||+++..       ..+.+|+.++. ..+|||||++++++.+    ...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            5788775 599999999999987  4678999998742       35678998865 4589999999999865    456


Q ss_pred             eEEEEEeccCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccc
Q 015965          186 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV  261 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~  261 (397)
                      +|||||||+||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999999999999998643 46999999999999999999999999999999999999985   56799999999998


Q ss_pred             cccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC--CCCC----CC
Q 015965          262 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIP----KN  335 (397)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~~~----~~  335 (397)
                      ..........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......  ..+|    ..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  243 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred             ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence            77777777889999999999999999999999999999999999999999776554443333222211  1122    25


Q ss_pred             CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          336 SQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       336 ~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      +++++.+||.+||+.||.+|||+.|+++
T Consensus       244 ~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         244 VSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            7899999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=398.48  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=210.7

Q ss_pred             ccccccceeeeeCCceEEEEEEC---CcceEEEEecCCCCChHHHHHHHHHHHHHhcC---CCCCeeeeeeEEec-----
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK-----  182 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----  182 (397)
                      ++|+++++||+|+||+||+|.+.   ++.||||+++...........+.+|+.+|+.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            68999999999999999999874   34599999876543333334456777776655   79999999999853     


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ...++++|||+.++.+..........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            34689999999887776666665678999999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--------------
Q 015965          263 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------  328 (397)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--------------  328 (397)
                      ..........||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+.....              
T Consensus       167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  246 (305)
T d1blxa_         167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP  246 (305)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred             cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence            766677788999999999999999999999999999999999999999999887776655443110              


Q ss_pred             -----------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          329 -----------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       329 -----------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                 ....+..+++.+.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       01134567899999999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=395.52  Aligned_cols=244  Identities=24%  Similarity=0.347  Sum_probs=201.5

Q ss_pred             cceeeeeCCceEEEEEE--CCcceEEEEecCCCCCh---HHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEec
Q 015965          119 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       119 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      +++||+|+||+||+|++  +++.||||+++......   ...+.+.+|+.+|++++|||||++++++..++.+|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57899999999999987  46789999997654322   22356889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC-CcccCCC
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAET  272 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~-~~~~~~~  272 (397)
                      .|+++..+. .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......+
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            877665554 44677999999999999999999999999999999999999999999999999999865543 3344568


Q ss_pred             CCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC---------------------
Q 015965          273 GTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------------  330 (397)
Q Consensus       273 gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~---------------------  330 (397)
                      ||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+......+                     
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999864 568999999999999999999999999988877666554321100                     


Q ss_pred             C-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 T-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ~-----~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                      .     ....+++++.+||.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0     01356789999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-52  Score=386.44  Aligned_cols=249  Identities=22%  Similarity=0.361  Sum_probs=208.0

Q ss_pred             ccccccceeeeeCCceEEEEEEC-CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEEe
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  192 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E~  192 (397)
                      ++|+++++||+|+||+||+|++. ++.||||+++.........+.+.+|+.+|++++|||||++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999875 57899999987655444467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccCC
Q 015965          193 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  271 (397)
Q Consensus       193 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~~  271 (397)
                      +.++.+..+ ....+.+++..+..++.||+.||+|||+.|||||||||+|||++.++.+||+|||.+....... .....
T Consensus        82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            966555554 4446889999999999999999999999999999999999999999999999999998765433 33455


Q ss_pred             CCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC---------------------
Q 015965          272 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------------  329 (397)
Q Consensus       272 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~---------------------  329 (397)
                      .|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+......                     
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence            78999999999865 45789999999999999999999999988876665554321000                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                            ......+++++.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1123567889999999999999999999999973

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=390.35  Aligned_cols=254  Identities=27%  Similarity=0.509  Sum_probs=205.8

Q ss_pred             ccccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC----ceEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV  189 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  189 (397)
                      .+|.+.++||+|+||+||+|++.++.||||+++...   .....+..|+..+.+++|||||++++++.+..    .+|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            468888999999999999999999999999987432   21222334566667889999999999997643    57999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                      |||+++|+|.+++++  ..+++..++.++.|++.||.|||+        +||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999986  468999999999999999999996        5999999999999999999999999999986


Q ss_pred             cccCC-----cccCCCCCcccccccccCCCC------CCCchhHHHHHHHHHHHHhCCCCCCCC---------------C
Q 015965          262 KAQSG-----VMTAETGTYRWMAPEVIEHKP------YDHKADVFSFGIVLWELLTGKLPYEYL---------------T  315 (397)
Q Consensus       262 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g~~P~~~~---------------~  315 (397)
                      .....     ......||+.|+|||++.+..      ++.++|||||||+||||+||..||...               .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            65432     233457999999999987643      567899999999999999998877321               2


Q ss_pred             hHHHHHHhhhcCCCCCCCCCC-----cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHh
Q 015965          316 PLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  372 (397)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~-----~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~  372 (397)
                      .............+|.++...     +..+.+|+.+||+.||++|||+.|+++.|+++.++-
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            223333444556666665432     356999999999999999999999999999987654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=390.63  Aligned_cols=240  Identities=25%  Similarity=0.473  Sum_probs=204.4

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCCh----HHHHHHHHHHHHHhcCC--CCCeeeeeeEEecCCc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  185 (397)
                      ++|++++.||+|+||+||+|.+.  ++.||||+++......    .....+.+|+.+|++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999984  6789999987543321    11234678999999987  8999999999999999


Q ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCceEEcccccccccc
Q 015965          186 LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKA  263 (397)
Q Consensus       186 ~~lv~E~~~g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-~~~vkl~DfG~a~~~~  263 (397)
                      .|+||||+.+ +++.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999976 578888876 578999999999999999999999999999999999999985 4799999999997654


Q ss_pred             cCCcccCCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCCCCCCCCcHHHHH
Q 015965          264 QSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  342 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  342 (397)
                      . ...+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+      .+...  ...++..+|+++.+
T Consensus       163 ~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 D-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFRQRVSSECQH  233 (273)
T ss_dssp             S-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCSSCCCHHHHH
T ss_pred             c-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCCCCCCHHHHH
Confidence            3 34556789999999999987665 567899999999999999999997532      12222  33567789999999


Q ss_pred             HHHHhchhCCCCCCCHHHHHH
Q 015965          343 LLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       343 ll~~cl~~dp~~Rps~~ell~  363 (397)
                      ||.+||+.||++|||+.|+++
T Consensus       234 li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=388.83  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=212.0

Q ss_pred             CCccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC
Q 015965          106 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  183 (397)
Q Consensus       106 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  183 (397)
                      ...|++ .++|+++++||+|+||+||+|.+.  ++.||||+++....+....+.+.+|+.+|++++|||||++++++...
T Consensus        11 ~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          11 KTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             SSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             Cceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            455777 478999999999999999999974  78899999987766667778899999999999999999999999765


Q ss_pred             C------ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccc
Q 015965          184 P------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       184 ~------~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                      +      .+|+||||+ +.+|..+.+.  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence            5      479999999 7788887754  679999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCC--------
Q 015965          258 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------  328 (397)
Q Consensus       258 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~--------  328 (397)
                      +++....  ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+.............        
T Consensus       167 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         167 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            9986543  3566789999999999865 4578999999999999999999999988776555433222110        


Q ss_pred             ---------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 015965          329 ---------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI  368 (397)
Q Consensus       329 ---------------------~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~--L~~l  368 (397)
                                           .......+++++.+||.+||..||.+|||+.|+++.  |+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                                 012335678999999999999999999999999863  5443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-50  Score=380.26  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=208.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeee-eeeEEecCCceEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTKPPSLCIVT  190 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~  190 (397)
                      ++|++++.||+|+||+||+|++.  ++.||||+++.....    .++.+|+.+++.++|+|++. +..++...+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            57999999999999999999974  678999998765432    34778999999998776554 555567778889999


Q ss_pred             EeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC---CCceEEcccccccccccCC-
Q 015965          191 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSG-  266 (397)
Q Consensus       191 E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~---~~~vkl~DfG~a~~~~~~~-  266 (397)
                      ||+ +++|.+.+......+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+...... 
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999 77888888777788999999999999999999999999999999999999864   4579999999998655432 


Q ss_pred             -------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh---hc---CCCCCCC
Q 015965          267 -------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV---QK---GLRPTIP  333 (397)
Q Consensus       267 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~---~~---~~~~~~~  333 (397)
                             ......||+.|||||++.+..++.++|||||||++|||++|..||......+......   ..   ...+..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   2234579999999999999999999999999999999999999998766544332221   11   1122345


Q ss_pred             CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhc
Q 015965          334 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  373 (397)
Q Consensus       334 ~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~  373 (397)
                      ..+|+++.+++.+||+.||++||++.++.+.|++++.+.+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            6789999999999999999999999999999999876544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-50  Score=376.62  Aligned_cols=257  Identities=18%  Similarity=0.282  Sum_probs=215.9

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCC-CCeeeeeeEEecCCceEEE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv  189 (397)
                      .++|+++++||+|+||+||+|++.  ++.||||+++.....    ..+.+|+..++.++| +|++.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            468999999999999999999974  678999998654322    246678888888875 8999999999999999999


Q ss_pred             EEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-----CCceEEccccccccccc
Q 015965          190 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQ  264 (397)
Q Consensus       190 ~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~-----~~~vkl~DfG~a~~~~~  264 (397)
                      |||+ +++|.+++......++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 88999999887778999999999999999999999999999999999999974     57899999999986543


Q ss_pred             CC--------cccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhc---CCCC
Q 015965          265 SG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQK---GLRP  330 (397)
Q Consensus       265 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~---~~~~~~~~~~---~~~~  330 (397)
                      ..        ......||+.|||||++.+..++.++||||||+++|||++|..||.+...   .+....+...   ....
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            21        23345799999999999999999999999999999999999999976533   2222222221   1122


Q ss_pred             CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHHHhch
Q 015965          331 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  374 (397)
Q Consensus       331 ~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~~L~~l~~~~~~  374 (397)
                      ..+..+|+++.+++..||..+|++||+++.+.+.|++++++.+.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            34467889999999999999999999999999999999876653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=381.92  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=204.1

Q ss_pred             ccccCcccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCC-
Q 015965          108 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-  184 (397)
Q Consensus       108 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  184 (397)
                      .|++. ++|+++++||+|+||+||+|.+.  ++.||||+++... .....+.+.+|+.+|++++||||+++++++..+. 
T Consensus         3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            35665 46999999999999999999874  7889999997543 4455678999999999999999999999997653 


Q ss_pred             ---ceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          185 ---SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       185 ---~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                         ..+++++|+.|++|.+++..  +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence               23445566679999999975  5799999999999999999999999999999999999999999999999999976


Q ss_pred             cccCC----cccCCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC------
Q 015965          262 KAQSG----VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  330 (397)
Q Consensus       262 ~~~~~----~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~------  330 (397)
                      .....    .....+||+.|+|||++ .+..++.++||||+||++|+|++|+.||...+..............+      
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            54432    23455799999999998 45567899999999999999999999998877654443322110000      


Q ss_pred             -----------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 -----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 -----------------------~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                             .....+++++.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                   112456789999999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-50  Score=382.20  Aligned_cols=248  Identities=24%  Similarity=0.329  Sum_probs=203.7

Q ss_pred             cccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec------CCce
Q 015965          115 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPSL  186 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~  186 (397)
                      +|+.+++||+|+||+||+|++.  ++.||||+++.....      +.+|+.+|++++||||+++++++..      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            6889999999999999999984  678999999765422      2369999999999999999999843      2347


Q ss_pred             EEEEEeccCCCHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccc
Q 015965          187 CIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKA  263 (397)
Q Consensus       187 ~lv~E~~~g~sL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~  263 (397)
                      ||||||++++.+.....  .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            89999997654333332  2356799999999999999999999999999999999999999775 89999999998877


Q ss_pred             cCCcccCCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---------------
Q 015965          264 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------------  327 (397)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~---------------  327 (397)
                      .........||+.|+|||++.+ ..|+.++||||+||++|||++|..||...+..+....+....               
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            6666777899999999998764 578999999999999999999999999887766555443210               


Q ss_pred             CC------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 015965          328 LR------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  368 (397)
Q Consensus       328 ~~------------~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~--~L~~l  368 (397)
                      ..            .......++++.+||.+||..||++|||+.|+++  .|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            00            0122457899999999999999999999999985  35444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=375.56  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=201.6

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec--------C
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------P  183 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~  183 (397)
                      ++|+++++||+|+||+||+|++.  ++.||||++............+.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            78999999999999999999974  6789999987665555455778899999999999999999998855        3


Q ss_pred             CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccc
Q 015965          184 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  263 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~  263 (397)
                      ..+|+||||+.++.+. ........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          90 GSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             -CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            4689999999766554 444446789999999999999999999999999999999999999999999999999997544


Q ss_pred             cC-----CcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC--CCC--
Q 015965          264 QS-----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIP--  333 (397)
Q Consensus       264 ~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~--~~~--  333 (397)
                      ..     ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...+.......+......+  ...  
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            32     223345799999999998754 68999999999999999999999999887766555443321111  000  


Q ss_pred             --------------------------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          334 --------------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       334 --------------------------~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                                ...++++.+||.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                                      013567889999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=368.34  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=210.0

Q ss_pred             ccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecCCceEEEEE
Q 015965          114 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  191 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~E  191 (397)
                      ++|+++++||+|+||+||+|++  +++.||||+++...........+.+|+.+|++++||||+++++++.+....++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999998  45679999998776666667889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccCC-cccC
Q 015965          192 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  270 (397)
Q Consensus       192 ~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~~-~~~~  270 (397)
                      ++.|++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus        82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            9988888877765 6788999999999999999999999999999999999999999999999999998766543 3344


Q ss_pred             CCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhhc----------------------
Q 015965          271 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQK----------------------  326 (397)
Q Consensus       271 ~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~P~~~~-~~~~~~~~~~~~----------------------  326 (397)
                      ..+++.|+|||++.... ++.++|||||||++|||++|+.||... +..+....+...                      
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            56788999999987654 689999999999999999999886543 333333322110                      


Q ss_pred             -----CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          327 -----GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       327 -----~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                           .........+++.+.+|+.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0111233456889999999999999999999999875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=380.24  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=210.8

Q ss_pred             CCCccccCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEec
Q 015965          105 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  182 (397)
Q Consensus       105 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  182 (397)
                      +.+.|++ +++|+++++||+|+||+||+|.+  +++.||||+++....+....+.+.+|+.+|++++|||||++++++..
T Consensus        10 ~~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~   88 (348)
T d2gfsa1          10 NKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   88 (348)
T ss_dssp             SSSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3456777 47899999999999999999987  46789999998776666667789999999999999999999999864


Q ss_pred             C-----CceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccc
Q 015965          183 P-----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  257 (397)
Q Consensus       183 ~-----~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG  257 (397)
                      .     ...+++|+|+.||+|.+++..  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus        89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          89 ARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             ccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence            3     334667777889999999964  579999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCcccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCCC------
Q 015965          258 VARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  330 (397)
Q Consensus       258 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~~------  330 (397)
                      ++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......+      
T Consensus       167 ~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         167 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             ---CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            9975433  34566899999999987665 46889999999999999999999999887666555443321111      


Q ss_pred             ---------------C--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          331 ---------------T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       331 ---------------~--------~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                     .        ....+++++.+||.+||..||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                           0        11357889999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=381.65  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=209.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE-----CCcceEEEEecCCCC--ChHHHHHHHHHHHHHhcCCC-CCeeeeeeEEec
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTK  182 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~  182 (397)
                      +..++|+++++||+|+||+||+|..     +++.||||+++....  .....+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3457899999999999999999986     356799999875432  11224567889999999977 899999999999


Q ss_pred             CCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEccccccccc
Q 015965          183 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  262 (397)
Q Consensus       183 ~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~  262 (397)
                      ...++++|||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999999987 467889999999999999999999999999999999999999999999999999765


Q ss_pred             cc--CCcccCCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--CCCCCCCCCC
Q 015965          263 AQ--SGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNS  336 (397)
Q Consensus       263 ~~--~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~--~~~~~~~~~~  336 (397)
                      ..  ........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||...+..+....+...  ...+.++..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            43  2334456799999999999654  4788999999999999999999999776543332222221  2245677889


Q ss_pred             cHHHHHHHHHhchhCCCCCCC-----HHHHHH
Q 015965          337 QPKLAELLERCWQQDPALRPD-----FSEIIE  363 (397)
Q Consensus       337 ~~~l~~ll~~cl~~dp~~Rps-----~~ell~  363 (397)
                      ++++.+||.+||+.||++|||     ++|+++
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            999999999999999999994     788764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.6e-49  Score=373.85  Aligned_cols=242  Identities=19%  Similarity=0.342  Sum_probs=201.6

Q ss_pred             cccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEec--CCceE
Q 015965          113 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSLC  187 (397)
Q Consensus       113 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~  187 (397)
                      .++|+++++||+|+||+||+|++.  ++.||||+++...     .+.+.+|+.+|++++ ||||+++++++..  ...++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            468999999999999999999974  6789999997542     356889999999996 9999999999974  35689


Q ss_pred             EEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC-ceEEcccccccccccCC
Q 015965          188 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG  266 (397)
Q Consensus       188 lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~-~vkl~DfG~a~~~~~~~  266 (397)
                      +||||+.+++|..+.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999987653    4699999999999999999999999999999999999998655 69999999998877666


Q ss_pred             cccCCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhh------------c------
Q 015965          267 VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQ------------K------  326 (397)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~-~~~~~~------------~------  326 (397)
                      ......||+.|+|||++.+. .++.++||||+||++|+|++|..||........ ...+..            .      
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            67778899999999998765 579999999999999999999999976543221 111100            0      


Q ss_pred             -----------------CCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          327 -----------------GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       327 -----------------~~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                                       .........+++++.+||++||..||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                             0011122346889999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=379.60  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=195.9

Q ss_pred             ccccccceeeeeCCceEEEEEEC--CcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCeeeeeeEEecC------Cc
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS  185 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  185 (397)
                      ++|+++++||+|+||+||+|.+.  ++.||||+++....+......+.+|+.+|++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999985  78899999988776777777899999999999999999999999643      57


Q ss_pred             eEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccccccccC
Q 015965          186 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  265 (397)
Q Consensus       186 ~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~~~~~  265 (397)
                      +|+||||+.+ ++.+.+   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus        97 ~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            8999999965 444444   356899999999999999999999999999999999999999999999999999887777


Q ss_pred             CcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCCC----------------
Q 015965          266 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------------  329 (397)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~~~~~~~~~~~~~----------------  329 (397)
                      .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......                
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence            7777778999999999999999999999999999999999999999887765544433211100                


Q ss_pred             ----CC--------------C------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 015965          330 ----PT--------------I------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  363 (397)
Q Consensus       330 ----~~--------------~------~~~~~~~l~~ll~~cl~~dp~~Rps~~ell~  363 (397)
                          +.              .      +...++++.+||++||..||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                00              0      0123567899999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-42  Score=330.82  Aligned_cols=248  Identities=20%  Similarity=0.337  Sum_probs=188.9

Q ss_pred             cCcccccccceeeeeCCceEEEEEE--CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-----------CCCeeeee
Q 015965          111 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQFI  177 (397)
Q Consensus       111 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~  177 (397)
                      +...+|+++++||+|+||+||+|++  +++.||||+++..   ....+.+.+|+.+++.++           |+||++++
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3446799999999999999999987  4688999999854   233456788998888775           57899999


Q ss_pred             eEEec--CCceEEEEEeccCCCHHHH--HHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCC---
Q 015965          178 GACTK--PPSLCIVTEFMSGGSVYDY--LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE---  249 (397)
Q Consensus       178 ~~~~~--~~~~~lv~E~~~g~sL~~~--l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nili~~~~---  249 (397)
                      +++..  ....+++|+++..+.....  .......+++..+..++.||+.||+|||+ .||+||||||+|||++.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            88754  3456667766655433222  23335678999999999999999999998 8999999999999998665   


Q ss_pred             ---ceEEcccccccccccCCcccCCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH------HHH
Q 015965          250 ---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL------QAA  320 (397)
Q Consensus       250 ---~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~P~~~~~~~------~~~  320 (397)
                         .++++|||.+.....  .....+||+.|+|||++.+..++.++|+||+||++++|++|+.||......      ...
T Consensus       167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence               499999999976543  345668999999999999999999999999999999999999999644321      011


Q ss_pred             HH---hhh--------c---------------C--------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 015965          321 VG---VVQ--------K---------------G--------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSE  360 (397)
Q Consensus       321 ~~---~~~--------~---------------~--------------~~~~~~~~~~~~l~~ll~~cl~~dp~~Rps~~e  360 (397)
                      ..   ...        .               .              .....+...++++.+||.+||..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            00   000        0               0              011122334678999999999999999999999


Q ss_pred             HHH
Q 015965          361 IIE  363 (397)
Q Consensus       361 ll~  363 (397)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.2e-26  Score=201.63  Aligned_cols=164  Identities=14%  Similarity=0.154  Sum_probs=121.1

Q ss_pred             cccceeeeeCCceEEEEEE-CCcceEEEEecCCCCC----------------hHHHHHHHHHHHHHhcCCCCCeeeeeeE
Q 015965          117 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----------------SDMQKEFAQEVFIMRKVRHKNVVQFIGA  179 (397)
Q Consensus       117 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~~~~~  179 (397)
                      .++++||+|+||+||+|.+ +++.||||+++.....                ........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999986 5688999998753211                0112345568899999999999998865


Q ss_pred             EecCCceEEEEEeccCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCceEEcccccc
Q 015965          180 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  259 (397)
Q Consensus       180 ~~~~~~~~lv~E~~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nili~~~~~vkl~DfG~a  259 (397)
                      ..    .+++|||+++..+.+        ++...+..++.|++.++.|||++||+||||||+|||+++++ ++|+|||.|
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a  149 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS  149 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence            42    389999998765432        45556778999999999999999999999999999999655 899999999


Q ss_pred             cccccCCcccCCCCCcccccc------cccCCCCCCCchhHHHHHHHH
Q 015965          260 RVKAQSGVMTAETGTYRWMAP------EVIEHKPYDHKADVFSFGIVL  301 (397)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~slG~~l  301 (397)
                      +....+...       .|...      +. -.+.|+.++|+||+.--+
T Consensus       150 ~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         150 VEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            765433211       11111      11 135688899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=4e-08  Score=87.09  Aligned_cols=139  Identities=12%  Similarity=0.084  Sum_probs=91.0

Q ss_pred             cccccceeeeeCCceEEEEEECCcceEEEEecCCCCChHHHHHHHHHHHHHhcCC-CCCeeeeeeEEecCCceEEEEEec
Q 015965          115 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM  193 (397)
Q Consensus       115 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~  193 (397)
                      .|++.+..+-++.+.||+....++.+.+|.........  ...+.+|...++.+. +--+++++.++..++..++||+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            45555554444557899998888889999876543221  224567777777654 333677788888888899999999


Q ss_pred             cCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015965          194 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  230 (397)
Q Consensus       194 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------------  230 (397)
                      +|.++.+....      ......++.++...+..||+                                           
T Consensus        93 ~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            99877554311      00111122333333333331                                           


Q ss_pred             ----------------CCcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          231 ----------------NNIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       231 ----------------~~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                                      ..++|+|+.|.||++++++.+-|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            1279999999999999877778999998853

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=8e-06  Score=71.34  Aligned_cols=136  Identities=13%  Similarity=0.157  Sum_probs=81.1

Q ss_pred             eeeeeCC-ceEEEEEECC-cceEEEEecCCCCChHHHHHHHHHHHHHhcCCC--CCeeeeeeEEecCCceEEEEEeccCC
Q 015965          121 KVASGSY-GDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       121 ~lg~G~~-g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~E~~~g~  196 (397)
                      .+..|.. +.||+....+ ..+++|.......     ..+..|...++.+..  -.+++++.++.+++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3445554 5789988754 4578898765432     235566776665542  33677888888888899999999886


Q ss_pred             CHHH--------------HHHhcc------CCC--CHHHHHHHH--------------------HHHHHHHHHHHhC---
Q 015965          197 SVYD--------------YLHKLK------GVF--KLPSLLKVA--------------------IDVSKGMNYLHQN---  231 (397)
Q Consensus       197 sL~~--------------~l~~~~------~~l--~~~~~~~i~--------------------~qi~~~l~~LH~~---  231 (397)
                      ++.+              .+.+..      ..+  .......-.                    ......+..+...   
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            5432              111110      000  000000000                    0111122333322   


Q ss_pred             ----CcccCCCCCCcEEeCCCCceEEcccccccc
Q 015965          232 ----NIIHRDLKAANLLMDENEVVKVADFGVARV  261 (397)
Q Consensus       232 ----~iiHrDlkp~Nili~~~~~vkl~DfG~a~~  261 (397)
                          .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                379999999999999877778999998853

>d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: SP0238-like
domain: UPF0237 protein SP0238
species: Streptococcus pneumoniae [TaxId: 1313]

Probab=97.69  E-value=4.8e-05  Score=54.36  Aligned_cols=65  Identities=25%  Similarity=0.282  Sum_probs=48.8

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK   69 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~~~   69 (397)
                      ||+++.|||++++.+|.+|++.|.||.+...+.. +|...=.+.++.....+.++++++++....+
T Consensus         5 itv~g~DrpGiVa~vt~~l~~~g~NI~d~~q~~~-~~~f~~~~~v~~~~~~~~~~l~~~l~~la~~   69 (83)
T d1zpva1           5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVL-DEYFTMMAVVSSDEKQDFTYLRNEFEAFGQT   69 (83)
T ss_dssp             EEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEE-TTEEEEEEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCCCHHHHHHHHHHHCCCeEEEEEeEEe-CCEEEEEEEEEEecCCCHHHHHHHHHHHHHH
Confidence            7999999999999999999999999999987644 3333333344433344678888888875444

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.68  E-value=0.00016  Score=67.43  Aligned_cols=76  Identities=12%  Similarity=-0.006  Sum_probs=45.9

Q ss_pred             ceeeeeCCceEEEEEE--CCcceEEEEecCCCC----C-hHHHHHHHHHHHHHhcCC---CCCeeeeeeEEecCCceEEE
Q 015965          120 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI----N-SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV  189 (397)
Q Consensus       120 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  189 (397)
                      +.||.|..-.||+.+.  .++.++||.-.+...    . .....+...|...|+.+.   ...+++++.+.  +...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            4689999999999864  356789997543110    0 001123445676666553   23466666553  3456889


Q ss_pred             EEeccCCC
Q 015965          190 TEFMSGGS  197 (397)
Q Consensus       190 ~E~~~g~s  197 (397)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

Probab=97.61  E-value=5.1e-05  Score=54.62  Aligned_cols=64  Identities=14%  Similarity=0.159  Sum_probs=48.9

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK   69 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~~~~~   69 (397)
                      ||+.+.|+|+++++++.+|++.|.||.++.-+ +..|...-++.|+ ++..+.++++++|++-..+
T Consensus         8 itv~G~DrpGiva~vt~~l~~~g~NI~d~~~~-~~~~~~~~~~~v~-~~~~~~~~l~~~L~~l~~~   71 (86)
T d1u8sa1           8 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIA-MFGKEFTLLMLIS-GSPSNITRVETTLPLLGQQ   71 (86)
T ss_dssp             EEEEEECCTTHHHHHHHHHHHTTCEEEEEEEE-EETTEEEEEEEEE-ECHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCChHHHHHHHHHHHCCCeEEEeEeE-EECCeeEEEEEEE-cCcccHHHHHHHHHHHHHH
Confidence            78999999999999999999999999998764 3444444444455 3556777888888775544

>d1u8sa2 d.58.18.5 (A:88-180) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

Probab=97.16  E-value=0.00059  Score=49.53  Aligned_cols=69  Identities=17%  Similarity=0.144  Sum_probs=47.2

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccC---CCceeeeEEe----cCCCchhHHHHHHHHHHHHHHhh
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV---DGYSLDVFVV----DGWPYEETEQLRAALEKEVLKLE   71 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~---~g~~l~~~vv----d~~~~~~~~~l~~~l~~~~~~~~   71 (397)
                      ||++.+.|||+++.++|.+|++.|.||.+.......   .+...+.|.+    .....-+.++++++++.-...+.
T Consensus         8 ~v~v~g~DrpGIV~~it~~la~~~~nI~~l~t~~~~a~~~~~~~~~f~~~~~~~~p~~~~~~~l~~~l~~l~~~l~   83 (93)
T d1u8sa2           8 EVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAISARVDSGCNLMQLQEEFDALCTALD   83 (93)
T ss_dssp             EEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEEEEECTTSCHHHHHHHHHHHHHHHT
T ss_pred             EEEEEECCCCCHHHHHHHHHHHcCCCchhhhcccccccCCcccCccEEEEEEEEcCccccHHHHHHHHHHHHHHce
Confidence            788999999999999999999999999997765422   2222222322    22233467888888887665543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.14  E-value=0.00063  Score=61.41  Aligned_cols=66  Identities=17%  Similarity=0.194  Sum_probs=41.5

Q ss_pred             ceEEEEEE-CCcceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCCe-----eeee--eEEecCCceEEEEEeccCC
Q 015965          128 GDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-----VQFI--GACTKPPSLCIVTEFMSGG  196 (397)
Q Consensus       128 g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~--~~~~~~~~~~lv~E~~~g~  196 (397)
                      =.||+++. .|+.+++|+.++...+.   .++..|...+..|...++     +..-  ..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            36999876 56779999998775543   446677777766642222     1111  1223445678899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.68  E-value=0.0026  Score=58.85  Aligned_cols=76  Identities=14%  Similarity=0.281  Sum_probs=48.4

Q ss_pred             ccccccceeeeeCCceEEEEEECC---------cceEEEEecCCCCChHHHHHHHHHHHHHhcCCCCC-eeeeeeEEecC
Q 015965          114 KHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKP  183 (397)
Q Consensus       114 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~  183 (397)
                      +.+++ +.|+-|-.=.+|+.+..+         +.|.+++.-.. ..   .....+|..+++.+.-.+ .+++++++.+ 
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            34444 567777777899987643         34777776522 11   234557888888775333 4577777643 


Q ss_pred             CceEEEEEeccCCCH
Q 015965          184 PSLCIVTEFMSGGSV  198 (397)
Q Consensus       184 ~~~~lv~E~~~g~sL  198 (397)
                         .+|+||++|.+|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               789999987544

>d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=96.60  E-value=0.0059  Score=42.35  Aligned_cols=53  Identities=21%  Similarity=0.220  Sum_probs=42.7

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccC-CCceeeeEEecCCCch
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPYE   54 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~-~g~~l~~~vvd~~~~~   54 (397)
                      |=+.+...|+|++|.+++++|++-|.||...+..... .|...-++.+|+...+
T Consensus         4 ~~L~i~~~D~PGvi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~~~   57 (78)
T d1ygya3           4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPD   57 (78)
T ss_dssp             EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCCCH
T ss_pred             eEEEEEeCCcCCHHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCccH
Confidence            4467788999999999999999999999998886544 4556667777876554

>d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: AF1403 N-terminal domain-like
domain: Hypothetical protein AF1403, N-terminal domain
species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]

Probab=96.26  E-value=0.0015  Score=45.45  Aligned_cols=62  Identities=19%  Similarity=0.172  Sum_probs=43.0

Q ss_pred             eEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCC-chhHHHHHHHHH
Q 015965            3 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP-YEETEQLRAALE   64 (397)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~-~~~~~~l~~~l~   64 (397)
                      .|.+-+.|+|++|+.+++++++.|.||...+.+...+|.+--.+.++=.. ..+.+.+.++|+
T Consensus         3 ~i~i~~~Dr~GlL~di~~~ia~~~~NI~~i~~~~~~~g~~~~~~~i~v~~~~~~l~~ll~kL~   65 (77)
T d1y7pa2           3 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILERVK   65 (77)
T ss_dssp             EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEEEEEECSSCHHHHHHHHH
T ss_pred             eEEEEEecCCChHHHHHHHHHHcCCCeEEEEeeccCCCeEEEEEEEEEEcCcccHHHHHHHHH
Confidence            57888999999999999999999999999998888888665555543211 124566665554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.24  E-value=0.0088  Score=53.02  Aligned_cols=30  Identities=30%  Similarity=0.406  Sum_probs=27.3

Q ss_pred             CCcccCCCCCCcEEeCCCCceEEccccccc
Q 015965          231 NNIIHRDLKAANLLMDENEVVKVADFGVAR  260 (397)
Q Consensus       231 ~~iiHrDlkp~Nili~~~~~vkl~DfG~a~  260 (397)
                      .|+||+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988888999999884

>d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=95.85  E-value=0.013  Score=39.63  Aligned_cols=56  Identities=16%  Similarity=0.223  Sum_probs=45.3

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecCCCchhHHHHHHHHHH
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |.+.--|+|+-|.+++++|++.|.||.-..+|.+. ++..=+|.||     +.+..++.|++
T Consensus         2 iaV~v~d~pG~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~   57 (71)
T d2f06a1           2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKE   57 (71)
T ss_dssp             EEEEEESSTTHHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHH
T ss_pred             EEEEecCCccHHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHH
Confidence            45677899999999999999999999999999876 6777777775     44555555554

>d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Escherichia coli [TaxId: 562]

Probab=95.70  E-value=0.0099  Score=41.81  Aligned_cols=38  Identities=18%  Similarity=0.423  Sum_probs=33.2

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD   39 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~   39 (397)
                      |=+++.-.|+|+.|++++++|++-|+||..-+.-+.-+
T Consensus        12 ~rl~i~~~d~PGvla~I~~~l~~~~iNI~~~~~~~~~~   49 (84)
T d1sc6a3          12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQ   49 (84)
T ss_dssp             EEEEEEEESCTTHHHHHHHHHHHTTCEEEEEEEEECSS
T ss_pred             eEEEEEeCCcCCHHHHHHHHHHHcCCCHHHhccccCCC
Confidence            55788899999999999999999999999987755544

>d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=94.89  E-value=0.057  Score=36.19  Aligned_cols=49  Identities=16%  Similarity=0.271  Sum_probs=40.4

Q ss_pred             CeeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCCCceeeeEEecC
Q 015965            1 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG   50 (397)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~g~~l~~~vvd~   50 (397)
                      +|.|.+-.-|||+.|.+++.+|++-|.||.--.++.|.+ +..--++||.
T Consensus         3 ~~QisV~~eNkpG~L~~v~~~~~~~~inI~sl~v~~t~~-~~i~Riiv~~   51 (70)
T d2f06a2           3 AKQLSIFLENKSGRLTEVTEVLAKENINLSALCIAENAD-FGILRGIVSD   51 (70)
T ss_dssp             EEEEEEEECSSSSHHHHHHHHHHHTTCCEEEEEEEECSS-CEEEEEEESC
T ss_pred             eEEEEEEEeCCCcHHHHHHHHHHHCCCCEEEEEEeecCC-CCEEEEEECC
Confidence            367888899999999999999999999999888876654 5555667763

>d2f1fa1 d.58.18.6 (A:2-77) Acetolactate synthase small subunit, IlvH {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Escherichia coli [TaxId: 562]

Probab=93.08  E-value=0.21  Score=33.77  Aligned_cols=63  Identities=21%  Similarity=0.215  Sum_probs=43.7

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccC-CCceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~-~g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |=|++-..|+|+.|++++.+++.=|.||.--.+--|- .|.+==.+++.+ ..+..+++...+++
T Consensus         2 htlsv~v~N~~GVL~RisglF~rRg~NI~Sl~v~~te~~~iSR~tivv~~-~~~~i~qi~kQL~K   65 (76)
T d2f1fa1           2 RILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG-DEKVLEQIEKQLHK   65 (76)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES-CHHHHHHHHHHHHH
T ss_pred             EEEEEEEECCCcHHHHHHHHHHhcCcceEEEEEcccCCCCeeEEEEEEEC-CHHHHHHHHHHHhC
Confidence            5578889999999999999999999999775553232 333323445555 44556666666654

>d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Nitrosomonas europaea [TaxId: 915]

Probab=92.98  E-value=0.18  Score=34.24  Aligned_cols=63  Identities=25%  Similarity=0.299  Sum_probs=46.8

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccc-cCCCceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~-t~~g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |-|.+-.-|+|+.|++++.+++.=|.||.--.+-. -.+|.+-=.++++|. .+..+++...|++
T Consensus         3 ~tisv~veN~pGvL~Ris~lF~rRg~NI~Sltv~~te~~~iSRmtivv~~~-~~~i~qi~kQL~K   66 (77)
T d2pc6a2           3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNGP-DEIVEQITKQLNK   66 (77)
T ss_dssp             EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEEC-HHHHHHHHHHHHH
T ss_pred             EEEEEEEECCccHHHHHHHHHhccCcceEEEEEeccCCCCeEEEEEEEECC-HHHHHHHHHHHhC
Confidence            67888899999999999999999999998765543 334555556676763 3556666666655

>d2fgca2 d.58.18.6 (A:27-104) Acetolactate synthase small subunit, IlvH {Thermotoga maritima [TaxId: 2336]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Thermotoga maritima [TaxId: 2336]

Probab=92.16  E-value=0.15  Score=34.78  Aligned_cols=63  Identities=25%  Similarity=0.361  Sum_probs=45.1

Q ss_pred             eeEEEEecCCcchHHHHHHHHhhcCCCceeecccccCC-CceeeeEEecCCCchhHHHHHHHHHH
Q 015965            2 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK   65 (397)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~~-g~~l~~~vvd~~~~~~~~~l~~~l~~   65 (397)
                      |-|.+-..|+|+.|++++.+++.=|.||.--.+--|-+ |.+==.++++| ..+..+++...+++
T Consensus         4 ~tisvlv~n~pGvL~Ri~~lF~rRg~NI~SL~v~~te~~~iSR~tivv~g-~~~~i~qi~kQl~K   67 (78)
T d2fgca2           4 HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKG-DDKTIEQIEKQAYK   67 (78)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHTTTCEEEEEEEEECSSTTEEEEEEEEEE-CTTHHHHHHHHHTT
T ss_pred             EEEEEEEeCCCcHHHHHHHHHhhCCcceEEEEEeecCCCCeEEEEEEEEc-CHHHHHHHHHHHhC
Confidence            66788899999999999999999999998766544433 33333456666 33556666665554

>d2qmwa2 d.58.18.3 (A:185-264) Prephenate dehydratase C-terminal domain {Staphylococcus aureus [TaxId: 1280]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phenylalanine metabolism regulatory domain
domain: Prephenate dehydratase C-terminal domain
species: Staphylococcus aureus [TaxId: 1280]

Probab=86.24  E-value=1.7  Score=29.37  Aligned_cols=35  Identities=20%  Similarity=0.238  Sum_probs=31.1

Q ss_pred             EEEEecCCcchHHHHHHHHhhcCCCceeecccccC
Q 015965            4 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV   38 (397)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~gl~i~~a~~f~t~   38 (397)
                      ++++..|+|+.|..+-+.+++-|+|++.-+.....
T Consensus         5 ~i~~~~d~pGaL~~vL~~F~~~~INLt~IeSRP~~   39 (80)
T d2qmwa2           5 LITPMHDKPGLLASVLNTFALFNINLSWIESRPLK   39 (80)
T ss_dssp             EEEESSCCTTHHHHHHHHHHTTTCCEEEEEEEECS
T ss_pred             EEEeCCCCCCHHHHHHHHHHHCCCCEEEEEeeecC
Confidence            56778899999999999999999999999887554